data_1xfq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xfq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.518 ' H ' ' HH ' ' A' ' 42' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.908 -0.077 . . . . 2.04 112.908 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -95.03 102.91 14.74 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.855 0.359 . . . . 1.26 111.697 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.726 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -119.69 140.41 43.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.886 0.374 . . . . 1.5 110.223 177.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.44 128.71 56.55 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.172 -0.677 . . . . 2.22 109.172 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 pp -129.95 158.05 40.62 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.415 0.626 . . . . 1.4 110.816 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -85.11 150.91 24.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.476 -0.784 . . . . 1.15 110.424 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.567 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -80.44 32.27 2.35 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.79 -0.641 . . . . 1.2 112.696 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 34' ' ' ASP . 30.5 t0 -126.24 -30.27 2.92 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.829 -0.434 . . . . 1.81 109.829 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.23 10.44 0.84 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.99 -1.1 . . . . 1.05 114.404 171.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -118.92 139.39 51.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 118.009 0.905 . . . . 1.79 111.998 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.491 HG21 HD12 ' A' ' 31' ' ' ILE . 43.5 mm -75.52 139.21 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.709 -0.678 . . . . 1.82 109.497 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 tp -106.95 -53.18 2.65 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.864 -0.335 . . . . 2.13 111.018 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -153.85 145.06 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.406 -0.518 . . . . 2.96 111.869 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.726 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 45.6 t80 -117.78 124.31 48.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.706 -0.679 . . . . 1.75 109.633 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 35.0 m-80 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.374 -0.376 . . . . 1.28 110.453 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.529 0 N-CA-C 111.133 -0.787 . . . . 3.32 111.133 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 60.9 32.36 20.02 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 123.913 0.42 . . . . 4.53 110.336 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.553 ' O ' HG23 ' A' ' 83' ' ' VAL . 67.4 t80 -50.21 -32.22 15.9 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.946 -0.57 . . . . 1.1 111.606 -177.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -69.81 -34.08 73.22 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 123.802 0.689 . . . . 3.89 109.698 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -84.18 -31.44 25.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.585 -0.734 . . . . 3.07 109.2 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.854 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -54.44 -41.15 71.49 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.371 -0.831 . . . . 0.61 111.972 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 79' ' ' PHE . 96.6 t -65.23 -53.49 39.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.405 -0.897 . . . . 1.36 110.942 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.43 -27.78 27.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.148 -0.478 . . . . 1.59 111.655 -170.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 t -66.57 -27.21 67.55 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.014 -0.736 . . . . 2.27 109.014 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.86 29.44 51.67 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.67 -0.695 . . . . 1.9 112.469 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -157.18 48.65 0.43 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.61 0.719 . . . . 2.08 111.519 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.854 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -74.82 79.71 2.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.4 -0.818 . . . . 1.22 111.198 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.3 p-10 -144.09 101.11 3.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.478 0.656 . . . . 2.15 109.528 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -147.42 147.8 30.62 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.806 -0.559 . . . . 2.03 110.535 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.605 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -109.32 115.55 30.19 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.046 -0.724 . . . . 4.31 109.046 169.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.515 ' HE2' ' HD2' ' A' ' 94' ' ' TYR . 84.1 t80 -132.17 126.97 34.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.804 -0.634 . . . . 2.95 109.97 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 9.7 pt-20 -97.23 130.63 44.43 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.481 -0.563 . . . . 1.97 109.481 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.515 ' HD2' ' HE2' ' A' ' 92' ' ' PHE . 27.4 t80 . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.636 -0.505 . . . . 4.56 109.636 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 80.4 tttt . . . . . 0 C--O 1.239 0.513 0 CA-C-O 120.483 0.183 . . . . 3.49 110.674 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.7 m -116.32 160.92 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.182 0.515 . . . . 1.72 111.353 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 85.8 tttt -125.03 123.98 40.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.31 -0.859 . . . . 2.83 109.184 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.1 t -101.74 119.42 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 116.45 -0.341 . . . . 1.64 110.34 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -106.79 104.33 13.98 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.22 -1.03 . . . . 1.35 108.22 168.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.535 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 55.0 mtm -97.5 145.57 26.08 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.276 -1.009 . . . . 2.72 108.276 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.507 ' CG ' ' HB2' ' A' ' 119' ' ' TRP . 19.4 ptpt -146.42 127.07 14.24 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.384 -0.527 . . . . 2.17 109.827 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.555 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 51.6 tttm -57.34 113.57 1.81 Allowed 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 116.064 -0.516 . . . . 2.33 109.906 170.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.44 138.93 38.9 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.701 -1.136 . . . . 1.12 110.485 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.5 mt -67.88 -8.58 37.69 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.245 -0.434 . . . . 2.97 110.918 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 m -70.94 -38.61 72.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 2.06 110.503 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.67 -105.76 0.34 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.73 -0.748 . . . . 1.52 112.81 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.29 65.05 7.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.597 0.713 . . . . 2.79 112.013 -175.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.567 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 1.7 p -157.67 157.97 34.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.922 -1.035 . . . . 0.95 108.506 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.555 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 28.9 m-85 -140.74 139.75 34.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.687 0.28 . . . . 0.98 110.603 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.507 ' HB2' ' CG ' ' A' ' 110' ' ' LYS . 38.9 m95 -93.09 162.48 14.02 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.288 0.566 . . . . 0.48 111.241 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.604 ' HB ' HG23 ' A' ' 31' ' ' ILE . 87.7 t -136.89 101.77 2.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.561 -1.199 . . . . 1.3 109.268 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -102.19 106.39 17.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.553 -0.536 . . . . 1.96 109.553 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 p -92.37 143.87 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.077 0.465 . . . . 2.21 110.244 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 56.6 tttp . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 109.677 -0.49 . . . . 3.87 109.677 -178.191 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.821 0 N-CA-C 112.208 -0.357 . . . . 2.04 112.208 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.42 102.38 3.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.95 0.405 . . . . 1.26 110.75 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.591 HG22 ' HB ' ' A' ' 120' ' ' VAL . 4.5 tt -132.02 141.07 46.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.927 0.394 . . . . 1.5 110.672 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.453 ' HB2' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -114.52 122.98 48.24 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.41 -0.959 . . . . 2.22 108.41 177.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.46 164.06 29.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.864 -0.607 . . . . 1.4 111.082 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.945 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 2.3 p30 -98.09 153.95 18.07 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.015 -0.539 . . . . 1.15 110.981 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.0 -17.03 75.22 Favored Glycine 0 CA--C 1.511 -0.17 0 CA-C-N 115.173 -0.921 . . . . 1.2 112.628 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.53 -38.98 92.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.97 0.414 . . . . 1.81 110.421 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.46 38.26 0.31 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.706 -0.759 . . . . 1.05 112.843 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.563 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 4.3 m-80 -134.25 147.96 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.976 -0.379 . . . . 1.79 109.976 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.7 mt -87.33 134.73 26.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.936 -0.394 . . . . 1.82 109.936 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.0 tp -101.56 -41.45 6.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 2.13 110.86 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -158.99 143.43 15.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.993 0.425 . . . . 2.96 111.204 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.452 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 40.9 t80 -114.34 114.86 26.47 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.601 -0.889 . . . . 1.75 108.601 174.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 121.168 0.509 . . . . 1.28 110.647 -173.756 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.525 ' HA3' ' HE2' ' A' ' 109' ' ' MET . . . . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 110.177 -1.169 . . . . 3.32 110.177 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm 67.12 31.65 6.65 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 123.987 0.463 . . . . 4.53 110.293 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.688 ' HA ' HD12 ' A' ' 88' ' ' LEU . 65.5 t80 -47.9 -36.86 12.94 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 112.245 0.461 . . . . 1.1 112.245 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.39 -39.64 74.42 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.418 0.627 . . . . 3.89 109.963 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.08 -29.02 48.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.158 -0.928 . . . . 3.07 108.917 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.819 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.82 -41.27 97.57 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.451 -0.795 . . . . 0.61 111.516 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.755 ' HA ' ' HH ' ' A' ' 118' ' ' TYR . 95.4 t -64.94 -51.83 61.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.431 -0.884 . . . . 1.36 110.674 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.64 -24.69 49.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.062 -0.517 . . . . 1.59 111.05 -172.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -65.21 -34.52 78.56 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.548 -0.908 . . . . 2.27 108.548 172.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.73 15.57 61.32 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.25 -0.886 . . . . 1.9 112.301 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -164.0 54.63 0.15 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.328 0.585 . . . . 2.08 111.838 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.819 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -65.37 96.11 0.22 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.519 -0.764 . . . . 1.22 111.547 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.6 p30 -145.05 108.53 4.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.32 0.581 . . . . 2.15 110.283 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -142.2 162.42 35.53 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.098 -0.501 . . . . 2.03 111.411 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.713 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 25.8 ptt? -151.5 116.08 5.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.815 0.816 . . . . 4.31 110.285 169.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -149.89 144.32 25.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.949 -1.023 . . . . 2.95 109.057 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.579 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 25.8 mt-10 -95.35 116.44 28.78 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.189 -0.671 . . . . 1.97 109.189 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 68.2 t80 . . . . . 0 N--CA 1.446 -0.63 0 CA-C-N 115.647 -0.706 . . . . 4.56 110.296 -172.415 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.723 -0.473 . . . . 3.49 109.723 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.52 160.72 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.125 0.488 . . . . 1.72 110.824 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 13.9 ttmm -116.86 124.17 48.85 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.64 -0.874 . . . . 2.83 108.64 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 91' ' ' MET . 1.1 m -109.32 104.32 16.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.167 0.508 . . . . 1.64 111.494 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 15.0 t-160 -109.84 105.1 14.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.723 -0.843 . . . . 1.35 108.723 172.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.525 ' HE2' ' HA3' ' A' ' 77' ' ' GLY . 53.6 mtm -117.86 144.31 45.52 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.815 -0.809 . . . . 2.72 108.815 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -149.34 129.67 13.77 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.142 -0.623 . . . . 2.17 110.187 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.422 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 75.5 tttt -56.85 114.91 2.29 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.787 -0.642 . . . . 2.33 110.366 174.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.543 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -62.62 145.81 53.59 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.792 -1.095 . . . . 1.12 110.251 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -67.07 1.27 2.08 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.305 0.483 . . . . 2.97 112.305 -177.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.6 t -91.6 6.24 46.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.799 0.333 . . . . 2.06 110.95 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -108.12 3.64 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.633 -0.794 . . . . 1.52 112.035 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.93 87.23 2.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.371 0.605 . . . . 2.79 110.628 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.945 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.3 p 179.25 151.32 0.34 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.824 -1.08 . . . . 0.95 109.169 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.755 ' HH ' ' HA ' ' A' ' 83' ' ' VAL . 22.6 m-85 -147.11 136.45 22.66 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.549 -0.537 . . . . 0.98 109.549 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.453 ' CD2' ' HB2' ' A' ' 32' ' ' GLN . 45.2 m95 -86.33 159.3 19.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.07 0.462 . . . . 0.48 110.481 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 31' ' ' ILE . 72.1 t -138.21 104.31 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.108 -0.951 . . . . 1.3 109.964 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.634 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 71.5 m-85 -110.4 116.75 31.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.0 -0.741 . . . . 1.96 109.0 175.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 18.1 m -115.79 154.62 17.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.551 0.691 . . . . 2.21 111.355 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.457 ' HE2' ' HE2' ' A' ' 106' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 115.066 -0.97 . . . . 3.87 109.077 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.473 0 N-CA-C 112.375 -0.29 . . . . 2.04 112.375 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.81 105.17 4.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.625 0.25 . . . . 1.26 110.537 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.72 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 6.3 tt -133.52 140.37 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.196 0.522 . . . . 1.5 111.097 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.564 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 3.2 pt20 -109.66 129.79 55.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.6 -0.727 . . . . 2.22 110.548 176.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.29 159.03 36.53 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.513 -0.767 . . . . 1.4 109.915 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.579 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 37.2 p30 -84.5 164.66 18.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.373 0.606 . . . . 1.15 111.439 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.53 21.13 3.84 Favored Glycine 0 C--N 1.322 -0.249 0 CA-C-N 115.257 -0.883 . . . . 1.2 112.441 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 34' ' ' ASP . 1.1 m-20 -112.08 -26.55 8.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.804 0.335 . . . . 1.81 110.329 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.45 11.61 7.22 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.907 -0.588 . . . . 1.05 111.86 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -109.53 143.59 38.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.892 0.377 . . . . 1.79 110.421 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.459 HG22 HD11 ' A' ' 31' ' ' ILE . 51.2 mm -79.9 139.41 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.227 -0.657 . . . . 1.82 109.227 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.3 tp -106.72 -52.31 2.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.628 -0.26 . . . . 2.13 111.095 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -163.19 147.14 10.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 2.96 111.336 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.72 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 49.0 t80 -114.27 151.23 33.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.01 -0.541 . . . . 1.75 110.118 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.961 -0.563 . . . . 1.28 110.22 -179.58 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.825 0 N-CA-C 111.303 -0.719 . . . . 3.32 111.303 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 62.03 37.93 14.46 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.654 0.382 . . . . 4.53 110.268 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.69 ' HD2' ' HE1' ' A' ' 109' ' ' MET . 69.6 t80 -47.34 -32.37 4.76 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.352 0.661 . . . . 1.1 112.247 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -62.46 -44.02 97.42 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 123.933 0.771 . . . . 3.89 110.291 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.11 -22.99 22.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.149 -0.478 . . . . 3.07 109.756 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.929 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.27 -38.03 92.7 Favored Glycine 0 N--CA 1.436 -1.3 0 CA-C-N 115.776 -0.647 . . . . 0.61 112.323 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 79' ' ' PHE . 69.2 t -69.81 -48.61 63.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.93 -0.635 . . . . 1.36 110.411 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.5 -23.74 42.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.423 -0.808 . . . . 1.59 111.352 -170.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.6 p -67.62 -28.41 67.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.494 0.664 . . . . 2.27 109.219 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.16 19.5 62.59 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.356 -0.838 . . . . 1.9 111.839 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -162.85 55.75 0.2 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.359 0.6 . . . . 2.08 111.225 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.929 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -69.07 83.61 0.33 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.553 -0.749 . . . . 1.22 111.326 176.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.9 p-10 -144.86 99.04 3.28 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.455 0.645 . . . . 2.15 109.789 171.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.425 HG23 ' N ' ' A' ' 91' ' ' MET . 11.9 m -146.31 152.52 39.27 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.136 -0.484 . . . . 2.03 110.333 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.425 ' N ' HG23 ' A' ' 90' ' ' THR . 16.8 ptt? -123.22 129.26 51.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.93 0.395 . . . . 4.31 110.323 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -150.66 142.96 24.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.806 -0.634 . . . . 2.95 109.759 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.61 117.1 29.83 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.663 -0.495 . . . . 1.97 109.663 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 108.685 -0.857 . . . . 4.56 108.685 -175.385 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.1 tttt . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 107.959 -1.126 . . . . 3.49 107.959 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -126.03 163.66 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.182 0.515 . . . . 1.72 110.867 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 22.1 ptmt -135.31 140.33 45.03 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.412 -0.813 . . . . 2.83 109.03 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.75 142.02 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-O 121.679 0.752 . . . . 1.64 112.157 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 18.5 t-160 -131.71 104.67 7.04 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.004 -1.48 . . . . 1.35 107.004 164.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.69 ' HE1' ' HD2' ' A' ' 79' ' ' PHE . 79.7 mtp -105.98 148.13 28.05 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.826 -0.805 . . . . 2.72 108.826 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.8 ptmm? -152.59 134.43 14.74 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.893 -0.723 . . . . 2.17 109.671 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.467 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 18.5 ttmm -56.95 115.35 2.55 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.409 0.623 . . . . 2.33 109.726 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.54 138.02 58.35 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.659 -1.155 . . . . 1.12 110.866 -172.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.52 -8.66 55.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.185 0.517 . . . . 2.97 109.974 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.2 m -65.41 -35.92 82.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.487 -0.779 . . . . 2.06 110.089 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.09 139.68 9.36 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.825 -0.625 . . . . 1.52 112.335 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.53 44.75 17.2 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.42 0.688 . . . . 2.79 112.091 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 2.9 p -158.98 157.16 30.77 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.249 -0.887 . . . . 0.95 110.383 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.467 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 39.8 m-85 -139.29 137.21 35.65 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.443 -0.577 . . . . 0.98 109.443 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.564 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 39.8 m95 -84.05 161.7 20.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.278 0.561 . . . . 0.48 111.27 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.576 HG23 ' HE2' ' A' ' 109' ' ' MET . 59.3 t -137.77 95.82 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.426 -1.261 . . . . 1.3 108.93 175.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 89.6 m-85 -90.31 101.55 14.27 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.414 -0.958 . . . . 1.96 108.414 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 7.1 p -116.97 134.02 61.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.81 0.338 . . . . 2.21 110.478 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.824 -0.436 . . . . 3.87 109.824 -176.406 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 C--O 1.226 -0.382 0 CA-C-O 120.374 -0.125 . . . . 2.04 112.945 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.14 102.9 14.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.997 0.427 . . . . 1.26 111.755 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.689 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -128.49 139.73 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.954 0.407 . . . . 1.5 110.025 175.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.584 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.3 pt20 -112.81 134.67 54.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.471 0.653 . . . . 2.22 111.416 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.62 161.84 23.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.149 -0.932 . . . . 1.4 110.019 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 36' ' ' ASP . 3.5 p30 -90.87 153.99 19.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.261 0.553 . . . . 1.15 110.77 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -79.07 28.23 2.25 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.591 -0.731 . . . . 1.2 111.381 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 34' ' ' ASP . 31.9 t70 -111.41 -35.34 5.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.803 -0.698 . . . . 1.81 109.402 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.42 22.45 1.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.803 -0.713 . . . . 1.05 112.992 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -135.31 153.47 51.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.085 0.469 . . . . 1.79 110.533 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.504 HG21 HD13 ' A' ' 31' ' ' ILE . 48.2 mm -76.16 141.61 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.188 -0.671 . . . . 1.82 109.188 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.443 HD21 ' NE2' ' A' ' 32' ' ' GLN . 32.8 tp -107.34 -52.29 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.915 -0.314 . . . . 2.13 110.963 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -160.93 140.84 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.702 -0.399 . . . . 2.96 111.72 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.689 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 76.8 t80 -104.41 139.03 39.94 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.769 -0.826 . . . . 1.75 108.769 171.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 . . . . . 0 C--N 1.319 -0.73 0 N-CA-C 110.001 -0.37 . . . . 1.28 110.001 -179.785 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 110.833 -0.907 . . . . 3.32 110.833 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 58.98 41.06 21.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.597 0.713 . . . . 4.53 109.376 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.475 ' O ' HG22 ' A' ' 83' ' ' VAL . 57.4 t80 -56.81 -36.25 69.7 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.628 -1.169 . . . . 1.1 111.259 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -59.49 -36.71 76.57 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 123.85 0.718 . . . . 3.89 110.52 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -86.07 -37.91 18.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.812 -0.631 . . . . 3.07 109.863 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.969 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.39 -43.58 89.99 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.721 -0.672 . . . . 0.61 112.015 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 79' ' ' PHE . 90.7 t -73.05 -50.63 30.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.508 -0.846 . . . . 1.36 111.211 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.79 -32.29 59.83 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.215 -0.448 . . . . 1.59 111.239 -169.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.6 m -72.55 -23.23 60.95 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.424 -0.584 . . . . 2.27 109.424 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 34.06 38.06 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.714 -0.675 . . . . 1.9 111.999 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -158.89 50.19 0.36 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.565 0.698 . . . . 2.08 112.005 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.969 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -73.76 88.31 1.75 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.763 -0.653 . . . . 1.22 111.45 177.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.0 p30 -143.26 101.52 3.82 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.525 -0.546 . . . . 2.15 109.525 175.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.0 t -168.47 163.36 12.56 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.13 0.49 . . . . 2.03 110.924 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.2 ptt? -104.4 136.28 44.27 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.411 -0.813 . . . . 4.31 110.014 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.439 ' O ' HG22 ' A' ' 107' ' ' VAL . 77.3 t80 -147.15 127.78 14.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.58 -0.736 . . . . 2.95 109.22 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 8.1 pt-20 -95.43 132.71 40.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.43 0.633 . . . . 1.97 110.804 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.9 t80 . . . . . 0 N--CA 1.446 -0.659 0 CA-C-N 114.76 -1.109 . . . . 4.56 108.777 -173.217 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 tttm . . . . . 0 C--O 1.236 0.354 0 CA-C-O 120.832 0.349 . . . . 3.49 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.2 m -114.74 167.87 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-N 115.548 -0.751 . . . . 1.72 110.141 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 19.8 ptmt -144.07 147.38 33.71 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.671 -0.412 . . . . 2.83 110.414 174.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.707 HG11 HG11 ' A' ' 122' ' ' VAL . 14.2 m -100.54 144.24 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-N 115.781 -0.645 . . . . 1.64 111.359 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -119.97 102.87 8.85 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.411 -1.7 . . . . 1.35 106.411 160.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.542 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 64.0 mtt -102.98 146.36 28.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.777 -0.823 . . . . 2.72 108.777 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 61.5 pttt -151.12 128.85 11.56 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.874 -0.73 . . . . 2.17 110.187 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 86.3 tttt -57.09 110.03 0.76 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.769 -0.65 . . . . 2.33 109.45 168.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.93 129.34 17.16 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.783 -1.099 . . . . 1.12 109.782 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.17 -5.92 20.62 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.225 0.328 . . . . 2.97 111.747 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -73.4 -43.13 61.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.817 0.342 . . . . 2.06 110.219 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.22 138.31 3.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.379 -0.915 . . . . 1.52 113.488 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.74 52.65 4.04 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.186 0.994 . . . . 2.79 113.374 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.512 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.1 p -158.92 156.21 29.1 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.56 -1.274 . . . . 0.95 107.56 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.4 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 41.9 m-85 -137.38 136.2 37.67 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.645 -0.422 . . . . 0.98 111.18 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.584 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 49.2 m95 -91.5 161.98 14.74 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.406 0.622 . . . . 0.48 111.824 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.52 97.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.39 -1.277 . . . . 1.3 109.226 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 66.3 m-85 -98.27 112.47 24.45 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.188 -0.671 . . . . 1.96 109.188 174.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.707 HG11 HG11 ' A' ' 107' ' ' VAL . 31.1 m -110.78 150.13 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.255 0.465 . . . . 2.21 112.255 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 pttt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 3.87 110.366 175.176 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 C--O 1.221 -0.68 0 CA-C-O 119.917 -0.379 . . . . 2.04 113.489 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -109.3 105.22 14.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.767 0.784 . . . . 1.26 110.828 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.621 HD13 HD11 ' A' ' 39' ' ' ILE . 4.3 tt -138.35 141.69 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.425 -0.352 . . . . 1.5 110.767 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.45 ' OE1' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -114.06 130.01 56.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.022 0.439 . . . . 2.22 109.842 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.7 pp -132.75 159.76 38.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.354 0.597 . . . . 1.4 111.366 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.6 p30 -76.99 157.83 30.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 1.15 110.782 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -77.76 30.98 1.73 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.361 -0.836 . . . . 1.2 112.675 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 34' ' ' ASP . 1.7 t0 -122.42 -31.94 3.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.211 0.529 . . . . 1.81 109.756 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.04 21.18 1.24 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.459 -0.877 . . . . 1.05 112.898 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.478 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 16.2 m-80 -125.27 156.49 38.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.045 0.45 . . . . 1.79 110.196 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.621 HD11 HD13 ' A' ' 31' ' ' ILE . 41.1 mm -81.53 142.75 13.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.965 -0.561 . . . . 1.82 109.999 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 HD13 ' OE1' ' A' ' 32' ' ' GLN . 89.1 mt -109.31 -53.23 2.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.395 -0.595 . . . . 2.13 109.395 172.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -133.81 117.27 16.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.579 -0.737 . . . . 2.96 110.656 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.558 ' HA ' HG13 ' A' ' 31' ' ' ILE . 18.5 t80 -106.01 117.93 35.31 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.277 -0.638 . . . . 1.75 109.277 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 84.6 m-20 . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 120.991 0.424 . . . . 1.28 110.529 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 111.728 -0.549 . . . . 3.32 111.728 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 58.28 41.07 23.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.376 0.608 . . . . 4.53 109.676 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.541 ' O ' HG21 ' A' ' 83' ' ' VAL . 56.0 t80 -56.24 -27.67 55.79 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.31 -0.859 . . . . 1.1 111.789 -171.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.86 -33.95 72.95 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 123.855 0.722 . . . . 3.89 110.277 -175.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -86.87 -29.07 22.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.765 -0.652 . . . . 3.07 109.531 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.711 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.25 -39.27 92.26 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 111.83 -0.508 . . . . 0.61 111.83 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.541 HG21 ' O ' ' A' ' 79' ' ' PHE . 95.2 t -66.86 -48.12 80.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.979 -0.61 . . . . 1.36 110.547 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.41 -26.61 51.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 1.59 111.206 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -60.1 -28.56 67.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.562 -0.533 . . . . 2.27 109.562 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.11 -10.26 47.37 Favored Glycine 0 CA--C 1.505 -0.551 0 C-N-CA 120.728 -0.749 . . . . 1.9 113.048 169.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -169.96 62.61 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.324 0.583 . . . . 2.08 110.145 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.711 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 2.9 tt -38.45 102.35 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 114.728 -1.123 . . . . 1.22 111.802 175.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 4.1 p30 -145.74 102.24 3.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.1 0.476 . . . . 2.15 109.822 176.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 2.5 p -138.8 154.34 48.47 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.924 -0.485 . . . . 2.03 111.764 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.24 138.1 36.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.768 -0.651 . . . . 4.31 109.76 171.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -163.3 140.37 7.41 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.377 -0.601 . . . . 2.95 109.377 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 39.2 mt-10 -91.74 110.78 22.13 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.356 -0.609 . . . . 1.97 109.356 177.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.5 t80 . . . . . 0 N--CA 1.45 -0.474 0 CA-C-N 115.649 -0.705 . . . . 4.56 110.872 -171.269 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 N--CA 1.444 -0.764 0 CA-C-O 120.755 0.312 . . . . 3.49 110.375 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.9 163.85 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.978 -0.556 . . . . 1.72 109.528 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 59.1 pttt -126.17 140.05 52.86 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.047 -0.723 . . . . 2.83 109.047 173.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.513 HG13 HG11 ' A' ' 122' ' ' VAL . 7.9 m -100.65 143.5 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 CA-C-O 121.144 0.497 . . . . 1.64 110.903 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 90' ' ' THR . 17.8 t-160 -143.85 102.73 3.95 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.656 -1.238 . . . . 1.35 107.656 164.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.55 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.1 OUTLIER -115.63 125.23 52.64 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.925 -1.139 . . . . 2.72 107.925 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.9 ptmm? -145.18 146.96 31.96 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.742 -0.783 . . . . 2.17 110.604 -171.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.51 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 13.1 ttpp -56.82 123.79 16.26 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.217 -0.901 . . . . 2.33 111.265 176.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.66 148.41 51.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.674 -1.148 . . . . 1.12 110.716 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.51 -4.1 37.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.091 0.472 . . . . 2.97 110.883 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -79.88 -21.91 43.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 2.06 110.933 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 139.16 -128.1 3.91 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.487 -0.864 . . . . 1.52 112.739 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.66 77.24 5.14 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.988 0.899 . . . . 2.79 110.76 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.443 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.9 p -162.94 157.14 20.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.267 -1.333 . . . . 0.95 108.194 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 25.1 m-85 -138.65 141.28 39.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.864 0.364 . . . . 0.98 110.608 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -87.98 165.75 14.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.145 0.498 . . . . 0.48 110.573 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.453 ' HB ' HG22 ' A' ' 31' ' ' ILE . 58.1 t -135.42 98.56 2.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.643 -1.162 . . . . 1.3 108.774 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 83.2 m-85 -103.86 119.96 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.372 -0.603 . . . . 1.96 109.372 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 107' ' ' VAL . 23.8 m -124.28 155.16 31.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.714 -0.476 . . . . 2.21 109.714 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt . . . . . 0 C--N 1.32 -0.683 0 C-N-CA 120.816 -0.353 . . . . 3.87 110.206 174.799 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 C--O 1.226 -0.358 0 CA-C-O 120.445 -0.086 . . . . 2.04 113.239 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 43' ' ' ASN . . . -107.49 118.73 37.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.139 0.495 . . . . 1.26 111.57 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.508 HG22 ' HB ' ' A' ' 120' ' ' VAL . 5.5 tt -136.19 141.01 42.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.222 -0.444 . . . . 1.5 110.121 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.51 ' HB2' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -115.37 125.08 52.77 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.5 -0.926 . . . . 2.22 108.5 179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.48 154.31 46.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.605 0.717 . . . . 1.4 111.456 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -73.71 146.61 44.29 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.025 -0.989 . . . . 1.15 110.045 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.558 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -82.09 36.28 2.55 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.804 -0.635 . . . . 1.2 112.961 -173.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -134.51 -24.97 1.52 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.854 0.359 . . . . 1.81 110.1 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.09 -4.28 2.6 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.099 -0.572 . . . . 1.05 112.494 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -90.78 149.76 21.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.511 0.196 . . . . 1.79 110.792 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.7 mm -92.8 140.06 16.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.822 -0.807 . . . . 1.82 108.822 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HG ' ' HG3' ' A' ' 41' ' ' GLN . 38.3 tp -113.28 -57.34 2.3 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.348 -0.541 . . . . 2.13 111.351 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 45.1 mt-30 -144.16 150.38 37.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.016 0.436 . . . . 2.96 111.405 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.45 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 55.9 t80 -127.04 117.78 23.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.956 -0.565 . . . . 1.75 109.551 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 109.83 -0.433 . . . . 1.28 109.83 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.689 0 N-CA-C 112.017 -0.433 . . . . 3.32 112.017 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 58.48 44.12 18.48 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 122.686 0.395 . . . . 4.53 110.538 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.58 ' O ' HG21 ' A' ' 83' ' ' VAL . 64.5 t80 -46.08 -43.0 14.29 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 113.456 0.91 . . . . 1.1 113.456 -167.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -79.64 -29.88 41.14 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 121.279 0.561 . . . . 3.89 110.155 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.53 -34.31 62.98 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.218 -1.03 . . . . 3.07 108.218 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.97 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.86 -40.08 89.29 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.732 -1.122 . . . . 0.61 111.395 175.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 79' ' ' PHE . 95.5 t -68.38 -54.27 22.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.378 -0.911 . . . . 1.36 111.046 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.15 -22.6 33.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 1.59 111.644 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.9 t -70.63 -29.51 65.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.483 -0.932 . . . . 2.27 108.483 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.24 23.23 49.12 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.53 -0.759 . . . . 1.9 112.169 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -156.04 52.59 0.56 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.45 0.643 . . . . 2.08 111.501 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.97 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.9 OUTLIER -74.37 73.72 1.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.603 -0.726 . . . . 1.22 111.083 175.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.9 t30 -143.16 99.29 3.42 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.572 -0.899 . . . . 2.15 108.572 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.4 m -140.26 146.36 38.5 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.017 -0.538 . . . . 2.03 110.41 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 16.4 ptt? -126.73 129.72 48.94 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.586 -0.524 . . . . 4.31 109.586 172.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -157.85 142.88 16.68 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.517 -0.549 . . . . 2.95 109.517 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -92.6 105.54 17.68 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 1.97 109.412 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 63.8 t80 . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.245 -0.889 . . . . 4.56 110.989 -170.259 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.1 tttp . . . . . 0 CA--C 1.512 -0.491 0 N-CA-C 109.422 -0.585 . . . . 3.49 109.422 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 22.9 m -123.27 160.24 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.27 0.557 . . . . 1.72 110.733 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -117.91 118.53 32.24 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.291 -1.003 . . . . 2.83 108.291 171.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.677 HG11 HG12 ' A' ' 122' ' ' VAL . 6.3 m -99.25 144.22 12.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.438 0.637 . . . . 1.64 111.606 -176.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 91' ' ' MET . 13.9 t-80 -137.74 103.51 5.03 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.665 -1.152 . . . . 1.35 108.162 164.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 3.5 mpp? -98.94 140.03 33.72 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 106.798 -1.556 . . . . 2.72 106.798 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.816 ' HG3' ' HB2' ' A' ' 119' ' ' TRP . 9.3 ptpt -141.02 125.27 17.44 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.701 -0.8 . . . . 2.17 110.09 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.668 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 82.7 tttt -57.72 106.79 0.38 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.976 -0.75 . . . . 2.33 108.976 170.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.37 127.86 20.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.929 -1.032 . . . . 1.12 110.323 -173.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.24 -7.12 33.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.267 0.556 . . . . 2.97 109.895 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.1 m -71.28 -26.1 62.73 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.164 -0.925 . . . . 2.06 110.043 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.44 145.02 18.32 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.174 -0.536 . . . . 1.52 112.973 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 55.75 38.27 29.89 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.511 0.672 . . . . 2.79 112.24 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.558 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 4.8 p -166.7 159.93 14.4 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.165 -0.925 . . . . 0.95 109.937 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.668 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 36.5 m-85 -140.48 139.57 35.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.048 -0.353 . . . . 0.98 110.048 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.816 ' HB2' ' HG3' ' A' ' 110' ' ' LYS . 41.1 m95 -92.53 162.49 14.18 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.19 0.519 . . . . 0.48 110.658 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.508 ' HB ' HG22 ' A' ' 31' ' ' ILE . 77.5 t -136.16 105.88 5.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.762 -1.108 . . . . 1.3 109.583 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 29.3 m-85 -109.45 123.05 48.72 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.767 -0.457 . . . . 1.96 109.767 175.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.677 HG12 HG11 ' A' ' 107' ' ' VAL . 30.0 m -118.93 157.92 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.124 0.488 . . . . 2.21 111.527 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 43.8 tttm . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.546 -0.752 . . . . 3.87 110.008 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.435 0 N-CA-C 111.532 -0.627 . . . . 2.04 111.532 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.17 107.74 13.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.982 -0.377 . . . . 1.26 109.982 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.659 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -131.04 139.45 51.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.824 0.345 . . . . 1.5 110.783 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.498 HE21 HD23 ' A' ' 40' ' ' LEU . 10.6 pt20 -105.22 114.5 28.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.633 0.73 . . . . 2.22 110.395 176.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.59 168.45 11.74 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.879 -1.055 . . . . 1.4 109.293 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 3.1 p30 -102.19 157.55 16.81 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.95 -0.7 . . . . 1.15 110.888 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -77.37 14.04 9.66 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.38 -0.827 . . . . 1.2 111.73 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 34' ' ' ASP . 23.3 m-20 -100.83 -12.57 18.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.27 0.557 . . . . 1.81 109.77 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.39 9.31 25.67 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.616 -0.72 . . . . 1.05 112.985 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -109.07 143.53 38.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.065 0.46 . . . . 1.79 110.944 -178.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.536 HG22 HD13 ' A' ' 31' ' ' ILE . 47.7 mm -94.09 126.63 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.141 -0.688 . . . . 1.82 109.141 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.498 HD23 HE21 ' A' ' 32' ' ' GLN . 17.9 tp -99.56 -49.49 4.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.851 -0.34 . . . . 2.13 110.996 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.565 ' O ' HG12 ' A' ' 31' ' ' ILE . 33.3 tt0 -157.6 142.94 17.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.813 0.34 . . . . 2.96 111.292 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.659 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 79.0 t80 -124.68 133.87 53.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.995 -0.548 . . . . 1.75 109.844 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 109.142 -0.688 . . . . 1.28 109.142 174.713 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.681 0 N-CA-C 110.511 -1.036 . . . . 3.32 110.511 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm 59.86 69.22 0.72 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.2 0.524 . . . . 4.53 109.701 -170.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.496 ' O ' HG22 ' A' ' 83' ' ' VAL . 74.8 t80 -53.46 -40.42 65.24 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.14 -0.936 . . . . 1.1 111.848 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -62.46 -30.82 71.52 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 123.679 0.612 . . . . 3.89 110.653 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -80.03 -35.24 37.51 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.085 -0.709 . . . . 3.07 109.085 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.938 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -62.08 -42.72 99.74 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.513 -0.767 . . . . 0.61 111.695 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 79' ' ' PHE . 84.1 t -65.81 -51.24 64.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.753 -0.724 . . . . 1.36 110.682 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.37 -21.65 55.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 1.59 110.853 -172.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.8 t -65.87 -35.61 81.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.899 -0.591 . . . . 2.27 109.431 171.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.94 15.28 63.25 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.335 -0.706 . . . . 1.9 111.335 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.714 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 3.0 p30 -166.02 62.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.785 0.802 . . . . 2.08 110.833 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.938 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.2 tt -68.86 98.24 0.91 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.048 -0.978 . . . . 1.22 110.603 172.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.635 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.0 p-10 -143.25 101.35 3.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.265 -0.574 . . . . 2.15 110.867 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.9 t -154.97 162.47 41.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.946 0.403 . . . . 2.03 110.608 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -130.0 116.05 18.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.694 -0.684 . . . . 4.31 109.877 175.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -126.68 134.13 50.78 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.015 -0.735 . . . . 2.95 109.015 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.693 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 7.1 pt-20 -106.13 117.27 33.59 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.908 -0.717 . . . . 1.97 110.361 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.8 t80 . . . . . 0 N--CA 1.447 -0.624 0 CA-C-N 114.763 -1.108 . . . . 4.56 109.873 -173.599 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.6 tttm . . . . . 0 C--O 1.235 0.319 0 N-CA-C 109.946 -0.39 . . . . 3.49 109.946 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.0 m -121.22 161.98 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.131 0.491 . . . . 1.72 111.803 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.693 ' HG2' ' HB3' ' A' ' 93' ' ' GLU . 47.0 mttm -108.5 138.28 45.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.525 -0.761 . . . . 2.83 109.638 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -107.87 102.54 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.8 -0.444 . . . . 1.64 109.8 167.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.759 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 8.3 t-160 -96.18 101.95 13.67 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.838 -1.542 . . . . 1.35 106.838 168.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.635 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 8.8 ttt -111.64 113.58 26.06 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.715 -1.216 . . . . 2.72 107.715 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 18.4 ptpt -129.59 132.14 46.69 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.3 -0.56 . . . . 2.17 110.564 -168.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.714 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 81.2 tttt -56.88 117.88 4.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 109.03 -0.73 . . . . 2.33 109.03 167.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -45.46 142.72 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.185 0.928 . . . . 1.12 110.767 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.8 tp -63.94 -25.83 68.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.202 -0.454 . . . . 2.97 110.691 -173.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.0 m -81.71 -50.81 8.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.961 -0.563 . . . . 2.06 109.811 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 128.31 -179.92 16.27 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.977 -0.63 . . . . 1.52 112.756 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.0 t70 61.64 31.6 18.66 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.944 0.878 . . . . 2.79 111.475 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.9 p 179.98 156.5 0.64 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.582 -1.19 . . . . 0.95 110.415 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.465 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 43.6 m-85 -136.17 134.74 38.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.469 -0.567 . . . . 0.98 109.469 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.539 ' O ' ' HG3' ' A' ' 109' ' ' MET . 47.3 m95 -86.52 163.87 17.25 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.291 0.567 . . . . 0.48 112.026 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.518 HG22 ' HE1' ' A' ' 109' ' ' MET . 60.0 t -132.12 97.42 2.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.387 -1.279 . . . . 1.3 109.037 174.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.759 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 58.3 m-85 -98.81 105.49 17.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.797 -0.446 . . . . 1.96 109.797 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 17.9 m -110.99 135.6 49.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.07 0.462 . . . . 2.21 111.482 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.607 -0.724 . . . . 3.87 109.288 178.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 112.174 -0.37 . . . . 2.04 112.174 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.82 109.64 18.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.449 0.642 . . . . 1.26 111.413 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.576 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 4.7 tt -138.57 140.38 39.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.857 -0.611 . . . . 1.5 110.051 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.675 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 2.8 pt20 -114.74 143.4 45.12 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.447 0.641 . . . . 2.22 110.712 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.532 ' HB3' HD11 ' A' ' 39' ' ' ILE . 3.0 pp -124.08 157.34 34.78 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.05 -0.977 . . . . 1.4 109.504 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.785 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.5 p30 -79.82 158.56 26.77 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.254 0.55 . . . . 1.15 110.439 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.42 21.1 3.05 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.594 -0.73 . . . . 1.2 111.884 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 34' ' ' ASP . 23.8 t70 -106.06 -32.37 8.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.342 -0.614 . . . . 1.81 109.342 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.67 11.16 3.03 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.417 -0.81 . . . . 1.05 112.485 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -118.78 155.89 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.687 -0.486 . . . . 1.79 109.687 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.532 HD11 ' HB3' ' A' ' 33' ' ' LEU . 43.4 mm -70.5 136.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.967 -0.753 . . . . 1.82 108.967 174.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.785 HD23 ' HB3' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -102.17 -65.24 1.0 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.023 -0.732 . . . . 2.13 109.023 -173.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -145.25 134.88 23.37 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.318 -0.855 . . . . 2.96 111.127 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.576 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 52.1 t80 -113.1 119.52 38.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.614 . . . . 1.75 109.941 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.53 0.681 . . . . 1.28 110.766 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.776 0 N-CA-C 110.065 -1.214 . . . . 3.32 110.065 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -130.43 61.29 1.6 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.857 -1.164 . . . . 4.53 107.857 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.579 ' HA ' HD13 ' A' ' 88' ' ' LEU . 36.2 t80 -86.54 -37.75 17.87 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 116.352 -0.386 . . . . 1.1 111.039 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HB2' ' HZ1' ' A' ' 80' ' ' LYS . 10.6 mtmp? -67.81 -32.04 72.32 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.383 -0.969 . . . . 3.89 108.383 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -82.49 -39.12 22.91 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.776 -1.556 . . . . 3.07 108.987 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.568 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -54.79 -38.11 63.63 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.13 -0.941 . . . . 0.61 112.364 -174.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 79' ' ' PHE . 61.8 t -69.19 -51.04 47.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.582 -0.809 . . . . 1.36 110.786 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.89 -23.43 23.95 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.173 -0.467 . . . . 1.59 112.253 -169.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.4 p -73.93 -33.3 63.89 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.828 -1.175 . . . . 2.27 107.828 172.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.88 19.2 65.95 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.082 -0.963 . . . . 1.9 111.13 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -153.78 52.3 0.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.554 0.693 . . . . 2.08 112.084 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.579 HD13 ' HA ' ' A' ' 79' ' ' PHE . 1.0 OUTLIER -67.24 86.45 0.16 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.53 -0.759 . . . . 1.22 111.24 174.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.708 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.6 p30 -144.25 100.67 3.59 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.337 0.589 . . . . 2.15 109.768 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.538 ' HG1' ' C ' ' A' ' 89' ' ' ASN . 32.8 m -148.76 146.99 28.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.88 -0.513 . . . . 2.03 109.992 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.405 ' N ' HG22 ' A' ' 90' ' ' THR . 17.9 ptm -98.76 114.86 27.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.613 -0.884 . . . . 4.31 108.613 167.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -121.73 129.67 52.88 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.373 -0.83 . . . . 2.95 109.418 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.523 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 22.3 mp0 -90.58 118.94 30.43 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.477 -0.934 . . . . 1.97 108.477 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.77 -0.65 . . . . 4.56 109.486 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.523 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 37.0 ttpt . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 110.018 -0.364 . . . . 3.49 110.018 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.3 m -102.15 161.92 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.298 0.57 . . . . 1.72 110.929 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 39.1 ttmt -116.37 126.72 53.88 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.241 -0.891 . . . . 2.83 109.494 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.64 103.7 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.865 -0.607 . . . . 1.64 109.411 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.935 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 5.7 t-160 -90.08 101.07 13.79 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.169 -1.789 . . . . 1.35 106.169 167.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.708 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.5 OUTLIER -102.2 120.46 40.49 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.294 -1.372 . . . . 2.72 107.294 -178.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -135.79 119.36 17.02 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.943 -0.703 . . . . 2.17 111.143 -165.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.5 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 81.2 tttt -55.81 116.48 2.97 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.152 0.501 . . . . 2.33 110.276 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 145.84 45.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.62 -1.173 . . . . 1.12 111.243 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.18 -8.08 56.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.867 -0.606 . . . . 2.97 110.131 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 t -80.32 -45.53 17.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.062 -0.517 . . . . 2.06 110.007 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.49 149.68 8.32 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.898 -0.667 . . . . 1.52 112.699 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 52.23 37.65 22.56 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.657 0.742 . . . . 2.79 111.644 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.0 p -159.98 154.03 23.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.845 -1.07 . . . . 0.95 109.761 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.5 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 66.2 m-85 -141.35 137.31 32.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.394 -0.366 . . . . 0.98 110.27 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.675 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 44.3 m95 -88.24 164.18 15.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.471 0.653 . . . . 0.48 111.65 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.7 t -136.21 96.1 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.017 -1.447 . . . . 1.3 108.391 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.935 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 63.5 m-85 -94.53 102.53 14.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.944 -1.132 . . . . 1.96 107.944 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 10.3 p -97.72 134.28 36.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 2.21 111.132 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 N--CA 1.45 -0.453 0 CA-C-N 115.992 -0.549 . . . . 3.87 109.729 -177.514 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 111.889 -0.484 . . . . 2.04 111.889 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.25 103.4 15.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.969 0.414 . . . . 1.26 111.073 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.497 HD11 HG21 ' A' ' 39' ' ' ILE . 5.7 tt -135.39 140.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.159 0.504 . . . . 1.5 111.212 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.456 ' HB3' ' CE2' ' A' ' 119' ' ' TRP . 12.3 pt20 -109.6 121.09 44.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.656 -0.702 . . . . 2.22 110.353 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 pp -123.15 152.34 41.26 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.078 -0.51 . . . . 1.4 110.833 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.49 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -70.93 154.13 42.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.762 -0.654 . . . . 1.15 110.142 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.517 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -76.79 31.17 1.49 Allowed Glycine 0 C--O 1.234 0.096 0 CA-C-N 115.781 -0.645 . . . . 1.2 113.31 -173.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 34' ' ' ASP . 12.4 t70 -135.44 -33.51 0.88 Allowed 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 122.84 0.456 . . . . 1.81 110.204 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.59 18.84 0.53 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.473 -0.87 . . . . 1.05 113.051 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -107.68 128.87 54.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.603 0.239 . . . . 1.79 110.789 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.497 HG21 HD11 ' A' ' 31' ' ' ILE . 46.9 mm -78.9 115.6 21.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.722 -0.217 . . . . 1.82 110.512 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.86 -47.44 9.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.072 0.463 . . . . 2.13 110.575 -173.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -159.34 142.39 14.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.911 -0.586 . . . . 2.96 111.416 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -114.44 117.59 31.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.656 -0.702 . . . . 1.75 110.191 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.855 -0.424 . . . . 1.28 109.855 -178.793 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.513 0 N-CA-C 112.071 -0.412 . . . . 3.32 112.071 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.16 8.95 39.78 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 110.392 -0.225 . . . . 4.53 110.392 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.741 ' HA ' HD12 ' A' ' 88' ' ' LEU . 6.1 t80 -49.93 -36.06 26.27 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.749 0.648 . . . . 1.1 112.749 -168.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -66.54 -30.42 70.73 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 121.394 0.616 . . . . 3.89 110.952 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -89.26 -41.5 12.15 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.876 -0.787 . . . . 3.07 108.876 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.819 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -51.41 -40.99 47.45 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.142 -0.935 . . . . 0.61 112.565 -173.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 79' ' ' PHE . 85.7 t -64.89 -52.08 58.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.463 -0.869 . . . . 1.36 110.942 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.07 -29.84 21.59 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.101 -0.5 . . . . 1.59 112.323 -168.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.8 p -72.94 -29.53 63.17 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.708 -0.849 . . . . 2.27 108.708 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.03 26.0 65.38 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.828 -0.909 . . . . 1.9 110.828 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -148.56 49.3 1.02 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.89 0.853 . . . . 2.08 111.759 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.819 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -71.79 78.4 0.86 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.142 -0.935 . . . . 1.22 111.644 176.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.5 p-10 -144.23 98.44 3.21 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.454 0.645 . . . . 2.15 109.787 174.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 91' ' ' MET . 4.1 m -149.16 157.43 43.37 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.789 -0.448 . . . . 2.03 109.789 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.468 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.5 ptt? -117.52 138.19 52.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.331 -0.395 . . . . 4.31 109.941 173.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -161.84 149.61 14.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.275 -0.639 . . . . 2.95 109.275 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.581 ' HG3' ' HD3' ' A' ' 106' ' ' LYS . 10.5 mp0 -92.28 121.02 33.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.599 -0.519 . . . . 1.97 109.599 176.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.0 t80 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.27 -0.423 . . . . 4.56 110.336 -177.324 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 109.103 -0.703 . . . . 3.49 109.103 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 27.3 m -104.17 159.49 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.295 0.569 . . . . 1.72 111.229 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.581 ' HD3' ' HG3' ' A' ' 93' ' ' GLU . 55.0 mmtt -101.73 120.61 40.63 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.085 -0.962 . . . . 2.83 108.668 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.543 HG13 ' HG3' ' A' ' 109' ' ' MET . 2.1 t -97.21 102.02 12.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.172 -0.677 . . . . 1.64 109.172 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 5.5 t-160 -101.31 103.56 14.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.765 -1.198 . . . . 1.35 107.765 170.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.576 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 62.0 mtt -106.67 144.18 33.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.058 -1.09 . . . . 2.72 108.058 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.6 ptpt -147.97 130.77 16.07 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.146 -0.621 . . . . 2.17 109.76 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.554 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 63.2 tttp -57.76 111.53 1.17 Allowed 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 109.038 -0.727 . . . . 2.33 109.038 168.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.63 144.75 13.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.781 -1.1 . . . . 1.12 110.085 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.39 -17.99 63.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.003 0.43 . . . . 2.97 110.098 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.2 m -63.0 -40.33 97.45 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.493 -0.776 . . . . 2.06 110.354 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.66 -61.8 0.4 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.72 -0.752 . . . . 1.52 113.475 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -87.45 41.42 0.98 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.438 0.637 . . . . 2.79 112.202 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.517 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.1 p -166.92 159.28 13.3 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.741 -0.663 . . . . 0.95 110.806 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 72.7 m-85 -139.06 135.63 34.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.835 -0.621 . . . . 0.98 109.615 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.456 ' CE2' ' HB3' ' A' ' 32' ' ' GLN . 42.2 m95 -87.77 163.13 16.64 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.352 0.596 . . . . 0.48 112.044 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.95 111.08 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.144 -1.389 . . . . 1.3 108.828 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 83.8 m-85 -111.9 110.08 20.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.529 -0.545 . . . . 1.96 109.529 174.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.34 125.03 63.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.585 0.231 . . . . 2.21 110.77 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 C--O 1.222 -0.348 0 N-CA-C 108.966 -0.753 . . . . 3.87 108.966 177.589 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 110.944 -0.863 . . . . 2.04 110.944 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.91 106.77 16.45 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.003 0.43 . . . . 1.26 111.156 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.429 HG21 ' HB ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -123.88 139.39 50.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.641 -0.503 . . . . 1.5 109.641 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.641 HE21 HD21 ' A' ' 40' ' ' LEU . 21.0 pt20 -110.48 126.57 54.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.786 -0.643 . . . . 2.22 110.529 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.56 163.35 21.15 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.548 -0.751 . . . . 1.4 110.046 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 45.9 p30 -87.06 165.93 15.41 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.47 0.653 . . . . 1.15 110.97 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.57 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -77.16 27.91 1.71 Allowed Glycine 0 C--N 1.319 -0.409 0 CA-C-N 115.251 -0.886 . . . . 1.2 112.243 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 34' ' ' ASP . 20.5 t70 -127.22 -8.97 5.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.084 0.469 . . . . 1.81 110.433 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.06 11.27 43.31 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.866 -0.683 . . . . 1.05 112.151 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.475 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -106.42 148.25 28.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.823 0.344 . . . . 1.79 110.195 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 31' ' ' ILE . 45.5 mm -84.22 129.45 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.548 -0.538 . . . . 1.82 109.548 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.641 HD21 HE21 ' A' ' 32' ' ' GLN . 29.5 tp -96.91 -48.59 5.37 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.954 -0.388 . . . . 2.13 109.954 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.52 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 31.5 tp60 -163.55 121.87 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.229 0.538 . . . . 2.96 111.096 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -89.72 123.92 34.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.444 -0.947 . . . . 1.75 108.444 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 121.218 0.532 . . . . 1.28 110.327 -177.468 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 112.183 -0.367 . . . . 3.32 112.183 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HE3' ' HB2' ' A' ' 78' ' ' LYS . 23.5 ttmt 53.65 70.22 0.62 Allowed 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.691 0.758 . . . . 4.53 109.543 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.629 ' HA ' HD12 ' A' ' 88' ' ' LEU . 71.7 t80 -50.1 -36.17 28.46 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.725 -1.125 . . . . 1.1 113.071 -166.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -72.38 -25.01 61.35 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.123 0.487 . . . . 3.89 110.557 -173.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -82.19 -31.52 30.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.138 -0.69 . . . . 3.07 109.138 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.998 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -64.3 -41.31 98.25 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.422 -0.808 . . . . 0.61 111.753 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 79' ' ' PHE . 57.9 t -67.79 -47.13 80.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.907 -0.647 . . . . 1.36 110.36 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.12 -32.07 63.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 1.59 110.848 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 64.6 p -67.28 -32.85 74.12 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.118 -0.697 . . . . 2.27 109.118 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.36 12.83 34.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.622 -0.717 . . . . 1.9 112.828 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.551 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.4 p30 -175.23 69.98 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.764 0.792 . . . . 2.08 110.224 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.998 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.3 tt -58.75 88.09 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.911 -1.04 . . . . 1.22 111.233 174.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.2 t30 -143.08 101.63 3.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.935 -0.575 . . . . 2.15 109.573 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.9 t -150.82 155.84 40.03 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 120.895 0.378 . . . . 2.03 110.064 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.631 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.7 ptt? -134.5 116.69 15.38 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.586 -0.734 . . . . 4.31 110.003 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -143.08 136.98 28.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.439 -0.8 . . . . 2.95 109.263 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.3 pt-20 -100.18 118.57 36.79 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.396 -0.522 . . . . 1.97 110.485 177.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.9 t80 . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 108.803 -0.814 . . . . 4.56 108.803 179.134 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 120.711 0.291 . . . . 3.49 111.542 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 32.1 m -110.27 158.69 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 115.78 -0.646 . . . . 1.72 109.869 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 24.1 ttmm -132.45 118.6 19.53 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.948 -0.569 . . . . 2.83 109.474 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.3 t -95.87 104.96 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-N 116.445 -0.343 . . . . 1.64 110.203 -176.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 3.4 t-160 -107.12 102.22 11.57 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.758 -1.201 . . . . 1.35 107.758 170.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.645 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 85.3 mtp -110.12 138.01 47.09 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.547 -1.279 . . . . 2.72 107.547 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 14.2 ptmm? -144.09 135.33 25.59 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.86 -0.736 . . . . 2.17 110.373 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.704 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 46.0 tttm -55.88 116.41 2.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.797 0.808 . . . . 2.33 110.569 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.35 150.46 22.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.172 -1.376 . . . . 1.12 110.716 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.48 -14.42 41.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.787 0.327 . . . . 2.97 111.257 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.4 t -76.12 -24.76 54.94 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.048 0.451 . . . . 2.06 110.326 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.57 -44.7 3.18 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.269 -0.491 . . . . 1.52 112.449 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.58 34.09 0.64 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.498 0.666 . . . . 2.79 111.673 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.45 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.2 p -169.95 159.37 7.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.167 -0.924 . . . . 0.95 110.427 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.704 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 32.2 m-85 -141.31 145.3 35.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.714 0.292 . . . . 0.98 110.297 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -93.23 165.64 12.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.46 0.647 . . . . 0.48 111.853 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.429 ' HB ' HG21 ' A' ' 31' ' ' ILE . 63.0 t -136.08 104.63 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.35 -1.295 . . . . 1.3 109.307 174.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.632 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 62.7 m-85 -106.63 104.79 14.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.463 -0.94 . . . . 1.96 108.463 174.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 12.2 p -105.09 135.48 42.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.25 0.548 . . . . 2.21 110.929 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 81.6 mttt . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.822 -0.627 . . . . 3.87 109.905 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.797 0 N-CA-C 111.756 -0.538 . . . . 2.04 111.756 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.49 114.24 16.52 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.903 0.382 . . . . 1.26 111.145 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.497 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 5.5 tt -118.58 140.63 41.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.429 -0.582 . . . . 1.5 109.429 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.559 ' OE1' ' HB3' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -120.99 143.82 48.84 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.295 0.569 . . . . 2.22 110.905 -175.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.48 160.93 33.76 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.062 -0.972 . . . . 1.4 110.37 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 36' ' ' ASP . 48.0 p30 -85.03 159.38 20.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.503 0.668 . . . . 1.15 110.863 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.542 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -77.83 20.55 3.61 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.062 -0.972 . . . . 1.2 111.935 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -99.78 -39.84 8.02 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.813 -0.81 . . . . 1.81 108.813 176.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.73 7.78 0.73 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.214 -0.993 . . . . 1.05 114.596 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.481 HD21 ' C ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -134.29 160.08 39.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.366 1.083 . . . . 1.79 112.472 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 31' ' ' ILE . 75.9 mt -75.27 143.19 13.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.619 -1.173 . . . . 1.82 110.656 -175.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.559 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 60.5 tp -119.48 -57.56 1.98 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.449 -0.341 . . . . 2.13 111.275 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.543 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 94.8 mt-30 -126.81 145.22 50.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.329 . . . . 2.96 111.332 -174.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.497 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 87.6 t80 -132.38 136.63 46.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 1.75 110.835 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 1.28 109.556 176.734 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 110.597 -1.001 . . . . 3.32 110.597 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt 57.47 46.08 18.6 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.135 -0.533 . . . . 4.53 109.63 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.577 ' O ' HG23 ' A' ' 83' ' ' VAL . 65.6 t80 -44.81 -42.26 7.7 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 113.436 0.902 . . . . 1.1 113.436 -166.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -68.68 -36.3 78.35 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.282 0.563 . . . . 3.89 110.395 -174.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.72 -30.79 28.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.527 -0.761 . . . . 3.07 109.103 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.911 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.97 -43.84 92.87 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.458 -0.792 . . . . 0.61 111.714 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.2 t -63.53 -52.56 56.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.565 -0.818 . . . . 1.36 110.843 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.33 -26.1 35.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 1.59 111.767 -170.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.6 t -67.61 -25.19 65.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.409 -0.589 . . . . 2.27 109.409 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.41 78.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.87 -0.605 . . . . 1.9 112.888 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.42 50.28 1.02 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.711 0.767 . . . . 2.08 111.616 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.911 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.1 tt -70.73 89.7 0.75 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.259 -0.882 . . . . 1.22 110.995 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.5 p30 -143.68 100.49 3.6 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.705 -0.85 . . . . 2.15 108.705 169.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 3.1 p -141.52 152.68 44.35 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.945 -0.472 . . . . 2.03 111.059 -174.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.644 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.5 ptm -120.07 116.49 25.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.6 0.714 . . . . 4.31 109.775 173.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -119.55 122.47 41.69 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.885 -1.052 . . . . 2.95 109.244 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HG2' ' HB3' ' A' ' 106' ' ' LYS . 49.2 mt-10 -92.86 130.47 38.45 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.423 -0.584 . . . . 1.97 109.423 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.6 t80 . . . . . 0 N--CA 1.449 -0.479 0 CA-C-N 115.973 -0.558 . . . . 4.56 110.356 -172.051 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttp . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 109.231 -0.655 . . . . 3.49 109.231 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -106.16 161.62 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.189 -0.46 . . . . 1.72 111.207 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.494 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 19.4 ptpt -139.18 127.06 22.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.585 -0.734 . . . . 2.83 109.292 176.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -92.91 144.89 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 C-N-CA 120.185 -0.606 . . . . 1.64 110.623 175.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.544 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 13.2 t-160 -131.69 102.8 6.04 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.43 -1.322 . . . . 1.35 107.43 164.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.677 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 11.2 ptp -101.88 123.72 46.29 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.664 -1.236 . . . . 2.72 107.664 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 21.1 ptmt -138.08 133.36 33.38 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 120.435 -0.506 . . . . 2.17 110.941 -165.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.535 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 64.4 tttp -56.75 115.41 2.55 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.335 -0.848 . . . . 2.33 111.144 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.77 147.09 39.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.513 -1.221 . . . . 1.12 110.425 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.19 -3.34 16.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.666 0.27 . . . . 2.97 111.335 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 p -84.58 -17.82 37.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.705 0.288 . . . . 2.06 111.366 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 127.64 -108.7 0.97 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.306 -0.95 . . . . 1.52 113.118 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -85.16 68.49 10.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.278 1.037 . . . . 2.79 110.956 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.542 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.7 p -158.52 154.09 26.14 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.668 -1.151 . . . . 0.95 108.719 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.535 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 50.1 m-85 -140.41 135.85 32.48 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.769 0.319 . . . . 0.98 110.364 -175.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.497 ' O ' ' HA ' ' A' ' 109' ' ' MET . 39.7 m95 -87.1 161.4 18.14 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 120.861 0.362 . . . . 0.48 110.086 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.4 t -140.01 95.88 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.215 -0.902 . . . . 1.3 108.938 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.544 ' CE1' ' HB3' ' A' ' 108' ' ' HIS . 7.8 p90 -119.53 141.23 49.41 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.991 -0.684 . . . . 1.96 110.528 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 123' ' ' LYS . 12.1 p -123.53 151.98 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.68 -0.691 . . . . 2.21 110.229 -175.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.404 ' N ' HG23 ' A' ' 122' ' ' VAL . 14.8 tptt . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 110.094 -0.336 . . . . 3.87 110.094 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.591 ' HA3' HG23 ' A' ' 122' ' ' VAL . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 111.919 -0.472 . . . . 2.04 111.919 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.75 102.44 12.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.041 0.448 . . . . 1.26 111.469 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.66 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 5.9 tt -137.61 141.85 38.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.978 -0.555 . . . . 1.5 109.957 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.509 ' HB3' ' CE3' ' A' ' 119' ' ' TRP . 0.7 OUTLIER -120.27 140.72 50.8 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.223 0.535 . . . . 2.22 110.811 -178.368 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB3' HD11 ' A' ' 39' ' ' ILE . 3.9 pp -134.71 162.85 31.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.439 -0.8 . . . . 1.4 111.152 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.545 ' HB3' HD12 ' A' ' 40' ' ' LEU . 10.4 p30 -83.61 158.26 21.96 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.697 -0.683 . . . . 1.15 110.876 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.57 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -72.83 2.15 34.69 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.311 -0.858 . . . . 1.2 112.191 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.44 -42.28 17.13 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.11 -0.7 . . . . 1.81 109.11 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.59 28.32 0.69 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.179 -0.919 . . . . 1.05 112.355 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -133.86 150.11 51.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.769 0.318 . . . . 1.79 110.23 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.572 HD11 ' HB3' ' A' ' 33' ' ' LEU . 12.1 mm -74.65 143.53 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 116.239 -0.437 . . . . 1.82 110.443 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 34' ' ' ASP . 85.7 mt -113.86 -50.89 2.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.837 0.351 . . . . 2.13 111.104 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -142.45 136.17 29.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.23 -0.441 . . . . 2.96 110.258 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.66 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 61.7 t80 -130.28 135.67 48.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.164 -0.471 . . . . 1.75 110.205 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.389 -0.368 . . . . 1.28 110.382 -178.01 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 N-CA-C 111.588 -0.605 . . . . 3.32 111.588 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.688 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 18.4 tptm 60.35 35.68 20.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.173 0.511 . . . . 4.53 110.315 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.742 ' HA ' HD11 ' A' ' 88' ' ' LEU . 62.0 t80 -48.8 -37.67 19.88 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.562 -0.745 . . . . 1.1 112.733 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -70.47 -36.87 74.11 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 123.576 0.547 . . . . 3.89 110.123 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.688 ' HB3' ' HG3' ' A' ' 78' ' ' LYS . 41.0 tt0 -80.55 -31.87 36.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.586 -0.734 . . . . 3.07 109.18 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.953 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.5 -46.25 93.4 Favored Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 115.666 -0.697 . . . . 0.61 111.88 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.4 t -69.15 -46.46 77.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.696 -0.752 . . . . 1.36 110.578 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.6 -28.84 63.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.864 -0.607 . . . . 1.59 110.555 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -69.69 -23.91 63.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.414 -0.812 . . . . 2.27 109.265 174.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.93 19.58 69.84 Favored Glycine 0 CA--C 1.505 -0.539 0 CA-C-N 115.685 -0.688 . . . . 1.9 112.198 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.401 ' C ' HD21 ' A' ' 87' ' ' ASN . 0.4 OUTLIER -163.4 55.57 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.246 0.546 . . . . 2.08 111.29 -175.287 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.953 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.1 tt -68.65 88.95 0.36 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.771 -0.649 . . . . 1.22 111.081 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.755 ' HA ' ' O ' ' A' ' 109' ' ' MET . 20.4 t30 -143.15 100.45 3.64 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.284 -0.636 . . . . 2.15 109.284 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.9 t -156.06 158.08 37.17 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.999 0.428 . . . . 2.03 110.687 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.514 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 19.5 ptt? -125.77 126.16 44.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.772 -0.649 . . . . 4.31 110.447 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.49 ' O ' HG23 ' A' ' 107' ' ' VAL . 90.1 t80 -146.08 130.16 17.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.676 -0.693 . . . . 2.95 109.795 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.779 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 12.9 pt-20 -104.62 127.1 52.27 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.046 0.451 . . . . 1.97 110.222 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 10.8 p90 . . . . . 0 N--CA 1.447 -0.61 0 CA-C-O 121.794 0.807 . . . . 4.56 109.154 178.622 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.4 tttm . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 109.552 -0.536 . . . . 3.49 109.552 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.4 159.89 8.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.008 -0.996 . . . . 1.72 111.588 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.779 ' HG3' ' HB3' ' A' ' 93' ' ' GLU . 25.0 ttpp -146.11 115.0 6.92 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.461 -0.791 . . . . 2.83 109.213 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 122' ' ' VAL . 12.9 m -88.54 144.56 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-O 121.373 0.606 . . . . 1.64 111.414 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.419 ' O ' ' HD1' ' A' ' 121' ' ' PHE . 14.6 t-160 -132.33 103.32 6.15 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 106.858 -1.534 . . . . 1.35 106.858 160.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.755 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 79.5 mtp -103.7 132.14 50.23 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.108 -1.442 . . . . 2.72 107.108 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.541 ' HG2' ' HB2' ' A' ' 119' ' ' TRP . 61.7 pttt -138.59 131.62 29.76 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.709 -0.796 . . . . 2.17 110.087 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 80.8 tttt -56.57 113.05 1.45 Allowed 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.784 -0.644 . . . . 2.33 110.188 172.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.427 ' HB1' ' OG ' ' A' ' 117' ' ' SER . . . -58.22 144.75 39.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.605 -1.18 . . . . 1.12 110.866 -173.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 73.4 mt -71.23 -9.81 58.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.041 -0.527 . . . . 2.97 110.846 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 p -73.13 -30.63 63.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.975 -0.557 . . . . 2.06 111.057 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.6 -126.16 2.82 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.74 -0.743 . . . . 1.52 112.668 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.65 79.24 2.01 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.989 0.899 . . . . 2.79 110.853 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.57 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.1 p -168.07 156.16 8.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.532 -1.213 . . . . 0.95 108.457 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.535 ' HH ' ' HA ' ' A' ' 83' ' ' VAL . 31.6 m-85 -140.24 137.36 34.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.64 0.257 . . . . 0.98 110.916 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.541 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . 45.1 m95 -83.64 162.81 20.65 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.227 0.536 . . . . 0.48 110.817 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.731 HG21 ' HE3' ' A' ' 109' ' ' MET . 50.9 t -137.23 97.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.744 -1.116 . . . . 1.3 109.659 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 89.8 m-85 -100.17 102.47 13.78 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.528 -0.545 . . . . 1.96 109.528 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.591 HG23 ' HA3' ' A' ' 29' ' ' GLY . 3.7 m -97.84 106.47 18.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.516 0.674 . . . . 2.21 110.026 176.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 N--CA 1.445 -0.712 0 O-C-N 121.963 -0.461 . . . . 3.87 110.773 -172.709 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 111.864 -0.494 . . . . 2.04 111.864 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.81 119.45 29.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.139 -0.319 . . . . 1.26 110.139 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -111.64 138.71 39.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.988 0.423 . . . . 1.5 110.604 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.635 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 7.6 pt20 -109.88 127.04 54.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.816 -0.629 . . . . 2.22 110.343 176.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' A' ' 39' ' ' ILE . 3.8 pp -118.69 159.03 24.39 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.288 -0.869 . . . . 1.4 109.577 177.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.761 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 1.9 p30 -84.24 151.59 24.71 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.174 -0.611 . . . . 1.15 109.976 176.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -73.3 5.18 21.86 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.431 -0.804 . . . . 1.2 112.606 -175.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.09 -39.34 13.69 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.495 -0.557 . . . . 1.81 109.495 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.79 36.99 0.19 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.611 -0.722 . . . . 1.05 111.935 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.761 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 19.0 m-80 -137.59 152.53 49.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.978 0.418 . . . . 1.79 110.342 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 33' ' ' LEU . 46.3 mm -95.14 123.28 47.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.879 -0.601 . . . . 1.82 110.057 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.496 HD23 ' NE2' ' A' ' 32' ' ' GLN . 35.2 tp -102.59 -52.06 3.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.754 0.279 . . . . 2.13 111.754 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.631 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 7.3 tt0 -142.52 122.49 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.902 0.382 . . . . 2.96 111.371 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -113.76 106.37 14.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.088 -0.506 . . . . 1.75 109.668 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 121.137 0.494 . . . . 1.28 110.587 -179.034 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 111.123 -0.791 . . . . 3.32 111.123 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 65.48 25.09 11.87 Favored 'General case' 0 C--O 1.223 -0.32 0 O-C-N 123.826 0.368 . . . . 4.53 110.191 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 83' ' ' VAL . 44.8 t80 -55.87 -29.93 60.7 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 112.541 0.571 . . . . 1.1 112.541 -167.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -81.4 -37.21 28.52 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.039 0.447 . . . . 3.89 110.204 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -78.72 -30.7 46.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.745 -0.835 . . . . 3.07 108.745 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.982 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.51 -43.98 90.56 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.067 -0.969 . . . . 0.61 111.873 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 79' ' ' PHE . 89.6 t -68.57 -52.56 35.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.424 -0.888 . . . . 1.36 111.047 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.19 -28.97 38.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.936 -0.575 . . . . 1.59 111.678 -169.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -72.07 -26.32 62.12 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.658 -0.867 . . . . 2.27 108.658 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.6 18.43 70.79 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.249 -0.887 . . . . 1.9 112.313 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -140.31 42.46 1.91 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.47 0.652 . . . . 2.08 111.897 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.982 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -69.21 89.13 0.45 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.363 -0.835 . . . . 1.22 111.609 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.1 p30 -143.95 100.9 3.65 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.453 -0.943 . . . . 2.15 108.453 169.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 17.8 p -131.85 151.1 51.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 121.879 -0.513 . . . . 2.03 111.12 -173.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 3.9 ppp? -118.79 129.34 55.19 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.647 -0.871 . . . . 4.31 108.647 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.468 ' HE2' ' HD2' ' A' ' 94' ' ' TYR . 38.5 t80 -139.28 127.85 23.08 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.906 -0.588 . . . . 2.95 109.463 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -90.62 107.3 19.08 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.764 -1.199 . . . . 1.97 107.764 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.468 ' HD2' ' HE2' ' A' ' 92' ' ' PHE . 43.1 t80 . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 121.157 0.503 . . . . 4.56 110.646 -173.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.0 tttm . . . . . 0 C--O 1.241 0.631 0 CA-C-O 120.69 0.281 . . . . 3.49 110.87 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.5 161.03 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.93 -0.577 . . . . 1.72 110.391 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -113.92 115.79 28.24 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.094 -1.076 . . . . 2.83 108.094 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 91' ' ' MET . 1.9 t -89.73 142.71 12.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 119.976 -0.689 . . . . 1.64 109.321 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.601 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 13.6 t-160 -140.47 103.51 4.57 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.437 -0.949 . . . . 1.35 108.437 167.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.681 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 61.5 mtt -92.19 140.68 29.38 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.045 -1.465 . . . . 2.72 107.045 173.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -149.27 129.95 14.09 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.349 -0.94 . . . . 2.17 111.202 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.534 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 38.1 tttp -55.22 117.81 3.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.481 -1.236 . . . . 2.33 110.435 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.18 147.71 9.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.783 -1.099 . . . . 1.12 111.256 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -62.03 -25.54 67.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.345 -0.389 . . . . 2.97 111.297 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.0 p -79.59 -56.0 4.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.044 0.449 . . . . 2.06 110.226 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.31 169.14 12.74 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.874 -0.679 . . . . 1.52 112.389 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.9 t70 60.32 28.86 18.5 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.243 1.02 . . . . 2.79 110.642 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.476 ' CB ' ' HA ' ' A' ' 34' ' ' ASP . 6.9 p -168.1 153.22 6.69 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.347 -1.297 . . . . 0.95 109.984 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.534 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 51.3 m-85 -140.98 139.68 34.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.226 -0.443 . . . . 0.98 110.117 -175.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.635 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 40.6 m95 -87.77 161.4 17.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.192 0.52 . . . . 0.48 111.448 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.515 HG21 ' HG2' ' A' ' 109' ' ' MET . 62.1 t -140.21 96.59 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.439 -1.255 . . . . 1.3 108.601 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' A' ' 108' ' ' HIS . 5.4 p90 -124.58 140.1 53.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.241 -0.583 . . . . 1.96 110.213 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.5 m -113.1 162.78 10.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.171 0.51 . . . . 2.21 111.342 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 79.4 tttt . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 115.421 -0.809 . . . . 3.87 109.29 -179.087 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.277 -0.179 . . . . 2.04 112.767 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.89 111.21 5.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.969 0.414 . . . . 1.26 111.719 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.739 HG13 ' HA ' ' A' ' 42' ' ' TYR . 1.2 tt -131.9 140.44 48.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.368 -0.378 . . . . 1.5 110.095 174.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.651 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 2.4 pt20 -108.27 130.8 55.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.42 0.629 . . . . 2.22 110.201 172.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -120.06 158.14 27.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.185 -0.916 . . . . 1.4 109.53 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -74.84 152.03 38.97 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.991 -0.55 . . . . 1.15 109.788 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.605 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -79.28 37.6 2.01 Favored Glycine 0 CA--C 1.506 -0.509 0 CA-C-N 115.906 -0.588 . . . . 1.2 112.237 -172.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 34' ' ' ASP . 11.4 t70 -140.47 -33.67 0.55 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.075 -0.562 . . . . 1.81 110.484 -178.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.97 11.75 0.49 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.459 -0.877 . . . . 1.05 113.183 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -106.07 144.71 32.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.151 -0.315 . . . . 1.79 110.151 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.466 HD12 HD11 ' A' ' 31' ' ' ILE . 44.7 mm -75.59 134.99 28.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.645 -0.502 . . . . 1.82 109.645 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.587 ' HB3' ' HG3' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -106.08 -62.69 1.34 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.938 -0.764 . . . . 2.13 108.938 -174.23 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.595 ' HB3' ' HG2' ' A' ' 32' ' ' GLN . 39.9 tt0 -144.69 110.34 5.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.838 -1.074 . . . . 2.96 110.359 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.739 ' HA ' HG13 ' A' ' 31' ' ' ILE . 19.2 t80 -100.06 110.78 23.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.008 -0.542 . . . . 1.75 109.659 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 120.847 0.356 . . . . 1.28 110.382 -177.162 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.519 0 N-CA-C 112.191 -0.364 . . . . 3.32 112.191 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 81' ' ' GLU . 73.8 mmtt -138.43 33.57 2.28 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 109.088 -0.708 . . . . 4.53 109.088 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.86 ' HA ' HD12 ' A' ' 88' ' ' LEU . 35.9 t80 -44.61 -47.35 10.39 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 114.094 1.146 . . . . 1.1 114.094 -160.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -79.58 -30.25 41.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.656 0.741 . . . . 3.89 109.578 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 68.1 tt0 -73.7 -31.52 63.46 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.975 -1.011 . . . . 3.07 108.274 176.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.78 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.27 -43.67 99.07 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.613 -1.176 . . . . 0.61 111.259 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.617 ' HA ' ' HH ' ' A' ' 118' ' ' TYR . 73.7 t -65.43 -47.68 85.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.368 -0.916 . . . . 1.36 110.526 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.8 -31.05 56.72 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.779 -0.646 . . . . 1.59 111.225 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.2 t -66.46 -34.26 77.53 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.264 -1.013 . . . . 2.27 108.264 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.62 12.48 58.15 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.24 -0.891 . . . . 1.9 111.699 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.541 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.3 p30 -162.28 59.13 0.23 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.572 0.701 . . . . 2.08 111.475 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 79' ' ' PHE . 1.4 tt -60.6 93.01 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.451 -0.795 . . . . 1.22 110.746 172.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.728 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.1 t30 -140.63 101.52 4.11 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.662 -0.495 . . . . 2.15 109.662 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 6.3 m -137.26 149.44 47.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.48 -0.327 . . . . 2.03 110.202 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.0 ptt? -134.08 128.8 34.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.063 -0.517 . . . . 4.31 109.865 175.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -161.83 154.01 19.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.964 -0.562 . . . . 2.95 109.937 -174.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.735 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 37.1 mt-10 -110.8 112.21 23.92 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.67 -0.493 . . . . 1.97 109.67 176.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 36.5 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 4.56 111.421 -177.405 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.785 ' HZ1' ' HB2' ' A' ' 104' ' ' LYS . 5.2 ttmp? . . . . . 0 N--CA 1.446 -0.635 0 CA-C-O 120.742 0.305 . . . . 3.49 110.418 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 17.3 m -109.45 159.48 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.903 -0.59 . . . . 1.72 111.324 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.735 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -108.85 113.43 26.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.827 -1.175 . . . . 2.83 107.827 175.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 91' ' ' MET . 3.5 m -100.45 144.86 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 C-N-CA 119.872 -0.731 . . . . 1.64 112.138 -178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.3 t-160 -135.9 102.19 4.98 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.335 -1.302 . . . . 1.35 107.497 164.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.728 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 63.1 mtt -100.92 116.33 32.52 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.459 -1.682 . . . . 2.72 106.459 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 58.8 pttt -132.14 136.64 47.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.218 -0.993 . . . . 2.17 110.999 -168.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.651 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 35.1 tttm -55.6 119.56 5.88 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.138 -0.937 . . . . 2.33 110.57 170.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.84 146.85 13.04 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.119 -0.946 . . . . 1.12 110.159 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.5 tp -61.96 -25.23 67.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.547 -0.297 . . . . 2.97 110.744 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.9 m -76.48 -67.42 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.363 -0.38 . . . . 2.06 110.749 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 143.89 161.93 9.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.63 -0.795 . . . . 1.52 112.447 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 t70 54.57 37.43 27.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.445 1.117 . . . . 2.79 111.003 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.605 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 5.5 p -167.8 150.41 5.77 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.346 -1.297 . . . . 0.95 108.962 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.651 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 57.2 m-85 -141.66 141.57 33.37 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.702 0.287 . . . . 0.98 110.416 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.651 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 46.3 m95 -90.58 165.73 13.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.457 0.646 . . . . 0.48 111.391 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.61 96.07 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.308 -1.314 . . . . 1.3 108.877 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 45.8 m-85 -92.71 132.24 37.1 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.613 -0.884 . . . . 1.96 108.613 172.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.46 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 8.2 p -144.75 137.03 21.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.788 0.328 . . . . 2.21 110.636 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 CA--C 1.52 -0.206 0 N-CA-C 109.85 -0.426 . . . . 3.87 109.85 -178.488 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 110.862 -0.895 . . . . 2.04 110.862 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.42 102.42 15.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.304 0.573 . . . . 1.26 112.148 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.555 HG13 ' HA ' ' A' ' 42' ' ' TYR . 5.4 tt -124.44 139.7 49.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.695 -0.684 . . . . 1.5 109.383 172.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -116.65 137.12 52.42 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.62 0.724 . . . . 2.22 111.844 -176.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.893 ' HB3' HD12 ' A' ' 39' ' ' ILE . 3.6 pp -126.86 165.34 19.52 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.824 -1.08 . . . . 1.4 110.31 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 14.8 p30 -97.2 158.66 15.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.302 0.573 . . . . 1.15 110.211 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.61 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -79.49 26.27 2.68 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.539 -0.755 . . . . 1.2 111.725 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 34' ' ' ASP . 5.7 t70 -104.91 -18.59 14.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.203 0.525 . . . . 1.81 109.691 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.44 3.73 5.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.312 -0.946 . . . . 1.05 114.209 171.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.81 159.84 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.97 0.885 . . . . 1.79 111.979 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.893 HD12 ' HB3' ' A' ' 33' ' ' LEU . 7.5 mm -70.06 146.79 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.066 -0.97 . . . . 1.82 109.747 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.498 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 46.8 tp -112.41 -46.17 3.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.219 -0.446 . . . . 2.13 110.666 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -147.08 119.98 8.72 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.288 0.566 . . . . 2.96 111.929 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.555 ' HA ' HG13 ' A' ' 31' ' ' ILE . 68.4 t80 -98.16 134.69 40.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.927 -0.578 . . . . 1.75 109.564 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.865 0.364 . . . . 1.28 110.786 -177.384 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 N-CA-C 111.293 -0.723 . . . . 3.32 111.293 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 81' ' ' GLU . 58.7 mtpt 63.26 86.06 0.12 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.605 0.717 . . . . 4.53 110.44 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.61 ' HZ ' ' HA2' ' A' ' 35' ' ' GLY . 92.4 t80 -74.5 -51.49 14.62 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.068 -0.969 . . . . 1.1 111.083 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -61.7 -30.84 71.01 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 123.861 0.726 . . . . 3.89 110.217 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 8.3 tp10 -75.3 -37.36 60.89 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.584 -0.895 . . . . 3.07 108.584 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.938 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.13 -42.27 97.01 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 115.227 -0.897 . . . . 0.61 111.396 176.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 79' ' ' PHE . 87.8 t -63.24 -50.01 80.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.296 -0.952 . . . . 1.36 110.685 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.75 -27.82 55.5 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.883 -0.599 . . . . 1.59 111.036 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.0 m -65.17 -25.58 67.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.471 -0.566 . . . . 2.27 109.471 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.38 22.58 70.09 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.729 -0.669 . . . . 1.9 112.467 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.629 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 8.8 p30 -165.54 48.66 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.37 0.605 . . . . 2.08 111.606 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.938 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.6 tt -58.28 93.81 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.382 -0.826 . . . . 1.22 111.991 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.6 p30 -145.71 100.61 3.45 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.202 -0.666 . . . . 2.15 109.202 172.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 91' ' ' MET . 3.7 m -149.43 154.14 38.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.552 -0.717 . . . . 2.03 110.145 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.588 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 24.0 ptt? -109.05 123.85 49.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.051 0.453 . . . . 4.31 110.242 172.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -122.88 112.31 17.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.034 -0.728 . . . . 2.95 109.034 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 31.1 mt-10 -105.8 106.52 17.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.391 -0.368 . . . . 1.97 110.209 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 24.1 p90 . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 121.42 0.628 . . . . 4.56 111.081 -177.604 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.567 ' HZ1' ' HB2' ' A' ' 104' ' ' LYS . 4.5 ttmp? . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.672 -0.492 . . . . 3.49 109.672 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 28.2 m -101.36 157.51 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.45 0.643 . . . . 1.72 110.866 175.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.628 ' HZ2' ' HB2' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -134.24 117.68 16.75 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.313 -0.858 . . . . 2.83 109.164 176.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.1 t -94.99 105.47 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.904 0 CA-C-N 115.824 -0.626 . . . . 1.64 109.958 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.0 t-160 -101.57 102.64 13.4 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.268 -1.382 . . . . 1.35 107.268 169.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 67.4 mtp -91.32 145.7 24.43 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.076 -1.083 . . . . 2.72 108.076 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -148.5 119.19 7.5 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.84 -0.744 . . . . 2.17 109.385 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.629 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 68.9 tttt -55.4 122.94 12.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.473 0.654 . . . . 2.33 111.043 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.26 146.14 52.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.745 -1.116 . . . . 1.12 110.436 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.44 4.34 11.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.026 0.441 . . . . 2.97 110.878 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.0 t -79.01 -55.94 4.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.989 -0.55 . . . . 2.06 109.764 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 134.02 126.5 2.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.81 -0.71 . . . . 1.52 112.654 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.86 35.47 25.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.84 0.828 . . . . 2.79 111.074 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.2 p -141.0 151.46 44.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.202 -1.363 . . . . 0.95 108.793 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.549 ' CE1' HG23 ' A' ' 83' ' ' VAL . 25.8 m-85 -142.88 136.99 29.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.397 -0.365 . . . . 0.98 110.271 -173.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.527 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 50.2 m95 -86.09 164.63 17.19 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.448 0.642 . . . . 0.48 110.961 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.554 HG12 HG11 ' A' ' 122' ' ' VAL . 57.7 t -134.76 97.26 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.264 -1.335 . . . . 1.3 108.472 175.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 52.9 m-85 -96.35 101.54 13.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.454 -0.943 . . . . 1.96 108.454 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.554 HG11 HG12 ' A' ' 120' ' ' VAL . 24.9 m -99.85 162.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.547 0.689 . . . . 2.21 111.533 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.458 ' HB3' ' CG ' ' A' ' 106' ' ' LYS . 56.9 tptt . . . . . 0 C--N 1.313 -0.979 0 CA-C-N 114.638 -1.165 . . . . 3.87 108.757 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 119.931 -0.371 . . . . 2.04 113.686 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.47 102.28 11.76 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.473 0.636 . . . . 1.26 111.18 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.519 HG13 ' HA ' ' A' ' 42' ' ' TYR . 4.4 tt -133.6 141.33 44.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.322 -0.399 . . . . 1.5 110.561 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.558 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 11.7 pt20 -113.88 135.01 54.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.27 0.557 . . . . 2.22 111.304 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.691 ' HB3' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -126.8 166.38 17.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.471 -0.786 . . . . 1.4 110.339 175.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.453 ' HA ' ' CB ' ' A' ' 117' ' ' SER . 3.3 p30 -92.06 158.3 16.3 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.876 -0.602 . . . . 1.15 110.576 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.441 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -81.05 11.97 39.62 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.337 -0.847 . . . . 1.2 112.082 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -90.94 -25.44 19.77 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.173 -0.677 . . . . 1.81 109.173 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.36 23.61 2.85 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.354 -0.839 . . . . 1.05 112.395 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -132.52 155.56 48.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.124 -0.324 . . . . 1.79 110.124 -177.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.691 HD12 ' HB3' ' A' ' 33' ' ' LEU . 36.6 mm -74.05 138.24 21.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.408 -0.96 . . . . 1.82 108.408 171.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.5 HD22 HE21 ' A' ' 32' ' ' GLN . 27.8 tp -105.21 -49.49 3.45 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.814 -0.354 . . . . 2.13 110.806 -174.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -154.97 128.22 8.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 2.96 110.999 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.519 ' HA ' HG13 ' A' ' 31' ' ' ILE . 66.0 t80 -98.63 119.66 37.73 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.917 -0.771 . . . . 1.75 108.917 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 . . . . . 0 C--N 1.324 -0.538 0 CA-C-O 121.051 0.453 . . . . 1.28 111.716 -169.547 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.889 0 N-CA-C 111.88 -0.488 . . . . 3.32 111.88 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt 65.25 18.24 11.32 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 123.656 0.268 . . . . 4.53 111.704 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.546 ' O ' HG22 ' A' ' 83' ' ' VAL . 42.5 t80 -49.5 -33.92 15.77 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 111.617 0.229 . . . . 1.1 111.617 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -62.36 -42.66 99.58 Favored 'General case' 0 C--N 1.34 0.191 0 O-C-N 124.103 0.877 . . . . 3.89 109.928 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -88.86 -23.16 22.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.775 -1.102 . . . . 3.07 109.827 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.683 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -62.73 -43.75 98.5 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 115.923 -0.58 . . . . 0.61 111.849 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 1.017 ' HA ' ' HH ' ' A' ' 118' ' ' TYR . 84.5 t -66.98 -47.02 83.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.842 -0.679 . . . . 1.36 110.34 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.77 -26.13 57.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.583 -0.735 . . . . 1.59 110.734 -173.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 t -63.64 -33.45 75.65 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.806 -0.813 . . . . 2.27 108.806 172.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.08 2.68 55.92 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.403 -0.817 . . . . 1.9 112.114 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.584 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -171.42 66.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.511 0.672 . . . . 2.08 111.401 -177.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.683 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -56.44 88.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.086 -0.961 . . . . 1.22 110.888 171.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.754 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.9 t30 -143.43 101.54 3.8 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.695 -0.483 . . . . 2.15 109.695 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -163.25 158.38 21.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.183 0.516 . . . . 2.03 110.875 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.8 ptp -91.99 137.46 32.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.223 -0.899 . . . . 4.31 108.941 170.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 107' ' ' VAL . 23.3 t80 -148.36 109.07 4.2 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.248 0.547 . . . . 2.95 109.981 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.44 104.24 15.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.147 -0.479 . . . . 1.97 109.768 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.2 p90 . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 121.067 0.46 . . . . 4.56 110.923 -177.008 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.06 -0.718 . . . . 3.49 109.06 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.21 155.46 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-O 121.34 0.591 . . . . 1.72 110.625 173.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.519 ' HB2' ' HG2' ' A' ' 123' ' ' LYS . 22.4 mtpp -128.97 105.58 8.31 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.25 -0.886 . . . . 2.83 108.903 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.766 HG21 ' HE1' ' A' ' 109' ' ' MET . 5.2 m -105.08 144.37 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 C-N-CA 119.562 -0.855 . . . . 1.64 112.177 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -117.61 103.11 9.73 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 105.674 -1.973 . . . . 1.35 105.674 156.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.766 ' HE1' HG21 ' A' ' 107' ' ' VAL . 9.1 ptp -106.28 128.4 53.94 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.081 -1.081 . . . . 2.72 108.081 -178.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 21.6 ptmt -139.44 133.16 30.6 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.613 -0.435 . . . . 2.17 110.847 -167.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.584 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 86.0 tttt -56.82 108.38 0.5 Allowed 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.597 0.713 . . . . 2.33 110.719 171.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.416 ' HB2' ' OG ' ' A' ' 117' ' ' SER . . . -53.7 137.38 37.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.104 -1.407 . . . . 1.12 110.489 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.62 3.81 7.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.247 -0.433 . . . . 2.97 110.93 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.9 m -80.91 -32.37 34.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 2.06 111.102 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 139.2 112.78 1.06 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.734 -0.746 . . . . 1.52 113.111 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 t70 26.96 72.48 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.821 1.248 . . . . 2.79 113.079 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 111' ' ' LYS . 1.3 p -153.81 159.71 41.97 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.837 -1.912 . . . . 0.95 105.837 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 1.017 ' HH ' ' HA ' ' A' ' 83' ' ' VAL . 17.1 m-85 -136.32 134.89 38.42 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.819 -0.752 . . . . 0.98 111.963 -175.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.558 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 41.9 m95 -85.89 165.85 16.46 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.746 -0.661 . . . . 0.48 111.164 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.525 HG23 HD23 ' A' ' 33' ' ' LEU . 95.9 t -139.21 97.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.388 -1.278 . . . . 1.3 108.877 172.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.527 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 90.3 m-85 -93.14 101.92 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.394 -0.965 . . . . 1.96 108.394 170.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 123' ' ' LYS . 13.2 p -115.62 149.99 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.153 0.502 . . . . 2.21 111.869 -172.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.519 ' HG2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.465 0 N-CA-C 108.147 -1.057 . . . . 3.87 108.147 173.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 122' ' ' VAL . . . . . . . . 0 N--CA 1.445 -0.735 0 N-CA-C 113.812 0.285 . . . . 2.04 113.812 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.34 102.72 14.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.662 0.615 . . . . 1.26 112.662 -166.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.45 HD12 HG21 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -126.49 139.9 50.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.11 -0.7 . . . . 1.5 109.11 172.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.573 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.2 pp0? -115.33 136.35 53.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.411 0.624 . . . . 2.22 111.366 -175.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -139.13 156.14 47.35 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.97 -1.014 . . . . 1.4 110.231 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.888 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 4.9 p30 -86.3 155.13 20.78 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.399 0.619 . . . . 1.15 110.673 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.59 14.48 17.68 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.375 -0.829 . . . . 1.2 111.871 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -100.97 -26.13 13.83 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.126 0.488 . . . . 1.81 109.689 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.59 28.84 0.94 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.826 -0.702 . . . . 1.05 113.414 173.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 21.9 m-80 -133.53 142.19 48.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.245 0.522 . . . . 1.79 111.13 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.45 HG21 HD12 ' A' ' 31' ' ' ILE . 81.3 mt -87.3 131.0 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.953 -0.758 . . . . 1.82 108.953 171.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.31 -49.7 3.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.927 0.344 . . . . 2.13 111.927 -171.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 31' ' ' ILE . 8.6 tt0 -141.84 128.76 20.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.984 0.421 . . . . 2.96 111.547 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -113.69 125.46 54.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.729 -0.668 . . . . 1.75 110.328 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 1.28 110.411 -177.464 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 111.201 -0.76 . . . . 3.32 111.201 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.5 tptt 68.57 10.54 7.94 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.016 0.436 . . . . 4.53 109.903 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.824 ' HA ' HD11 ' A' ' 88' ' ' LEU . 44.4 t80 -45.92 -40.9 10.8 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 113.975 1.102 . . . . 1.1 113.975 -165.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.945 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -63.94 -38.63 91.78 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 123.37 0.418 . . . . 3.89 110.421 -172.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.85 -27.89 20.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.695 -0.684 . . . . 3.07 109.584 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.903 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -55.32 -40.32 75.74 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.695 -0.684 . . . . 0.61 112.103 -177.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 79' ' ' PHE . 87.3 t -65.37 -53.39 40.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.533 -0.834 . . . . 1.36 110.954 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.67 -22.79 32.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.263 -0.426 . . . . 1.59 111.637 -171.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.6 t -70.86 -22.32 62.31 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.954 -0.758 . . . . 2.27 108.954 172.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.83 26.83 73.32 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.375 -0.83 . . . . 1.9 112.241 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 29.1 p30 -158.37 44.8 0.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.229 0.538 . . . . 2.08 111.72 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.903 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -66.06 86.4 0.1 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.151 -0.932 . . . . 1.22 111.777 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 109' ' ' MET . 2.6 t-20 -144.56 100.69 3.56 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.813 -0.355 . . . . 2.15 110.296 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.8 m -146.0 145.98 30.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.817 -0.438 . . . . 2.03 109.817 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.82 116.4 28.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.345 0.593 . . . . 4.31 109.609 170.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -133.62 154.55 50.81 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.274 -0.875 . . . . 2.95 109.136 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.795 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 7.6 pt-20 -131.28 123.05 27.53 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.78 -0.452 . . . . 1.97 109.78 174.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.2 t80 . . . . . 0 N--CA 1.445 -0.68 0 CA-C-N 115.57 -0.741 . . . . 4.56 110.251 -175.766 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.8 tttp . . . . . 0 C--O 1.239 0.525 0 CA-C-O 120.608 0.242 . . . . 3.49 110.379 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 27.6 m -105.67 160.74 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.361 0.601 . . . . 1.72 111.557 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.795 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 19.6 mmmt -117.46 141.14 48.69 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.152 -0.931 . . . . 2.83 109.5 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.2 102.32 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.113 0.482 . . . . 1.64 110.15 173.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.784 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.7 t-160 -108.91 102.82 11.8 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.652 -1.24 . . . . 1.35 107.652 171.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.742 ' HE3' ' HD2' ' A' ' 79' ' ' PHE . 59.8 mtp -108.78 143.75 37.52 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.709 -0.849 . . . . 2.72 108.709 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -147.55 133.88 19.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.974 -0.69 . . . . 2.17 110.5 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.656 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 84.0 tttt -55.9 111.59 0.97 Allowed 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 114.879 -1.055 . . . . 2.33 110.334 173.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.26 146.32 54.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.775 -1.102 . . . . 1.12 110.898 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.24 -6.83 25.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.983 -0.553 . . . . 2.97 110.709 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.49 ' HB2' ' OG ' ' A' ' 117' ' ' SER . 6.5 m -69.96 -29.41 66.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.746 -0.661 . . . . 2.06 110.617 176.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.16 -68.11 0.29 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.723 -0.751 . . . . 1.52 113.054 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -95.17 22.51 6.64 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.331 0.586 . . . . 2.79 111.503 -172.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.888 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.9 p -134.62 157.27 47.04 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.352 -0.84 . . . . 0.95 111.509 -173.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.656 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 48.3 m-85 -141.3 134.81 29.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.616 -0.72 . . . . 0.98 109.387 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.573 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 47.1 m95 -83.42 164.23 20.06 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.08 0.466 . . . . 0.48 110.673 -175.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 120' ' ' VAL . 15.0 p -138.34 97.18 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 122.581 1.181 . . . . 1.3 111.328 172.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.784 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 3.8 m-85 -86.69 102.29 14.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.516 -0.765 . . . . 1.96 109.094 177.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.566 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 25.4 m -100.88 153.58 4.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.157 0.503 . . . . 2.21 111.49 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 16.7 tppt? . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.865 -0.607 . . . . 3.87 109.679 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 122' ' ' VAL . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 112.529 -0.229 . . . . 2.04 112.529 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 43' ' ' ASN . . . -155.46 101.4 2.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.896 0.379 . . . . 1.26 110.255 175.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.521 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 3.2 tt -139.25 141.02 36.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.234 -0.439 . . . . 1.5 110.743 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.601 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.8 pt20 -110.81 126.33 54.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.322 0.582 . . . . 2.22 110.518 174.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.85 153.05 41.62 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.645 -0.707 . . . . 1.4 110.562 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.732 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -85.62 105.57 16.28 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.47 0.652 . . . . 1.15 112.407 -171.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 1.042 ' H ' ' HA ' ' A' ' 117' ' ' SER . . . 37.77 23.7 0.02 OUTLIER Glycine 0 N--CA 1.468 0.768 0 CA-C-N 113.272 -1.786 . . . . 1.2 117.42 161.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 34' ' ' ASP . 12.9 t70 174.75 -57.17 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.926 0.863 . . . . 1.81 111.756 -171.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.93 -31.35 0.03 OUTLIER Glycine 0 CA--C 1.524 0.655 0 C-N-CA 119.203 -1.475 . . . . 1.05 115.447 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.732 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 19.0 m-80 -67.84 116.33 8.39 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.728 1.264 . . . . 1.79 111.141 -173.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -70.73 128.62 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.928 -0.578 . . . . 1.82 110.616 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.7 tp -101.55 -47.58 4.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.75 -0.659 . . . . 2.13 110.799 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -151.07 142.86 23.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 2.96 111.401 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.521 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 69.1 t80 -130.5 138.5 50.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 1.75 109.729 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 39.8 m-80 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.851 0.358 . . . . 1.28 111.437 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.513 0 CA-C-O 120.231 -0.205 . . . . 3.32 112.595 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 58.38 25.15 12.5 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.73 -0.47 . . . . 4.53 109.73 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.609 ' HA ' HD13 ' A' ' 88' ' ' LEU . 38.7 t80 -50.51 -37.0 36.66 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.671 -0.695 . . . . 1.1 112.719 -165.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.48 -47.35 73.33 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 123.76 0.663 . . . . 3.89 110.343 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -82.35 -24.81 34.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.346 -0.612 . . . . 3.07 109.346 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.87 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -57.66 -42.97 94.53 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.304 -0.719 . . . . 0.61 111.304 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 79' ' ' PHE . 81.2 t -67.53 -53.85 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.434 -0.883 . . . . 1.36 111.019 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.35 -28.0 52.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.159 -0.473 . . . . 1.59 111.412 -169.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.0 t -66.98 -29.27 69.07 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.735 -0.839 . . . . 2.27 108.735 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.6 28.36 39.43 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.65 -0.705 . . . . 1.9 111.804 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -162.37 52.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.358 0.599 . . . . 2.08 111.816 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.87 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -73.13 86.35 1.38 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.907 -0.588 . . . . 1.22 110.658 177.111 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.728 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.2 t30 -143.9 102.35 3.88 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.619 -0.264 . . . . 2.15 110.474 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 t -152.26 161.64 42.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.343 -0.39 . . . . 2.03 110.194 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.466 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -127.04 146.71 50.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.892 -0.594 . . . . 4.31 109.79 174.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -164.19 141.85 6.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.052 -0.522 . . . . 2.95 109.802 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.496 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 44.5 mt-10 -103.01 113.14 26.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.361 -0.607 . . . . 1.97 109.361 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.8 t80 . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.456 . . . . 4.56 110.669 -172.956 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.496 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 15.0 ttpt . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.275 -0.639 . . . . 3.49 109.275 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 34.2 m -102.31 160.01 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 121.257 0.551 . . . . 1.72 110.457 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 123' ' ' LYS . 38.1 ttpt -129.31 110.64 12.11 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.207 -1.034 . . . . 2.83 108.207 172.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.8 m -98.86 144.68 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.485 0.66 . . . . 1.64 112.112 -175.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -137.11 102.08 4.74 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.646 -1.242 . . . . 1.35 107.646 161.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.728 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -97.12 133.46 41.74 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.376 -1.342 . . . . 2.72 107.376 173.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.512 ' HG3' ' HB2' ' A' ' 119' ' ' TRP . 14.8 ptpt -142.06 134.72 28.34 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.228 -0.589 . . . . 2.17 111.271 -172.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.586 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 39.1 tttm -56.31 115.11 2.28 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.501 -0.772 . . . . 2.33 110.534 170.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.44 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -64.91 147.2 53.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.563 -1.198 . . . . 1.12 111.431 -174.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.5 pt? -64.82 -10.11 25.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 2.97 111.356 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.2 p -79.84 -4.84 53.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.25 -0.432 . . . . 2.06 111.577 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.87 -122.82 6.72 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.638 -0.792 . . . . 1.52 112.229 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -72.15 85.63 1.04 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.547 0.689 . . . . 2.79 110.466 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 1.042 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 3.5 p -176.16 152.46 1.15 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.703 -1.135 . . . . 0.95 108.295 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 39.3 m-85 -142.07 139.16 32.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.639 0.257 . . . . 0.98 110.427 -176.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.601 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 46.1 m95 -88.39 166.81 14.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.488 0.661 . . . . 0.48 111.453 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.95 96.5 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.348 -1.296 . . . . 1.3 109.046 173.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.447 ' HE1' ' HD2' ' A' ' 110' ' ' LYS . 90.2 m-85 -95.05 124.33 39.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.402 -0.592 . . . . 1.96 109.402 173.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.474 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 26.0 t -128.52 132.79 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.868 0.366 . . . . 2.21 111.002 -176.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 74.7 mmtt . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 109.71 -0.478 . . . . 3.87 109.71 172.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.475 ' HA3' HG11 ' A' ' 122' ' ' VAL . . . . . . . . 0 N--CA 1.444 -0.803 0 N-CA-C 112.36 -0.296 . . . . 2.04 112.36 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.57 102.15 4.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.886 0.374 . . . . 1.26 110.363 173.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.576 HD11 HD11 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -138.98 140.31 38.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.678 -0.489 . . . . 1.5 109.678 178.02 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.707 ' HG2' ' HG2' ' A' ' 41' ' ' GLN . 3.7 pt20 -113.96 142.18 46.48 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.885 -0.726 . . . . 2.22 111.083 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.598 ' HB3' HD13 ' A' ' 39' ' ' ILE . 4.0 pp -133.02 163.89 28.23 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.083 -0.962 . . . . 1.4 110.094 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 2.1 p30 -90.05 151.83 21.45 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.131 0.491 . . . . 1.15 110.423 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -70.26 -9.65 64.44 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.553 -0.749 . . . . 1.2 111.883 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.449 ' HB3' ' OD1' ' A' ' 34' ' ' ASP . 30.3 t70 -73.04 -36.11 66.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.172 -0.514 . . . . 1.81 109.803 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.55 1.29 1.68 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.461 -0.876 . . . . 1.05 114.036 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.493 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 3.8 m-80 -107.44 158.39 17.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.34 0.57 . . . . 1.79 111.023 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.598 HD13 ' HB3' ' A' ' 33' ' ' LEU . 45.9 mm -85.49 140.99 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.811 -0.811 . . . . 1.82 108.811 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.537 HD22 ' NE2' ' A' ' 32' ' ' GLN . 29.9 tp -108.39 -54.21 2.54 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.361 -0.536 . . . . 2.13 110.933 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.707 ' HG2' ' HG2' ' A' ' 32' ' ' GLN . 26.4 pt20 -147.98 141.82 25.75 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.351 -0.54 . . . . 2.96 111.402 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -110.71 119.11 38.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.623 -0.717 . . . . 1.75 109.203 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--N 1.315 -0.928 0 N-CA-C 108.394 -0.965 . . . . 1.28 108.394 -178.337 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 111.478 -0.649 . . . . 3.32 111.478 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.5 pttt 42.59 47.77 4.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.432 0.693 . . . . 4.53 111.219 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.6 ' O ' HG22 ' A' ' 83' ' ' VAL . 43.0 t80 -50.36 -34.88 25.62 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 115.529 -0.76 . . . . 1.1 111.926 -171.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -66.72 -40.02 88.24 Favored 'General case' 0 C--N 1.344 0.338 0 O-C-N 123.813 0.695 . . . . 3.89 110.484 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -80.01 -31.42 39.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.098 -0.704 . . . . 3.07 109.098 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.817 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.37 -43.66 97.2 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.559 -0.746 . . . . 0.61 111.962 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 79' ' ' PHE . 99.3 t -64.6 -49.32 81.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.77 -0.715 . . . . 1.36 110.518 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.37 -24.48 39.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 1.59 111.413 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -65.35 -32.95 74.86 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.519 -0.548 . . . . 2.27 109.519 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.3 16.43 66.82 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.881 -0.676 . . . . 1.9 111.751 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -162.34 57.27 0.23 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.527 0.68 . . . . 2.08 110.861 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.817 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.5 tt -65.08 81.41 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.627 -0.715 . . . . 1.22 110.952 175.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.672 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 14.5 t30 -144.51 98.25 3.17 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.233 -0.654 . . . . 2.15 109.233 175.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.464 ' HG1' ' C ' ' A' ' 89' ' ' ASN . 6.4 m -153.29 153.83 33.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.808 -0.441 . . . . 2.03 109.808 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.432 ' N ' HG21 ' A' ' 90' ' ' THR . 17.7 ptm -101.01 116.14 32.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.349 -0.612 . . . . 4.31 109.349 167.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -114.86 109.95 18.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.794 -0.639 . . . . 2.95 109.873 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 9.4 pt-20 -104.39 114.57 28.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.063 0.459 . . . . 1.97 110.495 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 85.9 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.587 -0.733 . . . . 4.56 110.188 -176.976 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm . . . . . 0 C--O 1.236 0.369 0 N-CA-C 110.166 -0.309 . . . . 3.49 110.166 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 31.5 m -101.33 159.2 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 120.792 0.33 . . . . 1.72 110.361 172.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 43.6 mttp -127.26 123.33 36.23 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.157 -0.474 . . . . 2.83 110.702 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.47 102.85 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 109.229 -0.656 . . . . 1.64 109.229 173.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.721 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 3.3 t-160 -94.33 102.48 14.48 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.389 -1.708 . . . . 1.35 106.389 168.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.614 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 10.7 ttt -120.34 114.93 22.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.048 -1.093 . . . . 2.72 108.048 -173.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 64.6 pttt -134.16 135.44 43.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 120.048 -0.661 . . . . 2.17 110.418 -169.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.52 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 65.4 tttp -57.21 114.4 2.15 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.765 -0.652 . . . . 2.33 110.602 175.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.68 145.45 49.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.774 -1.103 . . . . 1.12 110.709 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.22 -13.08 61.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.208 -0.451 . . . . 2.97 110.478 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.5 m -61.84 -31.57 71.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.968 -0.56 . . . . 2.06 110.236 173.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 129.1 -96.82 0.4 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.575 -0.821 . . . . 1.52 113.03 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -88.68 49.02 1.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.603 0.716 . . . . 2.79 111.088 -171.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.0 p -147.43 159.37 43.79 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.503 -0.771 . . . . 0.95 109.968 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.539 ' CD2' ' HB3' ' A' ' 88' ' ' LEU . 36.1 m-85 -137.53 137.83 39.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.544 -0.298 . . . . 0.98 110.426 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.6 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 44.0 m95 -85.68 162.46 18.77 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.123 0.487 . . . . 0.48 111.176 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.537 HG22 ' HE3' ' A' ' 109' ' ' MET . 50.5 t -135.02 97.56 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.864 -1.062 . . . . 1.3 109.485 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.721 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 70.8 m-85 -102.31 104.29 14.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.607 -0.886 . . . . 1.96 108.607 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.475 HG11 ' HA3' ' A' ' 29' ' ' GLY . 9.9 p -92.74 148.61 4.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.789 -0.365 . . . . 2.21 110.576 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . 34.5 mtpt . . . . . 0 CA--C 1.507 -0.684 0 CA-C-N 116.167 -0.469 . . . . 3.87 110.173 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.611 0 CA-C-O 120.246 -0.197 . . . . 2.04 113.145 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.28 101.99 3.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.082 0.468 . . . . 1.26 110.918 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.665 HG13 ' HA ' ' A' ' 42' ' ' TYR . 7.1 tt -130.14 141.25 46.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.111 -0.495 . . . . 1.5 110.07 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.527 ' NE2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -113.88 129.05 56.63 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 116.13 -0.486 . . . . 2.22 109.91 -175.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.453 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.9 pp -126.0 157.55 37.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.156 0.503 . . . . 1.4 110.842 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 36' ' ' ASP . 3.6 p30 -79.24 156.84 27.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.544 0.688 . . . . 1.15 110.996 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -81.43 35.29 2.43 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.286 -0.87 . . . . 1.2 111.489 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 34' ' ' ASP . 27.1 t70 -123.56 -24.6 4.52 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.064 0.459 . . . . 1.81 110.048 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.57 7.5 4.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.722 -0.751 . . . . 1.05 113.291 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -126.94 159.49 33.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.129 0.49 . . . . 1.79 110.879 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 33' ' ' LEU . 10.9 mm -70.65 142.43 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 109.598 -0.519 . . . . 1.82 109.598 175.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.527 HD21 ' NE2' ' A' ' 32' ' ' GLN . 25.9 tp -109.01 -48.6 3.25 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.953 -0.388 . . . . 2.13 109.953 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -153.84 114.49 4.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 2.96 110.998 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.665 ' HA ' HG13 ' A' ' 31' ' ' ILE . 55.7 t80 -86.33 130.68 34.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.079 -0.51 . . . . 1.75 109.642 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 120.845 0.355 . . . . 1.28 110.356 -178.614 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.609 0 N-CA-C 111.49 -0.644 . . . . 3.32 111.49 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HG2' ' HB2' ' A' ' 81' ' ' GLU . 41.0 tttp 60.18 34.5 21.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.668 0.747 . . . . 4.53 109.037 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 83' ' ' VAL . 20.2 t80 -63.24 -41.3 99.06 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.105 -0.952 . . . . 1.1 112.109 -168.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -63.21 -34.67 78.14 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.73 0.644 . . . . 3.89 110.353 -176.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 78' ' ' LYS . 45.8 mt-10 -83.39 -31.47 26.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.254 -0.43 . . . . 3.07 109.928 175.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.887 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -57.86 -41.04 93.92 Favored Glycine 0 N--CA 1.436 -1.329 0 CA-C-N 115.716 -0.675 . . . . 0.61 112.119 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 79' ' ' PHE . 81.5 t -69.64 -51.02 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.698 -0.751 . . . . 1.36 110.914 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.58 -22.29 40.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.566 . . . . 1.59 111.688 -170.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.6 p -69.03 -33.68 74.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.845 -0.798 . . . . 2.27 108.845 172.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 111' ' ' LYS . . . 87.55 18.95 55.95 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.246 -0.888 . . . . 1.9 111.004 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -162.55 59.21 0.22 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.665 0.745 . . . . 2.08 110.976 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.887 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.3 tt -64.76 84.79 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.371 -0.831 . . . . 1.22 110.346 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.721 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.2 t30 -142.56 101.39 3.87 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.815 -0.439 . . . . 2.15 109.815 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.2 t -159.16 154.85 26.14 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.949 0.404 . . . . 2.03 110.267 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -112.66 131.71 55.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.593 -0.73 . . . . 4.31 109.776 177.417 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -140.37 131.96 27.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.684 -0.689 . . . . 2.95 109.812 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -101.13 116.8 33.68 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.87 -0.419 . . . . 1.97 109.87 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.2 t80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.625 -0.716 . . . . 4.56 109.978 -174.395 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt . . . . . 0 N--CA 1.445 -0.707 0 N-CA-C 108.738 -0.838 . . . . 3.49 108.738 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.1 m -101.07 157.73 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-O 121.152 0.501 . . . . 1.72 110.398 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -136.07 105.56 6.09 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.523 -0.762 . . . . 2.83 109.157 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.543 ' HB ' ' SD ' ' A' ' 109' ' ' MET . 0.8 OUTLIER -96.71 144.93 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 CA-C-O 121.257 0.551 . . . . 1.64 111.883 -178.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -135.4 103.92 5.66 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.778 -1.193 . . . . 1.35 107.778 162.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.721 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 3.6 mpp? -92.31 143.94 25.89 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.234 -1.395 . . . . 2.72 107.234 176.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -146.18 135.41 22.8 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.103 -1.039 . . . . 2.17 111.429 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.626 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 57.3 tttp -55.19 114.74 1.9 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.048 -0.978 . . . . 2.33 109.557 167.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 116' ' ' ASP . . . -49.35 139.24 11.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.076 -0.965 . . . . 1.12 110.98 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.0 mt -65.83 -15.74 63.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.145 -0.48 . . . . 2.97 110.871 -176.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.4 m -62.68 -57.36 11.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 2.06 110.067 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.3 -74.03 0.1 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.245 -0.742 . . . . 1.52 111.245 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 117' ' ' SER . 9.0 t70 -93.76 -167.52 1.71 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.579 -0.897 . . . . 2.79 108.579 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.539 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 37.0 p 60.4 155.67 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.47 1.108 . . . . 0.95 112.108 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.626 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 48.9 m-85 -136.55 138.36 41.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.53 -0.759 . . . . 0.98 109.678 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.518 ' CD2' ' HB2' ' A' ' 32' ' ' GLN . 44.1 m95 -91.43 164.76 13.71 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.302 0.573 . . . . 0.48 111.23 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.433 ' HB ' HG21 ' A' ' 31' ' ' ILE . 58.9 t -134.06 97.34 2.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.681 -1.145 . . . . 1.3 109.277 176.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -98.59 121.73 40.9 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.778 -0.823 . . . . 1.96 108.778 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.3 p -124.68 147.21 29.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.03 0.443 . . . . 2.21 111.119 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-N 115.86 -0.609 . . . . 3.87 109.468 175.748 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 120.746 0.307 . . . . 9.06 110.97 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.17 3.37 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.038 -0.727 . . . . 6.45 109.038 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -155.24 139.65 16.77 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.577 -1.192 . . . . 7.02 108.467 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.518 ' H ' ' HH ' ' A' ' 42' ' ' TYR . . . 105.45 -15.7 45.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.522 -0.847 . . . . 2.04 112.908 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -95.03 102.91 14.74 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.855 0.359 . . . . 1.26 111.697 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.726 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -119.69 140.41 43.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.886 0.374 . . . . 1.5 110.223 177.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.44 128.71 56.55 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.172 -0.677 . . . . 2.22 109.172 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 pp -129.95 158.05 40.62 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.415 0.626 . . . . 1.4 110.816 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -85.11 150.91 24.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.476 -0.784 . . . . 1.15 110.424 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.567 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -80.44 32.27 2.35 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.79 -0.641 . . . . 1.2 112.696 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 34' ' ' ASP . 30.5 t0 -126.24 -30.27 2.92 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.829 -0.434 . . . . 1.81 109.829 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.23 10.44 0.84 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.99 -1.1 . . . . 1.05 114.404 171.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 3.8 p30 -118.92 139.39 51.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 118.009 0.905 . . . . 1.79 111.998 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.491 HG21 HD12 ' A' ' 31' ' ' ILE . 43.5 mm -75.52 139.21 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.709 -0.678 . . . . 1.82 109.497 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 tp -106.95 -53.18 2.65 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.864 -0.335 . . . . 2.13 111.018 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -153.85 145.06 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.406 -0.518 . . . . 2.96 111.869 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.726 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 45.6 t80 -117.78 124.31 48.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.706 -0.679 . . . . 1.75 109.633 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 35.0 m-80 -85.49 96.65 9.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.374 -0.376 . . . . 1.28 110.453 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 176.18 -32.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.028 -0.987 . . . . 2.53 109.552 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.91 90.31 4.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.653 -0.703 . . . . 4.46 110.778 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -147.45 40.46 1.02 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.024 0.916 . . . . 7.21 108.767 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.04 94.32 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.191 -1.368 . . . . 7.0 110.427 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -78.85 87.05 4.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.478 0.656 . . . . 8.59 110.199 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 pt -113.79 23.77 4.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.294 -0.866 . . . . 9.53 111.29 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.9 m -136.48 157.23 47.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.053 -0.522 . . . . 10.16 109.813 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -112.63 45.97 1.24 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.513 -0.635 . . . . 10.12 111.513 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -84.03 173.23 11.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.967 0.413 . . . . 13.33 110.915 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.509 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 29.4 t70 -87.51 111.2 40.03 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.711 -0.848 . . . . 8.24 108.711 170.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 7.0 Cg_exo -74.65 19.89 0.45 Allowed 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.583 2.855 . . . . 8.73 113.822 -172.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -99.05 32.2 2.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.636 0.732 . . . . 9.47 109.778 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -96.42 -48.54 5.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.395 -0.821 . . . . 8.03 110.614 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.475 ' O ' HG12 ' A' ' 58' ' ' ILE . 16.9 m -124.62 170.84 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.081 -0.508 . . . . 5.42 110.883 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 57' ' ' VAL . 17.8 pt 50.73 166.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.49 1.516 . . . . 3.61 114.275 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.48 39.98 95.61 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 114.584 -1.189 . . . . 3.37 111.053 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.458 ' HB3' HG12 ' A' ' 39' ' ' ILE . 15.2 tppt? -105.31 101.99 11.5 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.025 0.44 . . . . 4.22 111.147 -171.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.464 ' N ' HD21 ' A' ' 61' ' ' ASN . 0.8 OUTLIER -94.46 109.16 21.05 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.395 -0.965 . . . . 4.71 108.395 171.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -90.31 96.54 10.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.469 0.652 . . . . 7.47 110.854 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 65' ' ' ASP . 9.2 p90 -78.05 155.43 30.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.044 -0.98 . . . . 8.88 110.007 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -75.77 74.36 2.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.745 0.783 . . . . 10.35 111.04 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.486 ' HB2' ' CD1' ' A' ' 63' ' ' PHE . 38.7 t70 -86.03 5.29 34.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.291 -0.868 . . . . 7.94 110.101 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.9 t 59.15 67.95 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.976 0.893 . . . . 9.58 109.762 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.64 84.08 16.17 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.029 -0.987 . . . . 9.32 110.328 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -87.53 3.44 6.35 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.518 2.145 . . . . 10.74 112.55 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.5 m -113.15 86.38 2.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.089 0.471 . . . . 11.49 111.076 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -130.15 56.81 1.73 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.954 -0.758 . . . . 11.26 108.954 169.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 64.92 11.8 7.3 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.952 -1.022 . . . . 11.56 112.144 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.7 t -149.36 83.78 6.39 Favored Pre-proline 0 C--N 1.323 -0.553 0 C-N-CA 120.905 -0.318 . . . . 11.11 110.96 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.22 -53.78 3.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.356 2.037 . . . . 11.05 110.44 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -93.23 120.42 33.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.37 -0.974 . . . . 11.76 108.37 166.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -65.99 117.37 8.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.144 -0.48 . . . . 10.74 111.677 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 50.4 -113.6 0.68 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.964 0.79 . . . . 7.67 112.284 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.84 76.0 0.34 Allowed Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 120.591 -0.814 . . . . 3.32 111.133 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 60.9 32.36 20.02 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 123.913 0.42 . . . . 4.53 110.336 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.553 ' O ' HG23 ' A' ' 83' ' ' VAL . 67.4 t80 -50.21 -32.22 15.9 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.946 -0.57 . . . . 1.1 111.606 -177.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -69.81 -34.08 73.22 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 123.802 0.689 . . . . 3.89 109.698 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -84.18 -31.44 25.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.585 -0.734 . . . . 3.07 109.2 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.854 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -54.44 -41.15 71.49 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.371 -0.831 . . . . 0.61 111.972 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 79' ' ' PHE . 96.6 t -65.23 -53.49 39.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.405 -0.897 . . . . 1.36 110.942 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.43 -27.78 27.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.148 -0.478 . . . . 1.59 111.655 -170.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 t -66.57 -27.21 67.55 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.014 -0.736 . . . . 2.27 109.014 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.86 29.44 51.67 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.67 -0.695 . . . . 1.9 112.469 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -157.18 48.65 0.43 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.61 0.719 . . . . 2.08 111.519 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.854 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -74.82 79.71 2.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.4 -0.818 . . . . 1.22 111.198 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.3 p-10 -144.09 101.11 3.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.478 0.656 . . . . 2.15 109.528 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -147.42 147.8 30.62 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.806 -0.559 . . . . 2.03 110.535 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.605 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -109.32 115.55 30.19 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.046 -0.724 . . . . 4.31 109.046 169.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.515 ' HE2' ' HD2' ' A' ' 94' ' ' TYR . 84.1 t80 -132.17 126.97 34.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.804 -0.634 . . . . 2.95 109.97 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 9.7 pt-20 -97.23 130.63 44.43 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.481 -0.563 . . . . 1.97 109.481 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.515 ' HD2' ' HE2' ' A' ' 92' ' ' PHE . 27.4 t80 -119.04 115.42 24.27 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.636 -0.505 . . . . 4.56 109.636 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -90.92 136.9 32.76 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.109 -0.496 . . . . 3.22 110.245 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -105.33 95.07 5.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.783 -0.451 . . . . 5.99 109.783 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.21 28.01 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.3 0.572 . . . . 6.06 110.562 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -100.31 -166.51 1.33 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.715 -0.675 . . . . 10.04 110.204 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.11 -58.33 2.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.476 -0.329 . . . . 8.93 110.549 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 96.4 mmm -95.74 33.4 1.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.764 0.316 . . . . 8.55 111.692 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 p -101.42 164.82 15.21 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.899 0.333 . . . . 5.39 111.899 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.78 -172.84 0.88 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.828 2.352 . . . . 5.02 112.273 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.1 p -84.71 161.39 20.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.392 -0.367 . . . . 2.85 111.756 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -64.64 112.02 3.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.689 -0.687 . . . . 3.49 110.674 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 20.7 m -116.32 160.92 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.182 0.515 . . . . 1.72 111.353 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 85.8 tttt -125.03 123.98 40.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.31 -0.859 . . . . 2.83 109.184 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.1 t -101.74 119.42 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 116.45 -0.341 . . . . 1.64 110.34 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -106.79 104.33 13.98 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.22 -1.03 . . . . 1.35 108.22 168.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.535 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 55.0 mtm -97.5 145.57 26.08 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.276 -1.009 . . . . 2.72 108.276 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.507 ' CG ' ' HB2' ' A' ' 119' ' ' TRP . 19.4 ptpt -146.42 127.07 14.24 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.384 -0.527 . . . . 2.17 109.827 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.555 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 51.6 tttm -57.34 113.57 1.81 Allowed 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 116.064 -0.516 . . . . 2.33 109.906 170.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.44 138.93 38.9 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.701 -1.136 . . . . 1.12 110.485 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.5 mt -67.88 -8.58 37.69 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.245 -0.434 . . . . 2.97 110.918 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 m -70.94 -38.61 72.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 2.06 110.503 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.67 -105.76 0.34 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.73 -0.748 . . . . 1.52 112.81 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.29 65.05 7.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.597 0.713 . . . . 2.79 112.013 -175.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.567 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 1.7 p -157.67 157.97 34.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.922 -1.035 . . . . 0.95 108.506 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.555 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 28.9 m-85 -140.74 139.75 34.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.687 0.28 . . . . 0.98 110.603 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.507 ' HB2' ' CG ' ' A' ' 110' ' ' LYS . 38.9 m95 -93.09 162.48 14.02 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.288 0.566 . . . . 0.48 111.241 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.604 ' HB ' HG23 ' A' ' 31' ' ' ILE . 87.7 t -136.89 101.77 2.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.561 -1.199 . . . . 1.3 109.268 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -102.19 106.39 17.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.553 -0.536 . . . . 1.96 109.553 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 p -92.37 143.87 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.077 0.465 . . . . 2.21 110.244 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -149.8 110.25 4.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.677 -0.49 . . . . 3.87 109.677 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 7.7 ptm180 -77.06 143.68 39.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.648 -0.421 . . . . 4.72 110.254 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.799 -0.637 . . . . 3.55 109.517 177.703 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.995 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.999 0.428 . . . . 9.06 110.61 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.63 -168.45 1.78 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.891 -0.595 . . . . 6.45 109.967 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -95.91 -31.68 13.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.083 0.468 . . . . 7.02 110.415 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.66 72.91 0.76 Allowed Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 121.062 -0.59 . . . . 2.04 112.208 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.42 102.38 3.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.95 0.405 . . . . 1.26 110.75 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.591 HG22 ' HB ' ' A' ' 120' ' ' VAL . 4.5 tt -132.02 141.07 46.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.927 0.394 . . . . 1.5 110.672 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.453 ' HB2' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -114.52 122.98 48.24 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.41 -0.959 . . . . 2.22 108.41 177.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.46 164.06 29.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.864 -0.607 . . . . 1.4 111.082 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.945 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 2.3 p30 -98.09 153.95 18.07 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.015 -0.539 . . . . 1.15 110.981 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.0 -17.03 75.22 Favored Glycine 0 CA--C 1.511 -0.17 0 CA-C-N 115.173 -0.921 . . . . 1.2 112.628 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.53 -38.98 92.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.97 0.414 . . . . 1.81 110.421 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.46 38.26 0.31 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.706 -0.759 . . . . 1.05 112.843 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.563 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 4.3 m-80 -134.25 147.96 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.976 -0.379 . . . . 1.79 109.976 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.745 HG13 ' HB3' ' A' ' 60' ' ' LYS . 86.7 mt -87.33 134.73 26.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.936 -0.394 . . . . 1.82 109.936 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.576 ' O ' HD11 ' A' ' 58' ' ' ILE . 45.0 tp -101.56 -41.45 6.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 2.13 110.86 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -158.99 143.43 15.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.993 0.425 . . . . 2.96 111.204 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.49 ' HB3' HG11 ' A' ' 57' ' ' VAL . 40.9 t80 -114.34 114.86 26.47 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.601 -0.889 . . . . 1.75 108.601 174.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -91.61 91.59 8.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.168 0.509 . . . . 1.28 110.647 -173.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -170.2 13.04 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.89 -1.05 . . . . 2.53 109.12 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.613 ' HB1' ' HB2' ' A' ' 48' ' ' ASP . . . -143.11 109.15 5.23 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.325 -0.852 . . . . 4.46 110.983 -174.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -137.6 97.55 3.48 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.758 -0.83 . . . . 7.21 108.758 172.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.87 -16.43 39.71 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.64 -0.984 . . . . 7.0 110.64 -169.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.613 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 4.1 m-20 -78.26 104.63 8.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.441 -0.379 . . . . 8.59 110.159 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.9 mm -103.1 132.96 48.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.395 -0.594 . . . . 9.53 109.395 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.0 p -117.4 173.21 6.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.785 0.326 . . . . 10.16 111.789 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.29 -108.41 1.89 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.791 -0.924 . . . . 10.12 110.791 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -83.34 89.34 7.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.247 -0.649 . . . . 13.33 109.247 171.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 23.7 t70 -127.8 107.24 20.43 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.054 -0.521 . . . . 8.24 110.829 -173.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 1.9 Cg_endo -83.4 36.94 0.63 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.505 2.803 . . . . 8.73 113.467 -175.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.51 -175.62 5.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.865 0.364 . . . . 9.47 110.42 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -100.0 25.35 7.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.398 0.618 . . . . 8.03 110.466 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 42' ' ' TYR . 42.6 t -76.7 88.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.399 -0.963 . . . . 5.42 108.399 174.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.576 HD11 ' O ' ' A' ' 40' ' ' LEU 0.264 13.7 tt 37.85 73.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 122.982 1.372 . . . . 3.61 111.963 -173.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.31 19.24 2.85 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 113.904 -1.498 . . . . 3.37 111.673 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.745 ' HB3' HG13 ' A' ' 39' ' ' ILE . 16.9 tppt? -105.23 115.58 30.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.127 -0.323 . . . . 4.22 110.127 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -125.17 94.85 4.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.191 0.52 . . . . 4.71 110.636 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.474 ' CE1' ' HB2' ' A' ' 64' ' ' LYS . 25.1 t80 34.82 79.09 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.756 -1.111 . . . . 7.47 113.217 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -92.8 21.12 5.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.812 0.815 . . . . 8.88 109.787 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.474 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 62.5 mttm -101.57 4.41 40.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.489 -0.778 . . . . 10.35 110.851 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -79.19 123.87 27.81 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.831 -0.433 . . . . 7.94 109.831 177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.9 t 54.79 78.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.327 0 O-C-N 123.762 0.664 . . . . 9.58 109.534 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.56 105.95 0.38 Allowed Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.261 -0.881 . . . . 9.32 112.27 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.53 172.1 5.94 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.099 2.533 . . . . 10.74 113.233 -174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.8 124.08 21.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.758 -0.655 . . . . 11.49 109.441 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -165.2 159.08 17.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.338 -0.392 . . . . 11.26 110.1 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -137.13 74.44 1.48 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.591 0.71 . . . . 11.56 109.301 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 70.0 m -153.91 121.2 2.92 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 114.982 -1.008 . . . . 11.11 108.824 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 72' ' ' SER . 5.4 Cg_exo -75.2 118.62 5.28 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.654 2.236 . . . . 11.05 112.607 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -80.1 43.65 0.63 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.053 -0.721 . . . . 11.76 109.053 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.532 ' CZ ' ' HD3' ' A' ' 78' ' ' LYS . 76.0 t80 -83.99 -42.43 16.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.23 -0.895 . . . . 10.74 111.633 -170.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' A' ' 79' ' ' PHE . 94.8 m-85 52.22 -96.98 0.05 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.618 0.574 . . . . 7.67 110.986 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.525 ' HA3' ' HE2' ' A' ' 109' ' ' MET . . . -139.32 71.35 0.44 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.177 -1.169 . . . . 3.32 110.177 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HD3' ' CZ ' ' A' ' 75' ' ' PHE . 45.8 mmtm 67.12 31.65 6.65 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 123.987 0.463 . . . . 4.53 110.293 -173.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.688 ' HA ' HD12 ' A' ' 88' ' ' LEU . 65.5 t80 -47.9 -36.86 12.94 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 112.245 0.461 . . . . 1.1 112.245 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.39 -39.64 74.42 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.418 0.627 . . . . 3.89 109.963 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.08 -29.02 48.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.158 -0.928 . . . . 3.07 108.917 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.819 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.82 -41.27 97.57 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.451 -0.795 . . . . 0.61 111.516 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.755 ' HA ' ' HH ' ' A' ' 118' ' ' TYR . 95.4 t -64.94 -51.83 61.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.431 -0.884 . . . . 1.36 110.674 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.64 -24.69 49.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.062 -0.517 . . . . 1.59 111.05 -172.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -65.21 -34.52 78.56 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.548 -0.908 . . . . 2.27 108.548 172.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.73 15.57 61.32 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.25 -0.886 . . . . 1.9 112.301 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -164.0 54.63 0.15 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.328 0.585 . . . . 2.08 111.838 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.819 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -65.37 96.11 0.22 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.519 -0.764 . . . . 1.22 111.547 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.6 p30 -145.05 108.53 4.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.32 0.581 . . . . 2.15 110.283 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -142.2 162.42 35.53 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.098 -0.501 . . . . 2.03 111.411 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.713 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 25.8 ptt? -151.5 116.08 5.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.815 0.816 . . . . 4.31 110.285 169.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -149.89 144.32 25.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.949 -1.023 . . . . 2.95 109.057 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.579 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 25.8 mt-10 -95.35 116.44 28.78 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.189 -0.671 . . . . 1.97 109.189 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -108.59 125.32 51.71 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.647 -0.706 . . . . 4.56 110.296 -172.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -96.91 150.31 20.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.833 -0.621 . . . . 3.22 111.481 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 93.2 m-85 -112.39 110.93 21.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.752 -0.658 . . . . 5.99 109.637 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 11.6 t70 63.94 -168.14 0.21 Allowed 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.804 0.69 . . . . 6.06 110.15 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.465 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 21.7 p90 -155.74 2.84 0.17 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.737 0.303 . . . . 10.04 111.219 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -114.51 104.02 11.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.236 -0.438 . . . . 8.93 109.956 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 56.0 mtm 62.05 18.38 9.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.12 -0.491 . . . . 8.55 111.056 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.5 m -129.99 95.97 27.03 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.122 0.487 . . . . 5.39 110.48 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -90.83 28.06 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.105 2.536 . . . . 5.02 112.529 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 96' ' ' PHE . 8.2 m -75.59 99.06 4.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.295 0.569 . . . . 2.85 110.904 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -122.47 133.82 54.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.76 -0.655 . . . . 3.49 109.723 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.52 160.72 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.125 0.488 . . . . 1.72 110.824 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 13.9 ttmm -116.86 124.17 48.85 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.64 -0.874 . . . . 2.83 108.64 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 91' ' ' MET . 1.1 m -109.32 104.32 16.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.167 0.508 . . . . 1.64 111.494 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 15.0 t-160 -109.84 105.1 14.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.723 -0.843 . . . . 1.35 108.723 172.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.525 ' HE2' ' HA3' ' A' ' 77' ' ' GLY . 53.6 mtm -117.86 144.31 45.52 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.815 -0.809 . . . . 2.72 108.815 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -149.34 129.67 13.77 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.142 -0.623 . . . . 2.17 110.187 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.422 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 75.5 tttt -56.85 114.91 2.29 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.787 -0.642 . . . . 2.33 110.366 174.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.543 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -62.62 145.81 53.59 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.792 -1.095 . . . . 1.12 110.251 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -67.07 1.27 2.08 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.305 0.483 . . . . 2.97 112.305 -177.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.6 t -91.6 6.24 46.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.799 0.333 . . . . 2.06 110.95 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -108.12 3.64 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.633 -0.794 . . . . 1.52 112.035 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.93 87.23 2.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.371 0.605 . . . . 2.79 110.628 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.945 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.3 p 179.25 151.32 0.34 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.824 -1.08 . . . . 0.95 109.169 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.755 ' HH ' ' HA ' ' A' ' 83' ' ' VAL . 22.6 m-85 -147.11 136.45 22.66 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.549 -0.537 . . . . 0.98 109.549 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.453 ' CD2' ' HB2' ' A' ' 32' ' ' GLN . 45.2 m95 -86.33 159.3 19.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.07 0.462 . . . . 0.48 110.481 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 31' ' ' ILE . 72.1 t -138.21 104.31 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.108 -0.951 . . . . 1.3 109.964 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.634 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 71.5 m-85 -110.4 116.75 31.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.0 -0.741 . . . . 1.96 109.0 175.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 18.1 m -115.79 154.62 17.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.551 0.691 . . . . 2.21 111.355 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.457 ' HE2' ' HE2' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -146.5 110.09 4.86 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.066 -0.97 . . . . 3.87 109.077 178.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -85.71 126.85 34.28 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.029 -0.532 . . . . 4.72 110.026 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 117.799 -1.096 . . . . 3.55 111.461 179.044 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.97 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.962 0.41 . . . . 9.06 111.753 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.81 92.19 8.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.003 0.43 . . . . 6.45 110.52 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -103.06 -170.98 1.87 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.099 -0.5 . . . . 7.02 110.895 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.62 37.94 1.67 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.781 -0.723 . . . . 2.04 112.375 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.81 105.17 4.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.625 0.25 . . . . 1.26 110.537 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.72 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 6.3 tt -133.52 140.37 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.196 0.522 . . . . 1.5 111.097 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.564 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 3.2 pt20 -109.66 129.79 55.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.6 -0.727 . . . . 2.22 110.548 176.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.29 159.03 36.53 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.513 -0.767 . . . . 1.4 109.915 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.579 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 37.2 p30 -84.5 164.66 18.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.373 0.606 . . . . 1.15 111.439 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.53 21.13 3.84 Favored Glycine 0 C--N 1.322 -0.249 0 CA-C-N 115.257 -0.883 . . . . 1.2 112.441 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 34' ' ' ASP . 1.1 m-20 -112.08 -26.55 8.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.804 0.335 . . . . 1.81 110.329 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.45 11.61 7.22 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.907 -0.588 . . . . 1.05 111.86 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -109.53 143.59 38.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.892 0.377 . . . . 1.79 110.421 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.729 HG21 ' HA ' ' A' ' 58' ' ' ILE . 51.2 mm -79.9 139.41 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.227 -0.657 . . . . 1.82 109.227 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.3 tp -106.72 -52.31 2.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.628 -0.26 . . . . 2.13 111.095 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -163.19 147.14 10.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 2.96 111.336 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.72 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 49.0 t80 -114.27 151.23 33.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.01 -0.541 . . . . 1.75 110.118 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -129.98 134.44 47.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.961 -0.563 . . . . 1.28 110.22 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.55 46.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.127 -0.488 . . . . 2.53 110.153 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.78 93.22 8.76 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.049 -0.26 . . . . 4.46 110.777 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 67.57 103.18 0.05 OUTLIER 'General case' 0 C--O 1.235 0.313 0 O-C-N 124.112 0.882 . . . . 7.21 111.5 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.17 35.97 0.16 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.442 -0.799 . . . . 7.0 111.491 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -75.53 98.82 4.06 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.115 -0.328 . . . . 8.59 110.115 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.9 pt 33.97 47.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.283 1.033 . . . . 9.53 112.848 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.2 m -93.82 84.97 4.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.659 -0.701 . . . . 10.16 110.576 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.83 -79.44 0.35 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.912 -0.661 . . . . 10.12 111.806 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 mtt-85 -144.61 156.25 44.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.121 -0.696 . . . . 13.33 109.121 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -103.5 106.66 52.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.506 0.669 . . . . 8.24 110.287 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.84 -29.27 3.52 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.579 2.186 . . . . 8.73 112.266 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -127.65 113.18 15.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.958 -0.565 . . . . 9.47 109.72 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -107.16 44.32 1.08 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.64 0.733 . . . . 8.03 109.646 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.42 -35.74 71.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.29 -0.868 . . . . 5.42 109.806 171.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.729 ' HA ' HG21 ' A' ' 39' ' ' ILE . 10.0 tt -73.4 146.99 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.893 -0.594 . . . . 3.61 109.725 174.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.415 ' N ' HG12 ' A' ' 58' ' ' ILE . . . 100.92 -1.18 55.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.465 -0.874 . . . . 3.37 111.711 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HB3' HG12 ' A' ' 39' ' ' ILE . 1.7 tppp? -69.25 90.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 4.22 110.036 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.476 HD21 ' C ' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -125.78 95.63 4.49 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.971 -0.752 . . . . 4.71 108.971 173.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.503 ' HD2' ' HD3' ' A' ' 60' ' ' LYS . 71.5 m-85 -148.37 129.91 14.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.956 -0.566 . . . . 7.47 110.299 -174.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -98.75 1.98 46.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.172 0.51 . . . . 8.88 110.142 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -96.05 -16.08 21.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.664 -0.698 . . . . 10.35 110.269 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.25 112.43 6.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.775 -0.648 . . . . 7.94 110.335 -173.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.4 -28.96 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.328 -0.396 . . . . 9.58 112.059 -174.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -38.22 110.27 0.54 Allowed Pre-proline 0 N--CA 1.471 0.597 0 N-CA-C 113.914 1.079 . . . . 9.32 113.914 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.32 -33.07 4.54 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.046 2.497 . . . . 10.74 111.071 171.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.8 m 61.94 179.43 0.12 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.447 -0.797 . . . . 11.49 111.881 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.3 p -79.02 -46.18 18.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.113 -0.699 . . . . 11.26 109.113 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -78.95 109.98 13.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.591 -0.731 . . . . 11.56 109.271 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.5 t -69.65 137.55 88.18 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.332 -0.395 . . . . 11.11 111.153 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.37 160.7 13.07 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.088 2.525 . . . . 11.05 112.265 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.45 124.5 23.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 11.76 111.205 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -84.7 -4.01 58.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 10.74 111.056 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 54.15 -106.3 0.31 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.914 -0.585 . . . . 7.67 111.43 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.72 60.03 0.37 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.676 -0.773 . . . . 3.32 111.303 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 62.03 37.93 14.46 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.654 0.382 . . . . 4.53 110.268 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.69 ' HD2' ' HE1' ' A' ' 109' ' ' MET . 69.6 t80 -47.34 -32.37 4.76 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.352 0.661 . . . . 1.1 112.247 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -62.46 -44.02 97.42 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 123.933 0.771 . . . . 3.89 110.291 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.11 -22.99 22.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.149 -0.478 . . . . 3.07 109.756 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.929 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.27 -38.03 92.7 Favored Glycine 0 N--CA 1.436 -1.3 0 CA-C-N 115.776 -0.647 . . . . 0.61 112.323 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 79' ' ' PHE . 69.2 t -69.81 -48.61 63.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.93 -0.635 . . . . 1.36 110.411 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.5 -23.74 42.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.423 -0.808 . . . . 1.59 111.352 -170.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.6 p -67.62 -28.41 67.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.494 0.664 . . . . 2.27 109.219 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.16 19.5 62.59 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.356 -0.838 . . . . 1.9 111.839 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -162.85 55.75 0.2 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.359 0.6 . . . . 2.08 111.225 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.929 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -69.07 83.61 0.33 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.553 -0.749 . . . . 1.22 111.326 176.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.9 p-10 -144.86 99.04 3.28 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.455 0.645 . . . . 2.15 109.789 171.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.425 HG23 ' N ' ' A' ' 91' ' ' MET . 11.9 m -146.31 152.52 39.27 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.136 -0.484 . . . . 2.03 110.333 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.425 ' N ' HG23 ' A' ' 90' ' ' THR . 16.8 ptt? -123.22 129.26 51.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.93 0.395 . . . . 4.31 110.323 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -150.66 142.96 24.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.806 -0.634 . . . . 2.95 109.759 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.61 117.1 29.83 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.663 -0.495 . . . . 1.97 109.663 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -108.67 88.99 2.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.685 -0.857 . . . . 4.56 108.685 -175.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.7 t -84.97 145.68 27.61 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.231 -0.895 . . . . 3.22 111.854 -172.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.787 ' HB3' ' HB ' ' A' ' 101' ' ' THR . 42.3 m-85 -126.32 117.83 23.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.808 -1.182 . . . . 5.99 107.808 171.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.44 -123.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.834 0.309 . . . . 6.06 111.834 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -107.94 9.43 28.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.002 0.429 . . . . 10.04 110.791 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -83.58 71.38 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.318 -0.401 . . . . 8.93 111.122 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 17.4 ptp 48.25 21.72 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.399 1.08 . . . . 8.55 112.394 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.787 ' HB ' ' HB3' ' A' ' 96' ' ' PHE . 2.3 p -95.61 151.9 38.82 Favored Pre-proline 0 N--CA 1.446 -0.674 0 CA-C-N 116.436 -0.347 . . . . 5.39 111.267 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 5.6 Cg_exo -80.07 -73.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.728 2.285 . . . . 5.02 113.416 -174.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.521 ' O ' ' HD2' ' A' ' 96' ' ' PHE . 21.3 p -128.47 164.79 21.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.191 0.519 . . . . 2.85 112.014 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.847 ' HD3' ' HA ' ' A' ' 125' ' ' VAL . 15.1 tttt -89.36 130.68 35.7 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.959 -1.126 . . . . 3.49 107.959 164.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -126.03 163.66 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.182 0.515 . . . . 1.72 110.867 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 22.1 ptmt -135.31 140.33 45.03 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.412 -0.813 . . . . 2.83 109.03 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.75 142.02 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-O 121.679 0.752 . . . . 1.64 112.157 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 18.5 t-160 -131.71 104.67 7.04 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.004 -1.48 . . . . 1.35 107.004 164.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.69 ' HE1' ' HD2' ' A' ' 79' ' ' PHE . 79.7 mtp -105.98 148.13 28.05 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.826 -0.805 . . . . 2.72 108.826 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.8 ptmm? -152.59 134.43 14.74 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.893 -0.723 . . . . 2.17 109.671 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.467 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 18.5 ttmm -56.95 115.35 2.55 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.409 0.623 . . . . 2.33 109.726 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.54 138.02 58.35 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.659 -1.155 . . . . 1.12 110.866 -172.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.52 -8.66 55.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.185 0.517 . . . . 2.97 109.974 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.2 m -65.41 -35.92 82.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.487 -0.779 . . . . 2.06 110.089 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.09 139.68 9.36 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.825 -0.625 . . . . 1.52 112.335 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.53 44.75 17.2 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.42 0.688 . . . . 2.79 112.091 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 2.9 p -158.98 157.16 30.77 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.249 -0.887 . . . . 0.95 110.383 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.467 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 39.8 m-85 -139.29 137.21 35.65 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.443 -0.577 . . . . 0.98 109.443 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.564 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 39.8 m95 -84.05 161.7 20.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.278 0.561 . . . . 0.48 111.27 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.576 HG23 ' HE2' ' A' ' 109' ' ' MET . 59.3 t -137.77 95.82 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.426 -1.261 . . . . 1.3 108.93 175.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 89.6 m-85 -90.31 101.55 14.27 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.414 -0.958 . . . . 1.96 108.414 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 7.1 p -116.97 134.02 61.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.81 0.338 . . . . 2.21 110.478 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -142.65 144.34 32.73 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.824 -0.436 . . . . 3.87 109.824 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -81.34 155.3 26.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.335 -0.393 . . . . 4.72 111.062 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.847 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 14.8 m . . . . . 0 C--O 1.252 1.204 0 O-C-N 124.998 1.436 . . . . 3.55 113.582 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.993 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.8 tp . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.857 0.361 . . . . 9.06 110.553 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.84 119.45 33.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.212 -0.449 . . . . 6.45 110.22 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.525 ' HE2' ' HA3' ' A' ' 47' ' ' GLY . 98.6 m-85 -80.1 152.28 29.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.29 -0.414 . . . . 7.02 110.971 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 57.81 44.61 94.19 Favored Glycine 0 C--O 1.226 -0.382 0 CA-C-N 115.917 -0.583 . . . . 2.04 112.945 175.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.14 102.9 14.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.997 0.427 . . . . 1.26 111.755 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.689 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -128.49 139.73 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.954 0.407 . . . . 1.5 110.025 175.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.584 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.3 pt20 -112.81 134.67 54.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.471 0.653 . . . . 2.22 111.416 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.62 161.84 23.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.149 -0.932 . . . . 1.4 110.019 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 36' ' ' ASP . 3.5 p30 -90.87 153.99 19.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.261 0.553 . . . . 1.15 110.77 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -79.07 28.23 2.25 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.591 -0.731 . . . . 1.2 111.381 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 34' ' ' ASP . 31.9 t70 -111.41 -35.34 5.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.803 -0.698 . . . . 1.81 109.402 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.42 22.45 1.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.803 -0.713 . . . . 1.05 112.992 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.606 ' OD1' ' HA ' ' A' ' 61' ' ' ASN . 47.0 m-80 -135.31 153.47 51.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.085 0.469 . . . . 1.79 110.533 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.567 HG12 ' HB3' ' A' ' 60' ' ' LYS . 48.2 mm -76.16 141.61 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.188 -0.671 . . . . 1.82 109.188 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.443 HD21 ' NE2' ' A' ' 32' ' ' GLN . 32.8 tp -107.34 -52.29 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.915 -0.314 . . . . 2.13 110.963 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -160.93 140.84 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.702 -0.399 . . . . 2.96 111.72 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.689 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 76.8 t80 -104.41 139.03 39.94 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.769 -0.826 . . . . 1.75 108.769 171.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -102.34 120.86 41.19 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.001 -0.37 . . . . 1.28 110.001 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.01 86.99 1.03 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.033 0.444 . . . . 2.53 110.338 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.5 132.41 35.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.694 -0.684 . . . . 4.46 110.636 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.86 166.37 21.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.276 -0.42 . . . . 7.21 110.786 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.525 ' HA3' ' HE2' ' A' ' 28' ' ' PHE . . . 115.76 -84.91 0.38 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.444 -0.662 . . . . 7.0 111.444 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -148.79 94.92 2.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.909 0.385 . . . . 8.59 111.03 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.3 pt -130.26 48.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.773 -0.649 . . . . 9.53 110.612 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 m -72.63 146.32 46.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.075 -0.511 . . . . 10.16 111.215 -174.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.95 170.8 18.41 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 111.619 -0.593 . . . . 10.12 111.619 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -134.38 50.18 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.965 0.383 . . . . 13.33 111.263 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -153.8 95.42 2.84 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.546 0.689 . . . . 8.24 111.148 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -77.86 -53.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.247 1.965 . . . . 8.73 112.041 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -80.38 79.35 6.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.497 0.665 . . . . 9.47 110.618 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -161.81 -46.94 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.008 -0.996 . . . . 8.03 108.668 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 58' ' ' ILE . 11.7 p -80.5 -35.99 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.498 -0.773 . . . . 5.42 109.555 170.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.482 ' HA ' HG23 ' A' ' 39' ' ' ILE . 45.9 pt -111.91 167.96 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.251 0.548 . . . . 3.61 110.537 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.63 9.92 82.4 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 114.987 -1.006 . . . . 3.37 111.507 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.567 ' HB3' HG12 ' A' ' 39' ' ' ILE . 44.9 tptt -77.04 86.54 3.55 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.256 -0.646 . . . . 4.22 109.256 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.606 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 16.0 m120 -120.44 95.21 4.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.406 -0.815 . . . . 4.71 109.828 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -150.48 154.52 37.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.592 -0.731 . . . . 7.47 109.438 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -60.25 -49.73 76.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.419 -0.586 . . . . 8.88 109.419 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -166.85 132.64 2.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.403 -0.817 . . . . 10.35 109.888 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -172.07 120.21 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.343 0.402 . . . . 7.94 110.437 175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 66' ' ' VAL . 11.6 p -150.35 37.33 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 122.329 1.061 . . . . 9.58 110.071 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 61.86 106.45 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 114.686 -1.143 . . . . 9.32 111.252 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.18 -26.94 53.76 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.603 2.869 . . . . 10.74 114.606 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.9 m -92.07 -15.75 27.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.637 0.606 . . . . 11.49 112.637 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.7 p -114.85 170.23 8.49 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.707 0.632 . . . . 11.26 112.707 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -144.86 149.58 35.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.466 -0.788 . . . . 11.56 109.011 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.2 t 57.02 79.29 0.33 Allowed Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 123.539 0.524 . . . . 11.11 110.095 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.62 -53.22 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.786 2.324 . . . . 11.05 112.604 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -167.63 -49.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 11.76 110.663 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -101.3 96.23 7.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.501 -0.318 . . . . 10.74 110.426 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -155.08 113.76 3.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 7.67 110.806 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -129.49 70.31 0.52 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.833 -0.907 . . . . 3.32 110.833 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 58.98 41.06 21.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.597 0.713 . . . . 4.53 109.376 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.475 ' O ' HG22 ' A' ' 83' ' ' VAL . 57.4 t80 -56.81 -36.25 69.7 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.628 -1.169 . . . . 1.1 111.259 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -59.49 -36.71 76.57 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 123.85 0.718 . . . . 3.89 110.52 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -86.07 -37.91 18.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.812 -0.631 . . . . 3.07 109.863 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.969 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.39 -43.58 89.99 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.721 -0.672 . . . . 0.61 112.015 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 79' ' ' PHE . 90.7 t -73.05 -50.63 30.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.508 -0.846 . . . . 1.36 111.211 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.79 -32.29 59.83 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.215 -0.448 . . . . 1.59 111.239 -169.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.6 m -72.55 -23.23 60.95 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.424 -0.584 . . . . 2.27 109.424 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 34.06 38.06 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.714 -0.675 . . . . 1.9 111.999 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -158.89 50.19 0.36 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.565 0.698 . . . . 2.08 112.005 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.969 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -73.76 88.31 1.75 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.763 -0.653 . . . . 1.22 111.45 177.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.0 p30 -143.26 101.52 3.82 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.525 -0.546 . . . . 2.15 109.525 175.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.0 t -168.47 163.36 12.56 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.13 0.49 . . . . 2.03 110.924 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.2 ptt? -104.4 136.28 44.27 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.411 -0.813 . . . . 4.31 110.014 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.439 ' O ' HG22 ' A' ' 107' ' ' VAL . 77.3 t80 -147.15 127.78 14.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.58 -0.736 . . . . 2.95 109.22 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 8.1 pt-20 -95.43 132.71 40.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.43 0.633 . . . . 1.97 110.804 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -108.39 94.92 5.32 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.76 -1.109 . . . . 4.56 108.777 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -90.73 150.54 21.59 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.624 -0.716 . . . . 3.22 110.28 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.439 ' CD2' ' HA ' ' A' ' 102' ' ' PRO . 7.5 p90 -65.3 109.2 2.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.825 -0.625 . . . . 5.99 110.97 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -143.37 63.93 1.35 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.009 -0.737 . . . . 6.06 109.009 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.3 t80 177.5 -149.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.127 -1.064 . . . . 10.04 108.127 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.21 -4.6 42.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.93 0.395 . . . . 8.93 110.836 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 52.6 tpp -69.46 135.66 50.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.834 -0.621 . . . . 8.55 109.991 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.504 ' HB ' ' CD ' ' A' ' 102' ' ' PRO . 8.9 p -80.38 169.51 19.44 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.212 -0.449 . . . . 5.39 111.113 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.504 ' CD ' ' HB ' ' A' ' 101' ' ' THR . 52.8 Cg_exo -56.41 86.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.931 2.421 . . . . 5.02 114.043 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 m -139.58 98.22 3.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.436 -0.802 . . . . 2.85 108.847 171.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -93.32 105.19 17.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.832 0.349 . . . . 3.49 110.878 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 22.2 m -114.74 167.87 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-N 115.548 -0.751 . . . . 1.72 110.141 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 19.8 ptmt -144.07 147.38 33.71 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.671 -0.412 . . . . 2.83 110.414 174.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.707 HG11 HG11 ' A' ' 122' ' ' VAL . 14.2 m -100.54 144.24 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-N 115.781 -0.645 . . . . 1.64 111.359 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -119.97 102.87 8.85 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.411 -1.7 . . . . 1.35 106.411 160.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.542 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 64.0 mtt -102.98 146.36 28.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.777 -0.823 . . . . 2.72 108.777 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 61.5 pttt -151.12 128.85 11.56 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.874 -0.73 . . . . 2.17 110.187 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 86.3 tttt -57.09 110.03 0.76 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.769 -0.65 . . . . 2.33 109.45 168.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.93 129.34 17.16 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.783 -1.099 . . . . 1.12 109.782 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.17 -5.92 20.62 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.225 0.328 . . . . 2.97 111.747 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -73.4 -43.13 61.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.817 0.342 . . . . 2.06 110.219 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.22 138.31 3.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.379 -0.915 . . . . 1.52 113.488 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.74 52.65 4.04 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.186 0.994 . . . . 2.79 113.374 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.512 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.1 p -158.92 156.21 29.1 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.56 -1.274 . . . . 0.95 107.56 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.4 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 41.9 m-85 -137.38 136.2 37.67 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.645 -0.422 . . . . 0.98 111.18 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.584 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 49.2 m95 -91.5 161.98 14.74 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.406 0.622 . . . . 0.48 111.824 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.52 97.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.39 -1.277 . . . . 1.3 109.226 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 66.3 m-85 -98.27 112.47 24.45 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.188 -0.671 . . . . 1.96 109.188 174.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.707 HG11 HG11 ' A' ' 107' ' ' VAL . 31.1 m -110.78 150.13 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.255 0.465 . . . . 2.21 112.255 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -159.09 145.72 16.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 3.87 110.366 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 19.7 ptt180 -90.58 104.87 17.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.779 -0.646 . . . . 4.72 111.479 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.427 ' OXT' HG12 ' A' ' 125' ' ' VAL . 3.4 p . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.112 -0.947 . . . . 3.55 110.4 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 1.008 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.915 -0.402 . . . . 9.06 109.915 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 69.35 145.39 0.05 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.085 0.866 . . . . 6.45 112.332 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 45' ' ' ALA . 94.9 m-85 -103.12 107.98 18.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.783 -0.644 . . . . 7.02 110.197 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 143.84 21.97 0.17 Allowed Glycine 0 C--O 1.221 -0.68 0 C-N-CA 120.292 -0.956 . . . . 2.04 113.489 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -109.3 105.22 14.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.767 0.784 . . . . 1.26 110.828 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.621 HD13 HD11 ' A' ' 39' ' ' ILE . 4.3 tt -138.35 141.69 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.425 -0.352 . . . . 1.5 110.767 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.45 ' OE1' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -114.06 130.01 56.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.022 0.439 . . . . 2.22 109.842 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.7 pp -132.75 159.76 38.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.354 0.597 . . . . 1.4 111.366 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.6 p30 -76.99 157.83 30.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 1.15 110.782 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -77.76 30.98 1.73 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.361 -0.836 . . . . 1.2 112.675 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 34' ' ' ASP . 1.7 t0 -122.42 -31.94 3.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.211 0.529 . . . . 1.81 109.756 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.04 21.18 1.24 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.459 -0.877 . . . . 1.05 112.898 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.478 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 16.2 m-80 -125.27 156.49 38.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.045 0.45 . . . . 1.79 110.196 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.865 HG12 ' HB3' ' A' ' 60' ' ' LYS . 41.1 mm -81.53 142.75 13.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.965 -0.561 . . . . 1.82 109.999 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 HD13 ' OE1' ' A' ' 32' ' ' GLN . 89.1 mt -109.31 -53.23 2.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.395 -0.595 . . . . 2.13 109.395 172.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -133.81 117.27 16.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.579 -0.737 . . . . 2.96 110.656 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.558 ' HA ' HG13 ' A' ' 31' ' ' ILE . 18.5 t80 -106.01 117.93 35.31 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.277 -0.638 . . . . 1.75 109.277 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 84.6 m-20 -99.35 99.74 10.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.991 0.424 . . . . 1.28 110.529 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.32 146.92 33.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.907 -0.588 . . . . 2.53 110.686 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.441 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . . . -100.54 139.73 35.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.001 -0.545 . . . . 4.46 110.178 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 68.14 -178.82 0.22 Allowed 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.935 0.772 . . . . 7.21 110.916 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.11 -159.53 26.33 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.576 -0.821 . . . . 7.0 112.336 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.759 ' HB2' ' HG2' ' A' ' 52' ' ' ARG . 5.8 p-10 -76.97 80.81 3.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.223 1.011 . . . . 8.59 111.116 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.9 -41.28 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.602 -1.181 . . . . 9.53 109.955 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -95.0 49.22 1.21 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 122.231 1.015 . . . . 10.16 110.111 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.82 113.89 3.58 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.108 -0.951 . . . . 10.12 111.345 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.759 ' HG2' ' HB2' ' A' ' 48' ' ' ASP . 39.9 mtt180 -79.48 106.24 11.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.044 0.449 . . . . 13.33 111.743 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -114.89 127.43 26.84 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.871 -0.788 . . . . 8.24 108.871 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.22 -4.1 14.84 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.541 2.161 . . . . 8.73 112.794 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.55 ' HE2' ' HA2' ' A' ' 59' ' ' GLY . 26.6 mtmm -120.93 91.25 3.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.397 . . . . 9.47 110.647 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -78.98 -20.2 49.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.262 0.553 . . . . 8.03 110.178 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 t -123.45 153.8 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.345 -0.983 . . . . 5.42 108.345 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.25 13.6 tt 38.7 73.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 122.799 1.285 . . . . 3.61 112.414 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.55 ' HA2' ' HE2' ' A' ' 55' ' ' LYS . . . -68.2 -29.19 73.19 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.415 -1.266 . . . . 3.37 111.787 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.865 ' HB3' HG12 ' A' ' 39' ' ' ILE . 23.2 tptm -99.26 91.03 4.77 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 120.904 0.383 . . . . 4.22 110.0 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -98.19 101.45 12.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.705 -0.679 . . . . 4.71 109.357 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 65' ' ' ASP . 5.5 t80 -156.15 175.1 14.42 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.42 -0.956 . . . . 7.47 108.42 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.447 ' CD1' ' HG2' ' A' ' 64' ' ' LYS . 54.4 t80 -86.64 -65.63 0.99 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.283 -0.636 . . . . 8.88 109.283 172.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HG2' ' CD1' ' A' ' 63' ' ' PHE . 17.0 ptpt -170.15 141.64 2.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.869 -0.789 . . . . 10.35 108.869 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.467 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 4.4 p-10 -152.98 173.94 14.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.034 0.445 . . . . 7.94 110.829 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.8 m -132.3 37.17 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 9.58 110.495 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.71 94.65 2.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.113 0.412 . . . . 9.32 112.113 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.09 102.91 0.83 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.389 2.059 . . . . 10.74 110.779 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.5 m -74.16 -69.11 0.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.497 . . . . 11.49 112.338 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 p -86.59 -43.24 12.83 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 111.712 0.264 . . . . 11.26 111.712 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -56.92 112.91 1.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.861 -0.609 . . . . 11.56 111.456 -175.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.444 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 49.9 m -90.86 -44.19 0.39 Allowed Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.592 -0.731 . . . . 11.11 112.49 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 72' ' ' SER . 42.6 Cg_exo -58.81 111.73 0.98 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.126 1.884 . . . . 11.05 112.534 176.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 72' ' ' SER . 15.1 mt-10 -106.26 102.7 12.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.948 -0.569 . . . . 11.76 110.036 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -109.93 19.06 19.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.054 0.454 . . . . 10.74 111.552 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 79' ' ' PHE . 93.4 m-85 -82.45 120.47 25.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.611 -0.514 . . . . 7.67 109.611 177.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.46 88.93 0.63 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.335 -0.936 . . . . 3.32 111.728 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 58.28 41.07 23.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.376 0.608 . . . . 4.53 109.676 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.541 ' O ' HG21 ' A' ' 83' ' ' VAL . 56.0 t80 -56.24 -27.67 55.79 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.31 -0.859 . . . . 1.1 111.789 -171.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.86 -33.95 72.95 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 123.855 0.722 . . . . 3.89 110.277 -175.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -86.87 -29.07 22.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.765 -0.652 . . . . 3.07 109.531 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.711 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.25 -39.27 92.26 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 111.83 -0.508 . . . . 0.61 111.83 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.541 HG21 ' O ' ' A' ' 79' ' ' PHE . 95.2 t -66.86 -48.12 80.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.979 -0.61 . . . . 1.36 110.547 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.41 -26.61 51.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 1.59 111.206 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -60.1 -28.56 67.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.562 -0.533 . . . . 2.27 109.562 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.11 -10.26 47.37 Favored Glycine 0 CA--C 1.505 -0.551 0 C-N-CA 120.728 -0.749 . . . . 1.9 113.048 169.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -169.96 62.61 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.324 0.583 . . . . 2.08 110.145 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.711 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 2.9 tt -38.45 102.35 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 114.728 -1.123 . . . . 1.22 111.802 175.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 4.1 p30 -145.74 102.24 3.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.1 0.476 . . . . 2.15 109.822 176.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 2.5 p -138.8 154.34 48.47 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.924 -0.485 . . . . 2.03 111.764 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.24 138.1 36.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.768 -0.651 . . . . 4.31 109.76 171.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -163.3 140.37 7.41 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.377 -0.601 . . . . 2.95 109.377 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 39.2 mt-10 -91.74 110.78 22.13 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.356 -0.609 . . . . 1.97 109.356 177.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -117.43 113.99 22.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.649 -0.705 . . . . 4.56 110.872 -171.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 104' ' ' LYS . 3.6 p -84.44 150.25 25.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.365 -0.38 . . . . 3.22 110.522 173.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.474 ' CD2' ' HB ' ' A' ' 103' ' ' THR . 71.9 m-85 -73.28 148.81 43.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.21 -0.45 . . . . 5.99 110.566 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.46 -79.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.082 -0.508 . . . . 6.06 110.561 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -148.58 84.19 1.48 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.184 -0.462 . . . . 10.04 109.818 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -103.12 -44.79 5.11 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.819 -0.808 . . . . 8.93 108.819 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 34.2 tpp 177.84 -53.19 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.677 -1.147 . . . . 8.55 108.699 175.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.3 m -111.18 138.29 21.22 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.122 -0.945 . . . . 5.39 109.289 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.07 60.13 3.05 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.703 2.269 . . . . 5.02 111.372 174.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.474 ' HB ' ' CD2' ' A' ' 96' ' ' PHE . 4.8 m -57.99 133.14 55.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.945 -0.57 . . . . 2.85 111.091 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' HA ' HG23 ' A' ' 95' ' ' THR . 63.9 tttp -108.16 103.55 12.77 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.214 -0.448 . . . . 3.49 110.375 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.9 163.85 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.978 -0.556 . . . . 1.72 109.528 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 59.1 pttt -126.17 140.05 52.86 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.047 -0.723 . . . . 2.83 109.047 173.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.513 HG13 HG11 ' A' ' 122' ' ' VAL . 7.9 m -100.65 143.5 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 CA-C-O 121.144 0.497 . . . . 1.64 110.903 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 90' ' ' THR . 17.8 t-160 -143.85 102.73 3.95 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.656 -1.238 . . . . 1.35 107.656 164.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.55 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.1 OUTLIER -115.63 125.23 52.64 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.925 -1.139 . . . . 2.72 107.925 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.9 ptmm? -145.18 146.96 31.96 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.742 -0.783 . . . . 2.17 110.604 -171.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.51 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 13.1 ttpp -56.82 123.79 16.26 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.217 -0.901 . . . . 2.33 111.265 176.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.66 148.41 51.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.674 -1.148 . . . . 1.12 110.716 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.51 -4.1 37.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.091 0.472 . . . . 2.97 110.883 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -79.88 -21.91 43.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 2.06 110.933 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 139.16 -128.1 3.91 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.487 -0.864 . . . . 1.52 112.739 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.66 77.24 5.14 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.988 0.899 . . . . 2.79 110.76 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.443 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.9 p -162.94 157.14 20.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.267 -1.333 . . . . 0.95 108.194 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 25.1 m-85 -138.65 141.28 39.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.864 0.364 . . . . 0.98 110.608 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -87.98 165.75 14.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.145 0.498 . . . . 0.48 110.573 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.453 ' HB ' HG22 ' A' ' 31' ' ' ILE . 58.1 t -135.42 98.56 2.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.643 -1.162 . . . . 1.3 108.774 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 83.2 m-85 -103.86 119.96 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.372 -0.603 . . . . 1.96 109.372 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 107' ' ' VAL . 23.8 m -124.28 155.16 31.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.714 -0.476 . . . . 2.21 109.714 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -156.73 132.19 9.33 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.816 -0.353 . . . . 3.87 110.206 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -88.5 139.7 30.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 4.72 110.257 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.819 -0.61 . . . . 3.55 110.365 -179.198 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.995 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 121.043 0.449 . . . . 9.06 110.558 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.89 30.84 4.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.255 0.55 . . . . 6.45 110.023 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -162.69 137.86 6.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.331 -0.85 . . . . 7.02 109.639 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 99.71 -6.7 58.97 Favored Glycine 0 C--O 1.226 -0.358 0 C-N-CA 120.819 -0.705 . . . . 2.04 113.239 175.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 43' ' ' ASN . . . -107.49 118.73 37.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.139 0.495 . . . . 1.26 111.57 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.508 HG22 ' HB ' ' A' ' 120' ' ' VAL . 5.5 tt -136.19 141.01 42.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.222 -0.444 . . . . 1.5 110.121 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.51 ' HB2' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -115.37 125.08 52.77 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.5 -0.926 . . . . 2.22 108.5 179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.48 154.31 46.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.605 0.717 . . . . 1.4 111.456 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -73.71 146.61 44.29 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.025 -0.989 . . . . 1.15 110.045 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.558 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -82.09 36.28 2.55 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.804 -0.635 . . . . 1.2 112.961 -173.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -134.51 -24.97 1.52 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.854 0.359 . . . . 1.81 110.1 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.09 -4.28 2.6 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.099 -0.572 . . . . 1.05 112.494 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.658 ' OD1' ' HA ' ' A' ' 61' ' ' ASN . 21.4 m-80 -90.78 149.76 21.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.511 0.196 . . . . 1.79 110.792 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.665 HG12 ' HB3' ' A' ' 60' ' ' LYS . 34.7 mm -92.8 140.06 16.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.822 -0.807 . . . . 1.82 108.822 173.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HG ' ' HG3' ' A' ' 41' ' ' GLN . 38.3 tp -113.28 -57.34 2.3 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.348 -0.541 . . . . 2.13 111.351 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 45.1 mt-30 -144.16 150.38 37.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.016 0.436 . . . . 2.96 111.405 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.602 ' CE1' ' HB2' ' A' ' 44' ' ' ALA . 55.9 t80 -127.04 117.78 23.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.956 -0.565 . . . . 1.75 109.551 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -98.44 92.19 5.55 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.83 -0.433 . . . . 1.28 109.83 -177.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 42' ' ' TYR . . . -171.54 155.4 4.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.232 -0.44 . . . . 2.53 110.382 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.88 90.96 5.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.013 0.435 . . . . 4.46 110.44 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -120.71 20.75 11.67 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.025 -0.731 . . . . 7.21 109.025 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.58 76.24 0.98 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.315 -0.857 . . . . 7.0 111.924 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.16 100.45 4.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.853 0.359 . . . . 8.59 110.279 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 mm 51.31 48.4 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.246 -0.888 . . . . 9.53 109.708 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.2 m 57.29 75.44 0.37 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.309 -0.86 . . . . 10.16 111.0 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.24 113.62 0.53 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.528 -0.76 . . . . 10.12 112.35 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -130.51 155.83 45.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.422 -0.585 . . . . 13.33 109.422 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -95.85 113.55 62.28 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.515 0.197 . . . . 8.24 110.999 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -96.99 23.76 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.439 2.76 . . . . 8.73 112.213 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -103.82 -52.52 2.95 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.478 0.656 . . . . 9.47 110.454 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -94.42 -31.98 13.74 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.766 -1.106 . . . . 8.03 109.919 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.809 HG11 HG13 ' A' ' 58' ' ' ILE . 25.1 t -111.38 123.81 67.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.679 -0.691 . . . . 5.42 110.107 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.809 HG13 HG11 ' A' ' 57' ' ' VAL . 65.7 mt 69.49 148.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.31 0.576 . . . . 3.61 111.132 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' N ' HG21 ' A' ' 58' ' ' ILE . . . 75.14 6.62 80.16 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.78 -0.724 . . . . 3.37 112.022 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.665 ' HB3' HG12 ' A' ' 39' ' ' ILE . 4.0 tppp? -74.24 99.82 3.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.31 -0.626 . . . . 4.22 109.31 176.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.658 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 14.2 m120 -106.35 98.52 8.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.0 -0.545 . . . . 4.71 110.074 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -119.03 136.26 54.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.567 -0.742 . . . . 7.47 109.257 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -103.18 154.33 19.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.865 0.364 . . . . 8.88 110.533 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 110.71 2.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.816 -0.629 . . . . 10.35 111.747 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 66' ' ' VAL . 9.0 p-10 -82.77 -62.7 1.53 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.659 -0.867 . . . . 7.94 108.659 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.475 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 7.6 p -122.84 -51.27 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.953 -0.758 . . . . 9.58 108.953 167.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.846 ' HB2' ' H2 ' ' A' ' 169' ' ' HC4 . . . 169.15 136.64 0.05 OUTLIER Pre-proline 0 C--O 1.232 0.169 0 C-N-CA 123.779 0.832 . . . . 9.32 109.366 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.08 92.87 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.658 2.239 . . . . 10.74 111.928 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.2 p -154.92 27.94 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 11.49 110.802 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -104.87 -41.52 5.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.373 -0.376 . . . . 11.26 111.49 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 72' ' ' SER . 33.3 t70 -58.48 -94.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.574 0.583 . . . . 11.56 112.574 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 71' ' ' ASP . 36.0 t 172.37 135.87 0.1 OUTLIER Pre-proline 0 C--O 1.233 0.209 0 CA-C-O 120.713 0.292 . . . . 11.11 110.316 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.75 71.26 6.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.836 2.357 . . . . 11.05 111.432 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.96 -57.69 9.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 11.76 110.32 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -123.86 23.04 8.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.452 0.644 . . . . 10.74 110.369 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -97.69 137.96 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.516 -0.765 . . . . 7.67 110.027 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.94 86.46 0.48 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.517 -0.849 . . . . 3.32 112.017 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 58.48 44.12 18.48 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 122.686 0.395 . . . . 4.53 110.538 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.58 ' O ' HG21 ' A' ' 83' ' ' VAL . 64.5 t80 -46.08 -43.0 14.29 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 113.456 0.91 . . . . 1.1 113.456 -167.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -79.64 -29.88 41.14 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 121.279 0.561 . . . . 3.89 110.155 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.53 -34.31 62.98 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.218 -1.03 . . . . 3.07 108.218 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.97 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.86 -40.08 89.29 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.732 -1.122 . . . . 0.61 111.395 175.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 79' ' ' PHE . 95.5 t -68.38 -54.27 22.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.378 -0.911 . . . . 1.36 111.046 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.15 -22.6 33.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 1.59 111.644 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.9 t -70.63 -29.51 65.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.483 -0.932 . . . . 2.27 108.483 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.24 23.23 49.12 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.53 -0.759 . . . . 1.9 112.169 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -156.04 52.59 0.56 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.45 0.643 . . . . 2.08 111.501 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.97 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.9 OUTLIER -74.37 73.72 1.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.603 -0.726 . . . . 1.22 111.083 175.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.9 t30 -143.16 99.29 3.42 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.572 -0.899 . . . . 2.15 108.572 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.4 m -140.26 146.36 38.5 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.017 -0.538 . . . . 2.03 110.41 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 16.4 ptt? -126.73 129.72 48.94 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.586 -0.524 . . . . 4.31 109.586 172.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -157.85 142.88 16.68 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.517 -0.549 . . . . 2.95 109.517 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -92.6 105.54 17.68 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 1.97 109.412 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -109.24 121.95 46.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.245 -0.889 . . . . 4.56 110.989 -170.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.4 p -93.13 150.79 20.26 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.935 -0.575 . . . . 3.22 111.064 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -99.86 166.49 11.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.906 -0.588 . . . . 5.99 110.068 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.87 62.2 4.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.368 0.604 . . . . 6.06 110.926 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.02 123.1 29.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.536 -0.757 . . . . 10.04 109.993 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -100.37 -30.83 11.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.415 -0.357 . . . . 8.93 110.948 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -59.88 -57.16 14.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.271 0.558 . . . . 8.55 109.967 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 m -112.97 132.5 22.31 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 108.816 -0.809 . . . . 5.39 108.816 172.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.39 86.12 0.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.078 1.852 . . . . 5.02 111.785 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.442 ' HA ' HH21 ' A' ' 124' ' ' ARG . 8.3 m -81.14 95.11 6.78 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.891 0.853 . . . . 2.85 109.517 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 34.1 tttp -122.34 126.43 48.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.849 -1.069 . . . . 3.49 109.422 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.468 HG13 ' HG2' ' A' ' 124' ' ' ARG . 22.9 m -123.27 160.24 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.27 0.557 . . . . 1.72 110.733 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -117.91 118.53 32.24 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.291 -1.003 . . . . 2.83 108.291 171.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.677 HG11 HG12 ' A' ' 122' ' ' VAL . 6.3 m -99.25 144.22 12.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.438 0.637 . . . . 1.64 111.606 -176.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 91' ' ' MET . 13.9 t-80 -137.74 103.51 5.03 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.665 -1.152 . . . . 1.35 108.162 164.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 3.5 mpp? -98.94 140.03 33.72 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 106.798 -1.556 . . . . 2.72 106.798 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.816 ' HG3' ' HB2' ' A' ' 119' ' ' TRP . 9.3 ptpt -141.02 125.27 17.44 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.701 -0.8 . . . . 2.17 110.09 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.668 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 82.7 tttt -57.72 106.79 0.38 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.976 -0.75 . . . . 2.33 108.976 170.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.37 127.86 20.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.929 -1.032 . . . . 1.12 110.323 -173.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.24 -7.12 33.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.267 0.556 . . . . 2.97 109.895 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.1 m -71.28 -26.1 62.73 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.164 -0.925 . . . . 2.06 110.043 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.44 145.02 18.32 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.174 -0.536 . . . . 1.52 112.973 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 55.75 38.27 29.89 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.511 0.672 . . . . 2.79 112.24 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.558 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 4.8 p -166.7 159.93 14.4 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.165 -0.925 . . . . 0.95 109.937 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.668 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 36.5 m-85 -140.48 139.57 35.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.048 -0.353 . . . . 0.98 110.048 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.816 ' HB2' ' HG3' ' A' ' 110' ' ' LYS . 41.1 m95 -92.53 162.49 14.18 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.19 0.519 . . . . 0.48 110.658 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.508 ' HB ' HG22 ' A' ' 31' ' ' ILE . 77.5 t -136.16 105.88 5.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.762 -1.108 . . . . 1.3 109.583 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 29.3 m-85 -109.45 123.05 48.72 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.767 -0.457 . . . . 1.96 109.767 175.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.677 HG12 HG11 ' A' ' 107' ' ' VAL . 30.0 m -118.93 157.92 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.124 0.488 . . . . 2.21 111.527 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 43.8 tttm -152.26 115.11 4.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.546 -0.752 . . . . 3.87 110.008 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.468 ' HG2' HG13 ' A' ' 105' ' ' VAL . 58.0 mtp180 -76.5 124.51 27.69 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.725 -0.39 . . . . 4.72 110.418 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.458 ' OXT' HG12 ' A' ' 125' ' ' VAL 0.254 7.2 p . . . . . 0 C--O 1.253 1.289 0 O-C-N 124.86 1.35 . . . . 3.55 113.147 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.995 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.93 -0.396 . . . . 9.06 109.93 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 68.86 143.81 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 O-C-N 124.105 0.878 . . . . 6.45 111.178 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -170.24 -68.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.813 -0.63 . . . . 7.02 109.876 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.84 56.37 0.45 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.581 -0.736 . . . . 2.04 111.532 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.17 107.74 13.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.982 -0.377 . . . . 1.26 109.982 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.659 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -131.04 139.45 51.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.824 0.345 . . . . 1.5 110.783 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.498 HE21 HD23 ' A' ' 40' ' ' LEU . 10.6 pt20 -105.22 114.5 28.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.633 0.73 . . . . 2.22 110.395 176.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.59 168.45 11.74 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.879 -1.055 . . . . 1.4 109.293 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 3.1 p30 -102.19 157.55 16.81 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.95 -0.7 . . . . 1.15 110.888 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -77.37 14.04 9.66 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.38 -0.827 . . . . 1.2 111.73 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 34' ' ' ASP . 23.3 m-20 -100.83 -12.57 18.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.27 0.557 . . . . 1.81 109.77 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.39 9.31 25.67 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.616 -0.72 . . . . 1.05 112.985 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -109.07 143.53 38.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.065 0.46 . . . . 1.79 110.944 -178.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.631 HG21 ' HA ' ' A' ' 58' ' ' ILE . 47.7 mm -94.09 126.63 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.141 -0.688 . . . . 1.82 109.141 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.498 HD23 HE21 ' A' ' 32' ' ' GLN . 17.9 tp -99.56 -49.49 4.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.851 -0.34 . . . . 2.13 110.996 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.565 ' O ' HG12 ' A' ' 31' ' ' ILE . 33.3 tt0 -157.6 142.94 17.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.813 0.34 . . . . 2.96 111.292 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.659 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 79.0 t80 -124.68 133.87 53.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.995 -0.548 . . . . 1.75 109.844 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -79.73 92.89 5.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.142 -0.688 . . . . 1.28 109.142 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.54 -55.33 4.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.744 -0.662 . . . . 2.53 111.387 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.91 148.66 28.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.224 -0.443 . . . . 4.46 110.881 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -130.97 90.0 2.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.987 -0.551 . . . . 7.21 109.639 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.66 -48.67 2.64 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.063 -0.517 . . . . 7.0 112.757 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.83 122.24 23.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.717 0.294 . . . . 8.59 110.739 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.2 pt -112.37 47.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.231 0.539 . . . . 9.53 111.783 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.4 m -82.48 80.99 8.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.209 0.528 . . . . 10.16 110.881 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.51 -134.74 9.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.571 -0.824 . . . . 10.12 112.754 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -136.22 167.53 21.11 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.14 -0.318 . . . . 13.33 110.14 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.465 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 5.9 p-10 -95.42 159.44 32.71 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.562 -0.903 . . . . 8.24 108.562 171.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 53' ' ' ASP . 13.7 Cg_endo -57.83 -49.59 12.64 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.418 2.079 . . . . 8.73 113.008 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.3 pttp 32.32 77.82 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.713 0.805 . . . . 9.47 112.441 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -157.09 -71.1 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.315 -0.857 . . . . 8.03 110.319 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -92.41 -27.95 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.684 -0.689 . . . . 5.42 110.676 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.631 ' HA ' HG21 ' A' ' 39' ' ' ILE . 46.8 pt -69.08 157.76 6.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.175 0.512 . . . . 3.61 111.882 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.49 37.73 90.17 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.311 -0.858 . . . . 3.37 111.668 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -100.86 122.24 43.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.641 0.258 . . . . 4.22 111.039 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -124.61 125.56 44.35 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.496 -0.557 . . . . 4.71 109.496 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -160.18 109.46 1.76 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.63 -0.714 . . . . 7.47 109.44 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -104.95 28.33 7.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.086 0.402 . . . . 8.88 112.086 -171.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -116.4 92.25 3.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.128 -0.693 . . . . 10.35 109.128 174.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -77.3 172.37 13.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.34 -0.845 . . . . 7.94 110.844 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.4 t 62.17 57.3 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 122.399 1.095 . . . . 9.58 108.871 -172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.647 ' HB1' ' HD3' ' A' ' 68' ' ' PRO . . . -152.64 -50.36 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 114.677 -1.147 . . . . 9.32 110.974 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.647 ' HD3' ' HB1' ' A' ' 67' ' ' ALA . 23.9 Cg_exo -65.8 156.57 63.42 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.829 1.686 . . . . 10.74 112.01 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.3 m -70.96 109.48 5.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.218 -0.446 . . . . 11.49 111.16 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.6 t -69.75 -35.77 75.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.924 -0.399 . . . . 11.26 109.924 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.5 t70 61.04 -92.12 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.542 0.737 . . . . 11.56 111.659 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.7 t -139.26 124.26 11.65 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.212 -0.662 . . . . 11.11 109.212 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.455 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 72.3 Cg_endo -76.11 11.83 1.66 Allowed 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.75 2.3 . . . . 11.05 113.459 -174.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -84.35 -21.61 30.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 11.76 111.85 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -53.06 146.48 11.18 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.602 0.593 . . . . 10.74 112.602 -173.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 69.79 -80.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.709 -1.132 . . . . 7.67 110.98 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.65 54.32 0.37 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.511 -1.036 . . . . 3.32 110.511 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 73' ' ' PRO . 35.2 mtmm 59.86 69.22 0.72 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.2 0.524 . . . . 4.53 109.701 -170.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.496 ' O ' HG22 ' A' ' 83' ' ' VAL . 74.8 t80 -53.46 -40.42 65.24 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.14 -0.936 . . . . 1.1 111.848 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -62.46 -30.82 71.52 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 123.679 0.612 . . . . 3.89 110.653 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -80.03 -35.24 37.51 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.085 -0.709 . . . . 3.07 109.085 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.938 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -62.08 -42.72 99.74 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.513 -0.767 . . . . 0.61 111.695 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 79' ' ' PHE . 84.1 t -65.81 -51.24 64.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.753 -0.724 . . . . 1.36 110.682 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.37 -21.65 55.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 1.59 110.853 -172.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.8 t -65.87 -35.61 81.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.899 -0.591 . . . . 2.27 109.431 171.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.94 15.28 63.25 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.335 -0.706 . . . . 1.9 111.335 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.714 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 3.0 p30 -166.02 62.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.785 0.802 . . . . 2.08 110.833 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.938 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.2 tt -68.86 98.24 0.91 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.048 -0.978 . . . . 1.22 110.603 172.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.635 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.0 p-10 -143.25 101.35 3.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.265 -0.574 . . . . 2.15 110.867 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.9 t -154.97 162.47 41.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.946 0.403 . . . . 2.03 110.608 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -130.0 116.05 18.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.694 -0.684 . . . . 4.31 109.877 175.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -126.68 134.13 50.78 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.015 -0.735 . . . . 2.95 109.015 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.693 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 7.1 pt-20 -106.13 117.27 33.59 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.908 -0.717 . . . . 1.97 110.361 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -109.27 128.54 55.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.763 -1.108 . . . . 4.56 109.873 -173.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 9.1 m -100.22 105.08 16.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.681 -0.691 . . . . 3.22 109.748 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 102' ' ' PRO . 77.8 m-85 -69.29 92.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 5.99 110.382 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.3 75.48 9.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 6.06 109.338 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -139.58 145.06 38.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.425 -0.807 . . . . 10.04 109.265 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 61.19 -145.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 O-C-N 123.598 0.561 . . . . 8.93 109.931 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 89.1 mmm -106.11 -3.75 21.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.801 0.334 . . . . 8.55 110.922 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.2 m -115.01 96.26 44.47 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.231 -0.441 . . . . 5.39 111.044 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 96' ' ' PHE . 6.2 Cg_exo -78.16 103.81 1.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.916 2.411 . . . . 5.02 111.989 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.426 HG22 HG13 ' A' ' 105' ' ' VAL . 36.4 m -80.56 99.27 8.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.163 0.506 . . . . 2.85 110.257 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 59.6 tttm -95.43 103.27 15.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.874 -0.603 . . . . 3.49 109.946 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 20.0 m -121.22 161.98 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.131 0.491 . . . . 1.72 111.803 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.775 ' HE2' HG12 ' A' ' 125' ' ' VAL . 47.0 mttm -108.5 138.28 45.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.525 -0.761 . . . . 2.83 109.638 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -107.87 102.54 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.8 -0.444 . . . . 1.64 109.8 167.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.759 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 8.3 t-160 -96.18 101.95 13.67 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.838 -1.542 . . . . 1.35 106.838 168.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.635 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 8.8 ttt -111.64 113.58 26.06 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.715 -1.216 . . . . 2.72 107.715 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 18.4 ptpt -129.59 132.14 46.69 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.3 -0.56 . . . . 2.17 110.564 -168.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.714 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 81.2 tttt -56.88 117.88 4.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 109.03 -0.73 . . . . 2.33 109.03 167.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -45.46 142.72 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.185 0.928 . . . . 1.12 110.767 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.8 tp -63.94 -25.83 68.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.202 -0.454 . . . . 2.97 110.691 -173.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.0 m -81.71 -50.81 8.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.961 -0.563 . . . . 2.06 109.811 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 128.31 -179.92 16.27 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.977 -0.63 . . . . 1.52 112.756 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.0 t70 61.64 31.6 18.66 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.944 0.878 . . . . 2.79 111.475 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.9 p 179.98 156.5 0.64 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.582 -1.19 . . . . 0.95 110.415 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.465 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 43.6 m-85 -136.17 134.74 38.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.469 -0.567 . . . . 0.98 109.469 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.539 ' O ' ' HG3' ' A' ' 109' ' ' MET . 47.3 m95 -86.52 163.87 17.25 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.291 0.567 . . . . 0.48 112.026 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.518 HG22 ' HE1' ' A' ' 109' ' ' MET . 60.0 t -132.12 97.42 2.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.387 -1.279 . . . . 1.3 109.037 174.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.759 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 58.3 m-85 -98.81 105.49 17.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.797 -0.446 . . . . 1.96 109.797 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 17.9 m -110.99 135.6 49.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.07 0.462 . . . . 2.21 111.482 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -150.46 138.57 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.607 -0.724 . . . . 3.87 109.288 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -89.41 92.46 9.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.254 0.55 . . . . 4.72 110.646 178.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.775 HG12 ' HE2' ' A' ' 106' ' ' LYS . 8.2 p . . . . . 0 C--O 1.249 1.068 0 CA-C-N 115.149 -0.932 . . . . 3.55 109.733 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.991 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.806 -0.442 . . . . 9.06 109.806 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.84 119.3 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.228 0.33 . . . . 6.45 110.213 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.614 ' H ' ' HH ' ' A' ' 42' ' ' TYR . 48.3 t80 -140.25 151.83 45.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.429 -0.35 . . . . 7.02 110.522 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 90.73 -109.62 3.7 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.956 -0.64 . . . . 2.04 112.174 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.82 109.64 18.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.449 0.642 . . . . 1.26 111.413 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.576 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 4.7 tt -138.57 140.38 39.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.857 -0.611 . . . . 1.5 110.051 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.675 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 2.8 pt20 -114.74 143.4 45.12 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.447 0.641 . . . . 2.22 110.712 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.532 ' HB3' HD11 ' A' ' 39' ' ' ILE . 3.0 pp -124.08 157.34 34.78 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.05 -0.977 . . . . 1.4 109.504 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.785 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.5 p30 -79.82 158.56 26.77 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.254 0.55 . . . . 1.15 110.439 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.42 21.1 3.05 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.594 -0.73 . . . . 1.2 111.884 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 34' ' ' ASP . 23.8 t70 -106.06 -32.37 8.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.342 -0.614 . . . . 1.81 109.342 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.67 11.16 3.03 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.417 -0.81 . . . . 1.05 112.485 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -118.78 155.89 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.687 -0.486 . . . . 1.79 109.687 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.864 HG12 ' HB3' ' A' ' 60' ' ' LYS . 43.4 mm -70.5 136.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.967 -0.753 . . . . 1.82 108.967 174.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.785 HD23 ' HB3' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -102.17 -65.24 1.0 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.023 -0.732 . . . . 2.13 109.023 -173.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -145.25 134.88 23.37 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.318 -0.855 . . . . 2.96 111.127 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.614 ' HH ' ' H ' ' A' ' 28' ' ' PHE . 52.1 t80 -113.1 119.52 38.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.614 . . . . 1.75 109.941 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.93 101.9 9.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.53 0.681 . . . . 1.28 110.766 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.15 106.63 10.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.426 -0.806 . . . . 2.53 110.523 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.95 130.2 45.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.914 -0.585 . . . . 4.46 110.151 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.59 88.72 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.892 -0.595 . . . . 7.21 112.295 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.94 17.39 11.86 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 109.736 -1.346 . . . . 7.0 109.736 169.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -122.39 154.22 38.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.611 -0.794 . . . . 8.59 109.914 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.6 mt -87.68 71.18 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.672 0.749 . . . . 9.53 109.574 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 t -152.79 173.52 15.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.282 -0.872 . . . . 10.16 109.722 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.437 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . -71.72 -81.02 0.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.025 -0.607 . . . . 10.12 111.651 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 13.0 mmm180 -126.4 166.76 16.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.733 -0.469 . . . . 13.33 109.733 172.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.549 ' OD2' ' HG2' ' A' ' 55' ' ' LYS . 49.4 t0 -125.8 89.08 53.12 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.615 -0.513 . . . . 8.24 109.615 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -97.2 23.74 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.32 2.68 . . . . 8.73 113.243 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HG2' ' OD2' ' A' ' 53' ' ' ASP . 9.8 ptpp? -111.72 166.73 10.93 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.944 -0.391 . . . . 9.47 109.944 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 67.72 25.16 8.15 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.954 0.883 . . . . 8.03 110.535 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 t -89.61 155.15 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.657 -0.701 . . . . 5.42 109.4 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.8 pt 38.13 64.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.278 1.031 . . . . 3.61 113.104 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.57 -30.38 56.51 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.38 -1.282 . . . . 3.37 112.448 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.864 ' HB3' HG12 ' A' ' 39' ' ' ILE . 25.3 ttmm -107.39 134.55 50.27 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 122.811 -0.229 . . . . 4.22 110.867 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -158.53 101.41 1.68 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.191 -0.459 . . . . 4.71 110.203 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -60.66 110.85 1.4 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 7.47 110.881 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -121.5 -58.2 1.78 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.5 . . . . 8.88 110.563 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.456 ' HE2' HG11 ' A' ' 66' ' ' VAL . 19.6 ptmt -100.34 120.18 39.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.306 0.574 . . . . 10.35 110.69 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.64 29.21 1.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.879 -0.6 . . . . 7.94 110.86 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.456 HG11 ' HE2' ' A' ' 64' ' ' LYS . 14.2 p -56.15 -30.34 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.744 -0.662 . . . . 9.58 110.756 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 69.48 95.84 0.05 OUTLIER Pre-proline 0 C--N 1.342 0.263 0 C-N-CA 123.507 0.723 . . . . 9.32 110.566 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.05 148.79 91.41 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.807 2.338 . . . . 10.74 111.421 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.1 m -70.98 -21.55 62.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.24 0.543 . . . . 11.49 109.783 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 m -136.01 132.98 36.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.787 -0.642 . . . . 11.26 110.167 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -162.0 154.61 19.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.82 -0.807 . . . . 11.56 108.82 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 p -142.44 88.68 8.74 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.132 0.419 . . . . 11.11 112.132 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.96 103.63 1.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.962 2.441 . . . . 11.05 111.074 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 8.3 tp10 -109.49 169.65 8.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.108 -0.496 . . . . 11.76 110.052 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 74' ' ' GLU . 74.9 m-85 76.08 23.68 1.25 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.851 0.719 . . . . 10.74 111.819 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -72.38 126.8 30.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.847 -0.615 . . . . 7.67 109.682 171.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -110.86 -80.17 1.09 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.669 -1.253 . . . . 3.32 110.065 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -130.43 61.29 1.6 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.857 -1.164 . . . . 4.53 107.857 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.579 ' HA ' HD13 ' A' ' 88' ' ' LEU . 36.2 t80 -86.54 -37.75 17.87 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 116.352 -0.386 . . . . 1.1 111.039 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HB2' ' HZ1' ' A' ' 80' ' ' LYS . 10.6 mtmp? -67.81 -32.04 72.32 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.383 -0.969 . . . . 3.89 108.383 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -82.49 -39.12 22.91 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.776 -1.556 . . . . 3.07 108.987 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.568 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -54.79 -38.11 63.63 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.13 -0.941 . . . . 0.61 112.364 -174.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 79' ' ' PHE . 61.8 t -69.19 -51.04 47.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.582 -0.809 . . . . 1.36 110.786 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.89 -23.43 23.95 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.173 -0.467 . . . . 1.59 112.253 -169.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.4 p -73.93 -33.3 63.89 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.828 -1.175 . . . . 2.27 107.828 172.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.88 19.2 65.95 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.082 -0.963 . . . . 1.9 111.13 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -153.78 52.3 0.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.554 0.693 . . . . 2.08 112.084 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.579 HD13 ' HA ' ' A' ' 79' ' ' PHE . 1.0 OUTLIER -67.24 86.45 0.16 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.53 -0.759 . . . . 1.22 111.24 174.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.708 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.6 p30 -144.25 100.67 3.59 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.337 0.589 . . . . 2.15 109.768 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.538 ' HG1' ' C ' ' A' ' 89' ' ' ASN . 32.8 m -148.76 146.99 28.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.88 -0.513 . . . . 2.03 109.992 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.405 ' N ' HG22 ' A' ' 90' ' ' THR . 17.9 ptm -98.76 114.86 27.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.613 -0.884 . . . . 4.31 108.613 167.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -121.73 129.67 52.88 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.373 -0.83 . . . . 2.95 109.418 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.523 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 22.3 mp0 -90.58 118.94 30.43 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.477 -0.934 . . . . 1.97 108.477 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -107.64 98.84 8.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.77 -0.65 . . . . 4.56 109.486 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 m -82.08 142.38 32.35 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.361 -0.836 . . . . 3.22 110.688 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.79 -36.34 6.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.18 -0.674 . . . . 5.99 109.18 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 102' ' ' PRO . 24.1 t0 -166.89 163.13 16.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.545 -0.752 . . . . 6.06 109.434 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.578 ' HH ' ' HZ2' ' A' ' 104' ' ' LYS . 3.1 m-85 -132.26 -8.58 3.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.334 -0.393 . . . . 10.04 110.903 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -95.13 -66.58 0.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.82 0.343 . . . . 8.93 110.652 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 46.0 ttm -84.18 -54.92 4.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.914 -0.585 . . . . 8.55 110.067 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.8 m -121.53 93.46 48.72 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.771 -0.649 . . . . 5.39 109.939 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 91.1 Cg_endo -81.58 24.88 0.67 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.874 2.383 . . . . 5.02 112.644 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.7 m -76.42 97.74 4.37 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.56 0.695 . . . . 2.85 110.357 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.578 ' HZ2' ' HH ' ' A' ' 98' ' ' TYR . 37.0 ttpt -100.2 133.29 44.83 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.352 -0.84 . . . . 3.49 110.018 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.3 m -102.15 161.92 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.298 0.57 . . . . 1.72 110.929 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 39.1 ttmt -116.37 126.72 53.88 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.241 -0.891 . . . . 2.83 109.494 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.64 103.7 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.865 -0.607 . . . . 1.64 109.411 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.935 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 5.7 t-160 -90.08 101.07 13.79 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.169 -1.789 . . . . 1.35 106.169 167.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.708 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.5 OUTLIER -102.2 120.46 40.49 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.294 -1.372 . . . . 2.72 107.294 -178.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -135.79 119.36 17.02 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.943 -0.703 . . . . 2.17 111.143 -165.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.5 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 81.2 tttt -55.81 116.48 2.97 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.152 0.501 . . . . 2.33 110.276 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 145.84 45.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.62 -1.173 . . . . 1.12 111.243 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.18 -8.08 56.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.867 -0.606 . . . . 2.97 110.131 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 t -80.32 -45.53 17.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.062 -0.517 . . . . 2.06 110.007 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.49 149.68 8.32 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.898 -0.667 . . . . 1.52 112.699 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 52.23 37.65 22.56 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.657 0.742 . . . . 2.79 111.644 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.0 p -159.98 154.03 23.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.845 -1.07 . . . . 0.95 109.761 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.5 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 66.2 m-85 -141.35 137.31 32.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.394 -0.366 . . . . 0.98 110.27 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.675 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 44.3 m95 -88.24 164.18 15.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.471 0.653 . . . . 0.48 111.65 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.7 t -136.21 96.1 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.017 -1.447 . . . . 1.3 108.391 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.935 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 63.5 m-85 -94.53 102.53 14.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.944 -1.132 . . . . 1.96 107.944 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 10.3 p -97.72 134.28 36.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 2.21 111.132 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -134.74 127.43 30.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.992 -0.549 . . . . 3.87 109.729 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.419 ' HG2' ' HZ ' ' A' ' 28' ' ' PHE . 10.0 ptm180 -97.66 151.18 20.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.912 0.387 . . . . 4.72 111.028 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.409 -0.805 . . . . 3.55 110.264 172.386 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.99 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.7 tp . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 110.58 -0.156 . . . . 9.06 110.58 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 123' ' ' LYS . . . 68.95 -76.79 0.06 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.894 0.746 . . . . 6.45 112.41 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -105.2 97.61 7.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.189 0.518 . . . . 7.02 110.994 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -112.47 45.82 1.26 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.24 -0.891 . . . . 2.04 111.889 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.25 103.4 15.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.969 0.414 . . . . 1.26 111.073 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.497 HD11 HG21 ' A' ' 39' ' ' ILE . 5.7 tt -135.39 140.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.159 0.504 . . . . 1.5 111.212 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.456 ' HB3' ' CE2' ' A' ' 119' ' ' TRP . 12.3 pt20 -109.6 121.09 44.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.656 -0.702 . . . . 2.22 110.353 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 pp -123.15 152.34 41.26 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.078 -0.51 . . . . 1.4 110.833 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.49 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -70.93 154.13 42.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.762 -0.654 . . . . 1.15 110.142 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.517 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -76.79 31.17 1.49 Allowed Glycine 0 C--O 1.234 0.096 0 CA-C-N 115.781 -0.645 . . . . 1.2 113.31 -173.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 34' ' ' ASP . 12.4 t70 -135.44 -33.51 0.88 Allowed 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 122.84 0.456 . . . . 1.81 110.204 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.59 18.84 0.53 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.473 -0.87 . . . . 1.05 113.051 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 30.8 m-80 -107.68 128.87 54.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.603 0.239 . . . . 1.79 110.789 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.562 HG23 ' HA ' ' A' ' 58' ' ' ILE . 46.9 mm -78.9 115.6 21.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.722 -0.217 . . . . 1.82 110.512 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.86 -47.44 9.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.072 0.463 . . . . 2.13 110.575 -173.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -159.34 142.39 14.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.911 -0.586 . . . . 2.96 111.416 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.415 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 27.5 t80 -114.44 117.59 31.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.656 -0.702 . . . . 1.75 110.191 -177.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -100.52 91.73 4.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.855 -0.424 . . . . 1.28 109.855 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -174.63 98.94 0.09 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.843 -0.617 . . . . 2.53 110.518 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.83 90.6 5.88 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.522 -0.547 . . . . 4.46 109.522 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.33 6.77 16.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.736 -0.666 . . . . 7.21 110.406 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.8 -74.91 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.044 -0.98 . . . . 7.0 111.266 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -152.23 159.89 43.47 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.213 -0.292 . . . . 8.59 110.213 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.5 mt -51.99 -51.57 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.648 -0.705 . . . . 9.53 110.275 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.6 m -82.49 62.95 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.7 0.762 . . . . 10.16 110.02 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.01 76.33 2.21 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.451 -0.795 . . . . 10.12 112.71 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -80.27 51.73 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.307 0.575 . . . . 13.33 110.162 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -93.58 117.6 67.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.754 -0.657 . . . . 8.24 110.553 -175.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -83.83 8.18 4.77 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.789 2.326 . . . . 8.73 113.047 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.757 ' HE3' ' HA ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -118.36 14.38 13.77 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.397 0.617 . . . . 9.47 111.303 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.89 0.31 25.78 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.163 -0.926 . . . . 8.03 109.548 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.549 ' O ' HG13 ' A' ' 39' ' ' ILE . 11.3 t 52.48 59.31 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.169 -0.923 . . . . 5.42 109.697 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.562 ' HA ' HG23 ' A' ' 39' ' ' ILE . 29.9 pt -134.61 166.37 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.476 -0.784 . . . . 3.61 111.184 -177.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.29 32.65 62.4 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.175 -0.921 . . . . 3.37 112.75 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 2.9 tppp? -111.23 96.38 6.09 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.995 0.426 . . . . 4.22 110.637 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -115.76 96.44 5.61 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.047 0.451 . . . . 4.71 110.384 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -129.73 152.37 49.3 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.309 -0.997 . . . . 7.47 108.309 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -78.72 -5.17 52.46 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.723 -0.391 . . . . 8.88 111.883 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -173.1 120.94 0.36 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.104 0.478 . . . . 10.35 111.056 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -86.54 -26.05 24.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.356 0.598 . . . . 7.94 109.632 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.8 t 58.63 56.8 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.83 -1.077 . . . . 9.58 110.438 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.41 83.51 9.85 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.871 -1.059 . . . . 9.32 109.878 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.41 -39.47 2.79 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.526 2.151 . . . . 10.74 112.424 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 49.0 t -150.23 96.28 2.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.401 . . . . 11.49 110.776 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 m -135.23 -62.47 0.71 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.856 0.36 . . . . 11.26 110.226 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -158.64 151.08 21.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 11.56 109.74 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.9 m -121.27 100.64 44.96 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.853 0.358 . . . . 11.11 110.474 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.1 -17.79 27.86 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.58 2.187 . . . . 11.05 111.567 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.66 151.02 40.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.386 -0.825 . . . . 11.76 109.374 177.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -87.78 96.23 10.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.45 0.643 . . . . 10.74 110.999 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.787 ' HB3' ' HB2' ' A' ' 79' ' ' PHE . 77.9 m-85 -82.64 137.18 34.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.387 -0.824 . . . . 7.67 109.35 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.08 -75.01 1.14 Allowed Glycine 0 CA--C 1.506 -0.513 0 C-N-CA 119.819 -1.181 . . . . 3.32 112.071 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.16 8.95 39.78 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 110.392 -0.225 . . . . 4.53 110.392 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.787 ' HB2' ' HB3' ' A' ' 76' ' ' TYR . 6.1 t80 -49.93 -36.06 26.27 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.749 0.648 . . . . 1.1 112.749 -168.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -66.54 -30.42 70.73 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 121.394 0.616 . . . . 3.89 110.952 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -89.26 -41.5 12.15 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.876 -0.787 . . . . 3.07 108.876 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.819 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -51.41 -40.99 47.45 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.142 -0.935 . . . . 0.61 112.565 -173.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 79' ' ' PHE . 85.7 t -64.89 -52.08 58.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.463 -0.869 . . . . 1.36 110.942 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.07 -29.84 21.59 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.101 -0.5 . . . . 1.59 112.323 -168.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.8 p -72.94 -29.53 63.17 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.708 -0.849 . . . . 2.27 108.708 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.03 26.0 65.38 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.828 -0.909 . . . . 1.9 110.828 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -148.56 49.3 1.02 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.89 0.853 . . . . 2.08 111.759 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.819 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -71.79 78.4 0.86 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.142 -0.935 . . . . 1.22 111.644 176.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.5 p-10 -144.23 98.44 3.21 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.454 0.645 . . . . 2.15 109.787 174.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 91' ' ' MET . 4.1 m -149.16 157.43 43.37 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.789 -0.448 . . . . 2.03 109.789 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.468 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.5 ptt? -117.52 138.19 52.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.331 -0.395 . . . . 4.31 109.941 173.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -161.84 149.61 14.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.275 -0.639 . . . . 2.95 109.275 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.581 ' HG3' ' HD3' ' A' ' 106' ' ' LYS . 10.5 mp0 -92.28 121.02 33.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.599 -0.519 . . . . 1.97 109.599 176.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -113.62 137.95 50.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.27 -0.423 . . . . 4.56 110.336 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.2 t -125.94 150.9 47.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.211 -0.45 . . . . 3.22 110.822 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -130.11 7.17 5.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.232 0.539 . . . . 5.99 110.359 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -159.16 136.77 10.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.178 -0.919 . . . . 6.06 108.634 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -138.28 158.64 43.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.41 -0.359 . . . . 10.04 111.869 -169.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 68.81 -59.84 0.46 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.201 0.938 . . . . 8.93 112.01 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 65.2 mtt -60.41 -50.15 74.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.387 0.613 . . . . 8.55 110.071 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 0.4 OUTLIER -129.38 150.25 75.04 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.329 -0.851 . . . . 5.39 110.471 175.136 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 9.2 Cg_endo -91.55 45.03 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.323 2.682 . . . . 5.02 112.058 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.1 m -71.76 97.19 1.73 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.447 0.641 . . . . 2.85 110.396 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.42 ' HD2' HG22 ' A' ' 125' ' ' VAL . 26.8 ttmt -126.89 111.61 14.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.503 -0.771 . . . . 3.49 109.103 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 27.3 m -104.17 159.49 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.295 0.569 . . . . 1.72 111.229 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.581 ' HD3' ' HG3' ' A' ' 93' ' ' GLU . 55.0 mmtt -101.73 120.61 40.63 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.085 -0.962 . . . . 2.83 108.668 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.543 HG13 ' HG3' ' A' ' 109' ' ' MET . 2.1 t -97.21 102.02 12.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.172 -0.677 . . . . 1.64 109.172 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 5.5 t-160 -101.31 103.56 14.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.765 -1.198 . . . . 1.35 107.765 170.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.688 ' HE1' ' HA ' ' A' ' 76' ' ' TYR . 62.0 mtt -106.67 144.18 33.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.058 -1.09 . . . . 2.72 108.058 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.6 ptpt -147.97 130.77 16.07 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.146 -0.621 . . . . 2.17 109.76 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.554 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 63.2 tttp -57.76 111.53 1.17 Allowed 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 109.038 -0.727 . . . . 2.33 109.038 168.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.63 144.75 13.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.781 -1.1 . . . . 1.12 110.085 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.39 -17.99 63.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.003 0.43 . . . . 2.97 110.098 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.2 m -63.0 -40.33 97.45 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.493 -0.776 . . . . 2.06 110.354 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.66 -61.8 0.4 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.72 -0.752 . . . . 1.52 113.475 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -87.45 41.42 0.98 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.438 0.637 . . . . 2.79 112.202 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.517 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.1 p -166.92 159.28 13.3 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.741 -0.663 . . . . 0.95 110.806 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 72.7 m-85 -139.06 135.63 34.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.835 -0.621 . . . . 0.98 109.615 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.456 ' CE2' ' HB3' ' A' ' 32' ' ' GLN . 42.2 m95 -87.77 163.13 16.64 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.352 0.596 . . . . 0.48 112.044 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.95 111.08 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.144 -1.389 . . . . 1.3 108.828 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 83.8 m-85 -111.9 110.08 20.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.529 -0.545 . . . . 1.96 109.529 174.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.34 125.03 63.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.585 0.231 . . . . 2.21 110.77 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 27' ' ' ALA . 97.1 mttt -144.63 137.81 26.93 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 108.966 -0.753 . . . . 3.87 108.966 177.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 14.0 ptt180 -81.68 155.63 25.47 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.285 0.564 . . . . 4.72 111.102 -175.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.42 HG22 ' HD2' ' A' ' 104' ' ' LYS . 61.4 t . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.37 -0.832 . . . . 3.55 109.291 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 1.011 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.855 0.36 . . . . 9.06 110.894 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' A' ' 43' ' ' ASN . . . -74.3 -34.95 63.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.923 -0.58 . . . . 6.45 110.696 175.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -63.22 129.19 39.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.432 -0.349 . . . . 7.02 110.158 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 107.63 -21.82 29.55 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.944 -0.863 . . . . 2.04 110.944 -172.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.91 106.77 16.45 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.003 0.43 . . . . 1.26 111.156 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.429 HG21 ' HB ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -123.88 139.39 50.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.641 -0.503 . . . . 1.5 109.641 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.641 HE21 HD21 ' A' ' 40' ' ' LEU . 21.0 pt20 -110.48 126.57 54.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.786 -0.643 . . . . 2.22 110.529 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.56 163.35 21.15 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.548 -0.751 . . . . 1.4 110.046 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 45.9 p30 -87.06 165.93 15.41 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.47 0.653 . . . . 1.15 110.97 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.57 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -77.16 27.91 1.71 Allowed Glycine 0 C--N 1.319 -0.409 0 CA-C-N 115.251 -0.886 . . . . 1.2 112.243 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 34' ' ' ASP . 20.5 t70 -127.22 -8.97 5.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.084 0.469 . . . . 1.81 110.433 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.06 11.27 43.31 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.866 -0.683 . . . . 1.05 112.151 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.475 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -106.42 148.25 28.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.823 0.344 . . . . 1.79 110.195 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 31' ' ' ILE . 45.5 mm -84.22 129.45 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.548 -0.538 . . . . 1.82 109.548 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.641 HD21 HE21 ' A' ' 32' ' ' GLN . 29.5 tp -96.91 -48.59 5.37 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.954 -0.388 . . . . 2.13 109.954 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 31.5 tp60 -163.55 121.87 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.229 0.538 . . . . 2.96 111.096 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -89.72 123.92 34.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.444 -0.947 . . . . 1.75 108.444 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.588 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 49.7 m-80 -81.94 112.93 19.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.218 0.532 . . . . 1.28 110.327 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.84 141.23 37.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.88 -0.6 . . . . 2.53 109.683 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.85 128.35 36.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.724 0.297 . . . . 4.46 110.859 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -68.54 99.4 0.97 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.827 -0.624 . . . . 7.21 110.664 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.05 -88.68 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.835 -0.697 . . . . 7.0 111.866 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -145.69 116.37 7.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.612 0.244 . . . . 8.59 111.275 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.7 mt -71.72 -37.44 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.415 -0.957 . . . . 9.53 108.415 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.432 ' O ' HG21 ' A' ' 50' ' ' THR . 12.5 t 43.38 69.27 0.41 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.384 -1.28 . . . . 10.16 112.728 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.26 158.63 8.18 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.154 -0.93 . . . . 10.12 112.327 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 52' ' ' ARG . 5.3 ptp85 -87.22 88.46 7.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.432 0.634 . . . . 13.33 110.161 176.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.581 ' OD1' ' HG3' ' A' ' 55' ' ' LYS . 6.9 t0 -76.65 128.97 80.7 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.503 -0.771 . . . . 8.24 110.275 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.18 39.29 0.59 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.083 2.522 . . . . 8.73 113.057 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 46.9 mttp -81.86 99.39 9.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.891 0.377 . . . . 9.47 111.418 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -103.71 5.58 36.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.272 0.558 . . . . 8.03 109.893 172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.426 ' O ' HG21 ' A' ' 57' ' ' VAL . 10.0 p -86.14 36.16 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 123.092 1.425 . . . . 5.42 109.956 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 59' ' ' GLY . 7.7 tp -154.59 149.69 12.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.56 -1.2 . . . . 3.61 109.265 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.431 ' N ' HG13 ' A' ' 58' ' ' ILE . . . 77.49 17.63 78.88 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.356 -0.698 . . . . 3.37 111.356 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 2.8 tppp? -90.01 94.23 9.71 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.867 0.365 . . . . 4.22 110.028 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -133.43 96.37 3.7 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.458 -0.941 . . . . 4.71 108.458 172.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -165.48 135.92 3.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.981 -1.009 . . . . 7.47 108.286 -170.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -81.79 37.02 0.46 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.127 0.489 . . . . 8.88 111.265 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -167.97 168.89 11.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.501 -0.772 . . . . 10.35 109.012 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.9 t70 62.0 71.67 0.53 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.832 0.825 . . . . 7.94 110.964 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.446 HG21 ' N ' ' A' ' 67' ' ' ALA . 9.2 m -113.98 -39.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.062 -0.972 . . . . 9.58 109.634 176.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' N ' HG21 ' A' ' 66' ' ' VAL . . . -112.05 115.88 49.97 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.755 -0.657 . . . . 9.32 109.579 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.13 -49.77 15.89 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.857 2.371 . . . . 10.74 112.67 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.447 ' HB3' ' H ' ' A' ' 70' ' ' THR . 18.2 m -151.0 -159.9 1.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.512 . . . . 11.49 110.34 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.447 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 6.1 m -64.61 121.11 13.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.983 0.364 . . . . 11.26 111.983 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.6 t70 66.59 107.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.968 0.793 . . . . 11.56 112.751 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.0 t -141.56 101.78 6.03 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.052 -0.522 . . . . 11.11 109.876 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.59 54.4 3.42 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.354 2.703 . . . . 11.05 112.053 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.62 -6.43 58.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.556 0.694 . . . . 11.76 109.817 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.577 ' HB3' ' H ' ' A' ' 79' ' ' PHE . 39.2 m-85 -81.52 101.64 10.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.54 -0.754 . . . . 10.74 109.77 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.423 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 63.6 m-85 -62.24 -69.43 0.25 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.564 . . . . 7.67 112.117 -173.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -90.86 39.43 3.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.579 -0.82 . . . . 3.32 112.183 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HE3' ' HB2' ' A' ' 78' ' ' LYS . 23.5 ttmt 53.65 70.22 0.62 Allowed 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.691 0.758 . . . . 4.53 109.543 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.629 ' HA ' HD12 ' A' ' 88' ' ' LEU . 71.7 t80 -50.1 -36.17 28.46 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.725 -1.125 . . . . 1.1 113.071 -166.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -72.38 -25.01 61.35 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.123 0.487 . . . . 3.89 110.557 -173.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -82.19 -31.52 30.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.138 -0.69 . . . . 3.07 109.138 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.998 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -64.3 -41.31 98.25 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.422 -0.808 . . . . 0.61 111.753 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 79' ' ' PHE . 57.9 t -67.79 -47.13 80.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.907 -0.647 . . . . 1.36 110.36 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.12 -32.07 63.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 1.59 110.848 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 64.6 p -67.28 -32.85 74.12 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.118 -0.697 . . . . 2.27 109.118 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.36 12.83 34.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.622 -0.717 . . . . 1.9 112.828 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.551 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.4 p30 -175.23 69.98 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.764 0.792 . . . . 2.08 110.224 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.998 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.3 tt -58.75 88.09 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.911 -1.04 . . . . 1.22 111.233 174.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.2 t30 -143.08 101.63 3.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.935 -0.575 . . . . 2.15 109.573 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.9 t -150.82 155.84 40.03 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 120.895 0.378 . . . . 2.03 110.064 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.631 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.7 ptt? -134.5 116.69 15.38 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.586 -0.734 . . . . 4.31 110.003 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -143.08 136.98 28.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.439 -0.8 . . . . 2.95 109.263 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.3 pt-20 -100.18 118.57 36.79 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.396 -0.522 . . . . 1.97 110.485 177.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -108.23 101.59 10.79 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.803 -0.814 . . . . 4.56 108.803 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 8.8 t -82.95 142.61 31.27 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.16 0.505 . . . . 3.22 110.73 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -98.2 107.24 19.66 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.814 -0.81 . . . . 5.99 108.814 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -58.04 -26.97 63.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.835 -0.431 . . . . 6.06 109.835 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.61 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 9.4 t80 65.13 -89.02 0.03 OUTLIER 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.187 -0.915 . . . . 10.04 111.498 168.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.61 ' HG3' ' O ' ' A' ' 98' ' ' TYR . 6.1 mt-30 -161.76 -55.37 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.032 0.533 . . . . 8.93 109.669 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -105.57 -70.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.707 -0.679 . . . . 8.55 110.567 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.4 t -105.89 141.96 23.8 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.769 -0.651 . . . . 5.39 110.515 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.71 118.78 5.82 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.378 2.052 . . . . 5.02 112.315 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.7 m -89.15 98.29 11.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.793 -0.817 . . . . 2.85 108.793 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 4.7 tmmm? -93.42 126.74 38.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.153 -0.476 . . . . 3.49 111.542 -171.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 32.1 m -110.27 158.69 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 115.78 -0.646 . . . . 1.72 109.869 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 24.1 ttmm -132.45 118.6 19.53 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.948 -0.569 . . . . 2.83 109.474 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.3 t -95.87 104.96 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-N 116.445 -0.343 . . . . 1.64 110.203 -176.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 3.4 t-160 -107.12 102.22 11.57 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.758 -1.201 . . . . 1.35 107.758 170.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.645 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 85.3 mtp -110.12 138.01 47.09 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.547 -1.279 . . . . 2.72 107.547 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 14.2 ptmm? -144.09 135.33 25.59 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.86 -0.736 . . . . 2.17 110.373 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.704 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 46.0 tttm -55.88 116.41 2.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.797 0.808 . . . . 2.33 110.569 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.35 150.46 22.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.172 -1.376 . . . . 1.12 110.716 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.48 -14.42 41.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.787 0.327 . . . . 2.97 111.257 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.4 t -76.12 -24.76 54.94 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.048 0.451 . . . . 2.06 110.326 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.57 -44.7 3.18 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.269 -0.491 . . . . 1.52 112.449 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.58 34.09 0.64 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.498 0.666 . . . . 2.79 111.673 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.45 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.2 p -169.95 159.37 7.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.167 -0.924 . . . . 0.95 110.427 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.704 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 32.2 m-85 -141.31 145.3 35.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.714 0.292 . . . . 0.98 110.297 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -93.23 165.64 12.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.46 0.647 . . . . 0.48 111.853 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.429 ' HB ' HG21 ' A' ' 31' ' ' ILE . 63.0 t -136.08 104.63 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.35 -1.295 . . . . 1.3 109.307 174.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.632 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 62.7 m-85 -106.63 104.79 14.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.463 -0.94 . . . . 1.96 108.463 174.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 12.2 p -105.09 135.48 42.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.25 0.548 . . . . 2.21 110.929 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 81.6 mttt -122.17 109.99 15.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.822 -0.627 . . . . 3.87 109.905 176.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.442 ' HD2' ' C ' ' A' ' 124' ' ' ARG . 3.8 ppt_? -104.29 147.19 27.78 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.776 -0.453 . . . . 4.72 109.776 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.443 ' OXT' HG12 ' A' ' 125' ' ' VAL . 3.6 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 117.968 -1.015 . . . . 3.55 109.99 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 1.001 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.688 ' H ' HD21 ' A' ' 26' ' ' LEU . 2.9 mm? . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.116 -0.698 . . . . 9.06 109.116 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.16 147.79 9.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.633 0.254 . . . . 6.45 111.535 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 55' ' ' LYS . 6.1 m-85 -76.09 78.33 2.93 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.579 -0.526 . . . . 7.02 109.579 167.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.18 -72.11 1.27 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.54 -0.838 . . . . 2.04 111.756 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.49 114.24 16.52 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.903 0.382 . . . . 1.26 111.145 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.497 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 5.5 tt -118.58 140.63 41.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.429 -0.582 . . . . 1.5 109.429 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.559 ' OE1' ' HB3' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -120.99 143.82 48.84 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.295 0.569 . . . . 2.22 110.905 -175.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.48 160.93 33.76 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.062 -0.972 . . . . 1.4 110.37 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 36' ' ' ASP . 48.0 p30 -85.03 159.38 20.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.503 0.668 . . . . 1.15 110.863 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.542 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -77.83 20.55 3.61 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.062 -0.972 . . . . 1.2 111.935 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -99.78 -39.84 8.02 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.813 -0.81 . . . . 1.81 108.813 176.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.73 7.78 0.73 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.214 -0.993 . . . . 1.05 114.596 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.608 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -134.29 160.08 39.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.366 1.083 . . . . 1.79 112.472 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 31' ' ' ILE . 75.9 mt -75.27 143.19 13.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.619 -1.173 . . . . 1.82 110.656 -175.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.559 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 60.5 tp -119.48 -57.56 1.98 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.449 -0.341 . . . . 2.13 111.275 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.543 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 94.8 mt-30 -126.81 145.22 50.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.329 . . . . 2.96 111.332 -174.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.497 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 87.6 t80 -132.38 136.63 46.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 1.75 110.835 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -105.28 107.12 17.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 1.28 109.556 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.97 -34.03 20.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.906 -0.588 . . . . 2.53 111.34 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.07 91.52 3.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.23 -0.441 . . . . 4.46 111.12 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -103.29 9.13 38.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.842 0.83 . . . . 7.21 109.391 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.05 -26.46 24.4 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.28 -0.873 . . . . 7.0 111.958 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.62 149.58 28.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.527 0.203 . . . . 8.59 110.462 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.4 mt -123.83 95.47 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.247 -0.433 . . . . 9.53 110.811 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 p -82.74 179.98 7.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.693 -0.23 . . . . 10.16 110.558 173.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.6 -53.34 0.23 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.144 -1.027 . . . . 10.12 113.447 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.816 HH22 ' HH ' ' A' ' 98' ' ' TYR . 33.9 ptt180 -96.43 69.43 2.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.381 0.61 . . . . 13.33 111.495 -174.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.403 ' OD2' ' HD1' ' A' ' 28' ' ' PHE . 4.1 m-20 -97.65 107.71 41.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.96 -0.564 . . . . 8.24 110.735 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 52' ' ' ARG . 16.4 Cg_exo -70.57 -28.73 20.99 Favored 'Trans proline' 0 CA--C 1.527 0.136 0 C-N-CA 123.154 2.57 . . . . 8.73 112.92 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 28' ' ' PHE . 27.6 mtpp 61.56 34.23 17.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.049 0.452 . . . . 9.47 111.17 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -94.61 -16.41 23.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.026 -0.534 . . . . 8.03 112.111 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.468 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 2.6 m -111.48 74.65 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.432 0.634 . . . . 5.42 112.34 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -176.69 150.79 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.423 -0.955 . . . . 3.61 108.423 173.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.27 29.84 26.71 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.032 -1.227 . . . . 3.37 110.032 -173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -104.11 124.07 48.42 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.088 -0.556 . . . . 4.22 109.878 -176.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -148.19 112.83 5.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.947 0.403 . . . . 4.71 110.961 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -151.01 5.29 0.48 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.576 -0.738 . . . . 7.47 109.992 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 63.31 -95.2 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.244 -0.889 . . . . 8.88 111.319 -174.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.702 ' HB2' ' HZ1' ' A' ' 64' ' ' LYS . 5.1 ttmp? -139.43 153.88 47.67 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.322 -0.251 . . . . 10.35 110.322 -176.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -65.3 139.05 58.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.008 0.432 . . . . 7.94 110.194 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 66' ' ' VAL . 13.2 p -127.17 39.07 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 122.909 1.338 . . . . 9.58 109.074 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.81 150.99 4.01 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.205 -1.361 . . . . 9.32 109.56 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.28 -4.33 10.35 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.992 2.462 . . . . 10.74 112.475 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.7 t -63.46 -46.68 85.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.346 -0.843 . . . . 11.49 111.249 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.473 ' OG1' ' H2 ' ' A' ' 169' ' ' HC4 . 3.0 m -106.84 156.16 18.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.199 -0.455 . . . . 11.26 111.11 -173.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.434 ' N ' HG23 ' A' ' 70' ' ' THR . 5.9 p-10 -162.54 168.91 21.13 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.661 -0.496 . . . . 11.56 109.661 175.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.2 m -76.18 118.84 74.21 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.692 -0.231 . . . . 11.11 111.548 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -96.95 -171.52 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.337 2.692 . . . . 11.05 112.859 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 56.67 62.86 2.13 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.657 -0.701 . . . . 11.76 111.64 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -78.64 90.9 4.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.991 -0.55 . . . . 10.74 110.617 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -114.59 -49.79 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.479 -0.328 . . . . 7.67 110.869 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.62 36.58 4.25 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.597 -1.001 . . . . 3.32 110.597 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt 57.47 46.08 18.6 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.135 -0.533 . . . . 4.53 109.63 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.577 ' O ' HG23 ' A' ' 83' ' ' VAL . 65.6 t80 -44.81 -42.26 7.7 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 113.436 0.902 . . . . 1.1 113.436 -166.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -68.68 -36.3 78.35 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.282 0.563 . . . . 3.89 110.395 -174.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.72 -30.79 28.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.527 -0.761 . . . . 3.07 109.103 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.911 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.97 -43.84 92.87 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.458 -0.792 . . . . 0.61 111.714 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.2 t -63.53 -52.56 56.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.565 -0.818 . . . . 1.36 110.843 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.33 -26.1 35.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 1.59 111.767 -170.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.6 t -67.61 -25.19 65.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.409 -0.589 . . . . 2.27 109.409 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.41 78.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.87 -0.605 . . . . 1.9 112.888 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.42 50.28 1.02 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.711 0.767 . . . . 2.08 111.616 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.911 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.1 tt -70.73 89.7 0.75 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.259 -0.882 . . . . 1.22 110.995 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.5 p30 -143.68 100.49 3.6 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.705 -0.85 . . . . 2.15 108.705 169.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 3.1 p -141.52 152.68 44.35 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.945 -0.472 . . . . 2.03 111.059 -174.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.644 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.5 ptm -120.07 116.49 25.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.6 0.714 . . . . 4.31 109.775 173.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -119.55 122.47 41.69 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.885 -1.052 . . . . 2.95 109.244 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HG2' ' HB3' ' A' ' 106' ' ' LYS . 49.2 mt-10 -92.86 130.47 38.45 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.423 -0.584 . . . . 1.97 109.423 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -108.21 124.21 49.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.973 -0.558 . . . . 4.56 110.356 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.8 t -81.4 151.36 27.95 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.629 -0.714 . . . . 3.22 111.293 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -74.27 115.48 13.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.284 -0.871 . . . . 5.99 111.514 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -71.39 -42.53 68.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.594 0.711 . . . . 6.06 109.772 175.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.816 ' HH ' HH22 ' A' ' 52' ' ' ARG . 8.8 p90 -92.68 146.62 23.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.064 -0.971 . . . . 10.04 111.136 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -97.87 26.48 5.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.372 0.606 . . . . 8.93 110.243 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.4 ttt -60.35 -61.78 2.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.766 -0.652 . . . . 8.55 110.147 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.1 t -145.88 148.91 37.59 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 115.323 -0.853 . . . . 5.39 108.966 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.65 88.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.28 1.986 . . . . 5.02 112.078 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.6 m -105.5 96.32 6.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.94 -0.573 . . . . 2.85 110.12 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -111.44 102.31 10.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.756 -0.656 . . . . 3.49 109.231 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -106.16 161.62 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.189 -0.46 . . . . 1.72 111.207 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.494 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 19.4 ptpt -139.18 127.06 22.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.585 -0.734 . . . . 2.83 109.292 176.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -92.91 144.89 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 C-N-CA 120.185 -0.606 . . . . 1.64 110.623 175.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.544 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 13.2 t-160 -131.69 102.8 6.04 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.43 -1.322 . . . . 1.35 107.43 164.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.677 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 11.2 ptp -101.88 123.72 46.29 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.664 -1.236 . . . . 2.72 107.664 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 21.1 ptmt -138.08 133.36 33.38 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 120.435 -0.506 . . . . 2.17 110.941 -165.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.535 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 64.4 tttp -56.75 115.41 2.55 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.335 -0.848 . . . . 2.33 111.144 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.77 147.09 39.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.513 -1.221 . . . . 1.12 110.425 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.19 -3.34 16.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.666 0.27 . . . . 2.97 111.335 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 p -84.58 -17.82 37.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.705 0.288 . . . . 2.06 111.366 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 127.64 -108.7 0.97 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.306 -0.95 . . . . 1.52 113.118 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -85.16 68.49 10.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.278 1.037 . . . . 2.79 110.956 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.542 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.7 p -158.52 154.09 26.14 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.668 -1.151 . . . . 0.95 108.719 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.535 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 50.1 m-85 -140.41 135.85 32.48 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.769 0.319 . . . . 0.98 110.364 -175.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.497 ' O ' ' HA ' ' A' ' 109' ' ' MET . 39.7 m95 -87.1 161.4 18.14 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 120.861 0.362 . . . . 0.48 110.086 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.4 t -140.01 95.88 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.215 -0.902 . . . . 1.3 108.938 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.544 ' CE1' ' HB3' ' A' ' 108' ' ' HIS . 7.8 p90 -119.53 141.23 49.41 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.991 -0.684 . . . . 1.96 110.528 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 123' ' ' LYS . 12.1 p -123.53 151.98 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.68 -0.691 . . . . 2.21 110.229 -175.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.404 ' N ' HG23 ' A' ' 122' ' ' VAL . 14.8 tptt -143.65 140.61 30.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.094 -0.336 . . . . 3.87 110.094 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -105.48 137.86 42.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.913 0.387 . . . . 4.72 111.09 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.647 -0.692 . . . . 3.55 109.961 178.701 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.999 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.796 0.331 . . . . 9.06 110.237 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.09 142.81 39.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.44 -0.346 . . . . 6.45 110.21 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -83.19 80.58 9.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.986 0.422 . . . . 7.02 111.147 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.591 ' HA3' HG23 ' A' ' 122' ' ' VAL . . . -89.2 55.51 3.97 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.961 -0.563 . . . . 2.04 111.919 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.75 102.44 12.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.041 0.448 . . . . 1.26 111.469 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.66 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 5.9 tt -137.61 141.85 38.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.978 -0.555 . . . . 1.5 109.957 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.509 ' HB3' ' CE3' ' A' ' 119' ' ' TRP . 0.7 OUTLIER -120.27 140.72 50.8 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.223 0.535 . . . . 2.22 110.811 -178.368 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.572 ' HB3' HD11 ' A' ' 39' ' ' ILE . 3.9 pp -134.71 162.85 31.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.439 -0.8 . . . . 1.4 111.152 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.545 ' HB3' HD12 ' A' ' 40' ' ' LEU . 10.4 p30 -83.61 158.26 21.96 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.697 -0.683 . . . . 1.15 110.876 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.57 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -72.83 2.15 34.69 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.311 -0.858 . . . . 1.2 112.191 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.44 -42.28 17.13 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.11 -0.7 . . . . 1.81 109.11 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.59 28.32 0.69 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.179 -0.919 . . . . 1.05 112.355 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.541 ' HA ' ' HG3' ' A' ' 60' ' ' LYS . 17.0 m-80 -133.86 150.11 51.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.769 0.318 . . . . 1.79 110.23 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.885 HG12 ' HB3' ' A' ' 60' ' ' LYS . 12.1 mm -74.65 143.53 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 116.239 -0.437 . . . . 1.82 110.443 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 34' ' ' ASP . 85.7 mt -113.86 -50.89 2.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.837 0.351 . . . . 2.13 111.104 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -142.45 136.17 29.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.23 -0.441 . . . . 2.96 110.258 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.767 ' HB3' ' HA ' ' A' ' 57' ' ' VAL . 61.7 t80 -130.28 135.67 48.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.164 -0.471 . . . . 1.75 110.205 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -104.7 142.02 35.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.389 -0.368 . . . . 1.28 110.382 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.79 151.07 20.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.257 -0.429 . . . . 2.53 110.478 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.57 106.17 18.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.337 -0.392 . . . . 4.46 111.075 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.85 179.21 5.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.213 -0.449 . . . . 7.21 110.235 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.61 -59.75 0.67 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.753 -0.737 . . . . 7.0 112.246 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.19 132.48 33.86 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.62 -0.511 . . . . 8.59 109.62 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.8 mm -92.67 44.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.812 0.815 . . . . 9.53 110.713 -174.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.1 p -138.07 42.87 2.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.878 -0.601 . . . . 10.16 109.834 171.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.63 117.77 0.91 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.117 -1.039 . . . . 10.12 113.036 -175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.596 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 2.8 mmp_? -109.33 104.51 13.64 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.307 -0.627 . . . . 13.33 109.307 171.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -68.36 130.6 92.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.763 -0.653 . . . . 8.24 111.233 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.92 -9.48 15.57 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.655 2.237 . . . . 8.73 111.643 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 64.06 94.31 0.05 Allowed 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.371 -0.831 . . . . 9.47 111.907 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -70.64 -54.2 12.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.735 -0.666 . . . . 8.03 109.338 172.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.767 ' HA ' ' HB3' ' A' ' 42' ' ' TYR . 47.2 t 62.61 -70.15 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.061 0.944 . . . . 5.42 112.612 176.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.0 pt -132.28 71.47 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 122.152 0.977 . . . . 3.61 110.513 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.46 -32.99 83.42 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 114.407 -1.27 . . . . 3.37 112.724 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.885 ' HB3' HG12 ' A' ' 39' ' ' ILE . 26.3 tptp -105.22 113.27 26.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.709 0.29 . . . . 4.22 110.701 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -138.03 112.5 8.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.506 -0.924 . . . . 4.71 108.506 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -61.59 99.31 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 7.47 111.168 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -107.49 13.51 26.78 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.678 -0.86 . . . . 8.88 108.678 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.7 mttp 62.3 49.72 4.14 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.71 -1.218 . . . . 10.35 107.71 -169.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -9.01 7.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 113.365 -1.743 . . . . 7.94 112.416 -171.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m 37.77 43.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.568 1.147 . . . . 9.58 113.5 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.45 102.64 52.23 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.63 -0.714 . . . . 9.32 109.256 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -40.89 113.03 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 124.169 3.246 . . . . 10.74 114.177 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.3 m -99.85 123.76 44.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.437 -0.801 . . . . 11.49 109.145 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 m -53.48 -51.8 61.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.594 -0.521 . . . . 11.26 109.594 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -167.76 -69.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.215 -0.902 . . . . 11.56 109.113 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.434 ' HB2' ' CD1' ' A' ' 76' ' ' TYR . 31.4 m -125.02 152.98 71.2 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.276 -0.875 . . . . 11.11 108.78 175.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.92 40.51 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.432 2.754 . . . . 11.05 113.44 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 65.72 -179.2 0.19 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.18 0.592 . . . . 11.76 111.429 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 65.47 23.67 11.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.651 -0.704 . . . . 10.74 111.253 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.823 ' HB2' ' HB2' ' A' ' 79' ' ' PHE . 51.6 p90 -113.21 143.62 44.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.954 -0.567 . . . . 7.67 110.615 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.87 90.91 0.65 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.827 -0.702 . . . . 3.32 111.588 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.688 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 18.4 tptm 60.35 35.68 20.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.173 0.511 . . . . 4.53 110.315 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.823 ' HB2' ' HB2' ' A' ' 76' ' ' TYR . 62.0 t80 -48.8 -37.67 19.88 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.562 -0.745 . . . . 1.1 112.733 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -70.47 -36.87 74.11 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 123.576 0.547 . . . . 3.89 110.123 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.688 ' HB3' ' HG3' ' A' ' 78' ' ' LYS . 41.0 tt0 -80.55 -31.87 36.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.586 -0.734 . . . . 3.07 109.18 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.953 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.5 -46.25 93.4 Favored Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 115.666 -0.697 . . . . 0.61 111.88 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.4 t -69.15 -46.46 77.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.696 -0.752 . . . . 1.36 110.578 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.6 -28.84 63.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.864 -0.607 . . . . 1.59 110.555 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -69.69 -23.91 63.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.414 -0.812 . . . . 2.27 109.265 174.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.93 19.58 69.84 Favored Glycine 0 CA--C 1.505 -0.539 0 CA-C-N 115.685 -0.688 . . . . 1.9 112.198 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.401 ' C ' HD21 ' A' ' 87' ' ' ASN . 0.4 OUTLIER -163.4 55.57 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.246 0.546 . . . . 2.08 111.29 -175.287 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.953 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.1 tt -68.65 88.95 0.36 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.771 -0.649 . . . . 1.22 111.081 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.755 ' HA ' ' O ' ' A' ' 109' ' ' MET . 20.4 t30 -143.15 100.45 3.64 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.284 -0.636 . . . . 2.15 109.284 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.9 t -156.06 158.08 37.17 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.999 0.428 . . . . 2.03 110.687 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.514 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 19.5 ptt? -125.77 126.16 44.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.772 -0.649 . . . . 4.31 110.447 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.49 ' O ' HG23 ' A' ' 107' ' ' VAL . 90.1 t80 -146.08 130.16 17.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.676 -0.693 . . . . 2.95 109.795 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.779 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 12.9 pt-20 -104.62 127.1 52.27 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.046 0.451 . . . . 1.97 110.222 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -122.3 94.09 4.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.794 0.807 . . . . 4.56 109.154 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.535 ' HB ' ' HG3' ' A' ' 104' ' ' LYS . 9.2 t -91.4 135.7 33.64 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.129 -0.941 . . . . 3.22 110.827 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.505 ' HA ' ' HB3' ' A' ' 102' ' ' PRO . 1.5 m-85 56.76 66.29 1.21 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.618 -0.719 . . . . 5.99 110.608 177.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -88.1 -151.61 0.2 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.319 -0.855 . . . . 6.06 111.345 -175.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -76.42 -13.36 60.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 10.04 110.864 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -69.82 127.97 34.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.436 -0.579 . . . . 8.93 109.436 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.563 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 49.7 ttm -62.09 -24.05 66.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.365 -0.38 . . . . 8.55 111.299 -176.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.5 m -95.51 95.22 1.65 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.232 -0.655 . . . . 5.39 109.232 171.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 100' ' ' MET . 5.7 Cg_exo -79.1 103.75 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.068 2.512 . . . . 5.02 112.496 -172.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.9 m -109.38 139.91 43.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.972 -0.558 . . . . 2.85 109.518 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.535 ' HG3' ' HB ' ' A' ' 95' ' ' THR . 62.4 tttm -84.18 99.31 10.44 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.737 -0.785 . . . . 3.49 109.552 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.525 HG12 ' HB3' ' A' ' 124' ' ' ARG . 17.9 m -109.4 159.89 8.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.008 -0.996 . . . . 1.72 111.588 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.779 ' HG3' ' HB3' ' A' ' 93' ' ' GLU . 25.0 ttpp -146.11 115.0 6.92 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.461 -0.791 . . . . 2.83 109.213 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 122' ' ' VAL . 12.9 m -88.54 144.56 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-O 121.373 0.606 . . . . 1.64 111.414 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.419 ' O ' ' HD1' ' A' ' 121' ' ' PHE . 14.6 t-160 -132.33 103.32 6.15 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 106.858 -1.534 . . . . 1.35 106.858 160.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.755 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 79.5 mtp -103.7 132.14 50.23 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.108 -1.442 . . . . 2.72 107.108 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.541 ' HG2' ' HB2' ' A' ' 119' ' ' TRP . 61.7 pttt -138.59 131.62 29.76 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.709 -0.796 . . . . 2.17 110.087 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 80.8 tttt -56.57 113.05 1.45 Allowed 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.784 -0.644 . . . . 2.33 110.188 172.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.427 ' HB1' ' OG ' ' A' ' 117' ' ' SER . . . -58.22 144.75 39.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.605 -1.18 . . . . 1.12 110.866 -173.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 73.4 mt -71.23 -9.81 58.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.041 -0.527 . . . . 2.97 110.846 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 p -73.13 -30.63 63.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.975 -0.557 . . . . 2.06 111.057 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.6 -126.16 2.82 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.74 -0.743 . . . . 1.52 112.668 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.65 79.24 2.01 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.989 0.899 . . . . 2.79 110.853 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.57 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.1 p -168.07 156.16 8.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.532 -1.213 . . . . 0.95 108.457 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.535 ' HH ' ' HA ' ' A' ' 83' ' ' VAL . 31.6 m-85 -140.24 137.36 34.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.64 0.257 . . . . 0.98 110.916 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.541 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . 45.1 m95 -83.64 162.81 20.65 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.227 0.536 . . . . 0.48 110.817 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.731 HG21 ' HE3' ' A' ' 109' ' ' MET . 50.9 t -137.23 97.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.744 -1.116 . . . . 1.3 109.659 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 89.8 m-85 -100.17 102.47 13.78 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.528 -0.545 . . . . 1.96 109.528 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.591 HG23 ' HA3' ' A' ' 29' ' ' GLY . 3.7 m -97.84 106.47 18.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.516 0.674 . . . . 2.21 110.026 176.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -109.34 109.44 20.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.963 -0.461 . . . . 3.87 110.773 -172.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.525 ' HB3' HG12 ' A' ' 105' ' ' VAL . 5.5 ppt_? -101.76 142.88 32.4 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.383 -0.599 . . . . 4.72 109.383 175.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.427 ' OXT' HG12 ' A' ' 125' ' ' VAL . 4.0 p . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.197 -0.906 . . . . 3.55 110.077 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 1.001 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.021 -0.363 . . . . 9.06 110.021 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.62 103.34 14.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.019 0.438 . . . . 6.45 110.332 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -81.74 133.29 35.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.196 -0.456 . . . . 7.02 111.323 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.76 -150.27 9.02 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.589 -0.732 . . . . 2.04 111.864 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.81 119.45 29.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.139 -0.319 . . . . 1.26 110.139 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -111.64 138.71 39.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.988 0.423 . . . . 1.5 110.604 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.635 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 7.6 pt20 -109.88 127.04 54.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.816 -0.629 . . . . 2.22 110.343 176.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' A' ' 39' ' ' ILE . 3.8 pp -118.69 159.03 24.39 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.288 -0.869 . . . . 1.4 109.577 177.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.761 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 1.9 p30 -84.24 151.59 24.71 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.174 -0.611 . . . . 1.15 109.976 176.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -73.3 5.18 21.86 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.431 -0.804 . . . . 1.2 112.606 -175.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.09 -39.34 13.69 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.495 -0.557 . . . . 1.81 109.495 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.79 36.99 0.19 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.611 -0.722 . . . . 1.05 111.935 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.761 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 19.0 m-80 -137.59 152.53 49.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.978 0.418 . . . . 1.79 110.342 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 33' ' ' LEU . 46.3 mm -95.14 123.28 47.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.879 -0.601 . . . . 1.82 110.057 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.496 HD23 ' NE2' ' A' ' 32' ' ' GLN . 35.2 tp -102.59 -52.06 3.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.754 0.279 . . . . 2.13 111.754 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.631 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 7.3 tt0 -142.52 122.49 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.902 0.382 . . . . 2.96 111.371 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -113.76 106.37 14.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.088 -0.506 . . . . 1.75 109.668 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -81.95 93.4 6.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.137 0.494 . . . . 1.28 110.587 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.22 -53.06 3.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.5 -0.773 . . . . 2.53 109.65 175.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.08 112.74 4.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.1 -0.954 . . . . 4.46 109.153 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.58 123.73 18.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.398 . . . . 7.21 110.527 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.83 19.01 38.4 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.805 -0.712 . . . . 7.0 111.995 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.92 118.07 30.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.391 -0.596 . . . . 8.59 109.391 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 pt -111.11 39.28 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.121 0.486 . . . . 9.53 112.24 -171.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.5 t -96.34 160.56 14.35 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.285 -0.635 . . . . 10.16 109.285 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -102.09 99.91 1.94 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.711 -0.757 . . . . 10.12 112.705 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 52' ' ' ARG . 56.5 mtt-85 -89.51 113.86 25.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.473 -0.936 . . . . 13.33 108.473 173.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 1.9 p-10 -66.19 132.39 94.48 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.568 0.699 . . . . 8.24 111.683 -170.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HB3' ' HA3' ' A' ' 59' ' ' GLY . 2.9 Cg_exo -77.44 18.86 0.77 Allowed 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 123.915 3.077 . . . . 8.73 113.846 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -92.12 23.36 3.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.584 0.707 . . . . 9.47 110.149 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -127.1 -87.01 0.59 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.147 -0.933 . . . . 8.03 110.366 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 HG13 HG21 ' A' ' 70' ' ' THR . 2.5 m -136.46 -44.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.386 -0.825 . . . . 5.42 110.861 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 11.9 tt -75.13 151.39 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.973 -0.38 . . . . 3.61 109.973 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.605 ' HA3' ' HB3' ' A' ' 54' ' ' PRO . . . 79.88 8.58 87.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.917 -0.658 . . . . 3.37 112.051 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.733 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 24.9 tptp -79.79 107.17 12.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.763 -0.458 . . . . 4.22 109.763 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . 5.7 m120 -143.4 96.39 2.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.853 0.359 . . . . 4.71 110.499 176.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -151.75 102.52 2.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.751 -0.833 . . . . 7.47 108.751 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -91.28 15.22 12.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 8.88 112.175 -170.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -122.18 158.95 28.26 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.215 -0.291 . . . . 10.35 110.215 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t70 74.84 -54.24 0.67 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.811 0.695 . . . . 7.94 111.387 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.4 t 53.11 49.94 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.081 0.943 . . . . 9.58 111.083 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.652 ' H ' ' HD2' ' A' ' 68' ' ' PRO . . . -105.39 -49.62 0.12 Allowed Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.411 -0.813 . . . . 9.32 110.213 170.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.652 ' HD2' ' H ' ' A' ' 67' ' ' ALA . 37.7 Cg_endo -66.53 101.96 0.57 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.753 1.635 . . . . 10.74 111.287 171.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.3 p -134.23 119.35 18.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.821 -0.627 . . . . 11.49 110.852 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.421 HG21 HG13 ' A' ' 57' ' ' VAL . 2.6 p -85.36 52.83 2.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.383 0.611 . . . . 11.26 110.71 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -78.5 97.38 5.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.542 -0.753 . . . . 11.56 110.539 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.42 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 12.7 t -131.9 129.19 21.81 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.692 -0.685 . . . . 11.11 109.36 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 72' ' ' SER . 14.2 Cg_exo -70.21 57.24 1.66 Allowed 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.167 2.578 . . . . 11.05 112.414 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.72 -64.18 0.91 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.016 -0.538 . . . . 11.76 109.684 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.84 24.43 2.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.675 -0.693 . . . . 10.74 109.8 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.705 ' HA ' ' HE1' ' A' ' 109' ' ' MET . 7.6 m-30 -64.92 133.18 51.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.81 -0.632 . . . . 7.67 111.254 -176.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -133.64 96.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.123 -0.791 . . . . 3.32 111.123 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 65.48 25.09 11.87 Favored 'General case' 0 C--O 1.223 -0.32 0 O-C-N 123.826 0.368 . . . . 4.53 110.191 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 83' ' ' VAL . 44.8 t80 -55.87 -29.93 60.7 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 112.541 0.571 . . . . 1.1 112.541 -167.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -81.4 -37.21 28.52 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.039 0.447 . . . . 3.89 110.204 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -78.72 -30.7 46.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.745 -0.835 . . . . 3.07 108.745 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.982 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.51 -43.98 90.56 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.067 -0.969 . . . . 0.61 111.873 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 79' ' ' PHE . 89.6 t -68.57 -52.56 35.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.424 -0.888 . . . . 1.36 111.047 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.19 -28.97 38.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.936 -0.575 . . . . 1.59 111.678 -169.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -72.07 -26.32 62.12 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.658 -0.867 . . . . 2.27 108.658 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.6 18.43 70.79 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.249 -0.887 . . . . 1.9 112.313 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -140.31 42.46 1.91 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.47 0.652 . . . . 2.08 111.897 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.982 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -69.21 89.13 0.45 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.363 -0.835 . . . . 1.22 111.609 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.1 p30 -143.95 100.9 3.65 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.453 -0.943 . . . . 2.15 108.453 169.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 17.8 p -131.85 151.1 51.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 121.879 -0.513 . . . . 2.03 111.12 -173.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 3.9 ppp? -118.79 129.34 55.19 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.647 -0.871 . . . . 4.31 108.647 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.468 ' HE2' ' HD2' ' A' ' 94' ' ' TYR . 38.5 t80 -139.28 127.85 23.08 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.906 -0.588 . . . . 2.95 109.463 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -90.62 107.3 19.08 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.764 -1.199 . . . . 1.97 107.764 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.468 ' HD2' ' HE2' ' A' ' 92' ' ' PHE . 43.1 t80 -108.84 103.25 12.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.157 0.503 . . . . 4.56 110.646 -173.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.488 HG23 ' H ' ' A' ' 97' ' ' ASP . 4.9 m -96.17 132.61 41.41 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.672 -0.695 . . . . 3.22 110.017 175.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.22 -27.22 42.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.853 -0.158 . . . . 5.99 110.798 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 102' ' ' PRO . 33.0 t70 69.33 171.71 0.3 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.827 0.704 . . . . 6.06 110.403 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.3 t80 67.46 -171.8 0.19 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.709 -0.478 . . . . 10.04 109.709 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 71.17 -178.16 0.21 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.981 0.512 . . . . 8.93 111.085 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -60.4 -38.84 85.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.362 0.601 . . . . 8.55 109.724 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 7.1 t -139.24 138.16 20.31 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.353 -0.839 . . . . 5.39 109.314 174.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.581 ' HB3' ' HA ' ' A' ' 97' ' ' ASP . 15.5 Cg_exo -67.81 101.49 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.344 2.029 . . . . 5.02 110.824 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.3 m -56.57 98.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 2.85 110.98 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 52.0 tttm -106.82 117.81 35.03 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.876 -0.602 . . . . 3.49 110.87 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.5 161.03 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.93 -0.577 . . . . 1.72 110.391 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.595 ' HE2' HG12 ' A' ' 125' ' ' VAL . 17.4 ttmm -113.92 115.79 28.24 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.094 -1.076 . . . . 2.83 108.094 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 91' ' ' MET . 1.9 t -89.73 142.71 12.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 119.976 -0.689 . . . . 1.64 109.321 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.601 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 13.6 t-160 -140.47 103.51 4.57 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.437 -0.949 . . . . 1.35 108.437 167.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.705 ' HE1' ' HA ' ' A' ' 76' ' ' TYR . 61.5 mtt -92.19 140.68 29.38 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.045 -1.465 . . . . 2.72 107.045 173.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -149.27 129.95 14.09 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.349 -0.94 . . . . 2.17 111.202 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.534 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 38.1 tttp -55.22 117.81 3.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.481 -1.236 . . . . 2.33 110.435 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.18 147.71 9.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.783 -1.099 . . . . 1.12 111.256 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -62.03 -25.54 67.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.345 -0.389 . . . . 2.97 111.297 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.0 p -79.59 -56.0 4.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.044 0.449 . . . . 2.06 110.226 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.31 169.14 12.74 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.874 -0.679 . . . . 1.52 112.389 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.9 t70 60.32 28.86 18.5 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.243 1.02 . . . . 2.79 110.642 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.476 ' CB ' ' HA ' ' A' ' 34' ' ' ASP . 6.9 p -168.1 153.22 6.69 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.347 -1.297 . . . . 0.95 109.984 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.534 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 51.3 m-85 -140.98 139.68 34.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.226 -0.443 . . . . 0.98 110.117 -175.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.635 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 40.6 m95 -87.77 161.4 17.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.192 0.52 . . . . 0.48 111.448 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.515 HG21 ' HG2' ' A' ' 109' ' ' MET . 62.1 t -140.21 96.59 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.439 -1.255 . . . . 1.3 108.601 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' A' ' 108' ' ' HIS . 5.4 p90 -124.58 140.1 53.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.241 -0.583 . . . . 1.96 110.213 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.5 m -113.1 162.78 10.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.171 0.51 . . . . 2.21 111.342 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -151.74 120.08 6.38 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.421 -0.809 . . . . 3.87 109.29 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -77.58 91.82 4.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.503 0.668 . . . . 4.72 111.202 -176.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.595 HG12 ' HE2' ' A' ' 106' ' ' LYS . 2.9 p . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.381 -0.827 . . . . 3.55 110.179 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.964 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.543 0.211 . . . . 9.06 111.356 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.9 -48.93 6.5 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.453 -0.943 . . . . 6.45 108.453 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -105.95 150.98 25.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.316 -0.856 . . . . 7.02 109.103 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 177.49 -57.17 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.427 -0.892 . . . . 2.04 112.767 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.89 111.21 5.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.969 0.414 . . . . 1.26 111.719 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.739 HG13 ' HA ' ' A' ' 42' ' ' TYR . 1.2 tt -131.9 140.44 48.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.368 -0.378 . . . . 1.5 110.095 174.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.651 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 2.4 pt20 -108.27 130.8 55.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.42 0.629 . . . . 2.22 110.201 172.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -120.06 158.14 27.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.185 -0.916 . . . . 1.4 109.53 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -74.84 152.03 38.97 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.991 -0.55 . . . . 1.15 109.788 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.605 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -79.28 37.6 2.01 Favored Glycine 0 CA--C 1.506 -0.509 0 CA-C-N 115.906 -0.588 . . . . 1.2 112.237 -172.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 34' ' ' ASP . 11.4 t70 -140.47 -33.67 0.55 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.075 -0.562 . . . . 1.81 110.484 -178.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.97 11.75 0.49 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.459 -0.877 . . . . 1.05 113.183 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 61' ' ' ASN . 17.0 m-80 -106.07 144.71 32.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.151 -0.315 . . . . 1.79 110.151 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.693 HG12 ' HB3' ' A' ' 60' ' ' LYS . 44.7 mm -75.59 134.99 28.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.645 -0.502 . . . . 1.82 109.645 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.587 ' HB3' ' HG3' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -106.08 -62.69 1.34 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.938 -0.764 . . . . 2.13 108.938 -174.23 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.595 ' HB3' ' HG2' ' A' ' 32' ' ' GLN . 39.9 tt0 -144.69 110.34 5.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.838 -1.074 . . . . 2.96 110.359 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.739 ' HA ' HG13 ' A' ' 31' ' ' ILE . 19.2 t80 -100.06 110.78 23.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.008 -0.542 . . . . 1.75 109.659 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -93.17 93.53 8.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.847 0.356 . . . . 1.28 110.382 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.89 133.23 33.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.969 -0.56 . . . . 2.53 110.14 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.43 92.16 6.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.063 0.458 . . . . 4.46 110.923 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.59 127.28 51.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.916 -0.584 . . . . 7.21 109.94 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.52 62.11 4.66 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.901 -0.88 . . . . 7.0 110.901 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -90.81 99.68 12.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.127 0.489 . . . . 8.59 110.864 -174.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.8 mt -90.81 -53.23 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.486 -0.779 . . . . 9.53 109.085 175.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -153.95 158.12 40.19 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.342 -0.844 . . . . 10.16 108.909 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.96 131.96 1.97 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.13 -1.033 . . . . 10.12 112.505 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.1 ptt85 -86.99 61.23 6.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.365 0.602 . . . . 13.33 110.444 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.414 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 33.4 t70 -108.26 103.24 49.86 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.634 . . . . 8.24 110.103 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 53' ' ' ASP . 89.4 Cg_exo -36.75 97.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.715 3.61 . . . . 8.73 113.974 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.83 106.49 17.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.236 -0.893 . . . . 9.47 109.412 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -85.94 -26.94 25.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.896 -0.593 . . . . 8.03 112.427 -172.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 58' ' ' ILE . 2.0 t -100.57 26.87 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.297 0.57 . . . . 5.42 111.316 -170.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.1 pt -152.86 156.12 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 116.033 -0.53 . . . . 3.61 110.093 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.31 28.17 64.08 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.596 -0.729 . . . . 3.37 111.71 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.693 ' HB3' HG12 ' A' ' 39' ' ' ILE . 49.4 tptt -90.82 113.9 26.17 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.961 0.41 . . . . 4.22 110.532 -174.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.469 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 3.5 p30 -114.37 124.97 53.29 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.67 -0.696 . . . . 4.71 110.224 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -133.59 129.05 36.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.262 -0.881 . . . . 7.47 109.594 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -119.59 -68.51 0.91 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.114 0.483 . . . . 8.88 110.809 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -149.95 29.86 0.73 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.861 0.839 . . . . 10.35 109.256 -177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.25 152.08 45.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.314 -1.312 . . . . 7.94 110.683 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 m -89.92 50.57 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.408 0.623 . . . . 9.58 112.378 -171.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 68' ' ' PRO . . . -84.32 -51.42 0.58 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.773 -0.649 . . . . 9.32 111.995 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 67' ' ' ALA . 34.7 Cg_endo -64.74 119.05 5.99 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.004 1.803 . . . . 10.74 112.724 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.1 m -135.54 112.49 10.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.705 -0.68 . . . . 11.49 111.033 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.45 HG21 ' N ' ' A' ' 71' ' ' ASP . 2.4 m 66.76 158.01 0.12 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.341 -0.845 . . . . 11.26 111.458 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.45 ' N ' HG21 ' A' ' 70' ' ' THR . 2.5 m-20 -62.59 120.17 10.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.918 0.389 . . . . 11.56 110.932 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 m -127.94 86.46 58.12 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.074 -0.512 . . . . 11.11 110.266 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.3 37.92 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.695 2.93 . . . . 11.05 112.955 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -85.82 -36.4 20.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.11 0.481 . . . . 11.76 110.495 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -132.71 178.86 6.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.681 -0.69 . . . . 10.74 109.313 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.82 ' HB2' ' HB2' ' A' ' 79' ' ' PHE . 43.7 p90 50.43 122.87 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.949 1.299 . . . . 7.67 113.291 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.61 -58.24 4.24 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.851 -1.166 . . . . 3.32 112.191 -172.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 81' ' ' GLU . 73.8 mmtt -138.43 33.57 2.28 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 109.088 -0.708 . . . . 4.53 109.088 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.86 ' HA ' HD12 ' A' ' 88' ' ' LEU . 35.9 t80 -44.61 -47.35 10.39 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 114.094 1.146 . . . . 1.1 114.094 -160.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -79.58 -30.25 41.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.656 0.741 . . . . 3.89 109.578 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 68.1 tt0 -73.7 -31.52 63.46 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.975 -1.011 . . . . 3.07 108.274 176.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.78 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.27 -43.67 99.07 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.613 -1.176 . . . . 0.61 111.259 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.617 ' HA ' ' HH ' ' A' ' 118' ' ' TYR . 73.7 t -65.43 -47.68 85.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.368 -0.916 . . . . 1.36 110.526 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.8 -31.05 56.72 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.779 -0.646 . . . . 1.59 111.225 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.2 t -66.46 -34.26 77.53 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.264 -1.013 . . . . 2.27 108.264 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.62 12.48 58.15 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.24 -0.891 . . . . 1.9 111.699 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.541 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.3 p30 -162.28 59.13 0.23 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.572 0.701 . . . . 2.08 111.475 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 79' ' ' PHE . 1.4 tt -60.6 93.01 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.451 -0.795 . . . . 1.22 110.746 172.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.728 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.1 t30 -140.63 101.52 4.11 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.662 -0.495 . . . . 2.15 109.662 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 6.3 m -137.26 149.44 47.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.48 -0.327 . . . . 2.03 110.202 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.0 ptt? -134.08 128.8 34.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.063 -0.517 . . . . 4.31 109.865 175.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -161.83 154.01 19.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.964 -0.562 . . . . 2.95 109.937 -174.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.735 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 37.1 mt-10 -110.8 112.21 23.92 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.67 -0.493 . . . . 1.97 109.67 176.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 96' ' ' PHE . 36.5 p90 -131.73 161.27 33.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 4.56 111.421 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.735 ' HG1' ' HH ' ' A' ' 98' ' ' TYR . 1.1 p -99.32 104.23 16.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.421 -0.809 . . . . 3.22 110.892 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.409 ' HB3' ' CE1' ' A' ' 94' ' ' TYR . 31.9 p90 -87.57 -17.81 31.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.928 0.394 . . . . 5.99 111.014 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -137.48 131.3 31.67 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.778 -0.453 . . . . 6.06 109.778 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.735 ' HH ' ' HG1' ' A' ' 95' ' ' THR . 97.6 m-85 -113.86 95.61 5.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.901 0.381 . . . . 10.04 111.345 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -112.32 -148.8 0.44 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.478 -0.564 . . . . 8.93 109.478 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -55.07 -47.62 74.63 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.196 -0.668 . . . . 8.55 109.196 173.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.2 p -100.25 144.83 29.18 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 115.211 -0.904 . . . . 5.39 110.151 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.24 100.64 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.182 1.921 . . . . 5.02 110.331 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.5 m -67.18 97.35 0.52 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.455 0.645 . . . . 2.85 110.21 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.785 ' HZ1' ' HB2' ' A' ' 104' ' ' LYS . 5.2 ttmp? -104.54 119.59 39.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.11 -0.95 . . . . 3.49 110.418 -174.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 17.3 m -109.45 159.48 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.903 -0.59 . . . . 1.72 111.324 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.735 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -108.85 113.43 26.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.827 -1.175 . . . . 2.83 107.827 175.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 91' ' ' MET . 3.5 m -100.45 144.86 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 C-N-CA 119.872 -0.731 . . . . 1.64 112.138 -178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.3 t-160 -135.9 102.19 4.98 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.335 -1.302 . . . . 1.35 107.497 164.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.728 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 63.1 mtt -100.92 116.33 32.52 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.459 -1.682 . . . . 2.72 106.459 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 58.8 pttt -132.14 136.64 47.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.218 -0.993 . . . . 2.17 110.999 -168.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.651 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 35.1 tttm -55.6 119.56 5.88 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.138 -0.937 . . . . 2.33 110.57 170.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.84 146.85 13.04 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.119 -0.946 . . . . 1.12 110.159 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.5 tp -61.96 -25.23 67.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.547 -0.297 . . . . 2.97 110.744 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.9 m -76.48 -67.42 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.363 -0.38 . . . . 2.06 110.749 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 143.89 161.93 9.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.63 -0.795 . . . . 1.52 112.447 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 t70 54.57 37.43 27.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.445 1.117 . . . . 2.79 111.003 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.605 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 5.5 p -167.8 150.41 5.77 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.346 -1.297 . . . . 0.95 108.962 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.651 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 57.2 m-85 -141.66 141.57 33.37 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.702 0.287 . . . . 0.98 110.416 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.651 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 46.3 m95 -90.58 165.73 13.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.457 0.646 . . . . 0.48 111.391 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.61 96.07 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.308 -1.314 . . . . 1.3 108.877 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 45.8 m-85 -92.71 132.24 37.1 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.613 -0.884 . . . . 1.96 108.613 172.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.46 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 8.2 p -144.75 137.03 21.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.788 0.328 . . . . 2.21 110.636 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -145.29 132.62 20.62 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.85 -0.426 . . . . 3.87 109.85 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -106.11 157.11 17.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.134 0.492 . . . . 4.72 110.624 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.613 HG12 ' HE2' ' A' ' 106' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 117.836 -1.078 . . . . 3.55 110.137 175.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.987 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD12 ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.368 -0.604 . . . . 9.06 109.368 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.432 ' H ' HD12 ' A' ' 26' ' ' LEU . . . -87.76 144.06 26.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.535 0.207 . . . . 6.45 110.811 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -124.26 -57.6 1.58 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.519 -0.549 . . . . 7.02 109.519 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.32 49.7 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.915 -1.039 . . . . 2.04 110.862 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.42 102.42 15.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.304 0.573 . . . . 1.26 112.148 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.555 HG13 ' HA ' ' A' ' 42' ' ' TYR . 5.4 tt -124.44 139.7 49.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.695 -0.684 . . . . 1.5 109.383 172.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -116.65 137.12 52.42 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.62 0.724 . . . . 2.22 111.844 -176.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.893 ' HB3' HD12 ' A' ' 39' ' ' ILE . 3.6 pp -126.86 165.34 19.52 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.824 -1.08 . . . . 1.4 110.31 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 14.8 p30 -97.2 158.66 15.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.302 0.573 . . . . 1.15 110.211 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.61 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -79.49 26.27 2.68 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.539 -0.755 . . . . 1.2 111.725 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 34' ' ' ASP . 5.7 t70 -104.91 -18.59 14.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.203 0.525 . . . . 1.81 109.691 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.44 3.73 5.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.312 -0.946 . . . . 1.05 114.209 171.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.432 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -144.81 159.84 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.97 0.885 . . . . 1.79 111.979 -176.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.893 HD12 ' HB3' ' A' ' 33' ' ' LEU . 7.5 mm -70.06 146.79 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.066 -0.97 . . . . 1.82 109.747 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.498 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 46.8 tp -112.41 -46.17 3.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.219 -0.446 . . . . 2.13 110.666 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -147.08 119.98 8.72 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.288 0.566 . . . . 2.96 111.929 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.867 ' HB3' HG12 ' A' ' 57' ' ' VAL . 68.4 t80 -98.16 134.69 40.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.927 -0.578 . . . . 1.75 109.564 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -107.1 101.16 10.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.865 0.364 . . . . 1.28 110.786 -177.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.63 109.18 20.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.001 -0.545 . . . . 2.53 110.213 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.53 125.2 28.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.101 -0.499 . . . . 4.46 110.064 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 64.35 70.71 0.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.816 0.817 . . . . 7.21 109.788 -174.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.66 -114.63 0.58 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.877 -1.056 . . . . 7.0 110.988 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -152.27 121.84 6.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.612 0.72 . . . . 8.59 110.679 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.84 81.43 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.734 -1.121 . . . . 9.53 109.125 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.29 153.72 43.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.608 -0.723 . . . . 10.16 111.683 -172.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.38 -48.42 85.29 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.403 -0.679 . . . . 10.12 111.403 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -109.89 84.67 1.97 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.241 -1.022 . . . . 13.33 108.241 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -94.15 126.7 47.66 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.337 -0.392 . . . . 8.24 110.314 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.51 -6.76 16.5 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.979 2.452 . . . . 8.73 112.832 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -91.95 150.93 20.75 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.872 -0.418 . . . . 9.47 109.872 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.409 ' HB3' HD11 ' A' ' 58' ' ' ILE . 57.0 tp60 -86.58 -23.16 25.89 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.008 -0.738 . . . . 8.03 109.008 175.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.867 HG12 ' HB3' ' A' ' 42' ' ' TYR . 6.0 t 56.2 67.93 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.139 -0.937 . . . . 5.42 110.579 177.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.697 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -128.59 157.03 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.517 -0.765 . . . . 3.61 110.484 -178.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.83 -26.54 12.7 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.59 -1.004 . . . . 3.37 110.59 170.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.639 ' HB3' HG12 ' A' ' 39' ' ' ILE . 4.2 tppp? -117.93 120.54 38.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.072 -0.564 . . . . 4.22 110.176 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -129.36 125.33 36.41 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.34 0.59 . . . . 4.71 110.085 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 38' ' ' ASN . 30.4 m-85 -70.28 95.86 1.06 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.481 -0.782 . . . . 7.47 111.384 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.463 ' CD1' ' HG2' ' A' ' 64' ' ' LYS . 75.9 t80 -94.35 -58.77 2.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.428 -0.953 . . . . 8.88 108.428 174.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HG2' ' CD1' ' A' ' 63' ' ' PHE . 13.9 ptpt 177.58 82.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.095 -0.957 . . . . 10.35 110.043 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -98.88 -69.24 0.77 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.737 -0.665 . . . . 7.94 110.242 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 66' ' ' VAL . 14.7 p 35.84 64.33 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 122.889 1.328 . . . . 9.58 112.873 176.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.09 141.48 74.56 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.095 -0.957 . . . . 9.32 110.778 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.97 14.64 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.735 2.29 . . . . 10.74 112.848 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.5 m -146.84 162.47 38.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.28 -0.637 . . . . 11.49 109.28 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.2 p 44.23 63.76 1.53 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.794 0.684 . . . . 11.26 112.055 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.61 -46.34 66.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.318 -0.855 . . . . 11.56 111.538 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.7 m -73.22 115.18 38.29 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.158 -0.474 . . . . 11.11 110.445 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.34 41.47 1.15 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.289 2.659 . . . . 11.05 111.779 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . 8.4 pt-20 -109.03 150.18 28.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.222 0.534 . . . . 11.76 111.963 -173.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -158.61 42.45 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.991 -1.115 . . . . 10.74 107.991 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.444 ' HB2' ' H ' ' A' ' 77' ' ' GLY . 15.3 m-85 -119.33 -97.83 0.46 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.35 -0.841 . . . . 7.67 110.781 -174.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.444 ' H ' ' HB2' ' A' ' 76' ' ' TYR . . . -138.56 56.44 0.65 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.293 -0.723 . . . . 3.32 111.293 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 81' ' ' GLU . 58.7 mtpt 63.26 86.06 0.12 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.605 0.717 . . . . 4.53 110.44 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.61 ' HZ ' ' HA2' ' A' ' 35' ' ' GLY . 92.4 t80 -74.5 -51.49 14.62 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.068 -0.969 . . . . 1.1 111.083 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -61.7 -30.84 71.01 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 123.861 0.726 . . . . 3.89 110.217 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 8.3 tp10 -75.3 -37.36 60.89 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.584 -0.895 . . . . 3.07 108.584 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.938 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.13 -42.27 97.01 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 115.227 -0.897 . . . . 0.61 111.396 176.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 79' ' ' PHE . 87.8 t -63.24 -50.01 80.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.296 -0.952 . . . . 1.36 110.685 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.75 -27.82 55.5 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.883 -0.599 . . . . 1.59 111.036 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.0 m -65.17 -25.58 67.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.471 -0.566 . . . . 2.27 109.471 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.38 22.58 70.09 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.729 -0.669 . . . . 1.9 112.467 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.629 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 8.8 p30 -165.54 48.66 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.37 0.605 . . . . 2.08 111.606 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.938 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.6 tt -58.28 93.81 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.382 -0.826 . . . . 1.22 111.991 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.6 p30 -145.71 100.61 3.45 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.202 -0.666 . . . . 2.15 109.202 172.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 91' ' ' MET . 3.7 m -149.43 154.14 38.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.552 -0.717 . . . . 2.03 110.145 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.588 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 24.0 ptt? -109.05 123.85 49.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.051 0.453 . . . . 4.31 110.242 172.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -122.88 112.31 17.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.034 -0.728 . . . . 2.95 109.034 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 31.1 mt-10 -105.8 106.52 17.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.391 -0.368 . . . . 1.97 110.209 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -127.59 132.77 49.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.42 0.628 . . . . 4.56 111.081 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 10.8 m -85.12 146.64 27.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.283 -0.871 . . . . 3.22 109.437 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.471 ' HD2' ' HB ' ' A' ' 103' ' ' THR . 73.2 m-85 -66.6 133.36 50.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.92 0.39 . . . . 5.99 110.73 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.11 112.78 6.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.872 -0.604 . . . . 6.06 109.983 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -155.32 -60.39 0.11 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.043 -0.526 . . . . 10.04 109.919 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.612 ' HG2' ' HG3' ' A' ' 100' ' ' MET . 36.2 tt0 -158.13 -78.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 8.93 110.733 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.612 ' HG3' ' HG2' ' A' ' 99' ' ' GLN . 87.9 mtp -118.58 -87.76 0.62 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.634 0.254 . . . . 8.55 110.37 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.63 92.0 13.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.315 0.579 . . . . 5.39 110.743 175.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -81.62 -60.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.913 2.408 . . . . 5.02 110.476 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 96' ' ' PHE . 30.7 m -144.54 127.72 16.67 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.531 -0.759 . . . . 2.85 109.509 173.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.567 ' HZ1' ' HB2' ' A' ' 104' ' ' LYS . 4.5 ttmp? -106.99 119.4 39.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.672 -0.492 . . . . 3.49 109.672 175.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.531 HG11 ' HB3' ' A' ' 124' ' ' ARG . 28.2 m -101.36 157.51 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.45 0.643 . . . . 1.72 110.866 175.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.628 ' HZ2' ' HB2' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -134.24 117.68 16.75 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.313 -0.858 . . . . 2.83 109.164 176.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.1 t -94.99 105.47 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.904 0 CA-C-N 115.824 -0.626 . . . . 1.64 109.958 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.0 t-160 -101.57 102.64 13.4 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.268 -1.382 . . . . 1.35 107.268 169.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 67.4 mtp -91.32 145.7 24.43 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.076 -1.083 . . . . 2.72 108.076 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -148.5 119.19 7.5 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.84 -0.744 . . . . 2.17 109.385 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.629 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 68.9 tttt -55.4 122.94 12.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.473 0.654 . . . . 2.33 111.043 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.26 146.14 52.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.745 -1.116 . . . . 1.12 110.436 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.44 4.34 11.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.026 0.441 . . . . 2.97 110.878 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.0 t -79.01 -55.94 4.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.989 -0.55 . . . . 2.06 109.764 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 134.02 126.5 2.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.81 -0.71 . . . . 1.52 112.654 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.86 35.47 25.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.84 0.828 . . . . 2.79 111.074 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.2 p -141.0 151.46 44.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.202 -1.363 . . . . 0.95 108.793 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.549 ' CE1' HG23 ' A' ' 83' ' ' VAL . 25.8 m-85 -142.88 136.99 29.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.397 -0.365 . . . . 0.98 110.271 -173.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.527 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 50.2 m95 -86.09 164.63 17.19 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.448 0.642 . . . . 0.48 110.961 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.554 HG12 HG11 ' A' ' 122' ' ' VAL . 57.7 t -134.76 97.26 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.264 -1.335 . . . . 1.3 108.472 175.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 52.9 m-85 -96.35 101.54 13.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.454 -0.943 . . . . 1.96 108.454 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.554 HG11 HG12 ' A' ' 120' ' ' VAL . 24.9 m -99.85 162.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.547 0.689 . . . . 2.21 111.533 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.458 ' HB3' ' CG ' ' A' ' 106' ' ' LYS . 56.9 tptt -152.68 120.71 6.18 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.638 -1.165 . . . . 3.87 108.757 171.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.531 ' HB3' HG11 ' A' ' 105' ' ' VAL . 13.5 ptm180 -107.79 122.23 46.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.181 0.515 . . . . 4.72 111.435 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.251 -0.881 . . . . 3.55 109.327 175.694 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.994 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.917 0.389 . . . . 9.06 110.218 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.01 118.62 33.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.276 -0.42 . . . . 6.45 110.706 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.404 ' HB2' ' OH ' ' A' ' 42' ' ' TYR . 75.4 m-85 -82.2 97.5 8.27 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.202 -0.666 . . . . 7.02 109.202 176.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -99.2 0.42 57.24 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.774 -0.727 . . . . 2.04 113.686 -172.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.47 102.28 11.76 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.473 0.636 . . . . 1.26 111.18 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.519 HG13 ' HA ' ' A' ' 42' ' ' TYR . 4.4 tt -133.6 141.33 44.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.322 -0.399 . . . . 1.5 110.561 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.558 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 11.7 pt20 -113.88 135.01 54.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.27 0.557 . . . . 2.22 111.304 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.691 ' HB3' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -126.8 166.38 17.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.471 -0.786 . . . . 1.4 110.339 175.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.453 ' HA ' ' CB ' ' A' ' 117' ' ' SER . 3.3 p30 -92.06 158.3 16.3 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.876 -0.602 . . . . 1.15 110.576 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.441 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -81.05 11.97 39.62 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.337 -0.847 . . . . 1.2 112.082 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -90.94 -25.44 19.77 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.173 -0.677 . . . . 1.81 109.173 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.36 23.61 2.85 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.354 -0.839 . . . . 1.05 112.395 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -132.52 155.56 48.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.124 -0.324 . . . . 1.79 110.124 -177.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.959 HG12 ' HB3' ' A' ' 60' ' ' LYS . 36.6 mm -74.05 138.24 21.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.408 -0.96 . . . . 1.82 108.408 171.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.5 HD22 HE21 ' A' ' 32' ' ' GLN . 27.8 tp -105.21 -49.49 3.45 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.814 -0.354 . . . . 2.13 110.806 -174.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -154.97 128.22 8.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 2.96 110.999 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.858 ' HB3' HG12 ' A' ' 57' ' ' VAL . 66.0 t80 -98.63 119.66 37.73 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.917 -0.771 . . . . 1.75 108.917 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -97.19 120.8 38.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.051 0.453 . . . . 1.28 111.716 -169.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.54 81.16 1.64 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.538 -0.755 . . . . 2.53 109.105 172.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.33 90.96 1.63 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.63 -0.714 . . . . 4.46 110.722 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -108.27 18.87 20.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.665 -0.698 . . . . 7.21 109.969 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.94 -3.17 9.9 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.201 -0.759 . . . . 7.0 111.201 -174.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -132.23 144.05 50.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.021 -0.733 . . . . 8.59 109.021 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.28 -42.12 82.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.113 -0.494 . . . . 9.53 110.426 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 m 67.22 150.42 0.06 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.492 -0.776 . . . . 10.16 111.123 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.77 120.43 18.82 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.058 -0.592 . . . . 10.12 112.618 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -71.02 136.33 48.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.614 0.245 . . . . 13.33 110.511 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -148.99 119.41 4.1 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.524 -0.307 . . . . 8.24 110.231 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.89 -14.74 32.7 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.901 2.401 . . . . 8.73 113.179 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -102.48 5.85 39.72 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.607 0.718 . . . . 9.47 110.98 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -96.11 -24.47 16.28 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.639 -1.164 . . . . 8.03 108.859 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.858 HG12 ' HB3' ' A' ' 42' ' ' TYR . 32.6 m -97.24 178.74 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.953 -1.022 . . . . 5.42 110.204 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.798 HG12 HG23 ' A' ' 57' ' ' VAL . 19.6 pt 37.31 65.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.262 1.025 . . . . 3.61 113.486 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.52 -36.52 54.3 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 114.533 -1.212 . . . . 3.37 111.808 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.959 ' HB3' HG12 ' A' ' 39' ' ' ILE . 53.9 tptt -88.46 92.15 9.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.084 0.468 . . . . 4.22 109.97 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -139.46 94.38 2.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.699 -0.682 . . . . 4.71 109.873 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.405 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 47.5 p90 174.26 132.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.424 -0.954 . . . . 7.47 108.424 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -100.02 -33.3 10.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.854 0.359 . . . . 8.88 111.028 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 44.0 mtpt -106.32 97.65 7.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.9 0.381 . . . . 10.35 111.456 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' HB2' ' HE1' ' A' ' 62' ' ' PHE . 16.2 t0 -90.36 112.32 23.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.081 -0.509 . . . . 7.94 109.738 174.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.8 m -124.91 22.42 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.234 0.54 . . . . 9.58 110.498 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -102.87 139.9 20.56 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.852 -0.613 . . . . 9.32 110.589 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 21.1 Cg_exo -65.86 80.76 0.26 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.927 2.418 . . . . 10.74 111.618 175.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 69.1 m -131.53 137.53 48.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.539 -0.755 . . . . 11.49 109.227 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 m -71.95 124.09 24.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.638 -0.255 . . . . 11.26 110.549 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -69.09 120.88 15.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.163 0.506 . . . . 11.56 109.912 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.478 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 35.2 t -168.65 -45.9 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.527 -0.761 . . . . 11.11 111.666 -174.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 72' ' ' SER . 51.8 Cg_exo -57.14 -43.52 52.47 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 121.944 1.762 . . . . 11.05 112.269 177.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 76' ' ' TYR . 1.2 mt-10 -91.42 -175.77 4.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.813 -0.63 . . . . 11.76 110.117 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 90.8 m-85 73.9 -28.17 0.19 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.386 0.675 . . . . 10.74 112.151 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.442 ' H ' ' C ' ' A' ' 74' ' ' GLU . 96.9 m-85 47.76 -97.89 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.472 0.709 . . . . 7.67 112.891 174.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.3 99.95 0.25 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.098 -1.049 . . . . 3.32 111.88 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt 65.25 18.24 11.32 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 123.656 0.268 . . . . 4.53 111.704 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.546 ' O ' HG22 ' A' ' 83' ' ' VAL . 42.5 t80 -49.5 -33.92 15.77 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 111.617 0.229 . . . . 1.1 111.617 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -62.36 -42.66 99.58 Favored 'General case' 0 C--N 1.34 0.191 0 O-C-N 124.103 0.877 . . . . 3.89 109.928 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -88.86 -23.16 22.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.775 -1.102 . . . . 3.07 109.827 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.683 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -62.73 -43.75 98.5 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 115.923 -0.58 . . . . 0.61 111.849 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 1.017 ' HA ' ' HH ' ' A' ' 118' ' ' TYR . 84.5 t -66.98 -47.02 83.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.842 -0.679 . . . . 1.36 110.34 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.77 -26.13 57.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.583 -0.735 . . . . 1.59 110.734 -173.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 t -63.64 -33.45 75.65 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.806 -0.813 . . . . 2.27 108.806 172.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.08 2.68 55.92 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.403 -0.817 . . . . 1.9 112.114 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.584 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -171.42 66.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.511 0.672 . . . . 2.08 111.401 -177.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.683 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -56.44 88.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.086 -0.961 . . . . 1.22 110.888 171.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.754 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.9 t30 -143.43 101.54 3.8 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.695 -0.483 . . . . 2.15 109.695 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -163.25 158.38 21.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.183 0.516 . . . . 2.03 110.875 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.8 ptp -91.99 137.46 32.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.223 -0.899 . . . . 4.31 108.941 170.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 107' ' ' VAL . 23.3 t80 -148.36 109.07 4.2 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.248 0.547 . . . . 2.95 109.981 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.44 104.24 15.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.147 -0.479 . . . . 1.97 109.768 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -121.11 150.31 41.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.067 0.46 . . . . 4.56 110.923 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 m -118.67 150.51 39.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.736 -0.665 . . . . 3.22 110.755 -176.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -86.84 127.9 35.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.917 -0.772 . . . . 5.99 108.917 172.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -58.54 -47.07 85.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.955 0.407 . . . . 6.06 110.529 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -130.19 -82.61 0.55 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 10.04 110.659 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 67.18 -67.32 0.17 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.882 0.739 . . . . 8.93 110.151 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.8 tpt -171.24 -59.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.78 -0.822 . . . . 8.55 108.78 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.3 m -125.73 96.4 38.11 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.248 -1.019 . . . . 5.39 108.248 174.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -45.29 101.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.741 2.961 . . . . 5.02 113.483 -172.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.0 m -105.54 135.95 46.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.795 -0.639 . . . . 2.85 110.612 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -97.76 124.19 42.01 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.06 -0.718 . . . . 3.49 109.06 171.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.21 155.46 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-O 121.34 0.591 . . . . 1.72 110.625 173.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.519 ' HB2' ' HG2' ' A' ' 123' ' ' LYS . 22.4 mtpp -128.97 105.58 8.31 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.25 -0.886 . . . . 2.83 108.903 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.766 HG21 ' HE1' ' A' ' 109' ' ' MET . 5.2 m -105.08 144.37 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 C-N-CA 119.562 -0.855 . . . . 1.64 112.177 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -117.61 103.11 9.73 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 105.674 -1.973 . . . . 1.35 105.674 156.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.766 ' HE1' HG21 ' A' ' 107' ' ' VAL . 9.1 ptp -106.28 128.4 53.94 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.081 -1.081 . . . . 2.72 108.081 -178.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 21.6 ptmt -139.44 133.16 30.6 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.613 -0.435 . . . . 2.17 110.847 -167.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.584 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 86.0 tttt -56.82 108.38 0.5 Allowed 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.597 0.713 . . . . 2.33 110.719 171.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.416 ' HB2' ' OG ' ' A' ' 117' ' ' SER . . . -53.7 137.38 37.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.104 -1.407 . . . . 1.12 110.489 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.62 3.81 7.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.247 -0.433 . . . . 2.97 110.93 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.9 m -80.91 -32.37 34.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 2.06 111.102 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 139.2 112.78 1.06 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.734 -0.746 . . . . 1.52 113.111 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 t70 26.96 72.48 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.821 1.248 . . . . 2.79 113.079 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 111' ' ' LYS . 1.3 p -153.81 159.71 41.97 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.837 -1.912 . . . . 0.95 105.837 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 1.017 ' HH ' ' HA ' ' A' ' 83' ' ' VAL . 17.1 m-85 -136.32 134.89 38.42 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.819 -0.752 . . . . 0.98 111.963 -175.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.558 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 41.9 m95 -85.89 165.85 16.46 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.746 -0.661 . . . . 0.48 111.164 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.525 HG23 HD23 ' A' ' 33' ' ' LEU . 95.9 t -139.21 97.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.388 -1.278 . . . . 1.3 108.877 172.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.527 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 90.3 m-85 -93.14 101.92 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.394 -0.965 . . . . 1.96 108.394 170.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 123' ' ' LYS . 13.2 p -115.62 149.99 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.153 0.502 . . . . 2.21 111.869 -172.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.519 ' HG2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -147.83 145.5 28.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.147 -1.057 . . . . 3.87 108.147 173.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -116.37 143.21 45.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.306 0.574 . . . . 4.72 112.124 -171.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.4 t . . . . . 0 C--O 1.252 1.222 0 CA-C-N 115.233 -0.894 . . . . 3.55 109.515 175.869 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.977 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.661 HD11 ' H ' ' A' ' 26' ' ' LEU . 7.1 mp . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.751 -0.462 . . . . 9.06 109.751 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.479 ' HB1' ' HB1' ' A' ' 45' ' ' ALA . . . -112.48 -171.97 1.96 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.42 -0.354 . . . . 6.45 110.203 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.458 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 97.6 m-85 71.71 152.21 0.11 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.8 0.687 . . . . 7.02 111.14 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 122' ' ' VAL . . . 166.13 -79.34 0.12 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.748 -1.215 . . . . 2.04 113.812 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.34 102.72 14.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.662 0.615 . . . . 1.26 112.662 -166.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.45 HD12 HG21 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -126.49 139.9 50.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.11 -0.7 . . . . 1.5 109.11 172.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.573 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.2 pp0? -115.33 136.35 53.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.411 0.624 . . . . 2.22 111.366 -175.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -139.13 156.14 47.35 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.97 -1.014 . . . . 1.4 110.231 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.888 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 4.9 p30 -86.3 155.13 20.78 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.399 0.619 . . . . 1.15 110.673 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.59 14.48 17.68 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.375 -0.829 . . . . 1.2 111.871 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -100.97 -26.13 13.83 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.126 0.488 . . . . 1.81 109.689 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.59 28.84 0.94 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.826 -0.702 . . . . 1.05 113.414 173.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 21.9 m-80 -133.53 142.19 48.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.245 0.522 . . . . 1.79 111.13 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.669 HG13 ' HB3' ' A' ' 60' ' ' LYS . 81.3 mt -87.3 131.0 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.953 -0.758 . . . . 1.82 108.953 171.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.31 -49.7 3.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.927 0.344 . . . . 2.13 111.927 -171.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 31' ' ' ILE . 8.6 tt0 -141.84 128.76 20.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.984 0.421 . . . . 2.96 111.547 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -113.69 125.46 54.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.729 -0.668 . . . . 1.75 110.328 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -127.75 102.78 6.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 1.28 110.411 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 28' ' ' PHE . . . -153.42 164.39 38.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.447 -0.342 . . . . 2.53 110.895 175.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HB1' ' HB1' ' A' ' 27' ' ' ALA . . . -74.99 102.63 4.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.074 -0.512 . . . . 4.46 110.93 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -112.34 84.33 1.95 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.768 -0.651 . . . . 7.21 109.676 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.27 -26.17 8.95 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.509 -0.769 . . . . 7.0 112.205 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -95.92 112.48 24.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.547 0.689 . . . . 8.59 109.485 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 pt -119.41 -28.32 2.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.394 -0.821 . . . . 9.53 111.707 -173.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.3 m -60.34 95.13 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.289 0.566 . . . . 10.16 111.659 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.21 4.33 66.67 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.935 -0.575 . . . . 10.12 112.19 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -109.31 157.32 18.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.729 0.3 . . . . 13.33 110.56 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.62 99.02 23.87 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 8.24 110.096 174.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.58 -22.27 74.04 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.258 2.638 . . . . 8.73 112.536 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -78.11 72.13 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.881 0.848 . . . . 9.47 110.503 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.23 -49.76 2.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.243 -0.889 . . . . 8.03 110.315 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.0 m -100.56 47.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.825 0.822 . . . . 5.42 110.603 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.455 HG12 ' N ' ' A' ' 59' ' ' GLY . 14.3 tt -163.54 156.25 2.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.946 -1.024 . . . . 3.61 109.049 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.455 ' N ' HG12 ' A' ' 58' ' ' ILE . . . 102.54 13.42 30.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.773 -0.727 . . . . 3.37 111.95 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.669 ' HB3' HG13 ' A' ' 39' ' ' ILE . 17.5 tppt? -78.11 119.14 21.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.659 -0.497 . . . . 4.22 109.659 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -131.11 98.42 4.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.895 -0.593 . . . . 4.71 110.175 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -131.69 114.5 14.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.841 -0.618 . . . . 7.47 109.99 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.588 ' HD1' ' HG2' ' A' ' 64' ' ' LYS . 43.1 t80 -97.28 -58.63 1.97 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.302 0.573 . . . . 8.88 109.765 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.588 ' HG2' ' HD1' ' A' ' 63' ' ' PHE . 20.3 pttp -154.81 166.77 32.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.415 -0.811 . . . . 10.35 109.136 177.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -119.74 174.83 6.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.885 0.374 . . . . 7.94 110.741 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 66' ' ' VAL . 11.6 p -148.9 37.96 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 122.73 1.252 . . . . 9.58 109.638 176.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -143.51 145.09 30.25 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.177 -0.919 . . . . 9.32 111.161 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.89 25.16 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.956 2.437 . . . . 10.74 112.604 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 45.4 t -151.92 78.94 1.25 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.7 -0.481 . . . . 11.49 109.7 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.0 p -123.57 -50.12 1.87 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.93 0.395 . . . . 11.26 111.331 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -81.9 117.36 22.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.272 0.558 . . . . 11.56 112.134 -176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 21.7 p -103.24 100.76 18.9 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 107.606 -1.257 . . . . 11.11 107.606 163.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 72' ' ' SER . 1.8 Cg_endo -41.24 103.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 124.079 3.186 . . . . 11.05 114.355 -168.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 72' ' ' SER . 11.4 pt-20 -153.2 100.15 2.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.672 0.749 . . . . 11.76 110.882 176.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -108.6 118.38 36.64 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.241 -0.651 . . . . 10.74 109.241 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.49 -72.47 0.18 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.116 -0.493 . . . . 7.67 111.635 -172.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -116.4 72.01 0.27 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.202 -0.999 . . . . 3.32 111.201 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.5 tptt 68.57 10.54 7.94 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.016 0.436 . . . . 4.53 109.903 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.824 ' HA ' HD11 ' A' ' 88' ' ' LEU . 44.4 t80 -45.92 -40.9 10.8 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 113.975 1.102 . . . . 1.1 113.975 -165.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.945 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -63.94 -38.63 91.78 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 123.37 0.418 . . . . 3.89 110.421 -172.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.85 -27.89 20.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.695 -0.684 . . . . 3.07 109.584 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.903 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -55.32 -40.32 75.74 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.695 -0.684 . . . . 0.61 112.103 -177.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 79' ' ' PHE . 87.3 t -65.37 -53.39 40.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.533 -0.834 . . . . 1.36 110.954 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.67 -22.79 32.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.263 -0.426 . . . . 1.59 111.637 -171.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.6 t -70.86 -22.32 62.31 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.954 -0.758 . . . . 2.27 108.954 172.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.83 26.83 73.32 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.375 -0.83 . . . . 1.9 112.241 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 29.1 p30 -158.37 44.8 0.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.229 0.538 . . . . 2.08 111.72 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.903 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -66.06 86.4 0.1 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.151 -0.932 . . . . 1.22 111.777 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 109' ' ' MET . 2.6 t-20 -144.56 100.69 3.56 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.813 -0.355 . . . . 2.15 110.296 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.8 m -146.0 145.98 30.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.817 -0.438 . . . . 2.03 109.817 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.82 116.4 28.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.345 0.593 . . . . 4.31 109.609 170.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -133.62 154.55 50.81 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.274 -0.875 . . . . 2.95 109.136 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.795 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 7.6 pt-20 -131.28 123.05 27.53 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.78 -0.452 . . . . 1.97 109.78 174.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -124.15 125.11 43.91 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.57 -0.741 . . . . 4.56 110.251 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 9.3 t -97.79 143.72 28.13 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.414 -0.587 . . . . 3.22 109.414 174.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -144.13 118.73 9.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.546 0.689 . . . . 5.99 111.022 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 10.1 t70 -82.43 97.98 8.66 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.439 -0.801 . . . . 6.06 109.087 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -71.55 -33.46 69.15 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.257 -0.577 . . . . 10.04 109.809 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -179.36 86.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.512 -0.767 . . . . 8.93 109.72 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 47.2 tpp 77.7 -14.71 0.82 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.781 0.832 . . . . 8.55 111.136 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 m -114.11 96.54 42.46 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.277 -0.42 . . . . 5.39 110.754 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 4.2 Cg_exo -73.92 98.31 1.06 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.743 2.295 . . . . 5.02 111.281 176.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 m -79.98 99.35 7.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.132 -0.486 . . . . 2.85 110.82 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 49.8 tttp -79.63 102.87 9.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.966 -0.561 . . . . 3.49 110.379 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 27.6 m -105.67 160.74 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.361 0.601 . . . . 1.72 111.557 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.795 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 19.6 mmmt -117.46 141.14 48.69 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.152 -0.931 . . . . 2.83 109.5 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.2 102.32 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.113 0.482 . . . . 1.64 110.15 173.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.784 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.7 t-160 -108.91 102.82 11.8 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.652 -1.24 . . . . 1.35 107.652 171.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.742 ' HE3' ' HD2' ' A' ' 79' ' ' PHE . 59.8 mtp -108.78 143.75 37.52 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.709 -0.849 . . . . 2.72 108.709 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -147.55 133.88 19.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.974 -0.69 . . . . 2.17 110.5 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.656 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 84.0 tttt -55.9 111.59 0.97 Allowed 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 114.879 -1.055 . . . . 2.33 110.334 173.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.26 146.32 54.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.775 -1.102 . . . . 1.12 110.898 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.24 -6.83 25.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.983 -0.553 . . . . 2.97 110.709 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.49 ' HB2' ' OG ' ' A' ' 117' ' ' SER . 6.5 m -69.96 -29.41 66.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.746 -0.661 . . . . 2.06 110.617 176.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.16 -68.11 0.29 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.723 -0.751 . . . . 1.52 113.054 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -95.17 22.51 6.64 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.331 0.586 . . . . 2.79 111.503 -172.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.888 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.9 p -134.62 157.27 47.04 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.352 -0.84 . . . . 0.95 111.509 -173.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.656 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 48.3 m-85 -141.3 134.81 29.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.616 -0.72 . . . . 0.98 109.387 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.573 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 47.1 m95 -83.42 164.23 20.06 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.08 0.466 . . . . 0.48 110.673 -175.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 120' ' ' VAL . 15.0 p -138.34 97.18 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 122.581 1.181 . . . . 1.3 111.328 172.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.784 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 3.8 m-85 -86.69 102.29 14.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.516 -0.765 . . . . 1.96 109.094 177.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.566 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 25.4 m -100.88 153.58 4.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.157 0.503 . . . . 2.21 111.49 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 16.7 tppt? -159.15 148.87 18.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.865 -0.607 . . . . 3.87 109.679 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -129.41 125.05 35.66 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.553 -0.536 . . . . 4.72 109.553 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.434 -0.793 . . . . 3.55 110.79 -174.626 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.985 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.675 0.274 . . . . 9.06 110.413 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -156.53 162.67 39.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 6.45 109.893 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -84.45 111.05 19.12 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.528 -0.545 . . . . 7.02 109.528 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 122' ' ' VAL . . . -119.85 70.68 0.35 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.388 -0.911 . . . . 2.04 112.529 -176.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 43' ' ' ASN . . . -155.46 101.4 2.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.896 0.379 . . . . 1.26 110.255 175.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.521 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 3.2 tt -139.25 141.02 36.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.234 -0.439 . . . . 1.5 110.743 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.601 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.8 pt20 -110.81 126.33 54.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.322 0.582 . . . . 2.22 110.518 174.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.85 153.05 41.62 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.645 -0.707 . . . . 1.4 110.562 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.732 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -85.62 105.57 16.28 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.47 0.652 . . . . 1.15 112.407 -171.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.042 ' H ' ' HA ' ' A' ' 117' ' ' SER . . . 37.77 23.7 0.02 OUTLIER Glycine 0 N--CA 1.468 0.768 0 CA-C-N 113.272 -1.786 . . . . 1.2 117.42 161.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 34' ' ' ASP . 12.9 t70 174.75 -57.17 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.926 0.863 . . . . 1.81 111.756 -171.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.93 -31.35 0.03 OUTLIER Glycine 0 CA--C 1.524 0.655 0 C-N-CA 119.203 -1.475 . . . . 1.05 115.447 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.732 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 19.0 m-80 -67.84 116.33 8.39 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.728 1.264 . . . . 1.79 111.141 -173.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -70.73 128.62 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.928 -0.578 . . . . 1.82 110.616 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.7 tp -101.55 -47.58 4.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.75 -0.659 . . . . 2.13 110.799 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -151.07 142.86 23.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 2.96 111.401 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.521 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 69.1 t80 -130.5 138.5 50.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 1.75 109.729 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 30' ' ' ALA . 39.8 m-80 -100.56 93.42 5.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.851 0.358 . . . . 1.28 111.437 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.86 -27.68 6.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.469 0.652 . . . . 2.53 109.435 171.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.27 130.89 13.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.159 -0.928 . . . . 4.46 109.444 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -96.35 3.42 52.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 7.21 110.473 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.33 -164.59 11.74 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.508 -0.769 . . . . 7.0 111.607 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -90.09 137.23 32.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.844 0.354 . . . . 8.59 110.782 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.6 42.43 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.564 -0.532 . . . . 9.53 109.564 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.7 m 50.47 54.63 10.82 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.309 -0.859 . . . . 10.16 110.902 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.75 142.87 3.69 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.744 -0.741 . . . . 10.12 111.883 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 52' ' ' ARG . 1.4 mpt_? -90.05 98.4 11.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.818 0.342 . . . . 13.33 110.501 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.61 108.9 40.21 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.268 -0.424 . . . . 8.24 110.729 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 52' ' ' ARG . 92.7 Cg_endo -93.78 1.9 3.19 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.184 2.589 . . . . 8.73 113.25 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -82.93 54.25 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.625 0.726 . . . . 9.47 111.076 -176.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.465 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . 77.2 mt-30 -115.82 10.29 15.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.121 -0.945 . . . . 8.03 110.75 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 t 56.52 68.74 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.623 0.725 . . . . 5.42 110.273 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.1 pt -133.19 170.25 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.729 -0.669 . . . . 3.61 110.598 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.73 38.75 66.79 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.658 -0.977 . . . . 3.37 110.658 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 58.7 tptt -74.95 85.98 2.28 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.901 -0.649 . . . . 4.22 110.16 -177.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.492 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 28.7 t-20 -93.51 96.28 9.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.473 0.654 . . . . 4.71 109.866 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 65' ' ' ASP . 42.7 t80 -164.95 88.34 0.46 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.719 -1.215 . . . . 7.47 107.719 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.679 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 56.6 t80 -72.52 -73.53 0.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.104 -0.498 . . . . 8.88 111.139 -171.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HE3' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -150.7 71.91 1.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 10.35 110.247 -177.019 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 4.4 m-20 -105.35 160.75 14.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.999 -0.546 . . . . 7.94 110.197 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.6 t -89.83 77.72 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.979 0.418 . . . . 9.58 110.037 -177.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.12 120.19 23.64 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.617 -0.72 . . . . 9.32 110.924 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.82 -38.29 94.66 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.236 2.624 . . . . 10.74 113.362 -174.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.411 ' O ' ' HB ' ' A' ' 70' ' ' THR . 15.1 t -81.42 -19.88 41.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 121.063 -0.255 . . . . 11.49 111.07 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 69' ' ' CYS . 25.9 m 71.07 -54.4 0.67 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.152 0.581 . . . . 11.26 111.87 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.18 92.01 5.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.046 0.45 . . . . 11.56 110.92 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.621 ' OG ' ' HD3' ' A' ' 73' ' ' PRO . 6.0 p -159.79 -43.25 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.637 -0.711 . . . . 11.11 111.77 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.621 ' HD3' ' OG ' ' A' ' 72' ' ' SER . 4.7 Cg_exo -82.51 115.27 2.5 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.12 1.88 . . . . 11.05 111.238 172.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.41 139.7 34.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.341 -0.391 . . . . 11.76 110.918 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -108.82 149.68 28.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.817 -0.438 . . . . 10.74 109.817 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -114.97 -76.15 0.58 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.091 0.775 . . . . 7.67 113.091 -170.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.2 86.0 0.4 Allowed Glycine 0 CA--C 1.506 -0.513 0 C-N-CA 119.581 -1.295 . . . . 3.32 112.595 -170.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 58.38 25.15 12.5 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.73 -0.47 . . . . 4.53 109.73 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.609 ' HA ' HD13 ' A' ' 88' ' ' LEU . 38.7 t80 -50.51 -37.0 36.66 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.671 -0.695 . . . . 1.1 112.719 -165.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.48 -47.35 73.33 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 123.76 0.663 . . . . 3.89 110.343 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -82.35 -24.81 34.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.346 -0.612 . . . . 3.07 109.346 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.87 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -57.66 -42.97 94.53 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.304 -0.719 . . . . 0.61 111.304 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 79' ' ' PHE . 81.2 t -67.53 -53.85 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.434 -0.883 . . . . 1.36 111.019 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.35 -28.0 52.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.159 -0.473 . . . . 1.59 111.412 -169.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.0 t -66.98 -29.27 69.07 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.735 -0.839 . . . . 2.27 108.735 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.6 28.36 39.43 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.65 -0.705 . . . . 1.9 111.804 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -162.37 52.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.358 0.599 . . . . 2.08 111.816 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.87 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -73.13 86.35 1.38 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.907 -0.588 . . . . 1.22 110.658 177.111 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.728 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.2 t30 -143.9 102.35 3.88 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.619 -0.264 . . . . 2.15 110.474 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 t -152.26 161.64 42.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.343 -0.39 . . . . 2.03 110.194 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.466 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -127.04 146.71 50.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.892 -0.594 . . . . 4.31 109.79 174.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -164.19 141.85 6.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.052 -0.522 . . . . 2.95 109.802 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.496 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 44.5 mt-10 -103.01 113.14 26.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.361 -0.607 . . . . 1.97 109.361 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -119.53 137.36 53.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.456 . . . . 4.56 110.669 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.428 HG23 ' HG3' ' A' ' 104' ' ' LYS . 1.4 p -93.68 145.03 24.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.385 -0.37 . . . . 3.22 110.472 176.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.88 120.43 42.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.185 0.517 . . . . 5.99 111.375 -177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 99' ' ' GLN . 31.9 m-20 -87.85 178.45 6.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.213 -0.903 . . . . 6.06 110.001 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.6 t80 73.27 -14.46 0.62 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.72 0.638 . . . . 10.04 110.842 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.482 ' H ' ' C ' ' A' ' 97' ' ' ASP . 25.4 mt-30 -80.92 166.13 21.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 8.93 109.749 173.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 65.8 mtt -93.36 -4.23 51.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.108 0.48 . . . . 8.55 110.67 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 8.6 t -132.54 141.39 41.03 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.687 -0.688 . . . . 5.39 109.729 175.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 6.4 Cg_exo -75.38 62.07 6.09 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.165 2.576 . . . . 5.02 112.299 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.7 m -71.7 133.33 45.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.173 -0.467 . . . . 2.85 110.568 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.496 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 15.0 ttpt -113.21 131.43 55.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.275 -0.639 . . . . 3.49 109.275 176.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.58 HG13 ' HG2' ' A' ' 124' ' ' ARG . 34.2 m -102.31 160.01 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 121.257 0.551 . . . . 1.72 110.457 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 123' ' ' LYS . 38.1 ttpt -129.31 110.64 12.11 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.207 -1.034 . . . . 2.83 108.207 172.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.8 m -98.86 144.68 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.485 0.66 . . . . 1.64 112.112 -175.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -137.11 102.08 4.74 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.646 -1.242 . . . . 1.35 107.646 161.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.728 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -97.12 133.46 41.74 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.376 -1.342 . . . . 2.72 107.376 173.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.512 ' HG3' ' HB2' ' A' ' 119' ' ' TRP . 14.8 ptpt -142.06 134.72 28.34 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.228 -0.589 . . . . 2.17 111.271 -172.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.586 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 39.1 tttm -56.31 115.11 2.28 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.501 -0.772 . . . . 2.33 110.534 170.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.44 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -64.91 147.2 53.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.563 -1.198 . . . . 1.12 111.431 -174.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.5 pt? -64.82 -10.11 25.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 2.97 111.356 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.2 p -79.84 -4.84 53.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.25 -0.432 . . . . 2.06 111.577 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.87 -122.82 6.72 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.638 -0.792 . . . . 1.52 112.229 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -72.15 85.63 1.04 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.547 0.689 . . . . 2.79 110.466 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 1.042 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 3.5 p -176.16 152.46 1.15 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.703 -1.135 . . . . 0.95 108.295 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 39.3 m-85 -142.07 139.16 32.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.639 0.257 . . . . 0.98 110.427 -176.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.601 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 46.1 m95 -88.39 166.81 14.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.488 0.661 . . . . 0.48 111.453 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.95 96.5 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.348 -1.296 . . . . 1.3 109.046 173.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.447 ' HE1' ' HD2' ' A' ' 110' ' ' LYS . 90.2 m-85 -95.05 124.33 39.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.402 -0.592 . . . . 1.96 109.402 173.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.474 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 26.0 t -128.52 132.79 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.868 0.366 . . . . 2.21 111.002 -176.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 74.7 mmtt -118.77 109.04 15.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.71 -0.478 . . . . 3.87 109.71 172.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.58 ' HG2' HG13 ' A' ' 105' ' ' VAL . 19.6 mtp180 -101.1 109.89 21.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.546 -0.297 . . . . 4.72 110.436 -175.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.125 -0.941 . . . . 3.55 111.22 -179.649 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.988 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.535 HD22 ' HE3' ' A' ' 123' ' ' LYS . 58.3 tp . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 120.775 0.322 . . . . 9.06 110.943 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.42 97.45 10.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.221 -0.445 . . . . 6.45 109.912 173.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -106.83 141.6 37.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.882 -0.599 . . . . 7.02 110.084 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.475 ' HA3' HG11 ' A' ' 122' ' ' VAL . . . -127.25 141.2 12.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.009 -0.615 . . . . 2.04 112.36 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.57 102.15 4.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.886 0.374 . . . . 1.26 110.363 173.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.576 HD11 HD11 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -138.98 140.31 38.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.678 -0.489 . . . . 1.5 109.678 178.02 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.707 ' HG2' ' HG2' ' A' ' 41' ' ' GLN . 3.7 pt20 -113.96 142.18 46.48 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.885 -0.726 . . . . 2.22 111.083 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.598 ' HB3' HD13 ' A' ' 39' ' ' ILE . 4.0 pp -133.02 163.89 28.23 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.083 -0.962 . . . . 1.4 110.094 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 2.1 p30 -90.05 151.83 21.45 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.131 0.491 . . . . 1.15 110.423 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -70.26 -9.65 64.44 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.553 -0.749 . . . . 1.2 111.883 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.449 ' HB3' ' OD1' ' A' ' 34' ' ' ASP . 30.3 t70 -73.04 -36.11 66.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.172 -0.514 . . . . 1.81 109.803 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' O ' ' HG2' ' A' ' 60' ' ' LYS . . . 140.55 1.29 1.68 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.461 -0.876 . . . . 1.05 114.036 171.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.493 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 3.8 m-80 -107.44 158.39 17.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.34 0.57 . . . . 1.79 111.023 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.861 HG12 ' HB3' ' A' ' 60' ' ' LYS . 45.9 mm -85.49 140.99 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.811 -0.811 . . . . 1.82 108.811 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.537 HD22 ' NE2' ' A' ' 32' ' ' GLN . 29.9 tp -108.39 -54.21 2.54 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.361 -0.536 . . . . 2.13 110.933 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.707 ' HG2' ' HG2' ' A' ' 32' ' ' GLN . 26.4 pt20 -147.98 141.82 25.75 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.351 -0.54 . . . . 2.96 111.402 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.416 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 92.3 t80 -110.71 119.11 38.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.623 -0.717 . . . . 1.75 109.203 175.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -95.16 159.85 14.82 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.394 -0.965 . . . . 1.28 108.394 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 72.3 166.66 0.3 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.724 0.64 . . . . 2.53 110.37 -172.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.14 130.95 48.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.101 0.477 . . . . 4.46 111.649 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.422 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 7.5 pt-20 -96.59 101.79 13.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.837 -0.619 . . . . 7.21 110.551 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.73 46.87 0.2 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.725 -0.75 . . . . 7.0 111.822 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -152.17 114.04 4.41 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.155 -0.313 . . . . 8.59 110.155 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.5 mt 54.87 50.89 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 122.137 0.97 . . . . 9.53 109.837 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 p -105.76 170.89 7.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.298 -0.865 . . . . 10.16 111.014 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.45 -56.26 0.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.714 -0.755 . . . . 10.12 111.887 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -129.78 156.18 44.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.664 0.269 . . . . 13.33 110.658 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 21.7 m-20 -81.72 119.23 74.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.938 -0.574 . . . . 8.24 111.236 -176.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 3.2 Cg_exo -82.04 -12.26 10.78 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.2 2.6 . . . . 8.73 111.632 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt 59.67 71.19 0.59 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.475 0.655 . . . . 9.47 110.661 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.422 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 17.9 mt-30 -103.57 -30.38 10.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.185 -0.916 . . . . 8.03 111.024 -177.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 57' ' ' VAL . 7.3 p -69.24 87.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 122.407 1.099 . . . . 5.42 110.626 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.758 ' HA ' HG23 ' A' ' 39' ' ' ILE . 36.8 mt 60.4 73.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 114.673 -1.149 . . . . 3.61 109.131 -174.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.24 -20.7 76.95 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.496 -1.229 . . . . 3.37 112.488 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.861 ' HB3' HG12 ' A' ' 39' ' ' ILE . 4.9 tppp? -118.73 106.64 12.77 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.984 0.392 . . . . 4.22 110.967 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -135.96 95.44 3.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.876 -0.602 . . . . 4.71 109.743 171.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.5 t80 48.57 83.02 0.04 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.55 -1.204 . . . . 7.47 112.513 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -100.95 -58.12 1.96 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.174 -0.676 . . . . 8.88 109.174 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' A' ' 66' ' ' VAL . 29.1 mtpp -149.94 -73.94 0.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.848 -1.538 . . . . 10.35 106.848 173.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 68.26 -14.68 0.24 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.759 -1.109 . . . . 7.94 113.603 163.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 67' ' ' ALA . 7.3 p -56.6 -43.29 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.043 0.449 . . . . 9.58 110.097 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.481 ' N ' HG11 ' A' ' 66' ' ' VAL . . . -124.86 103.48 30.87 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.194 -0.669 . . . . 9.32 109.194 174.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.4 80.44 1.95 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.989 2.459 . . . . 10.74 112.844 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -135.8 143.64 45.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.178 -0.464 . . . . 11.49 109.915 175.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.6 m 54.8 50.42 15.74 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.895 0.855 . . . . 11.26 110.184 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -142.05 112.87 7.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.166 -0.925 . . . . 11.56 109.888 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.1 m -156.7 121.16 2.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.235 -0.439 . . . . 11.11 110.929 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -86.45 89.77 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.169 2.579 . . . . 11.05 111.763 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 66.83 -77.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.574 -0.739 . . . . 11.76 112.196 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -133.44 149.03 51.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.156 0.503 . . . . 10.74 111.585 -173.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -145.16 129.59 17.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.329 -0.851 . . . . 7.67 109.692 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.8 86.95 1.47 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.709 -0.758 . . . . 3.32 111.478 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.5 pttt 42.59 47.77 4.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.432 0.693 . . . . 4.53 111.219 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.6 ' O ' HG22 ' A' ' 83' ' ' VAL . 43.0 t80 -50.36 -34.88 25.62 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 115.529 -0.76 . . . . 1.1 111.926 -171.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -66.72 -40.02 88.24 Favored 'General case' 0 C--N 1.344 0.338 0 O-C-N 123.813 0.695 . . . . 3.89 110.484 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -80.01 -31.42 39.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.098 -0.704 . . . . 3.07 109.098 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.817 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.37 -43.66 97.2 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.559 -0.746 . . . . 0.61 111.962 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 79' ' ' PHE . 99.3 t -64.6 -49.32 81.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.77 -0.715 . . . . 1.36 110.518 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.37 -24.48 39.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 1.59 111.413 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -65.35 -32.95 74.86 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.519 -0.548 . . . . 2.27 109.519 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.3 16.43 66.82 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.881 -0.676 . . . . 1.9 111.751 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -162.34 57.27 0.23 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.527 0.68 . . . . 2.08 110.861 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.817 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.5 tt -65.08 81.41 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.627 -0.715 . . . . 1.22 110.952 175.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.672 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 14.5 t30 -144.51 98.25 3.17 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.233 -0.654 . . . . 2.15 109.233 175.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.464 ' HG1' ' C ' ' A' ' 89' ' ' ASN . 6.4 m -153.29 153.83 33.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.808 -0.441 . . . . 2.03 109.808 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.432 ' N ' HG21 ' A' ' 90' ' ' THR . 17.7 ptm -101.01 116.14 32.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.349 -0.612 . . . . 4.31 109.349 167.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -114.86 109.95 18.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.794 -0.639 . . . . 2.95 109.873 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 9.4 pt-20 -104.39 114.57 28.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.063 0.459 . . . . 1.97 110.495 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -109.56 135.57 50.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.587 -0.733 . . . . 4.56 110.188 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.2 m -97.08 110.02 22.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.942 0.401 . . . . 3.22 110.563 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 51.7 m-85 -76.96 79.48 3.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.234 0.54 . . . . 5.99 110.886 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -101.16 123.03 44.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.293 -1.003 . . . . 6.06 108.293 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -155.82 -69.02 0.12 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.301 0.572 . . . . 10.04 110.252 -166.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -159.82 32.24 0.18 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.338 -0.986 . . . . 8.93 108.338 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.824 ' HG2' ' H ' ' A' ' 101' ' ' THR . 23.3 ttt -151.14 -161.07 1.26 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.752 -1.113 . . . . 8.55 108.395 -173.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.824 ' H ' ' HG2' ' A' ' 100' ' ' MET . 0.8 OUTLIER -80.48 152.52 73.04 Favored Pre-proline 0 N--CA 1.446 -0.668 0 O-C-N 121.962 -0.461 . . . . 5.39 110.563 174.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.38 94.78 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.343 2.029 . . . . 5.02 111.923 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 96' ' ' PHE . 16.9 m -90.91 97.84 11.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.1 -0.5 . . . . 2.85 110.652 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 125' ' ' VAL . 19.2 ttmm -84.11 115.13 22.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.123 -0.49 . . . . 3.49 110.166 177.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 31.5 m -101.33 159.2 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 120.792 0.33 . . . . 1.72 110.361 172.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 43.6 mttp -127.26 123.33 36.23 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.157 -0.474 . . . . 2.83 110.702 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.47 102.85 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 109.229 -0.656 . . . . 1.64 109.229 173.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.721 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 3.3 t-160 -94.33 102.48 14.48 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.389 -1.708 . . . . 1.35 106.389 168.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.614 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 10.7 ttt -120.34 114.93 22.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.048 -1.093 . . . . 2.72 108.048 -173.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 64.6 pttt -134.16 135.44 43.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 120.048 -0.661 . . . . 2.17 110.418 -169.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.52 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 65.4 tttp -57.21 114.4 2.15 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.765 -0.652 . . . . 2.33 110.602 175.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.68 145.45 49.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.774 -1.103 . . . . 1.12 110.709 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.22 -13.08 61.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.208 -0.451 . . . . 2.97 110.478 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.5 m -61.84 -31.57 71.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.968 -0.56 . . . . 2.06 110.236 173.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 129.1 -96.82 0.4 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.575 -0.821 . . . . 1.52 113.03 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -88.68 49.02 1.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.603 0.716 . . . . 2.79 111.088 -171.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.0 p -147.43 159.37 43.79 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.503 -0.771 . . . . 0.95 109.968 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.539 ' CD2' ' HB3' ' A' ' 88' ' ' LEU . 36.1 m-85 -137.53 137.83 39.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.544 -0.298 . . . . 0.98 110.426 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.6 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 44.0 m95 -85.68 162.46 18.77 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.123 0.487 . . . . 0.48 111.176 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.537 HG22 ' HE3' ' A' ' 109' ' ' MET . 50.5 t -135.02 97.56 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.864 -1.062 . . . . 1.3 109.485 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.721 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 70.8 m-85 -102.31 104.29 14.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.607 -0.886 . . . . 1.96 108.607 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.475 HG11 ' HA3' ' A' ' 29' ' ' GLY . 9.9 p -92.74 148.61 4.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.789 -0.365 . . . . 2.21 110.576 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.535 ' HE3' HD22 ' A' ' 26' ' ' LEU . 34.5 mtpt -150.23 162.52 40.31 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.167 -0.469 . . . . 3.87 110.173 176.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.493 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 4.6 ptp180 -124.88 144.67 50.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.224 -0.898 . . . . 4.72 108.818 170.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 124' ' ' ARG . 99.5 t . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.015 -0.993 . . . . 3.55 110.374 -175.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.995 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.6 tt . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.503 -0.555 . . . . 9.06 109.503 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.61 89.21 3.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.939 0.399 . . . . 6.45 110.587 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -82.78 82.61 8.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.373 -0.603 . . . . 7.02 109.373 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.72 60.84 4.63 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.895 -0.669 . . . . 2.04 113.145 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.28 101.99 3.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.082 0.468 . . . . 1.26 110.918 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.665 HG13 ' HA ' ' A' ' 42' ' ' TYR . 7.1 tt -130.14 141.25 46.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.111 -0.495 . . . . 1.5 110.07 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.527 ' NE2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -113.88 129.05 56.63 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 116.13 -0.486 . . . . 2.22 109.91 -175.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.453 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.9 pp -126.0 157.55 37.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.156 0.503 . . . . 1.4 110.842 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 36' ' ' ASP . 3.6 p30 -79.24 156.84 27.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.544 0.688 . . . . 1.15 110.996 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -81.43 35.29 2.43 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.286 -0.87 . . . . 1.2 111.489 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 34' ' ' ASP . 27.1 t70 -123.56 -24.6 4.52 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.064 0.459 . . . . 1.81 110.048 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.57 7.5 4.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.722 -0.751 . . . . 1.05 113.291 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -126.94 159.49 33.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.129 0.49 . . . . 1.79 110.879 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.72 HG12 ' HB3' ' A' ' 60' ' ' LYS . 10.9 mm -70.65 142.43 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 109.598 -0.519 . . . . 1.82 109.598 175.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.527 HD21 ' NE2' ' A' ' 32' ' ' GLN . 25.9 tp -109.01 -48.6 3.25 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.953 -0.388 . . . . 2.13 109.953 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -153.84 114.49 4.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 2.96 110.998 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.665 ' HA ' HG13 ' A' ' 31' ' ' ILE . 55.7 t80 -86.33 130.68 34.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.079 -0.51 . . . . 1.75 109.642 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -97.06 118.64 33.93 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.845 0.355 . . . . 1.28 110.356 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.76 171.7 13.79 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.948 -0.569 . . . . 2.53 109.579 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.94 117.51 29.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.566 0.222 . . . . 4.46 111.152 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 57.75 40.96 25.86 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.762 -0.653 . . . . 7.21 111.762 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.13 -59.44 7.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.68 -0.771 . . . . 7.0 112.353 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -108.78 151.18 26.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.943 0.401 . . . . 8.59 110.463 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.6 mt -102.76 53.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.23 -0.656 . . . . 9.53 109.23 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.455 HG22 ' N ' ' A' ' 51' ' ' GLY . 4.1 m 69.83 159.98 0.19 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.301 -0.863 . . . . 10.16 110.555 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.455 ' N ' HG22 ' A' ' 50' ' ' THR . . . 109.49 -33.59 6.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.465 -0.874 . . . . 10.12 112.571 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -88.41 161.15 17.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.898 0.38 . . . . 13.33 110.596 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 19.1 m-20 -83.47 138.77 41.36 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.802 -0.635 . . . . 8.24 110.593 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 25.6 Cg_exo -63.63 -31.86 69.72 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.949 2.433 . . . . 8.73 112.383 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -84.0 38.24 0.64 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.976 0.417 . . . . 9.47 111.227 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -129.68 7.71 5.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.298 0.57 . . . . 8.03 110.165 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.609 HG21 ' HB3' ' A' ' 42' ' ' TYR . 11.3 p -96.67 51.63 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.806 1.289 . . . . 5.42 111.402 -174.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -126.47 156.79 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.211 -0.904 . . . . 3.61 109.704 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.73 -23.99 5.72 Favored Glycine 0 C--N 1.313 -0.7 0 CA-C-N 115.572 -0.74 . . . . 3.37 111.93 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.839 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -118.27 123.01 44.36 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 110.009 -0.367 . . . . 4.22 110.009 179.212 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -137.66 96.45 3.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.001 0.429 . . . . 4.71 110.017 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -136.47 134.28 37.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.82 -0.627 . . . . 7.47 110.616 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -84.86 -17.17 38.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.423 0.63 . . . . 8.88 109.475 173.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -151.91 127.81 10.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.222 -0.899 . . . . 10.35 109.109 -179.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.46 ' H ' ' HE2' ' A' ' 64' ' ' LYS . 3.8 p-10 -73.14 160.8 31.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.687 0.279 . . . . 7.94 110.633 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 p -153.94 -60.7 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.168 -0.469 . . . . 9.58 111.117 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 39.91 70.14 1.56 Allowed Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 123.131 0.573 . . . . 9.32 111.804 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.33 -35.11 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.117 1.878 . . . . 10.74 113.212 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.8 m -115.03 -0.71 13.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.518 -0.31 . . . . 11.49 111.809 -173.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.8 m -136.21 149.79 48.71 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.66 -0.416 . . . . 11.26 111.455 -172.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -137.25 157.56 46.37 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.074 -1.084 . . . . 11.56 108.074 170.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.426 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 5.5 m 54.71 60.04 10.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 O-C-N 123.335 0.397 . . . . 11.11 110.413 -175.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 72' ' ' SER . 14.6 Cg_exo -67.7 -73.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.555 2.17 . . . . 11.05 112.334 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -133.54 89.96 2.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.277 -0.42 . . . . 11.76 110.09 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 68.16 97.4 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.821 0.82 . . . . 10.74 112.653 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -120.64 114.2 21.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.36 -0.836 . . . . 7.67 109.223 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.76 76.87 0.4 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.887 -1.149 . . . . 3.32 111.49 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HG2' ' HB2' ' A' ' 81' ' ' GLU . 41.0 tttp 60.18 34.5 21.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.668 0.747 . . . . 4.53 109.037 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.506 ' O ' HG22 ' A' ' 83' ' ' VAL . 20.2 t80 -63.24 -41.3 99.06 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.105 -0.952 . . . . 1.1 112.109 -168.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -63.21 -34.67 78.14 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.73 0.644 . . . . 3.89 110.353 -176.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 78' ' ' LYS . 45.8 mt-10 -83.39 -31.47 26.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.254 -0.43 . . . . 3.07 109.928 175.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.887 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -57.86 -41.04 93.92 Favored Glycine 0 N--CA 1.436 -1.329 0 CA-C-N 115.716 -0.675 . . . . 0.61 112.119 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 79' ' ' PHE . 81.5 t -69.64 -51.02 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.698 -0.751 . . . . 1.36 110.914 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.58 -22.29 40.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.566 . . . . 1.59 111.688 -170.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.6 p -69.03 -33.68 74.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.845 -0.798 . . . . 2.27 108.845 172.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 111' ' ' LYS . . . 87.55 18.95 55.95 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.246 -0.888 . . . . 1.9 111.004 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -162.55 59.21 0.22 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.665 0.745 . . . . 2.08 110.976 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.887 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.3 tt -64.76 84.79 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.371 -0.831 . . . . 1.22 110.346 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.721 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.2 t30 -142.56 101.39 3.87 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.815 -0.439 . . . . 2.15 109.815 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.2 t -159.16 154.85 26.14 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.949 0.404 . . . . 2.03 110.267 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -112.66 131.71 55.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.593 -0.73 . . . . 4.31 109.776 177.417 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -140.37 131.96 27.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.684 -0.689 . . . . 2.95 109.812 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -101.13 116.8 33.68 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.87 -0.419 . . . . 1.97 109.87 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -108.89 132.36 54.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.625 -0.716 . . . . 4.56 109.978 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.1 p -100.47 151.69 21.25 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.848 -0.615 . . . . 3.22 111.694 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.05 88.71 2.82 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.449 -0.574 . . . . 5.99 109.449 174.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.63 169.26 16.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.315 -0.857 . . . . 6.06 111.137 -175.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 73.37 -40.4 0.47 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.277 -0.874 . . . . 10.04 112.45 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -71.41 150.85 44.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.818 0.342 . . . . 8.93 110.934 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.9 ttt -64.53 -37.3 87.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.854 -0.612 . . . . 8.55 111.373 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.4 m -79.71 130.22 68.34 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.337 -0.392 . . . . 5.39 110.264 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.05 42.21 1.16 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.856 2.371 . . . . 5.02 112.222 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.531 ' HA ' ' OXT' ' A' ' 125' ' ' VAL . 43.7 m -64.89 98.87 0.3 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.461 0.648 . . . . 2.85 111.136 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -103.31 130.1 50.5 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.738 -0.838 . . . . 3.49 108.738 172.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.1 m -101.07 157.73 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-O 121.152 0.501 . . . . 1.72 110.398 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -136.07 105.56 6.09 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.523 -0.762 . . . . 2.83 109.157 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.543 ' HB ' ' SD ' ' A' ' 109' ' ' MET . 0.8 OUTLIER -96.71 144.93 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 CA-C-O 121.257 0.551 . . . . 1.64 111.883 -178.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -135.4 103.92 5.66 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.778 -1.193 . . . . 1.35 107.778 162.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.721 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 3.6 mpp? -92.31 143.94 25.89 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.234 -1.395 . . . . 2.72 107.234 176.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -146.18 135.41 22.8 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.103 -1.039 . . . . 2.17 111.429 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.626 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 57.3 tttp -55.19 114.74 1.9 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.048 -0.978 . . . . 2.33 109.557 167.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 116' ' ' ASP . . . -49.35 139.24 11.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.076 -0.965 . . . . 1.12 110.98 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.0 mt -65.83 -15.74 63.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.145 -0.48 . . . . 2.97 110.871 -176.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.4 m -62.68 -57.36 11.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 2.06 110.067 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.3 -74.03 0.1 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.245 -0.742 . . . . 1.52 111.245 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 117' ' ' SER . 9.0 t70 -93.76 -167.52 1.71 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.579 -0.897 . . . . 2.79 108.579 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.539 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 37.0 p 60.4 155.67 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.47 1.108 . . . . 0.95 112.108 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.626 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 48.9 m-85 -136.55 138.36 41.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.53 -0.759 . . . . 0.98 109.678 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.518 ' CD2' ' HB2' ' A' ' 32' ' ' GLN . 44.1 m95 -91.43 164.76 13.71 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.302 0.573 . . . . 0.48 111.23 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.433 ' HB ' HG21 ' A' ' 31' ' ' ILE . 58.9 t -134.06 97.34 2.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.681 -1.145 . . . . 1.3 109.277 176.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -98.59 121.73 40.9 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.778 -0.823 . . . . 1.96 108.778 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.3 p -124.68 147.21 29.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.03 0.443 . . . . 2.21 111.119 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -126.72 117.67 23.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.86 -0.609 . . . . 3.87 109.468 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -114.53 156.11 25.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.822 0.344 . . . . 4.72 110.61 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.531 ' OXT' ' HA ' ' A' ' 103' ' ' THR . 2.6 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.968 -1.015 . . . . 3.55 110.128 172.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' HC4 . . . . . 0.979 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' HH ' ' A' ' 42' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.908 -0.077 . . . . 1.4299999999999999 112.908 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -95.03 102.91 14.74 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.855 0.359 . . . . 0.69999999999999996 111.697 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.75 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -119.69 140.41 43.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.886 0.374 . . . . 0.90000000000000002 110.223 177.355 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.44 128.71 56.55 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.172 -0.677 . . . . 2.2200000000000002 109.172 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 pp -129.95 158.05 40.62 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.415 0.626 . . . . 0.71999999999999997 110.816 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -85.11 150.91 24.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.476 -0.784 . . . . 1.1499999999999999 110.424 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.572 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -80.44 32.27 2.35 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.79 -0.641 . . . . 1.2 112.696 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -126.24 -30.27 2.92 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.829 -0.434 . . . . 1.8100000000000001 109.829 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.23 10.44 0.84 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.99 -1.1 . . . . 1.05 114.404 171.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -118.92 139.39 51.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 118.009 0.905 . . . . 1.5700000000000001 111.998 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 31' ' ' ILE . 43.5 mm -75.52 139.21 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.709 -0.678 . . . . 1.1799999999999999 109.497 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 tp -106.95 -53.18 2.65 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.864 -0.335 . . . . 1.5600000000000001 111.018 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -153.85 145.06 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.406 -0.518 . . . . 2.4100000000000001 111.869 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.75 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 45.6 t80 -117.78 124.31 48.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.706 -0.679 . . . . 1.4199999999999999 109.633 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 35.0 m-80 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.374 -0.376 . . . . 1.21 110.453 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.529 0 N-CA-C 111.133 -0.787 . . . . 3.2000000000000002 111.133 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 60.9 32.36 20.02 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 123.913 0.42 . . . . 4.1399999999999997 110.336 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.576 ' O ' HG23 ' A' ' 83' ' ' VAL . 67.4 t80 -50.21 -32.22 15.9 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.946 -0.57 . . . . 0.94999999999999996 111.606 -177.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -69.81 -34.08 73.22 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 123.802 0.689 . . . . 3.48 109.698 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -84.18 -31.44 25.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.585 -0.734 . . . . 3.0699999999999998 109.2 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.904 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -54.44 -41.15 71.49 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.371 -0.831 . . . . 0.55000000000000004 111.972 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 79' ' ' PHE . 96.6 t -65.23 -53.49 39.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.405 -0.897 . . . . 0.84999999999999998 110.942 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.43 -27.78 27.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.148 -0.478 . . . . 1.1200000000000001 111.655 -170.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 t -66.57 -27.21 67.55 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.014 -0.736 . . . . 1.8799999999999999 109.014 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.86 29.44 51.67 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.67 -0.695 . . . . 1.6599999999999999 112.469 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -157.18 48.65 0.43 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.61 0.719 . . . . 2.0800000000000001 111.519 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.904 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -74.82 79.71 2.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.4 -0.818 . . . . 0.56000000000000005 111.198 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.3 p-10 -144.09 101.11 3.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.478 0.656 . . . . 2.0099999999999998 109.528 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -147.42 147.8 30.62 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.806 -0.559 . . . . 1.6699999999999999 110.535 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -109.32 115.55 30.19 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.046 -0.724 . . . . 3.9399999999999999 109.046 169.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.519 ' HE2' ' HD2' ' A' ' 94' ' ' TYR . 84.1 t80 -132.17 126.97 34.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.804 -0.634 . . . . 2.4700000000000002 109.97 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 9.7 pt-20 -97.23 130.63 44.43 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.481 -0.563 . . . . 1.97 109.481 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.519 ' HD2' ' HE2' ' A' ' 92' ' ' PHE . 27.4 t80 . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.636 -0.505 . . . . 4.29 109.636 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 80.4 tttt . . . . . 0 C--O 1.239 0.513 0 CA-C-O 120.483 0.183 . . . . 3.1200000000000001 110.674 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.7 m -116.32 160.92 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.182 0.515 . . . . 1.23 111.353 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 85.8 tttt -125.03 123.98 40.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.31 -0.859 . . . . 2.3599999999999999 109.184 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.1 t -101.74 119.42 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 116.45 -0.341 . . . . 1.1100000000000001 110.34 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -106.79 104.33 13.98 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.22 -1.03 . . . . 1.01 108.22 168.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 55.0 mtm -97.5 145.57 26.08 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.276 -1.009 . . . . 2.2200000000000002 108.276 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.508 ' CG ' ' HB2' ' A' ' 119' ' ' TRP . 19.4 ptpt -146.42 127.07 14.24 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.384 -0.527 . . . . 1.73 109.827 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.507 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 51.6 tttm -57.34 113.57 1.81 Allowed 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 116.064 -0.516 . . . . 1.78 109.906 170.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.44 138.93 38.9 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.701 -1.136 . . . . 0.45000000000000001 110.485 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.5 mt -67.88 -8.58 37.69 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.245 -0.434 . . . . 2.3900000000000001 110.918 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 m -70.94 -38.61 72.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 1.6599999999999999 110.503 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.67 -105.76 0.34 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.73 -0.748 . . . . 1.52 112.81 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.29 65.05 7.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.597 0.713 . . . . 2.79 112.013 -175.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.572 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 1.7 p -157.67 157.97 34.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.922 -1.035 . . . . 0.44 108.506 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.509 ' OH ' ' HA ' ' A' ' 83' ' ' VAL . 28.9 m-85 -140.74 139.75 34.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.687 0.28 . . . . 0.41999999999999998 110.603 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.508 ' HB2' ' CG ' ' A' ' 110' ' ' LYS . 38.9 m95 -93.09 162.48 14.02 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.288 0.566 . . . . 0.41999999999999998 111.241 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.629 ' HB ' HG23 ' A' ' 31' ' ' ILE . 87.7 t -136.89 101.77 2.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.561 -1.199 . . . . 0.62 109.268 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -102.19 106.39 17.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.553 -0.536 . . . . 1.49 109.553 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 p -92.37 143.87 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.077 0.465 . . . . 1.6100000000000001 110.244 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 56.6 tttp . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 109.677 -0.49 . . . . 3.4500000000000002 109.677 -178.191 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.821 0 N-CA-C 112.208 -0.357 . . . . 1.4299999999999999 112.208 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.42 102.38 3.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.95 0.405 . . . . 0.69999999999999996 110.75 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.604 HG23 ' HB ' ' A' ' 120' ' ' VAL . 4.5 tt -132.02 141.07 46.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.927 0.394 . . . . 0.90000000000000002 110.672 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HB2' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -114.52 122.98 48.24 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.41 -0.959 . . . . 2.2200000000000002 108.41 177.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.46 164.06 29.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.864 -0.607 . . . . 0.71999999999999997 111.082 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.963 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 2.3 p30 -98.09 153.95 18.07 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.015 -0.539 . . . . 1.1499999999999999 110.981 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.0 -17.03 75.22 Favored Glycine 0 CA--C 1.511 -0.17 0 CA-C-N 115.173 -0.921 . . . . 1.2 112.628 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.53 -38.98 92.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.97 0.414 . . . . 1.8100000000000001 110.421 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.46 38.26 0.31 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.706 -0.759 . . . . 1.05 112.843 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.564 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 4.3 m-80 -134.25 147.96 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.976 -0.379 . . . . 1.5700000000000001 109.976 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.7 mt -87.33 134.73 26.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.936 -0.394 . . . . 1.1799999999999999 109.936 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.0 tp -101.56 -41.45 6.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 1.5600000000000001 110.86 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -158.99 143.43 15.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.993 0.425 . . . . 2.4100000000000001 111.204 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.466 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 40.9 t80 -114.34 114.86 26.47 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.601 -0.889 . . . . 1.4199999999999999 108.601 174.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 121.168 0.509 . . . . 1.21 110.647 -173.756 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 110.177 -1.169 . . . . 3.2000000000000002 110.177 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm 67.12 31.65 6.65 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 123.987 0.463 . . . . 4.1399999999999997 110.293 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.704 ' HA ' HD11 ' A' ' 88' ' ' LEU . 65.5 t80 -47.9 -36.86 12.94 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 112.245 0.461 . . . . 0.94999999999999996 112.245 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.39 -39.64 74.42 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.418 0.627 . . . . 3.48 109.963 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.08 -29.02 48.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.158 -0.928 . . . . 3.0699999999999998 108.917 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.86 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.82 -41.27 97.57 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.451 -0.795 . . . . 0.55000000000000004 111.516 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 79' ' ' PHE . 95.4 t -64.94 -51.83 61.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.431 -0.884 . . . . 0.84999999999999998 110.674 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.64 -24.69 49.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.062 -0.517 . . . . 1.1200000000000001 111.05 -172.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -65.21 -34.52 78.56 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.548 -0.908 . . . . 1.8799999999999999 108.548 172.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.73 15.57 61.32 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.25 -0.886 . . . . 1.6599999999999999 112.301 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -164.0 54.63 0.15 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.328 0.585 . . . . 2.0800000000000001 111.838 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.86 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -65.37 96.11 0.22 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.519 -0.764 . . . . 0.56000000000000005 111.547 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.6 p30 -145.05 108.53 4.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.32 0.581 . . . . 2.0099999999999998 110.283 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -142.2 162.42 35.53 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.098 -0.501 . . . . 1.6699999999999999 111.411 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.72 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 25.8 ptt? -151.5 116.08 5.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.815 0.816 . . . . 3.9399999999999999 110.285 169.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -149.89 144.32 25.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.949 -1.023 . . . . 2.4700000000000002 109.057 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.598 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 25.8 mt-10 -95.35 116.44 28.78 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.189 -0.671 . . . . 1.97 109.189 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 68.2 t80 . . . . . 0 N--CA 1.446 -0.63 0 CA-C-N 115.647 -0.706 . . . . 4.29 110.296 -172.415 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.723 -0.473 . . . . 3.1200000000000001 109.723 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.52 160.72 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.125 0.488 . . . . 1.23 110.824 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 13.9 ttmm -116.86 124.17 48.85 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.64 -0.874 . . . . 2.3599999999999999 108.64 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 91' ' ' MET . 1.1 m -109.32 104.32 16.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.167 0.508 . . . . 1.1100000000000001 111.494 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 6.1 t60 -109.84 105.1 14.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.723 -0.843 . . . . 1.01 108.723 172.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 53.6 mtm -117.86 144.31 45.52 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.815 -0.809 . . . . 2.2200000000000002 108.815 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -149.34 129.67 13.77 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.142 -0.623 . . . . 1.73 110.187 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 75.5 tttt -56.85 114.91 2.29 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.787 -0.642 . . . . 1.78 110.366 174.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.554 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -62.62 145.81 53.59 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.792 -1.095 . . . . 0.45000000000000001 110.251 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.571 ' H ' ' CD1' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -67.07 1.27 2.08 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.305 0.483 . . . . 2.3900000000000001 112.305 -177.478 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.6 t -91.6 6.24 46.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.799 0.333 . . . . 1.6599999999999999 110.95 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -108.12 3.64 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.633 -0.794 . . . . 1.52 112.035 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.93 87.23 2.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.371 0.605 . . . . 2.79 110.628 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.963 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.3 p 179.25 151.32 0.34 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.824 -1.08 . . . . 0.44 109.169 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.475 ' OH ' ' HA ' ' A' ' 83' ' ' VAL . 22.6 m-85 -147.11 136.45 22.66 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.549 -0.537 . . . . 0.41999999999999998 109.549 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.468 ' CD2' ' HB2' ' A' ' 32' ' ' GLN . 45.2 m95 -86.33 159.3 19.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.07 0.462 . . . . 0.41999999999999998 110.481 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.604 ' HB ' HG23 ' A' ' 31' ' ' ILE . 72.1 t -138.21 104.31 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.108 -0.951 . . . . 0.62 109.964 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.656 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 71.5 m-85 -110.4 116.75 31.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.0 -0.741 . . . . 1.49 109.0 175.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 18.1 m -115.79 154.62 17.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.551 0.691 . . . . 1.6100000000000001 111.355 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HE2' ' HE2' ' A' ' 106' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 115.066 -0.97 . . . . 3.4500000000000002 109.077 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.582 ' N ' ' HH ' ' A' ' 42' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.473 0 N-CA-C 112.375 -0.29 . . . . 1.4299999999999999 112.375 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.81 105.17 4.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.625 0.25 . . . . 0.69999999999999996 110.537 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.741 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 6.3 tt -133.52 140.37 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.196 0.522 . . . . 0.90000000000000002 111.097 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.58 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 3.2 pt20 -109.66 129.79 55.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.6 -0.727 . . . . 2.2200000000000002 110.548 176.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.29 159.03 36.53 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.513 -0.767 . . . . 0.71999999999999997 109.915 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 37.2 p30 -84.5 164.66 18.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.373 0.606 . . . . 1.1499999999999999 111.439 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.53 21.13 3.84 Favored Glycine 0 C--N 1.322 -0.249 0 CA-C-N 115.257 -0.883 . . . . 1.2 112.441 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.08 -26.55 8.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.804 0.335 . . . . 1.8100000000000001 110.329 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.45 11.61 7.22 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.907 -0.588 . . . . 1.05 111.86 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -109.53 143.59 38.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.892 0.377 . . . . 1.5700000000000001 110.421 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.473 HG23 HD11 ' A' ' 31' ' ' ILE . 51.2 mm -79.9 139.41 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.227 -0.657 . . . . 1.1799999999999999 109.227 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.3 tp -106.72 -52.31 2.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.628 -0.26 . . . . 1.5600000000000001 111.095 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -163.19 147.14 10.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 2.4100000000000001 111.336 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.741 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 49.0 t80 -114.27 151.23 33.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.01 -0.541 . . . . 1.4199999999999999 110.118 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.961 -0.563 . . . . 1.21 110.22 -179.58 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.825 0 N-CA-C 111.303 -0.719 . . . . 3.2000000000000002 111.303 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 62.03 37.93 14.46 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.654 0.382 . . . . 4.1399999999999997 110.268 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.663 ' HA ' HD11 ' A' ' 88' ' ' LEU . 69.6 t80 -47.34 -32.37 4.76 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.352 0.661 . . . . 0.94999999999999996 112.247 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -62.46 -44.02 97.42 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 123.933 0.771 . . . . 3.48 110.291 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.11 -22.99 22.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.149 -0.478 . . . . 3.0699999999999998 109.756 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.966 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.27 -38.03 92.7 Favored Glycine 0 N--CA 1.436 -1.3 0 CA-C-N 115.776 -0.647 . . . . 0.55000000000000004 112.323 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 79' ' ' PHE . 69.2 t -69.81 -48.61 63.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.93 -0.635 . . . . 0.84999999999999998 110.411 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.5 -23.74 42.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.423 -0.808 . . . . 1.1200000000000001 111.352 -170.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.6 p -67.62 -28.41 67.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.494 0.664 . . . . 1.8799999999999999 109.219 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.16 19.5 62.59 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.356 -0.838 . . . . 1.6599999999999999 111.839 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -162.85 55.75 0.2 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.359 0.6 . . . . 2.0800000000000001 111.225 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.966 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -69.07 83.61 0.33 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.553 -0.749 . . . . 0.56000000000000005 111.326 176.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.9 p-10 -144.86 99.04 3.28 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.455 0.645 . . . . 2.0099999999999998 109.789 171.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 91' ' ' MET . 11.9 m -146.31 152.52 39.27 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.136 -0.484 . . . . 1.6699999999999999 110.333 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.416 ' N ' HG22 ' A' ' 90' ' ' THR . 16.8 ptt? -123.22 129.26 51.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.93 0.395 . . . . 3.9399999999999999 110.323 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -150.66 142.96 24.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.806 -0.634 . . . . 2.4700000000000002 109.759 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.61 117.1 29.83 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.663 -0.495 . . . . 1.97 109.663 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 108.685 -0.857 . . . . 4.29 108.685 -175.385 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.1 tttt . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 107.959 -1.126 . . . . 3.1200000000000001 107.959 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -126.03 163.66 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.182 0.515 . . . . 1.23 110.867 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 22.1 ptmt -135.31 140.33 45.03 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.412 -0.813 . . . . 2.3599999999999999 109.03 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.75 142.02 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-O 121.679 0.752 . . . . 1.1100000000000001 112.157 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 18.5 t-160 -131.71 104.67 7.04 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.004 -1.48 . . . . 1.01 107.004 164.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.587 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 79.7 mtp -105.98 148.13 28.05 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.826 -0.805 . . . . 2.2200000000000002 108.826 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.8 ptmm? -152.59 134.43 14.74 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.893 -0.723 . . . . 1.73 109.671 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.454 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 18.5 ttmm -56.95 115.35 2.55 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.409 0.623 . . . . 1.78 109.726 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.54 138.02 58.35 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.659 -1.155 . . . . 0.45000000000000001 110.866 -172.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.52 -8.66 55.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.185 0.517 . . . . 2.3900000000000001 109.974 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.2 m -65.41 -35.92 82.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.487 -0.779 . . . . 1.6599999999999999 110.089 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.09 139.68 9.36 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.825 -0.625 . . . . 1.52 112.335 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.53 44.75 17.2 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.42 0.688 . . . . 2.79 112.091 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 2.9 p -158.98 157.16 30.77 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.249 -0.887 . . . . 0.44 110.383 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.454 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 39.8 m-85 -139.29 137.21 35.65 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.443 -0.577 . . . . 0.41999999999999998 109.443 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.58 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 39.8 m95 -84.05 161.7 20.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.278 0.561 . . . . 0.41999999999999998 111.27 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.77 95.82 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.426 -1.261 . . . . 0.62 108.93 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 89.6 m-85 -90.31 101.55 14.27 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.414 -0.958 . . . . 1.49 108.414 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 7.1 p -116.97 134.02 61.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.81 0.338 . . . . 1.6100000000000001 110.478 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.824 -0.436 . . . . 3.4500000000000002 109.824 -176.406 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 C--O 1.226 -0.382 0 CA-C-O 120.374 -0.125 . . . . 1.4299999999999999 112.945 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.14 102.9 14.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.997 0.427 . . . . 0.69999999999999996 111.755 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.708 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -128.49 139.73 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.954 0.407 . . . . 0.90000000000000002 110.025 175.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.611 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 12.5 pt20 -112.81 134.67 54.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.471 0.653 . . . . 2.2200000000000002 111.416 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HB3' HD13 ' A' ' 39' ' ' ILE . 4.2 pp -122.62 161.84 23.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.149 -0.932 . . . . 0.71999999999999997 110.019 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 36' ' ' ASP . 3.5 p30 -90.87 153.99 19.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.261 0.553 . . . . 1.1499999999999999 110.77 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -79.07 28.23 2.25 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.591 -0.731 . . . . 1.2 111.381 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 34' ' ' ASP . 31.9 t70 -111.41 -35.34 5.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.803 -0.698 . . . . 1.8100000000000001 109.402 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.42 22.45 1.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.803 -0.713 . . . . 1.05 112.992 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -135.31 153.47 51.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.085 0.469 . . . . 1.5700000000000001 110.533 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.535 HG23 HD11 ' A' ' 31' ' ' ILE . 48.2 mm -76.16 141.61 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.188 -0.671 . . . . 1.1799999999999999 109.188 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.8 tp -107.34 -52.29 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.915 -0.314 . . . . 1.5600000000000001 110.963 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.406 ' O ' HG12 ' A' ' 31' ' ' ILE . 24.4 tt0 -160.93 140.84 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.702 -0.399 . . . . 2.4100000000000001 111.72 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.708 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 76.8 t80 -104.41 139.03 39.94 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.769 -0.826 . . . . 1.4199999999999999 108.769 171.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 . . . . . 0 C--N 1.319 -0.73 0 N-CA-C 110.001 -0.37 . . . . 1.21 110.001 -179.785 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 110.833 -0.907 . . . . 3.2000000000000002 110.833 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 58.98 41.06 21.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.597 0.713 . . . . 4.1399999999999997 109.376 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 83' ' ' VAL . 57.4 t80 -56.81 -36.25 69.7 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.628 -1.169 . . . . 0.94999999999999996 111.259 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -59.49 -36.71 76.57 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 123.85 0.718 . . . . 3.48 110.52 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -86.07 -37.91 18.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.812 -0.631 . . . . 3.0699999999999998 109.863 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 1.017 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.39 -43.58 89.99 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.721 -0.672 . . . . 0.55000000000000004 112.015 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 79' ' ' PHE . 90.7 t -73.05 -50.63 30.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.508 -0.846 . . . . 0.84999999999999998 111.211 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.79 -32.29 59.83 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.215 -0.448 . . . . 1.1200000000000001 111.239 -169.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.6 m -72.55 -23.23 60.95 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.424 -0.584 . . . . 1.8799999999999999 109.424 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 34.06 38.06 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.714 -0.675 . . . . 1.6599999999999999 111.999 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -158.89 50.19 0.36 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.565 0.698 . . . . 2.0800000000000001 112.005 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.017 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -73.76 88.31 1.75 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.763 -0.653 . . . . 0.56000000000000005 111.45 177.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.0 p30 -143.26 101.52 3.82 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.525 -0.546 . . . . 2.0099999999999998 109.525 175.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.0 t -168.47 163.36 12.56 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.13 0.49 . . . . 1.6699999999999999 110.924 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.2 ptt? -104.4 136.28 44.27 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.411 -0.813 . . . . 3.9399999999999999 110.014 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 107' ' ' VAL . 77.3 t80 -147.15 127.78 14.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.58 -0.736 . . . . 2.4700000000000002 109.22 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 8.1 pt-20 -95.43 132.71 40.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.43 0.633 . . . . 1.97 110.804 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.9 t80 . . . . . 0 N--CA 1.446 -0.659 0 CA-C-N 114.76 -1.109 . . . . 4.29 108.777 -173.217 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 tttm . . . . . 0 C--O 1.236 0.354 0 CA-C-O 120.832 0.349 . . . . 3.1200000000000001 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.2 m -114.74 167.87 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-N 115.548 -0.751 . . . . 1.23 110.141 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 19.8 ptmt -144.07 147.38 33.71 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.671 -0.412 . . . . 2.3599999999999999 110.414 174.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.727 HG12 HG12 ' A' ' 122' ' ' VAL . 14.2 m -100.54 144.24 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-N 115.781 -0.645 . . . . 1.1100000000000001 111.359 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -119.97 102.87 8.85 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.411 -1.7 . . . . 1.01 106.411 160.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 64.0 mtt -102.98 146.36 28.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.777 -0.823 . . . . 2.2200000000000002 108.777 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 61.5 pttt -151.12 128.85 11.56 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.874 -0.73 . . . . 1.73 110.187 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.09 110.03 0.76 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.769 -0.65 . . . . 1.78 109.45 168.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.93 129.34 17.16 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.783 -1.099 . . . . 0.45000000000000001 109.782 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.17 -5.92 20.62 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.225 0.328 . . . . 2.3900000000000001 111.747 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -73.4 -43.13 61.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.817 0.342 . . . . 1.6599999999999999 110.219 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.22 138.31 3.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.379 -0.915 . . . . 1.52 113.488 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.74 52.65 4.04 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.186 0.994 . . . . 2.79 113.374 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.513 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.1 p -158.92 156.21 29.1 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.56 -1.274 . . . . 0.44 107.56 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -137.38 136.2 37.67 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.645 -0.422 . . . . 0.41999999999999998 111.18 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.611 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 49.2 m95 -91.5 161.98 14.74 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.406 0.622 . . . . 0.41999999999999998 111.824 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.52 97.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.39 -1.277 . . . . 0.62 109.226 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 66.3 m-85 -98.27 112.47 24.45 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.188 -0.671 . . . . 1.49 109.188 174.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.727 HG12 HG12 ' A' ' 107' ' ' VAL . 31.1 m -110.78 150.13 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.255 0.465 . . . . 1.6100000000000001 112.255 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 pttt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 3.4500000000000002 110.366 175.176 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 C--O 1.221 -0.68 0 CA-C-O 119.917 -0.379 . . . . 1.4299999999999999 113.489 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -109.3 105.22 14.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.767 0.784 . . . . 0.69999999999999996 110.828 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.663 HD11 HD12 ' A' ' 39' ' ' ILE . 4.3 tt -138.35 141.69 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.425 -0.352 . . . . 0.90000000000000002 110.767 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' OE1' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -114.06 130.01 56.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.022 0.439 . . . . 2.2200000000000002 109.842 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.416 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.7 pp -132.75 159.76 38.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.354 0.597 . . . . 0.71999999999999997 111.366 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.6 p30 -76.99 157.83 30.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 1.1499999999999999 110.782 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.449 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -77.76 30.98 1.73 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.361 -0.836 . . . . 1.2 112.675 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -122.42 -31.94 3.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.211 0.529 . . . . 1.8100000000000001 109.756 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.04 21.18 1.24 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.459 -0.877 . . . . 1.05 112.898 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.484 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 16.2 m-80 -125.27 156.49 38.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.045 0.45 . . . . 1.5700000000000001 110.196 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.663 HD12 HD11 ' A' ' 31' ' ' ILE . 41.1 mm -81.53 142.75 13.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.965 -0.561 . . . . 1.1799999999999999 109.999 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.462 HD12 ' OE1' ' A' ' 32' ' ' GLN . 89.1 mt -109.31 -53.23 2.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.395 -0.595 . . . . 1.5600000000000001 109.395 172.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -133.81 117.27 16.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.579 -0.737 . . . . 2.4100000000000001 110.656 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.578 ' HA ' HG13 ' A' ' 31' ' ' ILE . 18.5 t80 -106.01 117.93 35.31 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.277 -0.638 . . . . 1.4199999999999999 109.277 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 84.6 m-20 . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 120.991 0.424 . . . . 1.21 110.529 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 111.728 -0.549 . . . . 3.2000000000000002 111.728 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 58.28 41.07 23.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.376 0.608 . . . . 4.1399999999999997 109.676 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 83' ' ' VAL . 56.0 t80 -56.24 -27.67 55.79 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.31 -0.859 . . . . 0.94999999999999996 111.789 -171.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.86 -33.95 72.95 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 123.855 0.722 . . . . 3.48 110.277 -175.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -86.87 -29.07 22.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.765 -0.652 . . . . 3.0699999999999998 109.531 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.737 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.25 -39.27 92.26 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 111.83 -0.508 . . . . 0.55000000000000004 111.83 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 79' ' ' PHE . 95.2 t -66.86 -48.12 80.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.979 -0.61 . . . . 0.84999999999999998 110.547 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.41 -26.61 51.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 1.1200000000000001 111.206 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -60.1 -28.56 67.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.562 -0.533 . . . . 1.8799999999999999 109.562 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.11 -10.26 47.37 Favored Glycine 0 CA--C 1.505 -0.551 0 C-N-CA 120.728 -0.749 . . . . 1.6599999999999999 113.048 169.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -169.96 62.61 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.324 0.583 . . . . 2.0800000000000001 110.145 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.737 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 2.9 tt -38.45 102.35 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 114.728 -1.123 . . . . 0.56000000000000005 111.802 175.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 4.1 p30 -145.74 102.24 3.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.1 0.476 . . . . 2.0099999999999998 109.822 176.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 2.5 p -138.8 154.34 48.47 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.924 -0.485 . . . . 1.6699999999999999 111.764 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.24 138.1 36.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.768 -0.651 . . . . 3.9399999999999999 109.76 171.329 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.45 ' O ' HG22 ' A' ' 107' ' ' VAL . 85.5 t80 -163.3 140.37 7.41 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.377 -0.601 . . . . 2.4700000000000002 109.377 -175.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 39.2 mt-10 -91.74 110.78 22.13 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.356 -0.609 . . . . 1.97 109.356 177.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.5 t80 . . . . . 0 N--CA 1.45 -0.474 0 CA-C-N 115.649 -0.705 . . . . 4.29 110.872 -171.269 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 N--CA 1.444 -0.764 0 CA-C-O 120.755 0.312 . . . . 3.1200000000000001 110.375 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.9 163.85 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.978 -0.556 . . . . 1.23 109.528 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 59.1 pttt -126.17 140.05 52.86 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.047 -0.723 . . . . 2.3599999999999999 109.047 173.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 122' ' ' VAL . 7.9 m -100.65 143.5 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 CA-C-O 121.144 0.497 . . . . 1.1100000000000001 110.903 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 90' ' ' THR . 1.5 t60 -143.85 102.73 3.95 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.656 -1.238 . . . . 1.01 107.656 164.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.553 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.1 OUTLIER -115.63 125.23 52.64 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.925 -1.139 . . . . 2.2200000000000002 107.925 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.9 ptmm? -145.18 146.96 31.96 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.742 -0.783 . . . . 1.73 110.604 -171.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 13.1 ttpp -56.82 123.79 16.26 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.217 -0.901 . . . . 1.78 111.265 176.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.66 148.41 51.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.674 -1.148 . . . . 0.45000000000000001 110.716 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.51 -4.1 37.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.091 0.472 . . . . 2.3900000000000001 110.883 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -79.88 -21.91 43.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 1.6599999999999999 110.933 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 139.16 -128.1 3.91 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.487 -0.864 . . . . 1.52 112.739 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.66 77.24 5.14 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.988 0.899 . . . . 2.79 110.76 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.449 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.9 p -162.94 157.14 20.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.267 -1.333 . . . . 0.44 108.194 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 25.1 m-85 -138.65 141.28 39.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.864 0.364 . . . . 0.41999999999999998 110.608 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 47.2 m95 -87.98 165.75 14.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.145 0.498 . . . . 0.41999999999999998 110.573 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.454 ' HB ' HG23 ' A' ' 31' ' ' ILE . 58.1 t -135.42 98.56 2.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.643 -1.162 . . . . 0.62 108.774 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 83.2 m-85 -103.86 119.96 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.372 -0.603 . . . . 1.49 109.372 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 107' ' ' VAL . 23.8 m -124.28 155.16 31.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.714 -0.476 . . . . 1.6100000000000001 109.714 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt . . . . . 0 C--N 1.32 -0.683 0 C-N-CA 120.816 -0.353 . . . . 3.4500000000000002 110.206 174.799 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 C--O 1.226 -0.358 0 CA-C-O 120.445 -0.086 . . . . 1.4299999999999999 113.239 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -107.49 118.73 37.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.139 0.495 . . . . 0.69999999999999996 111.57 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.543 HG23 ' HB ' ' A' ' 120' ' ' VAL . 5.5 tt -136.19 141.01 42.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.222 -0.444 . . . . 0.90000000000000002 110.121 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -115.37 125.08 52.77 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.5 -0.926 . . . . 2.2200000000000002 108.5 179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.48 154.31 46.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.605 0.717 . . . . 0.71999999999999997 111.456 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -73.71 146.61 44.29 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.025 -0.989 . . . . 1.1499999999999999 110.045 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.56 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -82.09 36.28 2.55 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.804 -0.635 . . . . 1.2 112.961 -173.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -134.51 -24.97 1.52 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.854 0.359 . . . . 1.8100000000000001 110.1 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.09 -4.28 2.6 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.099 -0.572 . . . . 1.05 112.494 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 21.4 m-80 -90.78 149.76 21.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.511 0.196 . . . . 1.5700000000000001 110.792 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.7 mm -92.8 140.06 16.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.822 -0.807 . . . . 1.1799999999999999 108.822 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.448 ' HG ' ' HG3' ' A' ' 41' ' ' GLN . 38.3 tp -113.28 -57.34 2.3 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.348 -0.541 . . . . 1.5600000000000001 111.351 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 45.1 mt-30 -144.16 150.38 37.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.016 0.436 . . . . 2.4100000000000001 111.405 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.464 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 55.9 t80 -127.04 117.78 23.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.956 -0.565 . . . . 1.4199999999999999 109.551 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 2.6 m-20 . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 109.83 -0.433 . . . . 1.21 109.83 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.689 0 N-CA-C 112.017 -0.433 . . . . 3.2000000000000002 112.017 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 58.48 44.12 18.48 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 122.686 0.395 . . . . 4.1399999999999997 110.538 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 83' ' ' VAL . 64.5 t80 -46.08 -43.0 14.29 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 113.456 0.91 . . . . 0.94999999999999996 113.456 -167.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -79.64 -29.88 41.14 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 121.279 0.561 . . . . 3.48 110.155 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.53 -34.31 62.98 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.218 -1.03 . . . . 3.0699999999999998 108.218 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 1.015 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.86 -40.08 89.29 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.732 -1.122 . . . . 0.55000000000000004 111.395 175.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 79' ' ' PHE . 95.5 t -68.38 -54.27 22.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.378 -0.911 . . . . 0.84999999999999998 111.046 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.15 -22.6 33.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 1.1200000000000001 111.644 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.9 t -70.63 -29.51 65.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.483 -0.932 . . . . 1.8799999999999999 108.483 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.24 23.23 49.12 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.53 -0.759 . . . . 1.6599999999999999 112.169 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -156.04 52.59 0.56 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.45 0.643 . . . . 2.0800000000000001 111.501 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.015 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.9 OUTLIER -74.37 73.72 1.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.603 -0.726 . . . . 0.56000000000000005 111.083 175.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.9 t30 -143.16 99.29 3.42 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.572 -0.899 . . . . 2.0099999999999998 108.572 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.4 m -140.26 146.36 38.5 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.017 -0.538 . . . . 1.6699999999999999 110.41 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 16.4 ptt? -126.73 129.72 48.94 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.586 -0.524 . . . . 3.9399999999999999 109.586 172.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -157.85 142.88 16.68 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.517 -0.549 . . . . 2.4700000000000002 109.517 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 55.2 mt-10 -92.6 105.54 17.68 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 1.97 109.412 176.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 63.8 t80 . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.245 -0.889 . . . . 4.29 110.989 -170.259 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.1 tttp . . . . . 0 CA--C 1.512 -0.491 0 N-CA-C 109.422 -0.585 . . . . 3.1200000000000001 109.422 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.27 160.24 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.27 0.557 . . . . 1.23 110.733 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 72.4 tttt -117.91 118.53 32.24 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.291 -1.003 . . . . 2.3599999999999999 108.291 171.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.697 HG12 HG12 ' A' ' 122' ' ' VAL . 6.3 m -99.25 144.22 12.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.438 0.637 . . . . 1.1100000000000001 111.606 -176.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -137.74 103.51 5.03 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.665 -1.152 . . . . 1.01 108.162 164.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 3.5 mpp? -98.94 140.03 33.72 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 106.798 -1.556 . . . . 2.2200000000000002 106.798 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.827 ' HG3' ' HB2' ' A' ' 119' ' ' TRP . 9.3 ptpt -141.02 125.27 17.44 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.701 -0.8 . . . . 1.73 110.09 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.64 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 82.7 tttt -57.72 106.79 0.38 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.976 -0.75 . . . . 1.78 108.976 170.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.37 127.86 20.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.929 -1.032 . . . . 0.45000000000000001 110.323 -173.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.24 -7.12 33.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.267 0.556 . . . . 2.3900000000000001 109.895 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.1 m -71.28 -26.1 62.73 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.164 -0.925 . . . . 1.6599999999999999 110.043 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.44 145.02 18.32 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.174 -0.536 . . . . 1.52 112.973 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 55.75 38.27 29.89 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.511 0.672 . . . . 2.79 112.24 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.56 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 4.8 p -166.7 159.93 14.4 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.165 -0.925 . . . . 0.44 109.937 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.64 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 36.5 m-85 -140.48 139.57 35.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.048 -0.353 . . . . 0.41999999999999998 110.048 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.827 ' HB2' ' HG3' ' A' ' 110' ' ' LYS . 41.1 m95 -92.53 162.49 14.18 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.19 0.519 . . . . 0.41999999999999998 110.658 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.543 ' HB ' HG23 ' A' ' 31' ' ' ILE . 77.5 t -136.16 105.88 5.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.762 -1.108 . . . . 0.62 109.583 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 29.3 m-85 -109.45 123.05 48.72 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.767 -0.457 . . . . 1.49 109.767 175.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.697 HG12 HG12 ' A' ' 107' ' ' VAL . 30.0 m -118.93 157.92 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.124 0.488 . . . . 1.6100000000000001 111.527 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 43.8 tttm . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.546 -0.752 . . . . 3.4500000000000002 110.008 178.694 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.435 0 N-CA-C 111.532 -0.627 . . . . 1.4299999999999999 111.532 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.17 107.74 13.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.982 -0.377 . . . . 0.69999999999999996 109.982 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.679 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -131.04 139.45 51.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.824 0.345 . . . . 0.90000000000000002 110.783 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.517 ' HB3' ' CE2' ' A' ' 119' ' ' TRP . 8.3 pt20 -105.22 114.5 28.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.633 0.73 . . . . 2.2200000000000002 110.395 176.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.59 168.45 11.74 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.879 -1.055 . . . . 0.71999999999999997 109.293 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.604 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 3.1 p30 -102.19 157.55 16.81 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.95 -0.7 . . . . 1.1499999999999999 110.888 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.408 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -77.37 14.04 9.66 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.38 -0.827 . . . . 1.2 111.73 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -100.83 -12.57 18.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.27 0.557 . . . . 1.8100000000000001 109.77 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.39 9.31 25.67 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.616 -0.72 . . . . 1.05 112.985 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.53 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 5.0 m-20 -109.07 143.53 38.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.065 0.46 . . . . 1.5700000000000001 110.944 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.559 HG23 HD11 ' A' ' 31' ' ' ILE . 47.7 mm -94.09 126.63 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.141 -0.688 . . . . 1.1799999999999999 109.141 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 tp -99.56 -49.49 4.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.851 -0.34 . . . . 1.5600000000000001 110.996 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.585 ' O ' HG12 ' A' ' 31' ' ' ILE . 33.3 tt0 -157.6 142.94 17.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.813 0.34 . . . . 2.4100000000000001 111.292 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.679 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 79.0 t80 -124.68 133.87 53.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.995 -0.548 . . . . 1.4199999999999999 109.844 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 109.142 -0.688 . . . . 1.21 109.142 174.713 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.681 0 N-CA-C 110.511 -1.036 . . . . 3.2000000000000002 110.511 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm 59.86 69.22 0.72 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.2 0.524 . . . . 4.1399999999999997 109.701 -170.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.507 ' O ' HG23 ' A' ' 83' ' ' VAL . 74.8 t80 -53.46 -40.42 65.24 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.14 -0.936 . . . . 0.94999999999999996 111.848 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -62.46 -30.82 71.52 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 123.679 0.612 . . . . 3.48 110.653 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -80.03 -35.24 37.51 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.085 -0.709 . . . . 3.0699999999999998 109.085 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.976 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -62.08 -42.72 99.74 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.513 -0.767 . . . . 0.55000000000000004 111.695 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 79' ' ' PHE . 84.1 t -65.81 -51.24 64.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.753 -0.724 . . . . 0.84999999999999998 110.682 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.37 -21.65 55.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 1.1200000000000001 110.853 -172.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.8 t -65.87 -35.61 81.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.899 -0.591 . . . . 1.8799999999999999 109.431 171.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.94 15.28 63.25 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.335 -0.706 . . . . 1.6599999999999999 111.335 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.741 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 3.0 p30 -166.02 62.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.785 0.802 . . . . 2.0800000000000001 110.833 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.976 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.2 tt -68.86 98.24 0.91 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.048 -0.978 . . . . 0.56000000000000005 110.603 172.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.638 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.0 p-10 -143.25 101.35 3.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.265 -0.574 . . . . 2.0099999999999998 110.867 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.9 t -154.97 162.47 41.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.946 0.403 . . . . 1.6699999999999999 110.608 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -130.0 116.05 18.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.694 -0.684 . . . . 3.9399999999999999 109.877 175.391 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -126.68 134.13 50.78 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.015 -0.735 . . . . 2.4700000000000002 109.015 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.709 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 7.1 pt-20 -106.13 117.27 33.59 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.908 -0.717 . . . . 1.97 110.361 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.8 t80 . . . . . 0 N--CA 1.447 -0.624 0 CA-C-N 114.763 -1.108 . . . . 4.29 109.873 -173.599 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.6 tttm . . . . . 0 C--O 1.235 0.319 0 N-CA-C 109.946 -0.39 . . . . 3.1200000000000001 109.946 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.0 m -121.22 161.98 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.131 0.491 . . . . 1.23 111.803 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.709 ' HG2' ' HB3' ' A' ' 93' ' ' GLU . 47.0 mttm -108.5 138.28 45.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.525 -0.761 . . . . 2.3599999999999999 109.638 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -107.87 102.54 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.8 -0.444 . . . . 1.1100000000000001 109.8 167.454 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.787 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 8.3 t-160 -96.18 101.95 13.67 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.838 -1.542 . . . . 1.01 106.838 168.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.638 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 8.8 ttt -111.64 113.58 26.06 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.715 -1.216 . . . . 2.2200000000000002 107.715 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 18.4 ptpt -129.59 132.14 46.69 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.3 -0.56 . . . . 1.73 110.564 -168.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.741 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 81.2 tttt -56.88 117.88 4.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 109.03 -0.73 . . . . 1.78 109.03 167.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -45.46 142.72 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.185 0.928 . . . . 0.45000000000000001 110.767 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.8 tp -63.94 -25.83 68.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.202 -0.454 . . . . 2.3900000000000001 110.691 -173.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.0 m -81.71 -50.81 8.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.961 -0.563 . . . . 1.6599999999999999 109.811 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 128.31 -179.92 16.27 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.977 -0.63 . . . . 1.52 112.756 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.0 t70 61.64 31.6 18.66 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.944 0.878 . . . . 2.79 111.475 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.9 p 179.98 156.5 0.64 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.582 -1.19 . . . . 0.44 110.415 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.448 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 43.6 m-85 -136.17 134.74 38.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.469 -0.567 . . . . 0.41999999999999998 109.469 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.561 ' O ' ' HA ' ' A' ' 109' ' ' MET . 47.3 m95 -86.52 163.87 17.25 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.291 0.567 . . . . 0.41999999999999998 112.026 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.498 HG22 ' HE3' ' A' ' 109' ' ' MET . 60.0 t -132.12 97.42 2.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.387 -1.279 . . . . 0.62 109.037 174.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.787 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 58.3 m-85 -98.81 105.49 17.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.797 -0.446 . . . . 1.49 109.797 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 17.9 m -110.99 135.6 49.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.07 0.462 . . . . 1.6100000000000001 111.482 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.607 -0.724 . . . . 3.4500000000000002 109.288 178.938 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 112.174 -0.37 . . . . 1.4299999999999999 112.174 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.82 109.64 18.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.449 0.642 . . . . 0.69999999999999996 111.413 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.594 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 4.7 tt -138.57 140.38 39.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.857 -0.611 . . . . 0.90000000000000002 110.051 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.696 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 2.8 pt20 -114.74 143.4 45.12 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.447 0.641 . . . . 2.2200000000000002 110.712 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.542 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.0 pp -124.08 157.34 34.78 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.05 -0.977 . . . . 0.71999999999999997 109.504 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.807 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.5 p30 -79.82 158.56 26.77 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.254 0.55 . . . . 1.1499999999999999 110.439 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.42 21.1 3.05 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.594 -0.73 . . . . 1.2 111.884 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 34' ' ' ASP . 23.8 t70 -106.06 -32.37 8.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.342 -0.614 . . . . 1.8100000000000001 109.342 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.67 11.16 3.03 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.417 -0.81 . . . . 1.05 112.485 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -118.78 155.89 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.687 -0.486 . . . . 1.5700000000000001 109.687 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.542 HD13 ' HB3' ' A' ' 33' ' ' LEU . 43.4 mm -70.5 136.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.967 -0.753 . . . . 1.1799999999999999 108.967 174.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.807 HD23 ' HB3' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -102.17 -65.24 1.0 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.023 -0.732 . . . . 1.5600000000000001 109.023 -173.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -145.25 134.88 23.37 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.318 -0.855 . . . . 2.4100000000000001 111.127 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.594 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 52.1 t80 -113.1 119.52 38.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.614 . . . . 1.4199999999999999 109.941 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.53 0.681 . . . . 1.21 110.766 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.776 0 N-CA-C 110.065 -1.214 . . . . 3.2000000000000002 110.065 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -130.43 61.29 1.6 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.857 -1.164 . . . . 4.1399999999999997 107.857 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.591 ' HA ' HD11 ' A' ' 88' ' ' LEU . 36.2 t80 -86.54 -37.75 17.87 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 116.352 -0.386 . . . . 0.94999999999999996 111.039 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -67.81 -32.04 72.32 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.383 -0.969 . . . . 3.48 108.383 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -82.49 -39.12 22.91 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.776 -1.556 . . . . 3.0699999999999998 108.987 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.603 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -54.79 -38.11 63.63 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.13 -0.941 . . . . 0.55000000000000004 112.364 -174.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 79' ' ' PHE . 61.8 t -69.19 -51.04 47.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.582 -0.809 . . . . 0.84999999999999998 110.786 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.89 -23.43 23.95 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.173 -0.467 . . . . 1.1200000000000001 112.253 -169.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.4 p -73.93 -33.3 63.89 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.828 -1.175 . . . . 1.8799999999999999 107.828 172.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.88 19.2 65.95 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.082 -0.963 . . . . 1.6599999999999999 111.13 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -153.78 52.3 0.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.554 0.693 . . . . 2.0800000000000001 112.084 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.603 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -67.24 86.45 0.16 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.53 -0.759 . . . . 0.56000000000000005 111.24 174.133 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.6 p30 -144.25 100.67 3.59 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.337 0.589 . . . . 2.0099999999999998 109.768 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.8 m -148.76 146.99 28.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.88 -0.513 . . . . 1.6699999999999999 109.992 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 17.9 ptm -98.76 114.86 27.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.613 -0.884 . . . . 3.9399999999999999 108.613 167.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -121.73 129.67 52.88 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.373 -0.83 . . . . 2.4700000000000002 109.418 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.527 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 22.3 mp0 -90.58 118.94 30.43 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.477 -0.934 . . . . 1.97 108.477 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.77 -0.65 . . . . 4.29 109.486 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.527 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 37.0 ttpt . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 110.018 -0.364 . . . . 3.1200000000000001 110.018 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.3 m -102.15 161.92 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.298 0.57 . . . . 1.23 110.929 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 39.1 ttmt -116.37 126.72 53.88 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.241 -0.891 . . . . 2.3599999999999999 109.494 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.64 103.7 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.865 -0.607 . . . . 1.1100000000000001 109.411 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.954 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 5.7 t-160 -90.08 101.07 13.79 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.169 -1.789 . . . . 1.01 106.169 167.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.719 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.5 OUTLIER -102.2 120.46 40.49 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.294 -1.372 . . . . 2.2200000000000002 107.294 -178.645 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -135.79 119.36 17.02 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.943 -0.703 . . . . 1.73 111.143 -165.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.481 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 81.2 tttt -55.81 116.48 2.97 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.152 0.501 . . . . 1.78 110.276 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 145.84 45.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.62 -1.173 . . . . 0.45000000000000001 111.243 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.9 mm? -77.18 -8.08 56.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.867 -0.606 . . . . 2.3900000000000001 110.131 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 t -80.32 -45.53 17.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.062 -0.517 . . . . 1.6599999999999999 110.007 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.49 149.68 8.32 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.898 -0.667 . . . . 1.52 112.699 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 52.23 37.65 22.56 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.657 0.742 . . . . 2.79 111.644 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.0 p -159.98 154.03 23.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.845 -1.07 . . . . 0.44 109.761 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 66.2 m-85 -141.35 137.31 32.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.394 -0.366 . . . . 0.41999999999999998 110.27 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.696 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 44.3 m95 -88.24 164.18 15.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.471 0.653 . . . . 0.41999999999999998 111.65 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.7 t -136.21 96.1 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.017 -1.447 . . . . 0.62 108.391 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.954 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 63.5 m-85 -94.53 102.53 14.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.944 -1.132 . . . . 1.49 107.944 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 10.3 p -97.72 134.28 36.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 1.6100000000000001 111.132 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 N--CA 1.45 -0.453 0 CA-C-N 115.992 -0.549 . . . . 3.4500000000000002 109.729 -177.514 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 111.889 -0.484 . . . . 1.4299999999999999 111.889 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.25 103.4 15.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.969 0.414 . . . . 0.69999999999999996 111.073 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.53 HD11 HG23 ' A' ' 39' ' ' ILE . 5.7 tt -135.39 140.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.159 0.504 . . . . 0.90000000000000002 111.212 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.484 ' HB3' ' CE2' ' A' ' 119' ' ' TRP . 12.3 pt20 -109.6 121.09 44.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.656 -0.702 . . . . 2.2200000000000002 110.353 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 pp -123.15 152.34 41.26 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.078 -0.51 . . . . 0.71999999999999997 110.833 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -70.93 154.13 42.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.762 -0.654 . . . . 1.1499999999999999 110.142 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.516 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -76.79 31.17 1.49 Allowed Glycine 0 C--O 1.234 0.096 0 CA-C-N 115.781 -0.645 . . . . 1.2 113.31 -173.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 34' ' ' ASP . 12.4 t70 -135.44 -33.51 0.88 Allowed 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 122.84 0.456 . . . . 1.8100000000000001 110.204 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.59 18.84 0.53 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.473 -0.87 . . . . 1.05 113.051 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -107.68 128.87 54.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.603 0.239 . . . . 1.5700000000000001 110.789 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.53 HG23 HD11 ' A' ' 31' ' ' ILE . 46.9 mm -78.9 115.6 21.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.722 -0.217 . . . . 1.1799999999999999 110.512 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.86 -47.44 9.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.072 0.463 . . . . 1.5600000000000001 110.575 -173.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -159.34 142.39 14.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.911 -0.586 . . . . 2.4100000000000001 111.416 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -114.44 117.59 31.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.656 -0.702 . . . . 1.4199999999999999 110.191 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.855 -0.424 . . . . 1.21 109.855 -178.793 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.513 0 N-CA-C 112.071 -0.412 . . . . 3.2000000000000002 112.071 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.16 8.95 39.78 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 110.392 -0.225 . . . . 4.1399999999999997 110.392 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.771 ' HA ' HD11 ' A' ' 88' ' ' LEU . 6.1 t80 -49.93 -36.06 26.27 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.749 0.648 . . . . 0.94999999999999996 112.749 -168.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 57.4 mmtt -66.54 -30.42 70.73 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 121.394 0.616 . . . . 3.48 110.952 -177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -89.26 -41.5 12.15 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.876 -0.787 . . . . 3.0699999999999998 108.876 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.828 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -51.41 -40.99 47.45 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.142 -0.935 . . . . 0.55000000000000004 112.565 -173.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 79' ' ' PHE . 85.7 t -64.89 -52.08 58.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.463 -0.869 . . . . 0.84999999999999998 110.942 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.07 -29.84 21.59 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.101 -0.5 . . . . 1.1200000000000001 112.323 -168.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.8 p -72.94 -29.53 63.17 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.708 -0.849 . . . . 1.8799999999999999 108.708 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.03 26.0 65.38 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.828 -0.909 . . . . 1.6599999999999999 110.828 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -148.56 49.3 1.02 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.89 0.853 . . . . 2.0800000000000001 111.759 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.828 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -71.79 78.4 0.86 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.142 -0.935 . . . . 0.56000000000000005 111.644 176.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.5 p-10 -144.23 98.44 3.21 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.454 0.645 . . . . 2.0099999999999998 109.787 174.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 91' ' ' MET . 4.1 m -149.16 157.43 43.37 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.789 -0.448 . . . . 1.6699999999999999 109.789 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.5 ptt? -117.52 138.19 52.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.331 -0.395 . . . . 3.9399999999999999 109.941 173.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -161.84 149.61 14.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.275 -0.639 . . . . 2.4700000000000002 109.275 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.582 ' HG3' ' HD3' ' A' ' 106' ' ' LYS . 10.5 mp0 -92.28 121.02 33.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.599 -0.519 . . . . 1.97 109.599 176.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.0 t80 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.27 -0.423 . . . . 4.29 110.336 -177.324 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 93' ' ' GLU . 26.8 ttmt . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 109.103 -0.703 . . . . 3.1200000000000001 109.103 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 27.3 m -104.17 159.49 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.295 0.569 . . . . 1.23 111.229 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.582 ' HD3' ' HG3' ' A' ' 93' ' ' GLU . 55.0 mmtt -101.73 120.61 40.63 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.085 -0.962 . . . . 2.3599999999999999 108.668 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.557 HG12 ' HG3' ' A' ' 109' ' ' MET . 2.1 t -97.21 102.02 12.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.172 -0.677 . . . . 1.1100000000000001 109.172 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 15.9 t60 -101.31 103.56 14.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.765 -1.198 . . . . 1.01 107.765 170.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 62.0 mtt -106.67 144.18 33.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.058 -1.09 . . . . 2.2200000000000002 108.058 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.6 ptpt -147.97 130.77 16.07 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.146 -0.621 . . . . 1.73 109.76 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.551 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 63.2 tttp -57.76 111.53 1.17 Allowed 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 109.038 -0.727 . . . . 1.78 109.038 168.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.63 144.75 13.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.781 -1.1 . . . . 0.45000000000000001 110.085 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.39 -17.99 63.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.003 0.43 . . . . 2.3900000000000001 110.098 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.2 m -63.0 -40.33 97.45 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.493 -0.776 . . . . 1.6599999999999999 110.354 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.66 -61.8 0.4 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.72 -0.752 . . . . 1.52 113.475 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -87.45 41.42 0.98 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.438 0.637 . . . . 2.79 112.202 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.516 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.1 p -166.92 159.28 13.3 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.741 -0.663 . . . . 0.44 110.806 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.551 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 72.7 m-85 -139.06 135.63 34.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.835 -0.621 . . . . 0.41999999999999998 109.615 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.484 ' CE2' ' HB3' ' A' ' 32' ' ' GLN . 42.2 m95 -87.77 163.13 16.64 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.352 0.596 . . . . 0.41999999999999998 112.044 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.95 111.08 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.144 -1.389 . . . . 0.62 108.828 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 83.8 m-85 -111.9 110.08 20.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.529 -0.545 . . . . 1.49 109.529 174.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.34 125.03 63.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.585 0.231 . . . . 1.6100000000000001 110.77 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 C--O 1.222 -0.348 0 N-CA-C 108.966 -0.753 . . . . 3.4500000000000002 108.966 177.589 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 110.944 -0.863 . . . . 1.4299999999999999 110.944 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.91 106.77 16.45 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.003 0.43 . . . . 0.69999999999999996 111.156 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.441 HG23 ' HB ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -123.88 139.39 50.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.641 -0.503 . . . . 0.90000000000000002 109.641 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 41' ' ' GLN . 12.2 pt20 -110.48 126.57 54.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.786 -0.643 . . . . 2.2200000000000002 110.529 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.56 163.35 21.15 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.548 -0.751 . . . . 0.71999999999999997 110.046 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 45.9 p30 -87.06 165.93 15.41 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.47 0.653 . . . . 1.1499999999999999 110.97 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.573 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -77.16 27.91 1.71 Allowed Glycine 0 C--N 1.319 -0.409 0 CA-C-N 115.251 -0.886 . . . . 1.2 112.243 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 34' ' ' ASP . 20.5 t70 -127.22 -8.97 5.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.084 0.469 . . . . 1.8100000000000001 110.433 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.06 11.27 43.31 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.866 -0.683 . . . . 1.05 112.151 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.485 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 5.2 m-20 -106.42 148.25 28.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.823 0.344 . . . . 1.5700000000000001 110.195 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 31' ' ' ILE . 45.5 mm -84.22 129.45 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.548 -0.538 . . . . 1.1799999999999999 109.548 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.5 tp -96.91 -48.59 5.37 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.954 -0.388 . . . . 1.5600000000000001 109.954 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 31.5 tp60 -163.55 121.87 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.229 0.538 . . . . 2.4100000000000001 111.096 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -89.72 123.92 34.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.444 -0.947 . . . . 1.4199999999999999 108.444 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 121.218 0.532 . . . . 1.21 110.327 -177.468 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 112.183 -0.367 . . . . 3.2000000000000002 112.183 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 78' ' ' LYS . 23.5 ttmt 53.65 70.22 0.62 Allowed 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.691 0.758 . . . . 4.1399999999999997 109.543 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.634 ' HA ' HD11 ' A' ' 88' ' ' LEU . 71.7 t80 -50.1 -36.17 28.46 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.725 -1.125 . . . . 0.94999999999999996 113.071 -166.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -72.38 -25.01 61.35 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.123 0.487 . . . . 3.48 110.557 -173.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -82.19 -31.52 30.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.138 -0.69 . . . . 3.0699999999999998 109.138 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 1.014 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -64.3 -41.31 98.25 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.422 -0.808 . . . . 0.55000000000000004 111.753 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 79' ' ' PHE . 57.9 t -67.79 -47.13 80.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.907 -0.647 . . . . 0.84999999999999998 110.36 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.12 -32.07 63.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 1.1200000000000001 110.848 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 64.6 p -67.28 -32.85 74.12 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.118 -0.697 . . . . 1.8799999999999999 109.118 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.36 12.83 34.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.622 -0.717 . . . . 1.6599999999999999 112.828 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.584 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.4 p30 -175.23 69.98 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.764 0.792 . . . . 2.0800000000000001 110.224 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.014 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.3 tt -58.75 88.09 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.911 -1.04 . . . . 0.56000000000000005 111.233 174.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.2 t30 -143.08 101.63 3.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.935 -0.575 . . . . 2.0099999999999998 109.573 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.9 t -150.82 155.84 40.03 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 120.895 0.378 . . . . 1.6699999999999999 110.064 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.7 ptt? -134.5 116.69 15.38 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.586 -0.734 . . . . 3.9399999999999999 110.003 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -143.08 136.98 28.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.439 -0.8 . . . . 2.4700000000000002 109.263 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.3 pt-20 -100.18 118.57 36.79 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.396 -0.522 . . . . 1.97 110.485 177.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.9 t80 . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 108.803 -0.814 . . . . 4.29 108.803 179.134 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 120.711 0.291 . . . . 3.1200000000000001 111.542 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 32.1 m -110.27 158.69 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 115.78 -0.646 . . . . 1.23 109.869 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 24.1 ttmm -132.45 118.6 19.53 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.948 -0.569 . . . . 2.3599999999999999 109.474 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.3 t -95.87 104.96 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-N 116.445 -0.343 . . . . 1.1100000000000001 110.203 -176.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.662 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 3.4 t-160 -107.12 102.22 11.57 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.758 -1.201 . . . . 1.01 107.758 170.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.659 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 85.3 mtp -110.12 138.01 47.09 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.547 -1.279 . . . . 2.2200000000000002 107.547 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 14.2 ptmm? -144.09 135.33 25.59 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.86 -0.736 . . . . 1.73 110.373 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.648 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 46.0 tttm -55.88 116.41 2.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.797 0.808 . . . . 1.78 110.569 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.35 150.46 22.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.172 -1.376 . . . . 0.45000000000000001 110.716 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.48 -14.42 41.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.787 0.327 . . . . 2.3900000000000001 111.257 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.4 t -76.12 -24.76 54.94 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.048 0.451 . . . . 1.6599999999999999 110.326 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.57 -44.7 3.18 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.269 -0.491 . . . . 1.52 112.449 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.58 34.09 0.64 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.498 0.666 . . . . 2.79 111.673 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 34' ' ' ASP . 2.2 p -169.95 159.37 7.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.167 -0.924 . . . . 0.44 110.427 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.648 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 32.2 m-85 -141.31 145.3 35.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.714 0.292 . . . . 0.41999999999999998 110.297 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.426 ' O ' ' HA ' ' A' ' 109' ' ' MET . 40.8 m95 -93.23 165.64 12.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.46 0.647 . . . . 0.41999999999999998 111.853 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 31' ' ' ILE . 63.0 t -136.08 104.63 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.35 -1.295 . . . . 0.62 109.307 174.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.662 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 62.7 m-85 -106.63 104.79 14.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.463 -0.94 . . . . 1.49 108.463 174.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 12.2 p -105.09 135.48 42.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.25 0.548 . . . . 1.6100000000000001 110.929 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 81.6 mttt . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.822 -0.627 . . . . 3.4500000000000002 109.905 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.797 0 N-CA-C 111.756 -0.538 . . . . 1.4299999999999999 111.756 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.49 114.24 16.52 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.903 0.382 . . . . 0.69999999999999996 111.145 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.503 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 5.5 tt -118.58 140.63 41.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.429 -0.582 . . . . 0.90000000000000002 109.429 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.572 ' OE1' ' HB3' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -120.99 143.82 48.84 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.295 0.569 . . . . 2.2200000000000002 110.905 -175.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.48 160.93 33.76 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.062 -0.972 . . . . 0.71999999999999997 110.37 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 48.0 p30 -85.03 159.38 20.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.503 0.668 . . . . 1.1499999999999999 110.863 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.552 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -77.83 20.55 3.61 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.062 -0.972 . . . . 1.2 111.935 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -99.78 -39.84 8.02 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.813 -0.81 . . . . 1.8100000000000001 108.813 176.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.73 7.78 0.73 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.214 -0.993 . . . . 1.05 114.596 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -134.29 160.08 39.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.366 1.083 . . . . 1.5700000000000001 112.472 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 31' ' ' ILE . 75.9 mt -75.27 143.19 13.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.619 -1.173 . . . . 1.1799999999999999 110.656 -175.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.574 ' HG ' ' HG3' ' A' ' 41' ' ' GLN . 60.5 tp -119.48 -57.56 1.98 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.449 -0.341 . . . . 1.5600000000000001 111.275 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.574 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 94.8 mt-30 -126.81 145.22 50.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.329 . . . . 2.4100000000000001 111.332 -174.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.503 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 87.6 t80 -132.38 136.63 46.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 1.4199999999999999 110.835 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 1.21 109.556 176.734 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 110.597 -1.001 . . . . 3.2000000000000002 110.597 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt 57.47 46.08 18.6 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.135 -0.533 . . . . 4.1399999999999997 109.63 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.596 ' O ' HG23 ' A' ' 83' ' ' VAL . 65.6 t80 -44.81 -42.26 7.7 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 113.436 0.902 . . . . 0.94999999999999996 113.436 -166.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -68.68 -36.3 78.35 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.282 0.563 . . . . 3.48 110.395 -174.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.72 -30.79 28.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.527 -0.761 . . . . 3.0699999999999998 109.103 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.958 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.97 -43.84 92.87 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.458 -0.792 . . . . 0.55000000000000004 111.714 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.2 t -63.53 -52.56 56.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.565 -0.818 . . . . 0.84999999999999998 110.843 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.33 -26.1 35.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 1.1200000000000001 111.767 -170.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.6 t -67.61 -25.19 65.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.409 -0.589 . . . . 1.8799999999999999 109.409 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.41 78.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.87 -0.605 . . . . 1.6599999999999999 112.888 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.42 50.28 1.02 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.711 0.767 . . . . 2.0800000000000001 111.616 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.958 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.1 tt -70.73 89.7 0.75 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.259 -0.882 . . . . 0.56000000000000005 110.995 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.5 p30 -143.68 100.49 3.6 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.705 -0.85 . . . . 2.0099999999999998 108.705 169.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 3.1 p -141.52 152.68 44.35 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.945 -0.472 . . . . 1.6699999999999999 111.059 -174.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.665 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.5 ptm -120.07 116.49 25.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.6 0.714 . . . . 3.9399999999999999 109.775 173.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -119.55 122.47 41.69 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.885 -1.052 . . . . 2.4700000000000002 109.244 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 106' ' ' LYS . 49.2 mt-10 -92.86 130.47 38.45 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.423 -0.584 . . . . 1.97 109.423 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.6 t80 . . . . . 0 N--CA 1.449 -0.479 0 CA-C-N 115.973 -0.558 . . . . 4.29 110.356 -172.051 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttp . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 109.231 -0.655 . . . . 3.1200000000000001 109.231 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -106.16 161.62 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.189 -0.46 . . . . 1.23 111.207 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 19.4 ptpt -139.18 127.06 22.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.585 -0.734 . . . . 2.3599999999999999 109.292 176.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -92.91 144.89 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 C-N-CA 120.185 -0.606 . . . . 1.1100000000000001 110.623 175.408 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 5.2 t60 -131.69 102.8 6.04 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.43 -1.322 . . . . 1.01 107.43 164.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.676 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 11.2 ptp -101.88 123.72 46.29 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.664 -1.236 . . . . 2.2200000000000002 107.664 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 21.1 ptmt -138.08 133.36 33.38 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 120.435 -0.506 . . . . 1.73 110.941 -165.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.491 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 64.4 tttp -56.75 115.41 2.55 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.335 -0.848 . . . . 1.78 111.144 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.77 147.09 39.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.513 -1.221 . . . . 0.45000000000000001 110.425 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.19 -3.34 16.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.666 0.27 . . . . 2.3900000000000001 111.335 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 p -84.58 -17.82 37.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.705 0.288 . . . . 1.6599999999999999 111.366 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 127.64 -108.7 0.97 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.306 -0.95 . . . . 1.52 113.118 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -85.16 68.49 10.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.278 1.037 . . . . 2.79 110.956 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.552 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.7 p -158.52 154.09 26.14 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.668 -1.151 . . . . 0.44 108.719 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 50.1 m-85 -140.41 135.85 32.48 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.769 0.319 . . . . 0.41999999999999998 110.364 -175.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.546 ' O ' ' HA ' ' A' ' 109' ' ' MET . 39.7 m95 -87.1 161.4 18.14 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 120.861 0.362 . . . . 0.41999999999999998 110.086 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.4 t -140.01 95.88 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.215 -0.902 . . . . 0.62 108.938 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 108' ' ' HIS . 7.8 p90 -119.53 141.23 49.41 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.991 -0.684 . . . . 1.49 110.528 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 123' ' ' LYS . 12.1 p -123.53 151.98 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.68 -0.691 . . . . 1.6100000000000001 110.229 -175.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 123' ' ' LYS . 14.8 tptt . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 110.094 -0.336 . . . . 3.4500000000000002 110.094 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 111.919 -0.472 . . . . 1.4299999999999999 111.919 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.75 102.44 12.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.041 0.448 . . . . 0.69999999999999996 111.469 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.676 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 5.9 tt -137.61 141.85 38.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.978 -0.555 . . . . 0.90000000000000002 109.957 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.526 ' HB3' ' CE3' ' A' ' 119' ' ' TRP . 0.7 OUTLIER -120.27 140.72 50.8 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.223 0.535 . . . . 2.2200000000000002 110.811 -178.368 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.604 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.9 pp -134.71 162.85 31.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.439 -0.8 . . . . 0.71999999999999997 111.152 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.565 ' HB3' HD11 ' A' ' 40' ' ' LEU . 10.4 p30 -83.61 158.26 21.96 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.697 -0.683 . . . . 1.1499999999999999 110.876 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.573 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -72.83 2.15 34.69 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.311 -0.858 . . . . 1.2 112.191 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.44 -42.28 17.13 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.11 -0.7 . . . . 1.8100000000000001 109.11 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.59 28.32 0.69 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.179 -0.919 . . . . 1.05 112.355 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -133.86 150.11 51.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.769 0.318 . . . . 1.5700000000000001 110.23 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.604 HD13 ' HB3' ' A' ' 33' ' ' LEU . 12.1 mm -74.65 143.53 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 116.239 -0.437 . . . . 1.1799999999999999 110.443 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' A' ' 34' ' ' ASP . 85.7 mt -113.86 -50.89 2.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.837 0.351 . . . . 1.5600000000000001 111.104 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -142.45 136.17 29.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.23 -0.441 . . . . 2.4100000000000001 110.258 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.676 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 61.7 t80 -130.28 135.67 48.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.164 -0.471 . . . . 1.4199999999999999 110.205 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.389 -0.368 . . . . 1.21 110.382 -178.01 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 N-CA-C 111.588 -0.605 . . . . 3.2000000000000002 111.588 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 18.4 tptm 60.35 35.68 20.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.173 0.511 . . . . 4.1399999999999997 110.315 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.746 ' HA ' HD11 ' A' ' 88' ' ' LEU . 62.0 t80 -48.8 -37.67 19.88 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.562 -0.745 . . . . 0.94999999999999996 112.733 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -70.47 -36.87 74.11 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 123.576 0.547 . . . . 3.48 110.123 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.731 ' HB3' ' HG3' ' A' ' 78' ' ' LYS . 41.0 tt0 -80.55 -31.87 36.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.586 -0.734 . . . . 3.0699999999999998 109.18 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.982 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.5 -46.25 93.4 Favored Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 115.666 -0.697 . . . . 0.55000000000000004 111.88 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.4 t -69.15 -46.46 77.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.696 -0.752 . . . . 0.84999999999999998 110.578 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.6 -28.84 63.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.864 -0.607 . . . . 1.1200000000000001 110.555 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -69.69 -23.91 63.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.414 -0.812 . . . . 1.8799999999999999 109.265 174.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.93 19.58 69.84 Favored Glycine 0 CA--C 1.505 -0.539 0 CA-C-N 115.685 -0.688 . . . . 1.6599999999999999 112.198 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -163.4 55.57 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.246 0.546 . . . . 2.0800000000000001 111.29 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.982 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.1 tt -68.65 88.95 0.36 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.771 -0.649 . . . . 0.56000000000000005 111.081 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.758 ' HA ' ' O ' ' A' ' 109' ' ' MET . 20.4 t30 -143.15 100.45 3.64 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.284 -0.636 . . . . 2.0099999999999998 109.284 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.9 t -156.06 158.08 37.17 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.999 0.428 . . . . 1.6699999999999999 110.687 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 19.5 ptt? -125.77 126.16 44.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.772 -0.649 . . . . 3.9399999999999999 110.447 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.55 ' O ' HG22 ' A' ' 107' ' ' VAL . 90.1 t80 -146.08 130.16 17.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.676 -0.693 . . . . 2.4700000000000002 109.795 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.774 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 12.9 pt-20 -104.62 127.1 52.27 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.046 0.451 . . . . 1.97 110.222 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 10.8 p90 . . . . . 0 N--CA 1.447 -0.61 0 CA-C-O 121.794 0.807 . . . . 4.29 109.154 178.622 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.4 tttm . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 109.552 -0.536 . . . . 3.1200000000000001 109.552 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.4 159.89 8.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.008 -0.996 . . . . 1.23 111.588 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.774 ' HG3' ' HB3' ' A' ' 93' ' ' GLU . 25.0 ttpp -146.11 115.0 6.92 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.461 -0.791 . . . . 2.3599999999999999 109.213 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 122' ' ' VAL . 12.9 m -88.54 144.56 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-O 121.373 0.606 . . . . 1.1100000000000001 111.414 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.417 ' O ' ' HD1' ' A' ' 121' ' ' PHE . 5.1 t60 -132.33 103.32 6.15 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 106.858 -1.534 . . . . 1.01 106.858 160.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.758 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 79.5 mtp -103.7 132.14 50.23 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.108 -1.442 . . . . 2.2200000000000002 107.108 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HG2' ' HB2' ' A' ' 119' ' ' TRP . 61.7 pttt -138.59 131.62 29.76 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.709 -0.796 . . . . 1.73 110.087 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.43 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 80.8 tttt -56.57 113.05 1.45 Allowed 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.784 -0.644 . . . . 1.78 110.188 172.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -58.22 144.75 39.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.605 -1.18 . . . . 0.45000000000000001 110.866 -173.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 73.4 mt -71.23 -9.81 58.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.041 -0.527 . . . . 2.3900000000000001 110.846 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 p -73.13 -30.63 63.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.975 -0.557 . . . . 1.6599999999999999 111.057 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.6 -126.16 2.82 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.74 -0.743 . . . . 1.52 112.668 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.65 79.24 2.01 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.989 0.899 . . . . 2.79 110.853 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.573 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.1 p -168.07 156.16 8.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.532 -1.213 . . . . 0.44 108.457 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.43 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 31.6 m-85 -140.24 137.36 34.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.64 0.257 . . . . 0.41999999999999998 110.916 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.577 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . 45.1 m95 -83.64 162.81 20.65 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.227 0.536 . . . . 0.41999999999999998 110.817 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 50.9 t -137.23 97.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.744 -1.116 . . . . 0.62 109.659 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 89.8 m-85 -100.17 102.47 13.78 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.528 -0.545 . . . . 1.49 109.528 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 107' ' ' VAL . 3.7 m -97.84 106.47 18.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.516 0.674 . . . . 1.6100000000000001 110.026 176.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 N--CA 1.445 -0.712 0 O-C-N 121.963 -0.461 . . . . 3.4500000000000002 110.773 -172.709 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 111.864 -0.494 . . . . 1.4299999999999999 111.864 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.81 119.45 29.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.139 -0.319 . . . . 0.69999999999999996 110.139 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -111.64 138.71 39.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.988 0.423 . . . . 0.90000000000000002 110.604 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.655 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 6.4 pt20 -109.88 127.04 54.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.816 -0.629 . . . . 2.2200000000000002 110.343 176.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.444 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.8 pp -118.69 159.03 24.39 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.288 -0.869 . . . . 0.71999999999999997 109.577 177.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.771 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 1.9 p30 -84.24 151.59 24.71 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.174 -0.611 . . . . 1.1499999999999999 109.976 176.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -73.3 5.18 21.86 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.431 -0.804 . . . . 1.2 112.606 -175.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.09 -39.34 13.69 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.495 -0.557 . . . . 1.8100000000000001 109.495 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.79 36.99 0.19 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.611 -0.722 . . . . 1.05 111.935 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.771 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 19.0 m-80 -137.59 152.53 49.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.978 0.418 . . . . 1.5700000000000001 110.342 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.444 HD13 ' HB3' ' A' ' 33' ' ' LEU . 46.3 mm -95.14 123.28 47.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.879 -0.601 . . . . 1.1799999999999999 110.057 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.2 tp -102.59 -52.06 3.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.754 0.279 . . . . 1.5600000000000001 111.754 -173.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.642 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 46.8 tt0 -142.52 122.49 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.902 0.382 . . . . 2.4100000000000001 111.371 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -113.76 106.37 14.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.088 -0.506 . . . . 1.4199999999999999 109.668 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 121.137 0.494 . . . . 1.21 110.587 -179.034 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 111.123 -0.791 . . . . 3.2000000000000002 111.123 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 65.48 25.09 11.87 Favored 'General case' 0 C--O 1.223 -0.32 0 O-C-N 123.826 0.368 . . . . 4.1399999999999997 110.191 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 83' ' ' VAL . 44.8 t80 -55.87 -29.93 60.7 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 112.541 0.571 . . . . 0.94999999999999996 112.541 -167.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -81.4 -37.21 28.52 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.039 0.447 . . . . 3.48 110.204 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -78.72 -30.7 46.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.745 -0.835 . . . . 3.0699999999999998 108.745 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 1.012 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.51 -43.98 90.56 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.067 -0.969 . . . . 0.55000000000000004 111.873 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 79' ' ' PHE . 89.6 t -68.57 -52.56 35.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.424 -0.888 . . . . 0.84999999999999998 111.047 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.19 -28.97 38.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.936 -0.575 . . . . 1.1200000000000001 111.678 -169.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -72.07 -26.32 62.12 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.658 -0.867 . . . . 1.8799999999999999 108.658 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.6 18.43 70.79 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.249 -0.887 . . . . 1.6599999999999999 112.313 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -140.31 42.46 1.91 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.47 0.652 . . . . 2.0800000000000001 111.897 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.012 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -69.21 89.13 0.45 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.363 -0.835 . . . . 0.56000000000000005 111.609 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.716 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.1 p30 -143.95 100.9 3.65 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.453 -0.943 . . . . 2.0099999999999998 108.453 169.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 17.8 p -131.85 151.1 51.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 121.879 -0.513 . . . . 1.6699999999999999 111.12 -173.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 3.9 ppp? -118.79 129.34 55.19 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.647 -0.871 . . . . 3.9399999999999999 108.647 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.469 ' HE2' ' HD2' ' A' ' 94' ' ' TYR . 38.5 t80 -139.28 127.85 23.08 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.906 -0.588 . . . . 2.4700000000000002 109.463 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -90.62 107.3 19.08 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.764 -1.199 . . . . 1.97 107.764 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.469 ' HD2' ' HE2' ' A' ' 92' ' ' PHE . 43.1 t80 . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 121.157 0.503 . . . . 4.29 110.646 -173.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.0 tttm . . . . . 0 C--O 1.241 0.631 0 CA-C-O 120.69 0.281 . . . . 3.1200000000000001 110.87 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.5 161.03 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.93 -0.577 . . . . 1.23 110.391 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -113.92 115.79 28.24 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.094 -1.076 . . . . 2.3599999999999999 108.094 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' MET . 1.9 t -89.73 142.71 12.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 119.976 -0.689 . . . . 1.1100000000000001 109.321 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.597 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 3.8 t60 -140.47 103.51 4.57 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.437 -0.949 . . . . 1.01 108.437 167.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.716 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 61.5 mtt -92.19 140.68 29.38 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.045 -1.465 . . . . 2.2200000000000002 107.045 173.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -149.27 129.95 14.09 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.349 -0.94 . . . . 1.73 111.202 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.502 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 38.1 tttp -55.22 117.81 3.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.481 -1.236 . . . . 1.78 110.435 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.18 147.71 9.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.783 -1.099 . . . . 0.45000000000000001 111.256 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -62.03 -25.54 67.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.345 -0.389 . . . . 2.3900000000000001 111.297 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.0 p -79.59 -56.0 4.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.044 0.449 . . . . 1.6599999999999999 110.226 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.31 169.14 12.74 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.874 -0.679 . . . . 1.52 112.389 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.9 t70 60.32 28.86 18.5 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.243 1.02 . . . . 2.79 110.642 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.489 ' CB ' ' HA ' ' A' ' 34' ' ' ASP . 6.9 p -168.1 153.22 6.69 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.347 -1.297 . . . . 0.44 109.984 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 51.3 m-85 -140.98 139.68 34.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.226 -0.443 . . . . 0.41999999999999998 110.117 -175.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.655 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 40.6 m95 -87.77 161.4 17.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.192 0.52 . . . . 0.41999999999999998 111.448 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.518 HG22 ' HG2' ' A' ' 109' ' ' MET . 62.1 t -140.21 96.59 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.439 -1.255 . . . . 0.62 108.601 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 108' ' ' HIS . 5.4 p90 -124.58 140.1 53.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.241 -0.583 . . . . 1.49 110.213 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.5 m -113.1 162.78 10.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.171 0.51 . . . . 1.6100000000000001 111.342 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 79.4 tttt . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 115.421 -0.809 . . . . 3.4500000000000002 109.29 -179.087 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.277 -0.179 . . . . 1.4299999999999999 112.767 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.89 111.21 5.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.969 0.414 . . . . 0.69999999999999996 111.719 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.745 HG13 ' HA ' ' A' ' 42' ' ' TYR . 1.2 tt -131.9 140.44 48.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.368 -0.378 . . . . 0.90000000000000002 110.095 174.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.669 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 2.4 pt20 -108.27 130.8 55.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.42 0.629 . . . . 2.2200000000000002 110.201 172.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -120.06 158.14 27.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.185 -0.916 . . . . 0.71999999999999997 109.53 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.84 152.03 38.97 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.991 -0.55 . . . . 1.1499999999999999 109.788 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.606 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -79.28 37.6 2.01 Favored Glycine 0 CA--C 1.506 -0.509 0 CA-C-N 115.906 -0.588 . . . . 1.2 112.237 -172.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -140.47 -33.67 0.55 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.075 -0.562 . . . . 1.8100000000000001 110.484 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.97 11.75 0.49 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.459 -0.877 . . . . 1.05 113.183 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -106.07 144.71 32.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.151 -0.315 . . . . 1.5700000000000001 110.151 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.472 HD12 HD11 ' A' ' 31' ' ' ILE . 44.7 mm -75.59 134.99 28.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.645 -0.502 . . . . 1.1799999999999999 109.645 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.601 ' HB3' ' HG3' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -106.08 -62.69 1.34 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.938 -0.764 . . . . 1.5600000000000001 108.938 -174.23 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.626 ' HB3' ' HG2' ' A' ' 32' ' ' GLN . 39.9 tt0 -144.69 110.34 5.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.838 -1.074 . . . . 2.4100000000000001 110.359 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.745 ' HA ' HG13 ' A' ' 31' ' ' ILE . 19.2 t80 -100.06 110.78 23.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.008 -0.542 . . . . 1.4199999999999999 109.659 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 120.847 0.356 . . . . 1.21 110.382 -177.162 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.519 0 N-CA-C 112.191 -0.364 . . . . 3.2000000000000002 112.191 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 81' ' ' GLU . 73.8 mmtt -138.43 33.57 2.28 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 109.088 -0.708 . . . . 4.1399999999999997 109.088 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.897 ' HA ' HD11 ' A' ' 88' ' ' LEU . 35.9 t80 -44.61 -47.35 10.39 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 114.094 1.146 . . . . 0.94999999999999996 114.094 -160.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -79.58 -30.25 41.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.656 0.741 . . . . 3.48 109.578 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 68.1 tt0 -73.7 -31.52 63.46 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.975 -1.011 . . . . 3.0699999999999998 108.274 176.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.817 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.27 -43.67 99.07 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.613 -1.176 . . . . 0.55000000000000004 111.259 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 79' ' ' PHE . 73.7 t -65.43 -47.68 85.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.368 -0.916 . . . . 0.84999999999999998 110.526 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.8 -31.05 56.72 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.779 -0.646 . . . . 1.1200000000000001 111.225 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.2 t -66.46 -34.26 77.53 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.264 -1.013 . . . . 1.8799999999999999 108.264 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.62 12.48 58.15 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.24 -0.891 . . . . 1.6599999999999999 111.699 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.561 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.3 p30 -162.28 59.13 0.23 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.572 0.701 . . . . 2.0800000000000001 111.475 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.897 HD11 ' HA ' ' A' ' 79' ' ' PHE . 1.4 tt -60.6 93.01 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.451 -0.795 . . . . 0.56000000000000005 110.746 172.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.729 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.1 t30 -140.63 101.52 4.11 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.662 -0.495 . . . . 2.0099999999999998 109.662 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 6.3 m -137.26 149.44 47.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.48 -0.327 . . . . 1.6699999999999999 110.202 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.0 ptt? -134.08 128.8 34.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.063 -0.517 . . . . 3.9399999999999999 109.865 175.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -161.83 154.01 19.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.964 -0.562 . . . . 2.4700000000000002 109.937 -174.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.741 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 37.1 mt-10 -110.8 112.21 23.92 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.67 -0.493 . . . . 1.97 109.67 176.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 36.5 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 4.29 111.421 -177.405 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 104' ' ' LYS . 5.2 ttmp? . . . . . 0 N--CA 1.446 -0.635 0 CA-C-O 120.742 0.305 . . . . 3.1200000000000001 110.418 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 17.3 m -109.45 159.48 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.903 -0.59 . . . . 1.23 111.324 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.741 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -108.85 113.43 26.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.827 -1.175 . . . . 2.3599999999999999 107.827 175.472 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 91' ' ' MET . 3.5 m -100.45 144.86 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 C-N-CA 119.872 -0.731 . . . . 1.1100000000000001 112.138 -178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.3 t-160 -135.9 102.19 4.98 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.335 -1.302 . . . . 1.01 107.497 164.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.729 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 63.1 mtt -100.92 116.33 32.52 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.459 -1.682 . . . . 2.2200000000000002 106.459 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 58.8 pttt -132.14 136.64 47.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.218 -0.993 . . . . 1.73 110.999 -168.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.634 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 35.1 tttm -55.6 119.56 5.88 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.138 -0.937 . . . . 1.78 110.57 170.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.84 146.85 13.04 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.119 -0.946 . . . . 0.45000000000000001 110.159 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.5 tp -61.96 -25.23 67.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.547 -0.297 . . . . 2.3900000000000001 110.744 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.9 m -76.48 -67.42 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.363 -0.38 . . . . 1.6599999999999999 110.749 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 143.89 161.93 9.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.63 -0.795 . . . . 1.52 112.447 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 t70 54.57 37.43 27.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.445 1.117 . . . . 2.79 111.003 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.606 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 5.5 p -167.8 150.41 5.77 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.346 -1.297 . . . . 0.44 108.962 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.634 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 57.2 m-85 -141.66 141.57 33.37 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.702 0.287 . . . . 0.41999999999999998 110.416 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.669 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 46.3 m95 -90.58 165.73 13.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.457 0.646 . . . . 0.41999999999999998 111.391 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.61 96.07 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.308 -1.314 . . . . 0.62 108.877 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.511 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 45.8 m-85 -92.71 132.24 37.1 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.613 -0.884 . . . . 1.49 108.613 172.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.459 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 8.2 p -144.75 137.03 21.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.788 0.328 . . . . 1.6100000000000001 110.636 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 CA--C 1.52 -0.206 0 N-CA-C 109.85 -0.426 . . . . 3.4500000000000002 109.85 -178.488 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 110.862 -0.895 . . . . 1.4299999999999999 110.862 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.42 102.42 15.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.304 0.573 . . . . 0.69999999999999996 112.148 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.568 HG13 ' HA ' ' A' ' 42' ' ' TYR . 5.4 tt -124.44 139.7 49.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.695 -0.684 . . . . 0.90000000000000002 109.383 172.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.551 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -116.65 137.12 52.42 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.62 0.724 . . . . 2.2200000000000002 111.844 -176.584 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.914 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.6 pp -126.86 165.34 19.52 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.824 -1.08 . . . . 0.71999999999999997 110.31 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 14.8 p30 -97.2 158.66 15.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.302 0.573 . . . . 1.1499999999999999 110.211 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.629 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -79.49 26.27 2.68 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.539 -0.755 . . . . 1.2 111.725 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 34' ' ' ASP . 5.7 t70 -104.91 -18.59 14.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.203 0.525 . . . . 1.8100000000000001 109.691 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.44 3.73 5.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.312 -0.946 . . . . 1.05 114.209 171.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -144.81 159.84 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.97 0.885 . . . . 1.5700000000000001 111.979 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.914 HD13 ' HB3' ' A' ' 33' ' ' LEU . 7.5 mm -70.06 146.79 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.066 -0.97 . . . . 1.1799999999999999 109.747 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.503 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 46.8 tp -112.41 -46.17 3.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.219 -0.446 . . . . 1.5600000000000001 110.666 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -147.08 119.98 8.72 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.288 0.566 . . . . 2.4100000000000001 111.929 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.568 ' HA ' HG13 ' A' ' 31' ' ' ILE . 68.4 t80 -98.16 134.69 40.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.927 -0.578 . . . . 1.4199999999999999 109.564 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.865 0.364 . . . . 1.21 110.786 -177.384 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 N-CA-C 111.293 -0.723 . . . . 3.2000000000000002 111.293 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 81' ' ' GLU . 58.7 mtpt 63.26 86.06 0.12 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.605 0.717 . . . . 4.1399999999999997 110.44 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.629 ' HZ ' ' HA2' ' A' ' 35' ' ' GLY . 92.4 t80 -74.5 -51.49 14.62 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.068 -0.969 . . . . 0.94999999999999996 111.083 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -61.7 -30.84 71.01 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 123.861 0.726 . . . . 3.48 110.217 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 8.3 tp10 -75.3 -37.36 60.89 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.584 -0.895 . . . . 3.0699999999999998 108.584 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.978 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.13 -42.27 97.01 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 115.227 -0.897 . . . . 0.55000000000000004 111.396 176.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.8 t -63.24 -50.01 80.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.296 -0.952 . . . . 0.84999999999999998 110.685 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.75 -27.82 55.5 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.883 -0.599 . . . . 1.1200000000000001 111.036 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.0 m -65.17 -25.58 67.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.471 -0.566 . . . . 1.8799999999999999 109.471 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.38 22.58 70.09 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.729 -0.669 . . . . 1.6599999999999999 112.467 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.647 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 8.8 p30 -165.54 48.66 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.37 0.605 . . . . 2.0800000000000001 111.606 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.978 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.6 tt -58.28 93.81 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.382 -0.826 . . . . 0.56000000000000005 111.991 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.694 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.6 p30 -145.71 100.61 3.45 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.202 -0.666 . . . . 2.0099999999999998 109.202 172.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 91' ' ' MET . 3.7 m -149.43 154.14 38.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.552 -0.717 . . . . 1.6699999999999999 110.145 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.589 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 24.0 ptt? -109.05 123.85 49.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.051 0.453 . . . . 3.9399999999999999 110.242 172.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -122.88 112.31 17.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.034 -0.728 . . . . 2.4700000000000002 109.034 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 31.1 mt-10 -105.8 106.52 17.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.391 -0.368 . . . . 1.97 110.209 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 24.1 p90 . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 121.42 0.628 . . . . 4.29 111.081 -177.604 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.672 -0.492 . . . . 3.1200000000000001 109.672 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 28.2 m -101.36 157.51 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.45 0.643 . . . . 1.23 110.866 175.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -134.24 117.68 16.75 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.313 -0.858 . . . . 2.3599999999999999 109.164 176.55 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.1 t -94.99 105.47 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.904 0 CA-C-N 115.824 -0.626 . . . . 1.1100000000000001 109.958 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.0 t-160 -101.57 102.64 13.4 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.268 -1.382 . . . . 1.01 107.268 169.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.694 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 67.4 mtp -91.32 145.7 24.43 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.076 -1.083 . . . . 2.2200000000000002 108.076 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -148.5 119.19 7.5 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.84 -0.744 . . . . 1.73 109.385 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.647 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 68.9 tttt -55.4 122.94 12.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.473 0.654 . . . . 1.78 111.043 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.26 146.14 52.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.745 -1.116 . . . . 0.45000000000000001 110.436 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.44 4.34 11.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.026 0.441 . . . . 2.3900000000000001 110.878 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.0 t -79.01 -55.94 4.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.989 -0.55 . . . . 1.6599999999999999 109.764 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 134.02 126.5 2.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.81 -0.71 . . . . 1.52 112.654 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.86 35.47 25.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.84 0.828 . . . . 2.79 111.074 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.2 p -141.0 151.46 44.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.202 -1.363 . . . . 0.44 108.793 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.559 ' CE1' HG22 ' A' ' 83' ' ' VAL . 25.8 m-85 -142.88 136.99 29.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.397 -0.365 . . . . 0.41999999999999998 110.271 -173.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.551 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 50.2 m95 -86.09 164.63 17.19 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.448 0.642 . . . . 0.41999999999999998 110.961 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.574 HG12 HG13 ' A' ' 122' ' ' VAL . 57.7 t -134.76 97.26 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.264 -1.335 . . . . 0.62 108.472 175.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 52.9 m-85 -96.35 101.54 13.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.454 -0.943 . . . . 1.49 108.454 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.574 HG13 HG12 ' A' ' 120' ' ' VAL . 24.9 m -99.85 162.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.547 0.689 . . . . 1.6100000000000001 111.533 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.468 ' HB3' ' CG ' ' A' ' 106' ' ' LYS . 56.9 tptt . . . . . 0 C--N 1.313 -0.979 0 CA-C-N 114.638 -1.165 . . . . 3.4500000000000002 108.757 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 119.931 -0.371 . . . . 1.4299999999999999 113.686 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.47 102.28 11.76 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.473 0.636 . . . . 0.69999999999999996 111.18 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.525 HG13 ' HA ' ' A' ' 42' ' ' TYR . 4.4 tt -133.6 141.33 44.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.322 -0.399 . . . . 0.90000000000000002 110.561 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.579 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 10.0 pt20 -113.88 135.01 54.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.27 0.557 . . . . 2.2200000000000002 111.304 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.726 ' HB3' HD13 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -126.8 166.38 17.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.471 -0.786 . . . . 0.71999999999999997 110.339 175.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.462 ' HA ' ' CB ' ' A' ' 117' ' ' SER . 3.3 p30 -92.06 158.3 16.3 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.876 -0.602 . . . . 1.1499999999999999 110.576 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -81.05 11.97 39.62 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.337 -0.847 . . . . 1.2 112.082 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -90.94 -25.44 19.77 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.173 -0.677 . . . . 1.8100000000000001 109.173 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.36 23.61 2.85 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.354 -0.839 . . . . 1.05 112.395 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -132.52 155.56 48.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.124 -0.324 . . . . 1.5700000000000001 110.124 -177.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.726 HD13 ' HB3' ' A' ' 33' ' ' LEU . 36.6 mm -74.05 138.24 21.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.408 -0.96 . . . . 1.1799999999999999 108.408 171.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.433 ' H ' ' HA ' ' A' ' 33' ' ' LEU . 27.8 tp -105.21 -49.49 3.45 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.814 -0.354 . . . . 1.5600000000000001 110.806 -174.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -154.97 128.22 8.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 2.4100000000000001 110.999 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.525 ' HA ' HG13 ' A' ' 31' ' ' ILE . 66.0 t80 -98.63 119.66 37.73 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.917 -0.771 . . . . 1.4199999999999999 108.917 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 . . . . . 0 C--N 1.324 -0.538 0 CA-C-O 121.051 0.453 . . . . 1.21 111.716 -169.547 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.889 0 N-CA-C 111.88 -0.488 . . . . 3.2000000000000002 111.88 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt 65.25 18.24 11.32 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 123.656 0.268 . . . . 4.1399999999999997 111.704 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.556 ' O ' HG23 ' A' ' 83' ' ' VAL . 42.5 t80 -49.5 -33.92 15.77 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 111.617 0.229 . . . . 0.94999999999999996 111.617 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -62.36 -42.66 99.58 Favored 'General case' 0 C--N 1.34 0.191 0 O-C-N 124.103 0.877 . . . . 3.48 109.928 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -88.86 -23.16 22.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.775 -1.102 . . . . 3.0699999999999998 109.827 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.717 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -62.73 -43.75 98.5 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 115.923 -0.58 . . . . 0.55000000000000004 111.849 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 79' ' ' PHE . 84.5 t -66.98 -47.02 83.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.842 -0.679 . . . . 0.84999999999999998 110.34 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.77 -26.13 57.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.583 -0.735 . . . . 1.1200000000000001 110.734 -173.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 t -63.64 -33.45 75.65 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.806 -0.813 . . . . 1.8799999999999999 108.806 172.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.08 2.68 55.92 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.403 -0.817 . . . . 1.6599999999999999 112.114 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.631 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -171.42 66.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.511 0.672 . . . . 2.0800000000000001 111.401 -177.567 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.717 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -56.44 88.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.086 -0.961 . . . . 0.56000000000000005 110.888 171.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.754 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.9 t30 -143.43 101.54 3.8 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.695 -0.483 . . . . 2.0099999999999998 109.695 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -163.25 158.38 21.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.183 0.516 . . . . 1.6699999999999999 110.875 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.8 ptp -91.99 137.46 32.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.223 -0.899 . . . . 3.9399999999999999 108.941 170.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.565 ' O ' HG22 ' A' ' 107' ' ' VAL . 23.3 t80 -148.36 109.07 4.2 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.248 0.547 . . . . 2.4700000000000002 109.981 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.44 104.24 15.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.147 -0.479 . . . . 1.97 109.768 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.2 p90 . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 121.067 0.46 . . . . 4.29 110.923 -177.008 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.06 -0.718 . . . . 3.1200000000000001 109.06 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.21 155.46 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-O 121.34 0.591 . . . . 1.23 110.625 173.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.532 ' HB2' ' HG2' ' A' ' 123' ' ' LYS . 22.4 mtpp -128.97 105.58 8.31 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.25 -0.886 . . . . 2.3599999999999999 108.903 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 92' ' ' PHE . 5.2 m -105.08 144.37 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 C-N-CA 119.562 -0.855 . . . . 1.1100000000000001 112.177 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -117.61 103.11 9.73 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 105.674 -1.973 . . . . 1.01 105.674 156.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.754 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 9.1 ptp -106.28 128.4 53.94 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.081 -1.081 . . . . 2.2200000000000002 108.081 -178.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 21.6 ptmt -139.44 133.16 30.6 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.613 -0.435 . . . . 1.73 110.847 -167.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 86.0 tttt -56.82 108.38 0.5 Allowed 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.597 0.713 . . . . 1.78 110.719 171.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.428 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -53.7 137.38 37.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.104 -1.407 . . . . 0.45000000000000001 110.489 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.62 3.81 7.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.247 -0.433 . . . . 2.3900000000000001 110.93 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.9 m -80.91 -32.37 34.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 1.6599999999999999 111.102 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 139.2 112.78 1.06 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.734 -0.746 . . . . 1.52 113.111 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 t70 26.96 72.48 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.821 1.248 . . . . 2.79 113.079 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 111' ' ' LYS . 1.3 p -153.81 159.71 41.97 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.837 -1.912 . . . . 0.44 105.837 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.536 ' HE1' HG22 ' A' ' 83' ' ' VAL . 17.1 m-85 -136.32 134.89 38.42 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.819 -0.752 . . . . 0.41999999999999998 111.963 -175.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.579 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 41.9 m95 -85.89 165.85 16.46 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.746 -0.661 . . . . 0.41999999999999998 111.164 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.547 HG23 HD21 ' A' ' 33' ' ' LEU . 95.9 t -139.21 97.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.388 -1.278 . . . . 0.62 108.877 172.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.543 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 90.3 m-85 -93.14 101.92 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.394 -0.965 . . . . 1.49 108.394 170.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 123' ' ' LYS . 13.2 p -115.62 149.99 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.153 0.502 . . . . 1.6100000000000001 111.869 -172.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HG2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.465 0 N-CA-C 108.147 -1.057 . . . . 3.4500000000000002 108.147 173.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 122' ' ' VAL . . . . . . . . 0 N--CA 1.445 -0.735 0 N-CA-C 113.812 0.285 . . . . 1.4299999999999999 113.812 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.34 102.72 14.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.662 0.615 . . . . 0.69999999999999996 112.662 -166.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -126.49 139.9 50.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.11 -0.7 . . . . 0.90000000000000002 109.11 172.72 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.59 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.2 pp0? -115.33 136.35 53.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.411 0.624 . . . . 2.2200000000000002 111.366 -175.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -139.13 156.14 47.35 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.97 -1.014 . . . . 0.71999999999999997 110.231 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.894 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 4.9 p30 -86.3 155.13 20.78 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.399 0.619 . . . . 1.1499999999999999 110.673 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.59 14.48 17.68 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.375 -0.829 . . . . 1.2 111.871 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -100.97 -26.13 13.83 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.126 0.488 . . . . 1.8100000000000001 109.689 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.59 28.84 0.94 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.826 -0.702 . . . . 1.05 113.414 173.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 21.9 m-80 -133.53 142.19 48.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.245 0.522 . . . . 1.5700000000000001 111.13 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.49 HG23 HD11 ' A' ' 31' ' ' ILE . 81.3 mt -87.3 131.0 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.953 -0.758 . . . . 1.1799999999999999 108.953 171.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' A' ' 34' ' ' ASP . 66.9 mt -108.31 -49.7 3.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.927 0.344 . . . . 1.5600000000000001 111.927 -171.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' HG12 ' A' ' 31' ' ' ILE . 60.3 tt0 -141.84 128.76 20.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.984 0.421 . . . . 2.4100000000000001 111.547 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -113.69 125.46 54.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.729 -0.668 . . . . 1.4199999999999999 110.328 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 1.21 110.411 -177.464 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 111.201 -0.76 . . . . 3.2000000000000002 111.201 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.5 tptt 68.57 10.54 7.94 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.016 0.436 . . . . 4.1399999999999997 109.903 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.822 ' HA ' HD11 ' A' ' 88' ' ' LEU . 44.4 t80 -45.92 -40.9 10.8 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 113.975 1.102 . . . . 0.94999999999999996 113.975 -165.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.951 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -63.94 -38.63 91.78 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 123.37 0.418 . . . . 3.48 110.421 -172.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.85 -27.89 20.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.695 -0.684 . . . . 3.0699999999999998 109.584 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.95 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -55.32 -40.32 75.74 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.695 -0.684 . . . . 0.55000000000000004 112.103 -177.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.3 t -65.37 -53.39 40.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.533 -0.834 . . . . 0.84999999999999998 110.954 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.67 -22.79 32.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.263 -0.426 . . . . 1.1200000000000001 111.637 -171.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.6 t -70.86 -22.32 62.31 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.954 -0.758 . . . . 1.8799999999999999 108.954 172.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.83 26.83 73.32 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.375 -0.83 . . . . 1.6599999999999999 112.241 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.489 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 29.1 p30 -158.37 44.8 0.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.229 0.538 . . . . 2.0800000000000001 111.72 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.95 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -66.06 86.4 0.1 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.151 -0.932 . . . . 0.56000000000000005 111.777 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 109' ' ' MET . 2.6 t-20 -144.56 100.69 3.56 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.813 -0.355 . . . . 2.0099999999999998 110.296 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.8 m -146.0 145.98 30.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.817 -0.438 . . . . 1.6699999999999999 109.817 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.82 116.4 28.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.345 0.593 . . . . 3.9399999999999999 109.609 170.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -133.62 154.55 50.81 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.274 -0.875 . . . . 2.4700000000000002 109.136 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.828 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 7.6 pt-20 -131.28 123.05 27.53 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.78 -0.452 . . . . 1.97 109.78 174.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.2 t80 . . . . . 0 N--CA 1.445 -0.68 0 CA-C-N 115.57 -0.741 . . . . 4.29 110.251 -175.766 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.8 tttp . . . . . 0 C--O 1.239 0.525 0 CA-C-O 120.608 0.242 . . . . 3.1200000000000001 110.379 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 27.6 m -105.67 160.74 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.361 0.601 . . . . 1.23 111.557 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.828 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 19.6 mmmt -117.46 141.14 48.69 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.152 -0.931 . . . . 2.3599999999999999 109.5 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.2 102.32 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.113 0.482 . . . . 1.1100000000000001 110.15 173.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.803 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 2.3 t60 -108.91 102.82 11.8 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.652 -1.24 . . . . 1.01 107.652 171.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 59.8 mtp -108.78 143.75 37.52 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.709 -0.849 . . . . 2.2200000000000002 108.709 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -147.55 133.88 19.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.974 -0.69 . . . . 1.73 110.5 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.598 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 84.0 tttt -55.9 111.59 0.97 Allowed 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 114.879 -1.055 . . . . 1.78 110.334 173.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.26 146.32 54.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.775 -1.102 . . . . 0.45000000000000001 110.898 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.24 -6.83 25.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.983 -0.553 . . . . 2.3900000000000001 110.709 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.496 ' HB2' ' OG ' ' A' ' 117' ' ' SER . 6.5 m -69.96 -29.41 66.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.746 -0.661 . . . . 1.6599999999999999 110.617 176.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.16 -68.11 0.29 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.723 -0.751 . . . . 1.52 113.054 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -95.17 22.51 6.64 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.331 0.586 . . . . 2.79 111.503 -172.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.894 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.9 p -134.62 157.27 47.04 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.352 -0.84 . . . . 0.44 111.509 -173.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.598 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 48.3 m-85 -141.3 134.81 29.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.616 -0.72 . . . . 0.41999999999999998 109.387 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.59 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 47.1 m95 -83.42 164.23 20.06 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.08 0.466 . . . . 0.41999999999999998 110.673 -175.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 120' ' ' VAL . 15.0 p -138.34 97.18 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 122.581 1.181 . . . . 0.62 111.328 172.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.803 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 3.8 m-85 -86.69 102.29 14.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.516 -0.765 . . . . 1.49 109.094 177.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.58 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 25.4 m -100.88 153.58 4.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.157 0.503 . . . . 1.6100000000000001 111.49 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 16.7 tppt? . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.865 -0.607 . . . . 3.4500000000000002 109.679 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 122' ' ' VAL . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 112.529 -0.229 . . . . 1.4299999999999999 112.529 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -155.46 101.4 2.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.896 0.379 . . . . 0.69999999999999996 110.255 175.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.541 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 3.2 tt -139.25 141.02 36.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.234 -0.439 . . . . 0.90000000000000002 110.743 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.619 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.8 pt20 -110.81 126.33 54.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.322 0.582 . . . . 2.2200000000000002 110.518 174.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.85 153.05 41.62 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.645 -0.707 . . . . 0.71999999999999997 110.562 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.742 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -85.62 105.57 16.28 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.47 0.652 . . . . 1.1499999999999999 112.407 -171.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 1.04 ' H ' ' HA ' ' A' ' 117' ' ' SER . . . 37.77 23.7 0.02 OUTLIER Glycine 0 N--CA 1.468 0.768 0 CA-C-N 113.272 -1.786 . . . . 1.2 117.42 161.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 34' ' ' ASP . 12.9 t70 174.75 -57.17 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.926 0.863 . . . . 1.8100000000000001 111.756 -171.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.93 -31.35 0.03 OUTLIER Glycine 0 CA--C 1.524 0.655 0 C-N-CA 119.203 -1.475 . . . . 1.05 115.447 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.742 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 19.0 m-80 -67.84 116.33 8.39 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.728 1.264 . . . . 1.5700000000000001 111.141 -173.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -70.73 128.62 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.928 -0.578 . . . . 1.1799999999999999 110.616 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.7 tp -101.55 -47.58 4.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.75 -0.659 . . . . 1.5600000000000001 110.799 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -151.07 142.86 23.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 2.4100000000000001 111.401 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.541 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 69.1 t80 -130.5 138.5 50.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 1.4199999999999999 109.729 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 39.8 m-80 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.851 0.358 . . . . 1.21 111.437 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.513 0 CA-C-O 120.231 -0.205 . . . . 3.2000000000000002 112.595 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 58.38 25.15 12.5 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.73 -0.47 . . . . 4.1399999999999997 109.73 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.646 ' HA ' HD11 ' A' ' 88' ' ' LEU . 38.7 t80 -50.51 -37.0 36.66 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.671 -0.695 . . . . 0.94999999999999996 112.719 -165.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.48 -47.35 73.33 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 123.76 0.663 . . . . 3.48 110.343 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -82.35 -24.81 34.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.346 -0.612 . . . . 3.0699999999999998 109.346 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.93 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -57.66 -42.97 94.53 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.304 -0.719 . . . . 0.55000000000000004 111.304 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 79' ' ' PHE . 81.2 t -67.53 -53.85 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.434 -0.883 . . . . 0.84999999999999998 111.019 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.35 -28.0 52.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.159 -0.473 . . . . 1.1200000000000001 111.412 -169.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.0 t -66.98 -29.27 69.07 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.735 -0.839 . . . . 1.8799999999999999 108.735 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.6 28.36 39.43 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.65 -0.705 . . . . 1.6599999999999999 111.804 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -162.37 52.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.358 0.599 . . . . 2.0800000000000001 111.816 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.93 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -73.13 86.35 1.38 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.907 -0.588 . . . . 0.56000000000000005 110.658 177.111 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.2 t30 -143.9 102.35 3.88 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.619 -0.264 . . . . 2.0099999999999998 110.474 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 t -152.26 161.64 42.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.343 -0.39 . . . . 1.6699999999999999 110.194 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -127.04 146.71 50.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.892 -0.594 . . . . 3.9399999999999999 109.79 174.754 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -164.19 141.85 6.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.052 -0.522 . . . . 2.4700000000000002 109.802 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.502 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 44.5 mt-10 -103.01 113.14 26.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.361 -0.607 . . . . 1.97 109.361 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.8 t80 . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.456 . . . . 4.29 110.669 -172.956 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.502 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 15.0 ttpt . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.275 -0.639 . . . . 3.1200000000000001 109.275 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 34.2 m -102.31 160.01 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 121.257 0.551 . . . . 1.23 110.457 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 123' ' ' LYS . 38.1 ttpt -129.31 110.64 12.11 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.207 -1.034 . . . . 2.3599999999999999 108.207 172.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.8 m -98.86 144.68 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.485 0.66 . . . . 1.1100000000000001 112.112 -175.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -137.11 102.08 4.74 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.646 -1.242 . . . . 1.01 107.646 161.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.738 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -97.12 133.46 41.74 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.376 -1.342 . . . . 2.2200000000000002 107.376 173.942 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HG3' ' HB2' ' A' ' 119' ' ' TRP . 14.8 ptpt -142.06 134.72 28.34 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.228 -0.589 . . . . 1.73 111.271 -172.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 39.1 tttm -56.31 115.11 2.28 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.501 -0.772 . . . . 1.78 110.534 170.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.441 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -64.91 147.2 53.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.563 -1.198 . . . . 0.45000000000000001 111.431 -174.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.5 pt? -64.82 -10.11 25.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 2.3900000000000001 111.356 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.2 p -79.84 -4.84 53.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.25 -0.432 . . . . 1.6599999999999999 111.577 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.87 -122.82 6.72 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.638 -0.792 . . . . 1.52 112.229 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -72.15 85.63 1.04 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.547 0.689 . . . . 2.79 110.466 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . 1.04 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 3.5 p -176.16 152.46 1.15 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.703 -1.135 . . . . 0.44 108.295 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.556 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 39.3 m-85 -142.07 139.16 32.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.639 0.257 . . . . 0.41999999999999998 110.427 -176.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.619 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 46.1 m95 -88.39 166.81 14.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.488 0.661 . . . . 0.41999999999999998 111.453 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.95 96.5 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.348 -1.296 . . . . 0.62 109.046 173.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.449 ' HE1' ' HD2' ' A' ' 110' ' ' LYS . 90.2 m-85 -95.05 124.33 39.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.402 -0.592 . . . . 1.49 109.402 173.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.479 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 26.0 t -128.52 132.79 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.868 0.366 . . . . 1.6100000000000001 111.002 -176.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 106' ' ' LYS . 74.7 mmtt . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 109.71 -0.478 . . . . 3.4500000000000002 109.71 172.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' HA3' HG12 ' A' ' 122' ' ' VAL . . . . . . . . 0 N--CA 1.444 -0.803 0 N-CA-C 112.36 -0.296 . . . . 1.4299999999999999 112.36 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.57 102.15 4.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.886 0.374 . . . . 0.69999999999999996 110.363 173.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.595 HD11 HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -138.98 140.31 38.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.678 -0.489 . . . . 0.90000000000000002 109.678 178.02 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.749 ' HG2' ' HG2' ' A' ' 41' ' ' GLN . 3.7 pt20 -113.96 142.18 46.48 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.885 -0.726 . . . . 2.2200000000000002 111.083 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.62 ' HB3' HD13 ' A' ' 39' ' ' ILE . 4.0 pp -133.02 163.89 28.23 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.083 -0.962 . . . . 0.71999999999999997 110.094 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 2.1 p30 -90.05 151.83 21.45 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.131 0.491 . . . . 1.1499999999999999 110.423 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -70.26 -9.65 64.44 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.553 -0.749 . . . . 1.2 111.883 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.45 ' HB3' ' OD1' ' A' ' 34' ' ' ASP . 30.3 t70 -73.04 -36.11 66.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.172 -0.514 . . . . 1.8100000000000001 109.803 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.55 1.29 1.68 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.461 -0.876 . . . . 1.05 114.036 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.495 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 3.8 m-80 -107.44 158.39 17.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.34 0.57 . . . . 1.5700000000000001 111.023 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.62 HD13 ' HB3' ' A' ' 33' ' ' LEU . 45.9 mm -85.49 140.99 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.811 -0.811 . . . . 1.1799999999999999 108.811 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.553 HD23 ' NE2' ' A' ' 32' ' ' GLN . 29.9 tp -108.39 -54.21 2.54 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.361 -0.536 . . . . 1.5600000000000001 110.933 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.749 ' HG2' ' HG2' ' A' ' 32' ' ' GLN . 26.4 pt20 -147.98 141.82 25.75 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.351 -0.54 . . . . 2.4100000000000001 111.402 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.407 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 92.3 t80 -110.71 119.11 38.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.623 -0.717 . . . . 1.4199999999999999 109.203 175.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--N 1.315 -0.928 0 N-CA-C 108.394 -0.965 . . . . 1.21 108.394 -178.337 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 111.478 -0.649 . . . . 3.2000000000000002 111.478 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.5 pttt 42.59 47.77 4.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.432 0.693 . . . . 4.1399999999999997 111.219 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 83' ' ' VAL . 43.0 t80 -50.36 -34.88 25.62 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 115.529 -0.76 . . . . 0.94999999999999996 111.926 -171.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -66.72 -40.02 88.24 Favored 'General case' 0 C--N 1.344 0.338 0 O-C-N 123.813 0.695 . . . . 3.48 110.484 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -80.01 -31.42 39.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.098 -0.704 . . . . 3.0699999999999998 109.098 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.854 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.37 -43.66 97.2 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.559 -0.746 . . . . 0.55000000000000004 111.962 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 79' ' ' PHE . 99.3 t -64.6 -49.32 81.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.77 -0.715 . . . . 0.84999999999999998 110.518 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.37 -24.48 39.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 1.1200000000000001 111.413 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -65.35 -32.95 74.86 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.519 -0.548 . . . . 1.8799999999999999 109.519 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.3 16.43 66.82 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.881 -0.676 . . . . 1.6599999999999999 111.751 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -162.34 57.27 0.23 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.527 0.68 . . . . 2.0800000000000001 110.861 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.854 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.5 tt -65.08 81.41 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.627 -0.715 . . . . 0.56000000000000005 110.952 175.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 14.5 t30 -144.51 98.25 3.17 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.233 -0.654 . . . . 2.0099999999999998 109.233 175.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 91' ' ' MET . 6.4 m -153.29 153.83 33.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.808 -0.441 . . . . 1.6699999999999999 109.808 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.436 ' N ' HG22 ' A' ' 90' ' ' THR . 17.7 ptm -101.01 116.14 32.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.349 -0.612 . . . . 3.9399999999999999 109.349 167.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -114.86 109.95 18.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.794 -0.639 . . . . 2.4700000000000002 109.873 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 9.4 pt-20 -104.39 114.57 28.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.063 0.459 . . . . 1.97 110.495 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 85.9 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.587 -0.733 . . . . 4.29 110.188 -176.976 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm . . . . . 0 C--O 1.236 0.369 0 N-CA-C 110.166 -0.309 . . . . 3.1200000000000001 110.166 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 31.5 m -101.33 159.2 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 120.792 0.33 . . . . 1.23 110.361 172.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 43.6 mttp -127.26 123.33 36.23 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.157 -0.474 . . . . 2.3599999999999999 110.702 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.47 102.85 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 109.229 -0.656 . . . . 1.1100000000000001 109.229 173.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.752 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 3.3 t-160 -94.33 102.48 14.48 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.389 -1.708 . . . . 1.01 106.389 168.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 10.7 ttt -120.34 114.93 22.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.048 -1.093 . . . . 2.2200000000000002 108.048 -173.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 64.6 pttt -134.16 135.44 43.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 120.048 -0.661 . . . . 1.73 110.418 -169.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 65.4 tttp -57.21 114.4 2.15 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.765 -0.652 . . . . 1.78 110.602 175.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.68 145.45 49.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.774 -1.103 . . . . 0.45000000000000001 110.709 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.22 -13.08 61.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.208 -0.451 . . . . 2.3900000000000001 110.478 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.5 m -61.84 -31.57 71.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.968 -0.56 . . . . 1.6599999999999999 110.236 173.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 129.1 -96.82 0.4 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.575 -0.821 . . . . 1.52 113.03 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -88.68 49.02 1.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.603 0.716 . . . . 2.79 111.088 -171.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.0 p -147.43 159.37 43.79 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.503 -0.771 . . . . 0.44 109.968 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.556 ' CD2' ' HB3' ' A' ' 88' ' ' LEU . 36.1 m-85 -137.53 137.83 39.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.544 -0.298 . . . . 0.41999999999999998 110.426 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.617 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 44.0 m95 -85.68 162.46 18.77 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.123 0.487 . . . . 0.41999999999999998 111.176 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.44 HG22 ' HE3' ' A' ' 109' ' ' MET . 50.5 t -135.02 97.56 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.864 -1.062 . . . . 0.62 109.485 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.752 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 70.8 m-85 -102.31 104.29 14.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.607 -0.886 . . . . 1.49 108.607 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.467 HG12 ' HA3' ' A' ' 29' ' ' GLY . 9.9 p -92.74 148.61 4.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.789 -0.365 . . . . 1.6100000000000001 110.576 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . 34.5 mtpt . . . . . 0 CA--C 1.507 -0.684 0 CA-C-N 116.167 -0.469 . . . . 3.4500000000000002 110.173 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.611 0 CA-C-O 120.246 -0.197 . . . . 1.4299999999999999 113.145 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.28 101.99 3.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.082 0.468 . . . . 0.69999999999999996 110.918 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.691 HG13 ' HA ' ' A' ' 42' ' ' TYR . 7.1 tt -130.14 141.25 46.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.111 -0.495 . . . . 0.90000000000000002 110.07 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.542 ' NE2' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -113.88 129.05 56.63 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 116.13 -0.486 . . . . 2.2200000000000002 109.91 -175.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.486 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.9 pp -126.0 157.55 37.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.156 0.503 . . . . 0.71999999999999997 110.842 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.436 ' HA ' ' CB ' ' A' ' 117' ' ' SER . 3.6 p30 -79.24 156.84 27.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.544 0.688 . . . . 1.1499999999999999 110.996 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.545 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -81.43 35.29 2.43 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.286 -0.87 . . . . 1.2 111.489 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -123.56 -24.6 4.52 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.064 0.459 . . . . 1.8100000000000001 110.048 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.57 7.5 4.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.722 -0.751 . . . . 1.05 113.291 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -126.94 159.49 33.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.129 0.49 . . . . 1.5700000000000001 110.879 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 33' ' ' LEU . 10.9 mm -70.65 142.43 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 109.598 -0.519 . . . . 1.1799999999999999 109.598 175.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.542 HD23 ' NE2' ' A' ' 32' ' ' GLN . 25.9 tp -109.01 -48.6 3.25 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.953 -0.388 . . . . 1.5600000000000001 109.953 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -153.84 114.49 4.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 2.4100000000000001 110.998 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.691 ' HA ' HG13 ' A' ' 31' ' ' ILE . 55.7 t80 -86.33 130.68 34.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.079 -0.51 . . . . 1.4199999999999999 109.642 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 120.845 0.355 . . . . 1.21 110.356 -178.614 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.609 0 N-CA-C 111.49 -0.644 . . . . 3.2000000000000002 111.49 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' ' HB2' ' A' ' 81' ' ' GLU . 41.0 tttp 60.18 34.5 21.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.668 0.747 . . . . 4.1399999999999997 109.037 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.51 ' O ' HG23 ' A' ' 83' ' ' VAL . 20.2 t80 -63.24 -41.3 99.06 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.105 -0.952 . . . . 0.94999999999999996 112.109 -168.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -63.21 -34.67 78.14 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.73 0.644 . . . . 3.48 110.353 -176.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HB2' ' HG2' ' A' ' 78' ' ' LYS . 45.8 mt-10 -83.39 -31.47 26.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.254 -0.43 . . . . 3.0699999999999998 109.928 175.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.926 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -57.86 -41.04 93.92 Favored Glycine 0 N--CA 1.436 -1.329 0 CA-C-N 115.716 -0.675 . . . . 0.55000000000000004 112.119 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 79' ' ' PHE . 81.5 t -69.64 -51.02 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.698 -0.751 . . . . 0.84999999999999998 110.914 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.58 -22.29 40.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.566 . . . . 1.1200000000000001 111.688 -170.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.6 p -69.03 -33.68 74.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.845 -0.798 . . . . 1.8799999999999999 108.845 172.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 111' ' ' LYS . . . 87.55 18.95 55.95 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.246 -0.888 . . . . 1.6599999999999999 111.004 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -162.55 59.21 0.22 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.665 0.745 . . . . 2.0800000000000001 110.976 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.926 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.3 tt -64.76 84.79 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.371 -0.831 . . . . 0.56000000000000005 110.346 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.74 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.2 t30 -142.56 101.39 3.87 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.815 -0.439 . . . . 2.0099999999999998 109.815 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.2 t -159.16 154.85 26.14 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.949 0.404 . . . . 1.6699999999999999 110.267 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -112.66 131.71 55.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.593 -0.73 . . . . 3.9399999999999999 109.776 177.417 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -140.37 131.96 27.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.684 -0.689 . . . . 2.4700000000000002 109.812 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -101.13 116.8 33.68 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.87 -0.419 . . . . 1.97 109.87 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.2 t80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.625 -0.716 . . . . 4.29 109.978 -174.395 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt . . . . . 0 N--CA 1.445 -0.707 0 N-CA-C 108.738 -0.838 . . . . 3.1200000000000001 108.738 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.1 m -101.07 157.73 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-O 121.152 0.501 . . . . 1.23 110.398 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 123' ' ' LYS . 63.8 tttp -136.07 105.56 6.09 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.523 -0.762 . . . . 2.3599999999999999 109.157 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.537 ' HB ' ' SD ' ' A' ' 109' ' ' MET . 0.8 OUTLIER -96.71 144.93 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 CA-C-O 121.257 0.551 . . . . 1.1100000000000001 111.883 -178.782 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -135.4 103.92 5.66 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.778 -1.193 . . . . 1.01 107.778 162.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.74 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 3.6 mpp? -92.31 143.94 25.89 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.234 -1.395 . . . . 2.2200000000000002 107.234 176.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.3 ptpt -146.18 135.41 22.8 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.103 -1.039 . . . . 1.73 111.429 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.592 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 57.3 tttp -55.19 114.74 1.9 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.048 -0.978 . . . . 1.78 109.557 167.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 116' ' ' ASP . . . -49.35 139.24 11.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.076 -0.965 . . . . 0.45000000000000001 110.98 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.0 mt -65.83 -15.74 63.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.145 -0.48 . . . . 2.3900000000000001 110.871 -176.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.4 m -62.68 -57.36 11.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 1.6599999999999999 110.067 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.3 -74.03 0.1 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.245 -0.742 . . . . 1.52 111.245 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 9.0 t70 -93.76 -167.52 1.71 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.579 -0.897 . . . . 2.79 108.579 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.545 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 37.0 p 60.4 155.67 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.47 1.108 . . . . 0.44 112.108 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.592 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 48.9 m-85 -136.55 138.36 41.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.53 -0.759 . . . . 0.41999999999999998 109.678 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.534 ' CD2' ' HB2' ' A' ' 32' ' ' GLN . 44.1 m95 -91.43 164.76 13.71 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.302 0.573 . . . . 0.41999999999999998 111.23 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.469 ' HB ' HG23 ' A' ' 31' ' ' ILE . 58.9 t -134.06 97.34 2.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.681 -1.145 . . . . 0.62 109.277 176.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -98.59 121.73 40.9 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.778 -0.823 . . . . 1.49 108.778 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.3 p -124.68 147.21 29.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.03 0.443 . . . . 1.6100000000000001 111.119 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 106' ' ' LYS . 51.6 mtpt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-N 115.86 -0.609 . . . . 3.4500000000000002 109.468 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 120.746 0.307 . . . . 8.7200000000000006 110.97 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.17 3.37 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.038 -0.727 . . . . 6.1799999999999997 109.038 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -155.24 139.65 16.77 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.577 -1.192 . . . . 6.1500000000000004 108.467 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.45 -15.7 45.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.522 -0.847 . . . . 1.4299999999999999 112.908 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -95.03 102.91 14.74 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.855 0.359 . . . . 0.69999999999999996 111.697 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.75 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -119.69 140.41 43.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.886 0.374 . . . . 0.90000000000000002 110.223 177.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.44 128.71 56.55 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.172 -0.677 . . . . 2.2200000000000002 109.172 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 pp -129.95 158.05 40.62 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.415 0.626 . . . . 0.71999999999999997 110.816 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -85.11 150.91 24.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.476 -0.784 . . . . 1.1499999999999999 110.424 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.572 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -80.44 32.27 2.35 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.79 -0.641 . . . . 1.2 112.696 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -126.24 -30.27 2.92 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.829 -0.434 . . . . 1.8100000000000001 109.829 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.23 10.44 0.84 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.99 -1.1 . . . . 1.05 114.404 171.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 3.8 p30 -118.92 139.39 51.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 118.009 0.905 . . . . 1.5700000000000001 111.998 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 31' ' ' ILE . 43.5 mm -75.52 139.21 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.709 -0.678 . . . . 1.1799999999999999 109.497 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 tp -106.95 -53.18 2.65 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.864 -0.335 . . . . 1.5600000000000001 111.018 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -153.85 145.06 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.406 -0.518 . . . . 2.4100000000000001 111.869 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.75 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 45.6 t80 -117.78 124.31 48.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.706 -0.679 . . . . 1.4199999999999999 109.633 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 35.0 m-80 -85.49 96.65 9.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.374 -0.376 . . . . 1.21 110.453 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 176.18 -32.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.028 -0.987 . . . . 2.5 109.552 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.91 90.31 4.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.653 -0.703 . . . . 4.0 110.778 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -147.45 40.46 1.02 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.024 0.916 . . . . 7.21 108.767 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.04 94.32 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.191 -1.368 . . . . 6.9699999999999998 110.427 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -78.85 87.05 4.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.478 0.656 . . . . 8.5899999999999999 110.199 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 pt -113.79 23.77 4.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.294 -0.866 . . . . 9.2400000000000002 111.29 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 51' ' ' GLY . 2.9 m -136.48 157.23 47.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.053 -0.522 . . . . 9.8200000000000003 109.813 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.404 ' N ' HG22 ' A' ' 50' ' ' THR . . . -112.63 45.97 1.24 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.513 -0.635 . . . . 9.6199999999999992 111.513 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -84.03 173.23 11.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.967 0.413 . . . . 12.720000000000001 110.915 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.5 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 29.4 t70 -87.51 111.2 40.03 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.711 -0.848 . . . . 8.2400000000000002 108.711 170.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 7.0 Cg_exo -74.65 19.89 0.45 Allowed 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.583 2.855 . . . . 8.1099999999999994 113.822 -172.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -99.05 32.2 2.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.636 0.732 . . . . 9.2400000000000002 109.778 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -96.42 -48.54 5.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.395 -0.821 . . . . 7.4000000000000004 110.614 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 58' ' ' ILE . 16.9 m -124.62 170.84 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.081 -0.508 . . . . 5.0599999999999996 110.883 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 57' ' ' VAL . 17.8 pt 50.73 166.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.49 1.516 . . . . 3.1699999999999999 114.275 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.48 39.98 95.61 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 114.584 -1.189 . . . . 3.2400000000000002 111.053 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' HB3' HG12 ' A' ' 39' ' ' ILE . 15.2 tppt? -105.31 101.99 11.5 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.025 0.44 . . . . 3.8500000000000001 111.147 -171.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -94.46 109.16 21.05 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.395 -0.965 . . . . 4.1799999999999997 108.395 171.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -90.31 96.54 10.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.469 0.652 . . . . 6.6600000000000001 110.854 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' A' ' 65' ' ' ASP . 9.2 p90 -78.05 155.43 30.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.044 -0.98 . . . . 8.1300000000000008 110.007 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -75.77 74.36 2.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.745 0.783 . . . . 10.050000000000001 111.04 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.497 ' HB2' ' CD1' ' A' ' 63' ' ' PHE . 38.7 t70 -86.03 5.29 34.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.291 -0.868 . . . . 7.9400000000000004 110.101 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.9 t 59.15 67.95 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.976 0.893 . . . . 9.3499999999999996 109.762 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.64 84.08 16.17 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.029 -0.987 . . . . 9.1600000000000001 110.328 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -87.53 3.44 6.35 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.518 2.145 . . . . 10.35 112.55 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.5 m -113.15 86.38 2.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.089 0.471 . . . . 11.49 111.076 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -130.15 56.81 1.73 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.954 -0.758 . . . . 10.949999999999999 108.954 169.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 64.92 11.8 7.3 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.952 -1.022 . . . . 11.56 112.144 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.7 t -149.36 83.78 6.39 Favored Pre-proline 0 C--N 1.323 -0.553 0 C-N-CA 120.905 -0.318 . . . . 10.960000000000001 110.96 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.22 -53.78 3.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.356 2.037 . . . . 10.68 110.44 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -93.23 120.42 33.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.37 -0.974 . . . . 11.76 108.37 166.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -65.99 117.37 8.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.677 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 50.4 -113.6 0.68 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.964 0.79 . . . . 7.5300000000000002 112.284 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.84 76.0 0.34 Allowed Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 120.591 -0.814 . . . . 3.2000000000000002 111.133 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 60.9 32.36 20.02 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 123.913 0.42 . . . . 4.1399999999999997 110.336 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.576 ' O ' HG23 ' A' ' 83' ' ' VAL . 67.4 t80 -50.21 -32.22 15.9 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.946 -0.57 . . . . 0.94999999999999996 111.606 -177.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -69.81 -34.08 73.22 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 123.802 0.689 . . . . 3.48 109.698 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -84.18 -31.44 25.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.585 -0.734 . . . . 3.0699999999999998 109.2 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.904 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -54.44 -41.15 71.49 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.371 -0.831 . . . . 0.55000000000000004 111.972 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 79' ' ' PHE . 96.6 t -65.23 -53.49 39.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.405 -0.897 . . . . 0.84999999999999998 110.942 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.43 -27.78 27.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.148 -0.478 . . . . 1.1200000000000001 111.655 -170.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 t -66.57 -27.21 67.55 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.014 -0.736 . . . . 1.8799999999999999 109.014 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.86 29.44 51.67 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.67 -0.695 . . . . 1.6599999999999999 112.469 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -157.18 48.65 0.43 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.61 0.719 . . . . 2.0800000000000001 111.519 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.904 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -74.82 79.71 2.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.4 -0.818 . . . . 0.56000000000000005 111.198 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.3 p-10 -144.09 101.11 3.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.478 0.656 . . . . 2.0099999999999998 109.528 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -147.42 147.8 30.62 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.806 -0.559 . . . . 1.6699999999999999 110.535 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -109.32 115.55 30.19 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.046 -0.724 . . . . 3.9399999999999999 109.046 169.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.519 ' HE2' ' HD2' ' A' ' 94' ' ' TYR . 84.1 t80 -132.17 126.97 34.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.804 -0.634 . . . . 2.4700000000000002 109.97 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 9.7 pt-20 -97.23 130.63 44.43 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.481 -0.563 . . . . 1.97 109.481 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.519 ' HD2' ' HE2' ' A' ' 92' ' ' PHE . 27.4 t80 -119.04 115.42 24.27 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.636 -0.505 . . . . 4.29 109.636 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -90.92 136.9 32.76 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.109 -0.496 . . . . 2.8900000000000001 110.245 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -105.33 95.07 5.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.783 -0.451 . . . . 5.25 109.783 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.21 28.01 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.3 0.572 . . . . 6.0599999999999996 110.562 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -100.31 -166.51 1.33 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.715 -0.675 . . . . 9.7699999999999996 110.204 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.11 -58.33 2.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.476 -0.329 . . . . 8.3399999999999999 110.549 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 96.4 mmm -95.74 33.4 1.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.764 0.316 . . . . 8.1899999999999995 111.692 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 p -101.42 164.82 15.21 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.899 0.333 . . . . 5.0999999999999996 111.899 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.78 -172.84 0.88 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.828 2.352 . . . . 4.5099999999999998 112.273 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.1 p -84.71 161.39 20.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.392 -0.367 . . . . 2.5899999999999999 111.756 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -64.64 112.02 3.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.689 -0.687 . . . . 3.1200000000000001 110.674 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 20.7 m -116.32 160.92 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.182 0.515 . . . . 1.23 111.353 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 85.8 tttt -125.03 123.98 40.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.31 -0.859 . . . . 2.3599999999999999 109.184 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.1 t -101.74 119.42 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 116.45 -0.341 . . . . 1.1100000000000001 110.34 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -106.79 104.33 13.98 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.22 -1.03 . . . . 1.01 108.22 168.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 55.0 mtm -97.5 145.57 26.08 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.276 -1.009 . . . . 2.2200000000000002 108.276 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.508 ' CG ' ' HB2' ' A' ' 119' ' ' TRP . 19.4 ptpt -146.42 127.07 14.24 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.384 -0.527 . . . . 1.73 109.827 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.507 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 51.6 tttm -57.34 113.57 1.81 Allowed 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 116.064 -0.516 . . . . 1.78 109.906 170.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.44 138.93 38.9 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.701 -1.136 . . . . 0.45000000000000001 110.485 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.5 mt -67.88 -8.58 37.69 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.245 -0.434 . . . . 2.3900000000000001 110.918 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 m -70.94 -38.61 72.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 1.6599999999999999 110.503 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.67 -105.76 0.34 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.73 -0.748 . . . . 1.52 112.81 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.29 65.05 7.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.597 0.713 . . . . 2.79 112.013 -175.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.572 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 1.7 p -157.67 157.97 34.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.922 -1.035 . . . . 0.44 108.506 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.509 ' OH ' ' HA ' ' A' ' 83' ' ' VAL . 28.9 m-85 -140.74 139.75 34.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.687 0.28 . . . . 0.41999999999999998 110.603 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.508 ' HB2' ' CG ' ' A' ' 110' ' ' LYS . 38.9 m95 -93.09 162.48 14.02 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.288 0.566 . . . . 0.41999999999999998 111.241 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.629 ' HB ' HG23 ' A' ' 31' ' ' ILE . 87.7 t -136.89 101.77 2.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.561 -1.199 . . . . 0.62 109.268 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -102.19 106.39 17.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.553 -0.536 . . . . 1.49 109.553 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 p -92.37 143.87 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.077 0.465 . . . . 1.6100000000000001 110.244 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -149.8 110.25 4.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.677 -0.49 . . . . 3.4500000000000002 109.677 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 7.7 ptm180 -77.06 143.68 39.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.648 -0.421 . . . . 4.2300000000000004 110.254 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.799 -0.637 . . . . 3.3399999999999999 109.517 177.703 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 1.007 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.999 0.428 . . . . 8.7200000000000006 110.61 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.63 -168.45 1.78 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.891 -0.595 . . . . 6.1799999999999997 109.967 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -95.91 -31.68 13.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.083 0.468 . . . . 6.1500000000000004 110.415 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.66 72.91 0.76 Allowed Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 121.062 -0.59 . . . . 1.4299999999999999 112.208 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.42 102.38 3.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.95 0.405 . . . . 0.69999999999999996 110.75 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.604 HG23 ' HB ' ' A' ' 120' ' ' VAL . 4.5 tt -132.02 141.07 46.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.927 0.394 . . . . 0.90000000000000002 110.672 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HB2' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -114.52 122.98 48.24 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.41 -0.959 . . . . 2.2200000000000002 108.41 177.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.46 164.06 29.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.864 -0.607 . . . . 0.71999999999999997 111.082 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.963 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 2.3 p30 -98.09 153.95 18.07 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.015 -0.539 . . . . 1.1499999999999999 110.981 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.0 -17.03 75.22 Favored Glycine 0 CA--C 1.511 -0.17 0 CA-C-N 115.173 -0.921 . . . . 1.2 112.628 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.53 -38.98 92.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.97 0.414 . . . . 1.8100000000000001 110.421 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.46 38.26 0.31 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.706 -0.759 . . . . 1.05 112.843 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.564 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 4.3 m-80 -134.25 147.96 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.976 -0.379 . . . . 1.5700000000000001 109.976 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.754 HG13 ' HB3' ' A' ' 60' ' ' LYS . 86.7 mt -87.33 134.73 26.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.936 -0.394 . . . . 1.1799999999999999 109.936 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 58' ' ' ILE . 45.0 tp -101.56 -41.45 6.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 1.5600000000000001 110.86 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -158.99 143.43 15.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.993 0.425 . . . . 2.4100000000000001 111.204 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.509 ' HB3' HG13 ' A' ' 57' ' ' VAL . 40.9 t80 -114.34 114.86 26.47 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.601 -0.889 . . . . 1.4199999999999999 108.601 174.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -91.61 91.59 8.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.168 0.509 . . . . 1.21 110.647 -173.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -170.2 13.04 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.89 -1.05 . . . . 2.5 109.12 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 48' ' ' ASP . . . -143.11 109.15 5.23 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.325 -0.852 . . . . 4.0 110.983 -174.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -137.6 97.55 3.48 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.758 -0.83 . . . . 7.21 108.758 172.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.87 -16.43 39.71 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.64 -0.984 . . . . 6.9699999999999998 110.64 -169.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.587 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 4.1 m-20 -78.26 104.63 8.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.441 -0.379 . . . . 8.5899999999999999 110.159 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.9 mm -103.1 132.96 48.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.395 -0.594 . . . . 9.2400000000000002 109.395 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.0 p -117.4 173.21 6.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.785 0.326 . . . . 9.8200000000000003 111.789 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.29 -108.41 1.89 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.791 -0.924 . . . . 9.6199999999999992 110.791 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -83.34 89.34 7.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.247 -0.649 . . . . 12.720000000000001 109.247 171.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 23.7 t70 -127.8 107.24 20.43 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.054 -0.521 . . . . 8.2400000000000002 110.829 -173.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 1.9 Cg_endo -83.4 36.94 0.63 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.505 2.803 . . . . 8.1099999999999994 113.467 -175.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.51 -175.62 5.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.865 0.364 . . . . 9.2400000000000002 110.42 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -100.0 25.35 7.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.398 0.618 . . . . 7.4000000000000004 110.466 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.509 HG13 ' HB3' ' A' ' 42' ' ' TYR . 42.6 t -76.7 88.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.399 -0.963 . . . . 5.0599999999999996 108.399 174.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 40' ' ' LEU 0.264 13.7 tt 37.85 73.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 122.982 1.372 . . . . 3.1699999999999999 111.963 -173.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.31 19.24 2.85 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 113.904 -1.498 . . . . 3.2400000000000002 111.673 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.754 ' HB3' HG13 ' A' ' 39' ' ' ILE . 16.9 tppt? -105.23 115.58 30.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.127 -0.323 . . . . 3.8500000000000001 110.127 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -125.17 94.85 4.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.191 0.52 . . . . 4.1799999999999997 110.636 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 64' ' ' LYS . 25.1 t80 34.82 79.09 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.756 -1.111 . . . . 6.6600000000000001 113.217 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -92.8 21.12 5.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.812 0.815 . . . . 8.1300000000000008 109.787 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 62.5 mttm -101.57 4.41 40.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.489 -0.778 . . . . 10.050000000000001 110.851 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -79.19 123.87 27.81 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.831 -0.433 . . . . 7.9400000000000004 109.831 177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.9 t 54.79 78.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.327 0 O-C-N 123.762 0.664 . . . . 9.3499999999999996 109.534 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.56 105.95 0.38 Allowed Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.261 -0.881 . . . . 9.1600000000000001 112.27 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.53 172.1 5.94 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.099 2.533 . . . . 10.35 113.233 -174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.8 124.08 21.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.758 -0.655 . . . . 11.49 109.441 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -165.2 159.08 17.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.338 -0.392 . . . . 10.949999999999999 110.1 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -137.13 74.44 1.48 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.591 0.71 . . . . 11.56 109.301 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.0 m -153.91 121.2 2.92 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 114.982 -1.008 . . . . 10.960000000000001 108.824 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.2 118.62 5.28 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.654 2.236 . . . . 10.68 112.607 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -80.1 43.65 0.63 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.053 -0.721 . . . . 11.76 109.053 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CZ ' ' HD3' ' A' ' 78' ' ' LYS . 76.0 t80 -83.99 -42.43 16.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.23 -0.895 . . . . 10.0 111.633 -170.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.565 ' HB2' ' HB2' ' A' ' 79' ' ' PHE . 94.8 m-85 52.22 -96.98 0.05 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.618 0.574 . . . . 7.5300000000000002 110.986 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -139.32 71.35 0.44 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.177 -1.169 . . . . 3.2000000000000002 110.177 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.529 ' HD3' ' CZ ' ' A' ' 75' ' ' PHE . 45.8 mmtm 67.12 31.65 6.65 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 123.987 0.463 . . . . 4.1399999999999997 110.293 -173.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.704 ' HA ' HD11 ' A' ' 88' ' ' LEU . 65.5 t80 -47.9 -36.86 12.94 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 112.245 0.461 . . . . 0.94999999999999996 112.245 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.39 -39.64 74.42 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.418 0.627 . . . . 3.48 109.963 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.08 -29.02 48.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.158 -0.928 . . . . 3.0699999999999998 108.917 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.86 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.82 -41.27 97.57 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.451 -0.795 . . . . 0.55000000000000004 111.516 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 79' ' ' PHE . 95.4 t -64.94 -51.83 61.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.431 -0.884 . . . . 0.84999999999999998 110.674 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.64 -24.69 49.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.062 -0.517 . . . . 1.1200000000000001 111.05 -172.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -65.21 -34.52 78.56 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.548 -0.908 . . . . 1.8799999999999999 108.548 172.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.73 15.57 61.32 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.25 -0.886 . . . . 1.6599999999999999 112.301 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -164.0 54.63 0.15 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.328 0.585 . . . . 2.0800000000000001 111.838 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.86 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -65.37 96.11 0.22 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.519 -0.764 . . . . 0.56000000000000005 111.547 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.6 p30 -145.05 108.53 4.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.32 0.581 . . . . 2.0099999999999998 110.283 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -142.2 162.42 35.53 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.098 -0.501 . . . . 1.6699999999999999 111.411 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.72 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 25.8 ptt? -151.5 116.08 5.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.815 0.816 . . . . 3.9399999999999999 110.285 169.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -149.89 144.32 25.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.949 -1.023 . . . . 2.4700000000000002 109.057 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.598 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 25.8 mt-10 -95.35 116.44 28.78 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.189 -0.671 . . . . 1.97 109.189 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -108.59 125.32 51.71 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.647 -0.706 . . . . 4.29 110.296 -172.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -96.91 150.31 20.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.833 -0.621 . . . . 2.8900000000000001 111.481 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 93.2 m-85 -112.39 110.93 21.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.752 -0.658 . . . . 5.25 109.637 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 11.6 t70 63.94 -168.14 0.21 Allowed 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.804 0.69 . . . . 6.0599999999999996 110.15 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.423 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 21.7 p90 -155.74 2.84 0.17 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.737 0.303 . . . . 9.7699999999999996 111.219 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -114.51 104.02 11.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.236 -0.438 . . . . 8.3399999999999999 109.956 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 56.0 mtm 62.05 18.38 9.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.12 -0.491 . . . . 8.1899999999999995 111.056 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.5 m -129.99 95.97 27.03 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.122 0.487 . . . . 5.0999999999999996 110.48 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -90.83 28.06 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.105 2.536 . . . . 4.5099999999999998 112.529 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 96' ' ' PHE . 8.2 m -75.59 99.06 4.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.295 0.569 . . . . 2.5899999999999999 110.904 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -122.47 133.82 54.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.76 -0.655 . . . . 3.1200000000000001 109.723 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.52 160.72 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.125 0.488 . . . . 1.23 110.824 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 13.9 ttmm -116.86 124.17 48.85 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.64 -0.874 . . . . 2.3599999999999999 108.64 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 91' ' ' MET . 1.1 m -109.32 104.32 16.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.167 0.508 . . . . 1.1100000000000001 111.494 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 6.1 t60 -109.84 105.1 14.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.723 -0.843 . . . . 1.01 108.723 172.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 53.6 mtm -117.86 144.31 45.52 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.815 -0.809 . . . . 2.2200000000000002 108.815 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -149.34 129.67 13.77 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.142 -0.623 . . . . 1.73 110.187 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 75.5 tttt -56.85 114.91 2.29 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.787 -0.642 . . . . 1.78 110.366 174.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.554 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -62.62 145.81 53.59 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.792 -1.095 . . . . 0.45000000000000001 110.251 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.571 ' H ' ' CD1' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -67.07 1.27 2.08 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.305 0.483 . . . . 2.3900000000000001 112.305 -177.478 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.6 t -91.6 6.24 46.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.799 0.333 . . . . 1.6599999999999999 110.95 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -108.12 3.64 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.633 -0.794 . . . . 1.52 112.035 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.93 87.23 2.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.371 0.605 . . . . 2.79 110.628 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.963 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.3 p 179.25 151.32 0.34 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.824 -1.08 . . . . 0.44 109.169 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.475 ' OH ' ' HA ' ' A' ' 83' ' ' VAL . 22.6 m-85 -147.11 136.45 22.66 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.549 -0.537 . . . . 0.41999999999999998 109.549 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.468 ' CD2' ' HB2' ' A' ' 32' ' ' GLN . 45.2 m95 -86.33 159.3 19.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.07 0.462 . . . . 0.41999999999999998 110.481 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.604 ' HB ' HG23 ' A' ' 31' ' ' ILE . 72.1 t -138.21 104.31 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.108 -0.951 . . . . 0.62 109.964 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.656 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 71.5 m-85 -110.4 116.75 31.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.0 -0.741 . . . . 1.49 109.0 175.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 18.1 m -115.79 154.62 17.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.551 0.691 . . . . 1.6100000000000001 111.355 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HE2' ' HE2' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -146.5 110.09 4.86 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.066 -0.97 . . . . 3.4500000000000002 109.077 178.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -85.71 126.85 34.28 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.029 -0.532 . . . . 4.2300000000000004 110.026 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 117.799 -1.096 . . . . 3.3399999999999999 111.461 179.044 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.977 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.962 0.41 . . . . 8.7200000000000006 111.753 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.81 92.19 8.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.003 0.43 . . . . 6.1799999999999997 110.52 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -103.06 -170.98 1.87 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.099 -0.5 . . . . 6.1500000000000004 110.895 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.62 37.94 1.67 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.781 -0.723 . . . . 1.4299999999999999 112.375 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.81 105.17 4.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.625 0.25 . . . . 0.69999999999999996 110.537 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.741 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 6.3 tt -133.52 140.37 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.196 0.522 . . . . 0.90000000000000002 111.097 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.58 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 3.2 pt20 -109.66 129.79 55.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.6 -0.727 . . . . 2.2200000000000002 110.548 176.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.29 159.03 36.53 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.513 -0.767 . . . . 0.71999999999999997 109.915 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 37.2 p30 -84.5 164.66 18.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.373 0.606 . . . . 1.1499999999999999 111.439 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.53 21.13 3.84 Favored Glycine 0 C--N 1.322 -0.249 0 CA-C-N 115.257 -0.883 . . . . 1.2 112.441 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.08 -26.55 8.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.804 0.335 . . . . 1.8100000000000001 110.329 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.45 11.61 7.22 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.907 -0.588 . . . . 1.05 111.86 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -109.53 143.59 38.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.892 0.377 . . . . 1.5700000000000001 110.421 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.763 HG21 ' HA ' ' A' ' 58' ' ' ILE . 51.2 mm -79.9 139.41 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.227 -0.657 . . . . 1.1799999999999999 109.227 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.3 tp -106.72 -52.31 2.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.628 -0.26 . . . . 1.5600000000000001 111.095 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -163.19 147.14 10.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 2.4100000000000001 111.336 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.741 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 49.0 t80 -114.27 151.23 33.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.01 -0.541 . . . . 1.4199999999999999 110.118 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -129.98 134.44 47.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.961 -0.563 . . . . 1.21 110.22 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.55 46.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.127 -0.488 . . . . 2.5 110.153 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.78 93.22 8.76 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.049 -0.26 . . . . 4.0 110.777 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 67.57 103.18 0.05 OUTLIER 'General case' 0 C--O 1.235 0.313 0 O-C-N 124.112 0.882 . . . . 7.21 111.5 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.17 35.97 0.16 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.442 -0.799 . . . . 6.9699999999999998 111.491 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -75.53 98.82 4.06 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.115 -0.328 . . . . 8.5899999999999999 110.115 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.9 pt 33.97 47.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.283 1.033 . . . . 9.2400000000000002 112.848 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.2 m -93.82 84.97 4.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.659 -0.701 . . . . 9.8200000000000003 110.576 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.83 -79.44 0.35 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.912 -0.661 . . . . 9.6199999999999992 111.806 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 mtt-85 -144.61 156.25 44.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.121 -0.696 . . . . 12.720000000000001 109.121 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -103.5 106.66 52.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.506 0.669 . . . . 8.2400000000000002 110.287 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.84 -29.27 3.52 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.579 2.186 . . . . 8.1099999999999994 112.266 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -127.65 113.18 15.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.958 -0.565 . . . . 9.2400000000000002 109.72 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -107.16 44.32 1.08 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.64 0.733 . . . . 7.4000000000000004 109.646 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.42 -35.74 71.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.29 -0.868 . . . . 5.0599999999999996 109.806 171.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.763 ' HA ' HG21 ' A' ' 39' ' ' ILE . 10.0 tt -73.4 146.99 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.893 -0.594 . . . . 3.1699999999999999 109.725 174.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.439 ' N ' HG12 ' A' ' 58' ' ' ILE . . . 100.92 -1.18 55.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.465 -0.874 . . . . 3.2400000000000002 111.711 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.54 ' HB3' HG12 ' A' ' 39' ' ' ILE . 1.7 tppp? -69.25 90.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 3.8500000000000001 110.036 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -125.78 95.63 4.49 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.971 -0.752 . . . . 4.1799999999999997 108.971 173.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.524 ' HD2' ' HD3' ' A' ' 60' ' ' LYS . 71.5 m-85 -148.37 129.91 14.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.956 -0.566 . . . . 6.6600000000000001 110.299 -174.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -98.75 1.98 46.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.172 0.51 . . . . 8.1300000000000008 110.142 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -96.05 -16.08 21.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.664 -0.698 . . . . 10.050000000000001 110.269 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.25 112.43 6.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.775 -0.648 . . . . 7.9400000000000004 110.335 -173.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.4 -28.96 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.328 -0.396 . . . . 9.3499999999999996 112.059 -174.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -38.22 110.27 0.54 Allowed Pre-proline 0 N--CA 1.471 0.597 0 N-CA-C 113.914 1.079 . . . . 9.1600000000000001 113.914 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.32 -33.07 4.54 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.046 2.497 . . . . 10.35 111.071 171.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.8 m 61.94 179.43 0.12 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.447 -0.797 . . . . 11.49 111.881 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.3 p -79.02 -46.18 18.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.113 -0.699 . . . . 10.949999999999999 109.113 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -78.95 109.98 13.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.591 -0.731 . . . . 11.56 109.271 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.5 t -69.65 137.55 88.18 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.332 -0.395 . . . . 10.960000000000001 111.153 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.37 160.7 13.07 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.088 2.525 . . . . 10.68 112.265 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.45 124.5 23.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 11.76 111.205 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -84.7 -4.01 58.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.056 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 54.15 -106.3 0.31 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.914 -0.585 . . . . 7.5300000000000002 111.43 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.72 60.03 0.37 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.676 -0.773 . . . . 3.2000000000000002 111.303 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 62.03 37.93 14.46 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.654 0.382 . . . . 4.1399999999999997 110.268 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.663 ' HA ' HD11 ' A' ' 88' ' ' LEU . 69.6 t80 -47.34 -32.37 4.76 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.352 0.661 . . . . 0.94999999999999996 112.247 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -62.46 -44.02 97.42 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 123.933 0.771 . . . . 3.48 110.291 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.11 -22.99 22.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.149 -0.478 . . . . 3.0699999999999998 109.756 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.966 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.27 -38.03 92.7 Favored Glycine 0 N--CA 1.436 -1.3 0 CA-C-N 115.776 -0.647 . . . . 0.55000000000000004 112.323 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 79' ' ' PHE . 69.2 t -69.81 -48.61 63.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.93 -0.635 . . . . 0.84999999999999998 110.411 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.5 -23.74 42.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.423 -0.808 . . . . 1.1200000000000001 111.352 -170.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.6 p -67.62 -28.41 67.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.494 0.664 . . . . 1.8799999999999999 109.219 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.16 19.5 62.59 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.356 -0.838 . . . . 1.6599999999999999 111.839 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -162.85 55.75 0.2 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.359 0.6 . . . . 2.0800000000000001 111.225 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.966 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -69.07 83.61 0.33 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.553 -0.749 . . . . 0.56000000000000005 111.326 176.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.9 p-10 -144.86 99.04 3.28 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.455 0.645 . . . . 2.0099999999999998 109.789 171.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 91' ' ' MET . 11.9 m -146.31 152.52 39.27 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.136 -0.484 . . . . 1.6699999999999999 110.333 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.416 ' N ' HG22 ' A' ' 90' ' ' THR . 16.8 ptt? -123.22 129.26 51.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.93 0.395 . . . . 3.9399999999999999 110.323 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -150.66 142.96 24.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.806 -0.634 . . . . 2.4700000000000002 109.759 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.61 117.1 29.83 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.663 -0.495 . . . . 1.97 109.663 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -108.67 88.99 2.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.685 -0.857 . . . . 4.29 108.685 -175.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.7 t -84.97 145.68 27.61 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.231 -0.895 . . . . 2.8900000000000001 111.854 -172.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.786 ' HB3' ' HB ' ' A' ' 101' ' ' THR . 42.3 m-85 -126.32 117.83 23.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.808 -1.182 . . . . 5.25 107.808 171.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.44 -123.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.834 0.309 . . . . 6.0599999999999996 111.834 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -107.94 9.43 28.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.002 0.429 . . . . 9.7699999999999996 110.791 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -83.58 71.38 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.318 -0.401 . . . . 8.3399999999999999 111.122 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 17.4 ptp 48.25 21.72 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.399 1.08 . . . . 8.1899999999999995 112.394 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.786 ' HB ' ' HB3' ' A' ' 96' ' ' PHE . 2.3 p -95.61 151.9 38.82 Favored Pre-proline 0 N--CA 1.446 -0.674 0 CA-C-N 116.436 -0.347 . . . . 5.0999999999999996 111.267 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 5.6 Cg_exo -80.07 -73.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.728 2.285 . . . . 4.5099999999999998 113.416 -174.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.518 ' O ' ' HD2' ' A' ' 96' ' ' PHE . 21.3 p -128.47 164.79 21.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.191 0.519 . . . . 2.5899999999999999 112.014 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.876 ' HD3' ' HA ' ' A' ' 125' ' ' VAL . 15.1 tttt -89.36 130.68 35.7 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.959 -1.126 . . . . 3.1200000000000001 107.959 164.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -126.03 163.66 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.182 0.515 . . . . 1.23 110.867 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 22.1 ptmt -135.31 140.33 45.03 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.412 -0.813 . . . . 2.3599999999999999 109.03 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.75 142.02 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-O 121.679 0.752 . . . . 1.1100000000000001 112.157 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 18.5 t-160 -131.71 104.67 7.04 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.004 -1.48 . . . . 1.01 107.004 164.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.587 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 79.7 mtp -105.98 148.13 28.05 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.826 -0.805 . . . . 2.2200000000000002 108.826 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.8 ptmm? -152.59 134.43 14.74 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.893 -0.723 . . . . 1.73 109.671 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.454 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 18.5 ttmm -56.95 115.35 2.55 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.409 0.623 . . . . 1.78 109.726 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.54 138.02 58.35 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.659 -1.155 . . . . 0.45000000000000001 110.866 -172.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.52 -8.66 55.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.185 0.517 . . . . 2.3900000000000001 109.974 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.2 m -65.41 -35.92 82.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.487 -0.779 . . . . 1.6599999999999999 110.089 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.09 139.68 9.36 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.825 -0.625 . . . . 1.52 112.335 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.53 44.75 17.2 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.42 0.688 . . . . 2.79 112.091 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 2.9 p -158.98 157.16 30.77 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.249 -0.887 . . . . 0.44 110.383 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.454 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 39.8 m-85 -139.29 137.21 35.65 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.443 -0.577 . . . . 0.41999999999999998 109.443 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.58 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 39.8 m95 -84.05 161.7 20.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.278 0.561 . . . . 0.41999999999999998 111.27 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.77 95.82 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.426 -1.261 . . . . 0.62 108.93 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 89.6 m-85 -90.31 101.55 14.27 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.414 -0.958 . . . . 1.49 108.414 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 7.1 p -116.97 134.02 61.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.81 0.338 . . . . 1.6100000000000001 110.478 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -142.65 144.34 32.73 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.824 -0.436 . . . . 3.4500000000000002 109.824 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -81.34 155.3 26.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.335 -0.393 . . . . 4.2300000000000004 111.062 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.876 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 14.8 m . . . . . 0 C--O 1.252 1.204 0 O-C-N 124.998 1.436 . . . . 3.3399999999999999 113.582 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 1.001 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.8 tp . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.857 0.361 . . . . 8.7200000000000006 110.553 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.84 119.45 33.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.212 -0.449 . . . . 6.1799999999999997 110.22 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.527 ' HE2' ' HA3' ' A' ' 47' ' ' GLY . 98.6 m-85 -80.1 152.28 29.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.29 -0.414 . . . . 6.1500000000000004 110.971 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 57.81 44.61 94.19 Favored Glycine 0 C--O 1.226 -0.382 0 CA-C-N 115.917 -0.583 . . . . 1.4299999999999999 112.945 175.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.14 102.9 14.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.997 0.427 . . . . 0.69999999999999996 111.755 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.708 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -128.49 139.73 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.954 0.407 . . . . 0.90000000000000002 110.025 175.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.611 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 12.5 pt20 -112.81 134.67 54.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.471 0.653 . . . . 2.2200000000000002 111.416 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HB3' HD13 ' A' ' 39' ' ' ILE . 4.2 pp -122.62 161.84 23.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.149 -0.932 . . . . 0.71999999999999997 110.019 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 36' ' ' ASP . 3.5 p30 -90.87 153.99 19.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.261 0.553 . . . . 1.1499999999999999 110.77 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -79.07 28.23 2.25 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.591 -0.731 . . . . 1.2 111.381 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 34' ' ' ASP . 31.9 t70 -111.41 -35.34 5.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.803 -0.698 . . . . 1.8100000000000001 109.402 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.42 22.45 1.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.803 -0.713 . . . . 1.05 112.992 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.612 ' OD1' ' HA ' ' A' ' 61' ' ' ASN . 47.0 m-80 -135.31 153.47 51.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.085 0.469 . . . . 1.5700000000000001 110.533 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.6 HG12 ' HB3' ' A' ' 60' ' ' LYS . 48.2 mm -76.16 141.61 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.188 -0.671 . . . . 1.1799999999999999 109.188 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.8 tp -107.34 -52.29 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.915 -0.314 . . . . 1.5600000000000001 110.963 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.406 ' O ' HG12 ' A' ' 31' ' ' ILE . 24.4 tt0 -160.93 140.84 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.702 -0.399 . . . . 2.4100000000000001 111.72 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.708 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 76.8 t80 -104.41 139.03 39.94 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.769 -0.826 . . . . 1.4199999999999999 108.769 171.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -102.34 120.86 41.19 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.001 -0.37 . . . . 1.21 110.001 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.01 86.99 1.03 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.033 0.444 . . . . 2.5 110.338 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.5 132.41 35.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.694 -0.684 . . . . 4.0 110.636 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.86 166.37 21.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.276 -0.42 . . . . 7.21 110.786 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.527 ' HA3' ' HE2' ' A' ' 28' ' ' PHE . . . 115.76 -84.91 0.38 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.444 -0.662 . . . . 6.9699999999999998 111.444 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -148.79 94.92 2.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.909 0.385 . . . . 8.5899999999999999 111.03 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.3 pt -130.26 48.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.773 -0.649 . . . . 9.2400000000000002 110.612 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 m -72.63 146.32 46.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.075 -0.511 . . . . 9.8200000000000003 111.215 -174.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.95 170.8 18.41 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 111.619 -0.593 . . . . 9.6199999999999992 111.619 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -134.38 50.18 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.965 0.383 . . . . 12.720000000000001 111.263 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -153.8 95.42 2.84 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.546 0.689 . . . . 8.2400000000000002 111.148 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -77.86 -53.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.247 1.965 . . . . 8.1099999999999994 112.041 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -80.38 79.35 6.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.497 0.665 . . . . 9.2400000000000002 110.618 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -161.81 -46.94 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.008 -0.996 . . . . 7.4000000000000004 108.668 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.529 HG13 HG23 ' A' ' 58' ' ' ILE . 11.7 p -80.5 -35.99 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.498 -0.773 . . . . 5.0599999999999996 109.555 170.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.548 ' HA ' HG21 ' A' ' 39' ' ' ILE . 45.9 pt -111.91 167.96 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.251 0.548 . . . . 3.1699999999999999 110.537 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.63 9.92 82.4 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 114.987 -1.006 . . . . 3.2400000000000002 111.507 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.6 ' HB3' HG12 ' A' ' 39' ' ' ILE . 44.9 tptt -77.04 86.54 3.55 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.256 -0.646 . . . . 3.8500000000000001 109.256 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.612 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 91.0 m-20 -120.44 95.21 4.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.406 -0.815 . . . . 4.1799999999999997 109.828 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -150.48 154.52 37.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.592 -0.731 . . . . 6.6600000000000001 109.438 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -60.25 -49.73 76.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.419 -0.586 . . . . 8.1300000000000008 109.419 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -166.85 132.64 2.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.403 -0.817 . . . . 10.050000000000001 109.888 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -172.07 120.21 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.343 0.402 . . . . 7.9400000000000004 110.437 175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 66' ' ' VAL . 11.6 p -150.35 37.33 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 122.329 1.061 . . . . 9.3499999999999996 110.071 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 61.86 106.45 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 114.686 -1.143 . . . . 9.1600000000000001 111.252 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.18 -26.94 53.76 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.603 2.869 . . . . 10.35 114.606 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.9 m -92.07 -15.75 27.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.637 0.606 . . . . 11.49 112.637 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.7 p -114.85 170.23 8.49 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.707 0.632 . . . . 10.949999999999999 112.707 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -144.86 149.58 35.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.466 -0.788 . . . . 11.56 109.011 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.2 t 57.02 79.29 0.33 Allowed Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 123.539 0.524 . . . . 10.960000000000001 110.095 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.62 -53.22 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.786 2.324 . . . . 10.68 112.604 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -167.63 -49.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 11.76 110.663 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -101.3 96.23 7.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.501 -0.318 . . . . 10.0 110.426 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -155.08 113.76 3.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 7.5300000000000002 110.806 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -129.49 70.31 0.52 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.833 -0.907 . . . . 3.2000000000000002 110.833 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 58.98 41.06 21.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.597 0.713 . . . . 4.1399999999999997 109.376 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 83' ' ' VAL . 57.4 t80 -56.81 -36.25 69.7 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.628 -1.169 . . . . 0.94999999999999996 111.259 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -59.49 -36.71 76.57 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 123.85 0.718 . . . . 3.48 110.52 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -86.07 -37.91 18.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.812 -0.631 . . . . 3.0699999999999998 109.863 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 1.017 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.39 -43.58 89.99 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.721 -0.672 . . . . 0.55000000000000004 112.015 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 79' ' ' PHE . 90.7 t -73.05 -50.63 30.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.508 -0.846 . . . . 0.84999999999999998 111.211 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.79 -32.29 59.83 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.215 -0.448 . . . . 1.1200000000000001 111.239 -169.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.6 m -72.55 -23.23 60.95 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.424 -0.584 . . . . 1.8799999999999999 109.424 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 34.06 38.06 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.714 -0.675 . . . . 1.6599999999999999 111.999 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -158.89 50.19 0.36 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.565 0.698 . . . . 2.0800000000000001 112.005 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.017 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -73.76 88.31 1.75 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.763 -0.653 . . . . 0.56000000000000005 111.45 177.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.0 p30 -143.26 101.52 3.82 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.525 -0.546 . . . . 2.0099999999999998 109.525 175.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.0 t -168.47 163.36 12.56 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.13 0.49 . . . . 1.6699999999999999 110.924 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.2 ptt? -104.4 136.28 44.27 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.411 -0.813 . . . . 3.9399999999999999 110.014 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 107' ' ' VAL . 77.3 t80 -147.15 127.78 14.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.58 -0.736 . . . . 2.4700000000000002 109.22 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 8.1 pt-20 -95.43 132.71 40.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.43 0.633 . . . . 1.97 110.804 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -108.39 94.92 5.32 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.76 -1.109 . . . . 4.29 108.777 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -90.73 150.54 21.59 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.624 -0.716 . . . . 2.8900000000000001 110.28 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.476 ' CD2' ' HA ' ' A' ' 102' ' ' PRO . 7.5 p90 -65.3 109.2 2.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.825 -0.625 . . . . 5.25 110.97 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -143.37 63.93 1.35 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.009 -0.737 . . . . 6.0599999999999996 109.009 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.408 ' CD1' ' HG3' ' A' ' 99' ' ' GLN . 10.3 t80 177.5 -149.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.127 -1.064 . . . . 9.7699999999999996 108.127 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.408 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -76.21 -4.6 42.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.93 0.395 . . . . 8.3399999999999999 110.836 176.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 52.6 tpp -69.46 135.66 50.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.834 -0.621 . . . . 8.1899999999999995 109.991 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.513 ' HB ' ' CD ' ' A' ' 102' ' ' PRO . 8.9 p -80.38 169.51 19.44 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.212 -0.449 . . . . 5.0999999999999996 111.113 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.513 ' CD ' ' HB ' ' A' ' 101' ' ' THR . 52.8 Cg_exo -56.41 86.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.931 2.421 . . . . 4.5099999999999998 114.043 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 m -139.58 98.22 3.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.436 -0.802 . . . . 2.5899999999999999 108.847 171.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -93.32 105.19 17.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.832 0.349 . . . . 3.1200000000000001 110.878 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 22.2 m -114.74 167.87 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-N 115.548 -0.751 . . . . 1.23 110.141 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 19.8 ptmt -144.07 147.38 33.71 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.671 -0.412 . . . . 2.3599999999999999 110.414 174.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.727 HG12 HG12 ' A' ' 122' ' ' VAL . 14.2 m -100.54 144.24 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-N 115.781 -0.645 . . . . 1.1100000000000001 111.359 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -119.97 102.87 8.85 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.411 -1.7 . . . . 1.01 106.411 160.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 64.0 mtt -102.98 146.36 28.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.777 -0.823 . . . . 2.2200000000000002 108.777 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 61.5 pttt -151.12 128.85 11.56 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.874 -0.73 . . . . 1.73 110.187 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.09 110.03 0.76 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.769 -0.65 . . . . 1.78 109.45 168.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.93 129.34 17.16 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.783 -1.099 . . . . 0.45000000000000001 109.782 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.17 -5.92 20.62 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.225 0.328 . . . . 2.3900000000000001 111.747 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -73.4 -43.13 61.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.817 0.342 . . . . 1.6599999999999999 110.219 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.22 138.31 3.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.379 -0.915 . . . . 1.52 113.488 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.74 52.65 4.04 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.186 0.994 . . . . 2.79 113.374 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.513 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.1 p -158.92 156.21 29.1 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.56 -1.274 . . . . 0.44 107.56 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -137.38 136.2 37.67 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.645 -0.422 . . . . 0.41999999999999998 111.18 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.611 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 49.2 m95 -91.5 161.98 14.74 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.406 0.622 . . . . 0.41999999999999998 111.824 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.52 97.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.39 -1.277 . . . . 0.62 109.226 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 66.3 m-85 -98.27 112.47 24.45 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.188 -0.671 . . . . 1.49 109.188 174.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.727 HG12 HG12 ' A' ' 107' ' ' VAL . 31.1 m -110.78 150.13 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.255 0.465 . . . . 1.6100000000000001 112.255 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -159.09 145.72 16.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 3.4500000000000002 110.366 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 19.7 ptt180 -90.58 104.87 17.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.779 -0.646 . . . . 4.2300000000000004 111.479 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.429 HG13 ' OXT' ' A' ' 125' ' ' VAL . 3.4 p . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.112 -0.947 . . . . 3.3399999999999999 110.4 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 1.016 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.915 -0.402 . . . . 8.7200000000000006 109.915 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 69.35 145.39 0.05 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.085 0.866 . . . . 6.1799999999999997 112.332 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' A' ' 45' ' ' ALA . 94.9 m-85 -103.12 107.98 18.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.783 -0.644 . . . . 6.1500000000000004 110.197 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 143.84 21.97 0.17 Allowed Glycine 0 C--O 1.221 -0.68 0 C-N-CA 120.292 -0.956 . . . . 1.4299999999999999 113.489 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -109.3 105.22 14.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.767 0.784 . . . . 0.69999999999999996 110.828 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.663 HD11 HD12 ' A' ' 39' ' ' ILE . 4.3 tt -138.35 141.69 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.425 -0.352 . . . . 0.90000000000000002 110.767 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' OE1' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -114.06 130.01 56.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.022 0.439 . . . . 2.2200000000000002 109.842 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.416 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.7 pp -132.75 159.76 38.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.354 0.597 . . . . 0.71999999999999997 111.366 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.6 p30 -76.99 157.83 30.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 1.1499999999999999 110.782 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.449 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -77.76 30.98 1.73 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.361 -0.836 . . . . 1.2 112.675 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -122.42 -31.94 3.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.211 0.529 . . . . 1.8100000000000001 109.756 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.04 21.18 1.24 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.459 -0.877 . . . . 1.05 112.898 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.484 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 16.2 m-80 -125.27 156.49 38.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.045 0.45 . . . . 1.5700000000000001 110.196 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.903 HG12 ' HB3' ' A' ' 60' ' ' LYS . 41.1 mm -81.53 142.75 13.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.965 -0.561 . . . . 1.1799999999999999 109.999 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD12 ' OE1' ' A' ' 32' ' ' GLN . 89.1 mt -109.31 -53.23 2.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.395 -0.595 . . . . 1.5600000000000001 109.395 172.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -133.81 117.27 16.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.579 -0.737 . . . . 2.4100000000000001 110.656 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.578 ' HA ' HG13 ' A' ' 31' ' ' ILE . 18.5 t80 -106.01 117.93 35.31 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.277 -0.638 . . . . 1.4199999999999999 109.277 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 84.6 m-20 -99.35 99.74 10.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.991 0.424 . . . . 1.21 110.529 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.32 146.92 33.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.907 -0.588 . . . . 2.5 110.686 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . . . -100.54 139.73 35.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.001 -0.545 . . . . 4.0 110.178 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 68.14 -178.82 0.22 Allowed 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.935 0.772 . . . . 7.21 110.916 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.11 -159.53 26.33 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.576 -0.821 . . . . 6.9699999999999998 112.336 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.764 ' HB2' ' HG2' ' A' ' 52' ' ' ARG . 5.8 p-10 -76.97 80.81 3.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.223 1.011 . . . . 8.5899999999999999 111.116 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.9 -41.28 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.602 -1.181 . . . . 9.2400000000000002 109.955 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -95.0 49.22 1.21 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 122.231 1.015 . . . . 9.8200000000000003 110.111 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.82 113.89 3.58 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.108 -0.951 . . . . 9.6199999999999992 111.345 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.764 ' HG2' ' HB2' ' A' ' 48' ' ' ASP . 39.9 mtt180 -79.48 106.24 11.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.044 0.449 . . . . 12.720000000000001 111.743 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -114.89 127.43 26.84 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.871 -0.788 . . . . 8.2400000000000002 108.871 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.22 -4.1 14.84 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.541 2.161 . . . . 8.1099999999999994 112.794 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.58 ' HE2' ' HA2' ' A' ' 59' ' ' GLY . 26.6 mtmm -120.93 91.25 3.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.397 . . . . 9.2400000000000002 110.647 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -78.98 -20.2 49.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.262 0.553 . . . . 7.4000000000000004 110.178 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 58' ' ' ILE . 12.5 t -123.45 153.8 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.345 -0.983 . . . . 5.0599999999999996 108.345 174.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.444 ' N ' HG12 ' A' ' 57' ' ' VAL 0.25 13.6 tt 38.7 73.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 122.799 1.285 . . . . 3.1699999999999999 112.414 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.58 ' HA2' ' HE2' ' A' ' 55' ' ' LYS . . . -68.2 -29.19 73.19 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.415 -1.266 . . . . 3.2400000000000002 111.787 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.903 ' HB3' HG12 ' A' ' 39' ' ' ILE . 23.2 tptm -99.26 91.03 4.77 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 120.904 0.383 . . . . 3.8500000000000001 110.0 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -98.19 101.45 12.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.705 -0.679 . . . . 4.1799999999999997 109.357 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 65' ' ' ASP . 5.5 t80 -156.15 175.1 14.42 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.42 -0.956 . . . . 6.6600000000000001 108.42 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.452 ' CD1' ' HG2' ' A' ' 64' ' ' LYS . 54.4 t80 -86.64 -65.63 0.99 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.283 -0.636 . . . . 8.1300000000000008 109.283 172.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HG2' ' CD1' ' A' ' 63' ' ' PHE . 17.0 ptpt -170.15 141.64 2.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.869 -0.789 . . . . 10.050000000000001 108.869 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.475 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 4.4 p-10 -152.98 173.94 14.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.034 0.445 . . . . 7.9400000000000004 110.829 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.8 m -132.3 37.17 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 9.3499999999999996 110.495 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.71 94.65 2.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.113 0.412 . . . . 9.1600000000000001 112.113 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.09 102.91 0.83 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.389 2.059 . . . . 10.35 110.779 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.5 m -74.16 -69.11 0.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.497 . . . . 11.49 112.338 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 p -86.59 -43.24 12.83 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 111.712 0.264 . . . . 10.949999999999999 111.712 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -56.92 112.91 1.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.861 -0.609 . . . . 11.56 111.456 -175.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.445 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 49.9 m -90.86 -44.19 0.39 Allowed Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.592 -0.731 . . . . 10.960000000000001 112.49 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 72' ' ' SER . 42.6 Cg_exo -58.81 111.73 0.98 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.126 1.884 . . . . 10.68 112.534 176.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 72' ' ' SER . 15.1 mt-10 -106.26 102.7 12.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.948 -0.569 . . . . 11.76 110.036 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -109.93 19.06 19.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.054 0.454 . . . . 10.0 111.552 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 79' ' ' PHE . 93.4 m-85 -82.45 120.47 25.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.611 -0.514 . . . . 7.5300000000000002 109.611 177.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.46 88.93 0.63 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.335 -0.936 . . . . 3.2000000000000002 111.728 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 58.28 41.07 23.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.376 0.608 . . . . 4.1399999999999997 109.676 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 83' ' ' VAL . 56.0 t80 -56.24 -27.67 55.79 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.31 -0.859 . . . . 0.94999999999999996 111.789 -171.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.86 -33.95 72.95 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 123.855 0.722 . . . . 3.48 110.277 -175.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -86.87 -29.07 22.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.765 -0.652 . . . . 3.0699999999999998 109.531 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.737 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.25 -39.27 92.26 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 111.83 -0.508 . . . . 0.55000000000000004 111.83 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 79' ' ' PHE . 95.2 t -66.86 -48.12 80.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.979 -0.61 . . . . 0.84999999999999998 110.547 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.41 -26.61 51.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 1.1200000000000001 111.206 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -60.1 -28.56 67.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.562 -0.533 . . . . 1.8799999999999999 109.562 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.11 -10.26 47.37 Favored Glycine 0 CA--C 1.505 -0.551 0 C-N-CA 120.728 -0.749 . . . . 1.6599999999999999 113.048 169.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -169.96 62.61 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.324 0.583 . . . . 2.0800000000000001 110.145 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.737 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 2.9 tt -38.45 102.35 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 114.728 -1.123 . . . . 0.56000000000000005 111.802 175.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 4.1 p30 -145.74 102.24 3.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.1 0.476 . . . . 2.0099999999999998 109.822 176.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 2.5 p -138.8 154.34 48.47 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.924 -0.485 . . . . 1.6699999999999999 111.764 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.24 138.1 36.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.768 -0.651 . . . . 3.9399999999999999 109.76 171.329 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.45 ' O ' HG22 ' A' ' 107' ' ' VAL . 85.5 t80 -163.3 140.37 7.41 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.377 -0.601 . . . . 2.4700000000000002 109.377 -175.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 39.2 mt-10 -91.74 110.78 22.13 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.356 -0.609 . . . . 1.97 109.356 177.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -117.43 113.99 22.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.649 -0.705 . . . . 4.29 110.872 -171.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 104' ' ' LYS . 3.6 p -84.44 150.25 25.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.365 -0.38 . . . . 2.8900000000000001 110.522 173.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.487 ' CD2' ' HB ' ' A' ' 103' ' ' THR . 71.9 m-85 -73.28 148.81 43.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.21 -0.45 . . . . 5.25 110.566 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.46 -79.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.082 -0.508 . . . . 6.0599999999999996 110.561 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -148.58 84.19 1.48 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.184 -0.462 . . . . 9.7699999999999996 109.818 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.431 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 4.1 mm100 -103.12 -44.79 5.11 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.819 -0.808 . . . . 8.3399999999999999 108.819 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 34.2 tpp 177.84 -53.19 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.677 -1.147 . . . . 8.1899999999999995 108.699 175.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 21.3 m -111.18 138.29 21.22 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.122 -0.945 . . . . 5.0999999999999996 109.289 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 12.9 Cg_exo -72.07 60.13 3.05 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.703 2.269 . . . . 4.5099999999999998 111.372 174.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.487 ' HB ' ' CD2' ' A' ' 96' ' ' PHE . 4.8 m -57.99 133.14 55.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.945 -0.57 . . . . 2.5899999999999999 111.091 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' HA ' HG22 ' A' ' 95' ' ' THR . 63.9 tttp -108.16 103.55 12.77 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.214 -0.448 . . . . 3.1200000000000001 110.375 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.9 163.85 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.978 -0.556 . . . . 1.23 109.528 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 59.1 pttt -126.17 140.05 52.86 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.047 -0.723 . . . . 2.3599999999999999 109.047 173.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 122' ' ' VAL . 7.9 m -100.65 143.5 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 CA-C-O 121.144 0.497 . . . . 1.1100000000000001 110.903 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 90' ' ' THR . 1.5 t60 -143.85 102.73 3.95 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.656 -1.238 . . . . 1.01 107.656 164.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.553 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.1 OUTLIER -115.63 125.23 52.64 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.925 -1.139 . . . . 2.2200000000000002 107.925 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.9 ptmm? -145.18 146.96 31.96 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.742 -0.783 . . . . 1.73 110.604 -171.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 13.1 ttpp -56.82 123.79 16.26 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.217 -0.901 . . . . 1.78 111.265 176.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.66 148.41 51.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.674 -1.148 . . . . 0.45000000000000001 110.716 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.51 -4.1 37.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.091 0.472 . . . . 2.3900000000000001 110.883 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -79.88 -21.91 43.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 1.6599999999999999 110.933 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 139.16 -128.1 3.91 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.487 -0.864 . . . . 1.52 112.739 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.66 77.24 5.14 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.988 0.899 . . . . 2.79 110.76 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.449 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.9 p -162.94 157.14 20.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.267 -1.333 . . . . 0.44 108.194 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 25.1 m-85 -138.65 141.28 39.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.864 0.364 . . . . 0.41999999999999998 110.608 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 47.2 m95 -87.98 165.75 14.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.145 0.498 . . . . 0.41999999999999998 110.573 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.454 ' HB ' HG23 ' A' ' 31' ' ' ILE . 58.1 t -135.42 98.56 2.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.643 -1.162 . . . . 0.62 108.774 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 83.2 m-85 -103.86 119.96 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.372 -0.603 . . . . 1.49 109.372 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 107' ' ' VAL . 23.8 m -124.28 155.16 31.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.714 -0.476 . . . . 1.6100000000000001 109.714 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -156.73 132.19 9.33 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.816 -0.353 . . . . 3.4500000000000002 110.206 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -88.5 139.7 30.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 4.2300000000000004 110.257 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.819 -0.61 . . . . 3.3399999999999999 110.365 -179.198 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 1.008 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 121.043 0.449 . . . . 8.7200000000000006 110.558 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.89 30.84 4.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.255 0.55 . . . . 6.1799999999999997 110.023 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -162.69 137.86 6.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.331 -0.85 . . . . 6.1500000000000004 109.639 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 99.71 -6.7 58.97 Favored Glycine 0 C--O 1.226 -0.358 0 C-N-CA 120.819 -0.705 . . . . 1.4299999999999999 113.239 175.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -107.49 118.73 37.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.139 0.495 . . . . 0.69999999999999996 111.57 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.543 HG23 ' HB ' ' A' ' 120' ' ' VAL . 5.5 tt -136.19 141.01 42.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.222 -0.444 . . . . 0.90000000000000002 110.121 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -115.37 125.08 52.77 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.5 -0.926 . . . . 2.2200000000000002 108.5 179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.48 154.31 46.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.605 0.717 . . . . 0.71999999999999997 111.456 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -73.71 146.61 44.29 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.025 -0.989 . . . . 1.1499999999999999 110.045 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.56 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -82.09 36.28 2.55 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.804 -0.635 . . . . 1.2 112.961 -173.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -134.51 -24.97 1.52 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.854 0.359 . . . . 1.8100000000000001 110.1 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.09 -4.28 2.6 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.099 -0.572 . . . . 1.05 112.494 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.669 ' OD1' ' HA ' ' A' ' 61' ' ' ASN . 21.4 m-80 -90.78 149.76 21.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.511 0.196 . . . . 1.5700000000000001 110.792 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.691 HG12 ' HB3' ' A' ' 60' ' ' LYS . 34.7 mm -92.8 140.06 16.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.822 -0.807 . . . . 1.1799999999999999 108.822 173.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.448 ' HG ' ' HG3' ' A' ' 41' ' ' GLN . 38.3 tp -113.28 -57.34 2.3 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.348 -0.541 . . . . 1.5600000000000001 111.351 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 45.1 mt-30 -144.16 150.38 37.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.016 0.436 . . . . 2.4100000000000001 111.405 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.631 ' CE1' ' HB3' ' A' ' 44' ' ' ALA . 55.9 t80 -127.04 117.78 23.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.956 -0.565 . . . . 1.4199999999999999 109.551 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 2.6 m-20 -98.44 92.19 5.55 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.83 -0.433 . . . . 1.21 109.83 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.631 ' HB3' ' CE1' ' A' ' 42' ' ' TYR . . . -171.54 155.4 4.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.232 -0.44 . . . . 2.5 110.382 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.88 90.96 5.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.013 0.435 . . . . 4.0 110.44 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -120.71 20.75 11.67 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.025 -0.731 . . . . 7.21 109.025 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.58 76.24 0.98 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.315 -0.857 . . . . 6.9699999999999998 111.924 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.16 100.45 4.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.853 0.359 . . . . 8.5899999999999999 110.279 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 mm 51.31 48.4 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.246 -0.888 . . . . 9.2400000000000002 109.708 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.2 m 57.29 75.44 0.37 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.309 -0.86 . . . . 9.8200000000000003 111.0 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.24 113.62 0.53 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.528 -0.76 . . . . 9.6199999999999992 112.35 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -130.51 155.83 45.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.422 -0.585 . . . . 12.720000000000001 109.422 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -95.85 113.55 62.28 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.515 0.197 . . . . 8.2400000000000002 110.999 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 86.8 Cg_endo -96.99 23.76 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.439 2.76 . . . . 8.1099999999999994 112.213 176.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -103.82 -52.52 2.95 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.478 0.656 . . . . 9.2400000000000002 110.454 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -94.42 -31.98 13.74 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.766 -1.106 . . . . 7.4000000000000004 109.919 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.828 HG12 HG13 ' A' ' 58' ' ' ILE . 25.1 t -111.38 123.81 67.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.679 -0.691 . . . . 5.0599999999999996 110.107 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.828 HG13 HG12 ' A' ' 57' ' ' VAL . 65.7 mt 69.49 148.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.31 0.576 . . . . 3.1699999999999999 111.132 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 58' ' ' ILE . . . 75.14 6.62 80.16 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.78 -0.724 . . . . 3.2400000000000002 112.022 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.691 ' HB3' HG12 ' A' ' 39' ' ' ILE . 4.0 tppp? -74.24 99.82 3.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.31 -0.626 . . . . 3.8500000000000001 109.31 176.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.669 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 14.2 m120 -106.35 98.52 8.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.0 -0.545 . . . . 4.1799999999999997 110.074 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -119.03 136.26 54.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.567 -0.742 . . . . 6.6600000000000001 109.257 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -103.18 154.33 19.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.865 0.364 . . . . 8.1300000000000008 110.533 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 110.71 2.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.816 -0.629 . . . . 10.050000000000001 111.747 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.455 ' OD1' HG12 ' A' ' 66' ' ' VAL . 9.0 p-10 -82.77 -62.7 1.53 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.659 -0.867 . . . . 7.9400000000000004 108.659 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 67' ' ' ALA . 7.6 p -122.84 -51.27 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.953 -0.758 . . . . 9.3499999999999996 108.953 167.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.857 ' HB3' ' H2 ' ' A' ' 169' ' ' HC4 . . . 169.15 136.64 0.05 OUTLIER Pre-proline 0 C--O 1.232 0.169 0 C-N-CA 123.779 0.832 . . . . 9.1600000000000001 109.366 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.08 92.87 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.658 2.239 . . . . 10.35 111.928 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.2 p -154.92 27.94 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 11.49 110.802 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -104.87 -41.52 5.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.373 -0.376 . . . . 10.949999999999999 111.49 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' SER . 33.3 t70 -58.48 -94.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.574 0.583 . . . . 11.56 112.574 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 71' ' ' ASP . 36.0 t 172.37 135.87 0.1 OUTLIER Pre-proline 0 C--O 1.233 0.209 0 CA-C-O 120.713 0.292 . . . . 10.960000000000001 110.316 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.75 71.26 6.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.836 2.357 . . . . 10.68 111.432 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.96 -57.69 9.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 11.76 110.32 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -123.86 23.04 8.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.452 0.644 . . . . 10.0 110.369 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -97.69 137.96 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.516 -0.765 . . . . 7.5300000000000002 110.027 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.94 86.46 0.48 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.517 -0.849 . . . . 3.2000000000000002 112.017 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 58.48 44.12 18.48 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 122.686 0.395 . . . . 4.1399999999999997 110.538 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 83' ' ' VAL . 64.5 t80 -46.08 -43.0 14.29 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 113.456 0.91 . . . . 0.94999999999999996 113.456 -167.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -79.64 -29.88 41.14 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 121.279 0.561 . . . . 3.48 110.155 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.53 -34.31 62.98 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.218 -1.03 . . . . 3.0699999999999998 108.218 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 1.015 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.86 -40.08 89.29 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.732 -1.122 . . . . 0.55000000000000004 111.395 175.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 79' ' ' PHE . 95.5 t -68.38 -54.27 22.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.378 -0.911 . . . . 0.84999999999999998 111.046 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.15 -22.6 33.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 1.1200000000000001 111.644 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.9 t -70.63 -29.51 65.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.483 -0.932 . . . . 1.8799999999999999 108.483 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.24 23.23 49.12 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.53 -0.759 . . . . 1.6599999999999999 112.169 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -156.04 52.59 0.56 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.45 0.643 . . . . 2.0800000000000001 111.501 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.015 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.9 OUTLIER -74.37 73.72 1.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.603 -0.726 . . . . 0.56000000000000005 111.083 175.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.9 t30 -143.16 99.29 3.42 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.572 -0.899 . . . . 2.0099999999999998 108.572 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.4 m -140.26 146.36 38.5 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.017 -0.538 . . . . 1.6699999999999999 110.41 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 16.4 ptt? -126.73 129.72 48.94 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.586 -0.524 . . . . 3.9399999999999999 109.586 172.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -157.85 142.88 16.68 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.517 -0.549 . . . . 2.4700000000000002 109.517 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 55.2 mt-10 -92.6 105.54 17.68 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 1.97 109.412 176.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -109.24 121.95 46.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.245 -0.889 . . . . 4.29 110.989 -170.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.4 p -93.13 150.79 20.26 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.935 -0.575 . . . . 2.8900000000000001 111.064 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -99.86 166.49 11.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.906 -0.588 . . . . 5.25 110.068 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.87 62.2 4.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.368 0.604 . . . . 6.0599999999999996 110.926 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.02 123.1 29.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.536 -0.757 . . . . 9.7699999999999996 109.993 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -100.37 -30.83 11.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.415 -0.357 . . . . 8.3399999999999999 110.948 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -59.88 -57.16 14.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.271 0.558 . . . . 8.1899999999999995 109.967 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 m -112.97 132.5 22.31 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 108.816 -0.809 . . . . 5.0999999999999996 108.816 172.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.39 86.12 0.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.078 1.852 . . . . 4.5099999999999998 111.785 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.456 ' HA ' HH21 ' A' ' 124' ' ' ARG . 8.3 m -81.14 95.11 6.78 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.891 0.853 . . . . 2.5899999999999999 109.517 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 34.1 tttp -122.34 126.43 48.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.849 -1.069 . . . . 3.1200000000000001 109.422 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.48 HG12 ' HG2' ' A' ' 124' ' ' ARG . 22.9 m -123.27 160.24 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.27 0.557 . . . . 1.23 110.733 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 72.4 tttt -117.91 118.53 32.24 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.291 -1.003 . . . . 2.3599999999999999 108.291 171.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.697 HG12 HG12 ' A' ' 122' ' ' VAL . 6.3 m -99.25 144.22 12.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.438 0.637 . . . . 1.1100000000000001 111.606 -176.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -137.74 103.51 5.03 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.665 -1.152 . . . . 1.01 108.162 164.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 3.5 mpp? -98.94 140.03 33.72 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 106.798 -1.556 . . . . 2.2200000000000002 106.798 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.827 ' HG3' ' HB2' ' A' ' 119' ' ' TRP . 9.3 ptpt -141.02 125.27 17.44 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.701 -0.8 . . . . 1.73 110.09 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.64 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 82.7 tttt -57.72 106.79 0.38 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.976 -0.75 . . . . 1.78 108.976 170.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.37 127.86 20.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.929 -1.032 . . . . 0.45000000000000001 110.323 -173.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.24 -7.12 33.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.267 0.556 . . . . 2.3900000000000001 109.895 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.1 m -71.28 -26.1 62.73 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.164 -0.925 . . . . 1.6599999999999999 110.043 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.44 145.02 18.32 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.174 -0.536 . . . . 1.52 112.973 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 55.75 38.27 29.89 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.511 0.672 . . . . 2.79 112.24 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.56 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 4.8 p -166.7 159.93 14.4 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.165 -0.925 . . . . 0.44 109.937 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.64 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 36.5 m-85 -140.48 139.57 35.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.048 -0.353 . . . . 0.41999999999999998 110.048 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.827 ' HB2' ' HG3' ' A' ' 110' ' ' LYS . 41.1 m95 -92.53 162.49 14.18 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.19 0.519 . . . . 0.41999999999999998 110.658 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.543 ' HB ' HG23 ' A' ' 31' ' ' ILE . 77.5 t -136.16 105.88 5.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.762 -1.108 . . . . 0.62 109.583 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 29.3 m-85 -109.45 123.05 48.72 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.767 -0.457 . . . . 1.49 109.767 175.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.697 HG12 HG12 ' A' ' 107' ' ' VAL . 30.0 m -118.93 157.92 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.124 0.488 . . . . 1.6100000000000001 111.527 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -152.26 115.11 4.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.546 -0.752 . . . . 3.4500000000000002 110.008 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.48 ' HG2' HG12 ' A' ' 105' ' ' VAL . 58.0 mtp180 -76.5 124.51 27.69 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.725 -0.39 . . . . 4.2300000000000004 110.418 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.462 HG13 ' OXT' ' A' ' 125' ' ' VAL 0.254 7.2 p . . . . . 0 C--O 1.253 1.289 0 O-C-N 124.86 1.35 . . . . 3.3399999999999999 113.147 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 1.001 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.93 -0.396 . . . . 8.7200000000000006 109.93 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 68.86 143.81 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 O-C-N 124.105 0.878 . . . . 6.1799999999999997 111.178 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -170.24 -68.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.813 -0.63 . . . . 6.1500000000000004 109.876 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.84 56.37 0.45 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.581 -0.736 . . . . 1.4299999999999999 111.532 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.17 107.74 13.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.982 -0.377 . . . . 0.69999999999999996 109.982 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.679 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -131.04 139.45 51.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.824 0.345 . . . . 0.90000000000000002 110.783 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.517 ' HB3' ' CE2' ' A' ' 119' ' ' TRP . 8.3 pt20 -105.22 114.5 28.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.633 0.73 . . . . 2.2200000000000002 110.395 176.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.59 168.45 11.74 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.879 -1.055 . . . . 0.71999999999999997 109.293 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.604 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 3.1 p30 -102.19 157.55 16.81 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.95 -0.7 . . . . 1.1499999999999999 110.888 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -77.37 14.04 9.66 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.38 -0.827 . . . . 1.2 111.73 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -100.83 -12.57 18.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.27 0.557 . . . . 1.8100000000000001 109.77 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.39 9.31 25.67 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.616 -0.72 . . . . 1.05 112.985 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.53 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -109.07 143.53 38.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.065 0.46 . . . . 1.5700000000000001 110.944 -178.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.615 HG21 ' HA ' ' A' ' 58' ' ' ILE . 47.7 mm -94.09 126.63 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.141 -0.688 . . . . 1.1799999999999999 109.141 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 tp -99.56 -49.49 4.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.851 -0.34 . . . . 1.5600000000000001 110.996 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.585 ' O ' HG12 ' A' ' 31' ' ' ILE . 33.3 tt0 -157.6 142.94 17.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.813 0.34 . . . . 2.4100000000000001 111.292 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.679 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 79.0 t80 -124.68 133.87 53.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.995 -0.548 . . . . 1.4199999999999999 109.844 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -79.73 92.89 5.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.142 -0.688 . . . . 1.21 109.142 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.54 -55.33 4.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.744 -0.662 . . . . 2.5 111.387 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.91 148.66 28.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.224 -0.443 . . . . 4.0 110.881 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -130.97 90.0 2.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.987 -0.551 . . . . 7.21 109.639 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.66 -48.67 2.64 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.063 -0.517 . . . . 6.9699999999999998 112.757 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.83 122.24 23.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.717 0.294 . . . . 8.5899999999999999 110.739 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.2 pt -112.37 47.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.231 0.539 . . . . 9.2400000000000002 111.783 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.4 m -82.48 80.99 8.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.209 0.528 . . . . 9.8200000000000003 110.881 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.51 -134.74 9.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.571 -0.824 . . . . 9.6199999999999992 112.754 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -136.22 167.53 21.11 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.14 -0.318 . . . . 12.720000000000001 110.14 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 5.9 p-10 -95.42 159.44 32.71 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.562 -0.903 . . . . 8.2400000000000002 108.562 171.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 53' ' ' ASP . 13.7 Cg_endo -57.83 -49.59 12.64 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.418 2.079 . . . . 8.1099999999999994 113.008 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.3 pttp 32.32 77.82 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.713 0.805 . . . . 9.2400000000000002 112.441 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -157.09 -71.1 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.315 -0.857 . . . . 7.4000000000000004 110.319 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -92.41 -27.95 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.684 -0.689 . . . . 5.0599999999999996 110.676 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.615 ' HA ' HG21 ' A' ' 39' ' ' ILE . 46.8 pt -69.08 157.76 6.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.175 0.512 . . . . 3.1699999999999999 111.882 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.49 37.73 90.17 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.311 -0.858 . . . . 3.2400000000000002 111.668 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -100.86 122.24 43.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.641 0.258 . . . . 3.8500000000000001 111.039 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -124.61 125.56 44.35 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.496 -0.557 . . . . 4.1799999999999997 109.496 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -160.18 109.46 1.76 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.63 -0.714 . . . . 6.6600000000000001 109.44 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -104.95 28.33 7.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.086 0.402 . . . . 8.1300000000000008 112.086 -171.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -116.4 92.25 3.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.128 -0.693 . . . . 10.050000000000001 109.128 174.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -77.3 172.37 13.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.34 -0.845 . . . . 7.9400000000000004 110.844 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.4 t 62.17 57.3 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 122.399 1.095 . . . . 9.3499999999999996 108.871 -172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.653 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -152.64 -50.36 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 114.677 -1.147 . . . . 9.1600000000000001 110.974 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 23.9 Cg_exo -65.8 156.57 63.42 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.829 1.686 . . . . 10.35 112.01 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.3 m -70.96 109.48 5.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.218 -0.446 . . . . 11.49 111.16 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.6 t -69.75 -35.77 75.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.924 -0.399 . . . . 10.949999999999999 109.924 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.5 t70 61.04 -92.12 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.542 0.737 . . . . 11.56 111.659 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.7 t -139.26 124.26 11.65 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.212 -0.662 . . . . 10.960000000000001 109.212 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 72.3 Cg_endo -76.11 11.83 1.66 Allowed 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.75 2.3 . . . . 10.68 113.459 -174.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -84.35 -21.61 30.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 11.76 111.85 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -53.06 146.48 11.18 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 -173.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 69.79 -80.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.709 -1.132 . . . . 7.5300000000000002 110.98 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.65 54.32 0.37 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.511 -1.036 . . . . 3.2000000000000002 110.511 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 73' ' ' PRO . 35.2 mtmm 59.86 69.22 0.72 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.2 0.524 . . . . 4.1399999999999997 109.701 -170.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.507 ' O ' HG23 ' A' ' 83' ' ' VAL . 74.8 t80 -53.46 -40.42 65.24 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.14 -0.936 . . . . 0.94999999999999996 111.848 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -62.46 -30.82 71.52 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 123.679 0.612 . . . . 3.48 110.653 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -80.03 -35.24 37.51 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.085 -0.709 . . . . 3.0699999999999998 109.085 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.976 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -62.08 -42.72 99.74 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.513 -0.767 . . . . 0.55000000000000004 111.695 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 79' ' ' PHE . 84.1 t -65.81 -51.24 64.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.753 -0.724 . . . . 0.84999999999999998 110.682 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.37 -21.65 55.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 1.1200000000000001 110.853 -172.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.8 t -65.87 -35.61 81.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.899 -0.591 . . . . 1.8799999999999999 109.431 171.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.94 15.28 63.25 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.335 -0.706 . . . . 1.6599999999999999 111.335 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.741 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 3.0 p30 -166.02 62.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.785 0.802 . . . . 2.0800000000000001 110.833 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.976 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.2 tt -68.86 98.24 0.91 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.048 -0.978 . . . . 0.56000000000000005 110.603 172.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.638 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.0 p-10 -143.25 101.35 3.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.265 -0.574 . . . . 2.0099999999999998 110.867 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.9 t -154.97 162.47 41.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.946 0.403 . . . . 1.6699999999999999 110.608 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -130.0 116.05 18.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.694 -0.684 . . . . 3.9399999999999999 109.877 175.391 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -126.68 134.13 50.78 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.015 -0.735 . . . . 2.4700000000000002 109.015 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.709 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 7.1 pt-20 -106.13 117.27 33.59 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.908 -0.717 . . . . 1.97 110.361 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -109.27 128.54 55.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.763 -1.108 . . . . 4.29 109.873 -173.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 9.1 m -100.22 105.08 16.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.681 -0.691 . . . . 2.8900000000000001 109.748 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 102' ' ' PRO . 77.8 m-85 -69.29 92.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 5.25 110.382 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.3 75.48 9.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 6.0599999999999996 109.338 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -139.58 145.06 38.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.425 -0.807 . . . . 9.7699999999999996 109.265 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 61.19 -145.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 O-C-N 123.598 0.561 . . . . 8.3399999999999999 109.931 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 89.1 mmm -106.11 -3.75 21.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.801 0.334 . . . . 8.1899999999999995 110.922 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.2 m -115.01 96.26 44.47 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.231 -0.441 . . . . 5.0999999999999996 111.044 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 96' ' ' PHE . 6.2 Cg_exo -78.16 103.81 1.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.916 2.411 . . . . 4.5099999999999998 111.989 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.427 HG22 HG13 ' A' ' 105' ' ' VAL . 36.4 m -80.56 99.27 8.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.163 0.506 . . . . 2.5899999999999999 110.257 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 59.6 tttm -95.43 103.27 15.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.874 -0.603 . . . . 3.1200000000000001 109.946 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 20.0 m -121.22 161.98 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.131 0.491 . . . . 1.23 111.803 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.789 ' HE2' HG13 ' A' ' 125' ' ' VAL . 47.0 mttm -108.5 138.28 45.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.525 -0.761 . . . . 2.3599999999999999 109.638 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -107.87 102.54 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.8 -0.444 . . . . 1.1100000000000001 109.8 167.454 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.787 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 8.3 t-160 -96.18 101.95 13.67 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.838 -1.542 . . . . 1.01 106.838 168.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.638 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 8.8 ttt -111.64 113.58 26.06 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.715 -1.216 . . . . 2.2200000000000002 107.715 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 18.4 ptpt -129.59 132.14 46.69 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.3 -0.56 . . . . 1.73 110.564 -168.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.741 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 81.2 tttt -56.88 117.88 4.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 109.03 -0.73 . . . . 1.78 109.03 167.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -45.46 142.72 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.185 0.928 . . . . 0.45000000000000001 110.767 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.8 tp -63.94 -25.83 68.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.202 -0.454 . . . . 2.3900000000000001 110.691 -173.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.0 m -81.71 -50.81 8.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.961 -0.563 . . . . 1.6599999999999999 109.811 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 128.31 -179.92 16.27 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.977 -0.63 . . . . 1.52 112.756 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.0 t70 61.64 31.6 18.66 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.944 0.878 . . . . 2.79 111.475 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.9 p 179.98 156.5 0.64 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.582 -1.19 . . . . 0.44 110.415 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.448 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 43.6 m-85 -136.17 134.74 38.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.469 -0.567 . . . . 0.41999999999999998 109.469 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.561 ' O ' ' HA ' ' A' ' 109' ' ' MET . 47.3 m95 -86.52 163.87 17.25 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.291 0.567 . . . . 0.41999999999999998 112.026 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.498 HG22 ' HE3' ' A' ' 109' ' ' MET . 60.0 t -132.12 97.42 2.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.387 -1.279 . . . . 0.62 109.037 174.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.787 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 58.3 m-85 -98.81 105.49 17.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.797 -0.446 . . . . 1.49 109.797 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 17.9 m -110.99 135.6 49.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.07 0.462 . . . . 1.6100000000000001 111.482 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -150.46 138.57 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.607 -0.724 . . . . 3.4500000000000002 109.288 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -89.41 92.46 9.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.254 0.55 . . . . 4.2300000000000004 110.646 178.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.789 HG13 ' HE2' ' A' ' 106' ' ' LYS . 8.2 p . . . . . 0 C--O 1.249 1.068 0 CA-C-N 115.149 -0.932 . . . . 3.3399999999999999 109.733 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 1.002 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.806 -0.442 . . . . 8.7200000000000006 109.806 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.84 119.3 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.228 0.33 . . . . 6.1799999999999997 110.213 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.424 ' HZ ' ' HG2' ' A' ' 124' ' ' ARG . 48.3 t80 -140.25 151.83 45.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.429 -0.35 . . . . 6.1500000000000004 110.522 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 90.73 -109.62 3.7 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.956 -0.64 . . . . 1.4299999999999999 112.174 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.82 109.64 18.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.449 0.642 . . . . 0.69999999999999996 111.413 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.594 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 4.7 tt -138.57 140.38 39.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.857 -0.611 . . . . 0.90000000000000002 110.051 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.696 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 2.8 pt20 -114.74 143.4 45.12 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.447 0.641 . . . . 2.2200000000000002 110.712 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.542 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.0 pp -124.08 157.34 34.78 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.05 -0.977 . . . . 0.71999999999999997 109.504 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.807 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.5 p30 -79.82 158.56 26.77 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.254 0.55 . . . . 1.1499999999999999 110.439 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.42 21.1 3.05 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.594 -0.73 . . . . 1.2 111.884 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 34' ' ' ASP . 23.8 t70 -106.06 -32.37 8.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.342 -0.614 . . . . 1.8100000000000001 109.342 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.67 11.16 3.03 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.417 -0.81 . . . . 1.05 112.485 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -118.78 155.89 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.687 -0.486 . . . . 1.5700000000000001 109.687 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.91 HG12 ' HB3' ' A' ' 60' ' ' LYS . 43.4 mm -70.5 136.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.967 -0.753 . . . . 1.1799999999999999 108.967 174.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.807 HD23 ' HB3' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -102.17 -65.24 1.0 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.023 -0.732 . . . . 1.5600000000000001 109.023 -173.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -145.25 134.88 23.37 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.318 -0.855 . . . . 2.4100000000000001 111.127 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.594 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 52.1 t80 -113.1 119.52 38.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.614 . . . . 1.4199999999999999 109.941 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.93 101.9 9.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.53 0.681 . . . . 1.21 110.766 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.15 106.63 10.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.426 -0.806 . . . . 2.5 110.523 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.95 130.2 45.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.914 -0.585 . . . . 4.0 110.151 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.59 88.72 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.892 -0.595 . . . . 7.21 112.295 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.94 17.39 11.86 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 109.736 -1.346 . . . . 6.9699999999999998 109.736 169.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -122.39 154.22 38.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.611 -0.794 . . . . 8.5899999999999999 109.914 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.6 mt -87.68 71.18 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.672 0.749 . . . . 9.2400000000000002 109.574 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 t -152.79 173.52 15.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.282 -0.872 . . . . 9.8200000000000003 109.722 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.437 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . -71.72 -81.02 0.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.025 -0.607 . . . . 9.6199999999999992 111.651 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 13.0 mmm180 -126.4 166.76 16.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.733 -0.469 . . . . 12.720000000000001 109.733 172.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.559 ' OD2' ' HG2' ' A' ' 55' ' ' LYS . 49.4 t0 -125.8 89.08 53.12 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.615 -0.513 . . . . 8.2400000000000002 109.615 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -97.2 23.74 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.32 2.68 . . . . 8.1099999999999994 113.243 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' OD2' ' A' ' 53' ' ' ASP . 9.8 ptpp? -111.72 166.73 10.93 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.944 -0.391 . . . . 9.2400000000000002 109.944 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 56' ' ' GLN . 28.2 tt0 67.72 25.16 8.15 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.954 0.883 . . . . 7.4000000000000004 110.535 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 58' ' ' ILE . 16.5 t -89.61 155.15 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.657 -0.701 . . . . 5.0599999999999996 109.4 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.46 ' N ' HG12 ' A' ' 57' ' ' VAL . 22.8 pt 38.13 64.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.278 1.031 . . . . 3.1699999999999999 113.104 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.57 -30.38 56.51 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.38 -1.282 . . . . 3.2400000000000002 112.448 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.91 ' HB3' HG12 ' A' ' 39' ' ' ILE . 25.3 ttmm -107.39 134.55 50.27 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 122.811 -0.229 . . . . 3.8500000000000001 110.867 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -158.53 101.41 1.68 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.191 -0.459 . . . . 4.1799999999999997 110.203 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -60.66 110.85 1.4 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 6.6600000000000001 110.881 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -121.5 -58.2 1.78 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.5 . . . . 8.1300000000000008 110.563 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HE2' HG11 ' A' ' 66' ' ' VAL . 19.6 ptmt -100.34 120.18 39.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.306 0.574 . . . . 10.050000000000001 110.69 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.64 29.21 1.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.879 -0.6 . . . . 7.9400000000000004 110.86 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.45 HG11 ' HE2' ' A' ' 64' ' ' LYS . 14.2 p -56.15 -30.34 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.744 -0.662 . . . . 9.3499999999999996 110.756 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 69.48 95.84 0.05 OUTLIER Pre-proline 0 C--N 1.342 0.263 0 C-N-CA 123.507 0.723 . . . . 9.1600000000000001 110.566 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.05 148.79 91.41 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.807 2.338 . . . . 10.35 111.421 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.1 m -70.98 -21.55 62.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.24 0.543 . . . . 11.49 109.783 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 m -136.01 132.98 36.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.787 -0.642 . . . . 10.949999999999999 110.167 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -162.0 154.61 19.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.82 -0.807 . . . . 11.56 108.82 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 p -142.44 88.68 8.74 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.132 0.419 . . . . 10.960000000000001 112.132 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.96 103.63 1.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.962 2.441 . . . . 10.68 111.074 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 8.3 tp10 -109.49 169.65 8.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.108 -0.496 . . . . 11.76 110.052 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 74' ' ' GLU . 74.9 m-85 76.08 23.68 1.25 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.851 0.719 . . . . 10.0 111.819 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -72.38 126.8 30.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.847 -0.615 . . . . 7.5300000000000002 109.682 171.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -110.86 -80.17 1.09 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.669 -1.253 . . . . 3.2000000000000002 110.065 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -130.43 61.29 1.6 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.857 -1.164 . . . . 4.1399999999999997 107.857 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.591 ' HA ' HD11 ' A' ' 88' ' ' LEU . 36.2 t80 -86.54 -37.75 17.87 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 116.352 -0.386 . . . . 0.94999999999999996 111.039 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -67.81 -32.04 72.32 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.383 -0.969 . . . . 3.48 108.383 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -82.49 -39.12 22.91 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.776 -1.556 . . . . 3.0699999999999998 108.987 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.603 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -54.79 -38.11 63.63 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.13 -0.941 . . . . 0.55000000000000004 112.364 -174.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 79' ' ' PHE . 61.8 t -69.19 -51.04 47.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.582 -0.809 . . . . 0.84999999999999998 110.786 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.89 -23.43 23.95 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.173 -0.467 . . . . 1.1200000000000001 112.253 -169.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.4 p -73.93 -33.3 63.89 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.828 -1.175 . . . . 1.8799999999999999 107.828 172.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.88 19.2 65.95 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.082 -0.963 . . . . 1.6599999999999999 111.13 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -153.78 52.3 0.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.554 0.693 . . . . 2.0800000000000001 112.084 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.603 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -67.24 86.45 0.16 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.53 -0.759 . . . . 0.56000000000000005 111.24 174.133 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.6 p30 -144.25 100.67 3.59 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.337 0.589 . . . . 2.0099999999999998 109.768 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.8 m -148.76 146.99 28.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.88 -0.513 . . . . 1.6699999999999999 109.992 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 17.9 ptm -98.76 114.86 27.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.613 -0.884 . . . . 3.9399999999999999 108.613 167.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -121.73 129.67 52.88 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.373 -0.83 . . . . 2.4700000000000002 109.418 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.527 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 22.3 mp0 -90.58 118.94 30.43 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.477 -0.934 . . . . 1.97 108.477 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -107.64 98.84 8.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.77 -0.65 . . . . 4.29 109.486 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 m -82.08 142.38 32.35 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.361 -0.836 . . . . 2.8900000000000001 110.688 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.79 -36.34 6.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.18 -0.674 . . . . 5.25 109.18 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 102' ' ' PRO . 24.1 t0 -166.89 163.13 16.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.545 -0.752 . . . . 6.0599999999999996 109.434 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -132.26 -8.58 3.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.334 -0.393 . . . . 9.7699999999999996 110.903 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -95.13 -66.58 0.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.82 0.343 . . . . 8.3399999999999999 110.652 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 46.0 ttm -84.18 -54.92 4.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.914 -0.585 . . . . 8.1899999999999995 110.067 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.8 m -121.53 93.46 48.72 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.771 -0.649 . . . . 5.0999999999999996 109.939 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 91.1 Cg_endo -81.58 24.88 0.67 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.874 2.383 . . . . 4.5099999999999998 112.644 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.7 m -76.42 97.74 4.37 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.56 0.695 . . . . 2.5899999999999999 110.357 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.527 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 37.0 ttpt -100.2 133.29 44.83 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.352 -0.84 . . . . 3.1200000000000001 110.018 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.3 m -102.15 161.92 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.298 0.57 . . . . 1.23 110.929 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 39.1 ttmt -116.37 126.72 53.88 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.241 -0.891 . . . . 2.3599999999999999 109.494 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.64 103.7 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.865 -0.607 . . . . 1.1100000000000001 109.411 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.954 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 5.7 t-160 -90.08 101.07 13.79 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.169 -1.789 . . . . 1.01 106.169 167.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.719 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.5 OUTLIER -102.2 120.46 40.49 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.294 -1.372 . . . . 2.2200000000000002 107.294 -178.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -135.79 119.36 17.02 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.943 -0.703 . . . . 1.73 111.143 -165.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.481 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 81.2 tttt -55.81 116.48 2.97 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.152 0.501 . . . . 1.78 110.276 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 145.84 45.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.62 -1.173 . . . . 0.45000000000000001 111.243 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.9 mm? -77.18 -8.08 56.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.867 -0.606 . . . . 2.3900000000000001 110.131 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 t -80.32 -45.53 17.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.062 -0.517 . . . . 1.6599999999999999 110.007 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.49 149.68 8.32 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.898 -0.667 . . . . 1.52 112.699 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 52.23 37.65 22.56 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.657 0.742 . . . . 2.79 111.644 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.0 p -159.98 154.03 23.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.845 -1.07 . . . . 0.44 109.761 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 66.2 m-85 -141.35 137.31 32.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.394 -0.366 . . . . 0.41999999999999998 110.27 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.696 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 44.3 m95 -88.24 164.18 15.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.471 0.653 . . . . 0.41999999999999998 111.65 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.7 t -136.21 96.1 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.017 -1.447 . . . . 0.62 108.391 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.954 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 63.5 m-85 -94.53 102.53 14.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.944 -1.132 . . . . 1.49 107.944 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 10.3 p -97.72 134.28 36.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 1.6100000000000001 111.132 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -134.74 127.43 30.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.992 -0.549 . . . . 3.4500000000000002 109.729 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.424 ' HG2' ' HZ ' ' A' ' 28' ' ' PHE . 10.0 ptm180 -97.66 151.18 20.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.912 0.387 . . . . 4.2300000000000004 111.028 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.409 -0.805 . . . . 3.3399999999999999 110.264 172.386 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.994 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.7 tp . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 110.58 -0.156 . . . . 8.7200000000000006 110.58 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 123' ' ' LYS . . . 68.95 -76.79 0.06 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.894 0.746 . . . . 6.1799999999999997 112.41 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -105.2 97.61 7.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.189 0.518 . . . . 6.1500000000000004 110.994 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -112.47 45.82 1.26 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.24 -0.891 . . . . 1.4299999999999999 111.889 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.25 103.4 15.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.969 0.414 . . . . 0.69999999999999996 111.073 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.53 HD11 HG23 ' A' ' 39' ' ' ILE . 5.7 tt -135.39 140.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.159 0.504 . . . . 0.90000000000000002 111.212 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.484 ' HB3' ' CE2' ' A' ' 119' ' ' TRP . 12.3 pt20 -109.6 121.09 44.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.656 -0.702 . . . . 2.2200000000000002 110.353 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 pp -123.15 152.34 41.26 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.078 -0.51 . . . . 0.71999999999999997 110.833 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -70.93 154.13 42.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.762 -0.654 . . . . 1.1499999999999999 110.142 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.516 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -76.79 31.17 1.49 Allowed Glycine 0 C--O 1.234 0.096 0 CA-C-N 115.781 -0.645 . . . . 1.2 113.31 -173.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 34' ' ' ASP . 12.4 t70 -135.44 -33.51 0.88 Allowed 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 122.84 0.456 . . . . 1.8100000000000001 110.204 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.59 18.84 0.53 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.473 -0.87 . . . . 1.05 113.051 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 30.8 m-80 -107.68 128.87 54.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.603 0.239 . . . . 1.5700000000000001 110.789 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.605 HG21 ' HA ' ' A' ' 58' ' ' ILE . 46.9 mm -78.9 115.6 21.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.722 -0.217 . . . . 1.1799999999999999 110.512 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.86 -47.44 9.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.072 0.463 . . . . 1.5600000000000001 110.575 -173.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -159.34 142.39 14.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.911 -0.586 . . . . 2.4100000000000001 111.416 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 27.5 t80 -114.44 117.59 31.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.656 -0.702 . . . . 1.4199999999999999 110.191 -177.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -100.52 91.73 4.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.855 -0.424 . . . . 1.21 109.855 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -174.63 98.94 0.09 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.843 -0.617 . . . . 2.5 110.518 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.83 90.6 5.88 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.522 -0.547 . . . . 4.0 109.522 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.33 6.77 16.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.736 -0.666 . . . . 7.21 110.406 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.8 -74.91 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.044 -0.98 . . . . 6.9699999999999998 111.266 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -152.23 159.89 43.47 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.213 -0.292 . . . . 8.5899999999999999 110.213 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.5 mt -51.99 -51.57 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.648 -0.705 . . . . 9.2400000000000002 110.275 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.6 m -82.49 62.95 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.7 0.762 . . . . 9.8200000000000003 110.02 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.01 76.33 2.21 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.451 -0.795 . . . . 9.6199999999999992 112.71 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -80.27 51.73 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.307 0.575 . . . . 12.720000000000001 110.162 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -93.58 117.6 67.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.754 -0.657 . . . . 8.2400000000000002 110.553 -175.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -83.83 8.18 4.77 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.789 2.326 . . . . 8.1099999999999994 113.047 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.773 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -118.36 14.38 13.77 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.397 0.617 . . . . 9.2400000000000002 111.303 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.89 0.31 25.78 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.163 -0.926 . . . . 7.4000000000000004 109.548 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 39' ' ' ILE . 11.3 t 52.48 59.31 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.169 -0.923 . . . . 5.0599999999999996 109.697 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.605 ' HA ' HG21 ' A' ' 39' ' ' ILE . 29.9 pt -134.61 166.37 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.476 -0.784 . . . . 3.1699999999999999 111.184 -177.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.29 32.65 62.4 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.175 -0.921 . . . . 3.2400000000000002 112.75 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 2.9 tppp? -111.23 96.38 6.09 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.995 0.426 . . . . 3.8500000000000001 110.637 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -115.76 96.44 5.61 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.047 0.451 . . . . 4.1799999999999997 110.384 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -129.73 152.37 49.3 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.309 -0.997 . . . . 6.6600000000000001 108.309 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -78.72 -5.17 52.46 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.723 -0.391 . . . . 8.1300000000000008 111.883 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -173.1 120.94 0.36 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.104 0.478 . . . . 10.050000000000001 111.056 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -86.54 -26.05 24.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.356 0.598 . . . . 7.9400000000000004 109.632 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.8 t 58.63 56.8 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.83 -1.077 . . . . 9.3499999999999996 110.438 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.41 83.51 9.85 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.871 -1.059 . . . . 9.1600000000000001 109.878 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.41 -39.47 2.79 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.526 2.151 . . . . 10.35 112.424 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 49.0 t -150.23 96.28 2.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.401 . . . . 11.49 110.776 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 m -135.23 -62.47 0.71 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.856 0.36 . . . . 10.949999999999999 110.226 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -158.64 151.08 21.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 11.56 109.74 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.9 m -121.27 100.64 44.96 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.853 0.358 . . . . 10.960000000000001 110.474 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.1 -17.79 27.86 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.58 2.187 . . . . 10.68 111.567 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.66 151.02 40.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.386 -0.825 . . . . 11.76 109.374 177.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -87.78 96.23 10.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.45 0.643 . . . . 10.0 110.999 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.812 ' HB3' ' HB2' ' A' ' 79' ' ' PHE . 77.9 m-85 -82.64 137.18 34.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.387 -0.824 . . . . 7.5300000000000002 109.35 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.08 -75.01 1.14 Allowed Glycine 0 CA--C 1.506 -0.513 0 C-N-CA 119.819 -1.181 . . . . 3.2000000000000002 112.071 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.16 8.95 39.78 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 110.392 -0.225 . . . . 4.1399999999999997 110.392 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.812 ' HB2' ' HB3' ' A' ' 76' ' ' TYR . 6.1 t80 -49.93 -36.06 26.27 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.749 0.648 . . . . 0.94999999999999996 112.749 -168.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 57.4 mmtt -66.54 -30.42 70.73 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 121.394 0.616 . . . . 3.48 110.952 -177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -89.26 -41.5 12.15 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.876 -0.787 . . . . 3.0699999999999998 108.876 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.828 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -51.41 -40.99 47.45 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.142 -0.935 . . . . 0.55000000000000004 112.565 -173.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 79' ' ' PHE . 85.7 t -64.89 -52.08 58.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.463 -0.869 . . . . 0.84999999999999998 110.942 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.07 -29.84 21.59 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.101 -0.5 . . . . 1.1200000000000001 112.323 -168.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.8 p -72.94 -29.53 63.17 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.708 -0.849 . . . . 1.8799999999999999 108.708 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.03 26.0 65.38 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.828 -0.909 . . . . 1.6599999999999999 110.828 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -148.56 49.3 1.02 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.89 0.853 . . . . 2.0800000000000001 111.759 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.828 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -71.79 78.4 0.86 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.142 -0.935 . . . . 0.56000000000000005 111.644 176.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.5 p-10 -144.23 98.44 3.21 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.454 0.645 . . . . 2.0099999999999998 109.787 174.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 91' ' ' MET . 4.1 m -149.16 157.43 43.37 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.789 -0.448 . . . . 1.6699999999999999 109.789 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.5 ptt? -117.52 138.19 52.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.331 -0.395 . . . . 3.9399999999999999 109.941 173.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -161.84 149.61 14.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.275 -0.639 . . . . 2.4700000000000002 109.275 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.582 ' HG3' ' HD3' ' A' ' 106' ' ' LYS . 10.5 mp0 -92.28 121.02 33.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.599 -0.519 . . . . 1.97 109.599 176.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -113.62 137.95 50.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.27 -0.423 . . . . 4.29 110.336 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.2 t -125.94 150.9 47.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.211 -0.45 . . . . 2.8900000000000001 110.822 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -130.11 7.17 5.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.232 0.539 . . . . 5.25 110.359 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -159.16 136.77 10.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.178 -0.919 . . . . 6.0599999999999996 108.634 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -138.28 158.64 43.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.41 -0.359 . . . . 9.7699999999999996 111.869 -169.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 68.81 -59.84 0.46 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.201 0.938 . . . . 8.3399999999999999 112.01 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 65.2 mtt -60.41 -50.15 74.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.387 0.613 . . . . 8.1899999999999995 110.071 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.38 150.25 75.04 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.329 -0.851 . . . . 5.0999999999999996 110.471 175.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -91.55 45.03 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.323 2.682 . . . . 4.5099999999999998 112.058 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.1 m -71.76 97.19 1.73 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.447 0.641 . . . . 2.5899999999999999 110.396 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HD2' HG21 ' A' ' 125' ' ' VAL . 26.8 ttmt -126.89 111.61 14.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.503 -0.771 . . . . 3.1200000000000001 109.103 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 27.3 m -104.17 159.49 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.295 0.569 . . . . 1.23 111.229 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.582 ' HD3' ' HG3' ' A' ' 93' ' ' GLU . 55.0 mmtt -101.73 120.61 40.63 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.085 -0.962 . . . . 2.3599999999999999 108.668 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.557 HG12 ' HG3' ' A' ' 109' ' ' MET . 2.1 t -97.21 102.02 12.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.172 -0.677 . . . . 1.1100000000000001 109.172 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 15.9 t60 -101.31 103.56 14.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.765 -1.198 . . . . 1.01 107.765 170.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 62.0 mtt -106.67 144.18 33.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.058 -1.09 . . . . 2.2200000000000002 108.058 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.6 ptpt -147.97 130.77 16.07 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.146 -0.621 . . . . 1.73 109.76 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.551 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 63.2 tttp -57.76 111.53 1.17 Allowed 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 109.038 -0.727 . . . . 1.78 109.038 168.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.63 144.75 13.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.781 -1.1 . . . . 0.45000000000000001 110.085 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.39 -17.99 63.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.003 0.43 . . . . 2.3900000000000001 110.098 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.2 m -63.0 -40.33 97.45 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.493 -0.776 . . . . 1.6599999999999999 110.354 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.66 -61.8 0.4 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.72 -0.752 . . . . 1.52 113.475 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -87.45 41.42 0.98 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.438 0.637 . . . . 2.79 112.202 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.516 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.1 p -166.92 159.28 13.3 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.741 -0.663 . . . . 0.44 110.806 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.551 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 72.7 m-85 -139.06 135.63 34.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.835 -0.621 . . . . 0.41999999999999998 109.615 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.484 ' CE2' ' HB3' ' A' ' 32' ' ' GLN . 42.2 m95 -87.77 163.13 16.64 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.352 0.596 . . . . 0.41999999999999998 112.044 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.95 111.08 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.144 -1.389 . . . . 0.62 108.828 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 83.8 m-85 -111.9 110.08 20.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.529 -0.545 . . . . 1.49 109.529 174.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.34 125.03 63.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.585 0.231 . . . . 1.6100000000000001 110.77 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 27' ' ' ALA . 97.1 mttt -144.63 137.81 26.93 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 108.966 -0.753 . . . . 3.4500000000000002 108.966 177.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 14.0 ptt180 -81.68 155.63 25.47 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.285 0.564 . . . . 4.2300000000000004 111.102 -175.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.443 HG21 ' HD2' ' A' ' 104' ' ' LYS . 61.4 t . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.37 -0.832 . . . . 3.3399999999999999 109.291 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 1.018 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.855 0.36 . . . . 8.7200000000000006 110.894 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 43' ' ' ASN . . . -74.3 -34.95 63.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.923 -0.58 . . . . 6.1799999999999997 110.696 175.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -63.22 129.19 39.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.432 -0.349 . . . . 6.1500000000000004 110.158 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.63 -21.82 29.55 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.944 -0.863 . . . . 1.4299999999999999 110.944 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.91 106.77 16.45 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.003 0.43 . . . . 0.69999999999999996 111.156 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.441 HG23 ' HB ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -123.88 139.39 50.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.641 -0.503 . . . . 0.90000000000000002 109.641 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 41' ' ' GLN . 12.2 pt20 -110.48 126.57 54.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.786 -0.643 . . . . 2.2200000000000002 110.529 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.56 163.35 21.15 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.548 -0.751 . . . . 0.71999999999999997 110.046 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 45.9 p30 -87.06 165.93 15.41 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.47 0.653 . . . . 1.1499999999999999 110.97 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.573 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -77.16 27.91 1.71 Allowed Glycine 0 C--N 1.319 -0.409 0 CA-C-N 115.251 -0.886 . . . . 1.2 112.243 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 34' ' ' ASP . 20.5 t70 -127.22 -8.97 5.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.084 0.469 . . . . 1.8100000000000001 110.433 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.06 11.27 43.31 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.866 -0.683 . . . . 1.05 112.151 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.485 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -106.42 148.25 28.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.823 0.344 . . . . 1.5700000000000001 110.195 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 31' ' ' ILE . 45.5 mm -84.22 129.45 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.548 -0.538 . . . . 1.1799999999999999 109.548 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.5 tp -96.91 -48.59 5.37 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.954 -0.388 . . . . 1.5600000000000001 109.954 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 31.5 tp60 -163.55 121.87 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.229 0.538 . . . . 2.4100000000000001 111.096 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.427 ' H ' HD13 ' A' ' 58' ' ' ILE . 77.2 t80 -89.72 123.92 34.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.444 -0.947 . . . . 1.4199999999999999 108.444 170.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.585 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 49.7 m-80 -81.94 112.93 19.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.218 0.532 . . . . 1.21 110.327 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.84 141.23 37.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.88 -0.6 . . . . 2.5 109.683 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.85 128.35 36.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.724 0.297 . . . . 4.0 110.859 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -68.54 99.4 0.97 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.827 -0.624 . . . . 7.21 110.664 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.05 -88.68 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.835 -0.697 . . . . 6.9699999999999998 111.866 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -145.69 116.37 7.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.612 0.244 . . . . 8.5899999999999999 111.275 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.7 mt -71.72 -37.44 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.415 -0.957 . . . . 9.2400000000000002 108.415 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 50' ' ' THR . 12.5 t 43.38 69.27 0.41 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.384 -1.28 . . . . 9.8200000000000003 112.728 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.26 158.63 8.18 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.154 -0.93 . . . . 9.6199999999999992 112.327 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 52' ' ' ARG . 5.3 ptp85 -87.22 88.46 7.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.432 0.634 . . . . 12.720000000000001 110.161 176.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.582 ' OD1' ' HG3' ' A' ' 55' ' ' LYS . 6.9 t0 -76.65 128.97 80.7 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.503 -0.771 . . . . 8.2400000000000002 110.275 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.18 39.29 0.59 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.083 2.522 . . . . 8.1099999999999994 113.057 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.582 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 46.9 mttp -81.86 99.39 9.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.891 0.377 . . . . 9.2400000000000002 111.418 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -103.71 5.58 36.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.272 0.558 . . . . 7.4000000000000004 109.893 172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 57' ' ' VAL . 10.0 p -86.14 36.16 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 123.092 1.425 . . . . 5.0599999999999996 109.956 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 42' ' ' TYR . 7.7 tp -154.59 149.69 12.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.56 -1.2 . . . . 3.1699999999999999 109.265 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 58' ' ' ILE . . . 77.49 17.63 78.88 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.356 -0.698 . . . . 3.2400000000000002 111.356 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 2.8 tppp? -90.01 94.23 9.71 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.867 0.365 . . . . 3.8500000000000001 110.028 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -133.43 96.37 3.7 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.458 -0.941 . . . . 4.1799999999999997 108.458 172.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -165.48 135.92 3.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.981 -1.009 . . . . 6.6600000000000001 108.286 -170.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -81.79 37.02 0.46 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.127 0.489 . . . . 8.1300000000000008 111.265 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 64' ' ' LYS . 26.9 tptt -167.97 168.89 11.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.501 -0.772 . . . . 10.050000000000001 109.012 178.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.9 t70 62.0 71.67 0.53 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.832 0.825 . . . . 7.9400000000000004 110.964 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 m -113.98 -39.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.062 -0.972 . . . . 9.3499999999999996 109.634 176.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.05 115.88 49.97 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.755 -0.657 . . . . 9.1600000000000001 109.579 175.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.13 -49.77 15.89 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.857 2.371 . . . . 10.35 112.67 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.424 ' HB3' ' H ' ' A' ' 70' ' ' THR . 18.2 m -151.0 -159.9 1.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.512 . . . . 11.49 110.34 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.424 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 6.1 m -64.61 121.11 13.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.983 0.364 . . . . 10.949999999999999 111.983 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.6 t70 66.59 107.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.968 0.793 . . . . 11.56 112.751 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.0 t -141.56 101.78 6.03 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.052 -0.522 . . . . 10.960000000000001 109.876 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.59 54.4 3.42 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.354 2.703 . . . . 10.68 112.053 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.62 -6.43 58.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.556 0.694 . . . . 11.76 109.817 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.659 ' HB3' ' H ' ' A' ' 79' ' ' PHE . 39.2 m-85 -81.52 101.64 10.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.54 -0.754 . . . . 10.0 109.77 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.439 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 63.6 m-85 -62.24 -69.43 0.25 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.564 . . . . 7.5300000000000002 112.117 -173.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -90.86 39.43 3.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.579 -0.82 . . . . 3.2000000000000002 112.183 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 78' ' ' LYS . 23.5 ttmt 53.65 70.22 0.62 Allowed 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.691 0.758 . . . . 4.1399999999999997 109.543 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.659 ' H ' ' HB3' ' A' ' 75' ' ' PHE . 71.7 t80 -50.1 -36.17 28.46 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.725 -1.125 . . . . 0.94999999999999996 113.071 -166.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -72.38 -25.01 61.35 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.123 0.487 . . . . 3.48 110.557 -173.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -82.19 -31.52 30.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.138 -0.69 . . . . 3.0699999999999998 109.138 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 1.014 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -64.3 -41.31 98.25 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.422 -0.808 . . . . 0.55000000000000004 111.753 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 79' ' ' PHE . 57.9 t -67.79 -47.13 80.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.907 -0.647 . . . . 0.84999999999999998 110.36 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.12 -32.07 63.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 1.1200000000000001 110.848 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 64.6 p -67.28 -32.85 74.12 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.118 -0.697 . . . . 1.8799999999999999 109.118 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.36 12.83 34.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.622 -0.717 . . . . 1.6599999999999999 112.828 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.584 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.4 p30 -175.23 69.98 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.764 0.792 . . . . 2.0800000000000001 110.224 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.014 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.3 tt -58.75 88.09 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.911 -1.04 . . . . 0.56000000000000005 111.233 174.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.2 t30 -143.08 101.63 3.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.935 -0.575 . . . . 2.0099999999999998 109.573 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.9 t -150.82 155.84 40.03 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 120.895 0.378 . . . . 1.6699999999999999 110.064 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.7 ptt? -134.5 116.69 15.38 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.586 -0.734 . . . . 3.9399999999999999 110.003 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -143.08 136.98 28.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.439 -0.8 . . . . 2.4700000000000002 109.263 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.3 pt-20 -100.18 118.57 36.79 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.396 -0.522 . . . . 1.97 110.485 177.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -108.23 101.59 10.79 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.803 -0.814 . . . . 4.29 108.803 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.704 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 8.8 t -82.95 142.61 31.27 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.16 0.505 . . . . 2.8900000000000001 110.73 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -98.2 107.24 19.66 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.814 -0.81 . . . . 5.25 108.814 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -58.04 -26.97 63.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.835 -0.431 . . . . 6.0599999999999996 109.835 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.609 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 9.4 t80 65.13 -89.02 0.03 OUTLIER 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.187 -0.915 . . . . 9.7699999999999996 111.498 168.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.609 ' HG3' ' O ' ' A' ' 98' ' ' TYR . 6.1 mt-30 -161.76 -55.37 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.032 0.533 . . . . 8.3399999999999999 109.669 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -105.57 -70.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.707 -0.679 . . . . 8.1899999999999995 110.567 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.4 t -105.89 141.96 23.8 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.769 -0.651 . . . . 5.0999999999999996 110.515 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.71 118.78 5.82 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.378 2.052 . . . . 4.5099999999999998 112.315 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.7 m -89.15 98.29 11.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.793 -0.817 . . . . 2.5899999999999999 108.793 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 4.7 tmmm? -93.42 126.74 38.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.153 -0.476 . . . . 3.1200000000000001 111.542 -171.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 32.1 m -110.27 158.69 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 115.78 -0.646 . . . . 1.23 109.869 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 24.1 ttmm -132.45 118.6 19.53 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.948 -0.569 . . . . 2.3599999999999999 109.474 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.3 t -95.87 104.96 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-N 116.445 -0.343 . . . . 1.1100000000000001 110.203 -176.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.662 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 3.4 t-160 -107.12 102.22 11.57 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.758 -1.201 . . . . 1.01 107.758 170.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.659 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 85.3 mtp -110.12 138.01 47.09 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.547 -1.279 . . . . 2.2200000000000002 107.547 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 14.2 ptmm? -144.09 135.33 25.59 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.86 -0.736 . . . . 1.73 110.373 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.648 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 46.0 tttm -55.88 116.41 2.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.797 0.808 . . . . 1.78 110.569 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.35 150.46 22.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.172 -1.376 . . . . 0.45000000000000001 110.716 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.48 -14.42 41.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.787 0.327 . . . . 2.3900000000000001 111.257 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.4 t -76.12 -24.76 54.94 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.048 0.451 . . . . 1.6599999999999999 110.326 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.57 -44.7 3.18 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.269 -0.491 . . . . 1.52 112.449 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.58 34.09 0.64 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.498 0.666 . . . . 2.79 111.673 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 34' ' ' ASP . 2.2 p -169.95 159.37 7.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.167 -0.924 . . . . 0.44 110.427 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.648 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 32.2 m-85 -141.31 145.3 35.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.714 0.292 . . . . 0.41999999999999998 110.297 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.426 ' O ' ' HA ' ' A' ' 109' ' ' MET . 40.8 m95 -93.23 165.64 12.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.46 0.647 . . . . 0.41999999999999998 111.853 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 31' ' ' ILE . 63.0 t -136.08 104.63 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.35 -1.295 . . . . 0.62 109.307 174.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.662 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 62.7 m-85 -106.63 104.79 14.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.463 -0.94 . . . . 1.49 108.463 174.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 12.2 p -105.09 135.48 42.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.25 0.548 . . . . 1.6100000000000001 110.929 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 81.6 mttt -122.17 109.99 15.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.822 -0.627 . . . . 3.4500000000000002 109.905 176.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.437 ' C ' ' HD2' ' A' ' 124' ' ' ARG . 3.8 ppt_? -104.29 147.19 27.78 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.776 -0.453 . . . . 4.2300000000000004 109.776 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.461 HG13 ' OXT' ' A' ' 125' ' ' VAL . 3.6 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 117.968 -1.015 . . . . 3.3399999999999999 109.99 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 1.009 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.116 -0.698 . . . . 8.7200000000000006 109.116 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.16 147.79 9.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.633 0.254 . . . . 6.1799999999999997 111.535 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.437 ' CZ ' ' HA ' ' A' ' 55' ' ' LYS . 6.1 m-85 -76.09 78.33 2.93 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.579 -0.526 . . . . 6.1500000000000004 109.579 167.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.18 -72.11 1.27 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.54 -0.838 . . . . 1.4299999999999999 111.756 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.49 114.24 16.52 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.903 0.382 . . . . 0.69999999999999996 111.145 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.503 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 5.5 tt -118.58 140.63 41.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.429 -0.582 . . . . 0.90000000000000002 109.429 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.572 ' OE1' ' HB3' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -120.99 143.82 48.84 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.295 0.569 . . . . 2.2200000000000002 110.905 -175.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.48 160.93 33.76 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.062 -0.972 . . . . 0.71999999999999997 110.37 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 48.0 p30 -85.03 159.38 20.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.503 0.668 . . . . 1.1499999999999999 110.863 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.552 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -77.83 20.55 3.61 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.062 -0.972 . . . . 1.2 111.935 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -99.78 -39.84 8.02 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.813 -0.81 . . . . 1.8100000000000001 108.813 176.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.73 7.78 0.73 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.214 -0.993 . . . . 1.05 114.596 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -134.29 160.08 39.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.366 1.083 . . . . 1.5700000000000001 112.472 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 31' ' ' ILE . 75.9 mt -75.27 143.19 13.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.619 -1.173 . . . . 1.1799999999999999 110.656 -175.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.574 ' HG ' ' HG3' ' A' ' 41' ' ' GLN . 60.5 tp -119.48 -57.56 1.98 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.449 -0.341 . . . . 1.5600000000000001 111.275 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.574 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 94.8 mt-30 -126.81 145.22 50.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.329 . . . . 2.4100000000000001 111.332 -174.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.503 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 87.6 t80 -132.38 136.63 46.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 1.4199999999999999 110.835 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -105.28 107.12 17.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 1.21 109.556 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.97 -34.03 20.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.906 -0.588 . . . . 2.5 111.34 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.07 91.52 3.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.23 -0.441 . . . . 4.0 111.12 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -103.29 9.13 38.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.842 0.83 . . . . 7.21 109.391 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.05 -26.46 24.4 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.28 -0.873 . . . . 6.9699999999999998 111.958 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.62 149.58 28.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.527 0.203 . . . . 8.5899999999999999 110.462 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.4 mt -123.83 95.47 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.247 -0.433 . . . . 9.2400000000000002 110.811 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 p -82.74 179.98 7.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.693 -0.23 . . . . 9.8200000000000003 110.558 173.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.6 -53.34 0.23 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.144 -1.027 . . . . 9.6199999999999992 113.447 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 33.9 ptt180 -96.43 69.43 2.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.381 0.61 . . . . 12.720000000000001 111.495 -174.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.402 ' OD2' ' HD1' ' A' ' 28' ' ' PHE . 4.1 m-20 -97.65 107.71 41.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.96 -0.564 . . . . 8.2400000000000002 110.735 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 52' ' ' ARG . 16.4 Cg_exo -70.57 -28.73 20.99 Favored 'Trans proline' 0 CA--C 1.527 0.136 0 C-N-CA 123.154 2.57 . . . . 8.1099999999999994 112.92 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' HA ' ' CZ ' ' A' ' 28' ' ' PHE . 27.6 mtpp 61.56 34.23 17.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.049 0.452 . . . . 9.2400000000000002 111.17 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -94.61 -16.41 23.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.026 -0.534 . . . . 7.4000000000000004 112.111 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.471 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 2.6 m -111.48 74.65 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.432 0.634 . . . . 5.0599999999999996 112.34 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -176.69 150.79 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.423 -0.955 . . . . 3.1699999999999999 108.423 173.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.27 29.84 26.71 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.032 -1.227 . . . . 3.2400000000000002 110.032 -173.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.614 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -104.11 124.07 48.42 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.088 -0.556 . . . . 3.8500000000000001 109.878 -176.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -148.19 112.83 5.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.947 0.403 . . . . 4.1799999999999997 110.961 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -151.01 5.29 0.48 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.576 -0.738 . . . . 6.6600000000000001 109.992 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 63.31 -95.2 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.244 -0.889 . . . . 8.1300000000000008 111.319 -174.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -139.43 153.88 47.67 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.322 -0.251 . . . . 10.050000000000001 110.322 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -65.3 139.05 58.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.008 0.432 . . . . 7.9400000000000004 110.194 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 66' ' ' VAL . 13.2 p -127.17 39.07 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 122.909 1.338 . . . . 9.3499999999999996 109.074 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.81 150.99 4.01 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.205 -1.361 . . . . 9.1600000000000001 109.56 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.28 -4.33 10.35 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.992 2.462 . . . . 10.35 112.475 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.7 t -63.46 -46.68 85.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.346 -0.843 . . . . 11.49 111.249 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.474 ' OG1' ' H2 ' ' A' ' 169' ' ' HC4 . 3.0 m -106.84 156.16 18.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.199 -0.455 . . . . 10.949999999999999 111.11 -173.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.418 ' N ' HG22 ' A' ' 70' ' ' THR . 5.9 p-10 -162.54 168.91 21.13 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.661 -0.496 . . . . 11.56 109.661 175.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.2 m -76.18 118.84 74.21 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.692 -0.231 . . . . 10.960000000000001 111.548 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -96.95 -171.52 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.337 2.692 . . . . 10.68 112.859 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 56.67 62.86 2.13 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.657 -0.701 . . . . 11.76 111.64 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -78.64 90.9 4.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.617 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -114.59 -49.79 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.479 -0.328 . . . . 7.5300000000000002 110.869 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.62 36.58 4.25 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.597 -1.001 . . . . 3.2000000000000002 110.597 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt 57.47 46.08 18.6 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.135 -0.533 . . . . 4.1399999999999997 109.63 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.596 ' O ' HG23 ' A' ' 83' ' ' VAL . 65.6 t80 -44.81 -42.26 7.7 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 113.436 0.902 . . . . 0.94999999999999996 113.436 -166.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -68.68 -36.3 78.35 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.282 0.563 . . . . 3.48 110.395 -174.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.72 -30.79 28.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.527 -0.761 . . . . 3.0699999999999998 109.103 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.958 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.97 -43.84 92.87 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.458 -0.792 . . . . 0.55000000000000004 111.714 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.2 t -63.53 -52.56 56.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.565 -0.818 . . . . 0.84999999999999998 110.843 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.33 -26.1 35.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 1.1200000000000001 111.767 -170.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.6 t -67.61 -25.19 65.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.409 -0.589 . . . . 1.8799999999999999 109.409 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.41 78.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.87 -0.605 . . . . 1.6599999999999999 112.888 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.42 50.28 1.02 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.711 0.767 . . . . 2.0800000000000001 111.616 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.958 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.1 tt -70.73 89.7 0.75 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.259 -0.882 . . . . 0.56000000000000005 110.995 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.5 p30 -143.68 100.49 3.6 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.705 -0.85 . . . . 2.0099999999999998 108.705 169.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 3.1 p -141.52 152.68 44.35 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.945 -0.472 . . . . 1.6699999999999999 111.059 -174.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.665 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.5 ptm -120.07 116.49 25.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.6 0.714 . . . . 3.9399999999999999 109.775 173.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -119.55 122.47 41.69 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.885 -1.052 . . . . 2.4700000000000002 109.244 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 106' ' ' LYS . 49.2 mt-10 -92.86 130.47 38.45 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.423 -0.584 . . . . 1.97 109.423 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -108.21 124.21 49.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.973 -0.558 . . . . 4.29 110.356 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.8 t -81.4 151.36 27.95 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.629 -0.714 . . . . 2.8900000000000001 111.293 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -74.27 115.48 13.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.284 -0.871 . . . . 5.25 111.514 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -71.39 -42.53 68.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.594 0.711 . . . . 6.0599999999999996 109.772 175.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -92.68 146.62 23.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.064 -0.971 . . . . 9.7699999999999996 111.136 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -97.87 26.48 5.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.372 0.606 . . . . 8.3399999999999999 110.243 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.4 ttt -60.35 -61.78 2.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.766 -0.652 . . . . 8.1899999999999995 110.147 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.1 t -145.88 148.91 37.59 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 115.323 -0.853 . . . . 5.0999999999999996 108.966 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.65 88.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.28 1.986 . . . . 4.5099999999999998 112.078 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.6 m -105.5 96.32 6.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.94 -0.573 . . . . 2.5899999999999999 110.12 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -111.44 102.31 10.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.756 -0.656 . . . . 3.1200000000000001 109.231 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -106.16 161.62 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.189 -0.46 . . . . 1.23 111.207 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 19.4 ptpt -139.18 127.06 22.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.585 -0.734 . . . . 2.3599999999999999 109.292 176.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -92.91 144.89 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 C-N-CA 120.185 -0.606 . . . . 1.1100000000000001 110.623 175.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 5.2 t60 -131.69 102.8 6.04 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.43 -1.322 . . . . 1.01 107.43 164.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.676 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 11.2 ptp -101.88 123.72 46.29 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.664 -1.236 . . . . 2.2200000000000002 107.664 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 21.1 ptmt -138.08 133.36 33.38 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 120.435 -0.506 . . . . 1.73 110.941 -165.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.491 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 64.4 tttp -56.75 115.41 2.55 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.335 -0.848 . . . . 1.78 111.144 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.77 147.09 39.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.513 -1.221 . . . . 0.45000000000000001 110.425 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.19 -3.34 16.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.666 0.27 . . . . 2.3900000000000001 111.335 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 p -84.58 -17.82 37.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.705 0.288 . . . . 1.6599999999999999 111.366 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 127.64 -108.7 0.97 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.306 -0.95 . . . . 1.52 113.118 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -85.16 68.49 10.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.278 1.037 . . . . 2.79 110.956 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.552 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.7 p -158.52 154.09 26.14 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.668 -1.151 . . . . 0.44 108.719 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 50.1 m-85 -140.41 135.85 32.48 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.769 0.319 . . . . 0.41999999999999998 110.364 -175.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.546 ' O ' ' HA ' ' A' ' 109' ' ' MET . 39.7 m95 -87.1 161.4 18.14 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 120.861 0.362 . . . . 0.41999999999999998 110.086 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.4 t -140.01 95.88 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.215 -0.902 . . . . 0.62 108.938 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 108' ' ' HIS . 7.8 p90 -119.53 141.23 49.41 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.991 -0.684 . . . . 1.49 110.528 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 123' ' ' LYS . 12.1 p -123.53 151.98 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.68 -0.691 . . . . 1.6100000000000001 110.229 -175.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 123' ' ' LYS . 14.8 tptt -143.65 140.61 30.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.094 -0.336 . . . . 3.4500000000000002 110.094 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -105.48 137.86 42.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.913 0.387 . . . . 4.2300000000000004 111.09 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.647 -0.692 . . . . 3.3399999999999999 109.961 178.701 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 1.007 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.796 0.331 . . . . 8.7200000000000006 110.237 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.416 ' HB3' ' HG3' ' A' ' 124' ' ' ARG . . . -109.09 142.81 39.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.44 -0.346 . . . . 6.1799999999999997 110.21 175.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -83.19 80.58 9.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.986 0.422 . . . . 6.1500000000000004 111.147 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -89.2 55.51 3.97 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.961 -0.563 . . . . 1.4299999999999999 111.919 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.75 102.44 12.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.041 0.448 . . . . 0.69999999999999996 111.469 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.676 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 5.9 tt -137.61 141.85 38.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.978 -0.555 . . . . 0.90000000000000002 109.957 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.526 ' HB3' ' CE3' ' A' ' 119' ' ' TRP . 0.7 OUTLIER -120.27 140.72 50.8 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.223 0.535 . . . . 2.2200000000000002 110.811 -178.368 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.604 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.9 pp -134.71 162.85 31.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.439 -0.8 . . . . 0.71999999999999997 111.152 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.565 ' HB3' HD11 ' A' ' 40' ' ' LEU . 10.4 p30 -83.61 158.26 21.96 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.697 -0.683 . . . . 1.1499999999999999 110.876 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.573 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -72.83 2.15 34.69 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.311 -0.858 . . . . 1.2 112.191 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.44 -42.28 17.13 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.11 -0.7 . . . . 1.8100000000000001 109.11 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.59 28.32 0.69 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.179 -0.919 . . . . 1.05 112.355 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.572 ' HA ' ' HG3' ' A' ' 60' ' ' LYS . 17.0 m-80 -133.86 150.11 51.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.769 0.318 . . . . 1.5700000000000001 110.23 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.939 HG12 ' HB3' ' A' ' 60' ' ' LYS . 12.1 mm -74.65 143.53 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 116.239 -0.437 . . . . 1.1799999999999999 110.443 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' A' ' 34' ' ' ASP . 85.7 mt -113.86 -50.89 2.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.837 0.351 . . . . 1.5600000000000001 111.104 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -142.45 136.17 29.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.23 -0.441 . . . . 2.4100000000000001 110.258 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.795 ' HB3' ' HA ' ' A' ' 57' ' ' VAL . 61.7 t80 -130.28 135.67 48.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.164 -0.471 . . . . 1.4199999999999999 110.205 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -104.7 142.02 35.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.389 -0.368 . . . . 1.21 110.382 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.79 151.07 20.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.257 -0.429 . . . . 2.5 110.478 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.57 106.17 18.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.337 -0.392 . . . . 4.0 111.075 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.85 179.21 5.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.213 -0.449 . . . . 7.21 110.235 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.61 -59.75 0.67 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.753 -0.737 . . . . 6.9699999999999998 112.246 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.19 132.48 33.86 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.62 -0.511 . . . . 8.5899999999999999 109.62 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.8 mm -92.67 44.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.812 0.815 . . . . 9.2400000000000002 110.713 -174.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.1 p -138.07 42.87 2.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.878 -0.601 . . . . 9.8200000000000003 109.834 171.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.63 117.77 0.91 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.117 -1.039 . . . . 9.6199999999999992 113.036 -175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.617 ' HA ' ' NE ' ' A' ' 52' ' ' ARG . 2.8 mmp_? -109.33 104.51 13.64 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.307 -0.627 . . . . 12.720000000000001 109.307 171.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -68.36 130.6 92.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.763 -0.653 . . . . 8.2400000000000002 111.233 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.92 -9.48 15.57 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.655 2.237 . . . . 8.1099999999999994 111.643 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 64.06 94.31 0.05 Allowed 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.371 -0.831 . . . . 9.2400000000000002 111.907 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -70.64 -54.2 12.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.735 -0.666 . . . . 7.4000000000000004 109.338 172.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.795 ' HA ' ' HB3' ' A' ' 42' ' ' TYR . 47.2 t 62.61 -70.15 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.061 0.944 . . . . 5.0599999999999996 112.612 176.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.0 pt -132.28 71.47 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 122.152 0.977 . . . . 3.1699999999999999 110.513 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.46 -32.99 83.42 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 114.407 -1.27 . . . . 3.2400000000000002 112.724 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.939 ' HB3' HG12 ' A' ' 39' ' ' ILE . 26.3 tptp -105.22 113.27 26.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.709 0.29 . . . . 3.8500000000000001 110.701 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -138.03 112.5 8.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.506 -0.924 . . . . 4.1799999999999997 108.506 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -61.59 99.31 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 6.6600000000000001 111.168 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -107.49 13.51 26.78 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.678 -0.86 . . . . 8.1300000000000008 108.678 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.7 mttp 62.3 49.72 4.14 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.71 -1.218 . . . . 10.050000000000001 107.71 -169.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -9.01 7.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 113.365 -1.743 . . . . 7.9400000000000004 112.416 -171.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m 37.77 43.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.568 1.147 . . . . 9.3499999999999996 113.5 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.45 102.64 52.23 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.63 -0.714 . . . . 9.1600000000000001 109.256 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -40.89 113.03 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 124.169 3.246 . . . . 10.35 114.177 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.3 m -99.85 123.76 44.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.437 -0.801 . . . . 11.49 109.145 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 m -53.48 -51.8 61.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.594 -0.521 . . . . 10.949999999999999 109.594 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -167.76 -69.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.215 -0.902 . . . . 11.56 109.113 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.457 ' HB2' ' CD1' ' A' ' 76' ' ' TYR . 31.4 m -125.02 152.98 71.2 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.276 -0.875 . . . . 10.960000000000001 108.78 175.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 72' ' ' SER . 7.6 Cg_exo -73.92 40.51 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.432 2.754 . . . . 10.68 113.44 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 65.72 -179.2 0.19 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.18 0.592 . . . . 11.76 111.429 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 65.47 23.67 11.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.253 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.852 ' HB2' ' HB2' ' A' ' 79' ' ' PHE . 51.6 p90 -113.21 143.62 44.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.954 -0.567 . . . . 7.5300000000000002 110.615 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.87 90.91 0.65 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.827 -0.702 . . . . 3.2000000000000002 111.588 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 18.4 tptm 60.35 35.68 20.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.173 0.511 . . . . 4.1399999999999997 110.315 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.852 ' HB2' ' HB2' ' A' ' 76' ' ' TYR . 62.0 t80 -48.8 -37.67 19.88 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.562 -0.745 . . . . 0.94999999999999996 112.733 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -70.47 -36.87 74.11 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 123.576 0.547 . . . . 3.48 110.123 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.731 ' HB3' ' HG3' ' A' ' 78' ' ' LYS . 41.0 tt0 -80.55 -31.87 36.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.586 -0.734 . . . . 3.0699999999999998 109.18 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.982 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.5 -46.25 93.4 Favored Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 115.666 -0.697 . . . . 0.55000000000000004 111.88 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.4 t -69.15 -46.46 77.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.696 -0.752 . . . . 0.84999999999999998 110.578 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.6 -28.84 63.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.864 -0.607 . . . . 1.1200000000000001 110.555 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -69.69 -23.91 63.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.414 -0.812 . . . . 1.8799999999999999 109.265 174.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.93 19.58 69.84 Favored Glycine 0 CA--C 1.505 -0.539 0 CA-C-N 115.685 -0.688 . . . . 1.6599999999999999 112.198 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -163.4 55.57 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.246 0.546 . . . . 2.0800000000000001 111.29 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.982 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.1 tt -68.65 88.95 0.36 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.771 -0.649 . . . . 0.56000000000000005 111.081 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.758 ' HA ' ' O ' ' A' ' 109' ' ' MET . 20.4 t30 -143.15 100.45 3.64 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.284 -0.636 . . . . 2.0099999999999998 109.284 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.9 t -156.06 158.08 37.17 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.999 0.428 . . . . 1.6699999999999999 110.687 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 19.5 ptt? -125.77 126.16 44.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.772 -0.649 . . . . 3.9399999999999999 110.447 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.55 ' O ' HG22 ' A' ' 107' ' ' VAL . 90.1 t80 -146.08 130.16 17.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.676 -0.693 . . . . 2.4700000000000002 109.795 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.774 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 12.9 pt-20 -104.62 127.1 52.27 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.046 0.451 . . . . 1.97 110.222 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -122.3 94.09 4.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.794 0.807 . . . . 4.29 109.154 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.532 ' HB ' ' HG3' ' A' ' 104' ' ' LYS . 9.2 t -91.4 135.7 33.64 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.129 -0.941 . . . . 2.8900000000000001 110.827 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 102' ' ' PRO . 1.5 m-85 56.76 66.29 1.21 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.618 -0.719 . . . . 5.25 110.608 177.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -88.1 -151.61 0.2 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.319 -0.855 . . . . 6.0599999999999996 111.345 -175.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -76.42 -13.36 60.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 9.7699999999999996 110.864 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -69.82 127.97 34.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.436 -0.579 . . . . 8.3399999999999999 109.436 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.558 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 49.7 ttm -62.09 -24.05 66.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.365 -0.38 . . . . 8.1899999999999995 111.299 -176.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.5 m -95.51 95.22 1.65 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.232 -0.655 . . . . 5.0999999999999996 109.232 171.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 100' ' ' MET . 5.7 Cg_exo -79.1 103.75 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.068 2.512 . . . . 4.5099999999999998 112.496 -172.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.9 m -109.38 139.91 43.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.972 -0.558 . . . . 2.5899999999999999 109.518 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.532 ' HG3' ' HB ' ' A' ' 95' ' ' THR . 62.4 tttm -84.18 99.31 10.44 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.737 -0.785 . . . . 3.1200000000000001 109.552 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 124' ' ' ARG . 17.9 m -109.4 159.89 8.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.008 -0.996 . . . . 1.23 111.588 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.774 ' HG3' ' HB3' ' A' ' 93' ' ' GLU . 25.0 ttpp -146.11 115.0 6.92 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.461 -0.791 . . . . 2.3599999999999999 109.213 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 122' ' ' VAL . 12.9 m -88.54 144.56 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-O 121.373 0.606 . . . . 1.1100000000000001 111.414 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.417 ' O ' ' HD1' ' A' ' 121' ' ' PHE . 5.1 t60 -132.33 103.32 6.15 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 106.858 -1.534 . . . . 1.01 106.858 160.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.758 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 79.5 mtp -103.7 132.14 50.23 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.108 -1.442 . . . . 2.2200000000000002 107.108 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HG2' ' HB2' ' A' ' 119' ' ' TRP . 61.7 pttt -138.59 131.62 29.76 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.709 -0.796 . . . . 1.73 110.087 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.43 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 80.8 tttt -56.57 113.05 1.45 Allowed 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.784 -0.644 . . . . 1.78 110.188 172.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -58.22 144.75 39.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.605 -1.18 . . . . 0.45000000000000001 110.866 -173.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 73.4 mt -71.23 -9.81 58.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.041 -0.527 . . . . 2.3900000000000001 110.846 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 p -73.13 -30.63 63.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.975 -0.557 . . . . 1.6599999999999999 111.057 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.6 -126.16 2.82 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.74 -0.743 . . . . 1.52 112.668 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.65 79.24 2.01 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.989 0.899 . . . . 2.79 110.853 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.573 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.1 p -168.07 156.16 8.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.532 -1.213 . . . . 0.44 108.457 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.43 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 31.6 m-85 -140.24 137.36 34.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.64 0.257 . . . . 0.41999999999999998 110.916 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.577 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . 45.1 m95 -83.64 162.81 20.65 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.227 0.536 . . . . 0.41999999999999998 110.817 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 50.9 t -137.23 97.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.744 -1.116 . . . . 0.62 109.659 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 89.8 m-85 -100.17 102.47 13.78 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.528 -0.545 . . . . 1.49 109.528 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 107' ' ' VAL . 3.7 m -97.84 106.47 18.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.516 0.674 . . . . 1.6100000000000001 110.026 176.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -109.34 109.44 20.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.963 -0.461 . . . . 3.4500000000000002 110.773 -172.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.559 ' HB3' HG12 ' A' ' 105' ' ' VAL . 5.5 ppt_? -101.76 142.88 32.4 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.383 -0.599 . . . . 4.2300000000000004 109.383 175.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.197 -0.906 . . . . 3.3399999999999999 110.077 177.528 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 1.015 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.021 -0.363 . . . . 8.7200000000000006 110.021 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.62 103.34 14.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.019 0.438 . . . . 6.1799999999999997 110.332 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -81.74 133.29 35.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.196 -0.456 . . . . 6.1500000000000004 111.323 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.76 -150.27 9.02 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.589 -0.732 . . . . 1.4299999999999999 111.864 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.81 119.45 29.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.139 -0.319 . . . . 0.69999999999999996 110.139 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -111.64 138.71 39.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.988 0.423 . . . . 0.90000000000000002 110.604 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.655 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 6.4 pt20 -109.88 127.04 54.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.816 -0.629 . . . . 2.2200000000000002 110.343 176.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.444 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.8 pp -118.69 159.03 24.39 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.288 -0.869 . . . . 0.71999999999999997 109.577 177.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.771 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 1.9 p30 -84.24 151.59 24.71 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.174 -0.611 . . . . 1.1499999999999999 109.976 176.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -73.3 5.18 21.86 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.431 -0.804 . . . . 1.2 112.606 -175.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.09 -39.34 13.69 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.495 -0.557 . . . . 1.8100000000000001 109.495 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.79 36.99 0.19 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.611 -0.722 . . . . 1.05 111.935 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.771 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 19.0 m-80 -137.59 152.53 49.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.978 0.418 . . . . 1.5700000000000001 110.342 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.444 HD13 ' HB3' ' A' ' 33' ' ' LEU . 46.3 mm -95.14 123.28 47.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.879 -0.601 . . . . 1.1799999999999999 110.057 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.2 tp -102.59 -52.06 3.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.754 0.279 . . . . 1.5600000000000001 111.754 -173.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.642 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 46.8 tt0 -142.52 122.49 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.902 0.382 . . . . 2.4100000000000001 111.371 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -113.76 106.37 14.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.088 -0.506 . . . . 1.4199999999999999 109.668 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -81.95 93.4 6.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.137 0.494 . . . . 1.21 110.587 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.22 -53.06 3.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.5 -0.773 . . . . 2.5 109.65 175.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.08 112.74 4.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.1 -0.954 . . . . 4.0 109.153 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.58 123.73 18.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.398 . . . . 7.21 110.527 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.83 19.01 38.4 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.805 -0.712 . . . . 6.9699999999999998 111.995 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.92 118.07 30.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.391 -0.596 . . . . 8.5899999999999999 109.391 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 pt -111.11 39.28 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.121 0.486 . . . . 9.2400000000000002 112.24 -171.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.5 t -96.34 160.56 14.35 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.285 -0.635 . . . . 9.8200000000000003 109.285 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -102.09 99.91 1.94 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.711 -0.757 . . . . 9.6199999999999992 112.705 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 52' ' ' ARG . 56.5 mtt-85 -89.51 113.86 25.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.473 -0.936 . . . . 12.720000000000001 108.473 173.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 1.9 p-10 -66.19 132.39 94.48 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.568 0.699 . . . . 8.2400000000000002 111.683 -170.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.606 ' HB3' ' HA3' ' A' ' 59' ' ' GLY . 2.9 Cg_exo -77.44 18.86 0.77 Allowed 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 123.915 3.077 . . . . 8.1099999999999994 113.846 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -92.12 23.36 3.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.584 0.707 . . . . 9.2400000000000002 110.149 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -127.1 -87.01 0.59 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.147 -0.933 . . . . 7.4000000000000004 110.366 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.44 HG12 HG21 ' A' ' 70' ' ' THR . 2.5 m -136.46 -44.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.386 -0.825 . . . . 5.0599999999999996 110.861 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 11.9 tt -75.13 151.39 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.973 -0.38 . . . . 3.1699999999999999 109.973 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.606 ' HA3' ' HB3' ' A' ' 54' ' ' PRO . . . 79.88 8.58 87.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.917 -0.658 . . . . 3.2400000000000002 112.051 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.745 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 24.9 tptp -79.79 107.17 12.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.763 -0.458 . . . . 3.8500000000000001 109.763 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.416 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . 68.3 m-20 -143.4 96.39 2.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.853 0.359 . . . . 4.1799999999999997 110.499 176.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -151.75 102.52 2.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.751 -0.833 . . . . 6.6600000000000001 108.751 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -91.28 15.22 12.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 8.1300000000000008 112.175 -170.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -122.18 158.95 28.26 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.215 -0.291 . . . . 10.050000000000001 110.215 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t70 74.84 -54.24 0.67 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.811 0.695 . . . . 7.9400000000000004 111.387 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.4 t 53.11 49.94 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.081 0.943 . . . . 9.3499999999999996 111.083 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.743 ' H ' ' HD2' ' A' ' 68' ' ' PRO . . . -105.39 -49.62 0.12 Allowed Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.411 -0.813 . . . . 9.1600000000000001 110.213 170.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.743 ' HD2' ' H ' ' A' ' 67' ' ' ALA . 37.7 Cg_endo -66.53 101.96 0.57 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.753 1.635 . . . . 10.35 111.287 171.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.3 p -134.23 119.35 18.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.821 -0.627 . . . . 11.49 110.852 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.44 HG21 HG12 ' A' ' 57' ' ' VAL . 2.6 p -85.36 52.83 2.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.383 0.611 . . . . 10.949999999999999 110.71 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -78.5 97.38 5.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.542 -0.753 . . . . 11.56 110.539 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.7 t -131.9 129.19 21.81 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.692 -0.685 . . . . 10.960000000000001 109.36 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.21 57.24 1.66 Allowed 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.167 2.578 . . . . 10.68 112.414 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.72 -64.18 0.91 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.016 -0.538 . . . . 11.76 109.684 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.84 24.43 2.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.675 -0.693 . . . . 10.0 109.8 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -64.92 133.18 51.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.81 -0.632 . . . . 7.5300000000000002 111.254 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -133.64 96.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.123 -0.791 . . . . 3.2000000000000002 111.123 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 65.48 25.09 11.87 Favored 'General case' 0 C--O 1.223 -0.32 0 O-C-N 123.826 0.368 . . . . 4.1399999999999997 110.191 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 83' ' ' VAL . 44.8 t80 -55.87 -29.93 60.7 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 112.541 0.571 . . . . 0.94999999999999996 112.541 -167.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -81.4 -37.21 28.52 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.039 0.447 . . . . 3.48 110.204 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -78.72 -30.7 46.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.745 -0.835 . . . . 3.0699999999999998 108.745 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 1.012 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.51 -43.98 90.56 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.067 -0.969 . . . . 0.55000000000000004 111.873 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 79' ' ' PHE . 89.6 t -68.57 -52.56 35.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.424 -0.888 . . . . 0.84999999999999998 111.047 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.19 -28.97 38.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.936 -0.575 . . . . 1.1200000000000001 111.678 -169.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -72.07 -26.32 62.12 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.658 -0.867 . . . . 1.8799999999999999 108.658 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.6 18.43 70.79 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.249 -0.887 . . . . 1.6599999999999999 112.313 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -140.31 42.46 1.91 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.47 0.652 . . . . 2.0800000000000001 111.897 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.012 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -69.21 89.13 0.45 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.363 -0.835 . . . . 0.56000000000000005 111.609 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.716 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.1 p30 -143.95 100.9 3.65 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.453 -0.943 . . . . 2.0099999999999998 108.453 169.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 17.8 p -131.85 151.1 51.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 121.879 -0.513 . . . . 1.6699999999999999 111.12 -173.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 3.9 ppp? -118.79 129.34 55.19 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.647 -0.871 . . . . 3.9399999999999999 108.647 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.469 ' HE2' ' HD2' ' A' ' 94' ' ' TYR . 38.5 t80 -139.28 127.85 23.08 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.906 -0.588 . . . . 2.4700000000000002 109.463 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -90.62 107.3 19.08 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.764 -1.199 . . . . 1.97 107.764 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.469 ' HD2' ' HE2' ' A' ' 92' ' ' PHE . 43.1 t80 -108.84 103.25 12.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.157 0.503 . . . . 4.29 110.646 -173.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.53 HG22 ' H ' ' A' ' 97' ' ' ASP . 4.9 m -96.17 132.61 41.41 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.672 -0.695 . . . . 2.8900000000000001 110.017 175.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.22 -27.22 42.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.853 -0.158 . . . . 5.25 110.798 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.57 ' HA ' ' HB3' ' A' ' 102' ' ' PRO . 33.0 t70 69.33 171.71 0.3 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.827 0.704 . . . . 6.0599999999999996 110.403 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.405 ' CG ' ' N ' ' A' ' 99' ' ' GLN . 49.3 t80 67.46 -171.8 0.19 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.709 -0.478 . . . . 9.7699999999999996 109.709 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.405 ' N ' ' CG ' ' A' ' 98' ' ' TYR . 41.2 mt-30 71.17 -178.16 0.21 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.981 0.512 . . . . 8.3399999999999999 111.085 176.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -60.4 -38.84 85.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.362 0.601 . . . . 8.1899999999999995 109.724 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 7.1 t -139.24 138.16 20.31 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.353 -0.839 . . . . 5.0999999999999996 109.314 174.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 97' ' ' ASP . 15.5 Cg_exo -67.81 101.49 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.344 2.029 . . . . 4.5099999999999998 110.824 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.3 m -56.57 98.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 2.5899999999999999 110.98 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 52.0 tttm -106.82 117.81 35.03 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.876 -0.602 . . . . 3.1200000000000001 110.87 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.5 161.03 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.93 -0.577 . . . . 1.23 110.391 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.618 ' HE2' HG13 ' A' ' 125' ' ' VAL . 17.4 ttmm -113.92 115.79 28.24 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.094 -1.076 . . . . 2.3599999999999999 108.094 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' MET . 1.9 t -89.73 142.71 12.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 119.976 -0.689 . . . . 1.1100000000000001 109.321 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.597 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 3.8 t60 -140.47 103.51 4.57 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.437 -0.949 . . . . 1.01 108.437 167.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.716 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 61.5 mtt -92.19 140.68 29.38 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.045 -1.465 . . . . 2.2200000000000002 107.045 173.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -149.27 129.95 14.09 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.349 -0.94 . . . . 1.73 111.202 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.502 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 38.1 tttp -55.22 117.81 3.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.481 -1.236 . . . . 1.78 110.435 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.18 147.71 9.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.783 -1.099 . . . . 0.45000000000000001 111.256 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -62.03 -25.54 67.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.345 -0.389 . . . . 2.3900000000000001 111.297 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.0 p -79.59 -56.0 4.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.044 0.449 . . . . 1.6599999999999999 110.226 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.31 169.14 12.74 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.874 -0.679 . . . . 1.52 112.389 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.9 t70 60.32 28.86 18.5 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.243 1.02 . . . . 2.79 110.642 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.489 ' CB ' ' HA ' ' A' ' 34' ' ' ASP . 6.9 p -168.1 153.22 6.69 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.347 -1.297 . . . . 0.44 109.984 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 51.3 m-85 -140.98 139.68 34.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.226 -0.443 . . . . 0.41999999999999998 110.117 -175.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.655 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 40.6 m95 -87.77 161.4 17.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.192 0.52 . . . . 0.41999999999999998 111.448 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.518 HG22 ' HG2' ' A' ' 109' ' ' MET . 62.1 t -140.21 96.59 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.439 -1.255 . . . . 0.62 108.601 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 108' ' ' HIS . 5.4 p90 -124.58 140.1 53.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.241 -0.583 . . . . 1.49 110.213 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.5 m -113.1 162.78 10.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.171 0.51 . . . . 1.6100000000000001 111.342 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -151.74 120.08 6.38 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.421 -0.809 . . . . 3.4500000000000002 109.29 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -77.58 91.82 4.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.503 0.668 . . . . 4.2300000000000004 111.202 -176.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.618 HG13 ' HE2' ' A' ' 106' ' ' LYS . 2.9 p . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.381 -0.827 . . . . 3.3399999999999999 110.179 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.969 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.543 0.211 . . . . 8.7200000000000006 111.356 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.9 -48.93 6.5 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.453 -0.943 . . . . 6.1799999999999997 108.453 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -105.95 150.98 25.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.316 -0.856 . . . . 6.1500000000000004 109.103 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 177.49 -57.17 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.427 -0.892 . . . . 1.4299999999999999 112.767 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.89 111.21 5.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.969 0.414 . . . . 0.69999999999999996 111.719 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.745 HG13 ' HA ' ' A' ' 42' ' ' TYR . 1.2 tt -131.9 140.44 48.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.368 -0.378 . . . . 0.90000000000000002 110.095 174.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.669 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 2.4 pt20 -108.27 130.8 55.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.42 0.629 . . . . 2.2200000000000002 110.201 172.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -120.06 158.14 27.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.185 -0.916 . . . . 0.71999999999999997 109.53 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.84 152.03 38.97 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.991 -0.55 . . . . 1.1499999999999999 109.788 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.606 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -79.28 37.6 2.01 Favored Glycine 0 CA--C 1.506 -0.509 0 CA-C-N 115.906 -0.588 . . . . 1.2 112.237 -172.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -140.47 -33.67 0.55 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.075 -0.562 . . . . 1.8100000000000001 110.484 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.97 11.75 0.49 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.459 -0.877 . . . . 1.05 113.183 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 61' ' ' ASN . 17.0 m-80 -106.07 144.71 32.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.151 -0.315 . . . . 1.5700000000000001 110.151 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.729 HG12 ' HB3' ' A' ' 60' ' ' LYS . 44.7 mm -75.59 134.99 28.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.645 -0.502 . . . . 1.1799999999999999 109.645 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.601 ' HB3' ' HG3' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -106.08 -62.69 1.34 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.938 -0.764 . . . . 1.5600000000000001 108.938 -174.23 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.626 ' HB3' ' HG2' ' A' ' 32' ' ' GLN . 39.9 tt0 -144.69 110.34 5.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.838 -1.074 . . . . 2.4100000000000001 110.359 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.745 ' HA ' HG13 ' A' ' 31' ' ' ILE . 19.2 t80 -100.06 110.78 23.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.008 -0.542 . . . . 1.4199999999999999 109.659 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -93.17 93.53 8.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.847 0.356 . . . . 1.21 110.382 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.89 133.23 33.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.969 -0.56 . . . . 2.5 110.14 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.43 92.16 6.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.063 0.458 . . . . 4.0 110.923 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.59 127.28 51.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.916 -0.584 . . . . 7.21 109.94 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.52 62.11 4.66 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.901 -0.88 . . . . 6.9699999999999998 110.901 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -90.81 99.68 12.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.127 0.489 . . . . 8.5899999999999999 110.864 -174.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.8 mt -90.81 -53.23 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.486 -0.779 . . . . 9.2400000000000002 109.085 175.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -153.95 158.12 40.19 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.342 -0.844 . . . . 9.8200000000000003 108.909 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.96 131.96 1.97 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.13 -1.033 . . . . 9.6199999999999992 112.505 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.1 ptt85 -86.99 61.23 6.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.365 0.602 . . . . 12.720000000000001 110.444 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.427 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 33.4 t70 -108.26 103.24 49.86 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.634 . . . . 8.2400000000000002 110.103 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 53' ' ' ASP . 89.4 Cg_exo -36.75 97.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.715 3.61 . . . . 8.1099999999999994 113.974 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.83 106.49 17.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.236 -0.893 . . . . 9.2400000000000002 109.412 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -85.94 -26.94 25.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.896 -0.593 . . . . 7.4000000000000004 112.427 -172.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.0 t -100.57 26.87 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.297 0.57 . . . . 5.0599999999999996 111.316 -170.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 57' ' ' VAL . 2.1 pt -152.86 156.12 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 116.033 -0.53 . . . . 3.1699999999999999 110.093 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.31 28.17 64.08 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.596 -0.729 . . . . 3.2400000000000002 111.71 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.729 ' HB3' HG12 ' A' ' 39' ' ' ILE . 49.4 tptt -90.82 113.9 26.17 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.961 0.41 . . . . 3.8500000000000001 110.532 -174.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.481 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 3.5 p30 -114.37 124.97 53.29 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.67 -0.696 . . . . 4.1799999999999997 110.224 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -133.59 129.05 36.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.262 -0.881 . . . . 6.6600000000000001 109.594 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -119.59 -68.51 0.91 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.114 0.483 . . . . 8.1300000000000008 110.809 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -149.95 29.86 0.73 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.861 0.839 . . . . 10.050000000000001 109.256 -177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.25 152.08 45.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.314 -1.312 . . . . 7.9400000000000004 110.683 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 m -89.92 50.57 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.408 0.623 . . . . 9.3499999999999996 112.378 -171.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.507 ' N ' ' HD2' ' A' ' 68' ' ' PRO . . . -84.32 -51.42 0.58 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.773 -0.649 . . . . 9.1600000000000001 111.995 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 67' ' ' ALA . 34.7 Cg_endo -64.74 119.05 5.99 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.004 1.803 . . . . 10.35 112.724 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.1 m -135.54 112.49 10.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.705 -0.68 . . . . 11.49 111.033 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 71' ' ' ASP . 2.4 m 66.76 158.01 0.12 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.341 -0.845 . . . . 10.949999999999999 111.458 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.452 ' N ' HG22 ' A' ' 70' ' ' THR . 2.5 m-20 -62.59 120.17 10.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.918 0.389 . . . . 11.56 110.932 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 m -127.94 86.46 58.12 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.074 -0.512 . . . . 10.960000000000001 110.266 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.3 37.92 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.695 2.93 . . . . 10.68 112.955 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -85.82 -36.4 20.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.11 0.481 . . . . 11.76 110.495 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -132.71 178.86 6.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.313 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.859 ' HB2' ' HB2' ' A' ' 79' ' ' PHE . 43.7 p90 50.43 122.87 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.949 1.299 . . . . 7.5300000000000002 113.291 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.61 -58.24 4.24 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.851 -1.166 . . . . 3.2000000000000002 112.191 -172.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 81' ' ' GLU . 73.8 mmtt -138.43 33.57 2.28 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 109.088 -0.708 . . . . 4.1399999999999997 109.088 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.897 ' HA ' HD11 ' A' ' 88' ' ' LEU . 35.9 t80 -44.61 -47.35 10.39 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 114.094 1.146 . . . . 0.94999999999999996 114.094 -160.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -79.58 -30.25 41.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.656 0.741 . . . . 3.48 109.578 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 68.1 tt0 -73.7 -31.52 63.46 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.975 -1.011 . . . . 3.0699999999999998 108.274 176.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.817 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.27 -43.67 99.07 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.613 -1.176 . . . . 0.55000000000000004 111.259 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 79' ' ' PHE . 73.7 t -65.43 -47.68 85.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.368 -0.916 . . . . 0.84999999999999998 110.526 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.8 -31.05 56.72 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.779 -0.646 . . . . 1.1200000000000001 111.225 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.2 t -66.46 -34.26 77.53 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.264 -1.013 . . . . 1.8799999999999999 108.264 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.62 12.48 58.15 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.24 -0.891 . . . . 1.6599999999999999 111.699 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.561 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.3 p30 -162.28 59.13 0.23 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.572 0.701 . . . . 2.0800000000000001 111.475 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.897 HD11 ' HA ' ' A' ' 79' ' ' PHE . 1.4 tt -60.6 93.01 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.451 -0.795 . . . . 0.56000000000000005 110.746 172.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.729 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.1 t30 -140.63 101.52 4.11 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.662 -0.495 . . . . 2.0099999999999998 109.662 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 6.3 m -137.26 149.44 47.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.48 -0.327 . . . . 1.6699999999999999 110.202 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.0 ptt? -134.08 128.8 34.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.063 -0.517 . . . . 3.9399999999999999 109.865 175.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -161.83 154.01 19.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.964 -0.562 . . . . 2.4700000000000002 109.937 -174.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.741 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 37.1 mt-10 -110.8 112.21 23.92 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.67 -0.493 . . . . 1.97 109.67 176.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 96' ' ' PHE . 36.5 p90 -131.73 161.27 33.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 4.29 111.421 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -99.32 104.23 16.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.421 -0.809 . . . . 2.8900000000000001 110.892 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.425 ' HB3' ' CE1' ' A' ' 94' ' ' TYR . 31.9 p90 -87.57 -17.81 31.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.928 0.394 . . . . 5.25 111.014 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -137.48 131.3 31.67 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.778 -0.453 . . . . 6.0599999999999996 109.778 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -113.86 95.61 5.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.901 0.381 . . . . 9.7699999999999996 111.345 -175.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -112.32 -148.8 0.44 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.478 -0.564 . . . . 8.3399999999999999 109.478 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -55.07 -47.62 74.63 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.196 -0.668 . . . . 8.1899999999999995 109.196 173.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.2 p -100.25 144.83 29.18 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 115.211 -0.904 . . . . 5.0999999999999996 110.151 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.24 100.64 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.182 1.921 . . . . 4.5099999999999998 110.331 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.5 m -67.18 97.35 0.52 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.455 0.645 . . . . 2.5899999999999999 110.21 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 104' ' ' LYS . 5.2 ttmp? -104.54 119.59 39.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.11 -0.95 . . . . 3.1200000000000001 110.418 -174.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 17.3 m -109.45 159.48 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.903 -0.59 . . . . 1.23 111.324 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.741 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -108.85 113.43 26.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.827 -1.175 . . . . 2.3599999999999999 107.827 175.472 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 91' ' ' MET . 3.5 m -100.45 144.86 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 C-N-CA 119.872 -0.731 . . . . 1.1100000000000001 112.138 -178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.3 t-160 -135.9 102.19 4.98 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.335 -1.302 . . . . 1.01 107.497 164.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.729 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 63.1 mtt -100.92 116.33 32.52 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.459 -1.682 . . . . 2.2200000000000002 106.459 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 58.8 pttt -132.14 136.64 47.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.218 -0.993 . . . . 1.73 110.999 -168.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.634 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 35.1 tttm -55.6 119.56 5.88 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.138 -0.937 . . . . 1.78 110.57 170.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.84 146.85 13.04 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.119 -0.946 . . . . 0.45000000000000001 110.159 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.5 tp -61.96 -25.23 67.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.547 -0.297 . . . . 2.3900000000000001 110.744 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.9 m -76.48 -67.42 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.363 -0.38 . . . . 1.6599999999999999 110.749 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 143.89 161.93 9.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.63 -0.795 . . . . 1.52 112.447 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 t70 54.57 37.43 27.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.445 1.117 . . . . 2.79 111.003 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.606 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 5.5 p -167.8 150.41 5.77 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.346 -1.297 . . . . 0.44 108.962 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.634 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 57.2 m-85 -141.66 141.57 33.37 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.702 0.287 . . . . 0.41999999999999998 110.416 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.669 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 46.3 m95 -90.58 165.73 13.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.457 0.646 . . . . 0.41999999999999998 111.391 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.61 96.07 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.308 -1.314 . . . . 0.62 108.877 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.511 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 45.8 m-85 -92.71 132.24 37.1 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.613 -0.884 . . . . 1.49 108.613 172.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.459 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 8.2 p -144.75 137.03 21.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.788 0.328 . . . . 1.6100000000000001 110.636 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -145.29 132.62 20.62 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.85 -0.426 . . . . 3.4500000000000002 109.85 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -106.11 157.11 17.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.134 0.492 . . . . 4.2300000000000004 110.624 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.622 HG13 ' HE2' ' A' ' 106' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 117.836 -1.078 . . . . 3.3399999999999999 110.137 175.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.995 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.368 -0.604 . . . . 8.7200000000000006 109.368 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.76 144.06 26.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.535 0.207 . . . . 6.1799999999999997 110.811 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -124.26 -57.6 1.58 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.519 -0.549 . . . . 6.1500000000000004 109.519 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.32 49.7 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.915 -1.039 . . . . 1.4299999999999999 110.862 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.42 102.42 15.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.304 0.573 . . . . 0.69999999999999996 112.148 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.568 HG13 ' HA ' ' A' ' 42' ' ' TYR . 5.4 tt -124.44 139.7 49.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.695 -0.684 . . . . 0.90000000000000002 109.383 172.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.551 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -116.65 137.12 52.42 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.62 0.724 . . . . 2.2200000000000002 111.844 -176.584 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.914 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.6 pp -126.86 165.34 19.52 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.824 -1.08 . . . . 0.71999999999999997 110.31 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 14.8 p30 -97.2 158.66 15.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.302 0.573 . . . . 1.1499999999999999 110.211 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.629 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -79.49 26.27 2.68 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.539 -0.755 . . . . 1.2 111.725 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 34' ' ' ASP . 5.7 t70 -104.91 -18.59 14.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.203 0.525 . . . . 1.8100000000000001 109.691 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.44 3.73 5.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.312 -0.946 . . . . 1.05 114.209 171.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.44 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 20.1 p-10 -144.81 159.84 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.97 0.885 . . . . 1.5700000000000001 111.979 -176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.914 HD13 ' HB3' ' A' ' 33' ' ' LEU . 7.5 mm -70.06 146.79 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.066 -0.97 . . . . 1.1799999999999999 109.747 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.503 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 46.8 tp -112.41 -46.17 3.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.219 -0.446 . . . . 1.5600000000000001 110.666 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -147.08 119.98 8.72 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.288 0.566 . . . . 2.4100000000000001 111.929 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.883 ' HB3' HG12 ' A' ' 57' ' ' VAL . 68.4 t80 -98.16 134.69 40.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.927 -0.578 . . . . 1.4199999999999999 109.564 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -107.1 101.16 10.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.865 0.364 . . . . 1.21 110.786 -177.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.63 109.18 20.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.001 -0.545 . . . . 2.5 110.213 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.53 125.2 28.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.101 -0.499 . . . . 4.0 110.064 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 64.35 70.71 0.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.816 0.817 . . . . 7.21 109.788 -174.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.66 -114.63 0.58 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.877 -1.056 . . . . 6.9699999999999998 110.988 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -152.27 121.84 6.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.612 0.72 . . . . 8.5899999999999999 110.679 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.84 81.43 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.734 -1.121 . . . . 9.2400000000000002 109.125 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.29 153.72 43.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.608 -0.723 . . . . 9.8200000000000003 111.683 -172.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.38 -48.42 85.29 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.403 -0.679 . . . . 9.6199999999999992 111.403 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -109.89 84.67 1.97 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.241 -1.022 . . . . 12.720000000000001 108.241 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -94.15 126.7 47.66 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.337 -0.392 . . . . 8.2400000000000002 110.314 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.51 -6.76 16.5 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.979 2.452 . . . . 8.1099999999999994 112.832 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -91.95 150.93 20.75 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.872 -0.418 . . . . 9.2400000000000002 109.872 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -86.58 -23.16 25.89 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.008 -0.738 . . . . 7.4000000000000004 109.008 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.883 HG12 ' HB3' ' A' ' 42' ' ' TYR . 6.0 t 56.2 67.93 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.139 -0.937 . . . . 5.0599999999999996 110.579 177.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.706 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -128.59 157.03 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.517 -0.765 . . . . 3.1699999999999999 110.484 -178.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.83 -26.54 12.7 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.59 -1.004 . . . . 3.2400000000000002 110.59 170.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.697 ' HB3' HG12 ' A' ' 39' ' ' ILE . 4.2 tppp? -117.93 120.54 38.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.072 -0.564 . . . . 3.8500000000000001 110.176 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -129.36 125.33 36.41 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.34 0.59 . . . . 4.1799999999999997 110.085 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 38' ' ' ASN . 30.4 m-85 -70.28 95.86 1.06 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.481 -0.782 . . . . 6.6600000000000001 111.384 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.484 ' CD1' ' HG2' ' A' ' 64' ' ' LYS . 75.9 t80 -94.35 -58.77 2.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.428 -0.953 . . . . 8.1300000000000008 108.428 174.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.484 ' HG2' ' CD1' ' A' ' 63' ' ' PHE . 13.9 ptpt 177.58 82.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.095 -0.957 . . . . 10.050000000000001 110.043 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -98.88 -69.24 0.77 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.737 -0.665 . . . . 7.9400000000000004 110.242 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 66' ' ' VAL . 14.7 p 35.84 64.33 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 122.889 1.328 . . . . 9.3499999999999996 112.873 176.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.09 141.48 74.56 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.095 -0.957 . . . . 9.1600000000000001 110.778 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.97 14.64 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.735 2.29 . . . . 10.35 112.848 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.5 m -146.84 162.47 38.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.28 -0.637 . . . . 11.49 109.28 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.2 p 44.23 63.76 1.53 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.794 0.684 . . . . 10.949999999999999 112.055 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.61 -46.34 66.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.318 -0.855 . . . . 11.56 111.538 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 19.7 m -73.22 115.18 38.29 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.158 -0.474 . . . . 10.960000000000001 110.445 178.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 72' ' ' SER . 3.1 Cg_exo -81.34 41.47 1.15 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.289 2.659 . . . . 10.68 111.779 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . 8.4 pt-20 -109.03 150.18 28.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.222 0.534 . . . . 11.76 111.963 -173.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -158.61 42.45 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.991 -1.115 . . . . 10.0 107.991 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -119.33 -97.83 0.46 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.35 -0.841 . . . . 7.5300000000000002 110.781 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -138.56 56.44 0.65 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.293 -0.723 . . . . 3.2000000000000002 111.293 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 81' ' ' GLU . 58.7 mtpt 63.26 86.06 0.12 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.605 0.717 . . . . 4.1399999999999997 110.44 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.629 ' HZ ' ' HA2' ' A' ' 35' ' ' GLY . 92.4 t80 -74.5 -51.49 14.62 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.068 -0.969 . . . . 0.94999999999999996 111.083 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -61.7 -30.84 71.01 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 123.861 0.726 . . . . 3.48 110.217 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 8.3 tp10 -75.3 -37.36 60.89 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.584 -0.895 . . . . 3.0699999999999998 108.584 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.978 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.13 -42.27 97.01 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 115.227 -0.897 . . . . 0.55000000000000004 111.396 176.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.8 t -63.24 -50.01 80.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.296 -0.952 . . . . 0.84999999999999998 110.685 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.75 -27.82 55.5 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.883 -0.599 . . . . 1.1200000000000001 111.036 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.0 m -65.17 -25.58 67.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.471 -0.566 . . . . 1.8799999999999999 109.471 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.38 22.58 70.09 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.729 -0.669 . . . . 1.6599999999999999 112.467 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.647 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 8.8 p30 -165.54 48.66 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.37 0.605 . . . . 2.0800000000000001 111.606 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.978 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.6 tt -58.28 93.81 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.382 -0.826 . . . . 0.56000000000000005 111.991 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.694 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.6 p30 -145.71 100.61 3.45 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.202 -0.666 . . . . 2.0099999999999998 109.202 172.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 91' ' ' MET . 3.7 m -149.43 154.14 38.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.552 -0.717 . . . . 1.6699999999999999 110.145 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.589 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 24.0 ptt? -109.05 123.85 49.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.051 0.453 . . . . 3.9399999999999999 110.242 172.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -122.88 112.31 17.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.034 -0.728 . . . . 2.4700000000000002 109.034 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 31.1 mt-10 -105.8 106.52 17.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.391 -0.368 . . . . 1.97 110.209 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -127.59 132.77 49.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.42 0.628 . . . . 4.29 111.081 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 10.8 m -85.12 146.64 27.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.283 -0.871 . . . . 2.8900000000000001 109.437 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.496 ' HD2' ' HB ' ' A' ' 103' ' ' THR . 73.2 m-85 -66.6 133.36 50.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.92 0.39 . . . . 5.25 110.73 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.11 112.78 6.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.872 -0.604 . . . . 6.0599999999999996 109.983 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -155.32 -60.39 0.11 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.043 -0.526 . . . . 9.7699999999999996 109.919 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.631 ' HG2' ' HG3' ' A' ' 100' ' ' MET . 36.2 tt0 -158.13 -78.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 8.3399999999999999 110.733 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.631 ' HG3' ' HG2' ' A' ' 99' ' ' GLN . 87.9 mtp -118.58 -87.76 0.62 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.634 0.254 . . . . 8.1899999999999995 110.37 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.63 92.0 13.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.315 0.579 . . . . 5.0999999999999996 110.743 175.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -81.62 -60.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.913 2.408 . . . . 4.5099999999999998 110.476 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 96' ' ' PHE . 30.7 m -144.54 127.72 16.67 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.531 -0.759 . . . . 2.5899999999999999 109.509 173.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 4.5 ttmp? -106.99 119.4 39.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.672 -0.492 . . . . 3.1200000000000001 109.672 175.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' A' ' 124' ' ' ARG . 28.2 m -101.36 157.51 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.45 0.643 . . . . 1.23 110.866 175.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -134.24 117.68 16.75 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.313 -0.858 . . . . 2.3599999999999999 109.164 176.55 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.1 t -94.99 105.47 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.904 0 CA-C-N 115.824 -0.626 . . . . 1.1100000000000001 109.958 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.0 t-160 -101.57 102.64 13.4 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.268 -1.382 . . . . 1.01 107.268 169.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.694 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 67.4 mtp -91.32 145.7 24.43 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.076 -1.083 . . . . 2.2200000000000002 108.076 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -148.5 119.19 7.5 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.84 -0.744 . . . . 1.73 109.385 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.647 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 68.9 tttt -55.4 122.94 12.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.473 0.654 . . . . 1.78 111.043 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.26 146.14 52.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.745 -1.116 . . . . 0.45000000000000001 110.436 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.44 4.34 11.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.026 0.441 . . . . 2.3900000000000001 110.878 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.0 t -79.01 -55.94 4.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.989 -0.55 . . . . 1.6599999999999999 109.764 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 134.02 126.5 2.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.81 -0.71 . . . . 1.52 112.654 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.86 35.47 25.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.84 0.828 . . . . 2.79 111.074 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.2 p -141.0 151.46 44.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.202 -1.363 . . . . 0.44 108.793 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.559 ' CE1' HG22 ' A' ' 83' ' ' VAL . 25.8 m-85 -142.88 136.99 29.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.397 -0.365 . . . . 0.41999999999999998 110.271 -173.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.551 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 50.2 m95 -86.09 164.63 17.19 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.448 0.642 . . . . 0.41999999999999998 110.961 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.574 HG12 HG13 ' A' ' 122' ' ' VAL . 57.7 t -134.76 97.26 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.264 -1.335 . . . . 0.62 108.472 175.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 52.9 m-85 -96.35 101.54 13.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.454 -0.943 . . . . 1.49 108.454 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.574 HG13 HG12 ' A' ' 120' ' ' VAL . 24.9 m -99.85 162.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.547 0.689 . . . . 1.6100000000000001 111.533 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.468 ' HB3' ' CG ' ' A' ' 106' ' ' LYS . 56.9 tptt -152.68 120.71 6.18 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.638 -1.165 . . . . 3.4500000000000002 108.757 171.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.554 ' HB3' HG12 ' A' ' 105' ' ' VAL . 13.5 ptm180 -107.79 122.23 46.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.181 0.515 . . . . 4.2300000000000004 111.435 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.251 -0.881 . . . . 3.3399999999999999 109.327 175.694 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 1.003 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.917 0.389 . . . . 8.7200000000000006 110.218 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.01 118.62 33.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.276 -0.42 . . . . 6.1799999999999997 110.706 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.416 ' HB2' ' OH ' ' A' ' 42' ' ' TYR . 75.4 m-85 -82.2 97.5 8.27 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.202 -0.666 . . . . 6.1500000000000004 109.202 176.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -99.2 0.42 57.24 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.774 -0.727 . . . . 1.4299999999999999 113.686 -172.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.47 102.28 11.76 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.473 0.636 . . . . 0.69999999999999996 111.18 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.525 HG13 ' HA ' ' A' ' 42' ' ' TYR . 4.4 tt -133.6 141.33 44.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.322 -0.399 . . . . 0.90000000000000002 110.561 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.579 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 10.0 pt20 -113.88 135.01 54.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.27 0.557 . . . . 2.2200000000000002 111.304 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.726 ' HB3' HD13 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -126.8 166.38 17.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.471 -0.786 . . . . 0.71999999999999997 110.339 175.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.462 ' HA ' ' CB ' ' A' ' 117' ' ' SER . 3.3 p30 -92.06 158.3 16.3 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.876 -0.602 . . . . 1.1499999999999999 110.576 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -81.05 11.97 39.62 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.337 -0.847 . . . . 1.2 112.082 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -90.94 -25.44 19.77 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.173 -0.677 . . . . 1.8100000000000001 109.173 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.36 23.61 2.85 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.354 -0.839 . . . . 1.05 112.395 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -132.52 155.56 48.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.124 -0.324 . . . . 1.5700000000000001 110.124 -177.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.99 HG12 ' HB3' ' A' ' 60' ' ' LYS . 36.6 mm -74.05 138.24 21.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.408 -0.96 . . . . 1.1799999999999999 108.408 171.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.433 ' H ' ' HA ' ' A' ' 33' ' ' LEU . 27.8 tp -105.21 -49.49 3.45 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.814 -0.354 . . . . 1.5600000000000001 110.806 -174.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -154.97 128.22 8.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 2.4100000000000001 110.999 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.889 ' HB3' HG12 ' A' ' 57' ' ' VAL . 66.0 t80 -98.63 119.66 37.73 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.917 -0.771 . . . . 1.4199999999999999 108.917 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -97.19 120.8 38.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.051 0.453 . . . . 1.21 111.716 -169.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.54 81.16 1.64 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.538 -0.755 . . . . 2.5 109.105 172.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.33 90.96 1.63 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.63 -0.714 . . . . 4.0 110.722 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -108.27 18.87 20.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.665 -0.698 . . . . 7.21 109.969 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.94 -3.17 9.9 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.201 -0.759 . . . . 6.9699999999999998 111.201 -174.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -132.23 144.05 50.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.021 -0.733 . . . . 8.5899999999999999 109.021 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.28 -42.12 82.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.113 -0.494 . . . . 9.2400000000000002 110.426 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 m 67.22 150.42 0.06 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.492 -0.776 . . . . 9.8200000000000003 111.123 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.77 120.43 18.82 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.058 -0.592 . . . . 9.6199999999999992 112.618 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -71.02 136.33 48.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.614 0.245 . . . . 12.720000000000001 110.511 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -148.99 119.41 4.1 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.524 -0.307 . . . . 8.2400000000000002 110.231 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.89 -14.74 32.7 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.901 2.401 . . . . 8.1099999999999994 113.179 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 72.1 mmtt -102.48 5.85 39.72 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.607 0.718 . . . . 9.2400000000000002 110.98 -178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -96.11 -24.47 16.28 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.639 -1.164 . . . . 7.4000000000000004 108.859 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.889 HG12 ' HB3' ' A' ' 42' ' ' TYR . 32.6 m -97.24 178.74 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.953 -1.022 . . . . 5.0599999999999996 110.204 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.863 HG12 HG23 ' A' ' 57' ' ' VAL . 19.6 pt 37.31 65.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.262 1.025 . . . . 3.1699999999999999 113.486 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.52 -36.52 54.3 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 114.533 -1.212 . . . . 3.2400000000000002 111.808 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.99 ' HB3' HG12 ' A' ' 39' ' ' ILE . 53.9 tptt -88.46 92.15 9.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.084 0.468 . . . . 3.8500000000000001 109.97 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -139.46 94.38 2.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.699 -0.682 . . . . 4.1799999999999997 109.873 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 174.26 132.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.424 -0.954 . . . . 6.6600000000000001 108.424 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -100.02 -33.3 10.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.854 0.359 . . . . 8.1300000000000008 111.028 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 44.0 mtpt -106.32 97.65 7.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.9 0.381 . . . . 10.050000000000001 111.456 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -90.36 112.32 23.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.081 -0.509 . . . . 7.9400000000000004 109.738 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.8 m -124.91 22.42 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.234 0.54 . . . . 9.3499999999999996 110.498 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -102.87 139.9 20.56 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.852 -0.613 . . . . 9.1600000000000001 110.589 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 21.1 Cg_exo -65.86 80.76 0.26 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.927 2.418 . . . . 10.35 111.618 175.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 69.1 m -131.53 137.53 48.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.539 -0.755 . . . . 11.49 109.227 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 m -71.95 124.09 24.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.638 -0.255 . . . . 10.949999999999999 110.549 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -69.09 120.88 15.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.163 0.506 . . . . 11.56 109.912 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.481 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 35.2 t -168.65 -45.9 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.527 -0.761 . . . . 10.960000000000001 111.666 -174.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 72' ' ' SER . 51.8 Cg_exo -57.14 -43.52 52.47 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 121.944 1.762 . . . . 10.68 112.269 177.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HG2' ' HD3' ' A' ' 60' ' ' LYS . 1.2 mt-10 -91.42 -175.77 4.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.813 -0.63 . . . . 11.76 110.117 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 90.8 m-85 73.9 -28.17 0.19 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.386 0.675 . . . . 10.0 112.151 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 47.76 -97.89 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.472 0.709 . . . . 7.5300000000000002 112.891 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.3 99.95 0.25 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.098 -1.049 . . . . 3.2000000000000002 111.88 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt 65.25 18.24 11.32 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 123.656 0.268 . . . . 4.1399999999999997 111.704 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.556 ' O ' HG23 ' A' ' 83' ' ' VAL . 42.5 t80 -49.5 -33.92 15.77 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 111.617 0.229 . . . . 0.94999999999999996 111.617 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -62.36 -42.66 99.58 Favored 'General case' 0 C--N 1.34 0.191 0 O-C-N 124.103 0.877 . . . . 3.48 109.928 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -88.86 -23.16 22.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.775 -1.102 . . . . 3.0699999999999998 109.827 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.717 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -62.73 -43.75 98.5 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 115.923 -0.58 . . . . 0.55000000000000004 111.849 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 79' ' ' PHE . 84.5 t -66.98 -47.02 83.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.842 -0.679 . . . . 0.84999999999999998 110.34 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.77 -26.13 57.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.583 -0.735 . . . . 1.1200000000000001 110.734 -173.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 t -63.64 -33.45 75.65 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.806 -0.813 . . . . 1.8799999999999999 108.806 172.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.08 2.68 55.92 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.403 -0.817 . . . . 1.6599999999999999 112.114 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.631 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -171.42 66.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.511 0.672 . . . . 2.0800000000000001 111.401 -177.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.717 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -56.44 88.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.086 -0.961 . . . . 0.56000000000000005 110.888 171.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.754 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.9 t30 -143.43 101.54 3.8 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.695 -0.483 . . . . 2.0099999999999998 109.695 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -163.25 158.38 21.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.183 0.516 . . . . 1.6699999999999999 110.875 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.8 ptp -91.99 137.46 32.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.223 -0.899 . . . . 3.9399999999999999 108.941 170.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.565 ' O ' HG22 ' A' ' 107' ' ' VAL . 23.3 t80 -148.36 109.07 4.2 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.248 0.547 . . . . 2.4700000000000002 109.981 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.44 104.24 15.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.147 -0.479 . . . . 1.97 109.768 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -121.11 150.31 41.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.067 0.46 . . . . 4.29 110.923 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 m -118.67 150.51 39.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.736 -0.665 . . . . 2.8900000000000001 110.755 -176.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -86.84 127.9 35.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.917 -0.772 . . . . 5.25 108.917 172.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -58.54 -47.07 85.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.955 0.407 . . . . 6.0599999999999996 110.529 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -130.19 -82.61 0.55 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 9.7699999999999996 110.659 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 67.18 -67.32 0.17 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.882 0.739 . . . . 8.3399999999999999 110.151 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.8 tpt -171.24 -59.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.78 -0.822 . . . . 8.1899999999999995 108.78 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.3 m -125.73 96.4 38.11 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.248 -1.019 . . . . 5.0999999999999996 108.248 174.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -45.29 101.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.741 2.961 . . . . 4.5099999999999998 113.483 -172.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.0 m -105.54 135.95 46.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.795 -0.639 . . . . 2.5899999999999999 110.612 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -97.76 124.19 42.01 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.06 -0.718 . . . . 3.1200000000000001 109.06 171.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.21 155.46 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-O 121.34 0.591 . . . . 1.23 110.625 173.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.532 ' HB2' ' HG2' ' A' ' 123' ' ' LYS . 22.4 mtpp -128.97 105.58 8.31 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.25 -0.886 . . . . 2.3599999999999999 108.903 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 92' ' ' PHE . 5.2 m -105.08 144.37 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 C-N-CA 119.562 -0.855 . . . . 1.1100000000000001 112.177 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -117.61 103.11 9.73 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 105.674 -1.973 . . . . 1.01 105.674 156.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.754 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 9.1 ptp -106.28 128.4 53.94 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.081 -1.081 . . . . 2.2200000000000002 108.081 -178.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 21.6 ptmt -139.44 133.16 30.6 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.613 -0.435 . . . . 1.73 110.847 -167.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 86.0 tttt -56.82 108.38 0.5 Allowed 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.597 0.713 . . . . 1.78 110.719 171.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.428 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -53.7 137.38 37.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.104 -1.407 . . . . 0.45000000000000001 110.489 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.62 3.81 7.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.247 -0.433 . . . . 2.3900000000000001 110.93 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.9 m -80.91 -32.37 34.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 1.6599999999999999 111.102 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 139.2 112.78 1.06 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.734 -0.746 . . . . 1.52 113.111 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 t70 26.96 72.48 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.821 1.248 . . . . 2.79 113.079 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 111' ' ' LYS . 1.3 p -153.81 159.71 41.97 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.837 -1.912 . . . . 0.44 105.837 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.536 ' HE1' HG22 ' A' ' 83' ' ' VAL . 17.1 m-85 -136.32 134.89 38.42 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.819 -0.752 . . . . 0.41999999999999998 111.963 -175.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.579 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 41.9 m95 -85.89 165.85 16.46 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.746 -0.661 . . . . 0.41999999999999998 111.164 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.547 HG23 HD21 ' A' ' 33' ' ' LEU . 95.9 t -139.21 97.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.388 -1.278 . . . . 0.62 108.877 172.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.543 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 90.3 m-85 -93.14 101.92 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.394 -0.965 . . . . 1.49 108.394 170.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 123' ' ' LYS . 13.2 p -115.62 149.99 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.153 0.502 . . . . 1.6100000000000001 111.869 -172.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HG2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -147.83 145.5 28.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.147 -1.057 . . . . 3.4500000000000002 108.147 173.294 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -116.37 143.21 45.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.306 0.574 . . . . 4.2300000000000004 112.124 -171.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.4 t . . . . . 0 C--O 1.252 1.222 0 CA-C-N 115.233 -0.894 . . . . 3.3399999999999999 109.515 175.869 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.979 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.751 -0.462 . . . . 8.7200000000000006 109.751 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 45' ' ' ALA . . . -112.48 -171.97 1.96 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.42 -0.354 . . . . 6.1799999999999997 110.203 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.407 ' HA ' ' HB1' ' A' ' 44' ' ' ALA . 97.6 m-85 71.71 152.21 0.11 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.8 0.687 . . . . 6.1500000000000004 111.14 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 122' ' ' VAL . . . 166.13 -79.34 0.12 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.748 -1.215 . . . . 1.4299999999999999 113.812 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.34 102.72 14.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.662 0.615 . . . . 0.69999999999999996 112.662 -166.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -126.49 139.9 50.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.11 -0.7 . . . . 0.90000000000000002 109.11 172.72 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.59 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.2 pp0? -115.33 136.35 53.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.411 0.624 . . . . 2.2200000000000002 111.366 -175.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -139.13 156.14 47.35 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.97 -1.014 . . . . 0.71999999999999997 110.231 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.894 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 4.9 p30 -86.3 155.13 20.78 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.399 0.619 . . . . 1.1499999999999999 110.673 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.59 14.48 17.68 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.375 -0.829 . . . . 1.2 111.871 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -100.97 -26.13 13.83 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.126 0.488 . . . . 1.8100000000000001 109.689 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.59 28.84 0.94 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.826 -0.702 . . . . 1.05 113.414 173.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 21.9 m-80 -133.53 142.19 48.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.245 0.522 . . . . 1.5700000000000001 111.13 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.672 HG13 ' HB3' ' A' ' 60' ' ' LYS . 81.3 mt -87.3 131.0 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.953 -0.758 . . . . 1.1799999999999999 108.953 171.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' A' ' 34' ' ' ASP . 66.9 mt -108.31 -49.7 3.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.927 0.344 . . . . 1.5600000000000001 111.927 -171.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' HG12 ' A' ' 31' ' ' ILE . 60.3 tt0 -141.84 128.76 20.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.984 0.421 . . . . 2.4100000000000001 111.547 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -113.69 125.46 54.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.729 -0.668 . . . . 1.4199999999999999 110.328 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -127.75 102.78 6.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 1.21 110.411 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 28' ' ' PHE . . . -153.42 164.39 38.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.447 -0.342 . . . . 2.5 110.895 175.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . . . -74.99 102.63 4.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.074 -0.512 . . . . 4.0 110.93 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -112.34 84.33 1.95 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.768 -0.651 . . . . 7.21 109.676 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.27 -26.17 8.95 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.509 -0.769 . . . . 6.9699999999999998 112.205 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -95.92 112.48 24.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.547 0.689 . . . . 8.5899999999999999 109.485 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 pt -119.41 -28.32 2.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.394 -0.821 . . . . 9.2400000000000002 111.707 -173.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.3 m -60.34 95.13 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.289 0.566 . . . . 9.8200000000000003 111.659 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.21 4.33 66.67 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.935 -0.575 . . . . 9.6199999999999992 112.19 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -109.31 157.32 18.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.729 0.3 . . . . 12.720000000000001 110.56 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.62 99.02 23.87 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 8.2400000000000002 110.096 174.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.58 -22.27 74.04 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.258 2.638 . . . . 8.1099999999999994 112.536 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -78.11 72.13 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.881 0.848 . . . . 9.2400000000000002 110.503 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.23 -49.76 2.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.243 -0.889 . . . . 7.4000000000000004 110.315 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.0 m -100.56 47.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.825 0.822 . . . . 5.0599999999999996 110.603 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.477 HG12 ' N ' ' A' ' 59' ' ' GLY . 14.3 tt -163.54 156.25 2.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.946 -1.024 . . . . 3.1699999999999999 109.049 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.477 ' N ' HG12 ' A' ' 58' ' ' ILE . . . 102.54 13.42 30.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.773 -0.727 . . . . 3.2400000000000002 111.95 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.672 ' HB3' HG13 ' A' ' 39' ' ' ILE . 17.5 tppt? -78.11 119.14 21.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.659 -0.497 . . . . 3.8500000000000001 109.659 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -131.11 98.42 4.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.895 -0.593 . . . . 4.1799999999999997 110.175 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -131.69 114.5 14.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.841 -0.618 . . . . 6.6600000000000001 109.99 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.578 ' HD1' ' HG2' ' A' ' 64' ' ' LYS . 43.1 t80 -97.28 -58.63 1.97 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.302 0.573 . . . . 8.1300000000000008 109.765 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.578 ' HG2' ' HD1' ' A' ' 63' ' ' PHE . 20.3 pttp -154.81 166.77 32.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.415 -0.811 . . . . 10.050000000000001 109.136 177.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -119.74 174.83 6.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.885 0.374 . . . . 7.9400000000000004 110.741 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 66' ' ' VAL . 11.6 p -148.9 37.96 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 122.73 1.252 . . . . 9.3499999999999996 109.638 176.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -143.51 145.09 30.25 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.177 -0.919 . . . . 9.1600000000000001 111.161 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.89 25.16 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.956 2.437 . . . . 10.35 112.604 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 45.4 t -151.92 78.94 1.25 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.7 -0.481 . . . . 11.49 109.7 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.0 p -123.57 -50.12 1.87 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.93 0.395 . . . . 10.949999999999999 111.331 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -81.9 117.36 22.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.272 0.558 . . . . 11.56 112.134 -176.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.432 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 21.7 p -103.24 100.76 18.9 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 107.606 -1.257 . . . . 10.960000000000001 107.606 163.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 72' ' ' SER . 1.8 Cg_endo -41.24 103.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 124.079 3.186 . . . . 10.68 114.355 -168.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 72' ' ' SER . 11.4 pt-20 -153.2 100.15 2.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.672 0.749 . . . . 11.76 110.882 176.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -108.6 118.38 36.64 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.241 -0.651 . . . . 10.0 109.241 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.49 -72.47 0.18 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.116 -0.493 . . . . 7.5300000000000002 111.635 -172.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -116.4 72.01 0.27 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.202 -0.999 . . . . 3.2000000000000002 111.201 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.5 tptt 68.57 10.54 7.94 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.016 0.436 . . . . 4.1399999999999997 109.903 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.822 ' HA ' HD11 ' A' ' 88' ' ' LEU . 44.4 t80 -45.92 -40.9 10.8 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 113.975 1.102 . . . . 0.94999999999999996 113.975 -165.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.951 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -63.94 -38.63 91.78 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 123.37 0.418 . . . . 3.48 110.421 -172.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.85 -27.89 20.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.695 -0.684 . . . . 3.0699999999999998 109.584 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.95 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -55.32 -40.32 75.74 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.695 -0.684 . . . . 0.55000000000000004 112.103 -177.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.3 t -65.37 -53.39 40.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.533 -0.834 . . . . 0.84999999999999998 110.954 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.67 -22.79 32.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.263 -0.426 . . . . 1.1200000000000001 111.637 -171.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.6 t -70.86 -22.32 62.31 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.954 -0.758 . . . . 1.8799999999999999 108.954 172.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.83 26.83 73.32 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.375 -0.83 . . . . 1.6599999999999999 112.241 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.489 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 29.1 p30 -158.37 44.8 0.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.229 0.538 . . . . 2.0800000000000001 111.72 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.95 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -66.06 86.4 0.1 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.151 -0.932 . . . . 0.56000000000000005 111.777 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 109' ' ' MET . 2.6 t-20 -144.56 100.69 3.56 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.813 -0.355 . . . . 2.0099999999999998 110.296 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.8 m -146.0 145.98 30.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.817 -0.438 . . . . 1.6699999999999999 109.817 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.82 116.4 28.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.345 0.593 . . . . 3.9399999999999999 109.609 170.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -133.62 154.55 50.81 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.274 -0.875 . . . . 2.4700000000000002 109.136 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.828 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 7.6 pt-20 -131.28 123.05 27.53 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.78 -0.452 . . . . 1.97 109.78 174.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -124.15 125.11 43.91 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.57 -0.741 . . . . 4.29 110.251 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 9.3 t -97.79 143.72 28.13 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.414 -0.587 . . . . 2.8900000000000001 109.414 174.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -144.13 118.73 9.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.546 0.689 . . . . 5.25 111.022 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 10.1 t70 -82.43 97.98 8.66 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.439 -0.801 . . . . 6.0599999999999996 109.087 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -71.55 -33.46 69.15 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.257 -0.577 . . . . 9.7699999999999996 109.809 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -179.36 86.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.512 -0.767 . . . . 8.3399999999999999 109.72 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 47.2 tpp 77.7 -14.71 0.82 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.781 0.832 . . . . 8.1899999999999995 111.136 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 m -114.11 96.54 42.46 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.277 -0.42 . . . . 5.0999999999999996 110.754 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 4.2 Cg_exo -73.92 98.31 1.06 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.743 2.295 . . . . 4.5099999999999998 111.281 176.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 m -79.98 99.35 7.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.132 -0.486 . . . . 2.5899999999999999 110.82 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 49.8 tttp -79.63 102.87 9.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.966 -0.561 . . . . 3.1200000000000001 110.379 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 27.6 m -105.67 160.74 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.361 0.601 . . . . 1.23 111.557 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.828 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 19.6 mmmt -117.46 141.14 48.69 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.152 -0.931 . . . . 2.3599999999999999 109.5 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.2 102.32 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.113 0.482 . . . . 1.1100000000000001 110.15 173.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.803 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 2.3 t60 -108.91 102.82 11.8 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.652 -1.24 . . . . 1.01 107.652 171.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 59.8 mtp -108.78 143.75 37.52 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.709 -0.849 . . . . 2.2200000000000002 108.709 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -147.55 133.88 19.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.974 -0.69 . . . . 1.73 110.5 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.598 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 84.0 tttt -55.9 111.59 0.97 Allowed 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 114.879 -1.055 . . . . 1.78 110.334 173.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.26 146.32 54.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.775 -1.102 . . . . 0.45000000000000001 110.898 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.24 -6.83 25.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.983 -0.553 . . . . 2.3900000000000001 110.709 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.496 ' HB2' ' OG ' ' A' ' 117' ' ' SER . 6.5 m -69.96 -29.41 66.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.746 -0.661 . . . . 1.6599999999999999 110.617 176.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.16 -68.11 0.29 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.723 -0.751 . . . . 1.52 113.054 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -95.17 22.51 6.64 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.331 0.586 . . . . 2.79 111.503 -172.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.894 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.9 p -134.62 157.27 47.04 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.352 -0.84 . . . . 0.44 111.509 -173.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.598 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 48.3 m-85 -141.3 134.81 29.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.616 -0.72 . . . . 0.41999999999999998 109.387 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.59 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 47.1 m95 -83.42 164.23 20.06 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.08 0.466 . . . . 0.41999999999999998 110.673 -175.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 120' ' ' VAL . 15.0 p -138.34 97.18 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 122.581 1.181 . . . . 0.62 111.328 172.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.803 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 3.8 m-85 -86.69 102.29 14.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.516 -0.765 . . . . 1.49 109.094 177.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.58 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 25.4 m -100.88 153.58 4.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.157 0.503 . . . . 1.6100000000000001 111.49 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 16.7 tppt? -159.15 148.87 18.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.865 -0.607 . . . . 3.4500000000000002 109.679 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -129.41 125.05 35.66 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.553 -0.536 . . . . 4.2300000000000004 109.553 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.434 -0.793 . . . . 3.3399999999999999 110.79 -174.626 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.988 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.675 0.274 . . . . 8.7200000000000006 110.413 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -156.53 162.67 39.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 6.1799999999999997 109.893 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -84.45 111.05 19.12 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.528 -0.545 . . . . 6.1500000000000004 109.528 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 122' ' ' VAL . . . -119.85 70.68 0.35 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.388 -0.911 . . . . 1.4299999999999999 112.529 -176.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -155.46 101.4 2.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.896 0.379 . . . . 0.69999999999999996 110.255 175.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.541 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 3.2 tt -139.25 141.02 36.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.234 -0.439 . . . . 0.90000000000000002 110.743 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.619 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.8 pt20 -110.81 126.33 54.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.322 0.582 . . . . 2.2200000000000002 110.518 174.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.85 153.05 41.62 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.645 -0.707 . . . . 0.71999999999999997 110.562 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.742 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -85.62 105.57 16.28 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.47 0.652 . . . . 1.1499999999999999 112.407 -171.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.04 ' H ' ' HA ' ' A' ' 117' ' ' SER . . . 37.77 23.7 0.02 OUTLIER Glycine 0 N--CA 1.468 0.768 0 CA-C-N 113.272 -1.786 . . . . 1.2 117.42 161.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 34' ' ' ASP . 12.9 t70 174.75 -57.17 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.926 0.863 . . . . 1.8100000000000001 111.756 -171.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.93 -31.35 0.03 OUTLIER Glycine 0 CA--C 1.524 0.655 0 C-N-CA 119.203 -1.475 . . . . 1.05 115.447 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.742 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 19.0 m-80 -67.84 116.33 8.39 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.728 1.264 . . . . 1.5700000000000001 111.141 -173.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.427 HD12 ' HB2' ' A' ' 60' ' ' LYS . 96.1 mt -70.73 128.62 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.928 -0.578 . . . . 1.1799999999999999 110.616 -178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.7 tp -101.55 -47.58 4.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.75 -0.659 . . . . 1.5600000000000001 110.799 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -151.07 142.86 23.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 2.4100000000000001 111.401 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.541 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 69.1 t80 -130.5 138.5 50.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 1.4199999999999999 109.729 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 39.8 m-80 -100.56 93.42 5.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.851 0.358 . . . . 1.21 111.437 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.86 -27.68 6.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.469 0.652 . . . . 2.5 109.435 171.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.27 130.89 13.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.159 -0.928 . . . . 4.0 109.444 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -96.35 3.42 52.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 7.21 110.473 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.33 -164.59 11.74 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.508 -0.769 . . . . 6.9699999999999998 111.607 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -90.09 137.23 32.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.844 0.354 . . . . 8.5899999999999999 110.782 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.6 42.43 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.564 -0.532 . . . . 9.2400000000000002 109.564 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.7 m 50.47 54.63 10.82 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.309 -0.859 . . . . 9.8200000000000003 110.902 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.75 142.87 3.69 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.744 -0.741 . . . . 9.6199999999999992 111.883 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 52' ' ' ARG . 1.4 mpt_? -90.05 98.4 11.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.818 0.342 . . . . 12.720000000000001 110.501 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.61 108.9 40.21 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.268 -0.424 . . . . 8.2400000000000002 110.729 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 52' ' ' ARG . 92.7 Cg_endo -93.78 1.9 3.19 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.184 2.589 . . . . 8.1099999999999994 113.25 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -82.93 54.25 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.625 0.726 . . . . 9.2400000000000002 111.076 -176.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . 77.2 mt-30 -115.82 10.29 15.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.121 -0.945 . . . . 7.4000000000000004 110.75 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 t 56.52 68.74 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.623 0.725 . . . . 5.0599999999999996 110.273 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.1 pt -133.19 170.25 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.729 -0.669 . . . . 3.1699999999999999 110.598 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.73 38.75 66.79 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.658 -0.977 . . . . 3.2400000000000002 110.658 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 58.7 tptt -74.95 85.98 2.28 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.901 -0.649 . . . . 3.8500000000000001 110.16 -177.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.503 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 28.7 t-20 -93.51 96.28 9.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.473 0.654 . . . . 4.1799999999999997 109.866 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 65' ' ' ASP . 42.7 t80 -164.95 88.34 0.46 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.719 -1.215 . . . . 6.6600000000000001 107.719 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.688 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 56.6 t80 -72.52 -73.53 0.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.104 -0.498 . . . . 8.1300000000000008 111.139 -171.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.688 ' HE3' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -150.7 71.91 1.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 10.050000000000001 110.247 -177.019 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 4.4 m-20 -105.35 160.75 14.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.999 -0.546 . . . . 7.9400000000000004 110.197 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.6 t -89.83 77.72 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.979 0.418 . . . . 9.3499999999999996 110.037 -177.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.12 120.19 23.64 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.617 -0.72 . . . . 9.1600000000000001 110.924 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.82 -38.29 94.66 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.236 2.624 . . . . 10.35 113.362 -174.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 70' ' ' THR . 15.1 t -81.42 -19.88 41.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 121.063 -0.255 . . . . 11.49 111.07 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 69' ' ' CYS . 25.9 m 71.07 -54.4 0.67 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.152 0.581 . . . . 10.949999999999999 111.87 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.18 92.01 5.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.046 0.45 . . . . 11.56 110.92 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.625 ' OG ' ' HD3' ' A' ' 73' ' ' PRO . 6.0 p -159.79 -43.25 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.637 -0.711 . . . . 10.960000000000001 111.77 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.625 ' HD3' ' OG ' ' A' ' 72' ' ' SER . 4.7 Cg_exo -82.51 115.27 2.5 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.12 1.88 . . . . 10.68 111.238 172.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.41 139.7 34.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.341 -0.391 . . . . 11.76 110.918 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -108.82 149.68 28.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -114.97 -76.15 0.58 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.091 0.775 . . . . 7.5300000000000002 113.091 -170.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.2 86.0 0.4 Allowed Glycine 0 CA--C 1.506 -0.513 0 C-N-CA 119.581 -1.295 . . . . 3.2000000000000002 112.595 -170.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 58.38 25.15 12.5 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.73 -0.47 . . . . 4.1399999999999997 109.73 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.646 ' HA ' HD11 ' A' ' 88' ' ' LEU . 38.7 t80 -50.51 -37.0 36.66 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.671 -0.695 . . . . 0.94999999999999996 112.719 -165.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.48 -47.35 73.33 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 123.76 0.663 . . . . 3.48 110.343 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -82.35 -24.81 34.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.346 -0.612 . . . . 3.0699999999999998 109.346 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.93 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -57.66 -42.97 94.53 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.304 -0.719 . . . . 0.55000000000000004 111.304 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 79' ' ' PHE . 81.2 t -67.53 -53.85 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.434 -0.883 . . . . 0.84999999999999998 111.019 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.35 -28.0 52.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.159 -0.473 . . . . 1.1200000000000001 111.412 -169.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.0 t -66.98 -29.27 69.07 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.735 -0.839 . . . . 1.8799999999999999 108.735 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.6 28.36 39.43 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.65 -0.705 . . . . 1.6599999999999999 111.804 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -162.37 52.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.358 0.599 . . . . 2.0800000000000001 111.816 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.93 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -73.13 86.35 1.38 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.907 -0.588 . . . . 0.56000000000000005 110.658 177.111 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.2 t30 -143.9 102.35 3.88 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.619 -0.264 . . . . 2.0099999999999998 110.474 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 t -152.26 161.64 42.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.343 -0.39 . . . . 1.6699999999999999 110.194 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -127.04 146.71 50.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.892 -0.594 . . . . 3.9399999999999999 109.79 174.754 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -164.19 141.85 6.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.052 -0.522 . . . . 2.4700000000000002 109.802 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.502 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 44.5 mt-10 -103.01 113.14 26.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.361 -0.607 . . . . 1.97 109.361 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -119.53 137.36 53.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.456 . . . . 4.29 110.669 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.455 HG23 ' HG3' ' A' ' 104' ' ' LYS . 1.4 p -93.68 145.03 24.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.385 -0.37 . . . . 2.8900000000000001 110.472 176.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.88 120.43 42.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.185 0.517 . . . . 5.25 111.375 -177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 99' ' ' GLN . 31.9 m-20 -87.85 178.45 6.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.213 -0.903 . . . . 6.0599999999999996 110.001 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.6 t80 73.27 -14.46 0.62 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.72 0.638 . . . . 9.7699999999999996 110.842 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.44 ' H ' ' C ' ' A' ' 97' ' ' ASP . 97.4 mt-30 -80.92 166.13 21.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 8.3399999999999999 109.749 173.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 65.8 mtt -93.36 -4.23 51.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.108 0.48 . . . . 8.1899999999999995 110.67 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.471 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 8.6 t -132.54 141.39 41.03 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.687 -0.688 . . . . 5.0999999999999996 109.729 175.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 6.4 Cg_exo -75.38 62.07 6.09 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.165 2.576 . . . . 4.5099999999999998 112.299 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.7 m -71.7 133.33 45.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.173 -0.467 . . . . 2.5899999999999999 110.568 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.502 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 15.0 ttpt -113.21 131.43 55.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.275 -0.639 . . . . 3.1200000000000001 109.275 176.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.601 HG12 ' HG2' ' A' ' 124' ' ' ARG . 34.2 m -102.31 160.01 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 121.257 0.551 . . . . 1.23 110.457 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 123' ' ' LYS . 38.1 ttpt -129.31 110.64 12.11 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.207 -1.034 . . . . 2.3599999999999999 108.207 172.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.8 m -98.86 144.68 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.485 0.66 . . . . 1.1100000000000001 112.112 -175.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -137.11 102.08 4.74 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.646 -1.242 . . . . 1.01 107.646 161.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.738 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -97.12 133.46 41.74 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.376 -1.342 . . . . 2.2200000000000002 107.376 173.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HG3' ' HB2' ' A' ' 119' ' ' TRP . 14.8 ptpt -142.06 134.72 28.34 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.228 -0.589 . . . . 1.73 111.271 -172.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 39.1 tttm -56.31 115.11 2.28 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.501 -0.772 . . . . 1.78 110.534 170.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.441 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -64.91 147.2 53.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.563 -1.198 . . . . 0.45000000000000001 111.431 -174.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.5 pt? -64.82 -10.11 25.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 2.3900000000000001 111.356 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.2 p -79.84 -4.84 53.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.25 -0.432 . . . . 1.6599999999999999 111.577 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.87 -122.82 6.72 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.638 -0.792 . . . . 1.52 112.229 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -72.15 85.63 1.04 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.547 0.689 . . . . 2.79 110.466 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 1.04 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 3.5 p -176.16 152.46 1.15 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.703 -1.135 . . . . 0.44 108.295 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.556 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 39.3 m-85 -142.07 139.16 32.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.639 0.257 . . . . 0.41999999999999998 110.427 -176.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.619 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 46.1 m95 -88.39 166.81 14.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.488 0.661 . . . . 0.41999999999999998 111.453 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.95 96.5 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.348 -1.296 . . . . 0.62 109.046 173.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.449 ' HE1' ' HD2' ' A' ' 110' ' ' LYS . 90.2 m-85 -95.05 124.33 39.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.402 -0.592 . . . . 1.49 109.402 173.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.479 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 26.0 t -128.52 132.79 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.868 0.366 . . . . 1.6100000000000001 111.002 -176.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 106' ' ' LYS . 74.7 mmtt -118.77 109.04 15.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.71 -0.478 . . . . 3.4500000000000002 109.71 172.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.601 ' HG2' HG12 ' A' ' 105' ' ' VAL . 19.6 mtp180 -101.1 109.89 21.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.546 -0.297 . . . . 4.2300000000000004 110.436 -175.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.125 -0.941 . . . . 3.3399999999999999 111.22 -179.649 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.994 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.533 HD21 ' HE3' ' A' ' 123' ' ' LYS . 58.3 tp . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 120.775 0.322 . . . . 8.7200000000000006 110.943 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.42 97.45 10.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.221 -0.445 . . . . 6.1799999999999997 109.912 173.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -106.83 141.6 37.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.882 -0.599 . . . . 6.1500000000000004 110.084 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' HA3' HG12 ' A' ' 122' ' ' VAL . . . -127.25 141.2 12.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.009 -0.615 . . . . 1.4299999999999999 112.36 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.57 102.15 4.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.886 0.374 . . . . 0.69999999999999996 110.363 173.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.595 HD11 HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -138.98 140.31 38.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.678 -0.489 . . . . 0.90000000000000002 109.678 178.02 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.749 ' HG2' ' HG2' ' A' ' 41' ' ' GLN . 3.7 pt20 -113.96 142.18 46.48 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.885 -0.726 . . . . 2.2200000000000002 111.083 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.62 ' HB3' HD13 ' A' ' 39' ' ' ILE . 4.0 pp -133.02 163.89 28.23 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.083 -0.962 . . . . 0.71999999999999997 110.094 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 2.1 p30 -90.05 151.83 21.45 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.131 0.491 . . . . 1.1499999999999999 110.423 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -70.26 -9.65 64.44 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.553 -0.749 . . . . 1.2 111.883 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.45 ' HB3' ' OD1' ' A' ' 34' ' ' ASP . 30.3 t70 -73.04 -36.11 66.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.172 -0.514 . . . . 1.8100000000000001 109.803 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.609 ' O ' ' HG2' ' A' ' 60' ' ' LYS . . . 140.55 1.29 1.68 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.461 -0.876 . . . . 1.05 114.036 171.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.495 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 3.8 m-80 -107.44 158.39 17.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.34 0.57 . . . . 1.5700000000000001 111.023 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.896 HG12 ' HB3' ' A' ' 60' ' ' LYS . 45.9 mm -85.49 140.99 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.811 -0.811 . . . . 1.1799999999999999 108.811 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.553 HD23 ' NE2' ' A' ' 32' ' ' GLN . 29.9 tp -108.39 -54.21 2.54 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.361 -0.536 . . . . 1.5600000000000001 110.933 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.749 ' HG2' ' HG2' ' A' ' 32' ' ' GLN . 26.4 pt20 -147.98 141.82 25.75 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.351 -0.54 . . . . 2.4100000000000001 111.402 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 92.3 t80 -110.71 119.11 38.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.623 -0.717 . . . . 1.4199999999999999 109.203 175.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.1 m-20 -95.16 159.85 14.82 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.394 -0.965 . . . . 1.21 108.394 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 43' ' ' ASN . . . 72.3 166.66 0.3 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.724 0.64 . . . . 2.5 110.37 -172.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.14 130.95 48.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.101 0.477 . . . . 4.0 111.649 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.426 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 7.5 pt-20 -96.59 101.79 13.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.837 -0.619 . . . . 7.21 110.551 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.73 46.87 0.2 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.725 -0.75 . . . . 6.9699999999999998 111.822 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -152.17 114.04 4.41 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.155 -0.313 . . . . 8.5899999999999999 110.155 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.5 mt 54.87 50.89 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 122.137 0.97 . . . . 9.2400000000000002 109.837 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 p -105.76 170.89 7.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.298 -0.865 . . . . 9.8200000000000003 111.014 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.45 -56.26 0.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.714 -0.755 . . . . 9.6199999999999992 111.887 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -129.78 156.18 44.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.664 0.269 . . . . 12.720000000000001 110.658 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 21.7 m-20 -81.72 119.23 74.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.938 -0.574 . . . . 8.2400000000000002 111.236 -176.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 3.2 Cg_exo -82.04 -12.26 10.78 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.2 2.6 . . . . 8.1099999999999994 111.632 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt 59.67 71.19 0.59 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.475 0.655 . . . . 9.2400000000000002 110.661 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 17.9 mt-30 -103.57 -30.38 10.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.185 -0.916 . . . . 7.4000000000000004 111.024 -177.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 57' ' ' VAL . 7.3 p -69.24 87.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 122.407 1.099 . . . . 5.0599999999999996 110.626 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.763 ' HA ' HG21 ' A' ' 39' ' ' ILE . 36.8 mt 60.4 73.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 114.673 -1.149 . . . . 3.1699999999999999 109.131 -174.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.24 -20.7 76.95 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.496 -1.229 . . . . 3.2400000000000002 112.488 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.896 ' HB3' HG12 ' A' ' 39' ' ' ILE . 4.9 tppp? -118.73 106.64 12.77 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.984 0.392 . . . . 3.8500000000000001 110.967 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -135.96 95.44 3.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.876 -0.602 . . . . 4.1799999999999997 109.743 171.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.5 t80 48.57 83.02 0.04 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.55 -1.204 . . . . 6.6600000000000001 112.513 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -100.95 -58.12 1.96 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.174 -0.676 . . . . 8.1300000000000008 109.174 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -149.94 -73.94 0.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.848 -1.538 . . . . 10.050000000000001 106.848 173.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 68.26 -14.68 0.24 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.759 -1.109 . . . . 7.9400000000000004 113.603 163.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 67' ' ' ALA . 7.3 p -56.6 -43.29 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.043 0.449 . . . . 9.3499999999999996 110.097 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 66' ' ' VAL . . . -124.86 103.48 30.87 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.194 -0.669 . . . . 9.1600000000000001 109.194 174.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.4 80.44 1.95 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.989 2.459 . . . . 10.35 112.844 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -135.8 143.64 45.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.178 -0.464 . . . . 11.49 109.915 175.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.6 m 54.8 50.42 15.74 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.895 0.855 . . . . 10.949999999999999 110.184 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -142.05 112.87 7.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.166 -0.925 . . . . 11.56 109.888 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.1 m -156.7 121.16 2.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.235 -0.439 . . . . 10.960000000000001 110.929 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -86.45 89.77 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.169 2.579 . . . . 10.68 111.763 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 66.83 -77.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.574 -0.739 . . . . 11.76 112.196 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -133.44 149.03 51.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.156 0.503 . . . . 10.0 111.585 -173.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -145.16 129.59 17.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.329 -0.851 . . . . 7.5300000000000002 109.692 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.8 86.95 1.47 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.709 -0.758 . . . . 3.2000000000000002 111.478 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.5 pttt 42.59 47.77 4.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.432 0.693 . . . . 4.1399999999999997 111.219 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 83' ' ' VAL . 43.0 t80 -50.36 -34.88 25.62 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 115.529 -0.76 . . . . 0.94999999999999996 111.926 -171.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -66.72 -40.02 88.24 Favored 'General case' 0 C--N 1.344 0.338 0 O-C-N 123.813 0.695 . . . . 3.48 110.484 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -80.01 -31.42 39.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.098 -0.704 . . . . 3.0699999999999998 109.098 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.854 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.37 -43.66 97.2 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.559 -0.746 . . . . 0.55000000000000004 111.962 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 79' ' ' PHE . 99.3 t -64.6 -49.32 81.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.77 -0.715 . . . . 0.84999999999999998 110.518 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.37 -24.48 39.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 1.1200000000000001 111.413 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -65.35 -32.95 74.86 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.519 -0.548 . . . . 1.8799999999999999 109.519 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.3 16.43 66.82 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.881 -0.676 . . . . 1.6599999999999999 111.751 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -162.34 57.27 0.23 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.527 0.68 . . . . 2.0800000000000001 110.861 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.854 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.5 tt -65.08 81.41 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.627 -0.715 . . . . 0.56000000000000005 110.952 175.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 14.5 t30 -144.51 98.25 3.17 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.233 -0.654 . . . . 2.0099999999999998 109.233 175.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 91' ' ' MET . 6.4 m -153.29 153.83 33.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.808 -0.441 . . . . 1.6699999999999999 109.808 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.436 ' N ' HG22 ' A' ' 90' ' ' THR . 17.7 ptm -101.01 116.14 32.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.349 -0.612 . . . . 3.9399999999999999 109.349 167.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -114.86 109.95 18.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.794 -0.639 . . . . 2.4700000000000002 109.873 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 9.4 pt-20 -104.39 114.57 28.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.063 0.459 . . . . 1.97 110.495 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -109.56 135.57 50.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.587 -0.733 . . . . 4.29 110.188 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.2 m -97.08 110.02 22.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.942 0.401 . . . . 2.8900000000000001 110.563 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.599 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 51.7 m-85 -76.96 79.48 3.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.234 0.54 . . . . 5.25 110.886 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -101.16 123.03 44.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.293 -1.003 . . . . 6.0599999999999996 108.293 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -155.82 -69.02 0.12 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.301 0.572 . . . . 9.7699999999999996 110.252 -166.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -159.82 32.24 0.18 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.338 -0.986 . . . . 8.3399999999999999 108.338 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.815 ' HG2' ' H ' ' A' ' 101' ' ' THR . 23.3 ttt -151.14 -161.07 1.26 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.752 -1.113 . . . . 8.1899999999999995 108.395 -173.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.815 ' H ' ' HG2' ' A' ' 100' ' ' MET . 0.8 OUTLIER -80.48 152.52 73.04 Favored Pre-proline 0 N--CA 1.446 -0.668 0 O-C-N 121.962 -0.461 . . . . 5.0999999999999996 110.563 174.458 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.38 94.78 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.343 2.029 . . . . 4.5099999999999998 111.923 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 96' ' ' PHE . 16.9 m -90.91 97.84 11.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.1 -0.5 . . . . 2.5899999999999999 110.652 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HD2' ' O ' ' A' ' 125' ' ' VAL . 19.2 ttmm -84.11 115.13 22.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.123 -0.49 . . . . 3.1200000000000001 110.166 177.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 31.5 m -101.33 159.2 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 120.792 0.33 . . . . 1.23 110.361 172.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 43.6 mttp -127.26 123.33 36.23 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.157 -0.474 . . . . 2.3599999999999999 110.702 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.47 102.85 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 109.229 -0.656 . . . . 1.1100000000000001 109.229 173.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.752 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 3.3 t-160 -94.33 102.48 14.48 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.389 -1.708 . . . . 1.01 106.389 168.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 10.7 ttt -120.34 114.93 22.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.048 -1.093 . . . . 2.2200000000000002 108.048 -173.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 64.6 pttt -134.16 135.44 43.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 120.048 -0.661 . . . . 1.73 110.418 -169.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 65.4 tttp -57.21 114.4 2.15 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.765 -0.652 . . . . 1.78 110.602 175.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.68 145.45 49.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.774 -1.103 . . . . 0.45000000000000001 110.709 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.22 -13.08 61.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.208 -0.451 . . . . 2.3900000000000001 110.478 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.5 m -61.84 -31.57 71.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.968 -0.56 . . . . 1.6599999999999999 110.236 173.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 129.1 -96.82 0.4 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.575 -0.821 . . . . 1.52 113.03 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -88.68 49.02 1.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.603 0.716 . . . . 2.79 111.088 -171.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.0 p -147.43 159.37 43.79 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.503 -0.771 . . . . 0.44 109.968 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.556 ' CD2' ' HB3' ' A' ' 88' ' ' LEU . 36.1 m-85 -137.53 137.83 39.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.544 -0.298 . . . . 0.41999999999999998 110.426 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.617 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 44.0 m95 -85.68 162.46 18.77 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.123 0.487 . . . . 0.41999999999999998 111.176 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.44 HG22 ' HE3' ' A' ' 109' ' ' MET . 50.5 t -135.02 97.56 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.864 -1.062 . . . . 0.62 109.485 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.752 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 70.8 m-85 -102.31 104.29 14.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.607 -0.886 . . . . 1.49 108.607 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.467 HG12 ' HA3' ' A' ' 29' ' ' GLY . 9.9 p -92.74 148.61 4.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.789 -0.365 . . . . 1.6100000000000001 110.576 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . 34.5 mtpt -150.23 162.52 40.31 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.167 -0.469 . . . . 3.4500000000000002 110.173 176.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.509 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 4.6 ptp180 -124.88 144.67 50.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.224 -0.898 . . . . 4.2300000000000004 108.818 170.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 124' ' ' ARG . 99.5 t . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.015 -0.993 . . . . 3.3399999999999999 110.374 -175.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 1.004 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.6 tt . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.503 -0.555 . . . . 8.7200000000000006 109.503 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.61 89.21 3.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.939 0.399 . . . . 6.1799999999999997 110.587 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -82.78 82.61 8.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.373 -0.603 . . . . 6.1500000000000004 109.373 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.72 60.84 4.63 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.895 -0.669 . . . . 1.4299999999999999 113.145 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.28 101.99 3.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.082 0.468 . . . . 0.69999999999999996 110.918 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.691 HG13 ' HA ' ' A' ' 42' ' ' TYR . 7.1 tt -130.14 141.25 46.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.111 -0.495 . . . . 0.90000000000000002 110.07 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.542 ' NE2' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -113.88 129.05 56.63 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 116.13 -0.486 . . . . 2.2200000000000002 109.91 -175.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.486 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.9 pp -126.0 157.55 37.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.156 0.503 . . . . 0.71999999999999997 110.842 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' HA ' ' CB ' ' A' ' 117' ' ' SER . 3.6 p30 -79.24 156.84 27.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.544 0.688 . . . . 1.1499999999999999 110.996 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.545 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -81.43 35.29 2.43 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.286 -0.87 . . . . 1.2 111.489 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -123.56 -24.6 4.52 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.064 0.459 . . . . 1.8100000000000001 110.048 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.57 7.5 4.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.722 -0.751 . . . . 1.05 113.291 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -126.94 159.49 33.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.129 0.49 . . . . 1.5700000000000001 110.879 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.756 HG12 ' HB3' ' A' ' 60' ' ' LYS . 10.9 mm -70.65 142.43 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 109.598 -0.519 . . . . 1.1799999999999999 109.598 175.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.542 HD23 ' NE2' ' A' ' 32' ' ' GLN . 25.9 tp -109.01 -48.6 3.25 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.953 -0.388 . . . . 1.5600000000000001 109.953 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -153.84 114.49 4.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 2.4100000000000001 110.998 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.691 ' HA ' HG13 ' A' ' 31' ' ' ILE . 55.7 t80 -86.33 130.68 34.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.079 -0.51 . . . . 1.4199999999999999 109.642 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -97.06 118.64 33.93 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.845 0.355 . . . . 1.21 110.356 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.76 171.7 13.79 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.948 -0.569 . . . . 2.5 109.579 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.94 117.51 29.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.566 0.222 . . . . 4.0 111.152 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 57.75 40.96 25.86 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.762 -0.653 . . . . 7.21 111.762 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.13 -59.44 7.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.68 -0.771 . . . . 6.9699999999999998 112.353 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -108.78 151.18 26.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.943 0.401 . . . . 8.5899999999999999 110.463 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.6 mt -102.76 53.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.23 -0.656 . . . . 9.2400000000000002 109.23 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.473 HG22 ' N ' ' A' ' 51' ' ' GLY . 4.1 m 69.83 159.98 0.19 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.301 -0.863 . . . . 9.8200000000000003 110.555 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 50' ' ' THR . . . 109.49 -33.59 6.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.465 -0.874 . . . . 9.6199999999999992 112.571 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -88.41 161.15 17.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.898 0.38 . . . . 12.720000000000001 110.596 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 19.1 m-20 -83.47 138.77 41.36 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.802 -0.635 . . . . 8.2400000000000002 110.593 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 25.6 Cg_exo -63.63 -31.86 69.72 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.949 2.433 . . . . 8.1099999999999994 112.383 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -84.0 38.24 0.64 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.976 0.417 . . . . 9.2400000000000002 111.227 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -129.68 7.71 5.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.298 0.57 . . . . 7.4000000000000004 110.165 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.629 HG22 ' HB3' ' A' ' 42' ' ' TYR . 11.3 p -96.67 51.63 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.806 1.289 . . . . 5.0599999999999996 111.402 -174.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -126.47 156.79 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.211 -0.904 . . . . 3.1699999999999999 109.704 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.73 -23.99 5.72 Favored Glycine 0 C--N 1.313 -0.7 0 CA-C-N 115.572 -0.74 . . . . 3.2400000000000002 111.93 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.86 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -118.27 123.01 44.36 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 110.009 -0.367 . . . . 3.8500000000000001 110.009 179.212 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -137.66 96.45 3.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.001 0.429 . . . . 4.1799999999999997 110.017 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -136.47 134.28 37.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.82 -0.627 . . . . 6.6600000000000001 110.616 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -84.86 -17.17 38.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.423 0.63 . . . . 8.1300000000000008 109.475 173.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -151.91 127.81 10.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.222 -0.899 . . . . 10.050000000000001 109.109 -179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' H ' ' HE2' ' A' ' 64' ' ' LYS . 3.8 p-10 -73.14 160.8 31.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.687 0.279 . . . . 7.9400000000000004 110.633 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.572 HG13 ' H ' ' A' ' 67' ' ' ALA . 3.3 p -153.94 -60.7 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.168 -0.469 . . . . 9.3499999999999996 111.117 173.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.572 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 39.91 70.14 1.56 Allowed Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 123.131 0.573 . . . . 9.1600000000000001 111.804 -177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.33 -35.11 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.117 1.878 . . . . 10.35 113.212 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.8 m -115.03 -0.71 13.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.518 -0.31 . . . . 11.49 111.809 -173.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.8 m -136.21 149.79 48.71 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.66 -0.416 . . . . 10.949999999999999 111.455 -172.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -137.25 157.56 46.37 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.074 -1.084 . . . . 11.56 108.074 170.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.42 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 5.5 m 54.71 60.04 10.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 O-C-N 123.335 0.397 . . . . 10.960000000000001 110.413 -175.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HD3' ' N ' ' A' ' 72' ' ' SER . 14.6 Cg_exo -67.7 -73.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.555 2.17 . . . . 10.68 112.334 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -133.54 89.96 2.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.277 -0.42 . . . . 11.76 110.09 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 68.16 97.4 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.821 0.82 . . . . 10.0 112.653 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -120.64 114.2 21.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.36 -0.836 . . . . 7.5300000000000002 109.223 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.76 76.87 0.4 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.887 -1.149 . . . . 3.2000000000000002 111.49 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' ' HB2' ' A' ' 81' ' ' GLU . 41.0 tttp 60.18 34.5 21.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.668 0.747 . . . . 4.1399999999999997 109.037 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' O ' HG23 ' A' ' 83' ' ' VAL . 20.2 t80 -63.24 -41.3 99.06 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.105 -0.952 . . . . 0.94999999999999996 112.109 -168.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -63.21 -34.67 78.14 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.73 0.644 . . . . 3.48 110.353 -176.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HB2' ' HG2' ' A' ' 78' ' ' LYS . 45.8 mt-10 -83.39 -31.47 26.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.254 -0.43 . . . . 3.0699999999999998 109.928 175.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.926 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -57.86 -41.04 93.92 Favored Glycine 0 N--CA 1.436 -1.329 0 CA-C-N 115.716 -0.675 . . . . 0.55000000000000004 112.119 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 79' ' ' PHE . 81.5 t -69.64 -51.02 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.698 -0.751 . . . . 0.84999999999999998 110.914 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.58 -22.29 40.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.566 . . . . 1.1200000000000001 111.688 -170.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.6 p -69.03 -33.68 74.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.845 -0.798 . . . . 1.8799999999999999 108.845 172.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 111' ' ' LYS . . . 87.55 18.95 55.95 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.246 -0.888 . . . . 1.6599999999999999 111.004 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -162.55 59.21 0.22 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.665 0.745 . . . . 2.0800000000000001 110.976 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.926 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.3 tt -64.76 84.79 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.371 -0.831 . . . . 0.56000000000000005 110.346 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.74 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.2 t30 -142.56 101.39 3.87 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.815 -0.439 . . . . 2.0099999999999998 109.815 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.2 t -159.16 154.85 26.14 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.949 0.404 . . . . 1.6699999999999999 110.267 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -112.66 131.71 55.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.593 -0.73 . . . . 3.9399999999999999 109.776 177.417 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -140.37 131.96 27.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.684 -0.689 . . . . 2.4700000000000002 109.812 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -101.13 116.8 33.68 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.87 -0.419 . . . . 1.97 109.87 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -108.89 132.36 54.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.625 -0.716 . . . . 4.29 109.978 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.1 p -100.47 151.69 21.25 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.848 -0.615 . . . . 2.8900000000000001 111.694 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.05 88.71 2.82 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.449 -0.574 . . . . 5.25 109.449 174.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.63 169.26 16.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.315 -0.857 . . . . 6.0599999999999996 111.137 -175.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 73.37 -40.4 0.47 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.277 -0.874 . . . . 9.7699999999999996 112.45 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -71.41 150.85 44.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.818 0.342 . . . . 8.3399999999999999 110.934 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.9 ttt -64.53 -37.3 87.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.854 -0.612 . . . . 8.1899999999999995 111.373 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.4 m -79.71 130.22 68.34 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.337 -0.392 . . . . 5.0999999999999996 110.264 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.05 42.21 1.16 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.856 2.371 . . . . 4.5099999999999998 112.222 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.53 ' HA ' ' OXT' ' A' ' 125' ' ' VAL . 43.7 m -64.89 98.87 0.3 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.461 0.648 . . . . 2.5899999999999999 111.136 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -103.31 130.1 50.5 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.738 -0.838 . . . . 3.1200000000000001 108.738 172.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.1 m -101.07 157.73 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-O 121.152 0.501 . . . . 1.23 110.398 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 123' ' ' LYS . 63.8 tttp -136.07 105.56 6.09 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.523 -0.762 . . . . 2.3599999999999999 109.157 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.537 ' HB ' ' SD ' ' A' ' 109' ' ' MET . 0.8 OUTLIER -96.71 144.93 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 CA-C-O 121.257 0.551 . . . . 1.1100000000000001 111.883 -178.782 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -135.4 103.92 5.66 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.778 -1.193 . . . . 1.01 107.778 162.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.74 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 3.6 mpp? -92.31 143.94 25.89 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.234 -1.395 . . . . 2.2200000000000002 107.234 176.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.3 ptpt -146.18 135.41 22.8 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.103 -1.039 . . . . 1.73 111.429 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.592 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 57.3 tttp -55.19 114.74 1.9 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.048 -0.978 . . . . 1.78 109.557 167.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 116' ' ' ASP . . . -49.35 139.24 11.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.076 -0.965 . . . . 0.45000000000000001 110.98 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.0 mt -65.83 -15.74 63.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.145 -0.48 . . . . 2.3900000000000001 110.871 -176.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.4 m -62.68 -57.36 11.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 1.6599999999999999 110.067 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.3 -74.03 0.1 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.245 -0.742 . . . . 1.52 111.245 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 9.0 t70 -93.76 -167.52 1.71 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.579 -0.897 . . . . 2.79 108.579 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.545 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 37.0 p 60.4 155.67 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.47 1.108 . . . . 0.44 112.108 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.592 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 48.9 m-85 -136.55 138.36 41.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.53 -0.759 . . . . 0.41999999999999998 109.678 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.534 ' CD2' ' HB2' ' A' ' 32' ' ' GLN . 44.1 m95 -91.43 164.76 13.71 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.302 0.573 . . . . 0.41999999999999998 111.23 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.469 ' HB ' HG23 ' A' ' 31' ' ' ILE . 58.9 t -134.06 97.34 2.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.681 -1.145 . . . . 0.62 109.277 176.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -98.59 121.73 40.9 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.778 -0.823 . . . . 1.49 108.778 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.3 p -124.68 147.21 29.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.03 0.443 . . . . 1.6100000000000001 111.119 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 106' ' ' LYS . 51.6 mtpt -126.72 117.67 23.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.86 -0.609 . . . . 3.4500000000000002 109.468 175.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -114.53 156.11 25.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.822 0.344 . . . . 4.2300000000000004 110.61 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.53 ' OXT' ' HA ' ' A' ' 103' ' ' THR . 2.6 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.968 -1.015 . . . . 3.3399999999999999 110.128 172.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' HC4 . . . . . 0.986 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' HH ' ' A' ' 42' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.908 -0.077 . . . . 1.4299999999999999 112.908 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -95.03 102.91 14.74 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.855 0.359 . . . . 0.69999999999999996 111.697 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.75 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -119.69 140.41 43.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.886 0.374 . . . . 0.90000000000000002 110.223 177.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.44 128.71 56.55 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.172 -0.677 . . . . 2.2200000000000002 109.172 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 pp -129.95 158.05 40.62 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.415 0.626 . . . . 0.71999999999999997 110.816 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -85.11 150.91 24.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.476 -0.784 . . . . 1.1499999999999999 110.424 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.572 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -80.44 32.27 2.35 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.79 -0.641 . . . . 1.2 112.696 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -126.24 -30.27 2.92 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.829 -0.434 . . . . 1.8100000000000001 109.829 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.23 10.44 0.84 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.99 -1.1 . . . . 1.05 114.404 171.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -118.92 139.39 51.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 118.009 0.905 . . . . 1.5700000000000001 111.998 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 31' ' ' ILE . 43.5 mm -75.52 139.21 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.709 -0.678 . . . . 1.1799999999999999 109.497 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 tp -106.95 -53.18 2.65 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.864 -0.335 . . . . 1.5600000000000001 111.018 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -153.85 145.06 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.406 -0.518 . . . . 2.4100000000000001 111.869 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.75 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 45.6 t80 -117.78 124.31 48.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.706 -0.679 . . . . 1.4199999999999999 109.633 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 35.0 m-80 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.374 -0.376 . . . . 1.21 110.453 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.529 0 N-CA-C 111.133 -0.787 . . . . 3.2000000000000002 111.133 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 60.9 32.36 20.02 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 123.913 0.42 . . . . 4.1399999999999997 110.336 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.576 ' O ' HG23 ' A' ' 83' ' ' VAL . 67.4 t80 -50.21 -32.22 15.9 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.946 -0.57 . . . . 0.94999999999999996 111.606 -177.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -69.81 -34.08 73.22 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 123.802 0.689 . . . . 3.48 109.698 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -84.18 -31.44 25.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.585 -0.734 . . . . 3.0699999999999998 109.2 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.904 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -54.44 -41.15 71.49 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.371 -0.831 . . . . 0.55000000000000004 111.972 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 79' ' ' PHE . 96.6 t -65.23 -53.49 39.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.405 -0.897 . . . . 0.84999999999999998 110.942 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.43 -27.78 27.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.148 -0.478 . . . . 1.1200000000000001 111.655 -170.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 t -66.57 -27.21 67.55 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.014 -0.736 . . . . 1.8799999999999999 109.014 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.86 29.44 51.67 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.67 -0.695 . . . . 1.6599999999999999 112.469 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -157.18 48.65 0.43 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.61 0.719 . . . . 2.0800000000000001 111.519 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.904 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -74.82 79.71 2.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.4 -0.818 . . . . 0.56000000000000005 111.198 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.3 p-10 -144.09 101.11 3.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.478 0.656 . . . . 2.0099999999999998 109.528 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -147.42 147.8 30.62 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.806 -0.559 . . . . 1.6699999999999999 110.535 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -109.32 115.55 30.19 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.046 -0.724 . . . . 3.9399999999999999 109.046 169.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.519 ' HE2' ' HD2' ' A' ' 94' ' ' TYR . 84.1 t80 -132.17 126.97 34.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.804 -0.634 . . . . 2.4700000000000002 109.97 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 9.7 pt-20 -97.23 130.63 44.43 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.481 -0.563 . . . . 1.97 109.481 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.519 ' HD2' ' HE2' ' A' ' 92' ' ' PHE . 27.4 t80 . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.636 -0.505 . . . . 4.29 109.636 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 80.4 tttt . . . . . 0 C--O 1.239 0.513 0 CA-C-O 120.483 0.183 . . . . 3.1200000000000001 110.674 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.7 m -116.32 160.92 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.182 0.515 . . . . 1.23 111.353 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 85.8 tttt -125.03 123.98 40.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.31 -0.859 . . . . 2.3599999999999999 109.184 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.1 t -101.74 119.42 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 116.45 -0.341 . . . . 1.1100000000000001 110.34 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -106.79 104.33 13.98 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.22 -1.03 . . . . 1.01 108.22 168.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 55.0 mtm -97.5 145.57 26.08 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.276 -1.009 . . . . 2.2200000000000002 108.276 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.508 ' CG ' ' HB2' ' A' ' 119' ' ' TRP . 19.4 ptpt -146.42 127.07 14.24 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.384 -0.527 . . . . 1.73 109.827 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.507 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 51.6 tttm -57.34 113.57 1.81 Allowed 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 116.064 -0.516 . . . . 1.78 109.906 170.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.44 138.93 38.9 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.701 -1.136 . . . . 0.45000000000000001 110.485 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.5 mt -67.88 -8.58 37.69 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.245 -0.434 . . . . 2.3900000000000001 110.918 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 m -70.94 -38.61 72.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 1.6599999999999999 110.503 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.67 -105.76 0.34 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.73 -0.748 . . . . 1.52 112.81 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.29 65.05 7.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.597 0.713 . . . . 2.79 112.013 -175.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.572 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 1.7 p -157.67 157.97 34.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.922 -1.035 . . . . 0.44 108.506 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.509 ' OH ' ' HA ' ' A' ' 83' ' ' VAL . 28.9 m-85 -140.74 139.75 34.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.687 0.28 . . . . 0.41999999999999998 110.603 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.508 ' HB2' ' CG ' ' A' ' 110' ' ' LYS . 38.9 m95 -93.09 162.48 14.02 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.288 0.566 . . . . 0.41999999999999998 111.241 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.629 ' HB ' HG23 ' A' ' 31' ' ' ILE . 87.7 t -136.89 101.77 2.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.561 -1.199 . . . . 0.62 109.268 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -102.19 106.39 17.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.553 -0.536 . . . . 1.49 109.553 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 p -92.37 143.87 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.077 0.465 . . . . 1.6100000000000001 110.244 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 56.6 tttp . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 109.677 -0.49 . . . . 3.4500000000000002 109.677 -178.191 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.821 0 N-CA-C 112.208 -0.357 . . . . 1.4299999999999999 112.208 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.42 102.38 3.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.95 0.405 . . . . 0.69999999999999996 110.75 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.604 HG23 ' HB ' ' A' ' 120' ' ' VAL . 4.5 tt -132.02 141.07 46.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.927 0.394 . . . . 0.90000000000000002 110.672 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HB2' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -114.52 122.98 48.24 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.41 -0.959 . . . . 2.2200000000000002 108.41 177.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.46 164.06 29.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.864 -0.607 . . . . 0.71999999999999997 111.082 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.963 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 2.3 p30 -98.09 153.95 18.07 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.015 -0.539 . . . . 1.1499999999999999 110.981 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.0 -17.03 75.22 Favored Glycine 0 CA--C 1.511 -0.17 0 CA-C-N 115.173 -0.921 . . . . 1.2 112.628 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.53 -38.98 92.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.97 0.414 . . . . 1.8100000000000001 110.421 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.46 38.26 0.31 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.706 -0.759 . . . . 1.05 112.843 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.564 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 4.3 m-80 -134.25 147.96 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.976 -0.379 . . . . 1.5700000000000001 109.976 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.7 mt -87.33 134.73 26.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.936 -0.394 . . . . 1.1799999999999999 109.936 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.0 tp -101.56 -41.45 6.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 1.5600000000000001 110.86 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -158.99 143.43 15.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.993 0.425 . . . . 2.4100000000000001 111.204 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.466 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 40.9 t80 -114.34 114.86 26.47 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.601 -0.889 . . . . 1.4199999999999999 108.601 174.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 121.168 0.509 . . . . 1.21 110.647 -173.756 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 110.177 -1.169 . . . . 3.2000000000000002 110.177 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm 67.12 31.65 6.65 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 123.987 0.463 . . . . 4.1399999999999997 110.293 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.704 ' HA ' HD11 ' A' ' 88' ' ' LEU . 65.5 t80 -47.9 -36.86 12.94 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 112.245 0.461 . . . . 0.94999999999999996 112.245 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.39 -39.64 74.42 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.418 0.627 . . . . 3.48 109.963 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.08 -29.02 48.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.158 -0.928 . . . . 3.0699999999999998 108.917 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.86 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.82 -41.27 97.57 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.451 -0.795 . . . . 0.55000000000000004 111.516 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 79' ' ' PHE . 95.4 t -64.94 -51.83 61.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.431 -0.884 . . . . 0.84999999999999998 110.674 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.64 -24.69 49.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.062 -0.517 . . . . 1.1200000000000001 111.05 -172.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -65.21 -34.52 78.56 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.548 -0.908 . . . . 1.8799999999999999 108.548 172.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.73 15.57 61.32 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.25 -0.886 . . . . 1.6599999999999999 112.301 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -164.0 54.63 0.15 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.328 0.585 . . . . 2.0800000000000001 111.838 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.86 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -65.37 96.11 0.22 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.519 -0.764 . . . . 0.56000000000000005 111.547 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.6 p30 -145.05 108.53 4.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.32 0.581 . . . . 2.0099999999999998 110.283 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -142.2 162.42 35.53 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.098 -0.501 . . . . 1.6699999999999999 111.411 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.72 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 25.8 ptt? -151.5 116.08 5.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.815 0.816 . . . . 3.9399999999999999 110.285 169.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -149.89 144.32 25.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.949 -1.023 . . . . 2.4700000000000002 109.057 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.598 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 25.8 mt-10 -95.35 116.44 28.78 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.189 -0.671 . . . . 1.97 109.189 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 68.2 t80 . . . . . 0 N--CA 1.446 -0.63 0 CA-C-N 115.647 -0.706 . . . . 4.29 110.296 -172.415 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.723 -0.473 . . . . 3.1200000000000001 109.723 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.52 160.72 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.125 0.488 . . . . 1.23 110.824 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 13.9 ttmm -116.86 124.17 48.85 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.64 -0.874 . . . . 2.3599999999999999 108.64 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 91' ' ' MET . 1.1 m -109.32 104.32 16.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.167 0.508 . . . . 1.1100000000000001 111.494 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 15.0 t-160 -109.84 105.1 14.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.723 -0.843 . . . . 1.01 108.723 172.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 53.6 mtm -117.86 144.31 45.52 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.815 -0.809 . . . . 2.2200000000000002 108.815 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -149.34 129.67 13.77 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.142 -0.623 . . . . 1.73 110.187 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 75.5 tttt -56.85 114.91 2.29 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.787 -0.642 . . . . 1.78 110.366 174.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.554 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -62.62 145.81 53.59 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.792 -1.095 . . . . 0.45000000000000001 110.251 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.571 ' H ' ' CD1' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -67.07 1.27 2.08 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.305 0.483 . . . . 2.3900000000000001 112.305 -177.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.6 t -91.6 6.24 46.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.799 0.333 . . . . 1.6599999999999999 110.95 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -108.12 3.64 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.633 -0.794 . . . . 1.52 112.035 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.93 87.23 2.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.371 0.605 . . . . 2.79 110.628 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.963 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.3 p 179.25 151.32 0.34 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.824 -1.08 . . . . 0.44 109.169 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.475 ' OH ' ' HA ' ' A' ' 83' ' ' VAL . 22.6 m-85 -147.11 136.45 22.66 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.549 -0.537 . . . . 0.41999999999999998 109.549 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.468 ' CD2' ' HB2' ' A' ' 32' ' ' GLN . 45.2 m95 -86.33 159.3 19.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.07 0.462 . . . . 0.41999999999999998 110.481 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.604 ' HB ' HG23 ' A' ' 31' ' ' ILE . 72.1 t -138.21 104.31 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.108 -0.951 . . . . 0.62 109.964 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.656 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 71.5 m-85 -110.4 116.75 31.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.0 -0.741 . . . . 1.49 109.0 175.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 18.1 m -115.79 154.62 17.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.551 0.691 . . . . 1.6100000000000001 111.355 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HE2' ' HE2' ' A' ' 106' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 115.066 -0.97 . . . . 3.4500000000000002 109.077 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.582 ' N ' ' HH ' ' A' ' 42' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.473 0 N-CA-C 112.375 -0.29 . . . . 1.4299999999999999 112.375 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.81 105.17 4.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.625 0.25 . . . . 0.69999999999999996 110.537 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.741 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 6.3 tt -133.52 140.37 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.196 0.522 . . . . 0.90000000000000002 111.097 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.58 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 3.2 pt20 -109.66 129.79 55.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.6 -0.727 . . . . 2.2200000000000002 110.548 176.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.29 159.03 36.53 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.513 -0.767 . . . . 0.71999999999999997 109.915 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 37.2 p30 -84.5 164.66 18.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.373 0.606 . . . . 1.1499999999999999 111.439 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.53 21.13 3.84 Favored Glycine 0 C--N 1.322 -0.249 0 CA-C-N 115.257 -0.883 . . . . 1.2 112.441 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.08 -26.55 8.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.804 0.335 . . . . 1.8100000000000001 110.329 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.45 11.61 7.22 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.907 -0.588 . . . . 1.05 111.86 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -109.53 143.59 38.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.892 0.377 . . . . 1.5700000000000001 110.421 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.473 HG23 HD11 ' A' ' 31' ' ' ILE . 51.2 mm -79.9 139.41 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.227 -0.657 . . . . 1.1799999999999999 109.227 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.3 tp -106.72 -52.31 2.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.628 -0.26 . . . . 1.5600000000000001 111.095 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -163.19 147.14 10.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 2.4100000000000001 111.336 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.741 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 49.0 t80 -114.27 151.23 33.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.01 -0.541 . . . . 1.4199999999999999 110.118 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.961 -0.563 . . . . 1.21 110.22 -179.58 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.825 0 N-CA-C 111.303 -0.719 . . . . 3.2000000000000002 111.303 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 62.03 37.93 14.46 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.654 0.382 . . . . 4.1399999999999997 110.268 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.663 ' HA ' HD11 ' A' ' 88' ' ' LEU . 69.6 t80 -47.34 -32.37 4.76 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.352 0.661 . . . . 0.94999999999999996 112.247 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -62.46 -44.02 97.42 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 123.933 0.771 . . . . 3.48 110.291 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.11 -22.99 22.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.149 -0.478 . . . . 3.0699999999999998 109.756 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.966 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.27 -38.03 92.7 Favored Glycine 0 N--CA 1.436 -1.3 0 CA-C-N 115.776 -0.647 . . . . 0.55000000000000004 112.323 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 79' ' ' PHE . 69.2 t -69.81 -48.61 63.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.93 -0.635 . . . . 0.84999999999999998 110.411 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.5 -23.74 42.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.423 -0.808 . . . . 1.1200000000000001 111.352 -170.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.6 p -67.62 -28.41 67.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.494 0.664 . . . . 1.8799999999999999 109.219 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.16 19.5 62.59 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.356 -0.838 . . . . 1.6599999999999999 111.839 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -162.85 55.75 0.2 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.359 0.6 . . . . 2.0800000000000001 111.225 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.966 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -69.07 83.61 0.33 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.553 -0.749 . . . . 0.56000000000000005 111.326 176.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.9 p-10 -144.86 99.04 3.28 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.455 0.645 . . . . 2.0099999999999998 109.789 171.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 91' ' ' MET . 11.9 m -146.31 152.52 39.27 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.136 -0.484 . . . . 1.6699999999999999 110.333 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.416 ' N ' HG22 ' A' ' 90' ' ' THR . 16.8 ptt? -123.22 129.26 51.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.93 0.395 . . . . 3.9399999999999999 110.323 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -150.66 142.96 24.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.806 -0.634 . . . . 2.4700000000000002 109.759 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.61 117.1 29.83 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.663 -0.495 . . . . 1.97 109.663 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 108.685 -0.857 . . . . 4.29 108.685 -175.385 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.1 tttt . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 107.959 -1.126 . . . . 3.1200000000000001 107.959 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -126.03 163.66 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.182 0.515 . . . . 1.23 110.867 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 22.1 ptmt -135.31 140.33 45.03 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.412 -0.813 . . . . 2.3599999999999999 109.03 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.75 142.02 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-O 121.679 0.752 . . . . 1.1100000000000001 112.157 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 18.5 t-160 -131.71 104.67 7.04 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.004 -1.48 . . . . 1.01 107.004 164.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.587 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 79.7 mtp -105.98 148.13 28.05 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.826 -0.805 . . . . 2.2200000000000002 108.826 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.8 ptmm? -152.59 134.43 14.74 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.893 -0.723 . . . . 1.73 109.671 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.454 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 18.5 ttmm -56.95 115.35 2.55 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.409 0.623 . . . . 1.78 109.726 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.54 138.02 58.35 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.659 -1.155 . . . . 0.45000000000000001 110.866 -172.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.52 -8.66 55.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.185 0.517 . . . . 2.3900000000000001 109.974 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.2 m -65.41 -35.92 82.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.487 -0.779 . . . . 1.6599999999999999 110.089 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.09 139.68 9.36 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.825 -0.625 . . . . 1.52 112.335 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.53 44.75 17.2 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.42 0.688 . . . . 2.79 112.091 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 2.9 p -158.98 157.16 30.77 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.249 -0.887 . . . . 0.44 110.383 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.454 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 39.8 m-85 -139.29 137.21 35.65 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.443 -0.577 . . . . 0.41999999999999998 109.443 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.58 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 39.8 m95 -84.05 161.7 20.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.278 0.561 . . . . 0.41999999999999998 111.27 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.77 95.82 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.426 -1.261 . . . . 0.62 108.93 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 89.6 m-85 -90.31 101.55 14.27 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.414 -0.958 . . . . 1.49 108.414 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 7.1 p -116.97 134.02 61.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.81 0.338 . . . . 1.6100000000000001 110.478 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.824 -0.436 . . . . 3.4500000000000002 109.824 -176.406 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 C--O 1.226 -0.382 0 CA-C-O 120.374 -0.125 . . . . 1.4299999999999999 112.945 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.14 102.9 14.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.997 0.427 . . . . 0.69999999999999996 111.755 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.708 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -128.49 139.73 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.954 0.407 . . . . 0.90000000000000002 110.025 175.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.611 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.3 pt20 -112.81 134.67 54.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.471 0.653 . . . . 2.2200000000000002 111.416 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HB3' HD13 ' A' ' 39' ' ' ILE . 4.2 pp -122.62 161.84 23.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.149 -0.932 . . . . 0.71999999999999997 110.019 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 36' ' ' ASP . 3.5 p30 -90.87 153.99 19.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.261 0.553 . . . . 1.1499999999999999 110.77 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -79.07 28.23 2.25 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.591 -0.731 . . . . 1.2 111.381 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 34' ' ' ASP . 31.9 t70 -111.41 -35.34 5.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.803 -0.698 . . . . 1.8100000000000001 109.402 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.42 22.45 1.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.803 -0.713 . . . . 1.05 112.992 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -135.31 153.47 51.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.085 0.469 . . . . 1.5700000000000001 110.533 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.535 HG23 HD11 ' A' ' 31' ' ' ILE . 48.2 mm -76.16 141.61 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.188 -0.671 . . . . 1.1799999999999999 109.188 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.455 HD23 ' NE2' ' A' ' 32' ' ' GLN . 32.8 tp -107.34 -52.29 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.915 -0.314 . . . . 1.5600000000000001 110.963 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.406 ' O ' HG12 ' A' ' 31' ' ' ILE . 24.4 tt0 -160.93 140.84 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.702 -0.399 . . . . 2.4100000000000001 111.72 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.708 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 76.8 t80 -104.41 139.03 39.94 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.769 -0.826 . . . . 1.4199999999999999 108.769 171.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 . . . . . 0 C--N 1.319 -0.73 0 N-CA-C 110.001 -0.37 . . . . 1.21 110.001 -179.785 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 110.833 -0.907 . . . . 3.2000000000000002 110.833 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 58.98 41.06 21.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.597 0.713 . . . . 4.1399999999999997 109.376 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 83' ' ' VAL . 57.4 t80 -56.81 -36.25 69.7 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.628 -1.169 . . . . 0.94999999999999996 111.259 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -59.49 -36.71 76.57 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 123.85 0.718 . . . . 3.48 110.52 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -86.07 -37.91 18.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.812 -0.631 . . . . 3.0699999999999998 109.863 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 1.017 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.39 -43.58 89.99 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.721 -0.672 . . . . 0.55000000000000004 112.015 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 79' ' ' PHE . 90.7 t -73.05 -50.63 30.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.508 -0.846 . . . . 0.84999999999999998 111.211 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.79 -32.29 59.83 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.215 -0.448 . . . . 1.1200000000000001 111.239 -169.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.6 m -72.55 -23.23 60.95 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.424 -0.584 . . . . 1.8799999999999999 109.424 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 34.06 38.06 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.714 -0.675 . . . . 1.6599999999999999 111.999 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -158.89 50.19 0.36 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.565 0.698 . . . . 2.0800000000000001 112.005 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.017 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -73.76 88.31 1.75 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.763 -0.653 . . . . 0.56000000000000005 111.45 177.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.0 p30 -143.26 101.52 3.82 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.525 -0.546 . . . . 2.0099999999999998 109.525 175.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.0 t -168.47 163.36 12.56 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.13 0.49 . . . . 1.6699999999999999 110.924 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.2 ptt? -104.4 136.28 44.27 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.411 -0.813 . . . . 3.9399999999999999 110.014 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 107' ' ' VAL . 77.3 t80 -147.15 127.78 14.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.58 -0.736 . . . . 2.4700000000000002 109.22 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 8.1 pt-20 -95.43 132.71 40.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.43 0.633 . . . . 1.97 110.804 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.9 t80 . . . . . 0 N--CA 1.446 -0.659 0 CA-C-N 114.76 -1.109 . . . . 4.29 108.777 -173.217 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 tttm . . . . . 0 C--O 1.236 0.354 0 CA-C-O 120.832 0.349 . . . . 3.1200000000000001 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.2 m -114.74 167.87 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-N 115.548 -0.751 . . . . 1.23 110.141 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 19.8 ptmt -144.07 147.38 33.71 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.671 -0.412 . . . . 2.3599999999999999 110.414 174.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.727 HG12 HG12 ' A' ' 122' ' ' VAL . 14.2 m -100.54 144.24 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-N 115.781 -0.645 . . . . 1.1100000000000001 111.359 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -119.97 102.87 8.85 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.411 -1.7 . . . . 1.01 106.411 160.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 64.0 mtt -102.98 146.36 28.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.777 -0.823 . . . . 2.2200000000000002 108.777 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 61.5 pttt -151.12 128.85 11.56 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.874 -0.73 . . . . 1.73 110.187 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.09 110.03 0.76 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.769 -0.65 . . . . 1.78 109.45 168.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.93 129.34 17.16 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.783 -1.099 . . . . 0.45000000000000001 109.782 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.17 -5.92 20.62 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.225 0.328 . . . . 2.3900000000000001 111.747 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -73.4 -43.13 61.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.817 0.342 . . . . 1.6599999999999999 110.219 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.22 138.31 3.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.379 -0.915 . . . . 1.52 113.488 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.74 52.65 4.04 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.186 0.994 . . . . 2.79 113.374 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.513 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.1 p -158.92 156.21 29.1 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.56 -1.274 . . . . 0.44 107.56 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -137.38 136.2 37.67 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.645 -0.422 . . . . 0.41999999999999998 111.18 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.611 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 49.2 m95 -91.5 161.98 14.74 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.406 0.622 . . . . 0.41999999999999998 111.824 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.52 97.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.39 -1.277 . . . . 0.62 109.226 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 66.3 m-85 -98.27 112.47 24.45 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.188 -0.671 . . . . 1.49 109.188 174.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.727 HG12 HG12 ' A' ' 107' ' ' VAL . 31.1 m -110.78 150.13 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.255 0.465 . . . . 1.6100000000000001 112.255 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 pttt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 3.4500000000000002 110.366 175.176 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 C--O 1.221 -0.68 0 CA-C-O 119.917 -0.379 . . . . 1.4299999999999999 113.489 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -109.3 105.22 14.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.767 0.784 . . . . 0.69999999999999996 110.828 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.663 HD11 HD12 ' A' ' 39' ' ' ILE . 4.3 tt -138.35 141.69 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.425 -0.352 . . . . 0.90000000000000002 110.767 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' OE1' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -114.06 130.01 56.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.022 0.439 . . . . 2.2200000000000002 109.842 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.416 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.7 pp -132.75 159.76 38.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.354 0.597 . . . . 0.71999999999999997 111.366 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.6 p30 -76.99 157.83 30.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 1.1499999999999999 110.782 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.449 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -77.76 30.98 1.73 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.361 -0.836 . . . . 1.2 112.675 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -122.42 -31.94 3.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.211 0.529 . . . . 1.8100000000000001 109.756 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.04 21.18 1.24 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.459 -0.877 . . . . 1.05 112.898 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.484 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 16.2 m-80 -125.27 156.49 38.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.045 0.45 . . . . 1.5700000000000001 110.196 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.663 HD12 HD11 ' A' ' 31' ' ' ILE . 41.1 mm -81.53 142.75 13.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.965 -0.561 . . . . 1.1799999999999999 109.999 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.462 HD12 ' OE1' ' A' ' 32' ' ' GLN . 89.1 mt -109.31 -53.23 2.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.395 -0.595 . . . . 1.5600000000000001 109.395 172.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -133.81 117.27 16.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.579 -0.737 . . . . 2.4100000000000001 110.656 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.578 ' HA ' HG13 ' A' ' 31' ' ' ILE . 18.5 t80 -106.01 117.93 35.31 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.277 -0.638 . . . . 1.4199999999999999 109.277 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 84.6 m-20 . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 120.991 0.424 . . . . 1.21 110.529 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 111.728 -0.549 . . . . 3.2000000000000002 111.728 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 58.28 41.07 23.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.376 0.608 . . . . 4.1399999999999997 109.676 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 83' ' ' VAL . 56.0 t80 -56.24 -27.67 55.79 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.31 -0.859 . . . . 0.94999999999999996 111.789 -171.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.86 -33.95 72.95 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 123.855 0.722 . . . . 3.48 110.277 -175.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -86.87 -29.07 22.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.765 -0.652 . . . . 3.0699999999999998 109.531 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.737 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.25 -39.27 92.26 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 111.83 -0.508 . . . . 0.55000000000000004 111.83 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 79' ' ' PHE . 95.2 t -66.86 -48.12 80.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.979 -0.61 . . . . 0.84999999999999998 110.547 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.41 -26.61 51.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 1.1200000000000001 111.206 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -60.1 -28.56 67.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.562 -0.533 . . . . 1.8799999999999999 109.562 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.11 -10.26 47.37 Favored Glycine 0 CA--C 1.505 -0.551 0 C-N-CA 120.728 -0.749 . . . . 1.6599999999999999 113.048 169.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -169.96 62.61 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.324 0.583 . . . . 2.0800000000000001 110.145 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.737 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 2.9 tt -38.45 102.35 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 114.728 -1.123 . . . . 0.56000000000000005 111.802 175.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 4.1 p30 -145.74 102.24 3.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.1 0.476 . . . . 2.0099999999999998 109.822 176.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 2.5 p -138.8 154.34 48.47 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.924 -0.485 . . . . 1.6699999999999999 111.764 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.24 138.1 36.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.768 -0.651 . . . . 3.9399999999999999 109.76 171.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.45 ' O ' HG22 ' A' ' 107' ' ' VAL . 85.5 t80 -163.3 140.37 7.41 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.377 -0.601 . . . . 2.4700000000000002 109.377 -175.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 39.2 mt-10 -91.74 110.78 22.13 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.356 -0.609 . . . . 1.97 109.356 177.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.5 t80 . . . . . 0 N--CA 1.45 -0.474 0 CA-C-N 115.649 -0.705 . . . . 4.29 110.872 -171.269 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 N--CA 1.444 -0.764 0 CA-C-O 120.755 0.312 . . . . 3.1200000000000001 110.375 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.9 163.85 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.978 -0.556 . . . . 1.23 109.528 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 59.1 pttt -126.17 140.05 52.86 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.047 -0.723 . . . . 2.3599999999999999 109.047 173.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 122' ' ' VAL . 7.9 m -100.65 143.5 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 CA-C-O 121.144 0.497 . . . . 1.1100000000000001 110.903 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 90' ' ' THR . 17.8 t-160 -143.85 102.73 3.95 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.656 -1.238 . . . . 1.01 107.656 164.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.553 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.1 OUTLIER -115.63 125.23 52.64 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.925 -1.139 . . . . 2.2200000000000002 107.925 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.9 ptmm? -145.18 146.96 31.96 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.742 -0.783 . . . . 1.73 110.604 -171.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 13.1 ttpp -56.82 123.79 16.26 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.217 -0.901 . . . . 1.78 111.265 176.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.66 148.41 51.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.674 -1.148 . . . . 0.45000000000000001 110.716 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.51 -4.1 37.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.091 0.472 . . . . 2.3900000000000001 110.883 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -79.88 -21.91 43.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 1.6599999999999999 110.933 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 139.16 -128.1 3.91 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.487 -0.864 . . . . 1.52 112.739 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.66 77.24 5.14 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.988 0.899 . . . . 2.79 110.76 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.449 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.9 p -162.94 157.14 20.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.267 -1.333 . . . . 0.44 108.194 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 25.1 m-85 -138.65 141.28 39.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.864 0.364 . . . . 0.41999999999999998 110.608 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 47.2 m95 -87.98 165.75 14.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.145 0.498 . . . . 0.41999999999999998 110.573 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.454 ' HB ' HG23 ' A' ' 31' ' ' ILE . 58.1 t -135.42 98.56 2.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.643 -1.162 . . . . 0.62 108.774 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 83.2 m-85 -103.86 119.96 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.372 -0.603 . . . . 1.49 109.372 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 107' ' ' VAL . 23.8 m -124.28 155.16 31.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.714 -0.476 . . . . 1.6100000000000001 109.714 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt . . . . . 0 C--N 1.32 -0.683 0 C-N-CA 120.816 -0.353 . . . . 3.4500000000000002 110.206 174.799 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 C--O 1.226 -0.358 0 CA-C-O 120.445 -0.086 . . . . 1.4299999999999999 113.239 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -107.49 118.73 37.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.139 0.495 . . . . 0.69999999999999996 111.57 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.543 HG23 ' HB ' ' A' ' 120' ' ' VAL . 5.5 tt -136.19 141.01 42.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.222 -0.444 . . . . 0.90000000000000002 110.121 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -115.37 125.08 52.77 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.5 -0.926 . . . . 2.2200000000000002 108.5 179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.48 154.31 46.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.605 0.717 . . . . 0.71999999999999997 111.456 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -73.71 146.61 44.29 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.025 -0.989 . . . . 1.1499999999999999 110.045 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.56 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -82.09 36.28 2.55 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.804 -0.635 . . . . 1.2 112.961 -173.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -134.51 -24.97 1.52 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.854 0.359 . . . . 1.8100000000000001 110.1 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.09 -4.28 2.6 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.099 -0.572 . . . . 1.05 112.494 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 21.4 m-80 -90.78 149.76 21.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.511 0.196 . . . . 1.5700000000000001 110.792 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.7 mm -92.8 140.06 16.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.822 -0.807 . . . . 1.1799999999999999 108.822 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.448 ' HG ' ' HG3' ' A' ' 41' ' ' GLN . 38.3 tp -113.28 -57.34 2.3 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.348 -0.541 . . . . 1.5600000000000001 111.351 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 45.1 mt-30 -144.16 150.38 37.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.016 0.436 . . . . 2.4100000000000001 111.405 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.464 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 55.9 t80 -127.04 117.78 23.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.956 -0.565 . . . . 1.4199999999999999 109.551 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.498 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 109.83 -0.433 . . . . 1.21 109.83 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.689 0 N-CA-C 112.017 -0.433 . . . . 3.2000000000000002 112.017 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 58.48 44.12 18.48 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 122.686 0.395 . . . . 4.1399999999999997 110.538 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 83' ' ' VAL . 64.5 t80 -46.08 -43.0 14.29 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 113.456 0.91 . . . . 0.94999999999999996 113.456 -167.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -79.64 -29.88 41.14 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 121.279 0.561 . . . . 3.48 110.155 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.53 -34.31 62.98 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.218 -1.03 . . . . 3.0699999999999998 108.218 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 1.015 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.86 -40.08 89.29 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.732 -1.122 . . . . 0.55000000000000004 111.395 175.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 79' ' ' PHE . 95.5 t -68.38 -54.27 22.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.378 -0.911 . . . . 0.84999999999999998 111.046 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.15 -22.6 33.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 1.1200000000000001 111.644 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.9 t -70.63 -29.51 65.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.483 -0.932 . . . . 1.8799999999999999 108.483 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.24 23.23 49.12 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.53 -0.759 . . . . 1.6599999999999999 112.169 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -156.04 52.59 0.56 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.45 0.643 . . . . 2.0800000000000001 111.501 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.015 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.9 OUTLIER -74.37 73.72 1.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.603 -0.726 . . . . 0.56000000000000005 111.083 175.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.9 t30 -143.16 99.29 3.42 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.572 -0.899 . . . . 2.0099999999999998 108.572 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.4 m -140.26 146.36 38.5 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.017 -0.538 . . . . 1.6699999999999999 110.41 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 16.4 ptt? -126.73 129.72 48.94 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.586 -0.524 . . . . 3.9399999999999999 109.586 172.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -157.85 142.88 16.68 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.517 -0.549 . . . . 2.4700000000000002 109.517 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 55.2 mt-10 -92.6 105.54 17.68 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 1.97 109.412 176.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 63.8 t80 . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.245 -0.889 . . . . 4.29 110.989 -170.259 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.1 tttp . . . . . 0 CA--C 1.512 -0.491 0 N-CA-C 109.422 -0.585 . . . . 3.1200000000000001 109.422 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.27 160.24 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.27 0.557 . . . . 1.23 110.733 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 72.4 tttt -117.91 118.53 32.24 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.291 -1.003 . . . . 2.3599999999999999 108.291 171.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.697 HG12 HG12 ' A' ' 122' ' ' VAL . 6.3 m -99.25 144.22 12.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.438 0.637 . . . . 1.1100000000000001 111.606 -176.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' A' ' 91' ' ' MET . 13.9 t-80 -137.74 103.51 5.03 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.665 -1.152 . . . . 1.01 108.162 164.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 3.5 mpp? -98.94 140.03 33.72 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 106.798 -1.556 . . . . 2.2200000000000002 106.798 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.827 ' HG3' ' HB2' ' A' ' 119' ' ' TRP . 9.3 ptpt -141.02 125.27 17.44 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.701 -0.8 . . . . 1.73 110.09 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.64 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 82.7 tttt -57.72 106.79 0.38 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.976 -0.75 . . . . 1.78 108.976 170.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.37 127.86 20.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.929 -1.032 . . . . 0.45000000000000001 110.323 -173.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.24 -7.12 33.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.267 0.556 . . . . 2.3900000000000001 109.895 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.1 m -71.28 -26.1 62.73 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.164 -0.925 . . . . 1.6599999999999999 110.043 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.44 145.02 18.32 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.174 -0.536 . . . . 1.52 112.973 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 55.75 38.27 29.89 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.511 0.672 . . . . 2.79 112.24 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.56 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 4.8 p -166.7 159.93 14.4 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.165 -0.925 . . . . 0.44 109.937 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.64 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 36.5 m-85 -140.48 139.57 35.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.048 -0.353 . . . . 0.41999999999999998 110.048 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.827 ' HB2' ' HG3' ' A' ' 110' ' ' LYS . 41.1 m95 -92.53 162.49 14.18 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.19 0.519 . . . . 0.41999999999999998 110.658 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.543 ' HB ' HG23 ' A' ' 31' ' ' ILE . 77.5 t -136.16 105.88 5.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.762 -1.108 . . . . 0.62 109.583 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 29.3 m-85 -109.45 123.05 48.72 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.767 -0.457 . . . . 1.49 109.767 175.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.697 HG12 HG12 ' A' ' 107' ' ' VAL . 30.0 m -118.93 157.92 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.124 0.488 . . . . 1.6100000000000001 111.527 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 43.8 tttm . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.546 -0.752 . . . . 3.4500000000000002 110.008 178.694 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.435 0 N-CA-C 111.532 -0.627 . . . . 1.4299999999999999 111.532 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.17 107.74 13.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.982 -0.377 . . . . 0.69999999999999996 109.982 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.679 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -131.04 139.45 51.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.824 0.345 . . . . 0.90000000000000002 110.783 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.551 HE21 HD23 ' A' ' 40' ' ' LEU . 10.6 pt20 -105.22 114.5 28.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.633 0.73 . . . . 2.2200000000000002 110.395 176.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.59 168.45 11.74 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.879 -1.055 . . . . 0.71999999999999997 109.293 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.604 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 3.1 p30 -102.19 157.55 16.81 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.95 -0.7 . . . . 1.1499999999999999 110.888 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.408 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -77.37 14.04 9.66 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.38 -0.827 . . . . 1.2 111.73 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -100.83 -12.57 18.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.27 0.557 . . . . 1.8100000000000001 109.77 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.39 9.31 25.67 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.616 -0.72 . . . . 1.05 112.985 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.53 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -109.07 143.53 38.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.065 0.46 . . . . 1.5700000000000001 110.944 -178.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.559 HG23 HD11 ' A' ' 31' ' ' ILE . 47.7 mm -94.09 126.63 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.141 -0.688 . . . . 1.1799999999999999 109.141 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.551 HD23 HE21 ' A' ' 32' ' ' GLN . 17.9 tp -99.56 -49.49 4.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.851 -0.34 . . . . 1.5600000000000001 110.996 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.585 ' O ' HG12 ' A' ' 31' ' ' ILE . 33.3 tt0 -157.6 142.94 17.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.813 0.34 . . . . 2.4100000000000001 111.292 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.679 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 79.0 t80 -124.68 133.87 53.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.995 -0.548 . . . . 1.4199999999999999 109.844 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 109.142 -0.688 . . . . 1.21 109.142 174.713 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.681 0 N-CA-C 110.511 -1.036 . . . . 3.2000000000000002 110.511 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm 59.86 69.22 0.72 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.2 0.524 . . . . 4.1399999999999997 109.701 -170.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.507 ' O ' HG23 ' A' ' 83' ' ' VAL . 74.8 t80 -53.46 -40.42 65.24 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.14 -0.936 . . . . 0.94999999999999996 111.848 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -62.46 -30.82 71.52 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 123.679 0.612 . . . . 3.48 110.653 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -80.03 -35.24 37.51 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.085 -0.709 . . . . 3.0699999999999998 109.085 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.976 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -62.08 -42.72 99.74 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.513 -0.767 . . . . 0.55000000000000004 111.695 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 79' ' ' PHE . 84.1 t -65.81 -51.24 64.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.753 -0.724 . . . . 0.84999999999999998 110.682 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.37 -21.65 55.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 1.1200000000000001 110.853 -172.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.8 t -65.87 -35.61 81.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.899 -0.591 . . . . 1.8799999999999999 109.431 171.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.94 15.28 63.25 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.335 -0.706 . . . . 1.6599999999999999 111.335 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.741 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 3.0 p30 -166.02 62.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.785 0.802 . . . . 2.0800000000000001 110.833 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.976 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.2 tt -68.86 98.24 0.91 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.048 -0.978 . . . . 0.56000000000000005 110.603 172.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.638 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.0 p-10 -143.25 101.35 3.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.265 -0.574 . . . . 2.0099999999999998 110.867 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.9 t -154.97 162.47 41.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.946 0.403 . . . . 1.6699999999999999 110.608 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -130.0 116.05 18.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.694 -0.684 . . . . 3.9399999999999999 109.877 175.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -126.68 134.13 50.78 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.015 -0.735 . . . . 2.4700000000000002 109.015 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.709 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 7.1 pt-20 -106.13 117.27 33.59 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.908 -0.717 . . . . 1.97 110.361 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.8 t80 . . . . . 0 N--CA 1.447 -0.624 0 CA-C-N 114.763 -1.108 . . . . 4.29 109.873 -173.599 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.6 tttm . . . . . 0 C--O 1.235 0.319 0 N-CA-C 109.946 -0.39 . . . . 3.1200000000000001 109.946 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.0 m -121.22 161.98 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.131 0.491 . . . . 1.23 111.803 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.709 ' HG2' ' HB3' ' A' ' 93' ' ' GLU . 47.0 mttm -108.5 138.28 45.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.525 -0.761 . . . . 2.3599999999999999 109.638 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -107.87 102.54 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.8 -0.444 . . . . 1.1100000000000001 109.8 167.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.787 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 8.3 t-160 -96.18 101.95 13.67 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.838 -1.542 . . . . 1.01 106.838 168.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.638 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 8.8 ttt -111.64 113.58 26.06 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.715 -1.216 . . . . 2.2200000000000002 107.715 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 18.4 ptpt -129.59 132.14 46.69 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.3 -0.56 . . . . 1.73 110.564 -168.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.741 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 81.2 tttt -56.88 117.88 4.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 109.03 -0.73 . . . . 1.78 109.03 167.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -45.46 142.72 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.185 0.928 . . . . 0.45000000000000001 110.767 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.8 tp -63.94 -25.83 68.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.202 -0.454 . . . . 2.3900000000000001 110.691 -173.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.0 m -81.71 -50.81 8.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.961 -0.563 . . . . 1.6599999999999999 109.811 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 128.31 -179.92 16.27 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.977 -0.63 . . . . 1.52 112.756 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.0 t70 61.64 31.6 18.66 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.944 0.878 . . . . 2.79 111.475 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.9 p 179.98 156.5 0.64 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.582 -1.19 . . . . 0.44 110.415 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.448 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 43.6 m-85 -136.17 134.74 38.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.469 -0.567 . . . . 0.41999999999999998 109.469 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.561 ' O ' ' HA ' ' A' ' 109' ' ' MET . 47.3 m95 -86.52 163.87 17.25 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.291 0.567 . . . . 0.41999999999999998 112.026 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.498 HG22 ' HE3' ' A' ' 109' ' ' MET . 60.0 t -132.12 97.42 2.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.387 -1.279 . . . . 0.62 109.037 174.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.787 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 58.3 m-85 -98.81 105.49 17.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.797 -0.446 . . . . 1.49 109.797 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 17.9 m -110.99 135.6 49.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.07 0.462 . . . . 1.6100000000000001 111.482 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.607 -0.724 . . . . 3.4500000000000002 109.288 178.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 112.174 -0.37 . . . . 1.4299999999999999 112.174 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.82 109.64 18.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.449 0.642 . . . . 0.69999999999999996 111.413 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.594 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 4.7 tt -138.57 140.38 39.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.857 -0.611 . . . . 0.90000000000000002 110.051 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.696 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 2.8 pt20 -114.74 143.4 45.12 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.447 0.641 . . . . 2.2200000000000002 110.712 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.542 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.0 pp -124.08 157.34 34.78 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.05 -0.977 . . . . 0.71999999999999997 109.504 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.807 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.5 p30 -79.82 158.56 26.77 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.254 0.55 . . . . 1.1499999999999999 110.439 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.42 21.1 3.05 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.594 -0.73 . . . . 1.2 111.884 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 34' ' ' ASP . 23.8 t70 -106.06 -32.37 8.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.342 -0.614 . . . . 1.8100000000000001 109.342 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.67 11.16 3.03 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.417 -0.81 . . . . 1.05 112.485 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -118.78 155.89 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.687 -0.486 . . . . 1.5700000000000001 109.687 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.542 HD13 ' HB3' ' A' ' 33' ' ' LEU . 43.4 mm -70.5 136.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.967 -0.753 . . . . 1.1799999999999999 108.967 174.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.807 HD23 ' HB3' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -102.17 -65.24 1.0 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.023 -0.732 . . . . 1.5600000000000001 109.023 -173.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -145.25 134.88 23.37 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.318 -0.855 . . . . 2.4100000000000001 111.127 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.594 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 52.1 t80 -113.1 119.52 38.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.614 . . . . 1.4199999999999999 109.941 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.53 0.681 . . . . 1.21 110.766 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.776 0 N-CA-C 110.065 -1.214 . . . . 3.2000000000000002 110.065 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -130.43 61.29 1.6 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.857 -1.164 . . . . 4.1399999999999997 107.857 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.591 ' HA ' HD11 ' A' ' 88' ' ' LEU . 36.2 t80 -86.54 -37.75 17.87 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 116.352 -0.386 . . . . 0.94999999999999996 111.039 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -67.81 -32.04 72.32 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.383 -0.969 . . . . 3.48 108.383 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -82.49 -39.12 22.91 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.776 -1.556 . . . . 3.0699999999999998 108.987 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.603 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -54.79 -38.11 63.63 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.13 -0.941 . . . . 0.55000000000000004 112.364 -174.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 79' ' ' PHE . 61.8 t -69.19 -51.04 47.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.582 -0.809 . . . . 0.84999999999999998 110.786 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.89 -23.43 23.95 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.173 -0.467 . . . . 1.1200000000000001 112.253 -169.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.4 p -73.93 -33.3 63.89 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.828 -1.175 . . . . 1.8799999999999999 107.828 172.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.88 19.2 65.95 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.082 -0.963 . . . . 1.6599999999999999 111.13 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -153.78 52.3 0.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.554 0.693 . . . . 2.0800000000000001 112.084 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.603 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -67.24 86.45 0.16 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.53 -0.759 . . . . 0.56000000000000005 111.24 174.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.6 p30 -144.25 100.67 3.59 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.337 0.589 . . . . 2.0099999999999998 109.768 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.8 m -148.76 146.99 28.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.88 -0.513 . . . . 1.6699999999999999 109.992 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 17.9 ptm -98.76 114.86 27.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.613 -0.884 . . . . 3.9399999999999999 108.613 167.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -121.73 129.67 52.88 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.373 -0.83 . . . . 2.4700000000000002 109.418 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.527 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 22.3 mp0 -90.58 118.94 30.43 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.477 -0.934 . . . . 1.97 108.477 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.77 -0.65 . . . . 4.29 109.486 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.527 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 37.0 ttpt . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 110.018 -0.364 . . . . 3.1200000000000001 110.018 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.3 m -102.15 161.92 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.298 0.57 . . . . 1.23 110.929 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 39.1 ttmt -116.37 126.72 53.88 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.241 -0.891 . . . . 2.3599999999999999 109.494 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.64 103.7 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.865 -0.607 . . . . 1.1100000000000001 109.411 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.954 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 5.7 t-160 -90.08 101.07 13.79 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.169 -1.789 . . . . 1.01 106.169 167.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.719 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.5 OUTLIER -102.2 120.46 40.49 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.294 -1.372 . . . . 2.2200000000000002 107.294 -178.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -135.79 119.36 17.02 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.943 -0.703 . . . . 1.73 111.143 -165.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.481 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 81.2 tttt -55.81 116.48 2.97 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.152 0.501 . . . . 1.78 110.276 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 145.84 45.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.62 -1.173 . . . . 0.45000000000000001 111.243 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.9 mm? -77.18 -8.08 56.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.867 -0.606 . . . . 2.3900000000000001 110.131 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 t -80.32 -45.53 17.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.062 -0.517 . . . . 1.6599999999999999 110.007 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.49 149.68 8.32 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.898 -0.667 . . . . 1.52 112.699 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 52.23 37.65 22.56 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.657 0.742 . . . . 2.79 111.644 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.0 p -159.98 154.03 23.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.845 -1.07 . . . . 0.44 109.761 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 66.2 m-85 -141.35 137.31 32.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.394 -0.366 . . . . 0.41999999999999998 110.27 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.696 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 44.3 m95 -88.24 164.18 15.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.471 0.653 . . . . 0.41999999999999998 111.65 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.7 t -136.21 96.1 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.017 -1.447 . . . . 0.62 108.391 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.954 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 63.5 m-85 -94.53 102.53 14.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.944 -1.132 . . . . 1.49 107.944 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 10.3 p -97.72 134.28 36.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 1.6100000000000001 111.132 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 N--CA 1.45 -0.453 0 CA-C-N 115.992 -0.549 . . . . 3.4500000000000002 109.729 -177.514 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 111.889 -0.484 . . . . 1.4299999999999999 111.889 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.25 103.4 15.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.969 0.414 . . . . 0.69999999999999996 111.073 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.53 HD11 HG23 ' A' ' 39' ' ' ILE . 5.7 tt -135.39 140.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.159 0.504 . . . . 0.90000000000000002 111.212 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.484 ' HB3' ' CE2' ' A' ' 119' ' ' TRP . 12.3 pt20 -109.6 121.09 44.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.656 -0.702 . . . . 2.2200000000000002 110.353 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 pp -123.15 152.34 41.26 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.078 -0.51 . . . . 0.71999999999999997 110.833 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -70.93 154.13 42.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.762 -0.654 . . . . 1.1499999999999999 110.142 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.516 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -76.79 31.17 1.49 Allowed Glycine 0 C--O 1.234 0.096 0 CA-C-N 115.781 -0.645 . . . . 1.2 113.31 -173.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 34' ' ' ASP . 12.4 t70 -135.44 -33.51 0.88 Allowed 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 122.84 0.456 . . . . 1.8100000000000001 110.204 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.59 18.84 0.53 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.473 -0.87 . . . . 1.05 113.051 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -107.68 128.87 54.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.603 0.239 . . . . 1.5700000000000001 110.789 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.53 HG23 HD11 ' A' ' 31' ' ' ILE . 46.9 mm -78.9 115.6 21.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.722 -0.217 . . . . 1.1799999999999999 110.512 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.86 -47.44 9.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.072 0.463 . . . . 1.5600000000000001 110.575 -173.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -159.34 142.39 14.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.911 -0.586 . . . . 2.4100000000000001 111.416 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -114.44 117.59 31.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.656 -0.702 . . . . 1.4199999999999999 110.191 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.855 -0.424 . . . . 1.21 109.855 -178.793 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.513 0 N-CA-C 112.071 -0.412 . . . . 3.2000000000000002 112.071 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.16 8.95 39.78 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 110.392 -0.225 . . . . 4.1399999999999997 110.392 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.771 ' HA ' HD11 ' A' ' 88' ' ' LEU . 6.1 t80 -49.93 -36.06 26.27 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.749 0.648 . . . . 0.94999999999999996 112.749 -168.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 57.4 mmtt -66.54 -30.42 70.73 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 121.394 0.616 . . . . 3.48 110.952 -177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -89.26 -41.5 12.15 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.876 -0.787 . . . . 3.0699999999999998 108.876 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.828 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -51.41 -40.99 47.45 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.142 -0.935 . . . . 0.55000000000000004 112.565 -173.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 79' ' ' PHE . 85.7 t -64.89 -52.08 58.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.463 -0.869 . . . . 0.84999999999999998 110.942 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.07 -29.84 21.59 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.101 -0.5 . . . . 1.1200000000000001 112.323 -168.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.8 p -72.94 -29.53 63.17 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.708 -0.849 . . . . 1.8799999999999999 108.708 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.03 26.0 65.38 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.828 -0.909 . . . . 1.6599999999999999 110.828 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -148.56 49.3 1.02 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.89 0.853 . . . . 2.0800000000000001 111.759 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.828 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -71.79 78.4 0.86 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.142 -0.935 . . . . 0.56000000000000005 111.644 176.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.5 p-10 -144.23 98.44 3.21 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.454 0.645 . . . . 2.0099999999999998 109.787 174.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 91' ' ' MET . 4.1 m -149.16 157.43 43.37 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.789 -0.448 . . . . 1.6699999999999999 109.789 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.5 ptt? -117.52 138.19 52.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.331 -0.395 . . . . 3.9399999999999999 109.941 173.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -161.84 149.61 14.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.275 -0.639 . . . . 2.4700000000000002 109.275 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.582 ' HG3' ' HD3' ' A' ' 106' ' ' LYS . 10.5 mp0 -92.28 121.02 33.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.599 -0.519 . . . . 1.97 109.599 176.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.0 t80 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.27 -0.423 . . . . 4.29 110.336 -177.324 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 93' ' ' GLU . 26.8 ttmt . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 109.103 -0.703 . . . . 3.1200000000000001 109.103 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 27.3 m -104.17 159.49 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.295 0.569 . . . . 1.23 111.229 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.582 ' HD3' ' HG3' ' A' ' 93' ' ' GLU . 55.0 mmtt -101.73 120.61 40.63 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.085 -0.962 . . . . 2.3599999999999999 108.668 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.557 HG12 ' HG3' ' A' ' 109' ' ' MET . 2.1 t -97.21 102.02 12.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.172 -0.677 . . . . 1.1100000000000001 109.172 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 5.5 t-160 -101.31 103.56 14.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.765 -1.198 . . . . 1.01 107.765 170.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 62.0 mtt -106.67 144.18 33.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.058 -1.09 . . . . 2.2200000000000002 108.058 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.6 ptpt -147.97 130.77 16.07 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.146 -0.621 . . . . 1.73 109.76 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.551 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 63.2 tttp -57.76 111.53 1.17 Allowed 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 109.038 -0.727 . . . . 1.78 109.038 168.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.63 144.75 13.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.781 -1.1 . . . . 0.45000000000000001 110.085 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.39 -17.99 63.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.003 0.43 . . . . 2.3900000000000001 110.098 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.2 m -63.0 -40.33 97.45 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.493 -0.776 . . . . 1.6599999999999999 110.354 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.66 -61.8 0.4 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.72 -0.752 . . . . 1.52 113.475 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -87.45 41.42 0.98 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.438 0.637 . . . . 2.79 112.202 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.516 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.1 p -166.92 159.28 13.3 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.741 -0.663 . . . . 0.44 110.806 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.551 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 72.7 m-85 -139.06 135.63 34.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.835 -0.621 . . . . 0.41999999999999998 109.615 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.484 ' CE2' ' HB3' ' A' ' 32' ' ' GLN . 42.2 m95 -87.77 163.13 16.64 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.352 0.596 . . . . 0.41999999999999998 112.044 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.95 111.08 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.144 -1.389 . . . . 0.62 108.828 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 83.8 m-85 -111.9 110.08 20.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.529 -0.545 . . . . 1.49 109.529 174.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.34 125.03 63.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.585 0.231 . . . . 1.6100000000000001 110.77 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 C--O 1.222 -0.348 0 N-CA-C 108.966 -0.753 . . . . 3.4500000000000002 108.966 177.589 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 110.944 -0.863 . . . . 1.4299999999999999 110.944 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.91 106.77 16.45 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.003 0.43 . . . . 0.69999999999999996 111.156 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.441 HG23 ' HB ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -123.88 139.39 50.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.641 -0.503 . . . . 0.90000000000000002 109.641 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.696 HE21 HD23 ' A' ' 40' ' ' LEU . 21.0 pt20 -110.48 126.57 54.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.786 -0.643 . . . . 2.2200000000000002 110.529 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.56 163.35 21.15 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.548 -0.751 . . . . 0.71999999999999997 110.046 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 45.9 p30 -87.06 165.93 15.41 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.47 0.653 . . . . 1.1499999999999999 110.97 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.573 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -77.16 27.91 1.71 Allowed Glycine 0 C--N 1.319 -0.409 0 CA-C-N 115.251 -0.886 . . . . 1.2 112.243 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 34' ' ' ASP . 20.5 t70 -127.22 -8.97 5.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.084 0.469 . . . . 1.8100000000000001 110.433 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.06 11.27 43.31 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.866 -0.683 . . . . 1.05 112.151 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.485 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -106.42 148.25 28.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.823 0.344 . . . . 1.5700000000000001 110.195 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 31' ' ' ILE . 45.5 mm -84.22 129.45 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.548 -0.538 . . . . 1.1799999999999999 109.548 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.696 HD23 HE21 ' A' ' 32' ' ' GLN . 29.5 tp -96.91 -48.59 5.37 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.954 -0.388 . . . . 1.5600000000000001 109.954 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 31.5 tp60 -163.55 121.87 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.229 0.538 . . . . 2.4100000000000001 111.096 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -89.72 123.92 34.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.444 -0.947 . . . . 1.4199999999999999 108.444 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 121.218 0.532 . . . . 1.21 110.327 -177.468 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 112.183 -0.367 . . . . 3.2000000000000002 112.183 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 78' ' ' LYS . 23.5 ttmt 53.65 70.22 0.62 Allowed 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.691 0.758 . . . . 4.1399999999999997 109.543 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.634 ' HA ' HD11 ' A' ' 88' ' ' LEU . 71.7 t80 -50.1 -36.17 28.46 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.725 -1.125 . . . . 0.94999999999999996 113.071 -166.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -72.38 -25.01 61.35 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.123 0.487 . . . . 3.48 110.557 -173.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -82.19 -31.52 30.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.138 -0.69 . . . . 3.0699999999999998 109.138 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 1.014 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -64.3 -41.31 98.25 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.422 -0.808 . . . . 0.55000000000000004 111.753 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 79' ' ' PHE . 57.9 t -67.79 -47.13 80.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.907 -0.647 . . . . 0.84999999999999998 110.36 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.12 -32.07 63.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 1.1200000000000001 110.848 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 64.6 p -67.28 -32.85 74.12 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.118 -0.697 . . . . 1.8799999999999999 109.118 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.36 12.83 34.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.622 -0.717 . . . . 1.6599999999999999 112.828 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.584 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.4 p30 -175.23 69.98 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.764 0.792 . . . . 2.0800000000000001 110.224 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.014 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.3 tt -58.75 88.09 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.911 -1.04 . . . . 0.56000000000000005 111.233 174.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.2 t30 -143.08 101.63 3.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.935 -0.575 . . . . 2.0099999999999998 109.573 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.9 t -150.82 155.84 40.03 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 120.895 0.378 . . . . 1.6699999999999999 110.064 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.7 ptt? -134.5 116.69 15.38 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.586 -0.734 . . . . 3.9399999999999999 110.003 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -143.08 136.98 28.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.439 -0.8 . . . . 2.4700000000000002 109.263 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.3 pt-20 -100.18 118.57 36.79 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.396 -0.522 . . . . 1.97 110.485 177.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.9 t80 . . . . . 0 N--CA 1.446 -0.671 0 N-CA-C 108.803 -0.814 . . . . 4.29 108.803 179.134 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 120.711 0.291 . . . . 3.1200000000000001 111.542 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 32.1 m -110.27 158.69 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 115.78 -0.646 . . . . 1.23 109.869 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 24.1 ttmm -132.45 118.6 19.53 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.948 -0.569 . . . . 2.3599999999999999 109.474 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.3 t -95.87 104.96 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-N 116.445 -0.343 . . . . 1.1100000000000001 110.203 -176.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.662 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 3.4 t-160 -107.12 102.22 11.57 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.758 -1.201 . . . . 1.01 107.758 170.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.659 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 85.3 mtp -110.12 138.01 47.09 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.547 -1.279 . . . . 2.2200000000000002 107.547 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 14.2 ptmm? -144.09 135.33 25.59 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.86 -0.736 . . . . 1.73 110.373 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.648 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 46.0 tttm -55.88 116.41 2.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.797 0.808 . . . . 1.78 110.569 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.35 150.46 22.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.172 -1.376 . . . . 0.45000000000000001 110.716 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.48 -14.42 41.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.787 0.327 . . . . 2.3900000000000001 111.257 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.4 t -76.12 -24.76 54.94 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.048 0.451 . . . . 1.6599999999999999 110.326 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.57 -44.7 3.18 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.269 -0.491 . . . . 1.52 112.449 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.58 34.09 0.64 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.498 0.666 . . . . 2.79 111.673 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 34' ' ' ASP . 2.2 p -169.95 159.37 7.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.167 -0.924 . . . . 0.44 110.427 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.648 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 32.2 m-85 -141.31 145.3 35.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.714 0.292 . . . . 0.41999999999999998 110.297 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.426 ' O ' ' HA ' ' A' ' 109' ' ' MET . 40.8 m95 -93.23 165.64 12.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.46 0.647 . . . . 0.41999999999999998 111.853 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 31' ' ' ILE . 63.0 t -136.08 104.63 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.35 -1.295 . . . . 0.62 109.307 174.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.662 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 62.7 m-85 -106.63 104.79 14.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.463 -0.94 . . . . 1.49 108.463 174.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 12.2 p -105.09 135.48 42.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.25 0.548 . . . . 1.6100000000000001 110.929 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 81.6 mttt . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.822 -0.627 . . . . 3.4500000000000002 109.905 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.797 0 N-CA-C 111.756 -0.538 . . . . 1.4299999999999999 111.756 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.49 114.24 16.52 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.903 0.382 . . . . 0.69999999999999996 111.145 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.503 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 5.5 tt -118.58 140.63 41.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.429 -0.582 . . . . 0.90000000000000002 109.429 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.572 ' OE1' ' HB3' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -120.99 143.82 48.84 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.295 0.569 . . . . 2.2200000000000002 110.905 -175.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.48 160.93 33.76 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.062 -0.972 . . . . 0.71999999999999997 110.37 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 48.0 p30 -85.03 159.38 20.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.503 0.668 . . . . 1.1499999999999999 110.863 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.552 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -77.83 20.55 3.61 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.062 -0.972 . . . . 1.2 111.935 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -99.78 -39.84 8.02 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.813 -0.81 . . . . 1.8100000000000001 108.813 176.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.73 7.78 0.73 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.214 -0.993 . . . . 1.05 114.596 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.486 HD22 ' C ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -134.29 160.08 39.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.366 1.083 . . . . 1.5700000000000001 112.472 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 31' ' ' ILE . 75.9 mt -75.27 143.19 13.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.619 -1.173 . . . . 1.1799999999999999 110.656 -175.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.574 ' HG ' ' HG3' ' A' ' 41' ' ' GLN . 60.5 tp -119.48 -57.56 1.98 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.449 -0.341 . . . . 1.5600000000000001 111.275 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.574 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 94.8 mt-30 -126.81 145.22 50.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.329 . . . . 2.4100000000000001 111.332 -174.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.503 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 87.6 t80 -132.38 136.63 46.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 1.4199999999999999 110.835 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 1.21 109.556 176.734 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 110.597 -1.001 . . . . 3.2000000000000002 110.597 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt 57.47 46.08 18.6 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.135 -0.533 . . . . 4.1399999999999997 109.63 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.596 ' O ' HG23 ' A' ' 83' ' ' VAL . 65.6 t80 -44.81 -42.26 7.7 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 113.436 0.902 . . . . 0.94999999999999996 113.436 -166.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -68.68 -36.3 78.35 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.282 0.563 . . . . 3.48 110.395 -174.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.72 -30.79 28.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.527 -0.761 . . . . 3.0699999999999998 109.103 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.958 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.97 -43.84 92.87 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.458 -0.792 . . . . 0.55000000000000004 111.714 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.2 t -63.53 -52.56 56.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.565 -0.818 . . . . 0.84999999999999998 110.843 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.33 -26.1 35.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 1.1200000000000001 111.767 -170.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.6 t -67.61 -25.19 65.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.409 -0.589 . . . . 1.8799999999999999 109.409 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.41 78.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.87 -0.605 . . . . 1.6599999999999999 112.888 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.42 50.28 1.02 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.711 0.767 . . . . 2.0800000000000001 111.616 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.958 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.1 tt -70.73 89.7 0.75 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.259 -0.882 . . . . 0.56000000000000005 110.995 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.5 p30 -143.68 100.49 3.6 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.705 -0.85 . . . . 2.0099999999999998 108.705 169.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 3.1 p -141.52 152.68 44.35 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.945 -0.472 . . . . 1.6699999999999999 111.059 -174.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.665 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.5 ptm -120.07 116.49 25.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.6 0.714 . . . . 3.9399999999999999 109.775 173.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -119.55 122.47 41.69 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.885 -1.052 . . . . 2.4700000000000002 109.244 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 106' ' ' LYS . 49.2 mt-10 -92.86 130.47 38.45 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.423 -0.584 . . . . 1.97 109.423 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.6 t80 . . . . . 0 N--CA 1.449 -0.479 0 CA-C-N 115.973 -0.558 . . . . 4.29 110.356 -172.051 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttp . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 109.231 -0.655 . . . . 3.1200000000000001 109.231 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -106.16 161.62 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.189 -0.46 . . . . 1.23 111.207 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 19.4 ptpt -139.18 127.06 22.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.585 -0.734 . . . . 2.3599999999999999 109.292 176.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -92.91 144.89 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 C-N-CA 120.185 -0.606 . . . . 1.1100000000000001 110.623 175.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 13.2 t-160 -131.69 102.8 6.04 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.43 -1.322 . . . . 1.01 107.43 164.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.676 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 11.2 ptp -101.88 123.72 46.29 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.664 -1.236 . . . . 2.2200000000000002 107.664 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 21.1 ptmt -138.08 133.36 33.38 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 120.435 -0.506 . . . . 1.73 110.941 -165.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.491 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 64.4 tttp -56.75 115.41 2.55 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.335 -0.848 . . . . 1.78 111.144 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.77 147.09 39.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.513 -1.221 . . . . 0.45000000000000001 110.425 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.19 -3.34 16.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.666 0.27 . . . . 2.3900000000000001 111.335 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 p -84.58 -17.82 37.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.705 0.288 . . . . 1.6599999999999999 111.366 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 127.64 -108.7 0.97 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.306 -0.95 . . . . 1.52 113.118 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -85.16 68.49 10.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.278 1.037 . . . . 2.79 110.956 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.552 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.7 p -158.52 154.09 26.14 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.668 -1.151 . . . . 0.44 108.719 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 50.1 m-85 -140.41 135.85 32.48 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.769 0.319 . . . . 0.41999999999999998 110.364 -175.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.546 ' O ' ' HA ' ' A' ' 109' ' ' MET . 39.7 m95 -87.1 161.4 18.14 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 120.861 0.362 . . . . 0.41999999999999998 110.086 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.4 t -140.01 95.88 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.215 -0.902 . . . . 0.62 108.938 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 108' ' ' HIS . 7.8 p90 -119.53 141.23 49.41 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.991 -0.684 . . . . 1.49 110.528 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 123' ' ' LYS . 12.1 p -123.53 151.98 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.68 -0.691 . . . . 1.6100000000000001 110.229 -175.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 123' ' ' LYS . 14.8 tptt . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 110.094 -0.336 . . . . 3.4500000000000002 110.094 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 111.919 -0.472 . . . . 1.4299999999999999 111.919 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.75 102.44 12.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.041 0.448 . . . . 0.69999999999999996 111.469 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.676 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 5.9 tt -137.61 141.85 38.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.978 -0.555 . . . . 0.90000000000000002 109.957 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.526 ' HB3' ' CE3' ' A' ' 119' ' ' TRP . 0.7 OUTLIER -120.27 140.72 50.8 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.223 0.535 . . . . 2.2200000000000002 110.811 -178.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.604 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.9 pp -134.71 162.85 31.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.439 -0.8 . . . . 0.71999999999999997 111.152 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.565 ' HB3' HD11 ' A' ' 40' ' ' LEU . 10.4 p30 -83.61 158.26 21.96 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.697 -0.683 . . . . 1.1499999999999999 110.876 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.573 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -72.83 2.15 34.69 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.311 -0.858 . . . . 1.2 112.191 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.44 -42.28 17.13 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.11 -0.7 . . . . 1.8100000000000001 109.11 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.59 28.32 0.69 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.179 -0.919 . . . . 1.05 112.355 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -133.86 150.11 51.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.769 0.318 . . . . 1.5700000000000001 110.23 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.604 HD13 ' HB3' ' A' ' 33' ' ' LEU . 12.1 mm -74.65 143.53 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 116.239 -0.437 . . . . 1.1799999999999999 110.443 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' A' ' 34' ' ' ASP . 85.7 mt -113.86 -50.89 2.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.837 0.351 . . . . 1.5600000000000001 111.104 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -142.45 136.17 29.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.23 -0.441 . . . . 2.4100000000000001 110.258 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.676 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 61.7 t80 -130.28 135.67 48.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.164 -0.471 . . . . 1.4199999999999999 110.205 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 116.389 -0.368 . . . . 1.21 110.382 -178.01 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 N-CA-C 111.588 -0.605 . . . . 3.2000000000000002 111.588 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 18.4 tptm 60.35 35.68 20.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.173 0.511 . . . . 4.1399999999999997 110.315 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.746 ' HA ' HD11 ' A' ' 88' ' ' LEU . 62.0 t80 -48.8 -37.67 19.88 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.562 -0.745 . . . . 0.94999999999999996 112.733 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -70.47 -36.87 74.11 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 123.576 0.547 . . . . 3.48 110.123 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.731 ' HB3' ' HG3' ' A' ' 78' ' ' LYS . 41.0 tt0 -80.55 -31.87 36.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.586 -0.734 . . . . 3.0699999999999998 109.18 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.982 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.5 -46.25 93.4 Favored Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 115.666 -0.697 . . . . 0.55000000000000004 111.88 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.4 t -69.15 -46.46 77.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.696 -0.752 . . . . 0.84999999999999998 110.578 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.6 -28.84 63.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.864 -0.607 . . . . 1.1200000000000001 110.555 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -69.69 -23.91 63.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.414 -0.812 . . . . 1.8799999999999999 109.265 174.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.93 19.58 69.84 Favored Glycine 0 CA--C 1.505 -0.539 0 CA-C-N 115.685 -0.688 . . . . 1.6599999999999999 112.198 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.411 ' C ' HD22 ' A' ' 87' ' ' ASN . 0.4 OUTLIER -163.4 55.57 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.246 0.546 . . . . 2.0800000000000001 111.29 -175.287 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.982 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.1 tt -68.65 88.95 0.36 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.771 -0.649 . . . . 0.56000000000000005 111.081 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.758 ' HA ' ' O ' ' A' ' 109' ' ' MET . 20.4 t30 -143.15 100.45 3.64 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.284 -0.636 . . . . 2.0099999999999998 109.284 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.9 t -156.06 158.08 37.17 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.999 0.428 . . . . 1.6699999999999999 110.687 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 19.5 ptt? -125.77 126.16 44.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.772 -0.649 . . . . 3.9399999999999999 110.447 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.55 ' O ' HG22 ' A' ' 107' ' ' VAL . 90.1 t80 -146.08 130.16 17.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.676 -0.693 . . . . 2.4700000000000002 109.795 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.774 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 12.9 pt-20 -104.62 127.1 52.27 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.046 0.451 . . . . 1.97 110.222 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 10.8 p90 . . . . . 0 N--CA 1.447 -0.61 0 CA-C-O 121.794 0.807 . . . . 4.29 109.154 178.622 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.4 tttm . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 109.552 -0.536 . . . . 3.1200000000000001 109.552 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.4 159.89 8.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.008 -0.996 . . . . 1.23 111.588 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.774 ' HG3' ' HB3' ' A' ' 93' ' ' GLU . 25.0 ttpp -146.11 115.0 6.92 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.461 -0.791 . . . . 2.3599999999999999 109.213 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 122' ' ' VAL . 12.9 m -88.54 144.56 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-O 121.373 0.606 . . . . 1.1100000000000001 111.414 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.417 ' O ' ' HD1' ' A' ' 121' ' ' PHE . 14.6 t-160 -132.33 103.32 6.15 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 106.858 -1.534 . . . . 1.01 106.858 160.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.758 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 79.5 mtp -103.7 132.14 50.23 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.108 -1.442 . . . . 2.2200000000000002 107.108 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HG2' ' HB2' ' A' ' 119' ' ' TRP . 61.7 pttt -138.59 131.62 29.76 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.709 -0.796 . . . . 1.73 110.087 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.43 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 80.8 tttt -56.57 113.05 1.45 Allowed 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.784 -0.644 . . . . 1.78 110.188 172.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -58.22 144.75 39.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.605 -1.18 . . . . 0.45000000000000001 110.866 -173.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 73.4 mt -71.23 -9.81 58.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.041 -0.527 . . . . 2.3900000000000001 110.846 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 p -73.13 -30.63 63.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.975 -0.557 . . . . 1.6599999999999999 111.057 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.6 -126.16 2.82 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.74 -0.743 . . . . 1.52 112.668 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.65 79.24 2.01 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.989 0.899 . . . . 2.79 110.853 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.573 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.1 p -168.07 156.16 8.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.532 -1.213 . . . . 0.44 108.457 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.43 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 31.6 m-85 -140.24 137.36 34.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.64 0.257 . . . . 0.41999999999999998 110.916 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.577 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . 45.1 m95 -83.64 162.81 20.65 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.227 0.536 . . . . 0.41999999999999998 110.817 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 50.9 t -137.23 97.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.744 -1.116 . . . . 0.62 109.659 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 89.8 m-85 -100.17 102.47 13.78 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.528 -0.545 . . . . 1.49 109.528 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 107' ' ' VAL . 3.7 m -97.84 106.47 18.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.516 0.674 . . . . 1.6100000000000001 110.026 176.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 68.1 mttm . . . . . 0 N--CA 1.445 -0.712 0 O-C-N 121.963 -0.461 . . . . 3.4500000000000002 110.773 -172.709 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 111.864 -0.494 . . . . 1.4299999999999999 111.864 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.81 119.45 29.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.139 -0.319 . . . . 0.69999999999999996 110.139 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -111.64 138.71 39.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.988 0.423 . . . . 0.90000000000000002 110.604 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.655 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 7.6 pt20 -109.88 127.04 54.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.816 -0.629 . . . . 2.2200000000000002 110.343 176.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.444 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.8 pp -118.69 159.03 24.39 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.288 -0.869 . . . . 0.71999999999999997 109.577 177.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.771 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 1.9 p30 -84.24 151.59 24.71 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.174 -0.611 . . . . 1.1499999999999999 109.976 176.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -73.3 5.18 21.86 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.431 -0.804 . . . . 1.2 112.606 -175.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.09 -39.34 13.69 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.495 -0.557 . . . . 1.8100000000000001 109.495 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.79 36.99 0.19 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.611 -0.722 . . . . 1.05 111.935 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.771 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 19.0 m-80 -137.59 152.53 49.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.978 0.418 . . . . 1.5700000000000001 110.342 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.444 HD13 ' HB3' ' A' ' 33' ' ' LEU . 46.3 mm -95.14 123.28 47.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.879 -0.601 . . . . 1.1799999999999999 110.057 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.503 HD23 ' NE2' ' A' ' 32' ' ' GLN . 35.2 tp -102.59 -52.06 3.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.754 0.279 . . . . 1.5600000000000001 111.754 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.642 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 7.3 tt0 -142.52 122.49 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.902 0.382 . . . . 2.4100000000000001 111.371 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -113.76 106.37 14.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.088 -0.506 . . . . 1.4199999999999999 109.668 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 121.137 0.494 . . . . 1.21 110.587 -179.034 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 111.123 -0.791 . . . . 3.2000000000000002 111.123 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 65.48 25.09 11.87 Favored 'General case' 0 C--O 1.223 -0.32 0 O-C-N 123.826 0.368 . . . . 4.1399999999999997 110.191 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 83' ' ' VAL . 44.8 t80 -55.87 -29.93 60.7 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 112.541 0.571 . . . . 0.94999999999999996 112.541 -167.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -81.4 -37.21 28.52 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.039 0.447 . . . . 3.48 110.204 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -78.72 -30.7 46.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.745 -0.835 . . . . 3.0699999999999998 108.745 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 1.012 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.51 -43.98 90.56 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.067 -0.969 . . . . 0.55000000000000004 111.873 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 79' ' ' PHE . 89.6 t -68.57 -52.56 35.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.424 -0.888 . . . . 0.84999999999999998 111.047 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.19 -28.97 38.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.936 -0.575 . . . . 1.1200000000000001 111.678 -169.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -72.07 -26.32 62.12 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.658 -0.867 . . . . 1.8799999999999999 108.658 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.6 18.43 70.79 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.249 -0.887 . . . . 1.6599999999999999 112.313 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -140.31 42.46 1.91 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.47 0.652 . . . . 2.0800000000000001 111.897 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.012 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -69.21 89.13 0.45 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.363 -0.835 . . . . 0.56000000000000005 111.609 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.716 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.1 p30 -143.95 100.9 3.65 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.453 -0.943 . . . . 2.0099999999999998 108.453 169.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 17.8 p -131.85 151.1 51.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 121.879 -0.513 . . . . 1.6699999999999999 111.12 -173.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 3.9 ppp? -118.79 129.34 55.19 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.647 -0.871 . . . . 3.9399999999999999 108.647 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.469 ' HE2' ' HD2' ' A' ' 94' ' ' TYR . 38.5 t80 -139.28 127.85 23.08 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.906 -0.588 . . . . 2.4700000000000002 109.463 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -90.62 107.3 19.08 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.764 -1.199 . . . . 1.97 107.764 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.469 ' HD2' ' HE2' ' A' ' 92' ' ' PHE . 43.1 t80 . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 121.157 0.503 . . . . 4.29 110.646 -173.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.0 tttm . . . . . 0 C--O 1.241 0.631 0 CA-C-O 120.69 0.281 . . . . 3.1200000000000001 110.87 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.5 161.03 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.93 -0.577 . . . . 1.23 110.391 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -113.92 115.79 28.24 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.094 -1.076 . . . . 2.3599999999999999 108.094 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' MET . 1.9 t -89.73 142.71 12.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 119.976 -0.689 . . . . 1.1100000000000001 109.321 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.597 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 13.6 t-160 -140.47 103.51 4.57 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.437 -0.949 . . . . 1.01 108.437 167.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.716 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 61.5 mtt -92.19 140.68 29.38 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.045 -1.465 . . . . 2.2200000000000002 107.045 173.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -149.27 129.95 14.09 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.349 -0.94 . . . . 1.73 111.202 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.502 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 38.1 tttp -55.22 117.81 3.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.481 -1.236 . . . . 1.78 110.435 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.18 147.71 9.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.783 -1.099 . . . . 0.45000000000000001 111.256 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -62.03 -25.54 67.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.345 -0.389 . . . . 2.3900000000000001 111.297 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.0 p -79.59 -56.0 4.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.044 0.449 . . . . 1.6599999999999999 110.226 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.31 169.14 12.74 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.874 -0.679 . . . . 1.52 112.389 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.9 t70 60.32 28.86 18.5 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.243 1.02 . . . . 2.79 110.642 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.489 ' CB ' ' HA ' ' A' ' 34' ' ' ASP . 6.9 p -168.1 153.22 6.69 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.347 -1.297 . . . . 0.44 109.984 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 51.3 m-85 -140.98 139.68 34.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.226 -0.443 . . . . 0.41999999999999998 110.117 -175.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.655 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 40.6 m95 -87.77 161.4 17.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.192 0.52 . . . . 0.41999999999999998 111.448 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.518 HG22 ' HG2' ' A' ' 109' ' ' MET . 62.1 t -140.21 96.59 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.439 -1.255 . . . . 0.62 108.601 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 108' ' ' HIS . 5.4 p90 -124.58 140.1 53.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.241 -0.583 . . . . 1.49 110.213 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.5 m -113.1 162.78 10.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.171 0.51 . . . . 1.6100000000000001 111.342 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 79.4 tttt . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 115.421 -0.809 . . . . 3.4500000000000002 109.29 -179.087 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.277 -0.179 . . . . 1.4299999999999999 112.767 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.89 111.21 5.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.969 0.414 . . . . 0.69999999999999996 111.719 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.745 HG13 ' HA ' ' A' ' 42' ' ' TYR . 1.2 tt -131.9 140.44 48.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.368 -0.378 . . . . 0.90000000000000002 110.095 174.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.669 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 2.4 pt20 -108.27 130.8 55.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.42 0.629 . . . . 2.2200000000000002 110.201 172.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -120.06 158.14 27.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.185 -0.916 . . . . 0.71999999999999997 109.53 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.84 152.03 38.97 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.991 -0.55 . . . . 1.1499999999999999 109.788 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.606 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -79.28 37.6 2.01 Favored Glycine 0 CA--C 1.506 -0.509 0 CA-C-N 115.906 -0.588 . . . . 1.2 112.237 -172.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -140.47 -33.67 0.55 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.075 -0.562 . . . . 1.8100000000000001 110.484 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.97 11.75 0.49 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.459 -0.877 . . . . 1.05 113.183 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -106.07 144.71 32.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.151 -0.315 . . . . 1.5700000000000001 110.151 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.472 HD12 HD11 ' A' ' 31' ' ' ILE . 44.7 mm -75.59 134.99 28.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.645 -0.502 . . . . 1.1799999999999999 109.645 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.601 ' HB3' ' HG3' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -106.08 -62.69 1.34 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.938 -0.764 . . . . 1.5600000000000001 108.938 -174.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.626 ' HB3' ' HG2' ' A' ' 32' ' ' GLN . 39.9 tt0 -144.69 110.34 5.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.838 -1.074 . . . . 2.4100000000000001 110.359 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.745 ' HA ' HG13 ' A' ' 31' ' ' ILE . 19.2 t80 -100.06 110.78 23.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.008 -0.542 . . . . 1.4199999999999999 109.659 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 120.847 0.356 . . . . 1.21 110.382 -177.162 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.519 0 N-CA-C 112.191 -0.364 . . . . 3.2000000000000002 112.191 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 81' ' ' GLU . 73.8 mmtt -138.43 33.57 2.28 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 109.088 -0.708 . . . . 4.1399999999999997 109.088 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.897 ' HA ' HD11 ' A' ' 88' ' ' LEU . 35.9 t80 -44.61 -47.35 10.39 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 114.094 1.146 . . . . 0.94999999999999996 114.094 -160.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -79.58 -30.25 41.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.656 0.741 . . . . 3.48 109.578 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 68.1 tt0 -73.7 -31.52 63.46 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.975 -1.011 . . . . 3.0699999999999998 108.274 176.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.817 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.27 -43.67 99.07 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.613 -1.176 . . . . 0.55000000000000004 111.259 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 79' ' ' PHE . 73.7 t -65.43 -47.68 85.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.368 -0.916 . . . . 0.84999999999999998 110.526 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.8 -31.05 56.72 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.779 -0.646 . . . . 1.1200000000000001 111.225 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.2 t -66.46 -34.26 77.53 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.264 -1.013 . . . . 1.8799999999999999 108.264 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.62 12.48 58.15 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.24 -0.891 . . . . 1.6599999999999999 111.699 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.561 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.3 p30 -162.28 59.13 0.23 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.572 0.701 . . . . 2.0800000000000001 111.475 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.897 HD11 ' HA ' ' A' ' 79' ' ' PHE . 1.4 tt -60.6 93.01 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.451 -0.795 . . . . 0.56000000000000005 110.746 172.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.729 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.1 t30 -140.63 101.52 4.11 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.662 -0.495 . . . . 2.0099999999999998 109.662 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 6.3 m -137.26 149.44 47.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.48 -0.327 . . . . 1.6699999999999999 110.202 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.0 ptt? -134.08 128.8 34.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.063 -0.517 . . . . 3.9399999999999999 109.865 175.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -161.83 154.01 19.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.964 -0.562 . . . . 2.4700000000000002 109.937 -174.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.741 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 37.1 mt-10 -110.8 112.21 23.92 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.67 -0.493 . . . . 1.97 109.67 176.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 36.5 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 4.29 111.421 -177.405 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 104' ' ' LYS . 5.2 ttmp? . . . . . 0 N--CA 1.446 -0.635 0 CA-C-O 120.742 0.305 . . . . 3.1200000000000001 110.418 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 17.3 m -109.45 159.48 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.903 -0.59 . . . . 1.23 111.324 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.741 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -108.85 113.43 26.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.827 -1.175 . . . . 2.3599999999999999 107.827 175.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 91' ' ' MET . 3.5 m -100.45 144.86 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 C-N-CA 119.872 -0.731 . . . . 1.1100000000000001 112.138 -178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.3 t-160 -135.9 102.19 4.98 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.335 -1.302 . . . . 1.01 107.497 164.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.729 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 63.1 mtt -100.92 116.33 32.52 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.459 -1.682 . . . . 2.2200000000000002 106.459 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 58.8 pttt -132.14 136.64 47.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.218 -0.993 . . . . 1.73 110.999 -168.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.634 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 35.1 tttm -55.6 119.56 5.88 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.138 -0.937 . . . . 1.78 110.57 170.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.84 146.85 13.04 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.119 -0.946 . . . . 0.45000000000000001 110.159 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.5 tp -61.96 -25.23 67.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.547 -0.297 . . . . 2.3900000000000001 110.744 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.9 m -76.48 -67.42 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.363 -0.38 . . . . 1.6599999999999999 110.749 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 143.89 161.93 9.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.63 -0.795 . . . . 1.52 112.447 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 t70 54.57 37.43 27.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.445 1.117 . . . . 2.79 111.003 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.606 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 5.5 p -167.8 150.41 5.77 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.346 -1.297 . . . . 0.44 108.962 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.634 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 57.2 m-85 -141.66 141.57 33.37 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.702 0.287 . . . . 0.41999999999999998 110.416 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.669 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 46.3 m95 -90.58 165.73 13.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.457 0.646 . . . . 0.41999999999999998 111.391 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.61 96.07 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.308 -1.314 . . . . 0.62 108.877 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.511 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 45.8 m-85 -92.71 132.24 37.1 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.613 -0.884 . . . . 1.49 108.613 172.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.459 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 8.2 p -144.75 137.03 21.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.788 0.328 . . . . 1.6100000000000001 110.636 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 CA--C 1.52 -0.206 0 N-CA-C 109.85 -0.426 . . . . 3.4500000000000002 109.85 -178.488 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 110.862 -0.895 . . . . 1.4299999999999999 110.862 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.42 102.42 15.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.304 0.573 . . . . 0.69999999999999996 112.148 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.568 HG13 ' HA ' ' A' ' 42' ' ' TYR . 5.4 tt -124.44 139.7 49.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.695 -0.684 . . . . 0.90000000000000002 109.383 172.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.551 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -116.65 137.12 52.42 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.62 0.724 . . . . 2.2200000000000002 111.844 -176.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.914 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.6 pp -126.86 165.34 19.52 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.824 -1.08 . . . . 0.71999999999999997 110.31 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 14.8 p30 -97.2 158.66 15.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.302 0.573 . . . . 1.1499999999999999 110.211 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.629 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -79.49 26.27 2.68 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.539 -0.755 . . . . 1.2 111.725 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 34' ' ' ASP . 5.7 t70 -104.91 -18.59 14.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.203 0.525 . . . . 1.8100000000000001 109.691 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.44 3.73 5.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.312 -0.946 . . . . 1.05 114.209 171.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.404 HD22 ' H ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -144.81 159.84 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.97 0.885 . . . . 1.5700000000000001 111.979 -176.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.914 HD13 ' HB3' ' A' ' 33' ' ' LEU . 7.5 mm -70.06 146.79 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.066 -0.97 . . . . 1.1799999999999999 109.747 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.503 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 46.8 tp -112.41 -46.17 3.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.219 -0.446 . . . . 1.5600000000000001 110.666 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -147.08 119.98 8.72 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.288 0.566 . . . . 2.4100000000000001 111.929 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.568 ' HA ' HG13 ' A' ' 31' ' ' ILE . 68.4 t80 -98.16 134.69 40.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.927 -0.578 . . . . 1.4199999999999999 109.564 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.865 0.364 . . . . 1.21 110.786 -177.384 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 N-CA-C 111.293 -0.723 . . . . 3.2000000000000002 111.293 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 81' ' ' GLU . 58.7 mtpt 63.26 86.06 0.12 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.605 0.717 . . . . 4.1399999999999997 110.44 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.629 ' HZ ' ' HA2' ' A' ' 35' ' ' GLY . 92.4 t80 -74.5 -51.49 14.62 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.068 -0.969 . . . . 0.94999999999999996 111.083 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -61.7 -30.84 71.01 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 123.861 0.726 . . . . 3.48 110.217 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 8.3 tp10 -75.3 -37.36 60.89 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.584 -0.895 . . . . 3.0699999999999998 108.584 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.978 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.13 -42.27 97.01 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 115.227 -0.897 . . . . 0.55000000000000004 111.396 176.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.8 t -63.24 -50.01 80.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.296 -0.952 . . . . 0.84999999999999998 110.685 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.75 -27.82 55.5 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.883 -0.599 . . . . 1.1200000000000001 111.036 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.0 m -65.17 -25.58 67.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.471 -0.566 . . . . 1.8799999999999999 109.471 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.38 22.58 70.09 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.729 -0.669 . . . . 1.6599999999999999 112.467 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.647 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 8.8 p30 -165.54 48.66 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.37 0.605 . . . . 2.0800000000000001 111.606 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.978 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.6 tt -58.28 93.81 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.382 -0.826 . . . . 0.56000000000000005 111.991 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.694 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.6 p30 -145.71 100.61 3.45 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.202 -0.666 . . . . 2.0099999999999998 109.202 172.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 91' ' ' MET . 3.7 m -149.43 154.14 38.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.552 -0.717 . . . . 1.6699999999999999 110.145 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.589 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 24.0 ptt? -109.05 123.85 49.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.051 0.453 . . . . 3.9399999999999999 110.242 172.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -122.88 112.31 17.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.034 -0.728 . . . . 2.4700000000000002 109.034 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 31.1 mt-10 -105.8 106.52 17.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.391 -0.368 . . . . 1.97 110.209 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 24.1 p90 . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 121.42 0.628 . . . . 4.29 111.081 -177.604 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? . . . . . 0 CA--C 1.512 -0.486 0 N-CA-C 109.672 -0.492 . . . . 3.1200000000000001 109.672 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 28.2 m -101.36 157.51 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.45 0.643 . . . . 1.23 110.866 175.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -134.24 117.68 16.75 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.313 -0.858 . . . . 2.3599999999999999 109.164 176.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.1 t -94.99 105.47 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.904 0 CA-C-N 115.824 -0.626 . . . . 1.1100000000000001 109.958 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.0 t-160 -101.57 102.64 13.4 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.268 -1.382 . . . . 1.01 107.268 169.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.694 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 67.4 mtp -91.32 145.7 24.43 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.076 -1.083 . . . . 2.2200000000000002 108.076 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -148.5 119.19 7.5 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.84 -0.744 . . . . 1.73 109.385 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.647 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 68.9 tttt -55.4 122.94 12.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.473 0.654 . . . . 1.78 111.043 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.26 146.14 52.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.745 -1.116 . . . . 0.45000000000000001 110.436 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.44 4.34 11.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.026 0.441 . . . . 2.3900000000000001 110.878 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.0 t -79.01 -55.94 4.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.989 -0.55 . . . . 1.6599999999999999 109.764 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 134.02 126.5 2.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.81 -0.71 . . . . 1.52 112.654 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.86 35.47 25.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.84 0.828 . . . . 2.79 111.074 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.2 p -141.0 151.46 44.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.202 -1.363 . . . . 0.44 108.793 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.559 ' CE1' HG22 ' A' ' 83' ' ' VAL . 25.8 m-85 -142.88 136.99 29.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.397 -0.365 . . . . 0.41999999999999998 110.271 -173.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.551 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 50.2 m95 -86.09 164.63 17.19 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.448 0.642 . . . . 0.41999999999999998 110.961 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.574 HG12 HG13 ' A' ' 122' ' ' VAL . 57.7 t -134.76 97.26 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.264 -1.335 . . . . 0.62 108.472 175.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 52.9 m-85 -96.35 101.54 13.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.454 -0.943 . . . . 1.49 108.454 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.574 HG13 HG12 ' A' ' 120' ' ' VAL . 24.9 m -99.85 162.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.547 0.689 . . . . 1.6100000000000001 111.533 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.468 ' HB3' ' CG ' ' A' ' 106' ' ' LYS . 56.9 tptt . . . . . 0 C--N 1.313 -0.979 0 CA-C-N 114.638 -1.165 . . . . 3.4500000000000002 108.757 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 119.931 -0.371 . . . . 1.4299999999999999 113.686 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.47 102.28 11.76 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.473 0.636 . . . . 0.69999999999999996 111.18 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.525 HG13 ' HA ' ' A' ' 42' ' ' TYR . 4.4 tt -133.6 141.33 44.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.322 -0.399 . . . . 0.90000000000000002 110.561 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.579 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 11.7 pt20 -113.88 135.01 54.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.27 0.557 . . . . 2.2200000000000002 111.304 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.726 ' HB3' HD13 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -126.8 166.38 17.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.471 -0.786 . . . . 0.71999999999999997 110.339 175.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.462 ' HA ' ' CB ' ' A' ' 117' ' ' SER . 3.3 p30 -92.06 158.3 16.3 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.876 -0.602 . . . . 1.1499999999999999 110.576 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -81.05 11.97 39.62 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.337 -0.847 . . . . 1.2 112.082 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -90.94 -25.44 19.77 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.173 -0.677 . . . . 1.8100000000000001 109.173 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.36 23.61 2.85 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.354 -0.839 . . . . 1.05 112.395 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -132.52 155.56 48.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.124 -0.324 . . . . 1.5700000000000001 110.124 -177.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.726 HD13 ' HB3' ' A' ' 33' ' ' LEU . 36.6 mm -74.05 138.24 21.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.408 -0.96 . . . . 1.1799999999999999 108.408 171.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.549 HD23 HE21 ' A' ' 32' ' ' GLN . 27.8 tp -105.21 -49.49 3.45 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.814 -0.354 . . . . 1.5600000000000001 110.806 -174.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -154.97 128.22 8.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 2.4100000000000001 110.999 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.525 ' HA ' HG13 ' A' ' 31' ' ' ILE . 66.0 t80 -98.63 119.66 37.73 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.917 -0.771 . . . . 1.4199999999999999 108.917 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 . . . . . 0 C--N 1.324 -0.538 0 CA-C-O 121.051 0.453 . . . . 1.21 111.716 -169.547 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.889 0 N-CA-C 111.88 -0.488 . . . . 3.2000000000000002 111.88 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt 65.25 18.24 11.32 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 123.656 0.268 . . . . 4.1399999999999997 111.704 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.556 ' O ' HG23 ' A' ' 83' ' ' VAL . 42.5 t80 -49.5 -33.92 15.77 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 111.617 0.229 . . . . 0.94999999999999996 111.617 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -62.36 -42.66 99.58 Favored 'General case' 0 C--N 1.34 0.191 0 O-C-N 124.103 0.877 . . . . 3.48 109.928 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -88.86 -23.16 22.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.775 -1.102 . . . . 3.0699999999999998 109.827 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.717 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -62.73 -43.75 98.5 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 115.923 -0.58 . . . . 0.55000000000000004 111.849 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 79' ' ' PHE . 84.5 t -66.98 -47.02 83.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.842 -0.679 . . . . 0.84999999999999998 110.34 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.77 -26.13 57.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.583 -0.735 . . . . 1.1200000000000001 110.734 -173.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 t -63.64 -33.45 75.65 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.806 -0.813 . . . . 1.8799999999999999 108.806 172.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.08 2.68 55.92 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.403 -0.817 . . . . 1.6599999999999999 112.114 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.631 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -171.42 66.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.511 0.672 . . . . 2.0800000000000001 111.401 -177.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.717 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -56.44 88.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.086 -0.961 . . . . 0.56000000000000005 110.888 171.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.754 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.9 t30 -143.43 101.54 3.8 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.695 -0.483 . . . . 2.0099999999999998 109.695 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -163.25 158.38 21.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.183 0.516 . . . . 1.6699999999999999 110.875 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.8 ptp -91.99 137.46 32.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.223 -0.899 . . . . 3.9399999999999999 108.941 170.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.565 ' O ' HG22 ' A' ' 107' ' ' VAL . 23.3 t80 -148.36 109.07 4.2 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.248 0.547 . . . . 2.4700000000000002 109.981 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.44 104.24 15.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.147 -0.479 . . . . 1.97 109.768 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.2 p90 . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 121.067 0.46 . . . . 4.29 110.923 -177.008 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.06 -0.718 . . . . 3.1200000000000001 109.06 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.21 155.46 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-O 121.34 0.591 . . . . 1.23 110.625 173.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.532 ' HB2' ' HG2' ' A' ' 123' ' ' LYS . 22.4 mtpp -128.97 105.58 8.31 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.25 -0.886 . . . . 2.3599999999999999 108.903 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 92' ' ' PHE . 5.2 m -105.08 144.37 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 C-N-CA 119.562 -0.855 . . . . 1.1100000000000001 112.177 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -117.61 103.11 9.73 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 105.674 -1.973 . . . . 1.01 105.674 156.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.754 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 9.1 ptp -106.28 128.4 53.94 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.081 -1.081 . . . . 2.2200000000000002 108.081 -178.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 21.6 ptmt -139.44 133.16 30.6 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.613 -0.435 . . . . 1.73 110.847 -167.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 86.0 tttt -56.82 108.38 0.5 Allowed 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.597 0.713 . . . . 1.78 110.719 171.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.428 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -53.7 137.38 37.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.104 -1.407 . . . . 0.45000000000000001 110.489 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.62 3.81 7.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.247 -0.433 . . . . 2.3900000000000001 110.93 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.9 m -80.91 -32.37 34.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 1.6599999999999999 111.102 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 139.2 112.78 1.06 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.734 -0.746 . . . . 1.52 113.111 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 t70 26.96 72.48 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.821 1.248 . . . . 2.79 113.079 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 111' ' ' LYS . 1.3 p -153.81 159.71 41.97 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.837 -1.912 . . . . 0.44 105.837 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.536 ' HE1' HG22 ' A' ' 83' ' ' VAL . 17.1 m-85 -136.32 134.89 38.42 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.819 -0.752 . . . . 0.41999999999999998 111.963 -175.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.579 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 41.9 m95 -85.89 165.85 16.46 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.746 -0.661 . . . . 0.41999999999999998 111.164 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.547 HG23 HD21 ' A' ' 33' ' ' LEU . 95.9 t -139.21 97.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.388 -1.278 . . . . 0.62 108.877 172.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.543 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 90.3 m-85 -93.14 101.92 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.394 -0.965 . . . . 1.49 108.394 170.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 123' ' ' LYS . 13.2 p -115.62 149.99 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.153 0.502 . . . . 1.6100000000000001 111.869 -172.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HG2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.465 0 N-CA-C 108.147 -1.057 . . . . 3.4500000000000002 108.147 173.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 122' ' ' VAL . . . . . . . . 0 N--CA 1.445 -0.735 0 N-CA-C 113.812 0.285 . . . . 1.4299999999999999 113.812 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.34 102.72 14.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.662 0.615 . . . . 0.69999999999999996 112.662 -166.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -126.49 139.9 50.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.11 -0.7 . . . . 0.90000000000000002 109.11 172.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.59 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.2 pp0? -115.33 136.35 53.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.411 0.624 . . . . 2.2200000000000002 111.366 -175.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -139.13 156.14 47.35 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.97 -1.014 . . . . 0.71999999999999997 110.231 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.894 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 4.9 p30 -86.3 155.13 20.78 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.399 0.619 . . . . 1.1499999999999999 110.673 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.59 14.48 17.68 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.375 -0.829 . . . . 1.2 111.871 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -100.97 -26.13 13.83 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.126 0.488 . . . . 1.8100000000000001 109.689 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.59 28.84 0.94 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.826 -0.702 . . . . 1.05 113.414 173.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 21.9 m-80 -133.53 142.19 48.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.245 0.522 . . . . 1.5700000000000001 111.13 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.49 HG23 HD11 ' A' ' 31' ' ' ILE . 81.3 mt -87.3 131.0 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.953 -0.758 . . . . 1.1799999999999999 108.953 171.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' A' ' 34' ' ' ASP . 66.9 mt -108.31 -49.7 3.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.927 0.344 . . . . 1.5600000000000001 111.927 -171.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' HG12 ' A' ' 31' ' ' ILE . 8.6 tt0 -141.84 128.76 20.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.984 0.421 . . . . 2.4100000000000001 111.547 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -113.69 125.46 54.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.729 -0.668 . . . . 1.4199999999999999 110.328 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 1.21 110.411 -177.464 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 111.201 -0.76 . . . . 3.2000000000000002 111.201 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.5 tptt 68.57 10.54 7.94 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.016 0.436 . . . . 4.1399999999999997 109.903 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.822 ' HA ' HD11 ' A' ' 88' ' ' LEU . 44.4 t80 -45.92 -40.9 10.8 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 113.975 1.102 . . . . 0.94999999999999996 113.975 -165.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.951 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -63.94 -38.63 91.78 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 123.37 0.418 . . . . 3.48 110.421 -172.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.85 -27.89 20.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.695 -0.684 . . . . 3.0699999999999998 109.584 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.95 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -55.32 -40.32 75.74 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.695 -0.684 . . . . 0.55000000000000004 112.103 -177.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.3 t -65.37 -53.39 40.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.533 -0.834 . . . . 0.84999999999999998 110.954 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.67 -22.79 32.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.263 -0.426 . . . . 1.1200000000000001 111.637 -171.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.6 t -70.86 -22.32 62.31 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.954 -0.758 . . . . 1.8799999999999999 108.954 172.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.83 26.83 73.32 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.375 -0.83 . . . . 1.6599999999999999 112.241 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.489 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 29.1 p30 -158.37 44.8 0.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.229 0.538 . . . . 2.0800000000000001 111.72 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.95 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -66.06 86.4 0.1 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.151 -0.932 . . . . 0.56000000000000005 111.777 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 109' ' ' MET . 2.6 t-20 -144.56 100.69 3.56 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.813 -0.355 . . . . 2.0099999999999998 110.296 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.8 m -146.0 145.98 30.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.817 -0.438 . . . . 1.6699999999999999 109.817 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.82 116.4 28.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.345 0.593 . . . . 3.9399999999999999 109.609 170.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -133.62 154.55 50.81 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.274 -0.875 . . . . 2.4700000000000002 109.136 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.828 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 7.6 pt-20 -131.28 123.05 27.53 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.78 -0.452 . . . . 1.97 109.78 174.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.2 t80 . . . . . 0 N--CA 1.445 -0.68 0 CA-C-N 115.57 -0.741 . . . . 4.29 110.251 -175.766 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.8 tttp . . . . . 0 C--O 1.239 0.525 0 CA-C-O 120.608 0.242 . . . . 3.1200000000000001 110.379 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 27.6 m -105.67 160.74 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.361 0.601 . . . . 1.23 111.557 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.828 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 19.6 mmmt -117.46 141.14 48.69 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.152 -0.931 . . . . 2.3599999999999999 109.5 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.2 102.32 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.113 0.482 . . . . 1.1100000000000001 110.15 173.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.803 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.7 t-160 -108.91 102.82 11.8 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.652 -1.24 . . . . 1.01 107.652 171.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 59.8 mtp -108.78 143.75 37.52 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.709 -0.849 . . . . 2.2200000000000002 108.709 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -147.55 133.88 19.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.974 -0.69 . . . . 1.73 110.5 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.598 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 84.0 tttt -55.9 111.59 0.97 Allowed 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 114.879 -1.055 . . . . 1.78 110.334 173.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.26 146.32 54.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.775 -1.102 . . . . 0.45000000000000001 110.898 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.24 -6.83 25.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.983 -0.553 . . . . 2.3900000000000001 110.709 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.496 ' HB2' ' OG ' ' A' ' 117' ' ' SER . 6.5 m -69.96 -29.41 66.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.746 -0.661 . . . . 1.6599999999999999 110.617 176.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.16 -68.11 0.29 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.723 -0.751 . . . . 1.52 113.054 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -95.17 22.51 6.64 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.331 0.586 . . . . 2.79 111.503 -172.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.894 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.9 p -134.62 157.27 47.04 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.352 -0.84 . . . . 0.44 111.509 -173.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.598 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 48.3 m-85 -141.3 134.81 29.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.616 -0.72 . . . . 0.41999999999999998 109.387 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.59 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 47.1 m95 -83.42 164.23 20.06 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.08 0.466 . . . . 0.41999999999999998 110.673 -175.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 120' ' ' VAL . 15.0 p -138.34 97.18 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 122.581 1.181 . . . . 0.62 111.328 172.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.803 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 3.8 m-85 -86.69 102.29 14.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.516 -0.765 . . . . 1.49 109.094 177.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.58 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 25.4 m -100.88 153.58 4.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.157 0.503 . . . . 1.6100000000000001 111.49 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 16.7 tppt? . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.865 -0.607 . . . . 3.4500000000000002 109.679 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 122' ' ' VAL . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 112.529 -0.229 . . . . 1.4299999999999999 112.529 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -155.46 101.4 2.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.896 0.379 . . . . 0.69999999999999996 110.255 175.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.541 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 3.2 tt -139.25 141.02 36.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.234 -0.439 . . . . 0.90000000000000002 110.743 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.619 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.8 pt20 -110.81 126.33 54.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.322 0.582 . . . . 2.2200000000000002 110.518 174.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.85 153.05 41.62 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.645 -0.707 . . . . 0.71999999999999997 110.562 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.742 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -85.62 105.57 16.28 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.47 0.652 . . . . 1.1499999999999999 112.407 -171.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 1.04 ' H ' ' HA ' ' A' ' 117' ' ' SER . . . 37.77 23.7 0.02 OUTLIER Glycine 0 N--CA 1.468 0.768 0 CA-C-N 113.272 -1.786 . . . . 1.2 117.42 161.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 34' ' ' ASP . 12.9 t70 174.75 -57.17 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.926 0.863 . . . . 1.8100000000000001 111.756 -171.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.93 -31.35 0.03 OUTLIER Glycine 0 CA--C 1.524 0.655 0 C-N-CA 119.203 -1.475 . . . . 1.05 115.447 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.742 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 19.0 m-80 -67.84 116.33 8.39 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.728 1.264 . . . . 1.5700000000000001 111.141 -173.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -70.73 128.62 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.928 -0.578 . . . . 1.1799999999999999 110.616 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.7 tp -101.55 -47.58 4.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.75 -0.659 . . . . 1.5600000000000001 110.799 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -151.07 142.86 23.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 2.4100000000000001 111.401 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.541 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 69.1 t80 -130.5 138.5 50.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 1.4199999999999999 109.729 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 39.8 m-80 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.851 0.358 . . . . 1.21 111.437 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.513 0 CA-C-O 120.231 -0.205 . . . . 3.2000000000000002 112.595 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 58.38 25.15 12.5 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.73 -0.47 . . . . 4.1399999999999997 109.73 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.646 ' HA ' HD11 ' A' ' 88' ' ' LEU . 38.7 t80 -50.51 -37.0 36.66 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.671 -0.695 . . . . 0.94999999999999996 112.719 -165.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.48 -47.35 73.33 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 123.76 0.663 . . . . 3.48 110.343 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -82.35 -24.81 34.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.346 -0.612 . . . . 3.0699999999999998 109.346 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.93 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -57.66 -42.97 94.53 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.304 -0.719 . . . . 0.55000000000000004 111.304 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 79' ' ' PHE . 81.2 t -67.53 -53.85 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.434 -0.883 . . . . 0.84999999999999998 111.019 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.35 -28.0 52.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.159 -0.473 . . . . 1.1200000000000001 111.412 -169.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.0 t -66.98 -29.27 69.07 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.735 -0.839 . . . . 1.8799999999999999 108.735 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.6 28.36 39.43 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.65 -0.705 . . . . 1.6599999999999999 111.804 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -162.37 52.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.358 0.599 . . . . 2.0800000000000001 111.816 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.93 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -73.13 86.35 1.38 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.907 -0.588 . . . . 0.56000000000000005 110.658 177.111 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.2 t30 -143.9 102.35 3.88 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.619 -0.264 . . . . 2.0099999999999998 110.474 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 t -152.26 161.64 42.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.343 -0.39 . . . . 1.6699999999999999 110.194 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -127.04 146.71 50.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.892 -0.594 . . . . 3.9399999999999999 109.79 174.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -164.19 141.85 6.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.052 -0.522 . . . . 2.4700000000000002 109.802 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.502 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 44.5 mt-10 -103.01 113.14 26.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.361 -0.607 . . . . 1.97 109.361 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.8 t80 . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.456 . . . . 4.29 110.669 -172.956 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.502 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 15.0 ttpt . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.275 -0.639 . . . . 3.1200000000000001 109.275 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 34.2 m -102.31 160.01 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 121.257 0.551 . . . . 1.23 110.457 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 123' ' ' LYS . 38.1 ttpt -129.31 110.64 12.11 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.207 -1.034 . . . . 2.3599999999999999 108.207 172.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.8 m -98.86 144.68 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.485 0.66 . . . . 1.1100000000000001 112.112 -175.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -137.11 102.08 4.74 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.646 -1.242 . . . . 1.01 107.646 161.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.738 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -97.12 133.46 41.74 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.376 -1.342 . . . . 2.2200000000000002 107.376 173.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HG3' ' HB2' ' A' ' 119' ' ' TRP . 14.8 ptpt -142.06 134.72 28.34 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.228 -0.589 . . . . 1.73 111.271 -172.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 39.1 tttm -56.31 115.11 2.28 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.501 -0.772 . . . . 1.78 110.534 170.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.441 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -64.91 147.2 53.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.563 -1.198 . . . . 0.45000000000000001 111.431 -174.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.5 pt? -64.82 -10.11 25.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 2.3900000000000001 111.356 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.2 p -79.84 -4.84 53.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.25 -0.432 . . . . 1.6599999999999999 111.577 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.87 -122.82 6.72 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.638 -0.792 . . . . 1.52 112.229 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -72.15 85.63 1.04 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.547 0.689 . . . . 2.79 110.466 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 1.04 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 3.5 p -176.16 152.46 1.15 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.703 -1.135 . . . . 0.44 108.295 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.556 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 39.3 m-85 -142.07 139.16 32.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.639 0.257 . . . . 0.41999999999999998 110.427 -176.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.619 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 46.1 m95 -88.39 166.81 14.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.488 0.661 . . . . 0.41999999999999998 111.453 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.95 96.5 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.348 -1.296 . . . . 0.62 109.046 173.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.449 ' HE1' ' HD2' ' A' ' 110' ' ' LYS . 90.2 m-85 -95.05 124.33 39.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.402 -0.592 . . . . 1.49 109.402 173.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.479 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 26.0 t -128.52 132.79 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.868 0.366 . . . . 1.6100000000000001 111.002 -176.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 106' ' ' LYS . 74.7 mmtt . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 109.71 -0.478 . . . . 3.4500000000000002 109.71 172.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' HA3' HG12 ' A' ' 122' ' ' VAL . . . . . . . . 0 N--CA 1.444 -0.803 0 N-CA-C 112.36 -0.296 . . . . 1.4299999999999999 112.36 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.57 102.15 4.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.886 0.374 . . . . 0.69999999999999996 110.363 173.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.595 HD11 HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -138.98 140.31 38.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.678 -0.489 . . . . 0.90000000000000002 109.678 178.02 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.749 ' HG2' ' HG2' ' A' ' 41' ' ' GLN . 3.7 pt20 -113.96 142.18 46.48 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.885 -0.726 . . . . 2.2200000000000002 111.083 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.62 ' HB3' HD13 ' A' ' 39' ' ' ILE . 4.0 pp -133.02 163.89 28.23 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.083 -0.962 . . . . 0.71999999999999997 110.094 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 2.1 p30 -90.05 151.83 21.45 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.131 0.491 . . . . 1.1499999999999999 110.423 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -70.26 -9.65 64.44 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.553 -0.749 . . . . 1.2 111.883 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.45 ' HB3' ' OD1' ' A' ' 34' ' ' ASP . 30.3 t70 -73.04 -36.11 66.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.172 -0.514 . . . . 1.8100000000000001 109.803 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.55 1.29 1.68 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.461 -0.876 . . . . 1.05 114.036 171.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.495 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 3.8 m-80 -107.44 158.39 17.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.34 0.57 . . . . 1.5700000000000001 111.023 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.62 HD13 ' HB3' ' A' ' 33' ' ' LEU . 45.9 mm -85.49 140.99 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.811 -0.811 . . . . 1.1799999999999999 108.811 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.553 HD23 ' NE2' ' A' ' 32' ' ' GLN . 29.9 tp -108.39 -54.21 2.54 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.361 -0.536 . . . . 1.5600000000000001 110.933 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.749 ' HG2' ' HG2' ' A' ' 32' ' ' GLN . 26.4 pt20 -147.98 141.82 25.75 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.351 -0.54 . . . . 2.4100000000000001 111.402 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.407 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 92.3 t80 -110.71 119.11 38.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.623 -0.717 . . . . 1.4199999999999999 109.203 175.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--N 1.315 -0.928 0 N-CA-C 108.394 -0.965 . . . . 1.21 108.394 -178.337 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 111.478 -0.649 . . . . 3.2000000000000002 111.478 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.5 pttt 42.59 47.77 4.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.432 0.693 . . . . 4.1399999999999997 111.219 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 83' ' ' VAL . 43.0 t80 -50.36 -34.88 25.62 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 115.529 -0.76 . . . . 0.94999999999999996 111.926 -171.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -66.72 -40.02 88.24 Favored 'General case' 0 C--N 1.344 0.338 0 O-C-N 123.813 0.695 . . . . 3.48 110.484 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -80.01 -31.42 39.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.098 -0.704 . . . . 3.0699999999999998 109.098 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.854 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.37 -43.66 97.2 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.559 -0.746 . . . . 0.55000000000000004 111.962 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 79' ' ' PHE . 99.3 t -64.6 -49.32 81.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.77 -0.715 . . . . 0.84999999999999998 110.518 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.37 -24.48 39.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 1.1200000000000001 111.413 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -65.35 -32.95 74.86 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.519 -0.548 . . . . 1.8799999999999999 109.519 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.3 16.43 66.82 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.881 -0.676 . . . . 1.6599999999999999 111.751 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -162.34 57.27 0.23 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.527 0.68 . . . . 2.0800000000000001 110.861 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.854 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.5 tt -65.08 81.41 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.627 -0.715 . . . . 0.56000000000000005 110.952 175.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 14.5 t30 -144.51 98.25 3.17 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.233 -0.654 . . . . 2.0099999999999998 109.233 175.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 91' ' ' MET . 6.4 m -153.29 153.83 33.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.808 -0.441 . . . . 1.6699999999999999 109.808 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.436 ' N ' HG22 ' A' ' 90' ' ' THR . 17.7 ptm -101.01 116.14 32.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.349 -0.612 . . . . 3.9399999999999999 109.349 167.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -114.86 109.95 18.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.794 -0.639 . . . . 2.4700000000000002 109.873 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 9.4 pt-20 -104.39 114.57 28.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.063 0.459 . . . . 1.97 110.495 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 85.9 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.587 -0.733 . . . . 4.29 110.188 -176.976 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm . . . . . 0 C--O 1.236 0.369 0 N-CA-C 110.166 -0.309 . . . . 3.1200000000000001 110.166 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 31.5 m -101.33 159.2 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 120.792 0.33 . . . . 1.23 110.361 172.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 43.6 mttp -127.26 123.33 36.23 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.157 -0.474 . . . . 2.3599999999999999 110.702 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.47 102.85 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 109.229 -0.656 . . . . 1.1100000000000001 109.229 173.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.752 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 3.3 t-160 -94.33 102.48 14.48 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.389 -1.708 . . . . 1.01 106.389 168.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 10.7 ttt -120.34 114.93 22.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.048 -1.093 . . . . 2.2200000000000002 108.048 -173.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 64.6 pttt -134.16 135.44 43.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 120.048 -0.661 . . . . 1.73 110.418 -169.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 65.4 tttp -57.21 114.4 2.15 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.765 -0.652 . . . . 1.78 110.602 175.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.68 145.45 49.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.774 -1.103 . . . . 0.45000000000000001 110.709 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.22 -13.08 61.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.208 -0.451 . . . . 2.3900000000000001 110.478 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.5 m -61.84 -31.57 71.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.968 -0.56 . . . . 1.6599999999999999 110.236 173.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 129.1 -96.82 0.4 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.575 -0.821 . . . . 1.52 113.03 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -88.68 49.02 1.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.603 0.716 . . . . 2.79 111.088 -171.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.0 p -147.43 159.37 43.79 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.503 -0.771 . . . . 0.44 109.968 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.556 ' CD2' ' HB3' ' A' ' 88' ' ' LEU . 36.1 m-85 -137.53 137.83 39.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.544 -0.298 . . . . 0.41999999999999998 110.426 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.617 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 44.0 m95 -85.68 162.46 18.77 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.123 0.487 . . . . 0.41999999999999998 111.176 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.44 HG22 ' HE3' ' A' ' 109' ' ' MET . 50.5 t -135.02 97.56 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.864 -1.062 . . . . 0.62 109.485 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.752 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 70.8 m-85 -102.31 104.29 14.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.607 -0.886 . . . . 1.49 108.607 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.467 HG12 ' HA3' ' A' ' 29' ' ' GLY . 9.9 p -92.74 148.61 4.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.789 -0.365 . . . . 1.6100000000000001 110.576 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . 34.5 mtpt . . . . . 0 CA--C 1.507 -0.684 0 CA-C-N 116.167 -0.469 . . . . 3.4500000000000002 110.173 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.611 0 CA-C-O 120.246 -0.197 . . . . 1.4299999999999999 113.145 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.28 101.99 3.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.082 0.468 . . . . 0.69999999999999996 110.918 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.691 HG13 ' HA ' ' A' ' 42' ' ' TYR . 7.1 tt -130.14 141.25 46.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.111 -0.495 . . . . 0.90000000000000002 110.07 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.542 ' NE2' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -113.88 129.05 56.63 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 116.13 -0.486 . . . . 2.2200000000000002 109.91 -175.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.486 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.9 pp -126.0 157.55 37.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.156 0.503 . . . . 0.71999999999999997 110.842 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.436 ' HA ' ' CB ' ' A' ' 117' ' ' SER . 3.6 p30 -79.24 156.84 27.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.544 0.688 . . . . 1.1499999999999999 110.996 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.545 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -81.43 35.29 2.43 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.286 -0.87 . . . . 1.2 111.489 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -123.56 -24.6 4.52 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.064 0.459 . . . . 1.8100000000000001 110.048 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.57 7.5 4.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.722 -0.751 . . . . 1.05 113.291 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -126.94 159.49 33.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.129 0.49 . . . . 1.5700000000000001 110.879 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 33' ' ' LEU . 10.9 mm -70.65 142.43 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 109.598 -0.519 . . . . 1.1799999999999999 109.598 175.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.542 HD23 ' NE2' ' A' ' 32' ' ' GLN . 25.9 tp -109.01 -48.6 3.25 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.953 -0.388 . . . . 1.5600000000000001 109.953 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -153.84 114.49 4.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 2.4100000000000001 110.998 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.691 ' HA ' HG13 ' A' ' 31' ' ' ILE . 55.7 t80 -86.33 130.68 34.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.079 -0.51 . . . . 1.4199999999999999 109.642 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 120.845 0.355 . . . . 1.21 110.356 -178.614 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.609 0 N-CA-C 111.49 -0.644 . . . . 3.2000000000000002 111.49 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' ' HB2' ' A' ' 81' ' ' GLU . 41.0 tttp 60.18 34.5 21.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.668 0.747 . . . . 4.1399999999999997 109.037 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.51 ' O ' HG23 ' A' ' 83' ' ' VAL . 20.2 t80 -63.24 -41.3 99.06 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.105 -0.952 . . . . 0.94999999999999996 112.109 -168.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -63.21 -34.67 78.14 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.73 0.644 . . . . 3.48 110.353 -176.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HB2' ' HG2' ' A' ' 78' ' ' LYS . 45.8 mt-10 -83.39 -31.47 26.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.254 -0.43 . . . . 3.0699999999999998 109.928 175.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.926 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -57.86 -41.04 93.92 Favored Glycine 0 N--CA 1.436 -1.329 0 CA-C-N 115.716 -0.675 . . . . 0.55000000000000004 112.119 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 79' ' ' PHE . 81.5 t -69.64 -51.02 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.698 -0.751 . . . . 0.84999999999999998 110.914 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.58 -22.29 40.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.566 . . . . 1.1200000000000001 111.688 -170.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.6 p -69.03 -33.68 74.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.845 -0.798 . . . . 1.8799999999999999 108.845 172.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 111' ' ' LYS . . . 87.55 18.95 55.95 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.246 -0.888 . . . . 1.6599999999999999 111.004 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -162.55 59.21 0.22 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.665 0.745 . . . . 2.0800000000000001 110.976 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.926 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.3 tt -64.76 84.79 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.371 -0.831 . . . . 0.56000000000000005 110.346 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.74 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.2 t30 -142.56 101.39 3.87 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.815 -0.439 . . . . 2.0099999999999998 109.815 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.2 t -159.16 154.85 26.14 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.949 0.404 . . . . 1.6699999999999999 110.267 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -112.66 131.71 55.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.593 -0.73 . . . . 3.9399999999999999 109.776 177.417 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -140.37 131.96 27.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.684 -0.689 . . . . 2.4700000000000002 109.812 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -101.13 116.8 33.68 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.87 -0.419 . . . . 1.97 109.87 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.2 t80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.625 -0.716 . . . . 4.29 109.978 -174.395 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt . . . . . 0 N--CA 1.445 -0.707 0 N-CA-C 108.738 -0.838 . . . . 3.1200000000000001 108.738 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.1 m -101.07 157.73 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-O 121.152 0.501 . . . . 1.23 110.398 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 123' ' ' LYS . 63.8 tttp -136.07 105.56 6.09 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.523 -0.762 . . . . 2.3599999999999999 109.157 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.537 ' HB ' ' SD ' ' A' ' 109' ' ' MET . 0.8 OUTLIER -96.71 144.93 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 CA-C-O 121.257 0.551 . . . . 1.1100000000000001 111.883 -178.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -135.4 103.92 5.66 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.778 -1.193 . . . . 1.01 107.778 162.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.74 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 3.6 mpp? -92.31 143.94 25.89 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.234 -1.395 . . . . 2.2200000000000002 107.234 176.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.3 ptpt -146.18 135.41 22.8 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.103 -1.039 . . . . 1.73 111.429 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.592 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 57.3 tttp -55.19 114.74 1.9 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.048 -0.978 . . . . 1.78 109.557 167.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 116' ' ' ASP . . . -49.35 139.24 11.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.076 -0.965 . . . . 0.45000000000000001 110.98 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.0 mt -65.83 -15.74 63.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.145 -0.48 . . . . 2.3900000000000001 110.871 -176.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.4 m -62.68 -57.36 11.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 1.6599999999999999 110.067 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.3 -74.03 0.1 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.245 -0.742 . . . . 1.52 111.245 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 9.0 t70 -93.76 -167.52 1.71 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.579 -0.897 . . . . 2.79 108.579 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.545 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 37.0 p 60.4 155.67 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.47 1.108 . . . . 0.44 112.108 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.592 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 48.9 m-85 -136.55 138.36 41.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.53 -0.759 . . . . 0.41999999999999998 109.678 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.534 ' CD2' ' HB2' ' A' ' 32' ' ' GLN . 44.1 m95 -91.43 164.76 13.71 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.302 0.573 . . . . 0.41999999999999998 111.23 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.469 ' HB ' HG23 ' A' ' 31' ' ' ILE . 58.9 t -134.06 97.34 2.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.681 -1.145 . . . . 0.62 109.277 176.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -98.59 121.73 40.9 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.778 -0.823 . . . . 1.49 108.778 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.3 p -124.68 147.21 29.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.03 0.443 . . . . 1.6100000000000001 111.119 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 106' ' ' LYS . 51.6 mtpt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-N 115.86 -0.609 . . . . 3.4500000000000002 109.468 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 120.746 0.307 . . . . 8.7200000000000006 110.97 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.17 3.37 53.65 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.038 -0.727 . . . . 6.1799999999999997 109.038 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -155.24 139.65 16.77 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.577 -1.192 . . . . 6.1500000000000004 108.467 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.45 -15.7 45.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.522 -0.847 . . . . 1.4299999999999999 112.908 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -95.03 102.91 14.74 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.855 0.359 . . . . 0.69999999999999996 111.697 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.75 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -119.69 140.41 43.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 120.886 0.374 . . . . 0.90000000000000002 110.223 177.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.44 128.71 56.55 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.172 -0.677 . . . . 2.2200000000000002 109.172 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 pp -129.95 158.05 40.62 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.415 0.626 . . . . 0.71999999999999997 110.816 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -85.11 150.91 24.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.476 -0.784 . . . . 1.1499999999999999 110.424 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.572 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -80.44 32.27 2.35 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.79 -0.641 . . . . 1.2 112.696 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -126.24 -30.27 2.92 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.829 -0.434 . . . . 1.8100000000000001 109.829 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.23 10.44 0.84 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.99 -1.1 . . . . 1.05 114.404 171.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 3.8 p30 -118.92 139.39 51.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 118.009 0.905 . . . . 1.5700000000000001 111.998 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 31' ' ' ILE . 43.5 mm -75.52 139.21 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.709 -0.678 . . . . 1.1799999999999999 109.497 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 tp -106.95 -53.18 2.65 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.864 -0.335 . . . . 1.5600000000000001 111.018 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -153.85 145.06 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.406 -0.518 . . . . 2.4100000000000001 111.869 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.75 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 45.6 t80 -117.78 124.31 48.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.706 -0.679 . . . . 1.4199999999999999 109.633 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 35.0 m-80 -85.49 96.65 9.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.374 -0.376 . . . . 1.21 110.453 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 176.18 -32.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.028 -0.987 . . . . 2.5 109.552 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.91 90.31 4.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.653 -0.703 . . . . 4.0 110.778 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -147.45 40.46 1.02 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.024 0.916 . . . . 7.21 108.767 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.04 94.32 0.1 OUTLIER Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.191 -1.368 . . . . 6.9699999999999998 110.427 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -78.85 87.05 4.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.478 0.656 . . . . 8.5899999999999999 110.199 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 pt -113.79 23.77 4.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.294 -0.866 . . . . 9.2400000000000002 111.29 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 51' ' ' GLY . 2.9 m -136.48 157.23 47.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.053 -0.522 . . . . 9.8200000000000003 109.813 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.404 ' N ' HG22 ' A' ' 50' ' ' THR . . . -112.63 45.97 1.24 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.513 -0.635 . . . . 9.6199999999999992 111.513 175.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -84.03 173.23 11.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.967 0.413 . . . . 12.720000000000001 110.915 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.5 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 29.4 t70 -87.51 111.2 40.03 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.711 -0.848 . . . . 8.2400000000000002 108.711 170.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 7.0 Cg_exo -74.65 19.89 0.45 Allowed 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.583 2.855 . . . . 8.1099999999999994 113.822 -172.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -99.05 32.2 2.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.636 0.732 . . . . 9.2400000000000002 109.778 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -96.42 -48.54 5.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.395 -0.821 . . . . 7.4000000000000004 110.614 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 58' ' ' ILE . 16.9 m -124.62 170.84 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.081 -0.508 . . . . 5.0599999999999996 110.883 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 57' ' ' VAL . 17.8 pt 50.73 166.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.49 1.516 . . . . 3.1699999999999999 114.275 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.48 39.98 95.61 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 114.584 -1.189 . . . . 3.2400000000000002 111.053 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' HB3' HG12 ' A' ' 39' ' ' ILE . 15.2 tppt? -105.31 101.99 11.5 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.025 0.44 . . . . 3.8500000000000001 111.147 -171.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.487 ' N ' HD22 ' A' ' 61' ' ' ASN . 0.8 OUTLIER -94.46 109.16 21.05 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.395 -0.965 . . . . 4.1799999999999997 108.395 171.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -90.31 96.54 10.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.469 0.652 . . . . 6.6600000000000001 110.854 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' A' ' 65' ' ' ASP . 9.2 p90 -78.05 155.43 30.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.044 -0.98 . . . . 8.1300000000000008 110.007 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -75.77 74.36 2.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.745 0.783 . . . . 10.050000000000001 111.04 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.497 ' HB2' ' CD1' ' A' ' 63' ' ' PHE . 38.7 t70 -86.03 5.29 34.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.291 -0.868 . . . . 7.9400000000000004 110.101 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.9 t 59.15 67.95 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.976 0.893 . . . . 9.3499999999999996 109.762 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.64 84.08 16.17 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.029 -0.987 . . . . 9.1600000000000001 110.328 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -87.53 3.44 6.35 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.518 2.145 . . . . 10.35 112.55 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 78.5 m -113.15 86.38 2.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.089 0.471 . . . . 11.49 111.076 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -130.15 56.81 1.73 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.954 -0.758 . . . . 10.949999999999999 108.954 169.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 64.92 11.8 7.3 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.952 -1.022 . . . . 11.56 112.144 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.7 t -149.36 83.78 6.39 Favored Pre-proline 0 C--N 1.323 -0.553 0 C-N-CA 120.905 -0.318 . . . . 10.960000000000001 110.96 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.22 -53.78 3.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.356 2.037 . . . . 10.68 110.44 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -93.23 120.42 33.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.37 -0.974 . . . . 11.76 108.37 166.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -65.99 117.37 8.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.677 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 50.4 -113.6 0.68 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.964 0.79 . . . . 7.5300000000000002 112.284 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.84 76.0 0.34 Allowed Glycine 0 CA--C 1.506 -0.529 0 C-N-CA 120.591 -0.814 . . . . 3.2000000000000002 111.133 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 60.9 32.36 20.02 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 123.913 0.42 . . . . 4.1399999999999997 110.336 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.576 ' O ' HG23 ' A' ' 83' ' ' VAL . 67.4 t80 -50.21 -32.22 15.9 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.946 -0.57 . . . . 0.94999999999999996 111.606 -177.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -69.81 -34.08 73.22 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 123.802 0.689 . . . . 3.48 109.698 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -84.18 -31.44 25.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.585 -0.734 . . . . 3.0699999999999998 109.2 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.904 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -54.44 -41.15 71.49 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.371 -0.831 . . . . 0.55000000000000004 111.972 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 79' ' ' PHE . 96.6 t -65.23 -53.49 39.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.405 -0.897 . . . . 0.84999999999999998 110.942 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.43 -27.78 27.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.148 -0.478 . . . . 1.1200000000000001 111.655 -170.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.2 t -66.57 -27.21 67.55 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.014 -0.736 . . . . 1.8799999999999999 109.014 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.86 29.44 51.67 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.67 -0.695 . . . . 1.6599999999999999 112.469 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -157.18 48.65 0.43 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.61 0.719 . . . . 2.0800000000000001 111.519 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.904 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -74.82 79.71 2.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.4 -0.818 . . . . 0.56000000000000005 111.198 178.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.3 p-10 -144.09 101.11 3.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.478 0.656 . . . . 2.0099999999999998 109.528 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.6 m -147.42 147.8 30.62 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.806 -0.559 . . . . 1.6699999999999999 110.535 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -109.32 115.55 30.19 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.046 -0.724 . . . . 3.9399999999999999 109.046 169.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.519 ' HE2' ' HD2' ' A' ' 94' ' ' TYR . 84.1 t80 -132.17 126.97 34.89 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.804 -0.634 . . . . 2.4700000000000002 109.97 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 9.7 pt-20 -97.23 130.63 44.43 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.481 -0.563 . . . . 1.97 109.481 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.519 ' HD2' ' HE2' ' A' ' 92' ' ' PHE . 27.4 t80 -119.04 115.42 24.27 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.636 -0.505 . . . . 4.29 109.636 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -90.92 136.9 32.76 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.109 -0.496 . . . . 2.8900000000000001 110.245 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -105.33 95.07 5.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.783 -0.451 . . . . 5.25 109.783 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.21 28.01 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.3 0.572 . . . . 6.0599999999999996 110.562 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -100.31 -166.51 1.33 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.715 -0.675 . . . . 9.7699999999999996 110.204 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.11 -58.33 2.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.476 -0.329 . . . . 8.3399999999999999 110.549 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 96.4 mmm -95.74 33.4 1.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.764 0.316 . . . . 8.1899999999999995 111.692 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 p -101.42 164.82 15.21 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 111.899 0.333 . . . . 5.0999999999999996 111.899 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.78 -172.84 0.88 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.828 2.352 . . . . 4.5099999999999998 112.273 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.1 p -84.71 161.39 20.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.392 -0.367 . . . . 2.5899999999999999 111.756 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -64.64 112.02 3.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.689 -0.687 . . . . 3.1200000000000001 110.674 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 20.7 m -116.32 160.92 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.182 0.515 . . . . 1.23 111.353 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 85.8 tttt -125.03 123.98 40.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.31 -0.859 . . . . 2.3599999999999999 109.184 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.1 t -101.74 119.42 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 116.45 -0.341 . . . . 1.1100000000000001 110.34 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -106.79 104.33 13.98 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.22 -1.03 . . . . 1.01 108.22 168.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 55.0 mtm -97.5 145.57 26.08 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.276 -1.009 . . . . 2.2200000000000002 108.276 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.508 ' CG ' ' HB2' ' A' ' 119' ' ' TRP . 19.4 ptpt -146.42 127.07 14.24 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.384 -0.527 . . . . 1.73 109.827 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.507 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 51.6 tttm -57.34 113.57 1.81 Allowed 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 116.064 -0.516 . . . . 1.78 109.906 170.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.44 138.93 38.9 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.701 -1.136 . . . . 0.45000000000000001 110.485 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.5 mt -67.88 -8.58 37.69 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.245 -0.434 . . . . 2.3900000000000001 110.918 -177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 m -70.94 -38.61 72.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 1.6599999999999999 110.503 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.67 -105.76 0.34 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.73 -0.748 . . . . 1.52 112.81 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.29 65.05 7.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.597 0.713 . . . . 2.79 112.013 -175.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.572 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 1.7 p -157.67 157.97 34.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.922 -1.035 . . . . 0.44 108.506 176.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.509 ' OH ' ' HA ' ' A' ' 83' ' ' VAL . 28.9 m-85 -140.74 139.75 34.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.687 0.28 . . . . 0.41999999999999998 110.603 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.508 ' HB2' ' CG ' ' A' ' 110' ' ' LYS . 38.9 m95 -93.09 162.48 14.02 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.288 0.566 . . . . 0.41999999999999998 111.241 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.629 ' HB ' HG23 ' A' ' 31' ' ' ILE . 87.7 t -136.89 101.77 2.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.561 -1.199 . . . . 0.62 109.268 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -102.19 106.39 17.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.553 -0.536 . . . . 1.49 109.553 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 p -92.37 143.87 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.077 0.465 . . . . 1.6100000000000001 110.244 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -149.8 110.25 4.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.677 -0.49 . . . . 3.4500000000000002 109.677 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 7.7 ptm180 -77.06 143.68 39.1 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.648 -0.421 . . . . 4.2300000000000004 110.254 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.799 -0.637 . . . . 3.3399999999999999 109.517 177.703 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 1.007 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.999 0.428 . . . . 8.7200000000000006 110.61 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.63 -168.45 1.78 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.891 -0.595 . . . . 6.1799999999999997 109.967 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -95.91 -31.68 13.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.083 0.468 . . . . 6.1500000000000004 110.415 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.66 72.91 0.76 Allowed Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 121.062 -0.59 . . . . 1.4299999999999999 112.208 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.42 102.38 3.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.95 0.405 . . . . 0.69999999999999996 110.75 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.604 HG23 ' HB ' ' A' ' 120' ' ' VAL . 4.5 tt -132.02 141.07 46.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.927 0.394 . . . . 0.90000000000000002 110.672 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.468 ' HB2' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -114.52 122.98 48.24 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.41 -0.959 . . . . 2.2200000000000002 108.41 177.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.46 164.06 29.04 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.864 -0.607 . . . . 0.71999999999999997 111.082 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.963 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 2.3 p30 -98.09 153.95 18.07 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.015 -0.539 . . . . 1.1499999999999999 110.981 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -71.0 -17.03 75.22 Favored Glycine 0 CA--C 1.511 -0.17 0 CA-C-N 115.173 -0.921 . . . . 1.2 112.628 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.53 -38.98 92.88 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.97 0.414 . . . . 1.8100000000000001 110.421 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.46 38.26 0.31 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.706 -0.759 . . . . 1.05 112.843 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.564 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 4.3 m-80 -134.25 147.96 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.976 -0.379 . . . . 1.5700000000000001 109.976 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.754 HG13 ' HB3' ' A' ' 60' ' ' LYS . 86.7 mt -87.33 134.73 26.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.936 -0.394 . . . . 1.1799999999999999 109.936 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 58' ' ' ILE . 45.0 tp -101.56 -41.45 6.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 1.5600000000000001 110.86 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -158.99 143.43 15.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.993 0.425 . . . . 2.4100000000000001 111.204 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.509 ' HB3' HG13 ' A' ' 57' ' ' VAL . 40.9 t80 -114.34 114.86 26.47 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.601 -0.889 . . . . 1.4199999999999999 108.601 174.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -91.61 91.59 8.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.168 0.509 . . . . 1.21 110.647 -173.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -170.2 13.04 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.89 -1.05 . . . . 2.5 109.12 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 48' ' ' ASP . . . -143.11 109.15 5.23 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.325 -0.852 . . . . 4.0 110.983 -174.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -137.6 97.55 3.48 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.758 -0.83 . . . . 7.21 108.758 172.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.87 -16.43 39.71 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.64 -0.984 . . . . 6.9699999999999998 110.64 -169.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.587 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 4.1 m-20 -78.26 104.63 8.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.441 -0.379 . . . . 8.5899999999999999 110.159 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.9 mm -103.1 132.96 48.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.395 -0.594 . . . . 9.2400000000000002 109.395 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.0 p -117.4 173.21 6.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.785 0.326 . . . . 9.8200000000000003 111.789 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.29 -108.41 1.89 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.791 -0.924 . . . . 9.6199999999999992 110.791 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -83.34 89.34 7.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.247 -0.649 . . . . 12.720000000000001 109.247 171.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 23.7 t70 -127.8 107.24 20.43 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.054 -0.521 . . . . 8.2400000000000002 110.829 -173.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 1.9 Cg_endo -83.4 36.94 0.63 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.505 2.803 . . . . 8.1099999999999994 113.467 -175.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.51 -175.62 5.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.865 0.364 . . . . 9.2400000000000002 110.42 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -100.0 25.35 7.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.398 0.618 . . . . 7.4000000000000004 110.466 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.509 HG13 ' HB3' ' A' ' 42' ' ' TYR . 42.6 t -76.7 88.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.399 -0.963 . . . . 5.0599999999999996 108.399 174.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 40' ' ' LEU 0.264 13.7 tt 37.85 73.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 122.982 1.372 . . . . 3.1699999999999999 111.963 -173.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.31 19.24 2.85 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 113.904 -1.498 . . . . 3.2400000000000002 111.673 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.754 ' HB3' HG13 ' A' ' 39' ' ' ILE . 16.9 tppt? -105.23 115.58 30.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.127 -0.323 . . . . 3.8500000000000001 110.127 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -125.17 94.85 4.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.191 0.52 . . . . 4.1799999999999997 110.636 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 64' ' ' LYS . 25.1 t80 34.82 79.09 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.756 -1.111 . . . . 6.6600000000000001 113.217 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -92.8 21.12 5.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.812 0.815 . . . . 8.1300000000000008 109.787 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 62.5 mttm -101.57 4.41 40.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.489 -0.778 . . . . 10.050000000000001 110.851 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -79.19 123.87 27.81 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.831 -0.433 . . . . 7.9400000000000004 109.831 177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.9 t 54.79 78.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.327 0 O-C-N 123.762 0.664 . . . . 9.3499999999999996 109.534 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.56 105.95 0.38 Allowed Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.261 -0.881 . . . . 9.1600000000000001 112.27 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -87.53 172.1 5.94 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.099 2.533 . . . . 10.35 113.233 -174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.8 124.08 21.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.758 -0.655 . . . . 11.49 109.441 175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -165.2 159.08 17.15 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.338 -0.392 . . . . 10.949999999999999 110.1 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -137.13 74.44 1.48 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.591 0.71 . . . . 11.56 109.301 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.0 m -153.91 121.2 2.92 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 114.982 -1.008 . . . . 10.960000000000001 108.824 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.2 118.62 5.28 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.654 2.236 . . . . 10.68 112.607 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -80.1 43.65 0.63 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.053 -0.721 . . . . 11.76 109.053 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CZ ' ' HD3' ' A' ' 78' ' ' LYS . 76.0 t80 -83.99 -42.43 16.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.23 -0.895 . . . . 10.0 111.633 -170.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.565 ' HB2' ' HB2' ' A' ' 79' ' ' PHE . 94.8 m-85 52.22 -96.98 0.05 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.618 0.574 . . . . 7.5300000000000002 110.986 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -139.32 71.35 0.44 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.177 -1.169 . . . . 3.2000000000000002 110.177 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.529 ' HD3' ' CZ ' ' A' ' 75' ' ' PHE . 45.8 mmtm 67.12 31.65 6.65 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 123.987 0.463 . . . . 4.1399999999999997 110.293 -173.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.704 ' HA ' HD11 ' A' ' 88' ' ' LEU . 65.5 t80 -47.9 -36.86 12.94 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 112.245 0.461 . . . . 0.94999999999999996 112.245 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.39 -39.64 74.42 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.418 0.627 . . . . 3.48 109.963 -177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.08 -29.02 48.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.158 -0.928 . . . . 3.0699999999999998 108.917 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.86 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.82 -41.27 97.57 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.451 -0.795 . . . . 0.55000000000000004 111.516 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 79' ' ' PHE . 95.4 t -64.94 -51.83 61.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.431 -0.884 . . . . 0.84999999999999998 110.674 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.64 -24.69 49.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.062 -0.517 . . . . 1.1200000000000001 111.05 -172.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -65.21 -34.52 78.56 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.548 -0.908 . . . . 1.8799999999999999 108.548 172.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.73 15.57 61.32 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.25 -0.886 . . . . 1.6599999999999999 112.301 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -164.0 54.63 0.15 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.328 0.585 . . . . 2.0800000000000001 111.838 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.86 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -65.37 96.11 0.22 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.519 -0.764 . . . . 0.56000000000000005 111.547 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.6 p30 -145.05 108.53 4.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.32 0.581 . . . . 2.0099999999999998 110.283 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -142.2 162.42 35.53 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.098 -0.501 . . . . 1.6699999999999999 111.411 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.72 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 25.8 ptt? -151.5 116.08 5.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.815 0.816 . . . . 3.9399999999999999 110.285 169.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -149.89 144.32 25.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.949 -1.023 . . . . 2.4700000000000002 109.057 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.598 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 25.8 mt-10 -95.35 116.44 28.78 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.189 -0.671 . . . . 1.97 109.189 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -108.59 125.32 51.71 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.647 -0.706 . . . . 4.29 110.296 -172.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -96.91 150.31 20.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.833 -0.621 . . . . 2.8900000000000001 111.481 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 93.2 m-85 -112.39 110.93 21.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.752 -0.658 . . . . 5.25 109.637 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 98' ' ' TYR . 11.6 t70 63.94 -168.14 0.21 Allowed 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.804 0.69 . . . . 6.0599999999999996 110.15 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.423 ' H ' ' CG ' ' A' ' 97' ' ' ASP . 21.7 p90 -155.74 2.84 0.17 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.737 0.303 . . . . 9.7699999999999996 111.219 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -114.51 104.02 11.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.236 -0.438 . . . . 8.3399999999999999 109.956 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 56.0 mtm 62.05 18.38 9.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.12 -0.491 . . . . 8.1899999999999995 111.056 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.5 m -129.99 95.97 27.03 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.122 0.487 . . . . 5.0999999999999996 110.48 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -90.83 28.06 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.105 2.536 . . . . 4.5099999999999998 112.529 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 96' ' ' PHE . 8.2 m -75.59 99.06 4.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.295 0.569 . . . . 2.5899999999999999 110.904 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -122.47 133.82 54.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.76 -0.655 . . . . 3.1200000000000001 109.723 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.52 160.72 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.125 0.488 . . . . 1.23 110.824 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 13.9 ttmm -116.86 124.17 48.85 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.64 -0.874 . . . . 2.3599999999999999 108.64 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 91' ' ' MET . 1.1 m -109.32 104.32 16.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.167 0.508 . . . . 1.1100000000000001 111.494 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 15.0 t-160 -109.84 105.1 14.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.723 -0.843 . . . . 1.01 108.723 172.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 53.6 mtm -117.86 144.31 45.52 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.815 -0.809 . . . . 2.2200000000000002 108.815 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -149.34 129.67 13.77 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.142 -0.623 . . . . 1.73 110.187 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 75.5 tttt -56.85 114.91 2.29 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.787 -0.642 . . . . 1.78 110.366 174.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.554 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -62.62 145.81 53.59 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.792 -1.095 . . . . 0.45000000000000001 110.251 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.571 ' H ' ' CD1' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -67.07 1.27 2.08 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.305 0.483 . . . . 2.3900000000000001 112.305 -177.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.6 t -91.6 6.24 46.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.799 0.333 . . . . 1.6599999999999999 110.95 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -108.12 3.64 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.633 -0.794 . . . . 1.52 112.035 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.93 87.23 2.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.371 0.605 . . . . 2.79 110.628 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.963 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.3 p 179.25 151.32 0.34 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.824 -1.08 . . . . 0.44 109.169 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.475 ' OH ' ' HA ' ' A' ' 83' ' ' VAL . 22.6 m-85 -147.11 136.45 22.66 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.549 -0.537 . . . . 0.41999999999999998 109.549 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.468 ' CD2' ' HB2' ' A' ' 32' ' ' GLN . 45.2 m95 -86.33 159.3 19.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.07 0.462 . . . . 0.41999999999999998 110.481 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.604 ' HB ' HG23 ' A' ' 31' ' ' ILE . 72.1 t -138.21 104.31 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.108 -0.951 . . . . 0.62 109.964 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.656 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 71.5 m-85 -110.4 116.75 31.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.0 -0.741 . . . . 1.49 109.0 175.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 18.1 m -115.79 154.62 17.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.551 0.691 . . . . 1.6100000000000001 111.355 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HE2' ' HE2' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -146.5 110.09 4.86 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.066 -0.97 . . . . 3.4500000000000002 109.077 178.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -85.71 126.85 34.28 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.029 -0.532 . . . . 4.2300000000000004 110.026 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.248 0.995 0 CA-C-O 117.799 -1.096 . . . . 3.3399999999999999 111.461 179.044 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.977 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.962 0.41 . . . . 8.7200000000000006 111.753 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.81 92.19 8.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.003 0.43 . . . . 6.1799999999999997 110.52 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -103.06 -170.98 1.87 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.099 -0.5 . . . . 6.1500000000000004 110.895 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.62 37.94 1.67 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.781 -0.723 . . . . 1.4299999999999999 112.375 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.81 105.17 4.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.625 0.25 . . . . 0.69999999999999996 110.537 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.741 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 6.3 tt -133.52 140.37 46.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.196 0.522 . . . . 0.90000000000000002 111.097 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.58 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 3.2 pt20 -109.66 129.79 55.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.6 -0.727 . . . . 2.2200000000000002 110.548 176.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.29 159.03 36.53 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.513 -0.767 . . . . 0.71999999999999997 109.915 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 37.2 p30 -84.5 164.66 18.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.373 0.606 . . . . 1.1499999999999999 111.439 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.53 21.13 3.84 Favored Glycine 0 C--N 1.322 -0.249 0 CA-C-N 115.257 -0.883 . . . . 1.2 112.441 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.08 -26.55 8.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.804 0.335 . . . . 1.8100000000000001 110.329 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.45 11.61 7.22 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.907 -0.588 . . . . 1.05 111.86 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -109.53 143.59 38.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.892 0.377 . . . . 1.5700000000000001 110.421 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.763 HG21 ' HA ' ' A' ' 58' ' ' ILE . 51.2 mm -79.9 139.41 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.227 -0.657 . . . . 1.1799999999999999 109.227 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.3 tp -106.72 -52.31 2.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.628 -0.26 . . . . 1.5600000000000001 111.095 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -163.19 147.14 10.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 2.4100000000000001 111.336 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.741 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 49.0 t80 -114.27 151.23 33.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.01 -0.541 . . . . 1.4199999999999999 110.118 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -129.98 134.44 47.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.961 -0.563 . . . . 1.21 110.22 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.55 46.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.127 -0.488 . . . . 2.5 110.153 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.78 93.22 8.76 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 121.049 -0.26 . . . . 4.0 110.777 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 67.57 103.18 0.05 OUTLIER 'General case' 0 C--O 1.235 0.313 0 O-C-N 124.112 0.882 . . . . 7.21 111.5 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.17 35.97 0.16 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.442 -0.799 . . . . 6.9699999999999998 111.491 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -75.53 98.82 4.06 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.115 -0.328 . . . . 8.5899999999999999 110.115 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.9 pt 33.97 47.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.283 1.033 . . . . 9.2400000000000002 112.848 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.2 m -93.82 84.97 4.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.659 -0.701 . . . . 9.8200000000000003 110.576 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.83 -79.44 0.35 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.912 -0.661 . . . . 9.6199999999999992 111.806 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 mtt-85 -144.61 156.25 44.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.121 -0.696 . . . . 12.720000000000001 109.121 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -103.5 106.66 52.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.506 0.669 . . . . 8.2400000000000002 110.287 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.84 -29.27 3.52 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.579 2.186 . . . . 8.1099999999999994 112.266 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -127.65 113.18 15.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.958 -0.565 . . . . 9.2400000000000002 109.72 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -107.16 44.32 1.08 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.64 0.733 . . . . 7.4000000000000004 109.646 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.42 -35.74 71.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.29 -0.868 . . . . 5.0599999999999996 109.806 171.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.763 ' HA ' HG21 ' A' ' 39' ' ' ILE . 10.0 tt -73.4 146.99 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.893 -0.594 . . . . 3.1699999999999999 109.725 174.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.439 ' N ' HG12 ' A' ' 58' ' ' ILE . . . 100.92 -1.18 55.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.465 -0.874 . . . . 3.2400000000000002 111.711 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.54 ' HB3' HG12 ' A' ' 39' ' ' ILE . 1.7 tppp? -69.25 90.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 3.8500000000000001 110.036 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.503 HD22 ' C ' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -125.78 95.63 4.49 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.971 -0.752 . . . . 4.1799999999999997 108.971 173.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.524 ' HD2' ' HD3' ' A' ' 60' ' ' LYS . 71.5 m-85 -148.37 129.91 14.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.956 -0.566 . . . . 6.6600000000000001 110.299 -174.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -98.75 1.98 46.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.172 0.51 . . . . 8.1300000000000008 110.142 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -96.05 -16.08 21.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.664 -0.698 . . . . 10.050000000000001 110.269 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.25 112.43 6.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.775 -0.648 . . . . 7.9400000000000004 110.335 -173.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.4 -28.96 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.328 -0.396 . . . . 9.3499999999999996 112.059 -174.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -38.22 110.27 0.54 Allowed Pre-proline 0 N--CA 1.471 0.597 0 N-CA-C 113.914 1.079 . . . . 9.1600000000000001 113.914 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.32 -33.07 4.54 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.046 2.497 . . . . 10.35 111.071 171.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.8 m 61.94 179.43 0.12 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.447 -0.797 . . . . 11.49 111.881 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.3 p -79.02 -46.18 18.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.113 -0.699 . . . . 10.949999999999999 109.113 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -78.95 109.98 13.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.591 -0.731 . . . . 11.56 109.271 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.5 t -69.65 137.55 88.18 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.332 -0.395 . . . . 10.960000000000001 111.153 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.37 160.7 13.07 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.088 2.525 . . . . 10.68 112.265 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.45 124.5 23.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 11.76 111.205 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -84.7 -4.01 58.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.056 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 54.15 -106.3 0.31 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.914 -0.585 . . . . 7.5300000000000002 111.43 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.72 60.03 0.37 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.676 -0.773 . . . . 3.2000000000000002 111.303 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 62.03 37.93 14.46 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.654 0.382 . . . . 4.1399999999999997 110.268 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.663 ' HA ' HD11 ' A' ' 88' ' ' LEU . 69.6 t80 -47.34 -32.37 4.76 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.352 0.661 . . . . 0.94999999999999996 112.247 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -62.46 -44.02 97.42 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 123.933 0.771 . . . . 3.48 110.291 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -89.11 -22.99 22.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.149 -0.478 . . . . 3.0699999999999998 109.756 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.966 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.27 -38.03 92.7 Favored Glycine 0 N--CA 1.436 -1.3 0 CA-C-N 115.776 -0.647 . . . . 0.55000000000000004 112.323 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 79' ' ' PHE . 69.2 t -69.81 -48.61 63.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.93 -0.635 . . . . 0.84999999999999998 110.411 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.5 -23.74 42.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.423 -0.808 . . . . 1.1200000000000001 111.352 -170.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.6 p -67.62 -28.41 67.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.494 0.664 . . . . 1.8799999999999999 109.219 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.16 19.5 62.59 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.356 -0.838 . . . . 1.6599999999999999 111.839 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -162.85 55.75 0.2 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.359 0.6 . . . . 2.0800000000000001 111.225 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.966 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -69.07 83.61 0.33 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.553 -0.749 . . . . 0.56000000000000005 111.326 176.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.9 p-10 -144.86 99.04 3.28 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.455 0.645 . . . . 2.0099999999999998 109.789 171.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 91' ' ' MET . 11.9 m -146.31 152.52 39.27 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.136 -0.484 . . . . 1.6699999999999999 110.333 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.416 ' N ' HG22 ' A' ' 90' ' ' THR . 16.8 ptt? -123.22 129.26 51.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.93 0.395 . . . . 3.9399999999999999 110.323 174.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -150.66 142.96 24.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.806 -0.634 . . . . 2.4700000000000002 109.759 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.61 117.1 29.83 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.663 -0.495 . . . . 1.97 109.663 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -108.67 88.99 2.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.685 -0.857 . . . . 4.29 108.685 -175.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.7 t -84.97 145.68 27.61 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.231 -0.895 . . . . 2.8900000000000001 111.854 -172.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.786 ' HB3' ' HB ' ' A' ' 101' ' ' THR . 42.3 m-85 -126.32 117.83 23.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.808 -1.182 . . . . 5.25 107.808 171.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.44 -123.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.834 0.309 . . . . 6.0599999999999996 111.834 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -107.94 9.43 28.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.002 0.429 . . . . 9.7699999999999996 110.791 -172.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -83.58 71.38 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.318 -0.401 . . . . 8.3399999999999999 111.122 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 17.4 ptp 48.25 21.72 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.399 1.08 . . . . 8.1899999999999995 112.394 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.786 ' HB ' ' HB3' ' A' ' 96' ' ' PHE . 2.3 p -95.61 151.9 38.82 Favored Pre-proline 0 N--CA 1.446 -0.674 0 CA-C-N 116.436 -0.347 . . . . 5.0999999999999996 111.267 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 5.6 Cg_exo -80.07 -73.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.728 2.285 . . . . 4.5099999999999998 113.416 -174.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.518 ' O ' ' HD2' ' A' ' 96' ' ' PHE . 21.3 p -128.47 164.79 21.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.191 0.519 . . . . 2.5899999999999999 112.014 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.876 ' HD3' ' HA ' ' A' ' 125' ' ' VAL . 15.1 tttt -89.36 130.68 35.7 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.959 -1.126 . . . . 3.1200000000000001 107.959 164.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -126.03 163.66 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.182 0.515 . . . . 1.23 110.867 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 22.1 ptmt -135.31 140.33 45.03 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.412 -0.813 . . . . 2.3599999999999999 109.03 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.75 142.02 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-O 121.679 0.752 . . . . 1.1100000000000001 112.157 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 18.5 t-160 -131.71 104.67 7.04 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.004 -1.48 . . . . 1.01 107.004 164.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.587 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 79.7 mtp -105.98 148.13 28.05 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.826 -0.805 . . . . 2.2200000000000002 108.826 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.8 ptmm? -152.59 134.43 14.74 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.893 -0.723 . . . . 1.73 109.671 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.454 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 18.5 ttmm -56.95 115.35 2.55 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.409 0.623 . . . . 1.78 109.726 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.54 138.02 58.35 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.659 -1.155 . . . . 0.45000000000000001 110.866 -172.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.52 -8.66 55.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.185 0.517 . . . . 2.3900000000000001 109.974 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.2 m -65.41 -35.92 82.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.487 -0.779 . . . . 1.6599999999999999 110.089 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.09 139.68 9.36 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.825 -0.625 . . . . 1.52 112.335 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.53 44.75 17.2 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.42 0.688 . . . . 2.79 112.091 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 2.9 p -158.98 157.16 30.77 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.249 -0.887 . . . . 0.44 110.383 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.454 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 39.8 m-85 -139.29 137.21 35.65 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.443 -0.577 . . . . 0.41999999999999998 109.443 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.58 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 39.8 m95 -84.05 161.7 20.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.278 0.561 . . . . 0.41999999999999998 111.27 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.77 95.82 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.426 -1.261 . . . . 0.62 108.93 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 89.6 m-85 -90.31 101.55 14.27 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.414 -0.958 . . . . 1.49 108.414 172.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 7.1 p -116.97 134.02 61.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.81 0.338 . . . . 1.6100000000000001 110.478 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -142.65 144.34 32.73 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.824 -0.436 . . . . 3.4500000000000002 109.824 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -81.34 155.3 26.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.335 -0.393 . . . . 4.2300000000000004 111.062 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.876 ' HA ' ' HD3' ' A' ' 104' ' ' LYS . 14.8 m . . . . . 0 C--O 1.252 1.204 0 O-C-N 124.998 1.436 . . . . 3.3399999999999999 113.582 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 1.001 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.8 tp . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 120.857 0.361 . . . . 8.7200000000000006 110.553 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.84 119.45 33.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.212 -0.449 . . . . 6.1799999999999997 110.22 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.527 ' HE2' ' HA3' ' A' ' 47' ' ' GLY . 98.6 m-85 -80.1 152.28 29.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.29 -0.414 . . . . 6.1500000000000004 110.971 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 57.81 44.61 94.19 Favored Glycine 0 C--O 1.226 -0.382 0 CA-C-N 115.917 -0.583 . . . . 1.4299999999999999 112.945 175.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.14 102.9 14.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.997 0.427 . . . . 0.69999999999999996 111.755 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.708 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -128.49 139.73 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.954 0.407 . . . . 0.90000000000000002 110.025 175.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.611 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.3 pt20 -112.81 134.67 54.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.471 0.653 . . . . 2.2200000000000002 111.416 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HB3' HD13 ' A' ' 39' ' ' ILE . 4.2 pp -122.62 161.84 23.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.149 -0.932 . . . . 0.71999999999999997 110.019 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 36' ' ' ASP . 3.5 p30 -90.87 153.99 19.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.261 0.553 . . . . 1.1499999999999999 110.77 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -79.07 28.23 2.25 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.591 -0.731 . . . . 1.2 111.381 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 34' ' ' ASP . 31.9 t70 -111.41 -35.34 5.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.803 -0.698 . . . . 1.8100000000000001 109.402 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.42 22.45 1.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.803 -0.713 . . . . 1.05 112.992 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.612 ' OD1' ' HA ' ' A' ' 61' ' ' ASN . 47.0 m-80 -135.31 153.47 51.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.085 0.469 . . . . 1.5700000000000001 110.533 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.6 HG12 ' HB3' ' A' ' 60' ' ' LYS . 48.2 mm -76.16 141.61 15.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.188 -0.671 . . . . 1.1799999999999999 109.188 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.455 HD23 ' NE2' ' A' ' 32' ' ' GLN . 32.8 tp -107.34 -52.29 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.915 -0.314 . . . . 1.5600000000000001 110.963 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.406 ' O ' HG12 ' A' ' 31' ' ' ILE . 24.4 tt0 -160.93 140.84 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.702 -0.399 . . . . 2.4100000000000001 111.72 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.708 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 76.8 t80 -104.41 139.03 39.94 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.769 -0.826 . . . . 1.4199999999999999 108.769 171.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -102.34 120.86 41.19 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.001 -0.37 . . . . 1.21 110.001 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.01 86.99 1.03 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.033 0.444 . . . . 2.5 110.338 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.5 132.41 35.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.694 -0.684 . . . . 4.0 110.636 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.86 166.37 21.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.276 -0.42 . . . . 7.21 110.786 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.527 ' HA3' ' HE2' ' A' ' 28' ' ' PHE . . . 115.76 -84.91 0.38 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.444 -0.662 . . . . 6.9699999999999998 111.444 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -148.79 94.92 2.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.909 0.385 . . . . 8.5899999999999999 111.03 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.3 pt -130.26 48.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.773 -0.649 . . . . 9.2400000000000002 110.612 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 m -72.63 146.32 46.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.075 -0.511 . . . . 9.8200000000000003 111.215 -174.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.95 170.8 18.41 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 111.619 -0.593 . . . . 9.6199999999999992 111.619 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -134.38 50.18 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.965 0.383 . . . . 12.720000000000001 111.263 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -153.8 95.42 2.84 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.546 0.689 . . . . 8.2400000000000002 111.148 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -77.86 -53.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.247 1.965 . . . . 8.1099999999999994 112.041 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -80.38 79.35 6.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.497 0.665 . . . . 9.2400000000000002 110.618 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -161.81 -46.94 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.008 -0.996 . . . . 7.4000000000000004 108.668 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.529 HG13 HG23 ' A' ' 58' ' ' ILE . 11.7 p -80.5 -35.99 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.498 -0.773 . . . . 5.0599999999999996 109.555 170.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.548 ' HA ' HG21 ' A' ' 39' ' ' ILE . 45.9 pt -111.91 167.96 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.251 0.548 . . . . 3.1699999999999999 110.537 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.63 9.92 82.4 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 114.987 -1.006 . . . . 3.2400000000000002 111.507 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.6 ' HB3' HG12 ' A' ' 39' ' ' ILE . 44.9 tptt -77.04 86.54 3.55 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.256 -0.646 . . . . 3.8500000000000001 109.256 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.612 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 16.0 m120 -120.44 95.21 4.64 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.406 -0.815 . . . . 4.1799999999999997 109.828 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -150.48 154.52 37.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.592 -0.731 . . . . 6.6600000000000001 109.438 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -60.25 -49.73 76.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.419 -0.586 . . . . 8.1300000000000008 109.419 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -166.85 132.64 2.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.403 -0.817 . . . . 10.050000000000001 109.888 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -172.07 120.21 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.343 0.402 . . . . 7.9400000000000004 110.437 175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 66' ' ' VAL . 11.6 p -150.35 37.33 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 122.329 1.061 . . . . 9.3499999999999996 110.071 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 61.86 106.45 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 114.686 -1.143 . . . . 9.1600000000000001 111.252 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.18 -26.94 53.76 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.603 2.869 . . . . 10.35 114.606 -171.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.9 m -92.07 -15.75 27.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.637 0.606 . . . . 11.49 112.637 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.7 p -114.85 170.23 8.49 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.707 0.632 . . . . 10.949999999999999 112.707 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -144.86 149.58 35.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.466 -0.788 . . . . 11.56 109.011 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.2 t 57.02 79.29 0.33 Allowed Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 123.539 0.524 . . . . 10.960000000000001 110.095 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.62 -53.22 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.786 2.324 . . . . 10.68 112.604 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -167.63 -49.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.16 -0.473 . . . . 11.76 110.663 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -101.3 96.23 7.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.501 -0.318 . . . . 10.0 110.426 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -155.08 113.76 3.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 7.5300000000000002 110.806 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -129.49 70.31 0.52 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.833 -0.907 . . . . 3.2000000000000002 110.833 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 58.98 41.06 21.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.597 0.713 . . . . 4.1399999999999997 109.376 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 83' ' ' VAL . 57.4 t80 -56.81 -36.25 69.7 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.628 -1.169 . . . . 0.94999999999999996 111.259 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -59.49 -36.71 76.57 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 123.85 0.718 . . . . 3.48 110.52 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -86.07 -37.91 18.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.812 -0.631 . . . . 3.0699999999999998 109.863 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 1.017 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.39 -43.58 89.99 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.721 -0.672 . . . . 0.55000000000000004 112.015 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 79' ' ' PHE . 90.7 t -73.05 -50.63 30.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.508 -0.846 . . . . 0.84999999999999998 111.211 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.79 -32.29 59.83 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.215 -0.448 . . . . 1.1200000000000001 111.239 -169.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.6 m -72.55 -23.23 60.95 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.424 -0.584 . . . . 1.8799999999999999 109.424 173.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.24 34.06 38.06 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.714 -0.675 . . . . 1.6599999999999999 111.999 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -158.89 50.19 0.36 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.565 0.698 . . . . 2.0800000000000001 112.005 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.017 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -73.76 88.31 1.75 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.763 -0.653 . . . . 0.56000000000000005 111.45 177.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.0 p30 -143.26 101.52 3.82 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.525 -0.546 . . . . 2.0099999999999998 109.525 175.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.0 t -168.47 163.36 12.56 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.13 0.49 . . . . 1.6699999999999999 110.924 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.2 ptt? -104.4 136.28 44.27 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.411 -0.813 . . . . 3.9399999999999999 110.014 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 107' ' ' VAL . 77.3 t80 -147.15 127.78 14.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.58 -0.736 . . . . 2.4700000000000002 109.22 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 8.1 pt-20 -95.43 132.71 40.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.43 0.633 . . . . 1.97 110.804 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -108.39 94.92 5.32 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.76 -1.109 . . . . 4.29 108.777 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.3 m -90.73 150.54 21.59 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.624 -0.716 . . . . 2.8900000000000001 110.28 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.476 ' CD2' ' HA ' ' A' ' 102' ' ' PRO . 7.5 p90 -65.3 109.2 2.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.825 -0.625 . . . . 5.25 110.97 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -143.37 63.93 1.35 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.009 -0.737 . . . . 6.0599999999999996 109.009 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.408 ' CD1' ' HG3' ' A' ' 99' ' ' GLN . 10.3 t80 177.5 -149.37 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.127 -1.064 . . . . 9.7699999999999996 108.127 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.408 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 0.7 OUTLIER -76.21 -4.6 42.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.93 0.395 . . . . 8.3399999999999999 110.836 176.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 52.6 tpp -69.46 135.66 50.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.834 -0.621 . . . . 8.1899999999999995 109.991 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.513 ' HB ' ' CD ' ' A' ' 102' ' ' PRO . 8.9 p -80.38 169.51 19.44 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.212 -0.449 . . . . 5.0999999999999996 111.113 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.513 ' CD ' ' HB ' ' A' ' 101' ' ' THR . 52.8 Cg_exo -56.41 86.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.931 2.421 . . . . 4.5099999999999998 114.043 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.7 m -139.58 98.22 3.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.436 -0.802 . . . . 2.5899999999999999 108.847 171.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -93.32 105.19 17.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.832 0.349 . . . . 3.1200000000000001 110.878 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 22.2 m -114.74 167.87 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-N 115.548 -0.751 . . . . 1.23 110.141 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 19.8 ptmt -144.07 147.38 33.71 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.671 -0.412 . . . . 2.3599999999999999 110.414 174.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.727 HG12 HG12 ' A' ' 122' ' ' VAL . 14.2 m -100.54 144.24 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-N 115.781 -0.645 . . . . 1.1100000000000001 111.359 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -119.97 102.87 8.85 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.411 -1.7 . . . . 1.01 106.411 160.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 64.0 mtt -102.98 146.36 28.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.777 -0.823 . . . . 2.2200000000000002 108.777 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 61.5 pttt -151.12 128.85 11.56 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.874 -0.73 . . . . 1.73 110.187 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.09 110.03 0.76 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.769 -0.65 . . . . 1.78 109.45 168.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.93 129.34 17.16 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.783 -1.099 . . . . 0.45000000000000001 109.782 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.17 -5.92 20.62 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.225 0.328 . . . . 2.3900000000000001 111.747 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -73.4 -43.13 61.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.817 0.342 . . . . 1.6599999999999999 110.219 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.22 138.31 3.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.379 -0.915 . . . . 1.52 113.488 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 41.74 52.65 4.04 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.186 0.994 . . . . 2.79 113.374 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.513 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.1 p -158.92 156.21 29.1 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.56 -1.274 . . . . 0.44 107.56 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -137.38 136.2 37.67 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.645 -0.422 . . . . 0.41999999999999998 111.18 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.611 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 49.2 m95 -91.5 161.98 14.74 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.406 0.622 . . . . 0.41999999999999998 111.824 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.52 97.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.39 -1.277 . . . . 0.62 109.226 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 66.3 m-85 -98.27 112.47 24.45 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.188 -0.671 . . . . 1.49 109.188 174.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.727 HG12 HG12 ' A' ' 107' ' ' VAL . 31.1 m -110.78 150.13 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.255 0.465 . . . . 1.6100000000000001 112.255 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -159.09 145.72 16.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 3.4500000000000002 110.366 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 19.7 ptt180 -90.58 104.87 17.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.779 -0.646 . . . . 4.2300000000000004 111.479 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.429 HG13 ' OXT' ' A' ' 125' ' ' VAL . 3.4 p . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.112 -0.947 . . . . 3.3399999999999999 110.4 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 1.016 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.915 -0.402 . . . . 8.7200000000000006 109.915 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 69.35 145.39 0.05 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.085 0.866 . . . . 6.1799999999999997 112.332 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' A' ' 45' ' ' ALA . 94.9 m-85 -103.12 107.98 18.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.783 -0.644 . . . . 6.1500000000000004 110.197 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 143.84 21.97 0.17 Allowed Glycine 0 C--O 1.221 -0.68 0 C-N-CA 120.292 -0.956 . . . . 1.4299999999999999 113.489 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' ASN . . . -109.3 105.22 14.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 117.767 0.784 . . . . 0.69999999999999996 110.828 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.663 HD11 HD12 ' A' ' 39' ' ' ILE . 4.3 tt -138.35 141.69 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.425 -0.352 . . . . 0.90000000000000002 110.767 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' OE1' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -114.06 130.01 56.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.022 0.439 . . . . 2.2200000000000002 109.842 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.416 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.7 pp -132.75 159.76 38.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.354 0.597 . . . . 0.71999999999999997 111.366 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 3.6 p30 -76.99 157.83 30.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 1.1499999999999999 110.782 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.449 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -77.76 30.98 1.73 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.361 -0.836 . . . . 1.2 112.675 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -122.42 -31.94 3.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.211 0.529 . . . . 1.8100000000000001 109.756 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.04 21.18 1.24 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.459 -0.877 . . . . 1.05 112.898 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.484 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 16.2 m-80 -125.27 156.49 38.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.045 0.45 . . . . 1.5700000000000001 110.196 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.903 HG12 ' HB3' ' A' ' 60' ' ' LYS . 41.1 mm -81.53 142.75 13.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.965 -0.561 . . . . 1.1799999999999999 109.999 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD12 ' OE1' ' A' ' 32' ' ' GLN . 89.1 mt -109.31 -53.23 2.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.395 -0.595 . . . . 1.5600000000000001 109.395 172.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -133.81 117.27 16.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.579 -0.737 . . . . 2.4100000000000001 110.656 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.578 ' HA ' HG13 ' A' ' 31' ' ' ILE . 18.5 t80 -106.01 117.93 35.31 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.277 -0.638 . . . . 1.4199999999999999 109.277 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 84.6 m-20 -99.35 99.74 10.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.991 0.424 . . . . 1.21 110.529 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.32 146.92 33.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.907 -0.588 . . . . 2.5 110.686 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . . . -100.54 139.73 35.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.001 -0.545 . . . . 4.0 110.178 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 68.14 -178.82 0.22 Allowed 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.935 0.772 . . . . 7.21 110.916 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.11 -159.53 26.33 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.576 -0.821 . . . . 6.9699999999999998 112.336 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.764 ' HB2' ' HG2' ' A' ' 52' ' ' ARG . 5.8 p-10 -76.97 80.81 3.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.223 1.011 . . . . 8.5899999999999999 111.116 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.9 -41.28 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.602 -1.181 . . . . 9.2400000000000002 109.955 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -95.0 49.22 1.21 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 122.231 1.015 . . . . 9.8200000000000003 110.111 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.82 113.89 3.58 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.108 -0.951 . . . . 9.6199999999999992 111.345 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.764 ' HG2' ' HB2' ' A' ' 48' ' ' ASP . 39.9 mtt180 -79.48 106.24 11.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.044 0.449 . . . . 12.720000000000001 111.743 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -114.89 127.43 26.84 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.871 -0.788 . . . . 8.2400000000000002 108.871 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.22 -4.1 14.84 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.541 2.161 . . . . 8.1099999999999994 112.794 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.58 ' HE2' ' HA2' ' A' ' 59' ' ' GLY . 26.6 mtmm -120.93 91.25 3.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.397 . . . . 9.2400000000000002 110.647 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -78.98 -20.2 49.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.262 0.553 . . . . 7.4000000000000004 110.178 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 58' ' ' ILE . 12.5 t -123.45 153.8 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.345 -0.983 . . . . 5.0599999999999996 108.345 174.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.444 ' N ' HG12 ' A' ' 57' ' ' VAL 0.25 13.6 tt 38.7 73.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 122.799 1.285 . . . . 3.1699999999999999 112.414 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.58 ' HA2' ' HE2' ' A' ' 55' ' ' LYS . . . -68.2 -29.19 73.19 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.415 -1.266 . . . . 3.2400000000000002 111.787 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.903 ' HB3' HG12 ' A' ' 39' ' ' ILE . 23.2 tptm -99.26 91.03 4.77 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 120.904 0.383 . . . . 3.8500000000000001 110.0 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -98.19 101.45 12.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.705 -0.679 . . . . 4.1799999999999997 109.357 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 65' ' ' ASP . 5.5 t80 -156.15 175.1 14.42 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.42 -0.956 . . . . 6.6600000000000001 108.42 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.452 ' CD1' ' HG2' ' A' ' 64' ' ' LYS . 54.4 t80 -86.64 -65.63 0.99 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.283 -0.636 . . . . 8.1300000000000008 109.283 172.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HG2' ' CD1' ' A' ' 63' ' ' PHE . 17.0 ptpt -170.15 141.64 2.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.869 -0.789 . . . . 10.050000000000001 108.869 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.475 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 4.4 p-10 -152.98 173.94 14.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.034 0.445 . . . . 7.9400000000000004 110.829 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.8 m -132.3 37.17 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 9.3499999999999996 110.495 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.71 94.65 2.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.113 0.412 . . . . 9.1600000000000001 112.113 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.09 102.91 0.83 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.389 2.059 . . . . 10.35 110.779 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.5 m -74.16 -69.11 0.47 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.108 -0.497 . . . . 11.49 112.338 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 p -86.59 -43.24 12.83 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 111.712 0.264 . . . . 10.949999999999999 111.712 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -56.92 112.91 1.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.861 -0.609 . . . . 11.56 111.456 -175.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.445 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 49.9 m -90.86 -44.19 0.39 Allowed Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.592 -0.731 . . . . 10.960000000000001 112.49 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 72' ' ' SER . 42.6 Cg_exo -58.81 111.73 0.98 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.126 1.884 . . . . 10.68 112.534 176.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 72' ' ' SER . 15.1 mt-10 -106.26 102.7 12.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.948 -0.569 . . . . 11.76 110.036 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -109.93 19.06 19.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.054 0.454 . . . . 10.0 111.552 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 79' ' ' PHE . 93.4 m-85 -82.45 120.47 25.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.611 -0.514 . . . . 7.5300000000000002 109.611 177.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.46 88.93 0.63 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.335 -0.936 . . . . 3.2000000000000002 111.728 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 58.28 41.07 23.95 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.376 0.608 . . . . 4.1399999999999997 109.676 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 83' ' ' VAL . 56.0 t80 -56.24 -27.67 55.79 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 115.31 -0.859 . . . . 0.94999999999999996 111.789 -171.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.86 -33.95 72.95 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 123.855 0.722 . . . . 3.48 110.277 -175.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -86.87 -29.07 22.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.765 -0.652 . . . . 3.0699999999999998 109.531 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.737 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.25 -39.27 92.26 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 111.83 -0.508 . . . . 0.55000000000000004 111.83 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 79' ' ' PHE . 95.2 t -66.86 -48.12 80.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.979 -0.61 . . . . 0.84999999999999998 110.547 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.41 -26.61 51.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 1.1200000000000001 111.206 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -60.1 -28.56 67.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.562 -0.533 . . . . 1.8799999999999999 109.562 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.11 -10.26 47.37 Favored Glycine 0 CA--C 1.505 -0.551 0 C-N-CA 120.728 -0.749 . . . . 1.6599999999999999 113.048 169.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -169.96 62.61 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.324 0.583 . . . . 2.0800000000000001 110.145 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.737 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 2.9 tt -38.45 102.35 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 114.728 -1.123 . . . . 0.56000000000000005 111.802 175.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 4.1 p30 -145.74 102.24 3.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.1 0.476 . . . . 2.0099999999999998 109.822 176.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 2.5 p -138.8 154.34 48.47 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.924 -0.485 . . . . 1.6699999999999999 111.764 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.24 138.1 36.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.768 -0.651 . . . . 3.9399999999999999 109.76 171.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.45 ' O ' HG22 ' A' ' 107' ' ' VAL . 85.5 t80 -163.3 140.37 7.41 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.377 -0.601 . . . . 2.4700000000000002 109.377 -175.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 39.2 mt-10 -91.74 110.78 22.13 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.356 -0.609 . . . . 1.97 109.356 177.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -117.43 113.99 22.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.649 -0.705 . . . . 4.29 110.872 -171.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 104' ' ' LYS . 3.6 p -84.44 150.25 25.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.365 -0.38 . . . . 2.8900000000000001 110.522 173.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.487 ' CD2' ' HB ' ' A' ' 103' ' ' THR . 71.9 m-85 -73.28 148.81 43.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.21 -0.45 . . . . 5.25 110.566 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.46 -79.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.082 -0.508 . . . . 6.0599999999999996 110.561 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -148.58 84.19 1.48 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.184 -0.462 . . . . 9.7699999999999996 109.818 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.431 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 4.1 mm100 -103.12 -44.79 5.11 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.819 -0.808 . . . . 8.3399999999999999 108.819 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 34.2 tpp 177.84 -53.19 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.677 -1.147 . . . . 8.1899999999999995 108.699 175.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 21.3 m -111.18 138.29 21.22 Favored Pre-proline 0 N--CA 1.446 -0.627 0 CA-C-N 115.122 -0.945 . . . . 5.0999999999999996 109.289 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 12.9 Cg_exo -72.07 60.13 3.05 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.703 2.269 . . . . 4.5099999999999998 111.372 174.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.487 ' HB ' ' CD2' ' A' ' 96' ' ' PHE . 4.8 m -57.99 133.14 55.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.945 -0.57 . . . . 2.5899999999999999 111.091 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' HA ' HG22 ' A' ' 95' ' ' THR . 63.9 tttp -108.16 103.55 12.77 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.214 -0.448 . . . . 3.1200000000000001 110.375 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.9 163.85 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.978 -0.556 . . . . 1.23 109.528 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 59.1 pttt -126.17 140.05 52.86 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.047 -0.723 . . . . 2.3599999999999999 109.047 173.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 122' ' ' VAL . 7.9 m -100.65 143.5 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 CA-C-O 121.144 0.497 . . . . 1.1100000000000001 110.903 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 90' ' ' THR . 17.8 t-160 -143.85 102.73 3.95 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.656 -1.238 . . . . 1.01 107.656 164.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.553 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.1 OUTLIER -115.63 125.23 52.64 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.925 -1.139 . . . . 2.2200000000000002 107.925 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.9 ptmm? -145.18 146.96 31.96 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 119.742 -0.783 . . . . 1.73 110.604 -171.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 13.1 ttpp -56.82 123.79 16.26 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.217 -0.901 . . . . 1.78 111.265 176.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.66 148.41 51.03 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.674 -1.148 . . . . 0.45000000000000001 110.716 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.51 -4.1 37.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.091 0.472 . . . . 2.3900000000000001 110.883 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -79.88 -21.91 43.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 1.6599999999999999 110.933 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 139.16 -128.1 3.91 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.487 -0.864 . . . . 1.52 112.739 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.66 77.24 5.14 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.988 0.899 . . . . 2.79 110.76 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.449 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.9 p -162.94 157.14 20.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.267 -1.333 . . . . 0.44 108.194 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 25.1 m-85 -138.65 141.28 39.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.864 0.364 . . . . 0.41999999999999998 110.608 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 32' ' ' GLN . 47.2 m95 -87.98 165.75 14.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.145 0.498 . . . . 0.41999999999999998 110.573 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.454 ' HB ' HG23 ' A' ' 31' ' ' ILE . 58.1 t -135.42 98.56 2.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.643 -1.162 . . . . 0.62 108.774 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 83.2 m-85 -103.86 119.96 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.372 -0.603 . . . . 1.49 109.372 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 107' ' ' VAL . 23.8 m -124.28 155.16 31.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.714 -0.476 . . . . 1.6100000000000001 109.714 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -156.73 132.19 9.33 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.816 -0.353 . . . . 3.4500000000000002 110.206 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -88.5 139.7 30.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 4.2300000000000004 110.257 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.819 -0.61 . . . . 3.3399999999999999 110.365 -179.198 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 1.008 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 121.043 0.449 . . . . 8.7200000000000006 110.558 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.89 30.84 4.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.255 0.55 . . . . 6.1799999999999997 110.023 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -162.69 137.86 6.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.331 -0.85 . . . . 6.1500000000000004 109.639 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 99.71 -6.7 58.97 Favored Glycine 0 C--O 1.226 -0.358 0 C-N-CA 120.819 -0.705 . . . . 1.4299999999999999 113.239 175.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -107.49 118.73 37.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.139 0.495 . . . . 0.69999999999999996 111.57 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.543 HG23 ' HB ' ' A' ' 120' ' ' VAL . 5.5 tt -136.19 141.01 42.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.222 -0.444 . . . . 0.90000000000000002 110.121 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -115.37 125.08 52.77 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.5 -0.926 . . . . 2.2200000000000002 108.5 179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.48 154.31 46.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.605 0.717 . . . . 0.71999999999999997 111.456 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -73.71 146.61 44.29 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.025 -0.989 . . . . 1.1499999999999999 110.045 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.56 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -82.09 36.28 2.55 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.804 -0.635 . . . . 1.2 112.961 -173.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -134.51 -24.97 1.52 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.854 0.359 . . . . 1.8100000000000001 110.1 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.09 -4.28 2.6 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.099 -0.572 . . . . 1.05 112.494 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.669 ' OD1' ' HA ' ' A' ' 61' ' ' ASN . 21.4 m-80 -90.78 149.76 21.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.511 0.196 . . . . 1.5700000000000001 110.792 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.691 HG12 ' HB3' ' A' ' 60' ' ' LYS . 34.7 mm -92.8 140.06 16.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.822 -0.807 . . . . 1.1799999999999999 108.822 173.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.448 ' HG ' ' HG3' ' A' ' 41' ' ' GLN . 38.3 tp -113.28 -57.34 2.3 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.348 -0.541 . . . . 1.5600000000000001 111.351 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 45.1 mt-30 -144.16 150.38 37.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.016 0.436 . . . . 2.4100000000000001 111.405 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.631 ' CE1' ' HB3' ' A' ' 44' ' ' ALA . 55.9 t80 -127.04 117.78 23.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.956 -0.565 . . . . 1.4199999999999999 109.551 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.498 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -98.44 92.19 5.55 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.83 -0.433 . . . . 1.21 109.83 -177.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.631 ' HB3' ' CE1' ' A' ' 42' ' ' TYR . . . -171.54 155.4 4.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.232 -0.44 . . . . 2.5 110.382 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.88 90.96 5.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.013 0.435 . . . . 4.0 110.44 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -120.71 20.75 11.67 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.025 -0.731 . . . . 7.21 109.025 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.58 76.24 0.98 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.315 -0.857 . . . . 6.9699999999999998 111.924 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.16 100.45 4.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.853 0.359 . . . . 8.5899999999999999 110.279 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 mm 51.31 48.4 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.246 -0.888 . . . . 9.2400000000000002 109.708 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.2 m 57.29 75.44 0.37 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.309 -0.86 . . . . 9.8200000000000003 111.0 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -168.24 113.62 0.53 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.528 -0.76 . . . . 9.6199999999999992 112.35 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -130.51 155.83 45.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.422 -0.585 . . . . 12.720000000000001 109.422 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -95.85 113.55 62.28 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.515 0.197 . . . . 8.2400000000000002 110.999 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 86.8 Cg_endo -96.99 23.76 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.439 2.76 . . . . 8.1099999999999994 112.213 176.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -103.82 -52.52 2.95 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.478 0.656 . . . . 9.2400000000000002 110.454 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -94.42 -31.98 13.74 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.766 -1.106 . . . . 7.4000000000000004 109.919 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.828 HG12 HG13 ' A' ' 58' ' ' ILE . 25.1 t -111.38 123.81 67.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.679 -0.691 . . . . 5.0599999999999996 110.107 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.828 HG13 HG12 ' A' ' 57' ' ' VAL . 65.7 mt 69.49 148.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.31 0.576 . . . . 3.1699999999999999 111.132 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 58' ' ' ILE . . . 75.14 6.62 80.16 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.78 -0.724 . . . . 3.2400000000000002 112.022 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.691 ' HB3' HG12 ' A' ' 39' ' ' ILE . 4.0 tppp? -74.24 99.82 3.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.31 -0.626 . . . . 3.8500000000000001 109.31 176.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.669 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 14.2 m120 -106.35 98.52 8.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.0 -0.545 . . . . 4.1799999999999997 110.074 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -119.03 136.26 54.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.567 -0.742 . . . . 6.6600000000000001 109.257 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -103.18 154.33 19.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.865 0.364 . . . . 8.1300000000000008 110.533 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 110.71 2.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.816 -0.629 . . . . 10.050000000000001 111.747 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.455 ' OD1' HG12 ' A' ' 66' ' ' VAL . 9.0 p-10 -82.77 -62.7 1.53 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.659 -0.867 . . . . 7.9400000000000004 108.659 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 67' ' ' ALA . 7.6 p -122.84 -51.27 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.953 -0.758 . . . . 9.3499999999999996 108.953 167.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.857 ' HB3' ' H2 ' ' A' ' 169' ' ' HC4 . . . 169.15 136.64 0.05 OUTLIER Pre-proline 0 C--O 1.232 0.169 0 C-N-CA 123.779 0.832 . . . . 9.1600000000000001 109.366 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.08 92.87 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.658 2.239 . . . . 10.35 111.928 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.2 p -154.92 27.94 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 11.49 110.802 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -104.87 -41.52 5.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.373 -0.376 . . . . 10.949999999999999 111.49 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' SER . 33.3 t70 -58.48 -94.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.574 0.583 . . . . 11.56 112.574 -175.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 71' ' ' ASP . 36.0 t 172.37 135.87 0.1 OUTLIER Pre-proline 0 C--O 1.233 0.209 0 CA-C-O 120.713 0.292 . . . . 10.960000000000001 110.316 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.75 71.26 6.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.836 2.357 . . . . 10.68 111.432 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.96 -57.69 9.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 11.76 110.32 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -123.86 23.04 8.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.452 0.644 . . . . 10.0 110.369 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -97.69 137.96 35.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.516 -0.765 . . . . 7.5300000000000002 110.027 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.94 86.46 0.48 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.517 -0.849 . . . . 3.2000000000000002 112.017 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm 58.48 44.12 18.48 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 122.686 0.395 . . . . 4.1399999999999997 110.538 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 83' ' ' VAL . 64.5 t80 -46.08 -43.0 14.29 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 113.456 0.91 . . . . 0.94999999999999996 113.456 -167.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -79.64 -29.88 41.14 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 121.279 0.561 . . . . 3.48 110.155 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -74.53 -34.31 62.98 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.218 -1.03 . . . . 3.0699999999999998 108.218 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 1.015 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.86 -40.08 89.29 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.732 -1.122 . . . . 0.55000000000000004 111.395 175.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 79' ' ' PHE . 95.5 t -68.38 -54.27 22.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.378 -0.911 . . . . 0.84999999999999998 111.046 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.15 -22.6 33.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 1.1200000000000001 111.644 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.9 t -70.63 -29.51 65.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.483 -0.932 . . . . 1.8799999999999999 108.483 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.24 23.23 49.12 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.53 -0.759 . . . . 1.6599999999999999 112.169 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -156.04 52.59 0.56 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.45 0.643 . . . . 2.0800000000000001 111.501 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.015 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 0.9 OUTLIER -74.37 73.72 1.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.603 -0.726 . . . . 0.56000000000000005 111.083 175.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.9 t30 -143.16 99.29 3.42 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.572 -0.899 . . . . 2.0099999999999998 108.572 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.4 m -140.26 146.36 38.5 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.017 -0.538 . . . . 1.6699999999999999 110.41 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 16.4 ptt? -126.73 129.72 48.94 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.586 -0.524 . . . . 3.9399999999999999 109.586 172.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -157.85 142.88 16.68 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.517 -0.549 . . . . 2.4700000000000002 109.517 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 55.2 mt-10 -92.6 105.54 17.68 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.412 -0.588 . . . . 1.97 109.412 176.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -109.24 121.95 46.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.245 -0.889 . . . . 4.29 110.989 -170.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.4 p -93.13 150.79 20.26 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.935 -0.575 . . . . 2.8900000000000001 111.064 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -99.86 166.49 11.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.906 -0.588 . . . . 5.25 110.068 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.87 62.2 4.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.368 0.604 . . . . 6.0599999999999996 110.926 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.02 123.1 29.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.536 -0.757 . . . . 9.7699999999999996 109.993 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -100.37 -30.83 11.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.415 -0.357 . . . . 8.3399999999999999 110.948 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -59.88 -57.16 14.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.271 0.558 . . . . 8.1899999999999995 109.967 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 m -112.97 132.5 22.31 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 108.816 -0.809 . . . . 5.0999999999999996 108.816 172.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.39 86.12 0.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.078 1.852 . . . . 4.5099999999999998 111.785 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.456 ' HA ' HH21 ' A' ' 124' ' ' ARG . 8.3 m -81.14 95.11 6.78 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.891 0.853 . . . . 2.5899999999999999 109.517 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 124' ' ' ARG . 34.1 tttp -122.34 126.43 48.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.849 -1.069 . . . . 3.1200000000000001 109.422 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.48 HG12 ' HG2' ' A' ' 124' ' ' ARG . 22.9 m -123.27 160.24 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.27 0.557 . . . . 1.23 110.733 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 72.4 tttt -117.91 118.53 32.24 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.291 -1.003 . . . . 2.3599999999999999 108.291 171.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.697 HG12 HG12 ' A' ' 122' ' ' VAL . 6.3 m -99.25 144.22 12.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.438 0.637 . . . . 1.1100000000000001 111.606 -176.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' A' ' 91' ' ' MET . 13.9 t-80 -137.74 103.51 5.03 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.665 -1.152 . . . . 1.01 108.162 164.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.682 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 3.5 mpp? -98.94 140.03 33.72 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 106.798 -1.556 . . . . 2.2200000000000002 106.798 175.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.827 ' HG3' ' HB2' ' A' ' 119' ' ' TRP . 9.3 ptpt -141.02 125.27 17.44 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.701 -0.8 . . . . 1.73 110.09 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.64 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 82.7 tttt -57.72 106.79 0.38 Allowed 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 108.976 -0.75 . . . . 1.78 108.976 170.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.37 127.86 20.95 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.929 -1.032 . . . . 0.45000000000000001 110.323 -173.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.24 -7.12 33.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.267 0.556 . . . . 2.3900000000000001 109.895 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.1 m -71.28 -26.1 62.73 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.164 -0.925 . . . . 1.6599999999999999 110.043 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.44 145.02 18.32 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.174 -0.536 . . . . 1.52 112.973 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 55.75 38.27 29.89 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.511 0.672 . . . . 2.79 112.24 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.56 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 4.8 p -166.7 159.93 14.4 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.165 -0.925 . . . . 0.44 109.937 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.64 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 36.5 m-85 -140.48 139.57 35.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.048 -0.353 . . . . 0.41999999999999998 110.048 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.827 ' HB2' ' HG3' ' A' ' 110' ' ' LYS . 41.1 m95 -92.53 162.49 14.18 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.19 0.519 . . . . 0.41999999999999998 110.658 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.543 ' HB ' HG23 ' A' ' 31' ' ' ILE . 77.5 t -136.16 105.88 5.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.762 -1.108 . . . . 0.62 109.583 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 29.3 m-85 -109.45 123.05 48.72 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.767 -0.457 . . . . 1.49 109.767 175.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.697 HG12 HG12 ' A' ' 107' ' ' VAL . 30.0 m -118.93 157.92 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.124 0.488 . . . . 1.6100000000000001 111.527 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -152.26 115.11 4.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.546 -0.752 . . . . 3.4500000000000002 110.008 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.48 ' HG2' HG12 ' A' ' 105' ' ' VAL . 58.0 mtp180 -76.5 124.51 27.69 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.725 -0.39 . . . . 4.2300000000000004 110.418 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.462 HG13 ' OXT' ' A' ' 125' ' ' VAL 0.254 7.2 p . . . . . 0 C--O 1.253 1.289 0 O-C-N 124.86 1.35 . . . . 3.3399999999999999 113.147 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 1.001 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.93 -0.396 . . . . 8.7200000000000006 109.93 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 68.86 143.81 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 O-C-N 124.105 0.878 . . . . 6.1799999999999997 111.178 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -170.24 -68.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.813 -0.63 . . . . 6.1500000000000004 109.876 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.84 56.37 0.45 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.581 -0.736 . . . . 1.4299999999999999 111.532 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.17 107.74 13.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.982 -0.377 . . . . 0.69999999999999996 109.982 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.679 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -131.04 139.45 51.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.824 0.345 . . . . 0.90000000000000002 110.783 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.551 HE21 HD23 ' A' ' 40' ' ' LEU . 10.6 pt20 -105.22 114.5 28.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.633 0.73 . . . . 2.2200000000000002 110.395 176.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 pp -121.59 168.45 11.74 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.879 -1.055 . . . . 0.71999999999999997 109.293 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.604 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 3.1 p30 -102.19 157.55 16.81 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.95 -0.7 . . . . 1.1499999999999999 110.888 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -77.37 14.04 9.66 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.38 -0.827 . . . . 1.2 111.73 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -100.83 -12.57 18.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.27 0.557 . . . . 1.8100000000000001 109.77 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.39 9.31 25.67 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.616 -0.72 . . . . 1.05 112.985 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.53 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -109.07 143.53 38.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.065 0.46 . . . . 1.5700000000000001 110.944 -178.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.615 HG21 ' HA ' ' A' ' 58' ' ' ILE . 47.7 mm -94.09 126.63 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.141 -0.688 . . . . 1.1799999999999999 109.141 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.551 HD23 HE21 ' A' ' 32' ' ' GLN . 17.9 tp -99.56 -49.49 4.39 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.851 -0.34 . . . . 1.5600000000000001 110.996 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.585 ' O ' HG12 ' A' ' 31' ' ' ILE . 33.3 tt0 -157.6 142.94 17.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.813 0.34 . . . . 2.4100000000000001 111.292 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.679 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 79.0 t80 -124.68 133.87 53.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.995 -0.548 . . . . 1.4199999999999999 109.844 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -79.73 92.89 5.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.142 -0.688 . . . . 1.21 109.142 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.54 -55.33 4.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.744 -0.662 . . . . 2.5 111.387 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.91 148.66 28.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.224 -0.443 . . . . 4.0 110.881 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -130.97 90.0 2.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.987 -0.551 . . . . 7.21 109.639 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.66 -48.67 2.64 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.063 -0.517 . . . . 6.9699999999999998 112.757 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.83 122.24 23.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.717 0.294 . . . . 8.5899999999999999 110.739 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.2 pt -112.37 47.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.231 0.539 . . . . 9.2400000000000002 111.783 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 21.4 m -82.48 80.99 8.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.209 0.528 . . . . 9.8200000000000003 110.881 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.51 -134.74 9.83 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.571 -0.824 . . . . 9.6199999999999992 112.754 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -136.22 167.53 21.11 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.14 -0.318 . . . . 12.720000000000001 110.14 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 5.9 p-10 -95.42 159.44 32.71 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.562 -0.903 . . . . 8.2400000000000002 108.562 171.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 53' ' ' ASP . 13.7 Cg_endo -57.83 -49.59 12.64 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.418 2.079 . . . . 8.1099999999999994 113.008 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.3 pttp 32.32 77.82 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.713 0.805 . . . . 9.2400000000000002 112.441 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -157.09 -71.1 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.315 -0.857 . . . . 7.4000000000000004 110.319 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -92.41 -27.95 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.684 -0.689 . . . . 5.0599999999999996 110.676 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.615 ' HA ' HG21 ' A' ' 39' ' ' ILE . 46.8 pt -69.08 157.76 6.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.175 0.512 . . . . 3.1699999999999999 111.882 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.49 37.73 90.17 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.311 -0.858 . . . . 3.2400000000000002 111.668 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -100.86 122.24 43.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.641 0.258 . . . . 3.8500000000000001 111.039 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -124.61 125.56 44.35 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.496 -0.557 . . . . 4.1799999999999997 109.496 173.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -160.18 109.46 1.76 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.63 -0.714 . . . . 6.6600000000000001 109.44 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -104.95 28.33 7.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.086 0.402 . . . . 8.1300000000000008 112.086 -171.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -116.4 92.25 3.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.128 -0.693 . . . . 10.050000000000001 109.128 174.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -77.3 172.37 13.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.34 -0.845 . . . . 7.9400000000000004 110.844 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.4 t 62.17 57.3 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 122.399 1.095 . . . . 9.3499999999999996 108.871 -172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.653 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -152.64 -50.36 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 114.677 -1.147 . . . . 9.1600000000000001 110.974 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 23.9 Cg_exo -65.8 156.57 63.42 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.829 1.686 . . . . 10.35 112.01 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.3 m -70.96 109.48 5.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.218 -0.446 . . . . 11.49 111.16 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.6 t -69.75 -35.77 75.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.924 -0.399 . . . . 10.949999999999999 109.924 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.5 t70 61.04 -92.12 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.542 0.737 . . . . 11.56 111.659 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.7 t -139.26 124.26 11.65 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.212 -0.662 . . . . 10.960000000000001 109.212 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 72.3 Cg_endo -76.11 11.83 1.66 Allowed 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.75 2.3 . . . . 10.68 113.459 -174.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -84.35 -21.61 30.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 11.76 111.85 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -53.06 146.48 11.18 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 -173.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 69.79 -80.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.709 -1.132 . . . . 7.5300000000000002 110.98 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -158.65 54.32 0.37 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.511 -1.036 . . . . 3.2000000000000002 110.511 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 73' ' ' PRO . 35.2 mtmm 59.86 69.22 0.72 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.2 0.524 . . . . 4.1399999999999997 109.701 -170.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.507 ' O ' HG23 ' A' ' 83' ' ' VAL . 74.8 t80 -53.46 -40.42 65.24 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.14 -0.936 . . . . 0.94999999999999996 111.848 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -62.46 -30.82 71.52 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 123.679 0.612 . . . . 3.48 110.653 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -80.03 -35.24 37.51 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.085 -0.709 . . . . 3.0699999999999998 109.085 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.976 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -62.08 -42.72 99.74 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.513 -0.767 . . . . 0.55000000000000004 111.695 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 79' ' ' PHE . 84.1 t -65.81 -51.24 64.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.753 -0.724 . . . . 0.84999999999999998 110.682 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.37 -21.65 55.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 1.1200000000000001 110.853 -172.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.8 t -65.87 -35.61 81.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.899 -0.591 . . . . 1.8799999999999999 109.431 171.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.94 15.28 63.25 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.335 -0.706 . . . . 1.6599999999999999 111.335 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.741 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 3.0 p30 -166.02 62.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.785 0.802 . . . . 2.0800000000000001 110.833 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.976 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.2 tt -68.86 98.24 0.91 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.048 -0.978 . . . . 0.56000000000000005 110.603 172.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.638 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.0 p-10 -143.25 101.35 3.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.265 -0.574 . . . . 2.0099999999999998 110.867 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.9 t -154.97 162.47 41.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 120.946 0.403 . . . . 1.6699999999999999 110.608 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -130.0 116.05 18.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.694 -0.684 . . . . 3.9399999999999999 109.877 175.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -126.68 134.13 50.78 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.015 -0.735 . . . . 2.4700000000000002 109.015 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.709 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 7.1 pt-20 -106.13 117.27 33.59 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.908 -0.717 . . . . 1.97 110.361 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -109.27 128.54 55.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.763 -1.108 . . . . 4.29 109.873 -173.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 9.1 m -100.22 105.08 16.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.681 -0.691 . . . . 2.8900000000000001 109.748 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 102' ' ' PRO . 77.8 m-85 -69.29 92.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 5.25 110.382 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.3 75.48 9.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 6.0599999999999996 109.338 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -139.58 145.06 38.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.425 -0.807 . . . . 9.7699999999999996 109.265 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 61.19 -145.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 O-C-N 123.598 0.561 . . . . 8.3399999999999999 109.931 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 89.1 mmm -106.11 -3.75 21.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.801 0.334 . . . . 8.1899999999999995 110.922 177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.2 m -115.01 96.26 44.47 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.231 -0.441 . . . . 5.0999999999999996 111.044 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 96' ' ' PHE . 6.2 Cg_exo -78.16 103.81 1.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.916 2.411 . . . . 4.5099999999999998 111.989 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.427 HG22 HG13 ' A' ' 105' ' ' VAL . 36.4 m -80.56 99.27 8.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.163 0.506 . . . . 2.5899999999999999 110.257 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 59.6 tttm -95.43 103.27 15.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.874 -0.603 . . . . 3.1200000000000001 109.946 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 20.0 m -121.22 161.98 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.131 0.491 . . . . 1.23 111.803 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.789 ' HE2' HG13 ' A' ' 125' ' ' VAL . 47.0 mttm -108.5 138.28 45.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.525 -0.761 . . . . 2.3599999999999999 109.638 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -107.87 102.54 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.8 -0.444 . . . . 1.1100000000000001 109.8 167.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.787 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 8.3 t-160 -96.18 101.95 13.67 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.838 -1.542 . . . . 1.01 106.838 168.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.638 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 8.8 ttt -111.64 113.58 26.06 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.715 -1.216 . . . . 2.2200000000000002 107.715 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 18.4 ptpt -129.59 132.14 46.69 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.3 -0.56 . . . . 1.73 110.564 -168.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.741 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 81.2 tttt -56.88 117.88 4.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 109.03 -0.73 . . . . 1.78 109.03 167.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -45.46 142.72 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.185 0.928 . . . . 0.45000000000000001 110.767 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.8 tp -63.94 -25.83 68.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.202 -0.454 . . . . 2.3900000000000001 110.691 -173.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.0 m -81.71 -50.81 8.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.961 -0.563 . . . . 1.6599999999999999 109.811 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 128.31 -179.92 16.27 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.977 -0.63 . . . . 1.52 112.756 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.0 t70 61.64 31.6 18.66 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.944 0.878 . . . . 2.79 111.475 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 4.9 p 179.98 156.5 0.64 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.582 -1.19 . . . . 0.44 110.415 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.448 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 43.6 m-85 -136.17 134.74 38.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.469 -0.567 . . . . 0.41999999999999998 109.469 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.561 ' O ' ' HA ' ' A' ' 109' ' ' MET . 47.3 m95 -86.52 163.87 17.25 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.291 0.567 . . . . 0.41999999999999998 112.026 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.498 HG22 ' HE3' ' A' ' 109' ' ' MET . 60.0 t -132.12 97.42 2.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.387 -1.279 . . . . 0.62 109.037 174.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.787 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 58.3 m-85 -98.81 105.49 17.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.797 -0.446 . . . . 1.49 109.797 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 17.9 m -110.99 135.6 49.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.07 0.462 . . . . 1.6100000000000001 111.482 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -150.46 138.57 20.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.607 -0.724 . . . . 3.4500000000000002 109.288 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -89.41 92.46 9.14 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.254 0.55 . . . . 4.2300000000000004 110.646 178.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.789 HG13 ' HE2' ' A' ' 106' ' ' LYS . 8.2 p . . . . . 0 C--O 1.249 1.068 0 CA-C-N 115.149 -0.932 . . . . 3.3399999999999999 109.733 -175.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 1.002 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 tp . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.806 -0.442 . . . . 8.7200000000000006 109.806 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.84 119.3 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.228 0.33 . . . . 6.1799999999999997 110.213 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.424 ' HZ ' ' HG2' ' A' ' 124' ' ' ARG . 48.3 t80 -140.25 151.83 45.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.429 -0.35 . . . . 6.1500000000000004 110.522 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 90.73 -109.62 3.7 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.956 -0.64 . . . . 1.4299999999999999 112.174 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.82 109.64 18.48 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.449 0.642 . . . . 0.69999999999999996 111.413 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.594 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 4.7 tt -138.57 140.38 39.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.857 -0.611 . . . . 0.90000000000000002 110.051 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.696 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 2.8 pt20 -114.74 143.4 45.12 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.447 0.641 . . . . 2.2200000000000002 110.712 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.542 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.0 pp -124.08 157.34 34.78 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.05 -0.977 . . . . 0.71999999999999997 109.504 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.807 ' HB3' HD23 ' A' ' 40' ' ' LEU . 4.5 p30 -79.82 158.56 26.77 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.254 0.55 . . . . 1.1499999999999999 110.439 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.42 21.1 3.05 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.594 -0.73 . . . . 1.2 111.884 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 34' ' ' ASP . 23.8 t70 -106.06 -32.37 8.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.342 -0.614 . . . . 1.8100000000000001 109.342 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.67 11.16 3.03 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.417 -0.81 . . . . 1.05 112.485 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -118.78 155.89 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.687 -0.486 . . . . 1.5700000000000001 109.687 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.91 HG12 ' HB3' ' A' ' 60' ' ' LYS . 43.4 mm -70.5 136.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.967 -0.753 . . . . 1.1799999999999999 108.967 174.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.807 HD23 ' HB3' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -102.17 -65.24 1.0 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.023 -0.732 . . . . 1.5600000000000001 109.023 -173.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -145.25 134.88 23.37 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.318 -0.855 . . . . 2.4100000000000001 111.127 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.594 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 52.1 t80 -113.1 119.52 38.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.614 . . . . 1.4199999999999999 109.941 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.93 101.9 9.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.53 0.681 . . . . 1.21 110.766 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.15 106.63 10.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.426 -0.806 . . . . 2.5 110.523 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.95 130.2 45.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.914 -0.585 . . . . 4.0 110.151 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.59 88.72 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.892 -0.595 . . . . 7.21 112.295 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.94 17.39 11.86 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 109.736 -1.346 . . . . 6.9699999999999998 109.736 169.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -122.39 154.22 38.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.611 -0.794 . . . . 8.5899999999999999 109.914 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.6 mt -87.68 71.18 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.672 0.749 . . . . 9.2400000000000002 109.574 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.9 t -152.79 173.52 15.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.282 -0.872 . . . . 9.8200000000000003 109.722 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.437 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . -71.72 -81.02 0.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.025 -0.607 . . . . 9.6199999999999992 111.651 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 51' ' ' GLY . 13.0 mmm180 -126.4 166.76 16.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.733 -0.469 . . . . 12.720000000000001 109.733 172.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.559 ' OD2' ' HG2' ' A' ' 55' ' ' LYS . 49.4 t0 -125.8 89.08 53.12 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.615 -0.513 . . . . 8.2400000000000002 109.615 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -97.2 23.74 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.32 2.68 . . . . 8.1099999999999994 113.243 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' OD2' ' A' ' 53' ' ' ASP . 9.8 ptpp? -111.72 166.73 10.93 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.944 -0.391 . . . . 9.2400000000000002 109.944 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 56' ' ' GLN . 28.2 tt0 67.72 25.16 8.15 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.954 0.883 . . . . 7.4000000000000004 110.535 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 58' ' ' ILE . 16.5 t -89.61 155.15 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.657 -0.701 . . . . 5.0599999999999996 109.4 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.46 ' N ' HG12 ' A' ' 57' ' ' VAL . 22.8 pt 38.13 64.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.278 1.031 . . . . 3.1699999999999999 113.104 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.57 -30.38 56.51 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.38 -1.282 . . . . 3.2400000000000002 112.448 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.91 ' HB3' HG12 ' A' ' 39' ' ' ILE . 25.3 ttmm -107.39 134.55 50.27 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 122.811 -0.229 . . . . 3.8500000000000001 110.867 -177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -158.53 101.41 1.68 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.191 -0.459 . . . . 4.1799999999999997 110.203 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -60.66 110.85 1.4 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 6.6600000000000001 110.881 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -121.5 -58.2 1.78 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.5 . . . . 8.1300000000000008 110.563 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HE2' HG11 ' A' ' 66' ' ' VAL . 19.6 ptmt -100.34 120.18 39.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.306 0.574 . . . . 10.050000000000001 110.69 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.64 29.21 1.18 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.879 -0.6 . . . . 7.9400000000000004 110.86 -176.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.45 HG11 ' HE2' ' A' ' 64' ' ' LYS . 14.2 p -56.15 -30.34 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.744 -0.662 . . . . 9.3499999999999996 110.756 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 69.48 95.84 0.05 OUTLIER Pre-proline 0 C--N 1.342 0.263 0 C-N-CA 123.507 0.723 . . . . 9.1600000000000001 110.566 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.05 148.79 91.41 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.807 2.338 . . . . 10.35 111.421 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.1 m -70.98 -21.55 62.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.24 0.543 . . . . 11.49 109.783 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 m -136.01 132.98 36.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.787 -0.642 . . . . 10.949999999999999 110.167 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -162.0 154.61 19.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.82 -0.807 . . . . 11.56 108.82 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 p -142.44 88.68 8.74 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.132 0.419 . . . . 10.960000000000001 112.132 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.96 103.63 1.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.962 2.441 . . . . 10.68 111.074 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 8.3 tp10 -109.49 169.65 8.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.108 -0.496 . . . . 11.76 110.052 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 74' ' ' GLU . 74.9 m-85 76.08 23.68 1.25 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.851 0.719 . . . . 10.0 111.819 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -72.38 126.8 30.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.847 -0.615 . . . . 7.5300000000000002 109.682 171.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -110.86 -80.17 1.09 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 119.669 -1.253 . . . . 3.2000000000000002 110.065 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -130.43 61.29 1.6 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.857 -1.164 . . . . 4.1399999999999997 107.857 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.591 ' HA ' HD11 ' A' ' 88' ' ' LEU . 36.2 t80 -86.54 -37.75 17.87 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 116.352 -0.386 . . . . 0.94999999999999996 111.039 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -67.81 -32.04 72.32 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.383 -0.969 . . . . 3.48 108.383 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -82.49 -39.12 22.91 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.776 -1.556 . . . . 3.0699999999999998 108.987 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.603 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -54.79 -38.11 63.63 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.13 -0.941 . . . . 0.55000000000000004 112.364 -174.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 79' ' ' PHE . 61.8 t -69.19 -51.04 47.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.582 -0.809 . . . . 0.84999999999999998 110.786 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.89 -23.43 23.95 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.173 -0.467 . . . . 1.1200000000000001 112.253 -169.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.4 p -73.93 -33.3 63.89 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.828 -1.175 . . . . 1.8799999999999999 107.828 172.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.88 19.2 65.95 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.082 -0.963 . . . . 1.6599999999999999 111.13 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -153.78 52.3 0.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.554 0.693 . . . . 2.0800000000000001 112.084 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.603 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -67.24 86.45 0.16 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.53 -0.759 . . . . 0.56000000000000005 111.24 174.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.6 p30 -144.25 100.67 3.59 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.337 0.589 . . . . 2.0099999999999998 109.768 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.8 m -148.76 146.99 28.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.88 -0.513 . . . . 1.6699999999999999 109.992 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 17.9 ptm -98.76 114.86 27.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.613 -0.884 . . . . 3.9399999999999999 108.613 167.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -121.73 129.67 52.88 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.373 -0.83 . . . . 2.4700000000000002 109.418 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.527 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 22.3 mp0 -90.58 118.94 30.43 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.477 -0.934 . . . . 1.97 108.477 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -107.64 98.84 8.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.77 -0.65 . . . . 4.29 109.486 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.1 m -82.08 142.38 32.35 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.361 -0.836 . . . . 2.8900000000000001 110.688 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.79 -36.34 6.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.18 -0.674 . . . . 5.25 109.18 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 102' ' ' PRO . 24.1 t0 -166.89 163.13 16.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.545 -0.752 . . . . 6.0599999999999996 109.434 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -132.26 -8.58 3.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.334 -0.393 . . . . 9.7699999999999996 110.903 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -95.13 -66.58 0.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.82 0.343 . . . . 8.3399999999999999 110.652 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 46.0 ttm -84.18 -54.92 4.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.914 -0.585 . . . . 8.1899999999999995 110.067 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.8 m -121.53 93.46 48.72 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.771 -0.649 . . . . 5.0999999999999996 109.939 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 91.1 Cg_endo -81.58 24.88 0.67 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.874 2.383 . . . . 4.5099999999999998 112.644 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.7 m -76.42 97.74 4.37 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.56 0.695 . . . . 2.5899999999999999 110.357 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.527 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 37.0 ttpt -100.2 133.29 44.83 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.352 -0.84 . . . . 3.1200000000000001 110.018 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.3 m -102.15 161.92 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.298 0.57 . . . . 1.23 110.929 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 39.1 ttmt -116.37 126.72 53.88 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.241 -0.891 . . . . 2.3599999999999999 109.494 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -102.64 103.7 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.865 -0.607 . . . . 1.1100000000000001 109.411 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.954 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 5.7 t-160 -90.08 101.07 13.79 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.169 -1.789 . . . . 1.01 106.169 167.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.719 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.5 OUTLIER -102.2 120.46 40.49 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.294 -1.372 . . . . 2.2200000000000002 107.294 -178.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -135.79 119.36 17.02 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 119.943 -0.703 . . . . 1.73 111.143 -165.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.481 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 81.2 tttt -55.81 116.48 2.97 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.152 0.501 . . . . 1.78 110.276 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 145.84 45.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.62 -1.173 . . . . 0.45000000000000001 111.243 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.9 mm? -77.18 -8.08 56.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.867 -0.606 . . . . 2.3900000000000001 110.131 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 t -80.32 -45.53 17.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.062 -0.517 . . . . 1.6599999999999999 110.007 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.49 149.68 8.32 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.898 -0.667 . . . . 1.52 112.699 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 52.23 37.65 22.56 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.657 0.742 . . . . 2.79 111.644 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.0 p -159.98 154.03 23.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.845 -1.07 . . . . 0.44 109.761 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 66.2 m-85 -141.35 137.31 32.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.394 -0.366 . . . . 0.41999999999999998 110.27 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.696 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 44.3 m95 -88.24 164.18 15.75 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.471 0.653 . . . . 0.41999999999999998 111.65 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.7 t -136.21 96.1 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.017 -1.447 . . . . 0.62 108.391 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.954 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 63.5 m-85 -94.53 102.53 14.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.944 -1.132 . . . . 1.49 107.944 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 10.3 p -97.72 134.28 36.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.193 0.521 . . . . 1.6100000000000001 111.132 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -134.74 127.43 30.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.992 -0.549 . . . . 3.4500000000000002 109.729 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.424 ' HG2' ' HZ ' ' A' ' 28' ' ' PHE . 10.0 ptm180 -97.66 151.18 20.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.912 0.387 . . . . 4.2300000000000004 111.028 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.409 -0.805 . . . . 3.3399999999999999 110.264 172.386 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.994 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.7 tp . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 110.58 -0.156 . . . . 8.7200000000000006 110.58 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 123' ' ' LYS . . . 68.95 -76.79 0.06 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.894 0.746 . . . . 6.1799999999999997 112.41 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -105.2 97.61 7.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.189 0.518 . . . . 6.1500000000000004 110.994 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -112.47 45.82 1.26 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.24 -0.891 . . . . 1.4299999999999999 111.889 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.25 103.4 15.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.969 0.414 . . . . 0.69999999999999996 111.073 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.53 HD11 HG23 ' A' ' 39' ' ' ILE . 5.7 tt -135.39 140.59 44.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.159 0.504 . . . . 0.90000000000000002 111.212 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.484 ' HB3' ' CE2' ' A' ' 119' ' ' TRP . 12.3 pt20 -109.6 121.09 44.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.656 -0.702 . . . . 2.2200000000000002 110.353 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 pp -123.15 152.34 41.26 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.078 -0.51 . . . . 0.71999999999999997 110.833 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 0.0 OUTLIER -70.93 154.13 42.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.762 -0.654 . . . . 1.1499999999999999 110.142 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.516 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -76.79 31.17 1.49 Allowed Glycine 0 C--O 1.234 0.096 0 CA-C-N 115.781 -0.645 . . . . 1.2 113.31 -173.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 34' ' ' ASP . 12.4 t70 -135.44 -33.51 0.88 Allowed 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 122.84 0.456 . . . . 1.8100000000000001 110.204 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.59 18.84 0.53 Allowed Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.473 -0.87 . . . . 1.05 113.051 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 30.8 m-80 -107.68 128.87 54.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.603 0.239 . . . . 1.5700000000000001 110.789 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.605 HG21 ' HA ' ' A' ' 58' ' ' ILE . 46.9 mm -78.9 115.6 21.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.722 -0.217 . . . . 1.1799999999999999 110.512 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.86 -47.44 9.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.072 0.463 . . . . 1.5600000000000001 110.575 -173.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -159.34 142.39 14.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.911 -0.586 . . . . 2.4100000000000001 111.416 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 27.5 t80 -114.44 117.59 31.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.656 -0.702 . . . . 1.4199999999999999 110.191 -177.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -100.52 91.73 4.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.855 -0.424 . . . . 1.21 109.855 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -174.63 98.94 0.09 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.843 -0.617 . . . . 2.5 110.518 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.83 90.6 5.88 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.522 -0.547 . . . . 4.0 109.522 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.33 6.77 16.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.736 -0.666 . . . . 7.21 110.406 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.8 -74.91 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.044 -0.98 . . . . 6.9699999999999998 111.266 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -152.23 159.89 43.47 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.213 -0.292 . . . . 8.5899999999999999 110.213 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.5 mt -51.99 -51.57 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.648 -0.705 . . . . 9.2400000000000002 110.275 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.6 m -82.49 62.95 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.7 0.762 . . . . 9.8200000000000003 110.02 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.01 76.33 2.21 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.451 -0.795 . . . . 9.6199999999999992 112.71 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -80.27 51.73 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.307 0.575 . . . . 12.720000000000001 110.162 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -93.58 117.6 67.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.754 -0.657 . . . . 8.2400000000000002 110.553 -175.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -83.83 8.18 4.77 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.789 2.326 . . . . 8.1099999999999994 113.047 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.773 ' HA ' ' HE3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -118.36 14.38 13.77 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.397 0.617 . . . . 9.2400000000000002 111.303 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.89 0.31 25.78 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.163 -0.926 . . . . 7.4000000000000004 109.548 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 39' ' ' ILE . 11.3 t 52.48 59.31 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.169 -0.923 . . . . 5.0599999999999996 109.697 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.605 ' HA ' HG21 ' A' ' 39' ' ' ILE . 29.9 pt -134.61 166.37 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.476 -0.784 . . . . 3.1699999999999999 111.184 -177.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.29 32.65 62.4 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.175 -0.921 . . . . 3.2400000000000002 112.75 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 2.9 tppp? -111.23 96.38 6.09 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.995 0.426 . . . . 3.8500000000000001 110.637 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -115.76 96.44 5.61 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.047 0.451 . . . . 4.1799999999999997 110.384 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -129.73 152.37 49.3 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.309 -0.997 . . . . 6.6600000000000001 108.309 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -78.72 -5.17 52.46 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.723 -0.391 . . . . 8.1300000000000008 111.883 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -173.1 120.94 0.36 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.104 0.478 . . . . 10.050000000000001 111.056 174.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -86.54 -26.05 24.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.356 0.598 . . . . 7.9400000000000004 109.632 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.8 t 58.63 56.8 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.83 -1.077 . . . . 9.3499999999999996 110.438 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.41 83.51 9.85 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.871 -1.059 . . . . 9.1600000000000001 109.878 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.41 -39.47 2.79 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.526 2.151 . . . . 10.35 112.424 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 49.0 t -150.23 96.28 2.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.401 . . . . 11.49 110.776 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 m -135.23 -62.47 0.71 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.856 0.36 . . . . 10.949999999999999 110.226 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -158.64 151.08 21.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 11.56 109.74 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.9 m -121.27 100.64 44.96 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.853 0.358 . . . . 10.960000000000001 110.474 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.1 -17.79 27.86 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.58 2.187 . . . . 10.68 111.567 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.66 151.02 40.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.386 -0.825 . . . . 11.76 109.374 177.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -87.78 96.23 10.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.45 0.643 . . . . 10.0 110.999 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.812 ' HB3' ' HB2' ' A' ' 79' ' ' PHE . 77.9 m-85 -82.64 137.18 34.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.387 -0.824 . . . . 7.5300000000000002 109.35 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.08 -75.01 1.14 Allowed Glycine 0 CA--C 1.506 -0.513 0 C-N-CA 119.819 -1.181 . . . . 3.2000000000000002 112.071 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.16 8.95 39.78 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 110.392 -0.225 . . . . 4.1399999999999997 110.392 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.812 ' HB2' ' HB3' ' A' ' 76' ' ' TYR . 6.1 t80 -49.93 -36.06 26.27 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.749 0.648 . . . . 0.94999999999999996 112.749 -168.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 57.4 mmtt -66.54 -30.42 70.73 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 121.394 0.616 . . . . 3.48 110.952 -177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -89.26 -41.5 12.15 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.876 -0.787 . . . . 3.0699999999999998 108.876 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.828 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -51.41 -40.99 47.45 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.142 -0.935 . . . . 0.55000000000000004 112.565 -173.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 79' ' ' PHE . 85.7 t -64.89 -52.08 58.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.463 -0.869 . . . . 0.84999999999999998 110.942 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.07 -29.84 21.59 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.101 -0.5 . . . . 1.1200000000000001 112.323 -168.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.8 p -72.94 -29.53 63.17 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.708 -0.849 . . . . 1.8799999999999999 108.708 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.03 26.0 65.38 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.828 -0.909 . . . . 1.6599999999999999 110.828 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -148.56 49.3 1.02 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.89 0.853 . . . . 2.0800000000000001 111.759 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.828 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -71.79 78.4 0.86 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.142 -0.935 . . . . 0.56000000000000005 111.644 176.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 109' ' ' MET . 5.5 p-10 -144.23 98.44 3.21 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.454 0.645 . . . . 2.0099999999999998 109.787 174.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 91' ' ' MET . 4.1 m -149.16 157.43 43.37 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.789 -0.448 . . . . 1.6699999999999999 109.789 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.5 ptt? -117.52 138.19 52.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.331 -0.395 . . . . 3.9399999999999999 109.941 173.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -161.84 149.61 14.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.275 -0.639 . . . . 2.4700000000000002 109.275 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.582 ' HG3' ' HD3' ' A' ' 106' ' ' LYS . 10.5 mp0 -92.28 121.02 33.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.599 -0.519 . . . . 1.97 109.599 176.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -113.62 137.95 50.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.27 -0.423 . . . . 4.29 110.336 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.2 t -125.94 150.9 47.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.211 -0.45 . . . . 2.8900000000000001 110.822 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -130.11 7.17 5.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.232 0.539 . . . . 5.25 110.359 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -159.16 136.77 10.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.178 -0.919 . . . . 6.0599999999999996 108.634 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -138.28 158.64 43.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.41 -0.359 . . . . 9.7699999999999996 111.869 -169.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 68.81 -59.84 0.46 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.201 0.938 . . . . 8.3399999999999999 112.01 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 65.2 mtt -60.41 -50.15 74.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.387 0.613 . . . . 8.1899999999999995 110.071 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.38 150.25 75.04 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.329 -0.851 . . . . 5.0999999999999996 110.471 175.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -91.55 45.03 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.323 2.682 . . . . 4.5099999999999998 112.058 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.1 m -71.76 97.19 1.73 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.447 0.641 . . . . 2.5899999999999999 110.396 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HD2' HG21 ' A' ' 125' ' ' VAL . 26.8 ttmt -126.89 111.61 14.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.503 -0.771 . . . . 3.1200000000000001 109.103 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 27.3 m -104.17 159.49 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.295 0.569 . . . . 1.23 111.229 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.582 ' HD3' ' HG3' ' A' ' 93' ' ' GLU . 55.0 mmtt -101.73 120.61 40.63 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.085 -0.962 . . . . 2.3599999999999999 108.668 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.557 HG12 ' HG3' ' A' ' 109' ' ' MET . 2.1 t -97.21 102.02 12.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.172 -0.677 . . . . 1.1100000000000001 109.172 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 5.5 t-160 -101.31 103.56 14.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.765 -1.198 . . . . 1.01 107.765 170.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 62.0 mtt -106.67 144.18 33.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.058 -1.09 . . . . 2.2200000000000002 108.058 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.6 ptpt -147.97 130.77 16.07 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.146 -0.621 . . . . 1.73 109.76 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.551 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 63.2 tttp -57.76 111.53 1.17 Allowed 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 109.038 -0.727 . . . . 1.78 109.038 168.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.63 144.75 13.21 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.781 -1.1 . . . . 0.45000000000000001 110.085 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.39 -17.99 63.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.003 0.43 . . . . 2.3900000000000001 110.098 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.2 m -63.0 -40.33 97.45 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.493 -0.776 . . . . 1.6599999999999999 110.354 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.66 -61.8 0.4 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.72 -0.752 . . . . 1.52 113.475 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -87.45 41.42 0.98 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.438 0.637 . . . . 2.79 112.202 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.516 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.1 p -166.92 159.28 13.3 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.741 -0.663 . . . . 0.44 110.806 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.551 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 72.7 m-85 -139.06 135.63 34.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.835 -0.621 . . . . 0.41999999999999998 109.615 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.484 ' CE2' ' HB3' ' A' ' 32' ' ' GLN . 42.2 m95 -87.77 163.13 16.64 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.352 0.596 . . . . 0.41999999999999998 112.044 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.95 111.08 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.144 -1.389 . . . . 0.62 108.828 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 83.8 m-85 -111.9 110.08 20.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.529 -0.545 . . . . 1.49 109.529 174.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.34 125.03 63.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.585 0.231 . . . . 1.6100000000000001 110.77 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 27' ' ' ALA . 97.1 mttt -144.63 137.81 26.93 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 108.966 -0.753 . . . . 3.4500000000000002 108.966 177.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 105' ' ' VAL . 14.0 ptt180 -81.68 155.63 25.47 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.285 0.564 . . . . 4.2300000000000004 111.102 -175.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.443 HG21 ' HD2' ' A' ' 104' ' ' LYS . 61.4 t . . . . . 0 C--O 1.248 0.98 0 CA-C-N 115.37 -0.832 . . . . 3.3399999999999999 109.291 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 1.018 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.855 0.36 . . . . 8.7200000000000006 110.894 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 43' ' ' ASN . . . -74.3 -34.95 63.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.923 -0.58 . . . . 6.1799999999999997 110.696 175.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -63.22 129.19 39.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.432 -0.349 . . . . 6.1500000000000004 110.158 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.63 -21.82 29.55 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.944 -0.863 . . . . 1.4299999999999999 110.944 -172.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.91 106.77 16.45 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.003 0.43 . . . . 0.69999999999999996 111.156 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.441 HG23 ' HB ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -123.88 139.39 50.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.641 -0.503 . . . . 0.90000000000000002 109.641 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.696 HE21 HD23 ' A' ' 40' ' ' LEU . 21.0 pt20 -110.48 126.57 54.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.786 -0.643 . . . . 2.2200000000000002 110.529 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.56 163.35 21.15 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.548 -0.751 . . . . 0.71999999999999997 110.046 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 45.9 p30 -87.06 165.93 15.41 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.47 0.653 . . . . 1.1499999999999999 110.97 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.573 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -77.16 27.91 1.71 Allowed Glycine 0 C--N 1.319 -0.409 0 CA-C-N 115.251 -0.886 . . . . 1.2 112.243 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 34' ' ' ASP . 20.5 t70 -127.22 -8.97 5.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.084 0.469 . . . . 1.8100000000000001 110.433 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.06 11.27 43.31 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.866 -0.683 . . . . 1.05 112.151 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.485 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -106.42 148.25 28.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.823 0.344 . . . . 1.5700000000000001 110.195 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 31' ' ' ILE . 45.5 mm -84.22 129.45 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.548 -0.538 . . . . 1.1799999999999999 109.548 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.696 HD23 HE21 ' A' ' 32' ' ' GLN . 29.5 tp -96.91 -48.59 5.37 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.954 -0.388 . . . . 1.5600000000000001 109.954 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 31.5 tp60 -163.55 121.87 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.229 0.538 . . . . 2.4100000000000001 111.096 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.427 ' H ' HD13 ' A' ' 58' ' ' ILE . 77.2 t80 -89.72 123.92 34.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.444 -0.947 . . . . 1.4199999999999999 108.444 170.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.585 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 49.7 m-80 -81.94 112.93 19.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.218 0.532 . . . . 1.21 110.327 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.84 141.23 37.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.88 -0.6 . . . . 2.5 109.683 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.85 128.35 36.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.724 0.297 . . . . 4.0 110.859 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -68.54 99.4 0.97 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.827 -0.624 . . . . 7.21 110.664 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.05 -88.68 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.835 -0.697 . . . . 6.9699999999999998 111.866 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -145.69 116.37 7.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.612 0.244 . . . . 8.5899999999999999 111.275 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.7 mt -71.72 -37.44 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.415 -0.957 . . . . 9.2400000000000002 108.415 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 50' ' ' THR . 12.5 t 43.38 69.27 0.41 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.384 -1.28 . . . . 9.8200000000000003 112.728 176.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.26 158.63 8.18 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.154 -0.93 . . . . 9.6199999999999992 112.327 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 52' ' ' ARG . 5.3 ptp85 -87.22 88.46 7.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.432 0.634 . . . . 12.720000000000001 110.161 176.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.582 ' OD1' ' HG3' ' A' ' 55' ' ' LYS . 6.9 t0 -76.65 128.97 80.7 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.503 -0.771 . . . . 8.2400000000000002 110.275 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.18 39.29 0.59 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.083 2.522 . . . . 8.1099999999999994 113.057 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.582 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 46.9 mttp -81.86 99.39 9.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.891 0.377 . . . . 9.2400000000000002 111.418 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -103.71 5.58 36.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.272 0.558 . . . . 7.4000000000000004 109.893 172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 57' ' ' VAL . 10.0 p -86.14 36.16 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 123.092 1.425 . . . . 5.0599999999999996 109.956 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 42' ' ' TYR . 7.7 tp -154.59 149.69 12.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.56 -1.2 . . . . 3.1699999999999999 109.265 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 58' ' ' ILE . . . 77.49 17.63 78.88 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.356 -0.698 . . . . 3.2400000000000002 111.356 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 2.8 tppp? -90.01 94.23 9.71 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.867 0.365 . . . . 3.8500000000000001 110.028 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -133.43 96.37 3.7 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.458 -0.941 . . . . 4.1799999999999997 108.458 172.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -165.48 135.92 3.7 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.981 -1.009 . . . . 6.6600000000000001 108.286 -170.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -81.79 37.02 0.46 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.127 0.489 . . . . 8.1300000000000008 111.265 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 64' ' ' LYS . 26.9 tptt -167.97 168.89 11.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.501 -0.772 . . . . 10.050000000000001 109.012 178.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.9 t70 62.0 71.67 0.53 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.832 0.825 . . . . 7.9400000000000004 110.964 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 m -113.98 -39.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.062 -0.972 . . . . 9.3499999999999996 109.634 176.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -112.05 115.88 49.97 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.755 -0.657 . . . . 9.1600000000000001 109.579 175.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.13 -49.77 15.89 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.857 2.371 . . . . 10.35 112.67 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.424 ' HB3' ' H ' ' A' ' 70' ' ' THR . 18.2 m -151.0 -159.9 1.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.512 . . . . 11.49 110.34 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.424 ' H ' ' HB3' ' A' ' 69' ' ' CYS . 6.1 m -64.61 121.11 13.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.983 0.364 . . . . 10.949999999999999 111.983 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.6 t70 66.59 107.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.968 0.793 . . . . 11.56 112.751 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.0 t -141.56 101.78 6.03 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.052 -0.522 . . . . 10.960000000000001 109.876 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.59 54.4 3.42 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.354 2.703 . . . . 10.68 112.053 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.62 -6.43 58.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.556 0.694 . . . . 11.76 109.817 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.659 ' HB3' ' H ' ' A' ' 79' ' ' PHE . 39.2 m-85 -81.52 101.64 10.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.54 -0.754 . . . . 10.0 109.77 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.439 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 63.6 m-85 -62.24 -69.43 0.25 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.564 . . . . 7.5300000000000002 112.117 -173.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -90.86 39.43 3.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.579 -0.82 . . . . 3.2000000000000002 112.183 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 78' ' ' LYS . 23.5 ttmt 53.65 70.22 0.62 Allowed 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.691 0.758 . . . . 4.1399999999999997 109.543 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.659 ' H ' ' HB3' ' A' ' 75' ' ' PHE . 71.7 t80 -50.1 -36.17 28.46 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.725 -1.125 . . . . 0.94999999999999996 113.071 -166.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -72.38 -25.01 61.35 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.123 0.487 . . . . 3.48 110.557 -173.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -82.19 -31.52 30.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.138 -0.69 . . . . 3.0699999999999998 109.138 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 1.014 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -64.3 -41.31 98.25 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.422 -0.808 . . . . 0.55000000000000004 111.753 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 79' ' ' PHE . 57.9 t -67.79 -47.13 80.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.907 -0.647 . . . . 0.84999999999999998 110.36 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.12 -32.07 63.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 1.1200000000000001 110.848 -172.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 64.6 p -67.28 -32.85 74.12 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.118 -0.697 . . . . 1.8799999999999999 109.118 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.36 12.83 34.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.622 -0.717 . . . . 1.6599999999999999 112.828 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.584 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.4 p30 -175.23 69.98 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.764 0.792 . . . . 2.0800000000000001 110.224 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.014 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.3 tt -58.75 88.09 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.911 -1.04 . . . . 0.56000000000000005 111.233 174.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.2 t30 -143.08 101.63 3.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.935 -0.575 . . . . 2.0099999999999998 109.573 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.9 t -150.82 155.84 40.03 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 120.895 0.378 . . . . 1.6699999999999999 110.064 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.7 ptt? -134.5 116.69 15.38 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.586 -0.734 . . . . 3.9399999999999999 110.003 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -143.08 136.98 28.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.439 -0.8 . . . . 2.4700000000000002 109.263 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 6.3 pt-20 -100.18 118.57 36.79 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.396 -0.522 . . . . 1.97 110.485 177.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -108.23 101.59 10.79 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.803 -0.814 . . . . 4.29 108.803 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.704 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 8.8 t -82.95 142.61 31.27 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.16 0.505 . . . . 2.8900000000000001 110.73 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -98.2 107.24 19.66 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.814 -0.81 . . . . 5.25 108.814 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -58.04 -26.97 63.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.835 -0.431 . . . . 6.0599999999999996 109.835 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.609 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 9.4 t80 65.13 -89.02 0.03 OUTLIER 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.187 -0.915 . . . . 9.7699999999999996 111.498 168.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.609 ' HG3' ' O ' ' A' ' 98' ' ' TYR . 6.1 mt-30 -161.76 -55.37 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.032 0.533 . . . . 8.3399999999999999 109.669 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -105.57 -70.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.707 -0.679 . . . . 8.1899999999999995 110.567 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.4 t -105.89 141.96 23.8 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.769 -0.651 . . . . 5.0999999999999996 110.515 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.71 118.78 5.82 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.378 2.052 . . . . 4.5099999999999998 112.315 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.7 m -89.15 98.29 11.68 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.793 -0.817 . . . . 2.5899999999999999 108.793 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 4.7 tmmm? -93.42 126.74 38.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.153 -0.476 . . . . 3.1200000000000001 111.542 -171.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 32.1 m -110.27 158.69 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 115.78 -0.646 . . . . 1.23 109.869 170.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 24.1 ttmm -132.45 118.6 19.53 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.948 -0.569 . . . . 2.3599999999999999 109.474 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.3 t -95.87 104.96 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-N 116.445 -0.343 . . . . 1.1100000000000001 110.203 -176.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.662 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 3.4 t-160 -107.12 102.22 11.57 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.758 -1.201 . . . . 1.01 107.758 170.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.659 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 85.3 mtp -110.12 138.01 47.09 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.547 -1.279 . . . . 2.2200000000000002 107.547 177.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 14.2 ptmm? -144.09 135.33 25.59 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.86 -0.736 . . . . 1.73 110.373 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.648 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 46.0 tttm -55.88 116.41 2.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.797 0.808 . . . . 1.78 110.569 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.35 150.46 22.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.172 -1.376 . . . . 0.45000000000000001 110.716 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.48 -14.42 41.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.787 0.327 . . . . 2.3900000000000001 111.257 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.4 t -76.12 -24.76 54.94 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.048 0.451 . . . . 1.6599999999999999 110.326 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.57 -44.7 3.18 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 121.269 -0.491 . . . . 1.52 112.449 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.58 34.09 0.64 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.498 0.666 . . . . 2.79 111.673 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 34' ' ' ASP . 2.2 p -169.95 159.37 7.72 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.167 -0.924 . . . . 0.44 110.427 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.648 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 32.2 m-85 -141.31 145.3 35.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.714 0.292 . . . . 0.41999999999999998 110.297 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.426 ' O ' ' HA ' ' A' ' 109' ' ' MET . 40.8 m95 -93.23 165.64 12.71 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.46 0.647 . . . . 0.41999999999999998 111.853 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.441 ' HB ' HG23 ' A' ' 31' ' ' ILE . 63.0 t -136.08 104.63 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.35 -1.295 . . . . 0.62 109.307 174.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.662 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 62.7 m-85 -106.63 104.79 14.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.463 -0.94 . . . . 1.49 108.463 174.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 12.2 p -105.09 135.48 42.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.25 0.548 . . . . 1.6100000000000001 110.929 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 81.6 mttt -122.17 109.99 15.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.822 -0.627 . . . . 3.4500000000000002 109.905 176.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.437 ' C ' ' HD2' ' A' ' 124' ' ' ARG . 3.8 ppt_? -104.29 147.19 27.78 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.776 -0.453 . . . . 4.2300000000000004 109.776 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.461 HG13 ' OXT' ' A' ' 125' ' ' VAL . 3.6 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 117.968 -1.015 . . . . 3.3399999999999999 109.99 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 1.009 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.116 -0.698 . . . . 8.7200000000000006 109.116 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.16 147.79 9.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.633 0.254 . . . . 6.1799999999999997 111.535 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.437 ' CZ ' ' HA ' ' A' ' 55' ' ' LYS . 6.1 m-85 -76.09 78.33 2.93 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.579 -0.526 . . . . 6.1500000000000004 109.579 167.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.18 -72.11 1.27 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.54 -0.838 . . . . 1.4299999999999999 111.756 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.49 114.24 16.52 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.903 0.382 . . . . 0.69999999999999996 111.145 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.503 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 5.5 tt -118.58 140.63 41.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.429 -0.582 . . . . 0.90000000000000002 109.429 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.572 ' OE1' ' HB3' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -120.99 143.82 48.84 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.295 0.569 . . . . 2.2200000000000002 110.905 -175.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.48 160.93 33.76 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.062 -0.972 . . . . 0.71999999999999997 110.37 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HB3' ' A' ' 117' ' ' SER . 48.0 p30 -85.03 159.38 20.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.503 0.668 . . . . 1.1499999999999999 110.863 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.552 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -77.83 20.55 3.61 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.062 -0.972 . . . . 1.2 111.935 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -99.78 -39.84 8.02 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.813 -0.81 . . . . 1.8100000000000001 108.813 176.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.73 7.78 0.73 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.214 -0.993 . . . . 1.05 114.596 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -134.29 160.08 39.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.366 1.083 . . . . 1.5700000000000001 112.472 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 31' ' ' ILE . 75.9 mt -75.27 143.19 13.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.619 -1.173 . . . . 1.1799999999999999 110.656 -175.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.574 ' HG ' ' HG3' ' A' ' 41' ' ' GLN . 60.5 tp -119.48 -57.56 1.98 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.449 -0.341 . . . . 1.5600000000000001 111.275 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.574 ' HG3' ' HG ' ' A' ' 40' ' ' LEU . 94.8 mt-30 -126.81 145.22 50.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.329 . . . . 2.4100000000000001 111.332 -174.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.503 ' HD2' ' HB ' ' A' ' 31' ' ' ILE . 87.6 t80 -132.38 136.63 46.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 1.4199999999999999 110.835 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -105.28 107.12 17.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 1.21 109.556 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.97 -34.03 20.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.906 -0.588 . . . . 2.5 111.34 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.07 91.52 3.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.23 -0.441 . . . . 4.0 111.12 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -103.29 9.13 38.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.842 0.83 . . . . 7.21 109.391 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.05 -26.46 24.4 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.28 -0.873 . . . . 6.9699999999999998 111.958 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.62 149.58 28.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.527 0.203 . . . . 8.5899999999999999 110.462 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.4 mt -123.83 95.47 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.247 -0.433 . . . . 9.2400000000000002 110.811 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 p -82.74 179.98 7.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.693 -0.23 . . . . 9.8200000000000003 110.558 173.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.6 -53.34 0.23 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.144 -1.027 . . . . 9.6199999999999992 113.447 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 33.9 ptt180 -96.43 69.43 2.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.381 0.61 . . . . 12.720000000000001 111.495 -174.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.402 ' OD2' ' HD1' ' A' ' 28' ' ' PHE . 4.1 m-20 -97.65 107.71 41.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.96 -0.564 . . . . 8.2400000000000002 110.735 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 52' ' ' ARG . 16.4 Cg_exo -70.57 -28.73 20.99 Favored 'Trans proline' 0 CA--C 1.527 0.136 0 C-N-CA 123.154 2.57 . . . . 8.1099999999999994 112.92 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' HA ' ' CZ ' ' A' ' 28' ' ' PHE . 27.6 mtpp 61.56 34.23 17.95 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.049 0.452 . . . . 9.2400000000000002 111.17 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -94.61 -16.41 23.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.026 -0.534 . . . . 7.4000000000000004 112.111 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.471 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 2.6 m -111.48 74.65 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.432 0.634 . . . . 5.0599999999999996 112.34 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -176.69 150.79 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.423 -0.955 . . . . 3.1699999999999999 108.423 173.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.27 29.84 26.71 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.032 -1.227 . . . . 3.2400000000000002 110.032 -173.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.614 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -104.11 124.07 48.42 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.088 -0.556 . . . . 3.8500000000000001 109.878 -176.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -148.19 112.83 5.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.947 0.403 . . . . 4.1799999999999997 110.961 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -151.01 5.29 0.48 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.576 -0.738 . . . . 6.6600000000000001 109.992 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 63.31 -95.2 0.05 OUTLIER 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.244 -0.889 . . . . 8.1300000000000008 111.319 -174.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -139.43 153.88 47.67 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.322 -0.251 . . . . 10.050000000000001 110.322 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -65.3 139.05 58.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.008 0.432 . . . . 7.9400000000000004 110.194 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 66' ' ' VAL . 13.2 p -127.17 39.07 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 122.909 1.338 . . . . 9.3499999999999996 109.074 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.81 150.99 4.01 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.205 -1.361 . . . . 9.1600000000000001 109.56 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.28 -4.33 10.35 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.992 2.462 . . . . 10.35 112.475 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.7 t -63.46 -46.68 85.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.346 -0.843 . . . . 11.49 111.249 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.474 ' OG1' ' H2 ' ' A' ' 169' ' ' HC4 . 3.0 m -106.84 156.16 18.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.199 -0.455 . . . . 10.949999999999999 111.11 -173.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.418 ' N ' HG22 ' A' ' 70' ' ' THR . 5.9 p-10 -162.54 168.91 21.13 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.661 -0.496 . . . . 11.56 109.661 175.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.2 m -76.18 118.84 74.21 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.692 -0.231 . . . . 10.960000000000001 111.548 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -96.95 -171.52 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.337 2.692 . . . . 10.68 112.859 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 56.67 62.86 2.13 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.657 -0.701 . . . . 11.76 111.64 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -78.64 90.9 4.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.617 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -114.59 -49.79 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.479 -0.328 . . . . 7.5300000000000002 110.869 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.62 36.58 4.25 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.597 -1.001 . . . . 3.2000000000000002 110.597 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt 57.47 46.08 18.6 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.135 -0.533 . . . . 4.1399999999999997 109.63 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.596 ' O ' HG23 ' A' ' 83' ' ' VAL . 65.6 t80 -44.81 -42.26 7.7 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 113.436 0.902 . . . . 0.94999999999999996 113.436 -166.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -68.68 -36.3 78.35 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 121.282 0.563 . . . . 3.48 110.395 -174.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.72 -30.79 28.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.527 -0.761 . . . . 3.0699999999999998 109.103 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.958 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.97 -43.84 92.87 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.458 -0.792 . . . . 0.55000000000000004 111.714 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.2 t -63.53 -52.56 56.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.565 -0.818 . . . . 0.84999999999999998 110.843 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.33 -26.1 35.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.049 -0.523 . . . . 1.1200000000000001 111.767 -170.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.6 t -67.61 -25.19 65.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.409 -0.589 . . . . 1.8799999999999999 109.409 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.41 78.44 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.87 -0.605 . . . . 1.6599999999999999 112.888 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.42 50.28 1.02 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.711 0.767 . . . . 2.0800000000000001 111.616 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.958 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.1 tt -70.73 89.7 0.75 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.259 -0.882 . . . . 0.56000000000000005 110.995 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.5 p30 -143.68 100.49 3.6 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.705 -0.85 . . . . 2.0099999999999998 108.705 169.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 3.1 p -141.52 152.68 44.35 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.945 -0.472 . . . . 1.6699999999999999 111.059 -174.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.665 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 22.5 ptm -120.07 116.49 25.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.6 0.714 . . . . 3.9399999999999999 109.775 173.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -119.55 122.47 41.69 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.885 -1.052 . . . . 2.4700000000000002 109.244 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 106' ' ' LYS . 49.2 mt-10 -92.86 130.47 38.45 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.423 -0.584 . . . . 1.97 109.423 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -108.21 124.21 49.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.973 -0.558 . . . . 4.29 110.356 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.8 t -81.4 151.36 27.95 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.629 -0.714 . . . . 2.8900000000000001 111.293 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -74.27 115.48 13.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.284 -0.871 . . . . 5.25 111.514 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -71.39 -42.53 68.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.594 0.711 . . . . 6.0599999999999996 109.772 175.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -92.68 146.62 23.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.064 -0.971 . . . . 9.7699999999999996 111.136 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -97.87 26.48 5.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.372 0.606 . . . . 8.3399999999999999 110.243 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 16.4 ttt -60.35 -61.78 2.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.766 -0.652 . . . . 8.1899999999999995 110.147 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.1 t -145.88 148.91 37.59 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 115.323 -0.853 . . . . 5.0999999999999996 108.966 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.65 88.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.28 1.986 . . . . 4.5099999999999998 112.078 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.6 m -105.5 96.32 6.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.94 -0.573 . . . . 2.5899999999999999 110.12 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -111.44 102.31 10.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.756 -0.656 . . . . 3.1200000000000001 109.231 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -106.16 161.62 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.189 -0.46 . . . . 1.23 111.207 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 19.4 ptpt -139.18 127.06 22.17 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.585 -0.734 . . . . 2.3599999999999999 109.292 176.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -92.91 144.89 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 C-N-CA 120.185 -0.606 . . . . 1.1100000000000001 110.623 175.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 13.2 t-160 -131.69 102.8 6.04 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.43 -1.322 . . . . 1.01 107.43 164.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.676 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 11.2 ptp -101.88 123.72 46.29 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.664 -1.236 . . . . 2.2200000000000002 107.664 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 21.1 ptmt -138.08 133.36 33.38 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 120.435 -0.506 . . . . 1.73 110.941 -165.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.491 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 64.4 tttp -56.75 115.41 2.55 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.335 -0.848 . . . . 1.78 111.144 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.77 147.09 39.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.513 -1.221 . . . . 0.45000000000000001 110.425 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.19 -3.34 16.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.666 0.27 . . . . 2.3900000000000001 111.335 -177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 p -84.58 -17.82 37.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.705 0.288 . . . . 1.6599999999999999 111.366 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 127.64 -108.7 0.97 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.306 -0.95 . . . . 1.52 113.118 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -85.16 68.49 10.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.278 1.037 . . . . 2.79 110.956 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.552 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 2.7 p -158.52 154.09 26.14 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.668 -1.151 . . . . 0.44 108.719 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 50.1 m-85 -140.41 135.85 32.48 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.769 0.319 . . . . 0.41999999999999998 110.364 -175.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.546 ' O ' ' HA ' ' A' ' 109' ' ' MET . 39.7 m95 -87.1 161.4 18.14 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 120.861 0.362 . . . . 0.41999999999999998 110.086 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.4 t -140.01 95.88 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.215 -0.902 . . . . 0.62 108.938 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 108' ' ' HIS . 7.8 p90 -119.53 141.23 49.41 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.991 -0.684 . . . . 1.49 110.528 175.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 123' ' ' LYS . 12.1 p -123.53 151.98 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.68 -0.691 . . . . 1.6100000000000001 110.229 -175.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 123' ' ' LYS . 14.8 tptt -143.65 140.61 30.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.094 -0.336 . . . . 3.4500000000000002 110.094 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -105.48 137.86 42.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.913 0.387 . . . . 4.2300000000000004 111.09 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.647 -0.692 . . . . 3.3399999999999999 109.961 178.701 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 1.007 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.796 0.331 . . . . 8.7200000000000006 110.237 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.416 ' HB3' ' HG3' ' A' ' 124' ' ' ARG . . . -109.09 142.81 39.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.44 -0.346 . . . . 6.1799999999999997 110.21 175.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -83.19 80.58 9.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.986 0.422 . . . . 6.1500000000000004 111.147 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -89.2 55.51 3.97 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.961 -0.563 . . . . 1.4299999999999999 111.919 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.75 102.44 12.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.041 0.448 . . . . 0.69999999999999996 111.469 -175.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.676 ' HB ' ' HD2' ' A' ' 42' ' ' TYR . 5.9 tt -137.61 141.85 38.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.978 -0.555 . . . . 0.90000000000000002 109.957 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.526 ' HB3' ' CE3' ' A' ' 119' ' ' TRP . 0.7 OUTLIER -120.27 140.72 50.8 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.223 0.535 . . . . 2.2200000000000002 110.811 -178.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.604 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.9 pp -134.71 162.85 31.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.439 -0.8 . . . . 0.71999999999999997 111.152 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.565 ' HB3' HD11 ' A' ' 40' ' ' LEU . 10.4 p30 -83.61 158.26 21.96 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.697 -0.683 . . . . 1.1499999999999999 110.876 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.573 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -72.83 2.15 34.69 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.311 -0.858 . . . . 1.2 112.191 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.44 -42.28 17.13 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.11 -0.7 . . . . 1.8100000000000001 109.11 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.59 28.32 0.69 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.179 -0.919 . . . . 1.05 112.355 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.572 ' HA ' ' HG3' ' A' ' 60' ' ' LYS . 17.0 m-80 -133.86 150.11 51.37 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.769 0.318 . . . . 1.5700000000000001 110.23 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.939 HG12 ' HB3' ' A' ' 60' ' ' LYS . 12.1 mm -74.65 143.53 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 116.239 -0.437 . . . . 1.1799999999999999 110.443 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' A' ' 34' ' ' ASP . 85.7 mt -113.86 -50.89 2.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.837 0.351 . . . . 1.5600000000000001 111.104 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -142.45 136.17 29.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.23 -0.441 . . . . 2.4100000000000001 110.258 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.795 ' HB3' ' HA ' ' A' ' 57' ' ' VAL . 61.7 t80 -130.28 135.67 48.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.164 -0.471 . . . . 1.4199999999999999 110.205 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -104.7 142.02 35.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.389 -0.368 . . . . 1.21 110.382 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.79 151.07 20.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.257 -0.429 . . . . 2.5 110.478 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.57 106.17 18.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.337 -0.392 . . . . 4.0 111.075 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.85 179.21 5.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.213 -0.449 . . . . 7.21 110.235 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.61 -59.75 0.67 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.753 -0.737 . . . . 6.9699999999999998 112.246 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.19 132.48 33.86 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.62 -0.511 . . . . 8.5899999999999999 109.62 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.8 mm -92.67 44.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.812 0.815 . . . . 9.2400000000000002 110.713 -174.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.1 p -138.07 42.87 2.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.878 -0.601 . . . . 9.8200000000000003 109.834 171.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.63 117.77 0.91 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.117 -1.039 . . . . 9.6199999999999992 113.036 -175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.617 ' HA ' ' NE ' ' A' ' 52' ' ' ARG . 2.8 mmp_? -109.33 104.51 13.64 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.307 -0.627 . . . . 12.720000000000001 109.307 171.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -68.36 130.6 92.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.763 -0.653 . . . . 8.2400000000000002 111.233 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.92 -9.48 15.57 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.655 2.237 . . . . 8.1099999999999994 111.643 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 64.06 94.31 0.05 Allowed 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.371 -0.831 . . . . 9.2400000000000002 111.907 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -70.64 -54.2 12.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.735 -0.666 . . . . 7.4000000000000004 109.338 172.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.795 ' HA ' ' HB3' ' A' ' 42' ' ' TYR . 47.2 t 62.61 -70.15 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.061 0.944 . . . . 5.0599999999999996 112.612 176.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.0 pt -132.28 71.47 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 122.152 0.977 . . . . 3.1699999999999999 110.513 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.46 -32.99 83.42 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 114.407 -1.27 . . . . 3.2400000000000002 112.724 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.939 ' HB3' HG12 ' A' ' 39' ' ' ILE . 26.3 tptp -105.22 113.27 26.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.709 0.29 . . . . 3.8500000000000001 110.701 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -138.03 112.5 8.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.506 -0.924 . . . . 4.1799999999999997 108.506 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -61.59 99.31 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 6.6600000000000001 111.168 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -107.49 13.51 26.78 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.678 -0.86 . . . . 8.1300000000000008 108.678 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.7 mttp 62.3 49.72 4.14 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.71 -1.218 . . . . 10.050000000000001 107.71 -169.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -9.01 7.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 113.365 -1.743 . . . . 7.9400000000000004 112.416 -171.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m 37.77 43.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.568 1.147 . . . . 9.3499999999999996 113.5 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.45 102.64 52.23 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.63 -0.714 . . . . 9.1600000000000001 109.256 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -40.89 113.03 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 124.169 3.246 . . . . 10.35 114.177 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.3 m -99.85 123.76 44.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.437 -0.801 . . . . 11.49 109.145 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 m -53.48 -51.8 61.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.594 -0.521 . . . . 10.949999999999999 109.594 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -167.76 -69.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.215 -0.902 . . . . 11.56 109.113 173.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.457 ' HB2' ' CD1' ' A' ' 76' ' ' TYR . 31.4 m -125.02 152.98 71.2 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.276 -0.875 . . . . 10.960000000000001 108.78 175.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 72' ' ' SER . 7.6 Cg_exo -73.92 40.51 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.432 2.754 . . . . 10.68 113.44 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 65.72 -179.2 0.19 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.18 0.592 . . . . 11.76 111.429 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 65.47 23.67 11.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.253 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.852 ' HB2' ' HB2' ' A' ' 79' ' ' PHE . 51.6 p90 -113.21 143.62 44.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.954 -0.567 . . . . 7.5300000000000002 110.615 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.87 90.91 0.65 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.827 -0.702 . . . . 3.2000000000000002 111.588 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 18.4 tptm 60.35 35.68 20.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.173 0.511 . . . . 4.1399999999999997 110.315 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.852 ' HB2' ' HB2' ' A' ' 76' ' ' TYR . 62.0 t80 -48.8 -37.67 19.88 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.562 -0.745 . . . . 0.94999999999999996 112.733 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -70.47 -36.87 74.11 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 123.576 0.547 . . . . 3.48 110.123 -171.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.731 ' HB3' ' HG3' ' A' ' 78' ' ' LYS . 41.0 tt0 -80.55 -31.87 36.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.586 -0.734 . . . . 3.0699999999999998 109.18 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.982 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.5 -46.25 93.4 Favored Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 115.666 -0.697 . . . . 0.55000000000000004 111.88 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.4 t -69.15 -46.46 77.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.696 -0.752 . . . . 0.84999999999999998 110.578 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.6 -28.84 63.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.864 -0.607 . . . . 1.1200000000000001 110.555 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -69.69 -23.91 63.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.414 -0.812 . . . . 1.8799999999999999 109.265 174.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.93 19.58 69.84 Favored Glycine 0 CA--C 1.505 -0.539 0 CA-C-N 115.685 -0.688 . . . . 1.6599999999999999 112.198 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.411 ' C ' HD22 ' A' ' 87' ' ' ASN . 0.4 OUTLIER -163.4 55.57 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.246 0.546 . . . . 2.0800000000000001 111.29 -175.287 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.982 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.1 tt -68.65 88.95 0.36 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.771 -0.649 . . . . 0.56000000000000005 111.081 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.758 ' HA ' ' O ' ' A' ' 109' ' ' MET . 20.4 t30 -143.15 100.45 3.64 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.284 -0.636 . . . . 2.0099999999999998 109.284 175.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.9 t -156.06 158.08 37.17 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.999 0.428 . . . . 1.6699999999999999 110.687 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 19.5 ptt? -125.77 126.16 44.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.772 -0.649 . . . . 3.9399999999999999 110.447 176.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.55 ' O ' HG22 ' A' ' 107' ' ' VAL . 90.1 t80 -146.08 130.16 17.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.676 -0.693 . . . . 2.4700000000000002 109.795 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.774 ' HB3' ' HG3' ' A' ' 106' ' ' LYS . 12.9 pt-20 -104.62 127.1 52.27 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.046 0.451 . . . . 1.97 110.222 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -122.3 94.09 4.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.794 0.807 . . . . 4.29 109.154 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.532 ' HB ' ' HG3' ' A' ' 104' ' ' LYS . 9.2 t -91.4 135.7 33.64 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.129 -0.941 . . . . 2.8900000000000001 110.827 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 102' ' ' PRO . 1.5 m-85 56.76 66.29 1.21 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.618 -0.719 . . . . 5.25 110.608 177.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -88.1 -151.61 0.2 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.319 -0.855 . . . . 6.0599999999999996 111.345 -175.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -76.42 -13.36 60.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.517 . . . . 9.7699999999999996 110.864 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -69.82 127.97 34.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.436 -0.579 . . . . 8.3399999999999999 109.436 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.558 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 49.7 ttm -62.09 -24.05 66.89 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.365 -0.38 . . . . 8.1899999999999995 111.299 -176.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.5 m -95.51 95.22 1.65 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.232 -0.655 . . . . 5.0999999999999996 109.232 171.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 100' ' ' MET . 5.7 Cg_exo -79.1 103.75 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.068 2.512 . . . . 4.5099999999999998 112.496 -172.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.9 m -109.38 139.91 43.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.972 -0.558 . . . . 2.5899999999999999 109.518 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.532 ' HG3' ' HB ' ' A' ' 95' ' ' THR . 62.4 tttm -84.18 99.31 10.44 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 119.737 -0.785 . . . . 3.1200000000000001 109.552 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 124' ' ' ARG . 17.9 m -109.4 159.89 8.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.008 -0.996 . . . . 1.23 111.588 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.774 ' HG3' ' HB3' ' A' ' 93' ' ' GLU . 25.0 ttpp -146.11 115.0 6.92 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.461 -0.791 . . . . 2.3599999999999999 109.213 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 122' ' ' VAL . 12.9 m -88.54 144.56 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-O 121.373 0.606 . . . . 1.1100000000000001 111.414 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.417 ' O ' ' HD1' ' A' ' 121' ' ' PHE . 14.6 t-160 -132.33 103.32 6.15 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 106.858 -1.534 . . . . 1.01 106.858 160.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.758 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 79.5 mtp -103.7 132.14 50.23 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.108 -1.442 . . . . 2.2200000000000002 107.108 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HG2' ' HB2' ' A' ' 119' ' ' TRP . 61.7 pttt -138.59 131.62 29.76 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.709 -0.796 . . . . 1.73 110.087 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.43 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 80.8 tttt -56.57 113.05 1.45 Allowed 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 115.784 -0.644 . . . . 1.78 110.188 172.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -58.22 144.75 39.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.605 -1.18 . . . . 0.45000000000000001 110.866 -173.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 73.4 mt -71.23 -9.81 58.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.041 -0.527 . . . . 2.3900000000000001 110.846 -177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 p -73.13 -30.63 63.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.975 -0.557 . . . . 1.6599999999999999 111.057 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 142.6 -126.16 2.82 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.74 -0.743 . . . . 1.52 112.668 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.65 79.24 2.01 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.989 0.899 . . . . 2.79 110.853 -176.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.573 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 3.1 p -168.07 156.16 8.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.532 -1.213 . . . . 0.44 108.457 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.43 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 31.6 m-85 -140.24 137.36 34.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.64 0.257 . . . . 0.41999999999999998 110.916 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.577 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . 45.1 m95 -83.64 162.81 20.65 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.227 0.536 . . . . 0.41999999999999998 110.817 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 50.9 t -137.23 97.33 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.744 -1.116 . . . . 0.62 109.659 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 89.8 m-85 -100.17 102.47 13.78 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.528 -0.545 . . . . 1.49 109.528 172.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 107' ' ' VAL . 3.7 m -97.84 106.47 18.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.516 0.674 . . . . 1.6100000000000001 110.026 176.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -109.34 109.44 20.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.963 -0.461 . . . . 3.4500000000000002 110.773 -172.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.559 ' HB3' HG12 ' A' ' 105' ' ' VAL . 5.5 ppt_? -101.76 142.88 32.4 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.383 -0.599 . . . . 4.2300000000000004 109.383 175.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.197 -0.906 . . . . 3.3399999999999999 110.077 177.528 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 1.015 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.021 -0.363 . . . . 8.7200000000000006 110.021 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.62 103.34 14.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.019 0.438 . . . . 6.1799999999999997 110.332 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -81.74 133.29 35.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.196 -0.456 . . . . 6.1500000000000004 111.323 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.76 -150.27 9.02 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.589 -0.732 . . . . 1.4299999999999999 111.864 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.81 119.45 29.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.139 -0.319 . . . . 0.69999999999999996 110.139 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -111.64 138.71 39.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.988 0.423 . . . . 0.90000000000000002 110.604 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.655 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 7.6 pt20 -109.88 127.04 54.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.816 -0.629 . . . . 2.2200000000000002 110.343 176.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.444 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.8 pp -118.69 159.03 24.39 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.288 -0.869 . . . . 0.71999999999999997 109.577 177.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.771 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 1.9 p30 -84.24 151.59 24.71 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.174 -0.611 . . . . 1.1499999999999999 109.976 176.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -73.3 5.18 21.86 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.431 -0.804 . . . . 1.2 112.606 -175.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.09 -39.34 13.69 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.495 -0.557 . . . . 1.8100000000000001 109.495 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.79 36.99 0.19 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.611 -0.722 . . . . 1.05 111.935 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.771 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 19.0 m-80 -137.59 152.53 49.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.978 0.418 . . . . 1.5700000000000001 110.342 -176.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.444 HD13 ' HB3' ' A' ' 33' ' ' LEU . 46.3 mm -95.14 123.28 47.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.879 -0.601 . . . . 1.1799999999999999 110.057 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.503 HD23 ' NE2' ' A' ' 32' ' ' GLN . 35.2 tp -102.59 -52.06 3.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.754 0.279 . . . . 1.5600000000000001 111.754 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.642 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 7.3 tt0 -142.52 122.49 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.902 0.382 . . . . 2.4100000000000001 111.371 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -113.76 106.37 14.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.088 -0.506 . . . . 1.4199999999999999 109.668 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -81.95 93.4 6.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.137 0.494 . . . . 1.21 110.587 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.22 -53.06 3.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.5 -0.773 . . . . 2.5 109.65 175.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.08 112.74 4.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.1 -0.954 . . . . 4.0 109.153 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.58 123.73 18.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.398 . . . . 7.21 110.527 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.83 19.01 38.4 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.805 -0.712 . . . . 6.9699999999999998 111.995 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.92 118.07 30.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.391 -0.596 . . . . 8.5899999999999999 109.391 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.7 pt -111.11 39.28 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.121 0.486 . . . . 9.2400000000000002 112.24 -171.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.5 t -96.34 160.56 14.35 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.285 -0.635 . . . . 9.8200000000000003 109.285 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -102.09 99.91 1.94 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.711 -0.757 . . . . 9.6199999999999992 112.705 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 52' ' ' ARG . 56.5 mtt-85 -89.51 113.86 25.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.473 -0.936 . . . . 12.720000000000001 108.473 173.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 1.9 p-10 -66.19 132.39 94.48 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.568 0.699 . . . . 8.2400000000000002 111.683 -170.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.606 ' HB3' ' HA3' ' A' ' 59' ' ' GLY . 2.9 Cg_exo -77.44 18.86 0.77 Allowed 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 123.915 3.077 . . . . 8.1099999999999994 113.846 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -92.12 23.36 3.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.584 0.707 . . . . 9.2400000000000002 110.149 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -127.1 -87.01 0.59 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.147 -0.933 . . . . 7.4000000000000004 110.366 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.44 HG12 HG21 ' A' ' 70' ' ' THR . 2.5 m -136.46 -44.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.386 -0.825 . . . . 5.0599999999999996 110.861 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 11.9 tt -75.13 151.39 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.973 -0.38 . . . . 3.1699999999999999 109.973 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.606 ' HA3' ' HB3' ' A' ' 54' ' ' PRO . . . 79.88 8.58 87.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.917 -0.658 . . . . 3.2400000000000002 112.051 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.745 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 24.9 tptp -79.79 107.17 12.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.763 -0.458 . . . . 3.8500000000000001 109.763 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.416 ' HA ' ' HB3' ' A' ' 38' ' ' ASN . 5.7 m120 -143.4 96.39 2.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.853 0.359 . . . . 4.1799999999999997 110.499 176.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -151.75 102.52 2.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.751 -0.833 . . . . 6.6600000000000001 108.751 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -91.28 15.22 12.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 8.1300000000000008 112.175 -170.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -122.18 158.95 28.26 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.215 -0.291 . . . . 10.050000000000001 110.215 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t70 74.84 -54.24 0.67 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.811 0.695 . . . . 7.9400000000000004 111.387 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.4 t 53.11 49.94 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 122.081 0.943 . . . . 9.3499999999999996 111.083 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.743 ' H ' ' HD2' ' A' ' 68' ' ' PRO . . . -105.39 -49.62 0.12 Allowed Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.411 -0.813 . . . . 9.1600000000000001 110.213 170.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.743 ' HD2' ' H ' ' A' ' 67' ' ' ALA . 37.7 Cg_endo -66.53 101.96 0.57 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 121.753 1.635 . . . . 10.35 111.287 171.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.3 p -134.23 119.35 18.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.821 -0.627 . . . . 11.49 110.852 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.44 HG21 HG12 ' A' ' 57' ' ' VAL . 2.6 p -85.36 52.83 2.56 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.383 0.611 . . . . 10.949999999999999 110.71 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -78.5 97.38 5.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.542 -0.753 . . . . 11.56 110.539 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.7 t -131.9 129.19 21.81 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.692 -0.685 . . . . 10.960000000000001 109.36 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.21 57.24 1.66 Allowed 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.167 2.578 . . . . 10.68 112.414 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.72 -64.18 0.91 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.016 -0.538 . . . . 11.76 109.684 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.84 24.43 2.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.675 -0.693 . . . . 10.0 109.8 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -64.92 133.18 51.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.81 -0.632 . . . . 7.5300000000000002 111.254 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -133.64 96.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.123 -0.791 . . . . 3.2000000000000002 111.123 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 65.48 25.09 11.87 Favored 'General case' 0 C--O 1.223 -0.32 0 O-C-N 123.826 0.368 . . . . 4.1399999999999997 110.191 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 83' ' ' VAL . 44.8 t80 -55.87 -29.93 60.7 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 112.541 0.571 . . . . 0.94999999999999996 112.541 -167.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -81.4 -37.21 28.52 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.039 0.447 . . . . 3.48 110.204 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -78.72 -30.7 46.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.745 -0.835 . . . . 3.0699999999999998 108.745 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 1.012 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.51 -43.98 90.56 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.067 -0.969 . . . . 0.55000000000000004 111.873 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 79' ' ' PHE . 89.6 t -68.57 -52.56 35.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.424 -0.888 . . . . 0.84999999999999998 111.047 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.19 -28.97 38.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.936 -0.575 . . . . 1.1200000000000001 111.678 -169.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -72.07 -26.32 62.12 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.658 -0.867 . . . . 1.8799999999999999 108.658 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.6 18.43 70.79 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.249 -0.887 . . . . 1.6599999999999999 112.313 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -140.31 42.46 1.91 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.47 0.652 . . . . 2.0800000000000001 111.897 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.012 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -69.21 89.13 0.45 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.363 -0.835 . . . . 0.56000000000000005 111.609 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.716 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.1 p30 -143.95 100.9 3.65 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.453 -0.943 . . . . 2.0099999999999998 108.453 169.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 17.8 p -131.85 151.1 51.91 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 121.879 -0.513 . . . . 1.6699999999999999 111.12 -173.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 3.9 ppp? -118.79 129.34 55.19 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.647 -0.871 . . . . 3.9399999999999999 108.647 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.469 ' HE2' ' HD2' ' A' ' 94' ' ' TYR . 38.5 t80 -139.28 127.85 23.08 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.906 -0.588 . . . . 2.4700000000000002 109.463 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -90.62 107.3 19.08 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.764 -1.199 . . . . 1.97 107.764 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.469 ' HD2' ' HE2' ' A' ' 92' ' ' PHE . 43.1 t80 -108.84 103.25 12.27 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.157 0.503 . . . . 4.29 110.646 -173.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.53 HG22 ' H ' ' A' ' 97' ' ' ASP . 4.9 m -96.17 132.61 41.41 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.672 -0.695 . . . . 2.8900000000000001 110.017 175.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.22 -27.22 42.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.853 -0.158 . . . . 5.25 110.798 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.57 ' HA ' ' HB3' ' A' ' 102' ' ' PRO . 33.0 t70 69.33 171.71 0.3 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.827 0.704 . . . . 6.0599999999999996 110.403 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.405 ' CG ' ' N ' ' A' ' 99' ' ' GLN . 49.3 t80 67.46 -171.8 0.19 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.709 -0.478 . . . . 9.7699999999999996 109.709 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.405 ' N ' ' CG ' ' A' ' 98' ' ' TYR . 41.2 mt-30 71.17 -178.16 0.21 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.981 0.512 . . . . 8.3399999999999999 111.085 176.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -60.4 -38.84 85.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.362 0.601 . . . . 8.1899999999999995 109.724 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 7.1 t -139.24 138.16 20.31 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.353 -0.839 . . . . 5.0999999999999996 109.314 174.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 97' ' ' ASP . 15.5 Cg_exo -67.81 101.49 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.344 2.029 . . . . 4.5099999999999998 110.824 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.3 m -56.57 98.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 2.5899999999999999 110.98 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 52.0 tttm -106.82 117.81 35.03 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.876 -0.602 . . . . 3.1200000000000001 110.87 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.5 161.03 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.93 -0.577 . . . . 1.23 110.391 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.618 ' HE2' HG13 ' A' ' 125' ' ' VAL . 17.4 ttmm -113.92 115.79 28.24 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.094 -1.076 . . . . 2.3599999999999999 108.094 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' MET . 1.9 t -89.73 142.71 12.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 119.976 -0.689 . . . . 1.1100000000000001 109.321 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.597 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 13.6 t-160 -140.47 103.51 4.57 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.437 -0.949 . . . . 1.01 108.437 167.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.716 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 61.5 mtt -92.19 140.68 29.38 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.045 -1.465 . . . . 2.2200000000000002 107.045 173.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -149.27 129.95 14.09 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.349 -0.94 . . . . 1.73 111.202 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.502 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 38.1 tttp -55.22 117.81 3.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.481 -1.236 . . . . 1.78 110.435 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.18 147.71 9.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.783 -1.099 . . . . 0.45000000000000001 111.256 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -62.03 -25.54 67.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.345 -0.389 . . . . 2.3900000000000001 111.297 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.0 p -79.59 -56.0 4.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.044 0.449 . . . . 1.6599999999999999 110.226 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.31 169.14 12.74 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.874 -0.679 . . . . 1.52 112.389 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.9 t70 60.32 28.86 18.5 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.243 1.02 . . . . 2.79 110.642 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.489 ' CB ' ' HA ' ' A' ' 34' ' ' ASP . 6.9 p -168.1 153.22 6.69 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.347 -1.297 . . . . 0.44 109.984 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 51.3 m-85 -140.98 139.68 34.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.226 -0.443 . . . . 0.41999999999999998 110.117 -175.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.655 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 40.6 m95 -87.77 161.4 17.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.192 0.52 . . . . 0.41999999999999998 111.448 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.518 HG22 ' HG2' ' A' ' 109' ' ' MET . 62.1 t -140.21 96.59 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.439 -1.255 . . . . 0.62 108.601 175.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 108' ' ' HIS . 5.4 p90 -124.58 140.1 53.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.241 -0.583 . . . . 1.49 110.213 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.5 m -113.1 162.78 10.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.171 0.51 . . . . 1.6100000000000001 111.342 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -151.74 120.08 6.38 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.421 -0.809 . . . . 3.4500000000000002 109.29 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -77.58 91.82 4.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.503 0.668 . . . . 4.2300000000000004 111.202 -176.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.618 HG13 ' HE2' ' A' ' 106' ' ' LYS . 2.9 p . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.381 -0.827 . . . . 3.3399999999999999 110.179 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.969 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.543 0.211 . . . . 8.7200000000000006 111.356 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.9 -48.93 6.5 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.453 -0.943 . . . . 6.1799999999999997 108.453 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -105.95 150.98 25.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.316 -0.856 . . . . 6.1500000000000004 109.103 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . 177.49 -57.17 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.427 -0.892 . . . . 1.4299999999999999 112.767 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.89 111.21 5.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.969 0.414 . . . . 0.69999999999999996 111.719 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.745 HG13 ' HA ' ' A' ' 42' ' ' TYR . 1.2 tt -131.9 140.44 48.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.368 -0.378 . . . . 0.90000000000000002 110.095 174.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.669 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 2.4 pt20 -108.27 130.8 55.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.42 0.629 . . . . 2.2200000000000002 110.201 172.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -120.06 158.14 27.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.185 -0.916 . . . . 0.71999999999999997 109.53 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.84 152.03 38.97 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.991 -0.55 . . . . 1.1499999999999999 109.788 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.606 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -79.28 37.6 2.01 Favored Glycine 0 CA--C 1.506 -0.509 0 CA-C-N 115.906 -0.588 . . . . 1.2 112.237 -172.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -140.47 -33.67 0.55 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.075 -0.562 . . . . 1.8100000000000001 110.484 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.97 11.75 0.49 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.459 -0.877 . . . . 1.05 113.183 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 61' ' ' ASN . 17.0 m-80 -106.07 144.71 32.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.151 -0.315 . . . . 1.5700000000000001 110.151 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.729 HG12 ' HB3' ' A' ' 60' ' ' LYS . 44.7 mm -75.59 134.99 28.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.645 -0.502 . . . . 1.1799999999999999 109.645 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.601 ' HB3' ' HG3' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -106.08 -62.69 1.34 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.938 -0.764 . . . . 1.5600000000000001 108.938 -174.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.626 ' HB3' ' HG2' ' A' ' 32' ' ' GLN . 39.9 tt0 -144.69 110.34 5.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.838 -1.074 . . . . 2.4100000000000001 110.359 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.745 ' HA ' HG13 ' A' ' 31' ' ' ILE . 19.2 t80 -100.06 110.78 23.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.008 -0.542 . . . . 1.4199999999999999 109.659 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -93.17 93.53 8.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.847 0.356 . . . . 1.21 110.382 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.89 133.23 33.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.969 -0.56 . . . . 2.5 110.14 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.43 92.16 6.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.063 0.458 . . . . 4.0 110.923 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -120.59 127.28 51.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.916 -0.584 . . . . 7.21 109.94 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.52 62.11 4.66 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.901 -0.88 . . . . 6.9699999999999998 110.901 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -90.81 99.68 12.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.127 0.489 . . . . 8.5899999999999999 110.864 -174.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.8 mt -90.81 -53.23 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.486 -0.779 . . . . 9.2400000000000002 109.085 175.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -153.95 158.12 40.19 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.342 -0.844 . . . . 9.8200000000000003 108.909 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.96 131.96 1.97 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.13 -1.033 . . . . 9.6199999999999992 112.505 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.1 ptt85 -86.99 61.23 6.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.365 0.602 . . . . 12.720000000000001 110.444 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.427 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 33.4 t70 -108.26 103.24 49.86 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.634 . . . . 8.2400000000000002 110.103 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 53' ' ' ASP . 89.4 Cg_exo -36.75 97.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.715 3.61 . . . . 8.1099999999999994 113.974 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.83 106.49 17.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.236 -0.893 . . . . 9.2400000000000002 109.412 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -85.94 -26.94 25.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.896 -0.593 . . . . 7.4000000000000004 112.427 -172.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.0 t -100.57 26.87 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.297 0.57 . . . . 5.0599999999999996 111.316 -170.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 57' ' ' VAL . 2.1 pt -152.86 156.12 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 116.033 -0.53 . . . . 3.1699999999999999 110.093 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.31 28.17 64.08 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.596 -0.729 . . . . 3.2400000000000002 111.71 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.729 ' HB3' HG12 ' A' ' 39' ' ' ILE . 49.4 tptt -90.82 113.9 26.17 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 120.961 0.41 . . . . 3.8500000000000001 110.532 -174.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.481 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 3.5 p30 -114.37 124.97 53.29 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.67 -0.696 . . . . 4.1799999999999997 110.224 176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -133.59 129.05 36.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.262 -0.881 . . . . 6.6600000000000001 109.594 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -119.59 -68.51 0.91 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.114 0.483 . . . . 8.1300000000000008 110.809 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -149.95 29.86 0.73 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.861 0.839 . . . . 10.050000000000001 109.256 -177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.25 152.08 45.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.314 -1.312 . . . . 7.9400000000000004 110.683 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 m -89.92 50.57 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.408 0.623 . . . . 9.3499999999999996 112.378 -171.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.507 ' N ' ' HD2' ' A' ' 68' ' ' PRO . . . -84.32 -51.42 0.58 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.773 -0.649 . . . . 9.1600000000000001 111.995 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 67' ' ' ALA . 34.7 Cg_endo -64.74 119.05 5.99 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.004 1.803 . . . . 10.35 112.724 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.1 m -135.54 112.49 10.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.705 -0.68 . . . . 11.49 111.033 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 71' ' ' ASP . 2.4 m 66.76 158.01 0.12 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.341 -0.845 . . . . 10.949999999999999 111.458 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.452 ' N ' HG22 ' A' ' 70' ' ' THR . 2.5 m-20 -62.59 120.17 10.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.918 0.389 . . . . 11.56 110.932 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 m -127.94 86.46 58.12 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.074 -0.512 . . . . 10.960000000000001 110.266 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -81.3 37.92 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.695 2.93 . . . . 10.68 112.955 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -85.82 -36.4 20.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.11 0.481 . . . . 11.76 110.495 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -132.71 178.86 6.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.313 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.859 ' HB2' ' HB2' ' A' ' 79' ' ' PHE . 43.7 p90 50.43 122.87 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.949 1.299 . . . . 7.5300000000000002 113.291 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.61 -58.24 4.24 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.851 -1.166 . . . . 3.2000000000000002 112.191 -172.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 81' ' ' GLU . 73.8 mmtt -138.43 33.57 2.28 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 109.088 -0.708 . . . . 4.1399999999999997 109.088 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.897 ' HA ' HD11 ' A' ' 88' ' ' LEU . 35.9 t80 -44.61 -47.35 10.39 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 114.094 1.146 . . . . 0.94999999999999996 114.094 -160.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -79.58 -30.25 41.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.656 0.741 . . . . 3.48 109.578 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 68.1 tt0 -73.7 -31.52 63.46 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.975 -1.011 . . . . 3.0699999999999998 108.274 176.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.817 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.27 -43.67 99.07 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.613 -1.176 . . . . 0.55000000000000004 111.259 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 79' ' ' PHE . 73.7 t -65.43 -47.68 85.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.368 -0.916 . . . . 0.84999999999999998 110.526 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.8 -31.05 56.72 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.779 -0.646 . . . . 1.1200000000000001 111.225 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.2 t -66.46 -34.26 77.53 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.264 -1.013 . . . . 1.8799999999999999 108.264 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.62 12.48 58.15 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.24 -0.891 . . . . 1.6599999999999999 111.699 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.561 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 6.3 p30 -162.28 59.13 0.23 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.572 0.701 . . . . 2.0800000000000001 111.475 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.897 HD11 ' HA ' ' A' ' 79' ' ' PHE . 1.4 tt -60.6 93.01 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.451 -0.795 . . . . 0.56000000000000005 110.746 172.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.729 ' HA ' ' O ' ' A' ' 109' ' ' MET . 8.1 t30 -140.63 101.52 4.11 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.662 -0.495 . . . . 2.0099999999999998 109.662 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 108' ' ' HIS . 6.3 m -137.26 149.44 47.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.48 -0.327 . . . . 1.6699999999999999 110.202 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 18.0 ptt? -134.08 128.8 34.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.063 -0.517 . . . . 3.9399999999999999 109.865 175.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -161.83 154.01 19.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.964 -0.562 . . . . 2.4700000000000002 109.937 -174.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.741 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 37.1 mt-10 -110.8 112.21 23.92 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.67 -0.493 . . . . 1.97 109.67 176.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 96' ' ' PHE . 36.5 p90 -131.73 161.27 33.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.133 0.492 . . . . 4.29 111.421 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -99.32 104.23 16.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.421 -0.809 . . . . 2.8900000000000001 110.892 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.425 ' HB3' ' CE1' ' A' ' 94' ' ' TYR . 31.9 p90 -87.57 -17.81 31.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.928 0.394 . . . . 5.25 111.014 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -137.48 131.3 31.67 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.778 -0.453 . . . . 6.0599999999999996 109.778 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -113.86 95.61 5.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.901 0.381 . . . . 9.7699999999999996 111.345 -175.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -112.32 -148.8 0.44 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.478 -0.564 . . . . 8.3399999999999999 109.478 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -55.07 -47.62 74.63 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.196 -0.668 . . . . 8.1899999999999995 109.196 173.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.2 p -100.25 144.83 29.18 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 115.211 -0.904 . . . . 5.0999999999999996 110.151 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.24 100.64 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.182 1.921 . . . . 4.5099999999999998 110.331 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.5 m -67.18 97.35 0.52 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.455 0.645 . . . . 2.5899999999999999 110.21 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 104' ' ' LYS . 5.2 ttmp? -104.54 119.59 39.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.11 -0.95 . . . . 3.1200000000000001 110.418 -174.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 17.3 m -109.45 159.48 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.903 -0.59 . . . . 1.23 111.324 177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.741 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -108.85 113.43 26.34 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.827 -1.175 . . . . 2.3599999999999999 107.827 175.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 91' ' ' MET . 3.5 m -100.45 144.86 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 C-N-CA 119.872 -0.731 . . . . 1.1100000000000001 112.138 -178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.3 t-160 -135.9 102.19 4.98 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.335 -1.302 . . . . 1.01 107.497 164.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.729 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 63.1 mtt -100.92 116.33 32.52 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.459 -1.682 . . . . 2.2200000000000002 106.459 176.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 58.8 pttt -132.14 136.64 47.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.218 -0.993 . . . . 1.73 110.999 -168.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.634 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 35.1 tttm -55.6 119.56 5.88 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.138 -0.937 . . . . 1.78 110.57 170.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.84 146.85 13.04 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.119 -0.946 . . . . 0.45000000000000001 110.159 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.5 tp -61.96 -25.23 67.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.547 -0.297 . . . . 2.3900000000000001 110.744 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.9 m -76.48 -67.42 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.363 -0.38 . . . . 1.6599999999999999 110.749 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 143.89 161.93 9.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.63 -0.795 . . . . 1.52 112.447 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 t70 54.57 37.43 27.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.445 1.117 . . . . 2.79 111.003 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.606 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 5.5 p -167.8 150.41 5.77 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.346 -1.297 . . . . 0.44 108.962 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.634 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 57.2 m-85 -141.66 141.57 33.37 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.702 0.287 . . . . 0.41999999999999998 110.416 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.669 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 46.3 m95 -90.58 165.73 13.59 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.457 0.646 . . . . 0.41999999999999998 111.391 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.0 t -135.61 96.07 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.308 -1.314 . . . . 0.62 108.877 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.511 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 45.8 m-85 -92.71 132.24 37.1 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.613 -0.884 . . . . 1.49 108.613 172.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.459 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 8.2 p -144.75 137.03 21.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.788 0.328 . . . . 1.6100000000000001 110.636 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -145.29 132.62 20.62 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.85 -0.426 . . . . 3.4500000000000002 109.85 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -106.11 157.11 17.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.134 0.492 . . . . 4.2300000000000004 110.624 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.622 HG13 ' HE2' ' A' ' 106' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 117.836 -1.078 . . . . 3.3399999999999999 110.137 175.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.995 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 109.368 -0.604 . . . . 8.7200000000000006 109.368 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.76 144.06 26.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.535 0.207 . . . . 6.1799999999999997 110.811 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -124.26 -57.6 1.58 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.519 -0.549 . . . . 6.1500000000000004 109.519 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.32 49.7 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 114.915 -1.039 . . . . 1.4299999999999999 110.862 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.42 102.42 15.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.304 0.573 . . . . 0.69999999999999996 112.148 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.568 HG13 ' HA ' ' A' ' 42' ' ' TYR . 5.4 tt -124.44 139.7 49.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.695 -0.684 . . . . 0.90000000000000002 109.383 172.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.551 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -116.65 137.12 52.42 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.62 0.724 . . . . 2.2200000000000002 111.844 -176.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.914 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.6 pp -126.86 165.34 19.52 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.824 -1.08 . . . . 0.71999999999999997 110.31 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 14.8 p30 -97.2 158.66 15.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.302 0.573 . . . . 1.1499999999999999 110.211 175.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.629 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -79.49 26.27 2.68 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.539 -0.755 . . . . 1.2 111.725 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 34' ' ' ASP . 5.7 t70 -104.91 -18.59 14.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.203 0.525 . . . . 1.8100000000000001 109.691 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.44 3.73 5.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.312 -0.946 . . . . 1.05 114.209 171.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.44 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -144.81 159.84 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.97 0.885 . . . . 1.5700000000000001 111.979 -176.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.914 HD13 ' HB3' ' A' ' 33' ' ' LEU . 7.5 mm -70.06 146.79 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.066 -0.97 . . . . 1.1799999999999999 109.747 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.503 ' HB3' ' OE1' ' A' ' 32' ' ' GLN . 46.8 tp -112.41 -46.17 3.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.219 -0.446 . . . . 1.5600000000000001 110.666 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -147.08 119.98 8.72 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.288 0.566 . . . . 2.4100000000000001 111.929 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.883 ' HB3' HG12 ' A' ' 57' ' ' VAL . 68.4 t80 -98.16 134.69 40.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.927 -0.578 . . . . 1.4199999999999999 109.564 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -107.1 101.16 10.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.865 0.364 . . . . 1.21 110.786 -177.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.63 109.18 20.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.001 -0.545 . . . . 2.5 110.213 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.53 125.2 28.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.101 -0.499 . . . . 4.0 110.064 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 64.35 70.71 0.49 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.816 0.817 . . . . 7.21 109.788 -174.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.66 -114.63 0.58 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.877 -1.056 . . . . 6.9699999999999998 110.988 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -152.27 121.84 6.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.612 0.72 . . . . 8.5899999999999999 110.679 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.84 81.43 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.734 -1.121 . . . . 9.2400000000000002 109.125 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.29 153.72 43.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.608 -0.723 . . . . 9.8200000000000003 111.683 -172.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.38 -48.42 85.29 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.403 -0.679 . . . . 9.6199999999999992 111.403 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -109.89 84.67 1.97 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.241 -1.022 . . . . 12.720000000000001 108.241 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -94.15 126.7 47.66 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.337 -0.392 . . . . 8.2400000000000002 110.314 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -77.51 -6.76 16.5 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.979 2.452 . . . . 8.1099999999999994 112.832 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -91.95 150.93 20.75 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.872 -0.418 . . . . 9.2400000000000002 109.872 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -86.58 -23.16 25.89 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.008 -0.738 . . . . 7.4000000000000004 109.008 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.883 HG12 ' HB3' ' A' ' 42' ' ' TYR . 6.0 t 56.2 67.93 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.139 -0.937 . . . . 5.0599999999999996 110.579 177.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.706 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -128.59 157.03 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.517 -0.765 . . . . 3.1699999999999999 110.484 -178.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.83 -26.54 12.7 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.59 -1.004 . . . . 3.2400000000000002 110.59 170.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.697 ' HB3' HG12 ' A' ' 39' ' ' ILE . 4.2 tppp? -117.93 120.54 38.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.072 -0.564 . . . . 3.8500000000000001 110.176 178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -129.36 125.33 36.41 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.34 0.59 . . . . 4.1799999999999997 110.085 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 38' ' ' ASN . 30.4 m-85 -70.28 95.86 1.06 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.481 -0.782 . . . . 6.6600000000000001 111.384 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.484 ' CD1' ' HG2' ' A' ' 64' ' ' LYS . 75.9 t80 -94.35 -58.77 2.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.428 -0.953 . . . . 8.1300000000000008 108.428 174.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.484 ' HG2' ' CD1' ' A' ' 63' ' ' PHE . 13.9 ptpt 177.58 82.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.095 -0.957 . . . . 10.050000000000001 110.043 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -98.88 -69.24 0.77 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.737 -0.665 . . . . 7.9400000000000004 110.242 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 66' ' ' VAL . 14.7 p 35.84 64.33 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 122.889 1.328 . . . . 9.3499999999999996 112.873 176.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.09 141.48 74.56 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.095 -0.957 . . . . 9.1600000000000001 110.778 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.97 14.64 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.735 2.29 . . . . 10.35 112.848 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 91.5 m -146.84 162.47 38.57 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.28 -0.637 . . . . 11.49 109.28 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.2 p 44.23 63.76 1.53 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.794 0.684 . . . . 10.949999999999999 112.055 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.61 -46.34 66.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.318 -0.855 . . . . 11.56 111.538 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 19.7 m -73.22 115.18 38.29 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.158 -0.474 . . . . 10.960000000000001 110.445 178.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 72' ' ' SER . 3.1 Cg_exo -81.34 41.47 1.15 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.289 2.659 . . . . 10.68 111.779 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . 8.4 pt-20 -109.03 150.18 28.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.222 0.534 . . . . 11.76 111.963 -173.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -158.61 42.45 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.991 -1.115 . . . . 10.0 107.991 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -119.33 -97.83 0.46 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.35 -0.841 . . . . 7.5300000000000002 110.781 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -138.56 56.44 0.65 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.293 -0.723 . . . . 3.2000000000000002 111.293 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 81' ' ' GLU . 58.7 mtpt 63.26 86.06 0.12 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.605 0.717 . . . . 4.1399999999999997 110.44 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.629 ' HZ ' ' HA2' ' A' ' 35' ' ' GLY . 92.4 t80 -74.5 -51.49 14.62 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.068 -0.969 . . . . 0.94999999999999996 111.083 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -61.7 -30.84 71.01 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 123.861 0.726 . . . . 3.48 110.217 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 8.3 tp10 -75.3 -37.36 60.89 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.584 -0.895 . . . . 3.0699999999999998 108.584 177.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.978 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.13 -42.27 97.01 Favored Glycine 0 N--CA 1.435 -1.415 0 CA-C-N 115.227 -0.897 . . . . 0.55000000000000004 111.396 176.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.8 t -63.24 -50.01 80.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.296 -0.952 . . . . 0.84999999999999998 110.685 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.75 -27.82 55.5 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.883 -0.599 . . . . 1.1200000000000001 111.036 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.0 m -65.17 -25.58 67.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.471 -0.566 . . . . 1.8799999999999999 109.471 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.38 22.58 70.09 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.729 -0.669 . . . . 1.6599999999999999 112.467 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.647 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 8.8 p30 -165.54 48.66 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.37 0.605 . . . . 2.0800000000000001 111.606 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.978 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.6 tt -58.28 93.81 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.382 -0.826 . . . . 0.56000000000000005 111.991 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.694 ' HA ' ' O ' ' A' ' 109' ' ' MET . 3.6 p30 -145.71 100.61 3.45 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.202 -0.666 . . . . 2.0099999999999998 109.202 172.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 91' ' ' MET . 3.7 m -149.43 154.14 38.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.552 -0.717 . . . . 1.6699999999999999 110.145 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.589 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 24.0 ptt? -109.05 123.85 49.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.051 0.453 . . . . 3.9399999999999999 110.242 172.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -122.88 112.31 17.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.034 -0.728 . . . . 2.4700000000000002 109.034 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 31.1 mt-10 -105.8 106.52 17.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.391 -0.368 . . . . 1.97 110.209 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -127.59 132.77 49.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.42 0.628 . . . . 4.29 111.081 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 10.8 m -85.12 146.64 27.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.283 -0.871 . . . . 2.8900000000000001 109.437 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.496 ' HD2' ' HB ' ' A' ' 103' ' ' THR . 73.2 m-85 -66.6 133.36 50.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.92 0.39 . . . . 5.25 110.73 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.11 112.78 6.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.872 -0.604 . . . . 6.0599999999999996 109.983 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -155.32 -60.39 0.11 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.043 -0.526 . . . . 9.7699999999999996 109.919 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.631 ' HG2' ' HG3' ' A' ' 100' ' ' MET . 36.2 tt0 -158.13 -78.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 8.3399999999999999 110.733 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.631 ' HG3' ' HG2' ' A' ' 99' ' ' GLN . 87.9 mtp -118.58 -87.76 0.62 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.634 0.254 . . . . 8.1899999999999995 110.37 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.63 92.0 13.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.315 0.579 . . . . 5.0999999999999996 110.743 175.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -81.62 -60.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.913 2.408 . . . . 4.5099999999999998 110.476 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 96' ' ' PHE . 30.7 m -144.54 127.72 16.67 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.531 -0.759 . . . . 2.5899999999999999 109.509 173.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 4.5 ttmp? -106.99 119.4 39.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.672 -0.492 . . . . 3.1200000000000001 109.672 175.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' A' ' 124' ' ' ARG . 28.2 m -101.36 157.51 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.45 0.643 . . . . 1.23 110.866 175.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -134.24 117.68 16.75 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.313 -0.858 . . . . 2.3599999999999999 109.164 176.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.1 t -94.99 105.47 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.904 0 CA-C-N 115.824 -0.626 . . . . 1.1100000000000001 109.958 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.0 t-160 -101.57 102.64 13.4 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.268 -1.382 . . . . 1.01 107.268 169.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.694 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 67.4 mtp -91.32 145.7 24.43 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.076 -1.083 . . . . 2.2200000000000002 108.076 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -148.5 119.19 7.5 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.84 -0.744 . . . . 1.73 109.385 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.647 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 68.9 tttt -55.4 122.94 12.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.473 0.654 . . . . 1.78 111.043 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.26 146.14 52.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.745 -1.116 . . . . 0.45000000000000001 110.436 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.44 4.34 11.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.026 0.441 . . . . 2.3900000000000001 110.878 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.0 t -79.01 -55.94 4.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.989 -0.55 . . . . 1.6599999999999999 109.764 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 134.02 126.5 2.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.81 -0.71 . . . . 1.52 112.654 176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.86 35.47 25.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.84 0.828 . . . . 2.79 111.074 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.2 p -141.0 151.46 44.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.202 -1.363 . . . . 0.44 108.793 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.559 ' CE1' HG22 ' A' ' 83' ' ' VAL . 25.8 m-85 -142.88 136.99 29.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.397 -0.365 . . . . 0.41999999999999998 110.271 -173.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.551 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 50.2 m95 -86.09 164.63 17.19 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.448 0.642 . . . . 0.41999999999999998 110.961 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.574 HG12 HG13 ' A' ' 122' ' ' VAL . 57.7 t -134.76 97.26 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.264 -1.335 . . . . 0.62 108.472 175.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 52.9 m-85 -96.35 101.54 13.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.454 -0.943 . . . . 1.49 108.454 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.574 HG13 HG12 ' A' ' 120' ' ' VAL . 24.9 m -99.85 162.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.547 0.689 . . . . 1.6100000000000001 111.533 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.468 ' HB3' ' CG ' ' A' ' 106' ' ' LYS . 56.9 tptt -152.68 120.71 6.18 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.638 -1.165 . . . . 3.4500000000000002 108.757 171.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.554 ' HB3' HG12 ' A' ' 105' ' ' VAL . 13.5 ptm180 -107.79 122.23 46.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.181 0.515 . . . . 4.2300000000000004 111.435 -177.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.251 -0.881 . . . . 3.3399999999999999 109.327 175.694 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 1.003 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.917 0.389 . . . . 8.7200000000000006 110.218 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.01 118.62 33.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.276 -0.42 . . . . 6.1799999999999997 110.706 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.416 ' HB2' ' OH ' ' A' ' 42' ' ' TYR . 75.4 m-85 -82.2 97.5 8.27 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.202 -0.666 . . . . 6.1500000000000004 109.202 176.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -99.2 0.42 57.24 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.774 -0.727 . . . . 1.4299999999999999 113.686 -172.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.47 102.28 11.76 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 117.473 0.636 . . . . 0.69999999999999996 111.18 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.525 HG13 ' HA ' ' A' ' 42' ' ' TYR . 4.4 tt -133.6 141.33 44.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.322 -0.399 . . . . 0.90000000000000002 110.561 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.579 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 11.7 pt20 -113.88 135.01 54.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.27 0.557 . . . . 2.2200000000000002 111.304 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.726 ' HB3' HD13 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -126.8 166.38 17.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.471 -0.786 . . . . 0.71999999999999997 110.339 175.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.462 ' HA ' ' CB ' ' A' ' 117' ' ' SER . 3.3 p30 -92.06 158.3 16.3 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.876 -0.602 . . . . 1.1499999999999999 110.576 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -81.05 11.97 39.62 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.337 -0.847 . . . . 1.2 112.082 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -90.94 -25.44 19.77 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.173 -0.677 . . . . 1.8100000000000001 109.173 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.36 23.61 2.85 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.354 -0.839 . . . . 1.05 112.395 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -132.52 155.56 48.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.124 -0.324 . . . . 1.5700000000000001 110.124 -177.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.99 HG12 ' HB3' ' A' ' 60' ' ' LYS . 36.6 mm -74.05 138.24 21.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.408 -0.96 . . . . 1.1799999999999999 108.408 171.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.549 HD23 HE21 ' A' ' 32' ' ' GLN . 27.8 tp -105.21 -49.49 3.45 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.814 -0.354 . . . . 1.5600000000000001 110.806 -174.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -154.97 128.22 8.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 2.4100000000000001 110.999 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.889 ' HB3' HG12 ' A' ' 57' ' ' VAL . 66.0 t80 -98.63 119.66 37.73 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.917 -0.771 . . . . 1.4199999999999999 108.917 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -97.19 120.8 38.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.051 0.453 . . . . 1.21 111.716 -169.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.54 81.16 1.64 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.538 -0.755 . . . . 2.5 109.105 172.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.33 90.96 1.63 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.63 -0.714 . . . . 4.0 110.722 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -108.27 18.87 20.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.665 -0.698 . . . . 7.21 109.969 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.94 -3.17 9.9 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.201 -0.759 . . . . 6.9699999999999998 111.201 -174.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -132.23 144.05 50.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.021 -0.733 . . . . 8.5899999999999999 109.021 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.28 -42.12 82.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.113 -0.494 . . . . 9.2400000000000002 110.426 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.0 m 67.22 150.42 0.06 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.492 -0.776 . . . . 9.8200000000000003 111.123 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.77 120.43 18.82 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.058 -0.592 . . . . 9.6199999999999992 112.618 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -71.02 136.33 48.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.614 0.245 . . . . 12.720000000000001 110.511 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -148.99 119.41 4.1 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.524 -0.307 . . . . 8.2400000000000002 110.231 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.89 -14.74 32.7 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.901 2.401 . . . . 8.1099999999999994 113.179 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 72.1 mmtt -102.48 5.85 39.72 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.607 0.718 . . . . 9.2400000000000002 110.98 -178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -96.11 -24.47 16.28 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.639 -1.164 . . . . 7.4000000000000004 108.859 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.889 HG12 ' HB3' ' A' ' 42' ' ' TYR . 32.6 m -97.24 178.74 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.953 -1.022 . . . . 5.0599999999999996 110.204 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.863 HG12 HG23 ' A' ' 57' ' ' VAL . 19.6 pt 37.31 65.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.262 1.025 . . . . 3.1699999999999999 113.486 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.52 -36.52 54.3 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 114.533 -1.212 . . . . 3.2400000000000002 111.808 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.99 ' HB3' HG12 ' A' ' 39' ' ' ILE . 53.9 tptt -88.46 92.15 9.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.084 0.468 . . . . 3.8500000000000001 109.97 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -139.46 94.38 2.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.699 -0.682 . . . . 4.1799999999999997 109.873 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 174.26 132.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.424 -0.954 . . . . 6.6600000000000001 108.424 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -100.02 -33.3 10.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.854 0.359 . . . . 8.1300000000000008 111.028 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 44.0 mtpt -106.32 97.65 7.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.9 0.381 . . . . 10.050000000000001 111.456 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -90.36 112.32 23.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.081 -0.509 . . . . 7.9400000000000004 109.738 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.8 m -124.91 22.42 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.234 0.54 . . . . 9.3499999999999996 110.498 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -102.87 139.9 20.56 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.852 -0.613 . . . . 9.1600000000000001 110.589 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 21.1 Cg_exo -65.86 80.76 0.26 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.927 2.418 . . . . 10.35 111.618 175.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 69.1 m -131.53 137.53 48.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.539 -0.755 . . . . 11.49 109.227 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 m -71.95 124.09 24.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.638 -0.255 . . . . 10.949999999999999 110.549 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -69.09 120.88 15.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.163 0.506 . . . . 11.56 109.912 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.481 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 35.2 t -168.65 -45.9 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.527 -0.761 . . . . 10.960000000000001 111.666 -174.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 72' ' ' SER . 51.8 Cg_exo -57.14 -43.52 52.47 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 121.944 1.762 . . . . 10.68 112.269 177.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HG2' ' HD3' ' A' ' 60' ' ' LYS . 1.2 mt-10 -91.42 -175.77 4.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.813 -0.63 . . . . 11.76 110.117 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 90.8 m-85 73.9 -28.17 0.19 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.386 0.675 . . . . 10.0 112.151 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 47.76 -97.89 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.472 0.709 . . . . 7.5300000000000002 112.891 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.3 99.95 0.25 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.098 -1.049 . . . . 3.2000000000000002 111.88 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt 65.25 18.24 11.32 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 123.656 0.268 . . . . 4.1399999999999997 111.704 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.556 ' O ' HG23 ' A' ' 83' ' ' VAL . 42.5 t80 -49.5 -33.92 15.77 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 111.617 0.229 . . . . 0.94999999999999996 111.617 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -62.36 -42.66 99.58 Favored 'General case' 0 C--N 1.34 0.191 0 O-C-N 124.103 0.877 . . . . 3.48 109.928 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -88.86 -23.16 22.85 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.775 -1.102 . . . . 3.0699999999999998 109.827 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.717 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -62.73 -43.75 98.5 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 115.923 -0.58 . . . . 0.55000000000000004 111.849 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 79' ' ' PHE . 84.5 t -66.98 -47.02 83.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.842 -0.679 . . . . 0.84999999999999998 110.34 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.77 -26.13 57.1 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.583 -0.735 . . . . 1.1200000000000001 110.734 -173.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 t -63.64 -33.45 75.65 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.806 -0.813 . . . . 1.8799999999999999 108.806 172.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.08 2.68 55.92 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.403 -0.817 . . . . 1.6599999999999999 112.114 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.631 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -171.42 66.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.511 0.672 . . . . 2.0800000000000001 111.401 -177.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.717 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -56.44 88.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.086 -0.961 . . . . 0.56000000000000005 110.888 171.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.754 ' HA ' ' O ' ' A' ' 109' ' ' MET . 27.9 t30 -143.43 101.54 3.8 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.695 -0.483 . . . . 2.0099999999999998 109.695 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.3 t -163.25 158.38 21.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.183 0.516 . . . . 1.6699999999999999 110.875 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 23.8 ptp -91.99 137.46 32.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.223 -0.899 . . . . 3.9399999999999999 108.941 170.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.565 ' O ' HG22 ' A' ' 107' ' ' VAL . 23.3 t80 -148.36 109.07 4.2 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.248 0.547 . . . . 2.4700000000000002 109.981 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -101.44 104.24 15.17 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.147 -0.479 . . . . 1.97 109.768 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -121.11 150.31 41.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.067 0.46 . . . . 4.29 110.923 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 m -118.67 150.51 39.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.736 -0.665 . . . . 2.8900000000000001 110.755 -176.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -86.84 127.9 35.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.917 -0.772 . . . . 5.25 108.917 172.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -58.54 -47.07 85.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.955 0.407 . . . . 6.0599999999999996 110.529 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -130.19 -82.61 0.55 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.022 -0.535 . . . . 9.7699999999999996 110.659 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 67.18 -67.32 0.17 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.882 0.739 . . . . 8.3399999999999999 110.151 -175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 15.8 tpt -171.24 -59.51 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.78 -0.822 . . . . 8.1899999999999995 108.78 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.3 m -125.73 96.4 38.11 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.248 -1.019 . . . . 5.0999999999999996 108.248 174.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -45.29 101.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.741 2.961 . . . . 4.5099999999999998 113.483 -172.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.0 m -105.54 135.95 46.01 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.795 -0.639 . . . . 2.5899999999999999 110.612 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -97.76 124.19 42.01 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.06 -0.718 . . . . 3.1200000000000001 109.06 171.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.2 m -101.21 155.46 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-O 121.34 0.591 . . . . 1.23 110.625 173.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.532 ' HB2' ' HG2' ' A' ' 123' ' ' LYS . 22.4 mtpp -128.97 105.58 8.31 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.25 -0.886 . . . . 2.3599999999999999 108.903 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 92' ' ' PHE . 5.2 m -105.08 144.37 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 C-N-CA 119.562 -0.855 . . . . 1.1100000000000001 112.177 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -117.61 103.11 9.73 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 105.674 -1.973 . . . . 1.01 105.674 156.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.754 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 9.1 ptp -106.28 128.4 53.94 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.081 -1.081 . . . . 2.2200000000000002 108.081 -178.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 21.6 ptmt -139.44 133.16 30.6 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.613 -0.435 . . . . 1.73 110.847 -167.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 87' ' ' ASN . 86.0 tttt -56.82 108.38 0.5 Allowed 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.597 0.713 . . . . 1.78 110.719 171.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.428 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -53.7 137.38 37.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.104 -1.407 . . . . 0.45000000000000001 110.489 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.62 3.81 7.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.247 -0.433 . . . . 2.3900000000000001 110.93 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.9 m -80.91 -32.37 34.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 1.6599999999999999 111.102 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 139.2 112.78 1.06 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.734 -0.746 . . . . 1.52 113.111 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 t70 26.96 72.48 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.821 1.248 . . . . 2.79 113.079 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 111' ' ' LYS . 1.3 p -153.81 159.71 41.97 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.837 -1.912 . . . . 0.44 105.837 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.536 ' HE1' HG22 ' A' ' 83' ' ' VAL . 17.1 m-85 -136.32 134.89 38.42 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.819 -0.752 . . . . 0.41999999999999998 111.963 -175.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.579 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 41.9 m95 -85.89 165.85 16.46 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.746 -0.661 . . . . 0.41999999999999998 111.164 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.547 HG23 HD21 ' A' ' 33' ' ' LEU . 95.9 t -139.21 97.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.388 -1.278 . . . . 0.62 108.877 172.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.543 ' HE1' ' HD3' ' A' ' 110' ' ' LYS . 90.3 m-85 -93.14 101.92 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.394 -0.965 . . . . 1.49 108.394 170.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 123' ' ' LYS . 13.2 p -115.62 149.99 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.153 0.502 . . . . 1.6100000000000001 111.869 -172.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HG2' ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -147.83 145.5 28.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.147 -1.057 . . . . 3.4500000000000002 108.147 173.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -116.37 143.21 45.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.306 0.574 . . . . 4.2300000000000004 112.124 -171.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.4 t . . . . . 0 C--O 1.252 1.222 0 CA-C-N 115.233 -0.894 . . . . 3.3399999999999999 109.515 175.869 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.979 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.751 -0.462 . . . . 8.7200000000000006 109.751 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 45' ' ' ALA . . . -112.48 -171.97 1.96 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.42 -0.354 . . . . 6.1799999999999997 110.203 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.407 ' HA ' ' HB1' ' A' ' 44' ' ' ALA . 97.6 m-85 71.71 152.21 0.11 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.8 0.687 . . . . 6.1500000000000004 111.14 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 122' ' ' VAL . . . 166.13 -79.34 0.12 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.748 -1.215 . . . . 1.4299999999999999 113.812 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.34 102.72 14.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.662 0.615 . . . . 0.69999999999999996 112.662 -166.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -126.49 139.9 50.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.11 -0.7 . . . . 0.90000000000000002 109.11 172.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.59 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.2 pp0? -115.33 136.35 53.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.411 0.624 . . . . 2.2200000000000002 111.366 -175.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 pp -139.13 156.14 47.35 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.97 -1.014 . . . . 0.71999999999999997 110.231 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.894 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 4.9 p30 -86.3 155.13 20.78 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.399 0.619 . . . . 1.1499999999999999 110.673 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.59 14.48 17.68 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.375 -0.829 . . . . 1.2 111.871 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -100.97 -26.13 13.83 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.126 0.488 . . . . 1.8100000000000001 109.689 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.59 28.84 0.94 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.826 -0.702 . . . . 1.05 113.414 173.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 21.9 m-80 -133.53 142.19 48.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.245 0.522 . . . . 1.5700000000000001 111.13 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.672 HG13 ' HB3' ' A' ' 60' ' ' LYS . 81.3 mt -87.3 131.0 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.953 -0.758 . . . . 1.1799999999999999 108.953 171.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' A' ' 34' ' ' ASP . 66.9 mt -108.31 -49.7 3.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.927 0.344 . . . . 1.5600000000000001 111.927 -171.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' HG12 ' A' ' 31' ' ' ILE . 8.6 tt0 -141.84 128.76 20.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.984 0.421 . . . . 2.4100000000000001 111.547 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -113.69 125.46 54.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.729 -0.668 . . . . 1.4199999999999999 110.328 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -127.75 102.78 6.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 1.21 110.411 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 28' ' ' PHE . . . -153.42 164.39 38.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.447 -0.342 . . . . 2.5 110.895 175.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . . . -74.99 102.63 4.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.074 -0.512 . . . . 4.0 110.93 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -112.34 84.33 1.95 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.768 -0.651 . . . . 7.21 109.676 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.27 -26.17 8.95 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.509 -0.769 . . . . 6.9699999999999998 112.205 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -95.92 112.48 24.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.547 0.689 . . . . 8.5899999999999999 109.485 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 pt -119.41 -28.32 2.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.394 -0.821 . . . . 9.2400000000000002 111.707 -173.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.3 m -60.34 95.13 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.289 0.566 . . . . 9.8200000000000003 111.659 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.21 4.33 66.67 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.935 -0.575 . . . . 9.6199999999999992 112.19 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -109.31 157.32 18.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.729 0.3 . . . . 12.720000000000001 110.56 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.62 99.02 23.87 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.003 -0.544 . . . . 8.2400000000000002 110.096 174.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.58 -22.27 74.04 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.258 2.638 . . . . 8.1099999999999994 112.536 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -78.11 72.13 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.881 0.848 . . . . 9.2400000000000002 110.503 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.23 -49.76 2.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.243 -0.889 . . . . 7.4000000000000004 110.315 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.0 m -100.56 47.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.825 0.822 . . . . 5.0599999999999996 110.603 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.477 HG12 ' N ' ' A' ' 59' ' ' GLY . 14.3 tt -163.54 156.25 2.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.946 -1.024 . . . . 3.1699999999999999 109.049 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.477 ' N ' HG12 ' A' ' 58' ' ' ILE . . . 102.54 13.42 30.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.773 -0.727 . . . . 3.2400000000000002 111.95 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.672 ' HB3' HG13 ' A' ' 39' ' ' ILE . 17.5 tppt? -78.11 119.14 21.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.659 -0.497 . . . . 3.8500000000000001 109.659 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -131.11 98.42 4.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.895 -0.593 . . . . 4.1799999999999997 110.175 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -131.69 114.5 14.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.841 -0.618 . . . . 6.6600000000000001 109.99 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.578 ' HD1' ' HG2' ' A' ' 64' ' ' LYS . 43.1 t80 -97.28 -58.63 1.97 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.302 0.573 . . . . 8.1300000000000008 109.765 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.578 ' HG2' ' HD1' ' A' ' 63' ' ' PHE . 20.3 pttp -154.81 166.77 32.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.415 -0.811 . . . . 10.050000000000001 109.136 177.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -119.74 174.83 6.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.885 0.374 . . . . 7.9400000000000004 110.741 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 66' ' ' VAL . 11.6 p -148.9 37.96 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 122.73 1.252 . . . . 9.3499999999999996 109.638 176.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -143.51 145.09 30.25 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.177 -0.919 . . . . 9.1600000000000001 111.161 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.89 25.16 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.956 2.437 . . . . 10.35 112.604 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 45.4 t -151.92 78.94 1.25 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.7 -0.481 . . . . 11.49 109.7 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.0 p -123.57 -50.12 1.87 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.93 0.395 . . . . 10.949999999999999 111.331 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -81.9 117.36 22.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.272 0.558 . . . . 11.56 112.134 -176.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.432 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 21.7 p -103.24 100.76 18.9 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 107.606 -1.257 . . . . 10.960000000000001 107.606 163.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 72' ' ' SER . 1.8 Cg_endo -41.24 103.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 124.079 3.186 . . . . 10.68 114.355 -168.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 72' ' ' SER . 11.4 pt-20 -153.2 100.15 2.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.672 0.749 . . . . 11.76 110.882 176.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -108.6 118.38 36.64 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.241 -0.651 . . . . 10.0 109.241 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.49 -72.47 0.18 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.116 -0.493 . . . . 7.5300000000000002 111.635 -172.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -116.4 72.01 0.27 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.202 -0.999 . . . . 3.2000000000000002 111.201 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.5 tptt 68.57 10.54 7.94 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.016 0.436 . . . . 4.1399999999999997 109.903 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.822 ' HA ' HD11 ' A' ' 88' ' ' LEU . 44.4 t80 -45.92 -40.9 10.8 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 113.975 1.102 . . . . 0.94999999999999996 113.975 -165.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.951 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -63.94 -38.63 91.78 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 123.37 0.418 . . . . 3.48 110.421 -172.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.85 -27.89 20.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.695 -0.684 . . . . 3.0699999999999998 109.584 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.95 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -55.32 -40.32 75.74 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.695 -0.684 . . . . 0.55000000000000004 112.103 -177.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.3 t -65.37 -53.39 40.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.533 -0.834 . . . . 0.84999999999999998 110.954 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.67 -22.79 32.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.263 -0.426 . . . . 1.1200000000000001 111.637 -171.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.6 t -70.86 -22.32 62.31 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.954 -0.758 . . . . 1.8799999999999999 108.954 172.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.83 26.83 73.32 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.375 -0.83 . . . . 1.6599999999999999 112.241 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.489 ' HA ' ' HD2' ' A' ' 111' ' ' LYS . 29.1 p30 -158.37 44.8 0.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.229 0.538 . . . . 2.0800000000000001 111.72 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.95 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.4 tt -66.06 86.4 0.1 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.151 -0.932 . . . . 0.56000000000000005 111.777 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 109' ' ' MET . 2.6 t-20 -144.56 100.69 3.56 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.813 -0.355 . . . . 2.0099999999999998 110.296 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.8 m -146.0 145.98 30.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.817 -0.438 . . . . 1.6699999999999999 109.817 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.82 116.4 28.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.345 0.593 . . . . 3.9399999999999999 109.609 170.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -133.62 154.55 50.81 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.274 -0.875 . . . . 2.4700000000000002 109.136 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.828 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 7.6 pt-20 -131.28 123.05 27.53 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.78 -0.452 . . . . 1.97 109.78 174.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -124.15 125.11 43.91 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.57 -0.741 . . . . 4.29 110.251 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 9.3 t -97.79 143.72 28.13 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.414 -0.587 . . . . 2.8900000000000001 109.414 174.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -144.13 118.73 9.76 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.546 0.689 . . . . 5.25 111.022 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 10.1 t70 -82.43 97.98 8.66 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.439 -0.801 . . . . 6.0599999999999996 109.087 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -71.55 -33.46 69.15 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.257 -0.577 . . . . 9.7699999999999996 109.809 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -179.36 86.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.512 -0.767 . . . . 8.3399999999999999 109.72 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 47.2 tpp 77.7 -14.71 0.82 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.781 0.832 . . . . 8.1899999999999995 111.136 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 m -114.11 96.54 42.46 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.277 -0.42 . . . . 5.0999999999999996 110.754 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 4.2 Cg_exo -73.92 98.31 1.06 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.743 2.295 . . . . 4.5099999999999998 111.281 176.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 m -79.98 99.35 7.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.132 -0.486 . . . . 2.5899999999999999 110.82 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 49.8 tttp -79.63 102.87 9.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.966 -0.561 . . . . 3.1200000000000001 110.379 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 27.6 m -105.67 160.74 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.361 0.601 . . . . 1.23 111.557 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.828 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 19.6 mmmt -117.46 141.14 48.69 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.152 -0.931 . . . . 2.3599999999999999 109.5 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.2 102.32 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-O 121.113 0.482 . . . . 1.1100000000000001 110.15 173.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.803 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 22.7 t-160 -108.91 102.82 11.8 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.652 -1.24 . . . . 1.01 107.652 171.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 59.8 mtp -108.78 143.75 37.52 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.709 -0.849 . . . . 2.2200000000000002 108.709 -178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -147.55 133.88 19.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.974 -0.69 . . . . 1.73 110.5 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.598 ' HA ' ' HD2' ' A' ' 118' ' ' TYR . 84.0 tttt -55.9 111.59 0.97 Allowed 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 114.879 -1.055 . . . . 1.78 110.334 173.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.26 146.32 54.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.775 -1.102 . . . . 0.45000000000000001 110.898 -173.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.24 -6.83 25.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.983 -0.553 . . . . 2.3900000000000001 110.709 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.496 ' HB2' ' OG ' ' A' ' 117' ' ' SER . 6.5 m -69.96 -29.41 66.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.746 -0.661 . . . . 1.6599999999999999 110.617 176.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 116.16 -68.11 0.29 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.723 -0.751 . . . . 1.52 113.054 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -95.17 22.51 6.64 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.331 0.586 . . . . 2.79 111.503 -172.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.894 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 5.9 p -134.62 157.27 47.04 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.352 -0.84 . . . . 0.44 111.509 -173.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.598 ' HD2' ' HA ' ' A' ' 111' ' ' LYS . 48.3 m-85 -141.3 134.81 29.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.616 -0.72 . . . . 0.41999999999999998 109.387 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.59 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 47.1 m95 -83.42 164.23 20.06 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.08 0.466 . . . . 0.41999999999999998 110.673 -175.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 120' ' ' VAL . 15.0 p -138.34 97.18 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 122.581 1.181 . . . . 0.62 111.328 172.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.803 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 3.8 m-85 -86.69 102.29 14.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.516 -0.765 . . . . 1.49 109.094 177.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.58 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 25.4 m -100.88 153.58 4.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.157 0.503 . . . . 1.6100000000000001 111.49 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 16.7 tppt? -159.15 148.87 18.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.865 -0.607 . . . . 3.4500000000000002 109.679 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -129.41 125.05 35.66 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.553 -0.536 . . . . 4.2300000000000004 109.553 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.434 -0.793 . . . . 3.3399999999999999 110.79 -174.626 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.988 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.675 0.274 . . . . 8.7200000000000006 110.413 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -156.53 162.67 39.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 6.1799999999999997 109.893 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -84.45 111.05 19.12 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.528 -0.545 . . . . 6.1500000000000004 109.528 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 122' ' ' VAL . . . -119.85 70.68 0.35 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.388 -0.911 . . . . 1.4299999999999999 112.529 -176.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' A' ' 43' ' ' ASN . . . -155.46 101.4 2.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.896 0.379 . . . . 0.69999999999999996 110.255 175.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.541 ' HB ' ' CD2' ' A' ' 42' ' ' TYR . 3.2 tt -139.25 141.02 36.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.234 -0.439 . . . . 0.90000000000000002 110.743 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.619 ' HB3' ' CD2' ' A' ' 119' ' ' TRP . 1.8 pt20 -110.81 126.33 54.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.322 0.582 . . . . 2.2200000000000002 110.518 174.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.85 153.05 41.62 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.645 -0.707 . . . . 0.71999999999999997 110.562 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.742 ' OD2' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -85.62 105.57 16.28 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.47 0.652 . . . . 1.1499999999999999 112.407 -171.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.04 ' H ' ' HA ' ' A' ' 117' ' ' SER . . . 37.77 23.7 0.02 OUTLIER Glycine 0 N--CA 1.468 0.768 0 CA-C-N 113.272 -1.786 . . . . 1.2 117.42 161.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 34' ' ' ASP . 12.9 t70 174.75 -57.17 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.926 0.863 . . . . 1.8100000000000001 111.756 -171.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.93 -31.35 0.03 OUTLIER Glycine 0 CA--C 1.524 0.655 0 C-N-CA 119.203 -1.475 . . . . 1.05 115.447 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.742 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 19.0 m-80 -67.84 116.33 8.39 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.728 1.264 . . . . 1.5700000000000001 111.141 -173.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.427 HD12 ' HB2' ' A' ' 60' ' ' LYS . 96.1 mt -70.73 128.62 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.928 -0.578 . . . . 1.1799999999999999 110.616 -178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.7 tp -101.55 -47.58 4.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.75 -0.659 . . . . 1.5600000000000001 110.799 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -151.07 142.86 23.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 2.4100000000000001 111.401 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.541 ' CD2' ' HB ' ' A' ' 31' ' ' ILE . 69.1 t80 -130.5 138.5 50.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.931 -0.577 . . . . 1.4199999999999999 109.729 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 30' ' ' ALA . 39.8 m-80 -100.56 93.42 5.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.851 0.358 . . . . 1.21 111.437 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.86 -27.68 6.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.469 0.652 . . . . 2.5 109.435 171.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.27 130.89 13.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.159 -0.928 . . . . 4.0 109.444 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -96.35 3.42 52.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 7.21 110.473 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.33 -164.59 11.74 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.508 -0.769 . . . . 6.9699999999999998 111.607 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -90.09 137.23 32.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.844 0.354 . . . . 8.5899999999999999 110.782 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.6 42.43 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.564 -0.532 . . . . 9.2400000000000002 109.564 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.7 m 50.47 54.63 10.82 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.309 -0.859 . . . . 9.8200000000000003 110.902 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.75 142.87 3.69 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.744 -0.741 . . . . 9.6199999999999992 111.883 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 52' ' ' ARG . 1.4 mpt_? -90.05 98.4 11.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.818 0.342 . . . . 12.720000000000001 110.501 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.61 108.9 40.21 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.268 -0.424 . . . . 8.2400000000000002 110.729 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 52' ' ' ARG . 92.7 Cg_endo -93.78 1.9 3.19 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.184 2.589 . . . . 8.1099999999999994 113.25 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -82.93 54.25 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.625 0.726 . . . . 9.2400000000000002 111.076 -176.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 42' ' ' TYR . 77.2 mt-30 -115.82 10.29 15.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.121 -0.945 . . . . 7.4000000000000004 110.75 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 t 56.52 68.74 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.623 0.725 . . . . 5.0599999999999996 110.273 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.1 pt -133.19 170.25 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.729 -0.669 . . . . 3.1699999999999999 110.598 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.73 38.75 66.79 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.658 -0.977 . . . . 3.2400000000000002 110.658 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 58.7 tptt -74.95 85.98 2.28 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.901 -0.649 . . . . 3.8500000000000001 110.16 -177.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.503 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 28.7 t-20 -93.51 96.28 9.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.473 0.654 . . . . 4.1799999999999997 109.866 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 65' ' ' ASP . 42.7 t80 -164.95 88.34 0.46 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.719 -1.215 . . . . 6.6600000000000001 107.719 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.688 ' O ' ' HE3' ' A' ' 64' ' ' LYS . 56.6 t80 -72.52 -73.53 0.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.104 -0.498 . . . . 8.1300000000000008 111.139 -171.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.688 ' HE3' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -150.7 71.91 1.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 10.050000000000001 110.247 -177.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 4.4 m-20 -105.35 160.75 14.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.999 -0.546 . . . . 7.9400000000000004 110.197 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.6 t -89.83 77.72 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.979 0.418 . . . . 9.3499999999999996 110.037 -177.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.12 120.19 23.64 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.617 -0.72 . . . . 9.1600000000000001 110.924 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.82 -38.29 94.66 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.236 2.624 . . . . 10.35 113.362 -174.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 70' ' ' THR . 15.1 t -81.42 -19.88 41.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 121.063 -0.255 . . . . 11.49 111.07 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 69' ' ' CYS . 25.9 m 71.07 -54.4 0.67 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.152 0.581 . . . . 10.949999999999999 111.87 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.18 92.01 5.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.046 0.45 . . . . 11.56 110.92 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.625 ' OG ' ' HD3' ' A' ' 73' ' ' PRO . 6.0 p -159.79 -43.25 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.637 -0.711 . . . . 10.960000000000001 111.77 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.625 ' HD3' ' OG ' ' A' ' 72' ' ' SER . 4.7 Cg_exo -82.51 115.27 2.5 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.12 1.88 . . . . 10.68 111.238 172.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -99.41 139.7 34.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.341 -0.391 . . . . 11.76 110.918 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -108.82 149.68 28.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -114.97 -76.15 0.58 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.091 0.775 . . . . 7.5300000000000002 113.091 -170.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.2 86.0 0.4 Allowed Glycine 0 CA--C 1.506 -0.513 0 C-N-CA 119.581 -1.295 . . . . 3.2000000000000002 112.595 -170.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 58.38 25.15 12.5 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.73 -0.47 . . . . 4.1399999999999997 109.73 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.646 ' HA ' HD11 ' A' ' 88' ' ' LEU . 38.7 t80 -50.51 -37.0 36.66 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 115.671 -0.695 . . . . 0.94999999999999996 112.719 -165.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.48 -47.35 73.33 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 123.76 0.663 . . . . 3.48 110.343 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -82.35 -24.81 34.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.346 -0.612 . . . . 3.0699999999999998 109.346 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.93 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -57.66 -42.97 94.53 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.304 -0.719 . . . . 0.55000000000000004 111.304 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 79' ' ' PHE . 81.2 t -67.53 -53.85 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.434 -0.883 . . . . 0.84999999999999998 111.019 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.35 -28.0 52.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.159 -0.473 . . . . 1.1200000000000001 111.412 -169.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.0 t -66.98 -29.27 69.07 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.735 -0.839 . . . . 1.8799999999999999 108.735 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.6 28.36 39.43 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.65 -0.705 . . . . 1.6599999999999999 111.804 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -162.37 52.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.358 0.599 . . . . 2.0800000000000001 111.816 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.93 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -73.13 86.35 1.38 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.907 -0.588 . . . . 0.56000000000000005 110.658 177.111 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 109' ' ' MET . 7.2 t30 -143.9 102.35 3.88 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.619 -0.264 . . . . 2.0099999999999998 110.474 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 t -152.26 161.64 42.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.343 -0.39 . . . . 1.6699999999999999 110.194 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -127.04 146.71 50.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.892 -0.594 . . . . 3.9399999999999999 109.79 174.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -164.19 141.85 6.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.052 -0.522 . . . . 2.4700000000000002 109.802 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.502 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 44.5 mt-10 -103.01 113.14 26.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.361 -0.607 . . . . 1.97 109.361 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -119.53 137.36 53.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.456 . . . . 4.29 110.669 -172.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.455 HG23 ' HG3' ' A' ' 104' ' ' LYS . 1.4 p -93.68 145.03 24.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.385 -0.37 . . . . 2.8900000000000001 110.472 176.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.88 120.43 42.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.185 0.517 . . . . 5.25 111.375 -177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 99' ' ' GLN . 31.9 m-20 -87.85 178.45 6.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.213 -0.903 . . . . 6.0599999999999996 110.001 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.6 t80 73.27 -14.46 0.62 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.72 0.638 . . . . 9.7699999999999996 110.842 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.44 ' H ' ' C ' ' A' ' 97' ' ' ASP . 25.4 mt-30 -80.92 166.13 21.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.125 -0.489 . . . . 8.3399999999999999 109.749 173.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 65.8 mtt -93.36 -4.23 51.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.108 0.48 . . . . 8.1899999999999995 110.67 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.471 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 8.6 t -132.54 141.39 41.03 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.687 -0.688 . . . . 5.0999999999999996 109.729 175.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 6.4 Cg_exo -75.38 62.07 6.09 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.165 2.576 . . . . 4.5099999999999998 112.299 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.7 m -71.7 133.33 45.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.173 -0.467 . . . . 2.5899999999999999 110.568 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.502 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 15.0 ttpt -113.21 131.43 55.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.275 -0.639 . . . . 3.1200000000000001 109.275 176.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.601 HG12 ' HG2' ' A' ' 124' ' ' ARG . 34.2 m -102.31 160.01 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 121.257 0.551 . . . . 1.23 110.457 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 123' ' ' LYS . 38.1 ttpt -129.31 110.64 12.11 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.207 -1.034 . . . . 2.3599999999999999 108.207 172.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 91' ' ' MET . 2.8 m -98.86 144.68 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-O 121.485 0.66 . . . . 1.1100000000000001 112.112 -175.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -137.11 102.08 4.74 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.646 -1.242 . . . . 1.01 107.646 161.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.738 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -97.12 133.46 41.74 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.376 -1.342 . . . . 2.2200000000000002 107.376 173.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HG3' ' HB2' ' A' ' 119' ' ' TRP . 14.8 ptpt -142.06 134.72 28.34 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.228 -0.589 . . . . 1.73 111.271 -172.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 39.1 tttm -56.31 115.11 2.28 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.501 -0.772 . . . . 1.78 110.534 170.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.441 ' HB3' ' OG ' ' A' ' 117' ' ' SER . . . -64.91 147.2 53.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.563 -1.198 . . . . 0.45000000000000001 111.431 -174.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.5 pt? -64.82 -10.11 25.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 2.3900000000000001 111.356 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.2 p -79.84 -4.84 53.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.25 -0.432 . . . . 1.6599999999999999 111.577 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.87 -122.82 6.72 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.638 -0.792 . . . . 1.52 112.229 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -72.15 85.63 1.04 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.547 0.689 . . . . 2.79 110.466 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 1.04 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 3.5 p -176.16 152.46 1.15 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.703 -1.135 . . . . 0.44 108.295 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.556 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 39.3 m-85 -142.07 139.16 32.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.639 0.257 . . . . 0.41999999999999998 110.427 -176.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.619 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 46.1 m95 -88.39 166.81 14.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.488 0.661 . . . . 0.41999999999999998 111.453 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.95 96.5 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.348 -1.296 . . . . 0.62 109.046 173.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.449 ' HE1' ' HD2' ' A' ' 110' ' ' LYS . 90.2 m-85 -95.05 124.33 39.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.402 -0.592 . . . . 1.49 109.402 173.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.479 ' O ' ' HA3' ' A' ' 29' ' ' GLY . 26.0 t -128.52 132.79 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.868 0.366 . . . . 1.6100000000000001 111.002 -176.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 106' ' ' LYS . 74.7 mmtt -118.77 109.04 15.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.71 -0.478 . . . . 3.4500000000000002 109.71 172.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.601 ' HG2' HG12 ' A' ' 105' ' ' VAL . 19.6 mtp180 -101.1 109.89 21.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.546 -0.297 . . . . 4.2300000000000004 110.436 -175.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.125 -0.941 . . . . 3.3399999999999999 111.22 -179.649 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.994 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.533 HD21 ' HE3' ' A' ' 123' ' ' LYS . 58.3 tp . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 120.775 0.322 . . . . 8.7200000000000006 110.943 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.42 97.45 10.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.221 -0.445 . . . . 6.1799999999999997 109.912 173.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -106.83 141.6 37.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.882 -0.599 . . . . 6.1500000000000004 110.084 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' HA3' HG12 ' A' ' 122' ' ' VAL . . . -127.25 141.2 12.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.009 -0.615 . . . . 1.4299999999999999 112.36 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.57 102.15 4.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.886 0.374 . . . . 0.69999999999999996 110.363 173.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.595 HD11 HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -138.98 140.31 38.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.678 -0.489 . . . . 0.90000000000000002 109.678 178.02 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.749 ' HG2' ' HG2' ' A' ' 41' ' ' GLN . 3.7 pt20 -113.96 142.18 46.48 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.885 -0.726 . . . . 2.2200000000000002 111.083 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.62 ' HB3' HD13 ' A' ' 39' ' ' ILE . 4.0 pp -133.02 163.89 28.23 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.083 -0.962 . . . . 0.71999999999999997 110.094 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 2.1 p30 -90.05 151.83 21.45 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.131 0.491 . . . . 1.1499999999999999 110.423 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA2' ' HZ ' ' A' ' 79' ' ' PHE . . . -70.26 -9.65 64.44 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.553 -0.749 . . . . 1.2 111.883 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.45 ' HB3' ' OD1' ' A' ' 34' ' ' ASP . 30.3 t70 -73.04 -36.11 66.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.172 -0.514 . . . . 1.8100000000000001 109.803 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.609 ' O ' ' HG2' ' A' ' 60' ' ' LYS . . . 140.55 1.29 1.68 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.461 -0.876 . . . . 1.05 114.036 171.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.495 ' HB2' ' OD2' ' A' ' 34' ' ' ASP . 3.8 m-80 -107.44 158.39 17.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.34 0.57 . . . . 1.5700000000000001 111.023 -174.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.896 HG12 ' HB3' ' A' ' 60' ' ' LYS . 45.9 mm -85.49 140.99 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.811 -0.811 . . . . 1.1799999999999999 108.811 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.553 HD23 ' NE2' ' A' ' 32' ' ' GLN . 29.9 tp -108.39 -54.21 2.54 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.361 -0.536 . . . . 1.5600000000000001 110.933 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.749 ' HG2' ' HG2' ' A' ' 32' ' ' GLN . 26.4 pt20 -147.98 141.82 25.75 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.351 -0.54 . . . . 2.4100000000000001 111.402 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CB ' ' HA ' ' A' ' 57' ' ' VAL . 92.3 t80 -110.71 119.11 38.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.623 -0.717 . . . . 1.4199999999999999 109.203 175.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 1.1 m-20 -95.16 159.85 14.82 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.394 -0.965 . . . . 1.21 108.394 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 43' ' ' ASN . . . 72.3 166.66 0.3 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.724 0.64 . . . . 2.5 110.37 -172.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.14 130.95 48.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.101 0.477 . . . . 4.0 111.649 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.426 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 7.5 pt-20 -96.59 101.79 13.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.837 -0.619 . . . . 7.21 110.551 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.73 46.87 0.2 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.725 -0.75 . . . . 6.9699999999999998 111.822 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -152.17 114.04 4.41 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.155 -0.313 . . . . 8.5899999999999999 110.155 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.5 mt 54.87 50.89 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 122.137 0.97 . . . . 9.2400000000000002 109.837 -177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 p -105.76 170.89 7.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.298 -0.865 . . . . 9.8200000000000003 111.014 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.45 -56.26 0.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.714 -0.755 . . . . 9.6199999999999992 111.887 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -129.78 156.18 44.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.664 0.269 . . . . 12.720000000000001 110.658 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 21.7 m-20 -81.72 119.23 74.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.938 -0.574 . . . . 8.2400000000000002 111.236 -176.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 3.2 Cg_exo -82.04 -12.26 10.78 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.2 2.6 . . . . 8.1099999999999994 111.632 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt 59.67 71.19 0.59 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.475 0.655 . . . . 9.2400000000000002 110.661 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' HB2' ' OE1' ' A' ' 46' ' ' GLU . 17.9 mt-30 -103.57 -30.38 10.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.185 -0.916 . . . . 7.4000000000000004 111.024 -177.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 57' ' ' VAL . 7.3 p -69.24 87.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 122.407 1.099 . . . . 5.0599999999999996 110.626 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.763 ' HA ' HG21 ' A' ' 39' ' ' ILE . 36.8 mt 60.4 73.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.086 0 CA-C-N 114.673 -1.149 . . . . 3.1699999999999999 109.131 -174.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.24 -20.7 76.95 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.496 -1.229 . . . . 3.2400000000000002 112.488 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.896 ' HB3' HG12 ' A' ' 39' ' ' ILE . 4.9 tppp? -118.73 106.64 12.77 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.984 0.392 . . . . 3.8500000000000001 110.967 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -135.96 95.44 3.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.876 -0.602 . . . . 4.1799999999999997 109.743 171.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.5 t80 48.57 83.02 0.04 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.55 -1.204 . . . . 6.6600000000000001 112.513 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -100.95 -58.12 1.96 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.174 -0.676 . . . . 8.1300000000000008 109.174 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -149.94 -73.94 0.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.848 -1.538 . . . . 10.050000000000001 106.848 173.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 68.26 -14.68 0.24 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.759 -1.109 . . . . 7.9400000000000004 113.603 163.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 67' ' ' ALA . 7.3 p -56.6 -43.29 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.043 0.449 . . . . 9.3499999999999996 110.097 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 66' ' ' VAL . . . -124.86 103.48 30.87 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.194 -0.669 . . . . 9.1600000000000001 109.194 174.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.4 80.44 1.95 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.989 2.459 . . . . 10.35 112.844 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -135.8 143.64 45.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.178 -0.464 . . . . 11.49 109.915 175.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.6 m 54.8 50.42 15.74 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.895 0.855 . . . . 10.949999999999999 110.184 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -142.05 112.87 7.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.166 -0.925 . . . . 11.56 109.888 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.1 m -156.7 121.16 2.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.235 -0.439 . . . . 10.960000000000001 110.929 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -86.45 89.77 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.169 2.579 . . . . 10.68 111.763 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 66.83 -77.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.574 -0.739 . . . . 11.76 112.196 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -133.44 149.03 51.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.156 0.503 . . . . 10.0 111.585 -173.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -145.16 129.59 17.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.329 -0.851 . . . . 7.5300000000000002 109.692 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.8 86.95 1.47 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.709 -0.758 . . . . 3.2000000000000002 111.478 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.5 pttt 42.59 47.77 4.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.432 0.693 . . . . 4.1399999999999997 111.219 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 83' ' ' VAL . 43.0 t80 -50.36 -34.88 25.62 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 115.529 -0.76 . . . . 0.94999999999999996 111.926 -171.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -66.72 -40.02 88.24 Favored 'General case' 0 C--N 1.344 0.338 0 O-C-N 123.813 0.695 . . . . 3.48 110.484 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -80.01 -31.42 39.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.098 -0.704 . . . . 3.0699999999999998 109.098 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.854 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.37 -43.66 97.2 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.559 -0.746 . . . . 0.55000000000000004 111.962 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 79' ' ' PHE . 99.3 t -64.6 -49.32 81.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.77 -0.715 . . . . 0.84999999999999998 110.518 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.37 -24.48 39.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 1.1200000000000001 111.413 -172.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -65.35 -32.95 74.86 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.519 -0.548 . . . . 1.8799999999999999 109.519 173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.3 16.43 66.82 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.881 -0.676 . . . . 1.6599999999999999 111.751 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -162.34 57.27 0.23 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.527 0.68 . . . . 2.0800000000000001 110.861 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.854 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.5 tt -65.08 81.41 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.627 -0.715 . . . . 0.56000000000000005 110.952 175.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 14.5 t30 -144.51 98.25 3.17 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.233 -0.654 . . . . 2.0099999999999998 109.233 175.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 91' ' ' MET . 6.4 m -153.29 153.83 33.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.808 -0.441 . . . . 1.6699999999999999 109.808 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.436 ' N ' HG22 ' A' ' 90' ' ' THR . 17.7 ptm -101.01 116.14 32.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.349 -0.612 . . . . 3.9399999999999999 109.349 167.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -114.86 109.95 18.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.794 -0.639 . . . . 2.4700000000000002 109.873 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 9.4 pt-20 -104.39 114.57 28.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.063 0.459 . . . . 1.97 110.495 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -109.56 135.57 50.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.587 -0.733 . . . . 4.29 110.188 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.2 m -97.08 110.02 22.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.942 0.401 . . . . 2.8900000000000001 110.563 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.599 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 51.7 m-85 -76.96 79.48 3.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.234 0.54 . . . . 5.25 110.886 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -101.16 123.03 44.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.293 -1.003 . . . . 6.0599999999999996 108.293 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -155.82 -69.02 0.12 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.301 0.572 . . . . 9.7699999999999996 110.252 -166.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -159.82 32.24 0.18 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.338 -0.986 . . . . 8.3399999999999999 108.338 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.815 ' HG2' ' H ' ' A' ' 101' ' ' THR . 23.3 ttt -151.14 -161.07 1.26 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.752 -1.113 . . . . 8.1899999999999995 108.395 -173.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.815 ' H ' ' HG2' ' A' ' 100' ' ' MET . 0.8 OUTLIER -80.48 152.52 73.04 Favored Pre-proline 0 N--CA 1.446 -0.668 0 O-C-N 121.962 -0.461 . . . . 5.0999999999999996 110.563 174.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.38 94.78 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.343 2.029 . . . . 4.5099999999999998 111.923 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 96' ' ' PHE . 16.9 m -90.91 97.84 11.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.1 -0.5 . . . . 2.5899999999999999 110.652 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HD2' ' O ' ' A' ' 125' ' ' VAL . 19.2 ttmm -84.11 115.13 22.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.123 -0.49 . . . . 3.1200000000000001 110.166 177.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 31.5 m -101.33 159.2 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 120.792 0.33 . . . . 1.23 110.361 172.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 43.6 mttp -127.26 123.33 36.23 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.157 -0.474 . . . . 2.3599999999999999 110.702 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.47 102.85 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 109.229 -0.656 . . . . 1.1100000000000001 109.229 173.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.752 ' HB3' ' HB2' ' A' ' 121' ' ' PHE . 3.3 t-160 -94.33 102.48 14.48 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.389 -1.708 . . . . 1.01 106.389 168.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 10.7 ttt -120.34 114.93 22.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.048 -1.093 . . . . 2.2200000000000002 108.048 -173.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 64.6 pttt -134.16 135.44 43.1 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 120.048 -0.661 . . . . 1.73 110.418 -169.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 65.4 tttp -57.21 114.4 2.15 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.765 -0.652 . . . . 1.78 110.602 175.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.68 145.45 49.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.774 -1.103 . . . . 0.45000000000000001 110.709 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.22 -13.08 61.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.208 -0.451 . . . . 2.3900000000000001 110.478 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.5 m -61.84 -31.57 71.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.968 -0.56 . . . . 1.6599999999999999 110.236 173.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 129.1 -96.82 0.4 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.575 -0.821 . . . . 1.52 113.03 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -88.68 49.02 1.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.603 0.716 . . . . 2.79 111.088 -171.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 34' ' ' ASP . 3.0 p -147.43 159.37 43.79 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.503 -0.771 . . . . 0.44 109.968 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.556 ' CD2' ' HB3' ' A' ' 88' ' ' LEU . 36.1 m-85 -137.53 137.83 39.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.544 -0.298 . . . . 0.41999999999999998 110.426 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.617 ' CD2' ' HB3' ' A' ' 32' ' ' GLN . 44.0 m95 -85.68 162.46 18.77 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.123 0.487 . . . . 0.41999999999999998 111.176 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.44 HG22 ' HE3' ' A' ' 109' ' ' MET . 50.5 t -135.02 97.56 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.864 -1.062 . . . . 0.62 109.485 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.752 ' HB2' ' HB3' ' A' ' 108' ' ' HIS . 70.8 m-85 -102.31 104.29 14.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.607 -0.886 . . . . 1.49 108.607 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.467 HG12 ' HA3' ' A' ' 29' ' ' GLY . 9.9 p -92.74 148.61 4.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.789 -0.365 . . . . 1.6100000000000001 110.576 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . 34.5 mtpt -150.23 162.52 40.31 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 116.167 -0.469 . . . . 3.4500000000000002 110.173 176.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.509 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 4.6 ptp180 -124.88 144.67 50.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.224 -0.898 . . . . 4.2300000000000004 108.818 170.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 124' ' ' ARG . 99.5 t . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.015 -0.993 . . . . 3.3399999999999999 110.374 -175.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 1.004 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.6 tt . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.503 -0.555 . . . . 8.7200000000000006 109.503 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.61 89.21 3.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.939 0.399 . . . . 6.1799999999999997 110.587 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -82.78 82.61 8.03 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.373 -0.603 . . . . 6.1500000000000004 109.373 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.72 60.84 4.63 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.895 -0.669 . . . . 1.4299999999999999 113.145 -175.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.28 101.99 3.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.082 0.468 . . . . 0.69999999999999996 110.918 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.691 HG13 ' HA ' ' A' ' 42' ' ' TYR . 7.1 tt -130.14 141.25 46.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.111 -0.495 . . . . 0.90000000000000002 110.07 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.542 ' NE2' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -113.88 129.05 56.63 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 116.13 -0.486 . . . . 2.2200000000000002 109.91 -175.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.486 ' HB3' HD13 ' A' ' 39' ' ' ILE . 3.9 pp -126.0 157.55 37.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.156 0.503 . . . . 0.71999999999999997 110.842 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' HA ' ' CB ' ' A' ' 117' ' ' SER . 3.6 p30 -79.24 156.84 27.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.544 0.688 . . . . 1.1499999999999999 110.996 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.545 ' N ' ' HA ' ' A' ' 117' ' ' SER . . . -81.43 35.29 2.43 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.286 -0.87 . . . . 1.2 111.489 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -123.56 -24.6 4.52 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.064 0.459 . . . . 1.8100000000000001 110.048 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.57 7.5 4.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.722 -0.751 . . . . 1.05 113.291 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -126.94 159.49 33.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.129 0.49 . . . . 1.5700000000000001 110.879 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.756 HG12 ' HB3' ' A' ' 60' ' ' LYS . 10.9 mm -70.65 142.43 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 109.598 -0.519 . . . . 1.1799999999999999 109.598 175.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.542 HD23 ' NE2' ' A' ' 32' ' ' GLN . 25.9 tp -109.01 -48.6 3.25 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.953 -0.388 . . . . 1.5600000000000001 109.953 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -153.84 114.49 4.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 2.4100000000000001 110.998 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.691 ' HA ' HG13 ' A' ' 31' ' ' ILE . 55.7 t80 -86.33 130.68 34.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.079 -0.51 . . . . 1.4199999999999999 109.642 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -97.06 118.64 33.93 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.845 0.355 . . . . 1.21 110.356 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.76 171.7 13.79 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.948 -0.569 . . . . 2.5 109.579 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.94 117.51 29.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.566 0.222 . . . . 4.0 111.152 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 57.75 40.96 25.86 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.762 -0.653 . . . . 7.21 111.762 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.13 -59.44 7.42 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.68 -0.771 . . . . 6.9699999999999998 112.353 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -108.78 151.18 26.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.943 0.401 . . . . 8.5899999999999999 110.463 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.6 mt -102.76 53.67 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.23 -0.656 . . . . 9.2400000000000002 109.23 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.473 HG22 ' N ' ' A' ' 51' ' ' GLY . 4.1 m 69.83 159.98 0.19 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.301 -0.863 . . . . 9.8200000000000003 110.555 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 50' ' ' THR . . . 109.49 -33.59 6.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.465 -0.874 . . . . 9.6199999999999992 112.571 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -88.41 161.15 17.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.898 0.38 . . . . 12.720000000000001 110.596 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 19.1 m-20 -83.47 138.77 41.36 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.802 -0.635 . . . . 8.2400000000000002 110.593 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 25.6 Cg_exo -63.63 -31.86 69.72 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.949 2.433 . . . . 8.1099999999999994 112.383 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -84.0 38.24 0.64 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.976 0.417 . . . . 9.2400000000000002 111.227 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -129.68 7.71 5.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.298 0.57 . . . . 7.4000000000000004 110.165 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.629 HG22 ' HB3' ' A' ' 42' ' ' TYR . 11.3 p -96.67 51.63 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.806 1.289 . . . . 5.0599999999999996 111.402 -174.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -126.47 156.79 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.211 -0.904 . . . . 3.1699999999999999 109.704 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.73 -23.99 5.72 Favored Glycine 0 C--N 1.313 -0.7 0 CA-C-N 115.572 -0.74 . . . . 3.2400000000000002 111.93 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.86 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -118.27 123.01 44.36 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 110.009 -0.367 . . . . 3.8500000000000001 110.009 179.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -137.66 96.45 3.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.001 0.429 . . . . 4.1799999999999997 110.017 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -136.47 134.28 37.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.82 -0.627 . . . . 6.6600000000000001 110.616 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -84.86 -17.17 38.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.423 0.63 . . . . 8.1300000000000008 109.475 173.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -151.91 127.81 10.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.222 -0.899 . . . . 10.050000000000001 109.109 -179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' H ' ' HE2' ' A' ' 64' ' ' LYS . 3.8 p-10 -73.14 160.8 31.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.687 0.279 . . . . 7.9400000000000004 110.633 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.572 HG13 ' H ' ' A' ' 67' ' ' ALA . 3.3 p -153.94 -60.7 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.168 -0.469 . . . . 9.3499999999999996 111.117 173.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.572 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 39.91 70.14 1.56 Allowed Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 123.131 0.573 . . . . 9.1600000000000001 111.804 -177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.33 -35.11 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.117 1.878 . . . . 10.35 113.212 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.8 m -115.03 -0.71 13.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.518 -0.31 . . . . 11.49 111.809 -173.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.8 m -136.21 149.79 48.71 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.66 -0.416 . . . . 10.949999999999999 111.455 -172.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -137.25 157.56 46.37 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.074 -1.084 . . . . 11.56 108.074 170.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.42 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 5.5 m 54.71 60.04 10.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 O-C-N 123.335 0.397 . . . . 10.960000000000001 110.413 -175.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HD3' ' N ' ' A' ' 72' ' ' SER . 14.6 Cg_exo -67.7 -73.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.555 2.17 . . . . 10.68 112.334 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -133.54 89.96 2.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.277 -0.42 . . . . 11.76 110.09 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 68.16 97.4 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.821 0.82 . . . . 10.0 112.653 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -120.64 114.2 21.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.36 -0.836 . . . . 7.5300000000000002 109.223 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -127.76 76.87 0.4 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.887 -1.149 . . . . 3.2000000000000002 111.49 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' ' HB2' ' A' ' 81' ' ' GLU . 41.0 tttp 60.18 34.5 21.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.668 0.747 . . . . 4.1399999999999997 109.037 -177.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' O ' HG23 ' A' ' 83' ' ' VAL . 20.2 t80 -63.24 -41.3 99.06 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.105 -0.952 . . . . 0.94999999999999996 112.109 -168.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -63.21 -34.67 78.14 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.73 0.644 . . . . 3.48 110.353 -176.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HB2' ' HG2' ' A' ' 78' ' ' LYS . 45.8 mt-10 -83.39 -31.47 26.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.254 -0.43 . . . . 3.0699999999999998 109.928 175.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.926 ' HA3' ' HG ' ' A' ' 88' ' ' LEU . . . -57.86 -41.04 93.92 Favored Glycine 0 N--CA 1.436 -1.329 0 CA-C-N 115.716 -0.675 . . . . 0.55000000000000004 112.119 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 79' ' ' PHE . 81.5 t -69.64 -51.02 45.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.698 -0.751 . . . . 0.84999999999999998 110.914 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.58 -22.29 40.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.566 . . . . 1.1200000000000001 111.688 -170.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.6 p -69.03 -33.68 74.0 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.845 -0.798 . . . . 1.8799999999999999 108.845 172.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 111' ' ' LYS . . . 87.55 18.95 55.95 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.246 -0.888 . . . . 1.6599999999999999 111.004 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -162.55 59.21 0.22 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.665 0.745 . . . . 2.0800000000000001 110.976 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.926 ' HG ' ' HA3' ' A' ' 82' ' ' GLY . 1.3 tt -64.76 84.79 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.371 -0.831 . . . . 0.56000000000000005 110.346 172.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.74 ' HA ' ' O ' ' A' ' 109' ' ' MET . 6.2 t30 -142.56 101.39 3.87 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.815 -0.439 . . . . 2.0099999999999998 109.815 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.2 t -159.16 154.85 26.14 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.949 0.404 . . . . 1.6699999999999999 110.267 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -112.66 131.71 55.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.593 -0.73 . . . . 3.9399999999999999 109.776 177.417 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -140.37 131.96 27.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.684 -0.689 . . . . 2.4700000000000002 109.812 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -101.13 116.8 33.68 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.87 -0.419 . . . . 1.97 109.87 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -108.89 132.36 54.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.625 -0.716 . . . . 4.29 109.978 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.1 p -100.47 151.69 21.25 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.848 -0.615 . . . . 2.8900000000000001 111.694 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.05 88.71 2.82 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.449 -0.574 . . . . 5.25 109.449 174.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.63 169.26 16.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.315 -0.857 . . . . 6.0599999999999996 111.137 -175.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 73.37 -40.4 0.47 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.277 -0.874 . . . . 9.7699999999999996 112.45 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -71.41 150.85 44.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.818 0.342 . . . . 8.3399999999999999 110.934 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.9 ttt -64.53 -37.3 87.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.854 -0.612 . . . . 8.1899999999999995 111.373 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.4 m -79.71 130.22 68.34 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.337 -0.392 . . . . 5.0999999999999996 110.264 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.05 42.21 1.16 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.856 2.371 . . . . 4.5099999999999998 112.222 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.53 ' HA ' ' OXT' ' A' ' 125' ' ' VAL . 43.7 m -64.89 98.87 0.3 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.461 0.648 . . . . 2.5899999999999999 111.136 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -103.31 130.1 50.5 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.738 -0.838 . . . . 3.1200000000000001 108.738 172.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.1 m -101.07 157.73 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-O 121.152 0.501 . . . . 1.23 110.398 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 123' ' ' LYS . 63.8 tttp -136.07 105.56 6.09 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.523 -0.762 . . . . 2.3599999999999999 109.157 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.537 ' HB ' ' SD ' ' A' ' 109' ' ' MET . 0.8 OUTLIER -96.71 144.93 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 CA-C-O 121.257 0.551 . . . . 1.1100000000000001 111.883 -178.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -135.4 103.92 5.66 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.778 -1.193 . . . . 1.01 107.778 162.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.74 ' O ' ' HA ' ' A' ' 89' ' ' ASN . 3.6 mpp? -92.31 143.94 25.89 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.234 -1.395 . . . . 2.2200000000000002 107.234 176.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 89' ' ' ASN . 13.3 ptpt -146.18 135.41 22.8 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.103 -1.039 . . . . 1.73 111.429 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.592 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 57.3 tttp -55.19 114.74 1.9 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.048 -0.978 . . . . 1.78 109.557 167.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 116' ' ' ASP . . . -49.35 139.24 11.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.076 -0.965 . . . . 0.45000000000000001 110.98 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 77.0 mt -65.83 -15.74 63.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.145 -0.48 . . . . 2.3900000000000001 110.871 -176.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.4 m -62.68 -57.36 11.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 1.6599999999999999 110.067 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.3 -74.03 0.1 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.245 -0.742 . . . . 1.52 111.245 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 9.0 t70 -93.76 -167.52 1.71 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.579 -0.897 . . . . 2.79 108.579 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.545 ' HA ' ' N ' ' A' ' 35' ' ' GLY . 37.0 p 60.4 155.67 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.47 1.108 . . . . 0.44 112.108 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.592 ' CD2' ' HA ' ' A' ' 111' ' ' LYS . 48.9 m-85 -136.55 138.36 41.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.53 -0.759 . . . . 0.41999999999999998 109.678 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.534 ' CD2' ' HB2' ' A' ' 32' ' ' GLN . 44.1 m95 -91.43 164.76 13.71 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.302 0.573 . . . . 0.41999999999999998 111.23 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.469 ' HB ' HG23 ' A' ' 31' ' ' ILE . 58.9 t -134.06 97.34 2.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.681 -1.145 . . . . 0.62 109.277 176.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -98.59 121.73 40.9 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.778 -0.823 . . . . 1.49 108.778 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.3 p -124.68 147.21 29.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.03 0.443 . . . . 1.6100000000000001 111.119 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 106' ' ' LYS . 51.6 mtpt -126.72 117.67 23.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.86 -0.609 . . . . 3.4500000000000002 109.468 175.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -114.53 156.11 25.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.822 0.344 . . . . 4.2300000000000004 110.61 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.53 ' OXT' ' HA ' ' A' ' 103' ' ' THR . 2.6 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.968 -1.015 . . . . 3.3399999999999999 110.128 172.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' HC4 . . . . . 0.986 ' O1 ' " H6'" ' A' ' 169' ' ' HC4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_